Citrus Sinensis ID: 003045
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 854 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.961 | 0.967 | 0.581 | 0.0 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.968 | 0.982 | 0.556 | 0.0 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.940 | 0.953 | 0.488 | 0.0 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.953 | 0.992 | 0.448 | 0.0 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.941 | 0.968 | 0.454 | 0.0 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.941 | 0.980 | 0.441 | 0.0 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.936 | 0.982 | 0.441 | 0.0 | |
| Q9SXB3 | 820 | G-type lectin S-receptor- | no | no | 0.941 | 0.980 | 0.453 | 0.0 | |
| O64770 | 804 | G-type lectin S-receptor- | no | no | 0.930 | 0.988 | 0.439 | 0.0 | |
| O64781 | 831 | G-type lectin S-receptor- | no | no | 0.942 | 0.968 | 0.439 | 0.0 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1000 bits (2585), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/857 (58%), Positives = 640/857 (74%), Gaps = 36/857 (4%)
Query: 14 ILLSFFLIVCSLAHFGRAVNTITKGQSIKDG---ESLISNGEIFELGFFSPENSSLRYVG 70
+ L FFL S+A NTI +G+S++DG + L+S + FELGFFSP +S+ R++G
Sbjct: 13 LFLYFFLYESSMA-----ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSN---ASVVSNN 127
IWY I++KAVVWVANR PISD+ G L I NDGNL++L+G +I VWSSN ++ +NN
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 128 TAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKS 187
+ D GN +L+ ++ + W+SFNHPTDT LP MRV VN G+N F SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDT----DRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIWEQLK-RRWRSGQWNSVIFTGVPTMATLTSFLFGFKL 246
+DPSPGN+++GVDP G+P+IV+WE K R+WRSGQWNS IFTG+P M+ LT++L+GFKL
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 247 S-PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYN 305
S P + GS+YFTYVP++ S LLRF++ ++G EE+LRW+ + KKW+ Q +P +C+ YN
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 306 FCGNFGICNALGSTK-CTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGG 364
CG FGIC+ GS C+C+ G+ EQ +GNWS GC RRT L+C+RN S G
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGY-----EQVSVGNWSRGCRRRTPLKCERNISV-----G 353
Query: 365 EDGFKVFKNVKLPDF--ADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVK 422
ED F K+VKLPDF + V E C+++CL+NCSCNAY+ + GIGCM+W +L+D++
Sbjct: 354 EDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQ 413
Query: 423 SFEKGGNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTIS 482
FE GG+ LH+RL DSE+G K AVI + V++G +L+G LLWRF+ S
Sbjct: 414 QFEAGGSSLHIRLADSEVGENRKTKIAVI-VAVLVGVILIGIFALLLWRFKRKKDVSGAY 472
Query: 483 CCKNNDTQLI--DMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEG 540
C KN DT ++ D++K +E ++ FSG D++++G VN ++L +F+ N IA+ATN F +
Sbjct: 473 CGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKE 532
Query: 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
N+LGRGGFGPV+KG L +G++IAVKRLS KSGQG++EFKNEIILIAKLQHRNLVRLLGCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+GEEKML+YEYMPNKSLD F+FD KQAL+DW RF+IIEGIARGLLYLHRDSRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDLK SN+LLD +MNPKISDFGMARIFG NQNEANT RVVGTYGYM+PEYAMEGLFSVKS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712
Query: 721 DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVL 780
DVYSFGVLLLEIVSG+RNTS R E+ SLI + W L+ G++ ELVDP IR + S+ + L
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL 772
Query: 781 RCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSM-RSSVDGDHFMEAHD 839
RCIHV MLCVQDSA RP MASV+LMLES+T TL PRQPTFTS R+S+D + +++
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832
Query: 840 --TVSSNDLTVTMVVGR 854
VSSN++T T+V+GR
Sbjct: 833 QYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 956 bits (2471), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/847 (55%), Positives = 611/847 (72%), Gaps = 20/847 (2%)
Query: 13 VILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIW 72
V L F +CS + N+ T+ +I++G+SLIS E FELGFF+P+NS+LRYVGIW
Sbjct: 11 VTTLLIFHQLCSNVSCSTS-NSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIW 69
Query: 73 YHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALL 132
Y I+ + VVWVANR +P+ D +G L I +DGNL+++NG + +WS+N SNNT A+L
Sbjct: 70 YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVL 129
Query: 133 EDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPS 192
G+L+L + D K YW+SFN+PTDT LPGMRV VN +LGENR F WKS SDPS
Sbjct: 130 FKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 193 PGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLS-PRES 251
PG ++MG+DP G+ +IVIWE KR+WRSG WNS IFTG+P M T++++GFKLS P +
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDR 246
Query: 252 DGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFG 311
DGS+YFTYV +++S LRF I DG EEQ RW+ + W+++Q +P+ +CE YN CGN+
Sbjct: 247 DGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYS 306
Query: 312 ICN---ALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGF 368
+C+ S KC+C++GF P H +QW ++S GC RR L C +++ +G EDGF
Sbjct: 307 VCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNC----NQSLVAGQEDGF 362
Query: 369 KVFKNVKLPDFADVV-SVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKG 427
V K +K+PDF VV ETCKD C ++CSC AYA + GIGCM+W +LID++ FE+G
Sbjct: 363 TVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLIDMEHFERG 422
Query: 428 GNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCCKNN 487
GN +++RL S+LGG + S I + VIGA LLG +W+LW+F+ K K
Sbjct: 423 GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLK---AFLWKKK 479
Query: 488 DTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGG 547
D + D+ + + D+S V+ G QV+ DL +F+F+++A AT F+E NKLG+GG
Sbjct: 480 DITVSDIIENR----DYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGG 535
Query: 548 FGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607
FG V+KG EG++IAVKRLS KS QGLEEFKNEI+LIAKLQHRNLVRLLGCCI+ EKM
Sbjct: 536 FGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKM 595
Query: 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667
L+YEYMPNKSLD F+FD +KQ LDW KR+ +I GIARGLLYLHRDSRL+IIHRDLKASN
Sbjct: 596 LLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASN 655
Query: 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGV 727
ILLD +MNPKISDFGMARIF + Q+ ANT RVVGTYGYMAPEYAMEG+FS KSDVYSFGV
Sbjct: 656 ILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGV 715
Query: 728 LLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGM 787
L+LEIVSGR+N SFR ++ SLI + W+LW++GK E++DP ++D+ + +RCIHVGM
Sbjct: 716 LILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGM 775
Query: 788 LCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLT 847
LC QDS ++RP M SV+LMLES+T LP PRQPTF S +S D + + HD S ND+T
Sbjct: 776 LCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVT 835
Query: 848 VTMVVGR 854
T +VGR
Sbjct: 836 FTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 773 bits (1995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/831 (48%), Positives = 538/831 (64%), Gaps = 28/831 (3%)
Query: 33 NTITKGQSIKDGES--LISNGEIFELGFFSPENSS--LRYVGIWYHQIDEKAVVWVANRN 88
+ IT IKD ES L+ IF GFF+P NS+ LRYVGIWY +I + VVWVAN++
Sbjct: 31 DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKD 90
Query: 89 RPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASV--VSNNTAALLEDDGNLILTNSEDI 146
PI+D G ++I DGNL V +G + VWS+N SV N T L D GNL+L +D
Sbjct: 91 SPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLML---QDN 147
Query: 147 GNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSP 206
N G+ W+SF HP D+ +P M +G + G N TSW S DPS GN+T G+ P P
Sbjct: 148 RNNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFP 207
Query: 207 QIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPANASY 266
+++IW+ WRSG WN +F G+P M +L FL GF L+ ++ G++ +Y AN S+
Sbjct: 208 ELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLL-FLDGFNLN-SDNQGTISMSY--ANDSF 263
Query: 267 LLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGICNALGSTKCTCMEG 326
+ F + +G Q W S + W + K P DC+ Y CG FG C+A + C C++G
Sbjct: 264 MYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKG 323
Query: 327 FVPKHFEQWRMGNWSAGCIRRTQLQC--QRNRSEAGESGGEDGFKVFKNVKLPDFADVVS 384
FVPK+ +W GNWS GC+R+ LQC QRN S G G DGF + +K+P A+
Sbjct: 324 FVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAERSE 383
Query: 385 VGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLLHVRLPDSELGGRS 444
++ C CL NCSC AYA GIGCMLW G+L+D++SF G L +R+ SEL S
Sbjct: 384 ASEQVCPKVCLDNCSCTAYAYDRGIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSELKTHS 443
Query: 445 KISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCCKNNDTQLIDMSKGQEISTDF 504
+ AV+ VIG +L+ A LL C+ D M K E T
Sbjct: 444 NL--AVMIAAPVIGVMLIAAVCVLL-----ACRKYKKRPAPAKDRSAELMFKRMEALT-- 494
Query: 505 SGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAV 564
SD +Q+ +L +F F +A +T+ FS NKLG+GGFGPV+KGKLPEGQ+IAV
Sbjct: 495 ---SDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAV 551
Query: 565 KRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD 624
KRLSRKSGQGLEE NE+++I+KLQHRNLV+LLGCCI+GEE+ML+YEYMP KSLD ++FD
Sbjct: 552 KRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFD 611
Query: 625 PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684
P KQ +LDW RF I+EGI RGLLYLHRDSRL+IIHRDLKASNILLDE++NPKISDFG+A
Sbjct: 612 PMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLA 671
Query: 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE 744
RIF N++EANT RVVGTYGYM+PEYAMEG FS KSDV+S GV+ LEI+SGRRN+S E
Sbjct: 672 RIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKE 731
Query: 745 ENS-SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803
EN+ +L+ + W LWN+G+A L DP + D + ++ +C+H+G+LCVQ+ A RP +++V
Sbjct: 732 ENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNV 791
Query: 804 VLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
+ ML +E +L P+QP F R + + + ++ VS ND+++T V GR
Sbjct: 792 IWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/860 (44%), Positives = 537/860 (62%), Gaps = 46/860 (5%)
Query: 1 MDIISNSKHPVSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFS 60
M + +S V +++LS F + SLA RA + + D E+++S+ F GFFS
Sbjct: 1 MRLHESSSPFVCILVLSCFFLSVSLAQ-ERAFFS----GKLNDSETIVSSFRTFRFGFFS 55
Query: 61 PENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSN 120
P NS+ RY GIWY+ + + V+WVAN+++PI+D G +++ DGNL+V +G +WS+N
Sbjct: 56 PVNSTSRYAGIWYNSVSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTN 115
Query: 121 ASV--VSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGE 178
S +N+T A L D GNL+L + L W+SF +PTD+ LP M VG N+ +G
Sbjct: 116 VSTQASANSTVAELLDSGNLVLKEASSDAYL----WESFKYPTDSWLPNMLVGTNARIGG 171
Query: 179 -NRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRR---WRSGQWNSVIFTGVPTM 234
N TSWKS SDPSPG++T + P++ I WRSG WN +F G+P +
Sbjct: 172 GNVTITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDV 231
Query: 235 ATLTSFLFGFKLSPRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQ 294
FL+ F ++ +++GS+ +Y AN S L F + + G+ + W + + W+V
Sbjct: 232 YA-GVFLYRFIVND-DTNGSVTMSY--ANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGL 287
Query: 295 KQPADDCELYNFCGNFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQR 354
+ PA +C+ Y CG F CN + C+C+ GF P++ +W GNWS GC RR LQC+R
Sbjct: 288 QVPATECDNYRRCGEFATCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCER 347
Query: 355 NRSEAGESGGEDGFKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLW 414
+ +G DGF + +KLPDFA + C CLQ CSC A A G GCM+W
Sbjct: 348 QNN----NGSADGFLRLRRMKLPDFARRSEASEPECLRTCLQTCSCIAAAHGLGYGCMIW 403
Query: 415 RGELIDVKSFEKGGNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRA 474
G L+D + G L++RL SE+ ++K ++ ++ G + + A+ LL R
Sbjct: 404 NGSLVDSQELSASGLDLYIRLAHSEI--KTKDKRPILIGTILAGGIFVVAACVLLARRIV 461
Query: 475 LCKDSTISCCKNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVAT 534
+ K + KG++ F + + G++ +L +F F +A AT
Sbjct: 462 MKKRAK--------------KKGRDAEQIFE-RVEALAGGNKGKLKELPLFEFQVLAAAT 506
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
N FS NKLG+GGFGPV+KGKL EGQ+IAVKRLSR SGQGLEE NE+++I+KLQHRNLV
Sbjct: 507 NNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLV 566
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+LLGCCI GEE+ML+YE+MP KSLD ++FD + LLDW RF II GI RGLLYLHRDS
Sbjct: 567 KLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDS 626
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
RLRIIHRDLKASNILLDE++ PKISDFG+ARIF N++EANT RVVGTYGYMAPEYAM G
Sbjct: 627 RLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGG 686
Query: 715 LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774
LFS KSDV+S GV+LLEI+SGRRN+ NS+L+ +VW++WNEG+ LVDP I D
Sbjct: 687 LFSEKSDVFSLGVILLEIISGRRNS------NSTLLAYVWSIWNEGEINSLVDPEIFDLL 740
Query: 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHF 834
+ ++ +CIH+G+LCVQ++A RP++++V ML SE +P P+QP F S + + +
Sbjct: 741 FEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFISRNNVPEAESS 800
Query: 835 MEAHDTVSSNDLTVTMVVGR 854
+ S N++T+T V GR
Sbjct: 801 ENSDLKDSINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/830 (45%), Positives = 531/830 (63%), Gaps = 26/830 (3%)
Query: 31 AVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRP 90
A + IT +D E+++SN F GFFSP NS+ RY GIW++ I + VVWVAN N P
Sbjct: 21 ATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSP 80
Query: 91 ISDERGTLTIGNDGNLMVLNGNSIAVWSSNA--SVVSNNTAALLEDDGNLILTNSEDIGN 148
I+D G ++I +GNL+V++G WS+N V +N A L + GNL+L + + G+
Sbjct: 81 INDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTNTGD 140
Query: 149 LGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQI 208
+ W+SF HP + +LP M + ++ G + SWKS DPSPG ++ G+ P P++
Sbjct: 141 --EILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPEL 198
Query: 209 VIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPANASYLL 268
V+W+ WRSG WN F G+P M + LF LS ++ GS+ +Y A + L
Sbjct: 199 VVWKDDLLMWRSGPWNGQYFIGLPNMDYRIN-LFELTLS-SDNRGSVSMSY--AGNTLLY 254
Query: 269 RFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGIC--NALGSTKCTCMEG 326
F + +G+ Q W+ + ++W K P+ C+ Y CG F C N + C C+ G
Sbjct: 255 HFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRG 314
Query: 327 FVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFKNVKLPDFADVVSVG 386
F P+ + +W GNW+ GC+R+ LQC+ + G S DGF + +K+P
Sbjct: 315 FKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDG-SRKSDGFVRVQKMKVPHNPQRSGAN 373
Query: 387 QETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLLHVRLPDSELGGRSKI 446
++ C + CL+NCSC AY+ GIGC+LW G L+D++ F G + ++RL DSE R+
Sbjct: 374 EQDCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNR 433
Query: 447 SNAVIAIIVVIGALLLGASVWL-LWRFRALCKDSTISCCKNNDTQLIDMSKGQEISTDFS 505
S VI + +++GA L +V L LW+ + KN +T+L++ + + +S++
Sbjct: 434 S-IVITVTLLVGAFLFAGTVVLALWKIAKHRE-------KNRNTRLLN-ERMEALSSNDV 484
Query: 506 GPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVK 565
G + +Q +L +F F +AVATN FS NKLG+GGFG V+KG+L EG DIAVK
Sbjct: 485 G----AILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVK 540
Query: 566 RLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDP 625
RLSR SGQG+EEF NE+++I+KLQHRNLVRLLG CI+GEE+ML+YE+MP LD ++FDP
Sbjct: 541 RLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDP 600
Query: 626 AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685
KQ LLDW RF II+GI RGL+YLHRDSRL+IIHRDLKASNILLDE++NPKISDFG+AR
Sbjct: 601 VKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLAR 660
Query: 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE- 744
IF N++E +T RVVGTYGYMAPEYAM GLFS KSDV+S GV+LLEIVSGRRN+SF +
Sbjct: 661 IFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDG 720
Query: 745 ENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+N +L + W LWN G+ + LVDP I + +N++ RC+HVG+LCVQD A RP++A+V+
Sbjct: 721 QNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVI 780
Query: 805 LMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
ML SE LP P+QP F R + + + ++ S N++++T + GR
Sbjct: 781 WMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/850 (44%), Positives = 530/850 (62%), Gaps = 46/850 (5%)
Query: 11 VSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVG 70
V V+ LS F + SLAH RA+ + T + D E+++S+ F GFFSP NS+ RY G
Sbjct: 11 VHVLSLSCFFLSVSLAH-ERALFSGT----LNDSETIVSSFRTFRFGFFSPVNSTNRYAG 65
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASV--VSNNT 128
IWY+ I + V+WVAN++ PI+D G ++I DGNL+V +G +WS+N S +N+T
Sbjct: 66 IWYNSIPVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANST 125
Query: 129 AALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGE-NRVFTSWKS 187
A L + GNL+L ++ N W+SF +PTD+ LP M VG N+ G N TSW +
Sbjct: 126 VAELLESGNLVLKDA----NTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTN 181
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIW---EQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGF 244
SDPSPG++T + P++ I+ + WRSG WN ++F G+P + FL+ F
Sbjct: 182 PSDPSPGSYTAALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYP-GLFLYRF 240
Query: 245 KLSPRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELY 304
K++ +++GS +Y AN S L + + G + W + + W++ + PA +C++Y
Sbjct: 241 KVND-DTNGSATMSY--ANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIY 297
Query: 305 NFCGNFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGG 364
+ CG + CN + C+C++GF P++ +W GNWS GCIR+ LQC+R ++ G
Sbjct: 298 SRCGQYTTCNPRKNPHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQNNK----GS 353
Query: 365 EDGFKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSF 424
D F + +K+PDFA + C CLQ+CSC A+A G GCM+W L+D +
Sbjct: 354 ADRFLKLQRMKMPDFARRSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNRSLVDSQVL 413
Query: 425 EKGGNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCC 484
G L +RL SE +++ ++ + G + + A+ LL R + K +
Sbjct: 414 SASGMDLSIRLAHSEF--KTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAK---- 467
Query: 485 KNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLG 544
KG + F + + GS+ +L +F F +A AT+ FS NKLG
Sbjct: 468 ----------KKGTDAEQIFKR-VEALAGGSREKLKELPLFEFQVLATATDNFSLSNKLG 516
Query: 545 RGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604
+GGFGPV+KG L EGQ+IAVKRLS+ SGQGLEE E+++I+KLQHRNLV+L GCCI GE
Sbjct: 517 QGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQHRNLVKLFGCCIAGE 576
Query: 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664
E+ML+YE+MP KSLD +IFDP + LLDW RF II GI RGLLYLHRDSRLRIIHRDLK
Sbjct: 577 ERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYLHRDSRLRIIHRDLK 636
Query: 665 ASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYS 724
ASNILLDE++ PKISDFG+ARIF N++EANT RVVGTYGYMAPEYAM GLFS KSDV+S
Sbjct: 637 ASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGLFSEKSDVFS 696
Query: 725 FGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIH 784
GV+LLEI+SGRRN+ +S+L+ HVW++WNEG+ +VDP I D + ++ +C+H
Sbjct: 697 LGVILLEIISGRRNS------HSTLLAHVWSIWNEGEINGMVDPEIFDQLFEKEIRKCVH 750
Query: 785 VGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSN 844
+ +LCVQD+A RP++++V +ML SE +P P+QP F ++ + S N
Sbjct: 751 IALLCVQDAANDRPSVSTVCMMLSSEVADIPEPKQPAFMPRNVGLEAEFSESIALKASIN 810
Query: 845 DLTVTMVVGR 854
++T+T V GR
Sbjct: 811 NVTITDVSGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/842 (44%), Positives = 509/842 (60%), Gaps = 42/842 (4%)
Query: 16 LSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQ 75
L F LI+ F IT+ + G++L S +ELGFFSP NS +YVGIW+
Sbjct: 12 LLFLLIIFPSCAFA----AITRASPLSIGQTLSSPNGTYELGFFSPNNSRNQYVGIWFKN 67
Query: 76 IDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDD 135
I + VVWVANR++P+++ LTI ++G+L+++ VWS + SN A L ++
Sbjct: 68 ITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIGETFSSNELRAELLEN 127
Query: 136 GNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGN 195
GNL+L + NL W+SF H DT L V + + RV +SWK+ +DPSPG
Sbjct: 128 GNLVLIDGVSERNL----WESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSPGE 183
Query: 196 FTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSM 255
F + Q PQ I + WR G W V FTG+P M S + F +S + G+
Sbjct: 184 FVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDG--SHVSKFDISQDVAAGTG 241
Query: 256 YFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGICNA 315
TY + L + ++ W+ + W + P C++YN CG FG+C
Sbjct: 242 SLTYSLERRNSNLSYTTLTSAGSLKIIWN-NGSGWVTDLEAPVSSCDVYNTCGPFGLCIR 300
Query: 316 LGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFKNVK 375
KC C++GFVPK E+W NW+ GC+RRT L C N S ++ D F + NVK
Sbjct: 301 SNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANVK 360
Query: 376 LPDFADVVS-VGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLLHVR 434
PDF + +S + +E C+ +CL NCSC A++ I IGC++W EL+DV F GG L +R
Sbjct: 361 PPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELVDVMQFVAGGETLSIR 420
Query: 435 LPDSELGGRSKISNAVIAIIVV-IGALLLGASVWLLWRFRALCKDSTISCCKNNDTQLID 493
L SEL G +++ V +I+ + + +L+ AS W WR++A K ND+ I
Sbjct: 421 LASSELAGSNRVKIIVASIVSISVFMILVFASYWY-WRYKA----------KQNDSNPIP 469
Query: 494 MSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHK 553
+ Q+ + Q+ D+ F+ TI TN FS NKLG+GGFGPV+K
Sbjct: 470 LETSQDAWRE------------QLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYK 517
Query: 554 GKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613
G L +G++IA+KRLS SGQGLEEF NEIILI+KLQHRNLVRLLGCCI+GEEK+LIYE+M
Sbjct: 518 GNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFM 577
Query: 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED 673
NKSL+ FIFD K+ LDW KRF II+GIA GLLYLHRDS LR++HRD+K SNILLDE+
Sbjct: 578 ANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEE 637
Query: 674 MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIV 733
MNPKISDFG+AR+F Q++ANT RVVGT GYM+PEYA G+FS KSD+Y+FGVLLLEI+
Sbjct: 638 MNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEII 697
Query: 734 SGRRNTSFRL-EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQD 792
+G+R +SF + EE +L+E W+ W E +L+D +I S S+++V RC+ +G+LC+Q
Sbjct: 698 TGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQ 757
Query: 793 SAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVV 852
A RP +A V+ ML + T LP P+QP F D E+ S N++T T +V
Sbjct: 758 QAGDRPNIAQVMSML-TTTMDLPKPKQPVFAMQVQESDS----ESKTMYSVNNITQTAIV 812
Query: 853 GR 854
GR
Sbjct: 813 GR 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB3|Y1112_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11280 OS=Arabidopsis thaliana GN=At1g11280 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 691 bits (1782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/853 (45%), Positives = 517/853 (60%), Gaps = 49/853 (5%)
Query: 11 VSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVG 70
+ ++L +FL + G A TI+ ++ G++L S G +ELGFFSP NS +YVG
Sbjct: 8 IGIVLFPWFLWLSLFLSCGYAAITISSPLTL--GQTLSSPGGFYELGFFSPNNSQNQYVG 65
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAA 130
IW+ +I + VVWVANR +PI+ LTI +G+L++L+ + VWS+ +SN A
Sbjct: 66 IWFKKITPRVVVWVANREKPITTPVANLTISRNGSLILLDSSKNVVWSTRRPSISNKCHA 125
Query: 131 LLEDDGNLILTN--SEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSA 188
L D GNL++ + SE++ WQSF +P DT LP + N A GE RV +SWKS
Sbjct: 126 KLLDTGNLVIVDDVSENL------LWQSFENPGDTMLPYSSLMYNLATGEKRVLSSWKSH 179
Query: 189 SDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSP 248
+DPSPG+F + + PQ QIV RSG W FTGVP M S+ F LS
Sbjct: 180 TDPSPGDFVVRLTPQVPAQIVTMRGSSVYKRSGPWAKTGFTGVPLMDE--SYTSPFSLSQ 237
Query: 249 RESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCG 308
+G+ F+Y+ +S L R I +G + R++G+ W + PA+ C+LY CG
Sbjct: 238 DVGNGTGLFSYL-QRSSELTRVIITSEGYLKTFRYNGTG--WVLDFITPANLCDLYGACG 294
Query: 309 NFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGF 368
FG+C TKC CM+GFVPK+ E+W+ GN ++GC+RRT+L CQ N S + G D F
Sbjct: 295 PFGLCVTSNPTKCKCMKGFVPKYKEEWKRGNMTSGCMRRTELSCQANLSTKTQGKGVDVF 354
Query: 369 KVFKNVKLPDFADVVS-VGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKG 427
NVK PD + S V + C CL NCSC+A+A I GIGC+LW ELID + G
Sbjct: 355 YRLANVKPPDLYEYASFVDADQCHQGCLSNCSCSAFAYITGIGCLLWNHELIDTIRYSVG 414
Query: 428 GNLLHVRLPDSELGG--RSKISNAVIAIIVVIGALLLGASVWLLWRFRALCK-DSTISCC 484
G L +RL SEL G R+KI I++ + + +L + WR+RA T +
Sbjct: 415 GEFLSIRLASSELAGSRRTKIIVGSISLSIFV---ILAFGSYKYWRYRAKQNVGPTWAFF 471
Query: 485 KNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLG 544
N+ + + QEIS L F NTI ATN F+ NKLG
Sbjct: 472 NNSQDSWKNGLEPQEIS-------------------GLTFFEMNTIRAATNNFNVSNKLG 512
Query: 545 RGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604
+GGFGPV+KG L + +DIAVKRLS SGQG EEF NEI LI+KLQHRNLVRLLGCCI GE
Sbjct: 513 QGGFGPVYKGTLSDKKDIAVKRLSSSSGQGTEEFMNEIKLISKLQHRNLVRLLGCCIDGE 572
Query: 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664
EK+LIYE++ NKSLD F+FD + +DW KRF II+G++RGLLYLHRDS +R+IHRDLK
Sbjct: 573 EKLLIYEFLVNKSLDTFLFDLTLKLQIDWPKRFNIIQGVSRGLLYLHRDSCMRVIHRDLK 632
Query: 665 ASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYS 724
SNILLD+ MNPKISDFG+AR+F Q++ NT +VVGT GYM+PEYA G+FS KSD+Y+
Sbjct: 633 VSNILLDDKMNPKISDFGLARMFQGTQHQDNTRKVVGTLGYMSPEYAWTGMFSEKSDIYA 692
Query: 725 FGVLLLEIVSGRRNTSFRL-EENSSLIEHVWNLWNEGKAMELVDPNIRDSSS--QNQVLR 781
FGVLLLEI+SG++ +SF EE +L+ H W W E ++L+D +I S S + +V R
Sbjct: 693 FGVLLLEIISGKKISSFCCGEEGKTLLGHAWECWLETGGVDLLDEDISSSCSPVEVEVAR 752
Query: 782 CIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTV 841
C+ +G+LC+Q A+ RP +A VV M+ S T LP P+QP F D +
Sbjct: 753 CVQIGLLCIQQQAVDRPNIAQVVTMMTSAT-DLPRPKQPLFALQIQ----DQESVVSVSK 807
Query: 842 SSNDLTVTMVVGR 854
S N +T T + GR
Sbjct: 808 SVNHVTQTEIYGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/846 (43%), Positives = 505/846 (59%), Gaps = 51/846 (6%)
Query: 13 VILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIW 72
++ + L+ L F A IT + ++L S+ I+ELGFFSP NS YVGIW
Sbjct: 6 IVFFACLLLFTVLLRFSYA--GITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIW 63
Query: 73 YHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALL 132
+ I + VVWVANR P +D L I ++G+L++ NG VWS + SN + A L
Sbjct: 64 FKGIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIGENFASNGSRAEL 123
Query: 133 EDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPS 192
D+GNL++ ++ G+ W+SF H DT LP + N A GE RV TSWK+ +DPS
Sbjct: 124 TDNGNLVVIDNAS----GRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPS 179
Query: 193 PGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESD 252
PG F + PQ Q++I R +R+G W FTG+P M + F + ++++
Sbjct: 180 PGVFVGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQ---QDAN 236
Query: 253 GSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGI 312
GS +FTY + L R I +G+ ++ R +G+ W + PA+ C++Y CG FG+
Sbjct: 237 GSGFFTYFDRSFK-LSRIIISSEGSMKRFRHNGT--DWELSYMAPANSCDIYGVCGPFGL 293
Query: 313 CNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDG--FKV 370
C KC C++GFVP E+W+ GNW+ GC R T+L CQ G S G+D F
Sbjct: 294 CIVSVPLKCKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQ------GNSTGKDVNIFHP 347
Query: 371 FKNVKLPDFADV-VSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGN 429
NVKLPDF + SV E C CL NCSC A+A I GIGC++W L+D F GG
Sbjct: 348 VTNVKLPDFYEYESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQNLMDAVQFSAGGE 407
Query: 430 LLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCCKNNDT 489
+L +RL SELGG + V + + + ++L ++ + WR+R K T+ ND
Sbjct: 408 ILSIRLAHSELGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDL 467
Query: 490 QLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFG 549
K +E+ L F NTI ATN FS NKLG+GGFG
Sbjct: 468 ------KSKEVP-------------------GLEFFEMNTIQTATNNFSLSNKLGQGGFG 502
Query: 550 PVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609
V+KGKL +G++IAVK+LS SGQG EEF NEI+LI+KLQHRNLVR+LGCCI+GEEK+LI
Sbjct: 503 SVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLI 562
Query: 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669
YE+M NKSLD F+FD K+ +DW KRF I++GIARGLLYLHRDSRL++IHRDLK SNIL
Sbjct: 563 YEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNIL 622
Query: 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
LDE MNPKISDFG+AR++ Q + T RVVGT GYM+PEYA G+FS KSD+YSFGVLL
Sbjct: 623 LDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLL 682
Query: 730 LEIVSGRRNTSFRL-EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGML 788
LEI+ G + + F EE +L+ + W W E K ++L+D ++ DS +V RC+ +G+L
Sbjct: 683 LEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLL 742
Query: 789 CVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTV 848
CVQ RP ++ ML + T LP P+QPTF D + D + N++T
Sbjct: 743 CVQHQPADRPNTLELLAML-TTTSDLPSPKQPTFVVHSRD---DESSLSKDLFTVNEMTQ 798
Query: 849 TMVVGR 854
+M++GR
Sbjct: 799 SMILGR 804
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/845 (43%), Positives = 507/845 (60%), Gaps = 40/845 (4%)
Query: 13 VILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIW 72
+++ + L++ FG A I + G++L S ++ELGFFSP NS +YVGIW
Sbjct: 24 MVIFACLLLLIIFPTFGYA--DINTSSPLSIGQTLSSPDGVYELGFFSPNNSRKQYVGIW 81
Query: 73 YHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALL 132
+ I + VVWVANR++P++ LTI ++G+L++L+G +WS+ + SN A L
Sbjct: 82 FKNIAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEAFTSNKCHAEL 141
Query: 133 EDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPS 192
D GNL++ +D+ GK W+SF + +T LP V + G+NRV TSW+S SDPS
Sbjct: 142 LDTGNLVVI--DDVS--GKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPS 197
Query: 193 PGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESD 252
PG FT+ PQ PQ +I WRSG W F+G+P + S++ F + +
Sbjct: 198 PGEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDA--SYVSPFTVLQDVAK 255
Query: 253 GSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGI 312
G+ F+Y L + +G + L DG K W + + P C+LY CG FG+
Sbjct: 256 GTASFSYSMLRNYKLSYVTLTSEGKMKILWNDG--KSWKLHFEAPTSSCDLYRACGPFGL 313
Query: 313 CNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFK 372
C + KC C++GFVPK ++W+ GNW++GC+RRTQL C N S + D F
Sbjct: 314 CVRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMT 373
Query: 373 NVKLPDFADVVS-VGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLL 431
VK PD + + E C CL NCSC A+A I GIGC++W EL+D F G L
Sbjct: 374 RVKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNRELVDTVQFLSDGESL 433
Query: 432 HVRLPDSELGG--RSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCCKNNDT 489
+RL SEL G R+KI + + L+ A + WR+R K N+
Sbjct: 434 SLRLASSELAGSNRTKIILGTTVSLSIFVILVFAA--YKSWRYRT----------KQNEP 481
Query: 490 QLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFG 549
+ + Q+ P D V+G +L F+ +TI ATN FS NKLG+GGFG
Sbjct: 482 NPMFIHSSQDAWAKDMEPQD-------VSGVNL--FDMHTIRTATNNFSSSNKLGQGGFG 532
Query: 550 PVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609
PV+KGKL +G++IAVKRLS SGQG +EF NEI LI+KLQH+NLVRLLGCCI+GEEK+LI
Sbjct: 533 PVYKGKLVDGKEIAVKRLSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLI 592
Query: 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669
YEY+ NKSLD+F+FD + +DW KRF II+G+ARGLLYLHRDSRLR+IHRDLK SNIL
Sbjct: 593 YEYLVNKSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNIL 652
Query: 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
LDE M PKISDFG+AR+ Q + NT RVVGT GYMAPEYA G+FS KSD+YSFGVLL
Sbjct: 653 LDEKMIPKISDFGLARMSQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLL 712
Query: 730 LEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLC 789
LEI+ G + + F EE +L+ + W W E K ++L+D + DSS +V RC+ +G+LC
Sbjct: 713 LEIIIGEKISRFS-EEGKTLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLC 771
Query: 790 VQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVT 849
VQ RP ++ ML + LP P+QPTFT S D D ++D ++ N++T +
Sbjct: 772 VQHQPADRPNTLELMSML-TTISELPSPKQPTFTV--HSRDDDS--TSNDLITVNEITQS 826
Query: 850 MVVGR 854
++ GR
Sbjct: 827 VIQGR 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 854 | ||||||
| 224076566 | 833 | predicted protein [Populus trichocarpa] | 0.962 | 0.986 | 0.665 | 0.0 | |
| 224076584 | 815 | predicted protein [Populus trichocarpa] | 0.941 | 0.986 | 0.671 | 0.0 | |
| 224114149 | 805 | predicted protein [Populus trichocarpa] | 0.942 | 1.0 | 0.631 | 0.0 | |
| 359496542 | 882 | PREDICTED: G-type lectin S-receptor-like | 0.988 | 0.956 | 0.640 | 0.0 | |
| 255567483 | 849 | S-locus-specific glycoprotein S6 precurs | 0.949 | 0.955 | 0.646 | 0.0 | |
| 15234429 | 849 | S-locus lectin protein kinase-like prote | 0.961 | 0.967 | 0.581 | 0.0 | |
| 110738232 | 849 | serine/threonine kinase - like protein [ | 0.961 | 0.967 | 0.579 | 0.0 | |
| 449434360 | 2802 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.296 | 0.579 | 0.0 | |
| 449524266 | 856 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.974 | 0.581 | 0.0 | |
| 312162749 | 849 | unknown [Arabidopsis lyrata] | 0.964 | 0.970 | 0.567 | 0.0 |
| >gi|224076566|ref|XP_002304962.1| predicted protein [Populus trichocarpa] gi|222847926|gb|EEE85473.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1127 bits (2914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/832 (66%), Positives = 670/832 (80%), Gaps = 10/832 (1%)
Query: 25 LAHFGRAVN-TITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVW 83
LA F A N T+T GQS+KDGESLIS E FELGFFSP NSSLRY GI Y++I ++A +W
Sbjct: 10 LAPFCHAANNTLTIGQSLKDGESLISVDENFELGFFSPGNSSLRYCGIRYYKIRDQAAIW 69
Query: 84 VANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNS 143
VANR +PIS G L IG DGNL+V +GN VWSSN SVVSNNTAA+L+ GNLIL+++
Sbjct: 70 VANREKPISGSNGVLRIGEDGNLLVTDGNGSPVWSSNTSVVSNNTAAMLDTTGNLILSSN 129
Query: 144 EDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQ 203
+ IG KAYWQSFN+PTDT+LP M+V ++SA E FTSWKSA+DPSPGNFTMGVDP+
Sbjct: 130 DSIGETDKAYWQSFNNPTDTYLPHMKVLISSA--EIHAFTSWKSANDPSPGNFTMGVDPR 187
Query: 204 GSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPAN 263
G+PQIVIWE+ +RRWRSG WN +IF+GVP M LT++ +GFK++ RESDG Y TY P++
Sbjct: 188 GAPQIVIWERSRRRWRSGHWNGLIFSGVPYMTALTTYRYGFKVT-RESDGKFYLTYNPSD 246
Query: 264 ASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGICNALGSTKCTC 323
+S L+RF+I W+G EEQ RW+ SAK W V+Q QP+++CE YN+CGNFG+C + GS KC C
Sbjct: 247 SSELMRFQITWNGFEEQKRWNESAKTWQVMQSQPSEECENYNYCGNFGVCTSSGSPKCRC 306
Query: 324 MEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFKNVKLPDFADVV 383
MEGF P+H +QWR+GNWS GC RR+ LQCQRN S SGGEDGFK + KLPDFADV
Sbjct: 307 MEGFEPRHPDQWRLGNWSGGCGRRSPLQCQRNTS----SGGEDGFKTLRGSKLPDFADVE 362
Query: 384 SVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLLHVRLPDSELGGR 443
S+ + C++ CL NCSC AYA + I CM+W G+LIDV+ F +GGN L+VRL DSELG R
Sbjct: 363 SISLDACREMCLNNCSCKAYAHVSQIQCMIWNGDLIDVQHFVEGGNTLYVRLADSELG-R 421
Query: 444 SKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCCKNN-DTQLIDMSKGQEIST 502
+++ VI +IV+ G L S+WLLW + K +T +C + + + D+SK +E ST
Sbjct: 422 NRMPTYVIILIVLAGLAFLAISIWLLWMLKKRLKAATSACTSSKCELPVYDLSKSKEYST 481
Query: 503 DFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI 562
D SG +D++ +GSQVNG+DL MFNFN +A AT+ FSE NKLG+GGFG V+KG LP G++I
Sbjct: 482 DASGSADLLKEGSQVNGSDLPMFNFNCLAAATDNFSEDNKLGQGGFGLVYKGTLPGGEEI 541
Query: 563 AVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI 622
AVKRLS+ SGQGL+EFKNEIILIAKLQHRNLVRLLGC IQG+EKMLIYEYMPNKSLD F+
Sbjct: 542 AVKRLSKISGQGLQEFKNEIILIAKLQHRNLVRLLGCSIQGDEKMLIYEYMPNKSLDYFL 601
Query: 623 FDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682
FDP KQALLDW+KRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE+MNPKISDFG
Sbjct: 602 FDPEKQALLDWSKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEEMNPKISDFG 661
Query: 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742
MARIFG NQ+E NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR
Sbjct: 662 MARIFGGNQSEINTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 721
Query: 743 LEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMAS 802
E LI + W+LWNEGKAM++VD +IRDS + +VLRCI +GMLCVQDSA++RP MAS
Sbjct: 722 QTERMILIAYAWDLWNEGKAMDIVDLSIRDSCDEKEVLRCIQIGMLCVQDSALHRPNMAS 781
Query: 803 VVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
VV+MLES T ++P+PRQPTFTS+R+S+D + +E + SS+DLTV +V GR
Sbjct: 782 VVVMLESSTTSIPLPRQPTFTSVRASIDPEISLEVQEVASSSDLTVKVVAGR 833
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076584|ref|XP_002304965.1| predicted protein [Populus trichocarpa] gi|222847929|gb|EEE85476.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1126 bits (2912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/814 (67%), Positives = 655/814 (80%), Gaps = 10/814 (1%)
Query: 25 LAHFGRAVN-TITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVW 83
LA F A N T+T GQS+KDGESLIS E FELGFFSP NSSLRY GI Y++I ++A +W
Sbjct: 10 LAPFCHAANNTLTIGQSLKDGESLISVDENFELGFFSPGNSSLRYCGIRYYKIRDQAAIW 69
Query: 84 VANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNS 143
VANR +PIS G L IG DGNL+V +GN VWSSNASVVSNNTAA+L+ GNLIL+++
Sbjct: 70 VANREKPISGSNGVLRIGEDGNLLVTDGNGSPVWSSNASVVSNNTAAMLDTTGNLILSSN 129
Query: 144 EDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQ 203
+ IG KAYWQSFN+PTDT+LP M+V V++A E VFTSWKSA+DPSPGNFTMGVDP+
Sbjct: 130 DSIGETDKAYWQSFNNPTDTYLPHMKVLVSTA--EIHVFTSWKSANDPSPGNFTMGVDPR 187
Query: 204 GSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPAN 263
G+PQIV+WE +RRWRSG WN +IF+GVP M T++ +GFK SP ESDG+ Y TY P++
Sbjct: 188 GTPQIVVWEGSRRRWRSGHWNGIIFSGVPYMKAFTTYQYGFKFSP-ESDGNFYVTYNPSD 246
Query: 264 ASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGICNALGSTKCTC 323
S LRF+I W+G EE +W+ SAK W VIQ QP+++CE YN+CGNFG+C GS KC C
Sbjct: 247 NSEFLRFQITWNGFEETKKWNESAKTWQVIQAQPSEECENYNYCGNFGVCTPSGSPKCRC 306
Query: 324 MEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFKNVKLPDFADVV 383
MEGF P+H +QWR+GNWS GC RR+ LQCQRN S SGGEDGFK + +KLPDFADV
Sbjct: 307 MEGFEPRHPDQWRLGNWSGGCGRRSPLQCQRNTS----SGGEDGFKTVRCMKLPDFADVK 362
Query: 384 SVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLLHVRLPDSELGGR 443
S+ + C+++CL NCSC AYA + I CM+W G+LIDV+ F +GGN L+VRL DSELG R
Sbjct: 363 SISLDACRERCLNNCSCKAYAHVSEIQCMIWNGDLIDVQHFVEGGNTLYVRLADSELG-R 421
Query: 444 SKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISCCKNN-DTQLIDMSKGQEIST 502
+++ VI +IV+ G L S+WLLW + K +T +C + + + D+SK +E ST
Sbjct: 422 NRMPTYVIILIVLAGLAFLAISIWLLWMLKKRLKAATSACTSSKCELPVYDLSKSKEYST 481
Query: 503 DFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI 562
D SG +D++ +GSQVNG+DL MFNFN +A AT+ FSE NKLG+GGFG V+KGKLP G++I
Sbjct: 482 DASGSADLLKEGSQVNGSDLPMFNFNCLAAATDNFSEENKLGQGGFGLVYKGKLPGGEEI 541
Query: 563 AVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI 622
AVKRLS SGQGL EFKNEIILIAKLQHRNLVRLLGC IQG+EKMLIYEYMPNKSLD F+
Sbjct: 542 AVKRLSNISGQGLLEFKNEIILIAKLQHRNLVRLLGCSIQGDEKMLIYEYMPNKSLDYFL 601
Query: 623 FDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682
FDP KQALLDW+KRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE+MNPKISDFG
Sbjct: 602 FDPEKQALLDWSKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEEMNPKISDFG 661
Query: 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742
MARIFG NQ+E NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR
Sbjct: 662 MARIFGGNQSEINTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 721
Query: 743 LEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMAS 802
E LI + W+LWNEGK ME+VDP+IRDS +N+VLRCI +GMLCVQDSA++RP+MAS
Sbjct: 722 QTERMILIAYAWDLWNEGKTMEIVDPSIRDSCDENEVLRCIQIGMLCVQDSALHRPSMAS 781
Query: 803 VVLMLESETPTLPVPRQPTFTSMRSSVDGDHFME 836
VV+MLES T +P+PRQP FTS+R+S+D + +E
Sbjct: 782 VVVMLESCTTNIPLPRQPNFTSVRASIDPEISLE 815
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114149|ref|XP_002316681.1| predicted protein [Populus trichocarpa] gi|222859746|gb|EEE97293.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1110 bits (2871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/852 (63%), Positives = 654/852 (76%), Gaps = 47/852 (5%)
Query: 3 IISNSKHPVSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPE 62
+I+ S+ PV V S + S A NT+TKGQSIKDGE+LIS E FELGFFSP
Sbjct: 1 MITMSRSPVIVFFFSLLFLAPSCH---AATNTLTKGQSIKDGETLISVDENFELGFFSPG 57
Query: 63 NSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNAS 122
NS+ RYVG+ Y +I ++AV+WVANR++PIS G L IG DGNLMV++GN +VWSSNAS
Sbjct: 58 NSTSRYVGVRYSKIQDQAVIWVANRDKPISGTDGVLRIGEDGNLMVVDGNGSSVWSSNAS 117
Query: 123 VVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVF 182
VS+NT +L+ GNLIL++++ IG+ KAYWQSFN+PTDT+LP M+V + SA E F
Sbjct: 118 FVSSNTTLMLDTTGNLILSSNDSIGDTDKAYWQSFNNPTDTYLPNMKVLIGSA--EIHAF 175
Query: 183 TSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLF 242
TSWKS SDPSPGNFTMGVDP+G+PQIV+WEQ +RRWRSG WN+ IF+GVP+MA LT++ +
Sbjct: 176 TSWKSTSDPSPGNFTMGVDPRGAPQIVVWEQSRRRWRSGHWNAQIFSGVPSMAALTTYRY 235
Query: 243 GFKLSPRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCE 302
GFK++P +DG Y TY P++ S L++F+I W+G EEQ RW+ S K W VIQ QP+++CE
Sbjct: 236 GFKVTP-GNDGKFYLTYNPSDPSELMKFQITWNGFEEQQRWNESTKAWQVIQSQPSEECE 294
Query: 303 LYNFCGNFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGES 362
YN CGNFG+C GS C C+EGF P+H +QWR+GN S GC RR+ LQCQRN S +
Sbjct: 295 KYNHCGNFGVCTPSGSPNCRCLEGFQPRHPDQWRLGNLSGGCERRSPLQCQRNTS----N 350
Query: 363 GGEDGFKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVK 422
GGEDGFK + KLPDFADV + + CK C NCSC AYA + GI CM+W G+L DV+
Sbjct: 351 GGEDGFKAVRCTKLPDFADVYQLSSDDCKKWCQNNCSCKAYAHVTGIQCMIWNGDLTDVQ 410
Query: 423 SFEKGGNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTIS 482
+ + GN L++RL SEL + +S
Sbjct: 411 NHMQSGNTLYMRLAYSELATSASMST---------------------------------- 436
Query: 483 CCKNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNK 542
N++ Q+ D+S+ +E +TD SGP D+V++GSQVNG DL MFNFN +A ATN FSE NK
Sbjct: 437 ---NHELQVYDLSRSKEYTTDLSGPGDLVLEGSQVNGPDLPMFNFNFVAAATNNFSEENK 493
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ 602
LG+GGFG V+KGKLP G++IAVKRLS+ SGQGL+EFKNEIILIAKLQHRNLVRLLGC IQ
Sbjct: 494 LGQGGFGHVYKGKLPGGEEIAVKRLSKISGQGLQEFKNEIILIAKLQHRNLVRLLGCSIQ 553
Query: 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRD 662
G+EKMLIYEYMPNKSLD F+FDP KQ LL+W KRF IIEGIARGLLYLHRDSRLRIIHRD
Sbjct: 554 GDEKMLIYEYMPNKSLDYFLFDPEKQGLLEWNKRFEIIEGIARGLLYLHRDSRLRIIHRD 613
Query: 663 LKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDV 722
LKASNILLDE MNPKISDFGMARIFG NQNE NTNRVVGTYGYMAPEYAMEGLFSVKSDV
Sbjct: 614 LKASNILLDEGMNPKISDFGMARIFGANQNEINTNRVVGTYGYMAPEYAMEGLFSVKSDV 673
Query: 723 YSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRC 782
YSFGVLLLEIVSGRRNTSFR+ ++ LI + W+LW+EGKAME+VDP+IRDS ++N+VLRC
Sbjct: 674 YSFGVLLLEIVSGRRNTSFRMTDHVILIAYAWDLWSEGKAMEMVDPSIRDSCNENEVLRC 733
Query: 783 IHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVS 842
I +GMLCVQDSA++RP MASVVLMLES T ++P+PR+PTFTS+R+S+D + FMEA + S
Sbjct: 734 IQLGMLCVQDSALHRPNMASVVLMLESSTTSIPLPREPTFTSVRASIDTETFMEAQEITS 793
Query: 843 SNDLTVTMVVGR 854
SNDLTV+MV GR
Sbjct: 794 SNDLTVSMVAGR 805
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496542|ref|XP_003635262.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/851 (64%), Positives = 670/851 (78%), Gaps = 7/851 (0%)
Query: 5 SNSKHPVSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENS 64
++ + P +VIL I SL F A NT+T+GQSI+DGE++ S+ + F LGFFSPENS
Sbjct: 38 ASCRCPTAVILF-LLSIFYSLPSFCYAANTLTQGQSIRDGETVNSSSQHFALGFFSPENS 96
Query: 65 SLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVV 124
+ RYVGIWY++I+ + VVWVANR+ PIS G L++ GNL+V +GN ++WSSNAS
Sbjct: 97 TSRYVGIWYNKIEGQTVVWVANRDSPISGTDGVLSLDKTGNLVVFDGNGSSIWSSNASAS 156
Query: 125 SNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTS 184
S+N+ A+L D GNL+L++S+++G+ KA+WQSFN TDT LPGM+V V+ +GENRVFTS
Sbjct: 157 SSNSTAILLDTGNLVLSSSDNVGDTDKAFWQSFNSSTDTFLPGMKVLVDETMGENRVFTS 216
Query: 185 WKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGF 244
WK+ DPSPGN+TMGVDP+ +PQIVIW+ R WRSG WN +IFTG+P M + S+ GF
Sbjct: 217 WKTEVDPSPGNYTMGVDPRAAPQIVIWDGSIRWWRSGHWNGLIFTGIPDMMAVYSY--GF 274
Query: 245 KLSPRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELY 304
K + E DG YFTY P+N+S LLRF++ W+G EEQLRWDG K+W V+Q QP ++CE Y
Sbjct: 275 KYTTDE-DGKSYFTYTPSNSSDLLRFQVRWNGTEEQLRWDGDKKEWGVVQSQPDNECEEY 333
Query: 305 NFCGNFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGG 364
N CG FGIC+ S C+C+EGF P+H +QW GNWS GC+RRTQLQC R+ S G +G
Sbjct: 334 NKCGAFGICSFENSASCSCLEGFHPRHVDQWNKGNWSGGCVRRTQLQCDRSTSANG-TGE 392
Query: 365 EDGFKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSF 424
DGF + VKLPDFAD V++ + C+ +CLQNCSC AYA + GIGCM+W G+L+D++ F
Sbjct: 393 GDGFLTVEGVKLPDFADRVNLENKECEKQCLQNCSCMAYAHVTGIGCMMWGGDLVDIQHF 452
Query: 425 EKGG-NLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTISC 483
+GG LH+RL SELGG+ I+ VI IIVV+GA+ L S WLLWRFRA +
Sbjct: 453 AEGGRTTLHLRLAGSELGGKG-IAKLVIVIIVVVGAVFLSLSTWLLWRFRAKLRAFLNLG 511
Query: 484 CKNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKL 543
+ N+ ++ +S G+E S DFSG D+V +G Q +G++L +FNF +A AT FS+ NKL
Sbjct: 512 QRKNELPILYVSGGREFSKDFSGSVDLVGEGKQGSGSELPLFNFKCVAAATGNFSDENKL 571
Query: 544 GRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603
G+GGFGPV+KG LP G++IAVKRLSR+SGQGLEEFKNE+ LIAKLQHRNLVRLLGCCI+G
Sbjct: 572 GQGGFGPVYKGMLPGGEEIAVKRLSRRSGQGLEEFKNEMTLIAKLQHRNLVRLLGCCIEG 631
Query: 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDL 663
EEKML+YEYMPNKSLD FIFDPAKQA LDW KRF IIEGIARGLLYLHRDSRLRIIHRD+
Sbjct: 632 EEKMLLYEYMPNKSLDFFIFDPAKQAELDWRKRFTIIEGIARGLLYLHRDSRLRIIHRDM 691
Query: 664 KASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVY 723
KASNILLDE+MNPKISDFGMARIFG +QNEANT RVVGTYGYM+PEYAMEGLFSVKSDVY
Sbjct: 692 KASNILLDEEMNPKISDFGMARIFGGDQNEANTTRVVGTYGYMSPEYAMEGLFSVKSDVY 751
Query: 724 SFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCI 783
SFGVLLLEIVSGRRNTSFRL E+S+L+ W LWNEGKAME VD +IRDS SQ++VLRCI
Sbjct: 752 SFGVLLLEIVSGRRNTSFRLTEHSNLLSFAWQLWNEGKAMEFVDSSIRDSCSQDEVLRCI 811
Query: 784 HVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSS 843
VGMLCVQDS +YRPTM++VVLMLESET TLP+PRQPTFTS RSS+D D F E + VSS
Sbjct: 812 KVGMLCVQDSTIYRPTMSTVVLMLESETATLPMPRQPTFTSTRSSIDLDLFSEGLEIVSS 871
Query: 844 NDLTVTMVVGR 854
N++T++ VVGR
Sbjct: 872 NNITLSAVVGR 882
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567483|ref|XP_002524721.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223536082|gb|EEF37740.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/829 (64%), Positives = 648/829 (78%), Gaps = 18/829 (2%)
Query: 34 TITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISD 93
TITKGQ + DGE ++S E FELGFFSP S+ RYVGI YH+I ++ V+WVANR PISD
Sbjct: 31 TITKGQLVPDGEIILSEDENFELGFFSPGISTFRYVGIRYHKIQDQPVIWVANRQTPISD 90
Query: 94 ERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNN-TAALLEDDGNLILTNSEDIGNLGKA 152
+ G LTIG DGNL+V NG + VWSSN S + +N T A L D GNL+L+ GN G
Sbjct: 91 KTGVLTIGEDGNLIVRNGRGLEVWSSNVSSLLSNNTQATLADSGNLVLS-----GN-GAT 144
Query: 153 YWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWE 212
YW+SF HPTDT LP M+V + S+ EN+ FTSWKSA+DPSPGNFTMGVDP+G+PQIVIWE
Sbjct: 145 YWESFKHPTDTFLPNMKV-LASSSEENKAFTSWKSANDPSPGNFTMGVDPRGAPQIVIWE 203
Query: 213 QLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPANASYLLRFRI 272
Q +RRWRSG WN IFTGVP M LT+ L+GFK DG+MY TY P++AS +RF+I
Sbjct: 204 QSRRRWRSGYWNGQIFTGVPNMTALTNLLYGFKTEI--DDGNMYITYNPSSASDFMRFQI 261
Query: 273 GWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGICNALGSTKCTCMEGFVPKHF 332
DG+EEQL+W+ S KW V+Q+QPA+DCE YNFCG+FG+C A + +C CMEGF P++
Sbjct: 262 SIDGHEEQLKWNESQNKWDVMQRQPANDCEFYNFCGDFGVCTASENPRCRCMEGFEPRNE 321
Query: 333 EQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFKNVKLPDFADVVSV-GQETCK 391
QWR GNWS GC+RR+ L+CQRN S G S +D FK K KLPDF DV V E C+
Sbjct: 322 HQWRRGNWSGGCVRRSPLRCQRNTSIGGGSSTDDKFKELKCNKLPDFVDVHGVLPLEDCQ 381
Query: 392 DKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKGGNLLHVRLPDSELGGRSKISNAVI 451
CL +CSCNAYA + IGCM+W LIDV+ F + G ++H+RL SE SK+S AVI
Sbjct: 382 ILCLSDCSCNAYAVVANIGCMIWGENLIDVQDFGRPGIVMHLRLAASEFD-ESKLSTAVI 440
Query: 452 AIIVVIGALLLGASVWLLW----RFRALCKDSTISCCKNNDTQLIDMSKGQEISTDFSGP 507
A+IVV G + + + LLW + + L +++S K ++T DMSK + S++ SGP
Sbjct: 441 ALIVVAGVVFVAICICLLWVLKRKLKVLPAAASVSLNKPSETPFSDMSKSKGYSSEMSGP 500
Query: 508 SDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRL 567
+D+V+DGSQVNG DL +FNF+ +A AT+ F+E NKLG+GGFG V+KGKLP G++IAVKRL
Sbjct: 501 ADLVIDGSQVNGPDLPLFNFSAVAAATDNFAEENKLGQGGFGHVYKGKLPSGEEIAVKRL 560
Query: 568 SRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAK 627
S+ SGQGLEEFKNEIILIAKLQHRNLVRLLGCCI GEEK+L+YEYMPNKSLD F+FDPAK
Sbjct: 561 SKISGQGLEEFKNEIILIAKLQHRNLVRLLGCCIHGEEKLLLYEYMPNKSLDFFLFDPAK 620
Query: 628 QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687
QA+LDW RF II+GIARGL+YLHRDSRLRIIHRDLKASNILLDE+MNPKISDFGMARIF
Sbjct: 621 QAMLDWKTRFTIIKGIARGLVYLHRDSRLRIIHRDLKASNILLDEEMNPKISDFGMARIF 680
Query: 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747
G NQNE NTNRVVGTYGYM+PEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR +++
Sbjct: 681 GGNQNELNTNRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRQSDHA 740
Query: 748 SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807
SLI + W LWNE KA+ELVDP+IRDS + +VLRCI VGMLCVQDSA+ RPTM+S+VLML
Sbjct: 741 SLIAYAWELWNEDKAIELVDPSIRDSCCKKEVLRCIQVGMLCVQDSAVQRPTMSSIVLML 800
Query: 808 ESET-PTLPVPRQPTFTSMRSSVD-GDHFMEAHDTVSSNDLTVTMVVGR 854
ES T P LP+PRQPT+TSMR+S+D D +++ + VSSND+TVTMVVGR
Sbjct: 801 ESNTAPNLPLPRQPTYTSMRASIDTSDIYLDGQEIVSSNDVTVTMVVGR 849
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15234429|ref|NP_193870.1| S-locus lectin protein kinase-like protein [Arabidopsis thaliana] gi|75220153|sp|O81906.1|B120_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase B120; Flags: Precursor gi|3402758|emb|CAA20204.1| serine/threonine kinase-like protein [Arabidopsis thaliana] gi|7268936|emb|CAB81246.1| serine/threonine kinase-like protein [Arabidopsis thaliana] gi|157086543|gb|ABV21215.1| At4g21390 [Arabidopsis thaliana] gi|332659047|gb|AEE84447.1| S-locus lectin protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2585), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/857 (58%), Positives = 640/857 (74%), Gaps = 36/857 (4%)
Query: 14 ILLSFFLIVCSLAHFGRAVNTITKGQSIKDG---ESLISNGEIFELGFFSPENSSLRYVG 70
+ L FFL S+A NTI +G+S++DG + L+S + FELGFFSP +S+ R++G
Sbjct: 13 LFLYFFLYESSMA-----ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSN---ASVVSNN 127
IWY I++KAVVWVANR PISD+ G L I NDGNL++L+G +I VWSSN ++ +NN
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 128 TAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKS 187
+ D GN +L+ ++ + W+SFNHPTDT LP MRV VN G+N F SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDT----DRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIWEQLK-RRWRSGQWNSVIFTGVPTMATLTSFLFGFKL 246
+DPSPGN+++GVDP G+P+IV+WE K R+WRSGQWNS IFTG+P M+ LT++L+GFKL
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 247 S-PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYN 305
S P + GS+YFTYVP++ S LLRF++ ++G EE+LRW+ + KKW+ Q +P +C+ YN
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 306 FCGNFGICNALGSTK-CTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGG 364
CG FGIC+ GS C+C+ G+ EQ +GNWS GC RRT L+C+RN S G
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGY-----EQVSVGNWSRGCRRRTPLKCERNISV-----G 353
Query: 365 EDGFKVFKNVKLPDF--ADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVK 422
ED F K+VKLPDF + V E C+++CL+NCSCNAY+ + GIGCM+W +L+D++
Sbjct: 354 EDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQ 413
Query: 423 SFEKGGNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTIS 482
FE GG+ LH+RL DSE+G K AVI + V++G +L+G LLWRF+ S
Sbjct: 414 QFEAGGSSLHIRLADSEVGENRKTKIAVI-VAVLVGVILIGIFALLLWRFKRKKDVSGAY 472
Query: 483 CCKNNDTQLI--DMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEG 540
C KN DT ++ D++K +E ++ FSG D++++G VN ++L +F+ N IA+ATN F +
Sbjct: 473 CGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKE 532
Query: 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
N+LGRGGFGPV+KG L +G++IAVKRLS KSGQG++EFKNEIILIAKLQHRNLVRLLGCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+GEEKML+YEYMPNKSLD F+FD KQAL+DW RF+IIEGIARGLLYLHRDSRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDLK SN+LLD +MNPKISDFGMARIFG NQNEANT RVVGTYGYM+PEYAMEGLFSVKS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712
Query: 721 DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVL 780
DVYSFGVLLLEIVSG+RNTS R E+ SLI + W L+ G++ ELVDP IR + S+ + L
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL 772
Query: 781 RCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSM-RSSVDGDHFMEAHD 839
RCIHV MLCVQDSA RP MASV+LMLES+T TL PRQPTFTS R+S+D + +++
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832
Query: 840 --TVSSNDLTVTMVVGR 854
VSSN++T T+V+GR
Sbjct: 833 QYIVSSNEITSTVVLGR 849
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110738232|dbj|BAF01045.1| serine/threonine kinase - like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2581), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/857 (57%), Positives = 639/857 (74%), Gaps = 36/857 (4%)
Query: 14 ILLSFFLIVCSLAHFGRAVNTITKGQSIKDG---ESLISNGEIFELGFFSPENSSLRYVG 70
+ L FFL S+A NTI +G+S++DG + L+S + FELGFFSP +S+ R++G
Sbjct: 13 LFLYFFLYESSMA-----ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSN---ASVVSNN 127
IWY I++KAVVWVANR PISD+ G L I NDGNL++L+G +I VWSSN ++ +NN
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 128 TAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKS 187
+ D GN +L+ ++ + W+SFNHPTDT LP MRV VN G+N F SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDT----DRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIWEQLK-RRWRSGQWNSVIFTGVPTMATLTSFLFGFKL 246
+DPSPGN+++GVDP G+P+IV+WE K R+WRSGQWNS IFTG+P M+ LT++L+GFKL
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 247 S-PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYN 305
S P + GS+YFTYVP++ S LLRF++ ++G EE+LRW+ + KKW+ Q +P +C+ YN
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 306 FCGNFGICNALGSTK-CTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGG 364
CG FGIC+ GS C+C+ G+ EQ +GNWS GC RRT L+C+RN S G
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGY-----EQVSVGNWSRGCRRRTPLKCERNISV-----G 353
Query: 365 EDGFKVFKNVKLPDF--ADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVK 422
ED F K+VKLPDF + V E C+++CL+NCSCNAY+ + GIGCM+W +L+D++
Sbjct: 354 EDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQ 413
Query: 423 SFEKGGNLLHVRLPDSELGGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTIS 482
FE GG+ LH+RL DSE+G K AVI + V++G +L+G LLWRF+ S
Sbjct: 414 QFEAGGSSLHIRLADSEVGENRKTKIAVI-VAVLVGVILIGIFALLLWRFKRKKDVSGAY 472
Query: 483 CCKNNDTQLI--DMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEG 540
C KN DT ++ D++K +E ++ FSG D++++G VN ++L +F+ N IA+ATN F +
Sbjct: 473 CGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKE 532
Query: 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
N+LGRGGFGPV+KG L +G++IAVKRLS KSGQG++EFKNEIILIAKLQHRNLVRLLGCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+GEEKML+YEYMPNKSLD F+FD KQAL+DW RF+IIEGIARGLLYLHRDSRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDLK SN+LLD +MNPKISDFGMARIFG NQNEANT RVVGTYGYM+PEYAMEGLFSVKS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712
Query: 721 DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVL 780
DVYSFGVLLLEIVSG+RNTS R E+ SLI + W L+ G++ ELVDP IR + S+ + L
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL 772
Query: 781 RCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSM-RSSVDGDHFMEAHD 839
RCIHV MLCVQDSA RP MAS +LMLES+T TL PRQPTFTS R+S+D + +++
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASALLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832
Query: 840 --TVSSNDLTVTMVVGR 854
VSSN++T T+V+GR
Sbjct: 833 QYIVSSNEITSTVVLGR 849
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434360|ref|XP_004134964.1| PREDICTED: uncharacterized protein LOC101207147 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 988 bits (2553), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/852 (57%), Positives = 629/852 (73%), Gaps = 21/852 (2%)
Query: 11 VSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDG--ESLISNGEIFELGFFSPENSSLRY 68
+ ++SFFL CS F A ++ITKG+ ++DG E+L+S + +ELGFFSP NSSLRY
Sbjct: 12 LQFFVISFFL--CSSPLFCDAADSITKGRGLRDGSNETLVSLDDSYELGFFSPINSSLRY 69
Query: 69 VGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNT 128
VGIWYH+I+E++V+WVANR+RP+ + G L IG+DGNL+VL+GN+ +VW+SN + S
Sbjct: 70 VGIWYHKIEEQSVIWVANRDRPLRNRNGVLIIGDDGNLVVLDGNN-SVWTSNITANSFEP 128
Query: 129 AAL-LEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKS 187
L L + G L+L++ +D L K +W SF HPTDT LP M V VN +GE R+F SWKS
Sbjct: 129 RNLTLLNHGALVLSSGDD---LSKVHWSSFEHPTDTFLPNMVVKVNPQMGEKRMFMSWKS 185
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLS 247
+DP+ GN+ +GVDP+G+ QI++W R WRSG W+ IF+G+PTM + + L+GFK++
Sbjct: 186 ETDPAVGNYCLGVDPRGAVQIIVWNGNNRWWRSGHWDKQIFSGIPTMRSTS--LYGFKIT 243
Query: 248 PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFC 307
+ + ++ T+ N L+F+I WDG E Q R + + +KW I+ P++DC+ YNFC
Sbjct: 244 SDDGN-NISVTFEALNDLDKLKFQIQWDGKEAQQRLNETTRKWDTIRLLPSNDCDFYNFC 302
Query: 308 GNFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAG---ESGG 364
G+FG+C+ KC+C +GF+PK+ E+W G WS GC R+T L QR +S E
Sbjct: 303 GDFGVCSENSRLKCSCPQGFIPKNKERWDKGIWSDGCRRKTPLLEQRMKSSPNGTIEDSE 362
Query: 365 EDGFKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSF 424
+DGF VKLPDF + V E+C+D+C N SC AY+D PGIGC W G L D++ F
Sbjct: 363 QDGFVDVLFVKLPDFITGIFV-VESCRDRCSSNSSCVAYSDAPGIGCATWDGPLKDIQRF 421
Query: 425 EKGGNLLHVRLPDSEL---GGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTI 481
E GN LH+R+ S+L SK+S VI I GA + LLW+FR K +T
Sbjct: 422 EGAGNTLHLRIAHSDLTPVDSESKLSTGVIVAICFGGAAAIAIIALLLWKFRGKTKAATT 481
Query: 482 SCCKNN-DTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEG 540
S +N + + D+SK +E+S + SGP ++ ++G ++G DL MFNFN IA AT+ FSE
Sbjct: 482 SEPQNKTEVPMFDLSKSKELSAELSGPYELGIEGENLSGPDLPMFNFNCIAAATDNFSEE 541
Query: 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
NKLG+GGFGPV+KGKLP GQ+IAVKRLS +SGQGLEEFKNEIILI KLQHRNLVRLLG C
Sbjct: 542 NKLGQGGFGPVYKGKLPCGQEIAVKRLSVRSGQGLEEFKNEIILIGKLQHRNLVRLLGYC 601
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
IQGE+K+L+YEYMPNKSLD F+FDP KQALLDW KR +I+EGIARGLLYLHRDSRL IIH
Sbjct: 602 IQGEDKLLLYEYMPNKSLDWFLFDPNKQALLDWKKRLSIVEGIARGLLYLHRDSRLLIIH 661
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEA-NTNRVVGTYGYMAPEYAMEGLFSVK 719
RDLKASNILLDEDMNPKISDFGMARIFG NQNEA NT RVVGTYGYMAPEYAMEGLFSVK
Sbjct: 662 RDLKASNILLDEDMNPKISDFGMARIFGGNQNEATNTIRVVGTYGYMAPEYAMEGLFSVK 721
Query: 720 SDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQV 779
SDVYSFGVLLLE++ GRRNTSFR E +LI + W LWN+G+A+EL+DP+IRDSS +N+V
Sbjct: 722 SDVYSFGVLLLELICGRRNTSFRSTEYLTLISYAWKLWNDGRAIELLDPSIRDSSPENEV 781
Query: 780 LRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHD 839
L+CIHV MLCVQDS YRPT+ S+VLMLESE+ +LP PRQPT+TS R+S+D D F E HD
Sbjct: 782 LKCIHVAMLCVQDSPAYRPTLQSLVLMLESESTSLPQPRQPTYTSTRASIDIDLFTEGHD 841
Query: 840 TVSSNDLTVTMV 851
VSSND+TVTM+
Sbjct: 842 IVSSNDVTVTML 853
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449524266|ref|XP_004169144.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2536), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/855 (58%), Positives = 631/855 (73%), Gaps = 21/855 (2%)
Query: 11 VSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDG--ESLISNGEIFELGFFSPENSSLRY 68
+ ++SFFL CS F A N+ITKG+ ++DG E+L+S + +ELGFFSP NSSLRY
Sbjct: 12 LQFFVISFFL--CSSPLFCDAANSITKGRGLRDGSNETLVSLDDSYELGFFSPINSSLRY 69
Query: 69 VGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNT 128
VGIWYH+I+E++V+WVANR+RP+ + G L IG+DGNL+VL+GN+ +VW+SN + S
Sbjct: 70 VGIWYHKIEEQSVIWVANRDRPLRNRNGVLIIGDDGNLVVLDGNN-SVWTSNITANSFEP 128
Query: 129 AAL-LEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKS 187
L L + G L+L++ +D L K +W SF HPTDT LP M V VN +GE R+F SWKS
Sbjct: 129 RNLTLLNHGALVLSSGDD---LSKVHWSSFEHPTDTFLPNMVVKVNPQMGEKRMFMSWKS 185
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLS 247
+DP+ GN+ +GVDP+G+ QI++W R WRSG W+ IF+G+PTM + + L+GFK++
Sbjct: 186 ETDPAVGNYCLGVDPRGAVQIIVWNGNNRWWRSGHWDKQIFSGIPTMRSTS--LYGFKIT 243
Query: 248 PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFC 307
+ + ++ T+ N L+F+I WDG E Q R + + +KW I+ P++DC+ YNFC
Sbjct: 244 SDDGN-NISVTFEALNDLDKLKFQIQWDGKEAQQRLNETTRKWDTIRLLPSNDCDFYNFC 302
Query: 308 GNFGICNALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAG---ESGG 364
G+FG+C+ KC+C +GF+PK+ E+W G WS GC R+T L QR +S E
Sbjct: 303 GDFGVCSENSRLKCSCPQGFIPKNKERWDKGIWSDGCRRKTPLLEQRMKSSPNGTIEDSE 362
Query: 365 EDGFKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSF 424
+DGF VKLPDF + V E+C+D+C N SC AY+D PGIGC W G L D++ F
Sbjct: 363 QDGFVDVLFVKLPDFITGIFV-VESCRDRCSSNSSCVAYSDAPGIGCATWDGPLKDIQRF 421
Query: 425 EKGGNLLHVRLPDSEL---GGRSKISNAVIAIIVVIGALLLGASVWLLWRFRALCKDSTI 481
E GN LH+R+ S+L SK+S VI I GA + LLW+FR K +T
Sbjct: 422 EGAGNTLHLRIAHSDLTPVDSESKLSTGVIVAICFGGAAAIAIIALLLWKFRGKTKAATT 481
Query: 482 SCCKN-NDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEG 540
S +N + + D+SK +E+S + SGP ++ ++G ++G DL MFNFN IA AT+ FSE
Sbjct: 482 SEPQNKTEVPMFDLSKSKELSAELSGPYELGIEGENLSGPDLPMFNFNYIAAATDNFSEE 541
Query: 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
NKLG+GGFGPV+KGKLP GQ+IAVKRLS +SGQGLEEFKNEIILI KLQHRNLVRLLG C
Sbjct: 542 NKLGQGGFGPVYKGKLPCGQEIAVKRLSVRSGQGLEEFKNEIILIGKLQHRNLVRLLGYC 601
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
IQGE+K+L+YEYMPNKSLD F+FDP KQALLDW KR +I+EGIARGLLYLHRDSRL IIH
Sbjct: 602 IQGEDKLLLYEYMPNKSLDWFLFDPNKQALLDWKKRLSIVEGIARGLLYLHRDSRLLIIH 661
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEA-NTNRVVGTYGYMAPEYAMEGLFSVK 719
RDLKASNILLDEDMNPKISDFGMARIFG NQNEA NT RVVGTYGYMAPEYAMEGLFSVK
Sbjct: 662 RDLKASNILLDEDMNPKISDFGMARIFGGNQNEATNTIRVVGTYGYMAPEYAMEGLFSVK 721
Query: 720 SDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQV 779
SDVYSFGVLLLE++ GRRNTSFR E +LI + W LWN+G+A+EL+DP+IRDSS +N+V
Sbjct: 722 SDVYSFGVLLLELICGRRNTSFRSTEYLTLISYAWKLWNDGRAIELLDPSIRDSSPENEV 781
Query: 780 LRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHD 839
L+CIHV MLCVQDS YRPT+ S+VLMLESE+ +LP PRQPT+TS R+S+D D F E HD
Sbjct: 782 LKCIHVAMLCVQDSPAYRPTLQSLVLMLESESTSLPQPRQPTYTSTRASIDIDLFTEGHD 841
Query: 840 TVSSNDLTVTMVVGR 854
VSSND+TVTM+ GR
Sbjct: 842 IVSSNDVTVTMLDGR 856
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312162749|gb|ADQ37364.1| unknown [Arabidopsis lyrata] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2514), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/867 (56%), Positives = 640/867 (73%), Gaps = 43/867 (4%)
Query: 8 KHPVSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDG---ESLISNGEIFELGFFSPENS 64
K +S+ L FF + S A +T+ +G+S++DG + L+S + FELGFFSP +S
Sbjct: 6 KTSLSLPLFIFFFLYQS----SIAADTLRRGESLRDGLNHKPLVSPKKTFELGFFSPGSS 61
Query: 65 SLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVV 124
+ RY+GIWY I++KAVVWVANR PISD+ G LTI NDGNL++L+G +I VWSSN
Sbjct: 62 TRRYLGIWYGNIEDKAVVWVANRASPISDQSGVLTISNDGNLVLLDGKNITVWSSNIESS 121
Query: 125 SNNT---AALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRV 181
+NN + D GN +L+ ++ + W+SFNHPTDT LP M+V VN G+N
Sbjct: 122 TNNNNNRVVSIHDTGNFVLSETD----TDRVIWESFNHPTDTFLPQMKVRVNPQTGDNHA 177
Query: 182 FTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLK-RRWRSGQWNSVIFTGVPTMATLTSF 240
F SW+S +DPSPGN+++GVDP G+P+IV+W+ K R+WRSGQWNS IFTG+P M+ LT++
Sbjct: 178 FVSWRSETDPSPGNYSLGVDPSGAPEIVLWKGNKTRKWRSGQWNSAIFTGIPNMSLLTNY 237
Query: 241 LFGFKLS-PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPAD 299
L+GFKLS P + GS+YFTYVP+++S LLRF++ ++G EE+LRW+ + KKW+ Q +P
Sbjct: 238 LYGFKLSSPPDETGSVYFTYVPSDSSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDS 297
Query: 300 DCELYNFCGNFGICNALGSTK-CTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSE 358
+C+ YN CG FGIC+ GS C+C+ G+ EQ +GNWS GC RRT L+C+RN S
Sbjct: 298 ECDQYNRCGKFGICDMKGSNGICSCIHGY-----EQVSVGNWSRGCRRRTPLKCERNISV 352
Query: 359 AGESGGEDGFKVFKNVKLPDFA----DVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLW 414
GED F K+VKLPDF D+V C+++CL+NCSCNAY+ + GIGCM+W
Sbjct: 353 -----GEDEFLTLKSVKLPDFEIPAHDLVDPAD--CRERCLRNCSCNAYSLVGGIGCMIW 405
Query: 415 RGELIDVKSFEKGGNLLHVRLPDSELG--GRSKISNAVIAIIVVIGALLLGASVWLLWRF 472
+L+D++ FE GG+ LH+RL DSE+G ++KI+ V ++ V+ +L LLWRF
Sbjct: 406 NQDLVDLQQFEAGGSSLHIRLADSEVGENKKTKIAVIVAVLVGVVLVGILAL---LLWRF 462
Query: 473 RALCKDSTISCCKNNDTQLI--DMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTI 530
+ S C KN DT ++ DM+K +E ++ FSG D++++G VN ++L +F N I
Sbjct: 463 KKKKDVSGAYCGKNTDTSVVVADMTKNKETTSAFSGSVDIMIEGKAVNTSELPVFCLNAI 522
Query: 531 AVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH 590
A+ATN F + N+LGRGGFGPV+KG L +G++IAVKRLS KSGQG++EFKNEIILIAKLQH
Sbjct: 523 AIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQH 582
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
RNLVRLLGCC +GEEKML+YEYMPNKSLD F+FD KQAL+DW RF+IIEGIARGLLYL
Sbjct: 583 RNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYL 642
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
HRDSRLRIIHRDLK SN+LLD +MNPKISDFGMARIFG NQNEANT RVVGTYGYM+PEY
Sbjct: 643 HRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEY 702
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770
AMEGLFSVKSDVYSFGVLLLEIVSG+RNTS R E+ SLI + W L+ G++ ELVDP I
Sbjct: 703 AMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTYGRSEELVDPKI 762
Query: 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTS-MRSSV 829
R + ++ + LRCIHV MLCVQDSA RP MA+V+LMLES+T TL PR+PTFTS R+S+
Sbjct: 763 RVTCNKREALRCIHVAMLCVQDSAAERPNMAAVLLMLESDTATLAAPREPTFTSNRRNSI 822
Query: 830 DGDHFMEAHD--TVSSNDLTVTMVVGR 854
D + +++ VSSN++T T+V+GR
Sbjct: 823 DVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Source: Arabidopsis lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 854 | ||||||
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.961 | 0.967 | 0.563 | 6.6e-255 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.968 | 0.982 | 0.540 | 5.3e-246 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.967 | 0.974 | 0.461 | 7.9e-188 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.960 | 0.987 | 0.437 | 1.7e-185 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.391 | 0.410 | 0.582 | 1.3e-178 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.385 | 0.409 | 0.568 | 1.3e-178 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.947 | 0.951 | 0.432 | 4.6e-176 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.392 | 0.403 | 0.565 | 1.2e-175 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.384 | 0.408 | 0.556 | 1.5e-175 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.393 | 0.415 | 0.531 | 3.2e-175 |
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2454 (868.9 bits), Expect = 6.6e-255, P = 6.6e-255
Identities = 483/857 (56%), Positives = 618/857 (72%)
Query: 14 ILLSFFLIVCSLAHFGRAVNTITKGQSIKDG---ESLISNGEIFELGFFSPENSSLRYVG 70
+ L FFL S+A NTI +G+S++DG + L+S + FELGFFSP +S+ R++G
Sbjct: 13 LFLYFFLYESSMA-----ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGXXXXXXXXXXXXXXXXXXX 130
IWY I++KAVVWVANR PISD+ G L I NDGNL++L+G
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 131 L---LEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKS 187
+ D GN +L+ ++ + W+SFNHPTDT LP MRV VN G+N F SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDT----DRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 188 ASDPSPGNFTMGVDPQGSPQIVIWEQLK-RRWRSGQWNSVIFTGVPTMATLTSFLFGFKL 246
+DPSPGN+++GVDP G+P+IV+WE K R+WRSGQWNS IFTG+P M+ LT++L+GFKL
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 247 S-PRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYN 305
S P + GS+YFTYVP++ S LLRF++ ++G EE+LRW+ + KKW+ Q +P +C+ YN
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 306 FCGNFGICNALGSTK-CTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGG 364
CG FGIC+ GS C+C+ G+ EQ +GNWS GC RRT L+C+RN S G
Sbjct: 304 RCGKFGICDMKGSNGICSCIHGY-----EQVSVGNWSRGCRRRTPLKCERNISV-----G 353
Query: 365 EDGFKVFKNVKLPDFA--DVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVK 422
ED F K+VKLPDF + V E C+++CL+NCSCNAY+ + GIGCM+W +L+D++
Sbjct: 354 EDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQ 413
Query: 423 SFEKGGNLLHVRLPDSELGGRSKISNXXXXXXXXXXXXXXXXSVWLLWRFRALCKDSTIS 482
FE GG+ LH+RL DSE+G K ++ LLWRF+ S
Sbjct: 414 QFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFAL-LLWRFKRKKDVSGAY 472
Query: 483 CCKNNDTQLI--DMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEG 540
C KN DT ++ D++K +E ++ FSG D++++G VN ++L +F+ N IA+ATN F +
Sbjct: 473 CGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKE 532
Query: 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
N+LGRGGFGPV+KG L +G++IAVKRLS KSGQG++EFKNEIILIAKLQHRNLVRLLGCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+GEEKML+YEYMPNKSLD F+FD KQAL+DW RF+IIEGIARGLLYLHRDSRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDLK SN+LLD +MNPKISDFGMARIFG NQNEANT RVVGTYGYM+PEYAMEGLFSVKS
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKS 712
Query: 721 DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVL 780
DVYSFGVLLLEIVSG+RNTS R E+ SLI + W L+ G++ ELVDP IR + S+ + L
Sbjct: 713 DVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREAL 772
Query: 781 RCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMR-SSVDGDHFMEAHD 839
RCIHV MLCVQDSA RP MASV+LMLES+T TL PRQPTFTS R +S+D + +++
Sbjct: 773 RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQ 832
Query: 840 T--VSSNDLTVTMVVGR 854
VSSN++T T+V+GR
Sbjct: 833 QYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2370 (839.3 bits), Expect = 5.3e-246, P = 5.3e-246
Identities = 458/847 (54%), Positives = 593/847 (70%)
Query: 13 VILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIW 72
V L F +CS + N+ T+ +I++G+SLIS E FELGFF+P+NS+LRYVGIW
Sbjct: 11 VTTLLIFHQLCSNVSCSTS-NSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIW 69
Query: 73 YHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGXXXXXXXXXXXXXXXXXXXLL 132
Y I+ + VVWVANR +P+ D +G L I +DGNL+++NG +L
Sbjct: 70 YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVL 129
Query: 133 EDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPS 192
G+L+L + D K YW+SFN+PTDT LPGMRV VN +LGENR F WKS SDPS
Sbjct: 130 FKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 193 PGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLS-PRES 251
PG ++MG+DP G+ +IVIWE KR+WRSG WNS IFTG+P M T++++GFKLS P +
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDR 246
Query: 252 DGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFG 311
DGS+YFTYV +++S LRF I DG EEQ RW+ + W+++Q +P+ +CE YN CGN+
Sbjct: 247 DGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYS 306
Query: 312 ICN---ALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGF 368
+C+ S KC+C++GF P H +QW ++S GC RR L C N+S +G EDGF
Sbjct: 307 VCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNC--NQSLV--AGQEDGF 362
Query: 369 KVFKNVKLPDFADVV-SVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKG 427
V K +K+PDF VV ETCKD C ++CSC AYA + GIGCM+W +LID++ FE+G
Sbjct: 363 TVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIWTRDLIDMEHFERG 422
Query: 428 GNLLHVRLPDSELGGRSKISNXXXXXXXXXXXXXXXXSVWLLWRFRALCKDSTISCCKNN 487
GN +++RL S+LGG + S +W+LW+F+ K K
Sbjct: 423 GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFK---KSLKAFLWKKK 479
Query: 488 DTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGG 547
D + D+ + ++ S S P ++V G QV+ DL +F+F+++A AT F+E NKLG+GG
Sbjct: 480 DITVSDIIENRDYS---SSPIKVLV-GDQVDTPDLPIFSFDSVASATGDFAEENKLGQGG 535
Query: 548 FGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607
FG V+KG EG++IAVKRLS KS QGLEEFKNEI+LIAKLQHRNLVRLLGCCI+ EKM
Sbjct: 536 FGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKM 595
Query: 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667
L+YEYMPNKSLD F+FD +KQ LDW KR+ +I GIARGLLYLHRDSRL+IIHRDLKASN
Sbjct: 596 LLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASN 655
Query: 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGV 727
ILLD +MNPKISDFGMARIF + Q+ ANT RVVGTYGYMAPEYAMEG+FS KSDVYSFGV
Sbjct: 656 ILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGV 715
Query: 728 LLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGM 787
L+LEIVSGR+N SFR ++ SLI + W+LW++GK E++DP ++D+ + +RCIHVGM
Sbjct: 716 LILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGM 775
Query: 788 LCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLT 847
LC QDS ++RP M SV+LMLES+T LP PRQPTF S +S D + + HD S ND+T
Sbjct: 776 LCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVT 835
Query: 848 VTMVVGR 854
T +VGR
Sbjct: 836 FTTIVGR 842
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1821 (646.1 bits), Expect = 7.9e-188, P = 7.9e-188
Identities = 398/863 (46%), Positives = 517/863 (59%)
Query: 10 PVSVILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGE-IFELGFFSPE--NSSL 66
P + LL +C +A + +T+ +G+S+ +L+S+ E +FE GFF+P+ S
Sbjct: 5 PRLLFLLLAGASLCCVA--AQKTDTLRQGESLSGAATLVSSPEGVFEAGFFAPDPKQPSR 62
Query: 67 RYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGXXXXXXXXXXXXXXX 126
+Y+GIWYH I + VVWVANR P + +LT+ G+L VL+G
Sbjct: 63 QYLGIWYHSISPRTVVWVANRVAPATSASPSLTLTVTGDLRVLDGTAANGTADAPLLWSS 122
Query: 127 XXXXLLEDDG--NLIL--TNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS-ALG--EN 179
G + +L T S ++ + W SF HPTDT L GMR+ + + G E
Sbjct: 123 NTTSRAGPRGGYSAVLQDTGSLEVRSEDGVLWDSFWHPTDTILSGMRITLQAPGRGPKER 182
Query: 180 RVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLK-RRWRSGQWNSVIFTGVPTMATLT 238
+FTSW S +DPSPG + +G+DP S Q IW+ WRSGQWN V F G+P
Sbjct: 183 MLFTSWASETDPSPGRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPWRPLYR 242
Query: 239 SFLFGFKLSPRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPA 298
S GF + G+ Y+TY N S L RF + +G + S++ W ++ QP+
Sbjct: 243 S---GFTPAIDPVLGN-YYTYTATNTS-LQRFVVLPNGTDICYMVRKSSQDWELVWYQPS 297
Query: 299 DDCELYNFCGNFGICNAL--GSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNR 356
++CE Y CG C A G KCTC++GF PK EQW GNWS GCIR L C+ N
Sbjct: 298 NECEYYATCGPNAKCTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCETN- 356
Query: 357 SEAGESGGEDGFKVFKNVKLPDFADVVS-VGQET-CKDKCLQNCSCNAYADIPGIGCMLW 414
+SG DGF N+K PDF+ VS VG E C+ CL NCSC AY GC+ W
Sbjct: 357 ----QSG--DGFLPMGNIKWPDFSYWVSTVGDEPGCRTVCLNNCSCGAYVYTATTGCLAW 410
Query: 415 RGELIDVKSFEKGGNLLHVRLPDSELGGRSKISNXXXXXXXXXXXXXXXXSVWLLWRFRA 474
ELID+ + G L+++LP SEL G I + L W+
Sbjct: 411 GNELIDMHELQTGAYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAA-CLLLWWKHGR 469
Query: 475 LCKDSTISC--CKNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAV 532
KD+ +++ TQ S +IS D V DG +L +++ + I
Sbjct: 470 NIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDD-VEDGKS---HELKVYSLDRIRT 525
Query: 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
AT+ FS+ NKLG GGFGPV+ G LP G+++AVKRL R SGQGLEEFKNE+ILIAKLQHRN
Sbjct: 526 ATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRN 585
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
LVRLLGCCI EEK+L+YEYMPNKSLD F+F+P KQ LLDW KRF IIEGIARGLLYLHR
Sbjct: 586 LVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHR 645
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
DSRLR++HRDLKASNILLD DM PKISDFGMAR+FG +QN+ NTNRVVGT+GYM+PEYAM
Sbjct: 646 DSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAM 705
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS-SLIEHVWNLWNEGKAMELVDPNIR 771
EG+FSVKSDVY FGVL+LEI++G+R SF E+S ++ + W WNE A EL+DP IR
Sbjct: 706 EGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIR 765
Query: 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDG 831
S S QVLRCIH+ +LCVQD A RP + +V+LML +++ +LP PR PT ++
Sbjct: 766 ASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIES 825
Query: 832 DHFMEAHDTVSSNDLTVTMVVGR 854
E + S +T+T + GR
Sbjct: 826 SKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1799 (638.3 bits), Expect = 1.7e-185, P = 1.7e-185
Identities = 371/848 (43%), Positives = 519/848 (61%)
Query: 14 ILLSFFLIVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWY 73
+L+ ++C A + IT +D E+++SN F GFFSP NS+ RY GIW+
Sbjct: 4 LLILLLTLICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWF 63
Query: 74 HQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGXXXXXXXXXXXXXXXXXXXLLE 133
+ I + VVWVAN N PI+D G ++I +GNL+V++G
Sbjct: 64 NNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFY-- 121
Query: 134 DDGNLILT-NSEDIG--NLG-KAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSAS 189
L+ T N +G N G + W+SF HP + +LP M + ++ G + SWKS
Sbjct: 122 --ARLLNTGNLVLLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPF 179
Query: 190 DPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPR 249
DPSPG ++ G+ P P++V+W+ WRSG WN F G+P M + LF LS
Sbjct: 180 DPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRIN-LFELTLSS- 237
Query: 250 ESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGN 309
++ GS+ +Y A + L F + +G+ Q W+ + ++W K P+ C+ Y CG
Sbjct: 238 DNRGSVSMSY--AGNTLLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQ 295
Query: 310 FGICNAL-GSTK-CTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDG 367
F C GST C C+ GF P+ + +W GNW+ GC+R+ LQC+ + G S DG
Sbjct: 296 FASCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDG-SRKSDG 354
Query: 368 FKVFKNVKLPDFADVVSVGQETCKDKCLQNCSCNAYADIPGIGCMLWRGELIDVKSFEKG 427
F + +K+P ++ C + CL+NCSC AY+ GIGC+LW G L+D++ F
Sbjct: 355 FVRVQKMKVPHNPQRSGANEQDCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGT 414
Query: 428 GNLLHVRLPDSELGGRSKISNXXXXXXXXXXXXXXXXSVWLLWRFRALCKDSTISCCKNN 487
G + ++RL DSE R+ S V LW+ + K KN
Sbjct: 415 GVVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWK---IAKHRE----KNR 467
Query: 488 DTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGG 547
+T+L++ + + +S++ G ++V+ Q +L +F F +AVATN FS NKLG+GG
Sbjct: 468 NTRLLN-ERMEALSSNDVGA--ILVN--QYKLKELPLFEFQVLAVATNNFSITNKLGQGG 522
Query: 548 FGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607
FG V+KG+L EG DIAVKRLSR SGQG+EEF NE+++I+KLQHRNLVRLLG CI+GEE+M
Sbjct: 523 FGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERM 582
Query: 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667
L+YE+MP LD ++FDP KQ LLDW RF II+GI RGL+YLHRDSRL+IIHRDLKASN
Sbjct: 583 LVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASN 642
Query: 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGV 727
ILLDE++NPKISDFG+ARIF N++E +T RVVGTYGYMAPEYAM GLFS KSDV+S GV
Sbjct: 643 ILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGV 702
Query: 728 LLLEIVSGRRNTSFRLE-ENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVG 786
+LLEIVSGRRN+SF + +N +L + W LWN G+ + LVDP I + +N++ RC+HVG
Sbjct: 703 ILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVG 762
Query: 787 MLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDL 846
+LCVQD A RP++A+V+ ML SE LP P+QP F R + + + ++ S N++
Sbjct: 763 LLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNV 822
Query: 847 TVTMVVGR 854
++T + GR
Sbjct: 823 SLTKITGR 830
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 1.3e-178, Sum P(2) = 1.3e-178
Identities = 198/340 (58%), Positives = 252/340 (74%)
Query: 516 QVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGL 575
Q+ D+ F+ TI TN FS NKLG+GGFGPV+KG L +G++IA+KRLS SGQGL
Sbjct: 480 QLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGL 539
Query: 576 EEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTK 635
EEF NEIILI+KLQHRNLVRLLGCCI+GEEK+LIYE+M NKSL+ FIFD K+ LDW K
Sbjct: 540 EEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPK 599
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
RF II+GIA GLLYLHRDS LR++HRD+K SNILLDE+MNPKISDFG+AR+F Q++AN
Sbjct: 600 RFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQAN 659
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL-EENSSLIEHVW 754
T RVVGT GYM+PEYA G+FS KSD+Y+FGVLLLEI++G+R +SF + EE +L+E W
Sbjct: 660 TRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAW 719
Query: 755 NLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTL 814
+ W E +L+D +I S S+++V RC+ +G+LC+Q A RP +A V+ ML + T L
Sbjct: 720 DSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTT-TMDL 778
Query: 815 PVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
P P+QP F D E+ S N++T T +VGR
Sbjct: 779 PKPKQPVFAMQVQESDS----ESKTMYSVNNITQTAIVGR 814
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 967 (345.5 bits), Expect = 1.3e-178, Sum P(2) = 1.3e-178
Identities = 190/334 (56%), Positives = 244/334 (73%)
Query: 522 LAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNE 581
L F NTI ATN FS NKLG+GGFG V+KGKL +G++IAVK+LS SGQG EEF NE
Sbjct: 475 LEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNE 534
Query: 582 IILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIE 641
I+LI+KLQHRNLVR+LGCCI+GEEK+LIYE+M NKSLD F+FD K+ +DW KRF I++
Sbjct: 535 IVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQ 594
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
GIARGLLYLHRDSRL++IHRDLK SNILLDE MNPKISDFG+AR++ Q + T RVVG
Sbjct: 595 GIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVG 654
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL-EENSSLIEHVWNLWNEG 760
T GYM+PEYA G+FS KSD+YSFGVLLLEI+ G + + F EE +L+ + W W E
Sbjct: 655 TLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGET 714
Query: 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQP 820
K ++L+D ++ DS +V RC+ +G+LCVQ RP ++ ML + T LP P+QP
Sbjct: 715 KGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTT-TSDLPSPKQP 773
Query: 821 TFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
TF S D + + + D + N++T +M++GR
Sbjct: 774 TFVV--HSRDDESSL-SKDLFTVNEMTQSMILGR 804
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1710 (607.0 bits), Expect = 4.6e-176, P = 4.6e-176
Identities = 373/863 (43%), Positives = 524/863 (60%)
Query: 18 FFLIVCSLAHFGRAVNTITKGQS--IKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQ 75
FFL++ A + + NT++ +S I +++S G +FELGFF P S Y+GIWY
Sbjct: 16 FFLLILFPA-YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKA 74
Query: 76 IDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGXXXXXXXXXXXXXXXXXXXLLE-- 133
I ++ VWVANR+ P+S GTL I +D NL+VL+ + E
Sbjct: 75 ISKRTYVWVANRDTPLSSSIGTLKI-SDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELL 133
Query: 134 DDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSP 193
D+GN +L +S++ G WQSF+ PTDT LP M++G ++ G NR SWKS DPS
Sbjct: 134 DNGNFVLRDSKNSAPDG-VLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSS 192
Query: 194 GNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDG 253
G+F+ ++ +G P+I +W + R +RSG WN + F+GVP M +F F S E
Sbjct: 193 GDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTY 252
Query: 254 SMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGIC 313
S T + R I G ++ W +A+ W+ P D C+ Y CG +G C
Sbjct: 253 SFRIT----KSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYC 308
Query: 314 NALGSTKCTCMEGFVPKHFEQWRMGNWSAGCIRRTQLQCQRNRSEAGESGGEDGFKVFKN 373
++ S C C++GF P++ + W + + S GC+R+T L C GG DGF K
Sbjct: 309 DSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSC----------GGGDGFVRLKK 358
Query: 374 VKLPDF--ADVV-SVGQETCKDKCLQNCSCNAYA--DI--PGIGCMLWRGELIDVKSFEK 426
+KLPD A V +G + C+ KCL++C+C A+A DI G GC+ W GEL D++++ K
Sbjct: 359 MKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAK 418
Query: 427 GGNLLHVRLPDSELGG-RSKISNXXXXXXXXXXXXXXXXSVWLLWRFRALCKDSTISCCK 485
GG L+VRL ++L R++ + ++ LW+ + K S +
Sbjct: 419 GGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQ--KRSILI--- 473
Query: 486 NNDTQLIDMSKGQEISTDFSGPSDMVVDG----SQVNGTD---LAMFNFNTIAVATNYFS 538
+T ++D Q S D +++V+ S+ N TD L + F +A+ATN FS
Sbjct: 474 --ETPIVDH---QLRSRDLL-MNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFS 527
Query: 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
NKLG+GGFG V+KGKL +GQ++AVKRLS+ S QG +EFKNE+ LIA+LQH NLVRLL
Sbjct: 528 NANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLA 587
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
CC+ EKMLIYEY+ N SLD +FD ++ + L+W RF II GIARGLLYLH+DSR RI
Sbjct: 588 CCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRI 647
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSV 718
IHRDLKASNILLD+ M PKISDFGMARIFG ++ EANT +VVGTYGYM+PEYAM+G+FS+
Sbjct: 648 IHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSM 707
Query: 719 KSDVYSFGVLLLEIVSGRRNTSF-RLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS-- 775
KSDV+SFGVLLLEI+S +RN F + + +L+ VW W EGK +E++DP I DSSS
Sbjct: 708 KSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTF 767
Query: 776 -QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSVDGDHF 834
Q+++LRCI +G+LCVQ+ A RPTM+ V+LML SE+ T+P P+ P + RS +D D
Sbjct: 768 RQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSS 827
Query: 835 MEAH---DTVSSNDLTVTMVVGR 854
++ + N +TV+++ R
Sbjct: 828 SSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 1.2e-175, Sum P(2) = 1.2e-175
Identities = 194/343 (56%), Positives = 251/343 (73%)
Query: 512 VDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS 571
++ V+G +L F+ +TI ATN FS NKLG+GGFGPV+KGKL +G++IAVKRLS S
Sbjct: 497 MEPQDVSGVNL--FDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSS 554
Query: 572 GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL 631
GQG +EF NEI LI+KLQH+NLVRLLGCCI+GEEK+LIYEY+ NKSLD+F+FD + +
Sbjct: 555 GQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEI 614
Query: 632 DWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691
DW KRF II+G+ARGLLYLHRDSRLR+IHRDLK SNILLDE M PKISDFG+AR+ Q
Sbjct: 615 DWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQ 674
Query: 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751
+ NT RVVGT GYMAPEYA G+FS KSD+YSFGVLLLEI+ G + + F EE +L+
Sbjct: 675 YQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFS-EEGKTLLA 733
Query: 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811
+ W W E K ++L+D + DSS +V RC+ +G+LCVQ RP ++ ML + +
Sbjct: 734 YAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMSMLTTIS 793
Query: 812 PTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
LP P+QPTFT S D D ++D ++ N++T +++ GR
Sbjct: 794 E-LPSPKQPTFTV--HSRDDDS--TSNDLITVNEITQSVIQGR 831
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 1.5e-175, Sum P(2) = 1.5e-175
Identities = 186/334 (55%), Positives = 246/334 (73%)
Query: 522 LAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNE 581
L F TI +ATN FS NKLG+GGFGPV+KGKL +G++IAVKRLS SGQG EEF NE
Sbjct: 474 LYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 533
Query: 582 IILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIE 641
I+LI+KLQH NLVR+LGCCI+GEE++L+YE+M NKSLD FIFD K+ +DW KRF+II+
Sbjct: 534 ILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSIIQ 593
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
GIARGLLYLHRDSRLRIIHRD+K SNILLD+ MNPKISDFG+AR++ + + NT R+VG
Sbjct: 594 GIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVG 653
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE-ENSSLIEHVWNLWNEG 760
T GYM+PEYA G+FS KSD YSFGVLLLE++SG + + F + E +L+ + W W E
Sbjct: 654 TLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLAYAWESWCEN 713
Query: 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQP 820
+ +D + DS ++V RC+ +G+LCVQ RP ++ ML + T LP+P++P
Sbjct: 714 GGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPADRPNTLELLSMLTT-TSDLPLPKEP 772
Query: 821 TFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
TF ++ +S DG D ++ N++T ++V+GR
Sbjct: 773 TF-AVHTSDDGSR---TSDLITVNEVTQSVVLGR 802
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 3.2e-175, Sum P(2) = 3.2e-175
Identities = 183/344 (53%), Positives = 244/344 (70%)
Query: 512 VDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS 571
++ V+G L F NTI AT+ FS NKLG+GGFG V+KGKL +G++IAVKRLS S
Sbjct: 473 LEPQDVSG--LKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSS 530
Query: 572 GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL 631
GQG EEF NEI+LI+KLQH+NLVR+LGCCI+GEE++L+YE++ NKSLD F+FD K+ +
Sbjct: 531 GQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEI 590
Query: 632 DWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691
DW KRF IIEGIARGL YLHRDS LR+IHRDLK SNILLDE MNPKISDFG+AR++ +
Sbjct: 591 DWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTE 650
Query: 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL-EENSSLI 750
+ NT RV GT GYMAPEYA G+FS KSD+YSFGV+LLEI++G + + F + +L+
Sbjct: 651 YQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLL 710
Query: 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810
+ W W E ++L+D ++ DS +V RC+ +G+LCVQ RP ++ ML +
Sbjct: 711 AYAWESWCESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRPNTMELLSMLTT- 769
Query: 811 TPTLPVPRQPTFTSMRSSVDGDHFMEAHDTVSSNDLTVTMVVGR 854
T L P+QPTF + D + + TV N++T ++++GR
Sbjct: 770 TSDLTSPKQPTFVV--HTRDEESLSQGLITV--NEMTQSVILGR 809
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81906 | B120_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5810 | 0.9613 | 0.9670 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.2021.1 | hypothetical protein (833 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 854 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-35 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-32 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-24 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 80/204 (39%), Positives = 110/204 (53%), Gaps = 18/204 (8%)
Query: 540 GNKLGRGGFGPVHKGKL-----PEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNL 593
G KLG G FG V+KGKL + ++AVK L S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V+LLG C + E ++ EYM L ++ + L + + IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEY 710
IHRDL A N L+ E++ KISDFG++R + + + R G +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS 734
EG F+ KSDV+SFGVLL EI +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 5e-54
Identities = 81/204 (39%), Positives = 112/204 (54%), Gaps = 17/204 (8%)
Query: 540 GNKLGRGGFGPVHKGKL-----PEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNL 593
G KLG G FG V+KG L + ++AVK L S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V+LLG C + E M++ EYMP L ++ + L + + IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEY 710
IHRDL A N L+ E++ KISDFG++R + + + +V G +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS 734
EG F+ KSDV+SFGVLL EI +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-51
Identities = 76/206 (36%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 541 NKLGRGGFGPVHKGKL----PEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNLVR 595
KLG G FG V+KGKL + ++AVK L S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFI------FDPAKQALLDWTKRFAIIEGIARGLLY 649
LLG C + E L+ EYM L ++ F +++ L + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANTNRVVGTYGYMAP 708
L + +HRDL A N L+ ED+ KISDFG++R ++ + T + +MAP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVS 734
E +G+F+ KSDV+SFGVLL EI +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 80/203 (39%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 540 GNKLGRGGFGPVHKGKL---PEGQDI--AVKRLSRKSG-QGLEEFKNEIILIAKLQHRNL 593
G KLG G FG V+KG L EG + AVK L + + EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
VRLLG C QGE ++ EYMP L F+ L + IA+G+ YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANTNRVVGTYGYMAPEYAM 712
+HRDL A N L+ E++ KISDFG++R I+ + + +MAPE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLK 177
Query: 713 EGLFSVKSDVYSFGVLLLEIVSG 735
+G F+ KSDV+SFGVLL EI +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 71/194 (36%), Positives = 105/194 (54%), Gaps = 11/194 (5%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
LG GGFG V+ + G+ +A+K + ++ S LEE EI ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
L+ EY SL + + + L + I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 661 RDLKASNILLDED-MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-YAMEGLFSV 718
RDLK NILLD D K++DFG++++ +++ +VGT YMAPE +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 719 KSDVYSFGVLLLEI 732
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKLQHRNLV 594
+ KLG G FG V+ + G+ +A+K + +K + E EI ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
RL ++ L+ EY L + + L + RF + + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQ-ILSALEYLHS-- 115
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
I+HRDLK NILLDED + K++DFG+AR VGT YMAPE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 715 LFSVKSDVYSFGVLLLEIVSGR 736
+ D++S GV+L E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 75/205 (36%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRL---SRKSGQGLEEFKNEIILIAKLQHRN 592
+ KLG G FG V+K K I AVK L S KS + + + EI ++ +L H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+VRL+ + L+ EY L ++ ++ L + I I RGL YLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-YA 711
IIHRDLK NILLDE+ KI+DFG+A+ + + T VGT YMAPE
Sbjct: 117 ---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLL 171
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGR 736
+ K DV+S GV+L E+++G+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
G LGRG FG V+ + G+ +AVK LS S + LE + EI +++ LQH N+VR
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 597 LGCCIQGEEKML-IY-EYMPNKSLDLFI--FDPAKQALL-DWTKRFAIIEGIARGLLYLH 651
G E+ L I+ EY+ SL + F + ++ +T++ I GL YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ------ILEGLAYLH 118
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
I+HRD+K +NIL+D D K++DFG A+ G + T V GT +MAPE
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGRR 737
+ +D++S G ++E+ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 536 YFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
F K+G+GGFG V+K + G+++A+K + +S + E+ NEI ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEGIARGLL 648
+ G ++ +E ++ E+ SL K L + + + + +GL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
YLH IIHRD+KA+NILL D K+ DFG++ + N +VGT +MAP
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAP 166
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
E + K+D++S G+ +E+ G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 40/114 (35%), Positives = 67/114 (58%), Gaps = 4/114 (3%)
Query: 218 WRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPANASYLLRFRIGWDGN 277
WRSG WN + F+G+P M L+ +++ F E++ +Y+TY N S R + +G+
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFT----ENNEEVYYTYRMTNNSIYSRLTLSSEGS 56
Query: 278 EEQLRWDGSAKKWSVIQKQPADDCELYNFCGNFGICNALGSTKCTCMEGFVPKH 331
E+ W +++ W++ P D C++Y CG +G C+ S KC C++GFVPK+
Sbjct: 57 LERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 57/115 (49%), Positives = 76/115 (66%), Gaps = 6/115 (5%)
Query: 78 EKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGN 137
+ VVWVANR P++D TL + +DGNL++ +GN VWSSN S + A+L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 138 LILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPS 192
L+L ++ GK WQSF+HPTDT LPG + G N +G +R TSWKS +DPS
Sbjct: 61 LVLYDNS-----GKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 51/122 (41%), Positives = 72/122 (59%), Gaps = 7/122 (5%)
Query: 39 QSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTL 98
+ G++L+S+G +FELGFF S Y I Y + VVWVANR+ P S TL
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNP-SGSSCTL 59
Query: 99 TIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFN 158
T+ +DGNL++ +G+ VWSSN + V+ N +L DDGNL+L + G WQSF+
Sbjct: 60 TLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVL-----YDSDGNFLWQSFD 114
Query: 159 HP 160
+P
Sbjct: 115 YP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 2e-34
Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 20/278 (7%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQH-RNLVR 595
KLG G FG V+ + + +A+K L++K + +E F EI ++A L H N+V+
Sbjct: 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L L+ EY+ SL+ + ++ L ++ I+ I L YLH
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---S 119
Query: 656 LRIIHRDLKASNILLDEDMN-PKISDFGMARIFGFNQNEAN----TNRVVGTYGYMAPEY 710
IIHRD+K NILLD D K+ DFG+A++ + ++ + VGT GYMAPE
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 711 AMEGLF---SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767
+ S SD++S G+ L E+++G F E+NSS + E +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPT-PSLA 236
Query: 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805
+ S+ + + + R + +S +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 69/198 (34%), Positives = 104/198 (52%), Gaps = 6/198 (3%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
F+ KLG G FG V +G +A+K L ++F+ E+ + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
C GE +I E M SL F+ P Q L + +A G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
IHRDL A NIL+ ED+ K++DFG+AR+ + ++ ++ Y + APE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 717 SVKSDVYSFGVLLLEIVS 734
S KSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 76/200 (38%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCC 600
KLG G FG V G +AVK L K G E F E ++ KL+H LV+L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+ E ++ EYM SL F+ + L + + IA G+ YL IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLES---RNYIH 126
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGLFS 717
RDL A NIL+ E++ KI+DFG+AR+ ++ A G + APE A G F+
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFT 182
Query: 718 VKSDVYSFGVLLLEIVS-GR 736
+KSDV+SFG+LL EIV+ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 71/206 (34%), Positives = 112/206 (54%), Gaps = 17/206 (8%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLS--RKSGQGLEEFKNEIILIAKLQHRNL 593
+ G+ +GRG FG V+KG L G +A+K++S + + L+ EI L+ L+H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFI--FDPAKQALLDWTKRFAIIEGIARGLLYLH 651
V+ +G + +I EY N SL I F P ++L+ + + + +GL YLH
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVY--VYQVLQGLAYLH 116
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-Y 710
+IHRD+KA+NIL +D K++DFG+A N + VVGT +MAPE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVI 171
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGR 736
M G S SD++S G ++E+++G
Sbjct: 172 EMSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 68/221 (30%), Positives = 118/221 (53%), Gaps = 22/221 (9%)
Query: 543 LGRGGFGPVHKGK-LPEGQ----DIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRL 596
LG G FG V+KG +PEG+ +A+K L ++ + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPA----KQALLDWTKRFAIIEGIARGLLYLHR 652
LG C+ + LI + MP L ++ + Q LL+W + IA+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
R++HRDL A N+L+ + KI+DFG+A++ ++ E + +MA E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 713 EGLFSVKSDVYSFGVLLLEIVS-GRR-NTSFRLEENSSLIE 751
+++ KSDV+S+GV + E+++ G + E L+E
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 16/280 (5%)
Query: 541 NKLGRGGFGPVHKGKLPEGQD-----IAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLV 594
+LG G FG V + D +AVK L+ Q +F+ EI ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 595 RLLGCC--IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ G C G LI EY+P+ SL ++ Q L F+ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLGS 127
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN--EANTNRVVGTYGYMAPEY 710
R IHRDL A NIL++ + KISDFG+A++ +++ + Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770
FS SDV+SFGV L E+ + + E +I + +EL+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810
R + + LC + RP+ A ++L+++
Sbjct: 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 75/201 (37%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
G +G+G FG V G GQ +AVK L S + F E ++ L+H NLV+LLG
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+QG ++ EYM SL ++ + + L FA+ + G+ YL
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NF 123
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPEYAMEGLF 716
+HRDL A N+L+ ED+ K+SDFG+A+ EA+ + G + APE E F
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 717 SVKSDVYSFGVLLLEIVS-GR 736
S KSDV+SFG+LL EI S GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 47/121 (38%), Positives = 72/121 (59%), Gaps = 8/121 (6%)
Query: 39 QSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTL 98
++ G++L+S +FELGFF+ + Y I Y + VVWVANR+ P+SD TL
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQND-YNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58
Query: 99 TIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFN 158
T+ +DGNL++ +G+ VWSSN + + N +L DDGNL++ + G WQSF+
Sbjct: 59 TLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVI-----YDSDGNFLWQSFD 113
Query: 159 H 159
+
Sbjct: 114 Y 114
|
Length = 114 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 73/219 (33%), Positives = 114/219 (52%), Gaps = 27/219 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGKL--PEGQD----IAVKRLSRK-SGQGLEEFKNEIILIAKLQ 589
F E +LG G FG V+KG+L P + +A+K L + +EF+ E L++ LQ
Sbjct: 9 FLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIF-------------DPAKQALLDWTKR 636
H N+V LLG C + + +++EY+ + L F+ D ++ LD +
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
I IA G+ YL S +HRDL A N L+ E + KISDFG++R I+ +
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ ++ +M PE + G F+ +SD++SFGV+L EI S
Sbjct: 184 SKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
+ K+G G G V+K G+++A+K++ R Q E NEI+++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF-------AIIEGIAR 645
+V + G+E ++ EYM SL ++ + + +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
GL YLH +IHRD+K+ NILL +D + K++DFG A +++ N+ VVGT +
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
MAPE + K D++S G++ +E+ G
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 72/205 (35%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 541 NKLGRGGFGPVHKG--KLPEGQ--DIAVKRLSR-KSGQGLEEFKNEIILIAKLQHRNLVR 595
+LG G FG V KG + G+ ++AVK L + G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFD----PAKQALLDWTKRFAIIEGIARGLLYLH 651
L+G C +GE ML+ E P L ++ P L + + +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSD-LKELAHQ------VAMGMAYLE 112
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPE 709
+HRDL A N+LL KISDFGM+R G ++ G + + APE
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPE 168
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVS 734
G FS KSDV+S+GV L E S
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 72/236 (30%), Positives = 107/236 (45%), Gaps = 36/236 (15%)
Query: 543 LGRGGFGPVHKGK---LPEGQD---IAVKRLSRKSGQGLEE-FKNEIILIAKLQHRNLVR 595
LG G FG V G+ L D +AVK L + + F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 596 LLGCCIQGEEKMLIYEYMPNKSL---------DLFIFDPAKQALLDWTKR--FAIIEGIA 644
G C +G+ ++++EYM + L D + + T I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN---RVVG 701
G++YL + +HRDL N L+ D+ KI DFGM+R + T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVGG 182
Query: 702 T----YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
+M PE M F+ +SDV+SFGV+L EI + + + L N +IE +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECI 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 543 LGRGGFGPV----HKGKLPEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVR 595
LG+G FG V K G+ A+K L +K + +E E +++++ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
L Q EEK+ L+ EY P +LF + + RF E I L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGG--ELFSHLSKEGRFSEERARFYAAE-IVLALEYLHS-- 111
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
L II+RDLK NILLD D + K++DFG+A+ + NT GT Y+APE +
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 715 LFSVKSDVYSFGVLLLEIVSGR 736
+ D +S GVLL E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
++G+G FG V+ + +G+ +K LS S + E+ NE+ ++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQA-------LLDWTKRFAIIEGIARGLLYL 650
+ + ++ EY L I K+ +LDW F + L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FV---QLCLALKYL 119
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
H SR +I+HRD+K NI L + K+ DFG++++ + A T VVGT Y++PE
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGRR 737
++ KSD++S G +L E+ + +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 542 KLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGC 599
LG+G G V+K + P G+ A+K++ + ++ E+ + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF--AIIEGIAR----GLLYLHRD 653
+ E ++ EYM SL LL + ++ IAR GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLA---------DLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
IIHRD+K SN+L++ KI+DFG++++ N VGT YM+PE
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQG 174
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
+S +D++S G+ LLE G+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 542 KLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
KLG G +G V+K GQ +A+K + + L+E EI ++ + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 601 IQGEEKMLIYEYMPNKS-LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
+ + ++ EY S D+ L + AI+ +GL YLH + I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKI 121
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVK 719
HRD+KA NILL+E+ K++DFG++ + NT V+GT +MAPE E ++ K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNK 179
Query: 720 SDVYSFGVLLLEIVSGR 736
+D++S G+ +E+ G+
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 79/197 (40%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCC 600
KLG G FG V G +A+K L K G E F E L+ +LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
Q E +I EYM N SL F+ P L K + IA G+ ++ R + IH
Sbjct: 71 TQ-EPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDL+A+NIL+ E + KI+DFG+AR+ N+ A + APE G F++KS
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKS 184
Query: 721 DVYSFGVLLLEIVS-GR 736
DV+SFG+LL EIV+ GR
Sbjct: 185 DVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 73/221 (33%), Positives = 107/221 (48%), Gaps = 22/221 (9%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+LG G FG VH GK D+A+K + R+ ++F E ++ KL H NLV+L G
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDP----AKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
C + ++ EYM N L ++ + + LLD + + YL +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD------VCEAMEYLESNG- 120
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAM 712
IHRDL A N L+ ED K+SDFG+AR +Q ++ GT + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFD 174
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
FS KSDV+SFGVL+ E+ S + + NS ++E V
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCC 600
KLG G FG V +G +AVK L K G ++F E ++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
E ++ E M SL ++ A +AL + + +A G+ YL + IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGLFS 717
RDL A N+L+ E+ K++DFG+AR+ + EA G + APE A+ FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 718 VKSDVYSFGVLLLEIVS-GR 736
+KSDV+SFG+LL EIV+ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQD------IAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNLVR 595
LGRG FG V K ++ + VK L K EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFI------FDPAKQALLDWTKRFAIIEGIARGLLY 649
LLG C + E +I EY L F+ + K L ++ A+ IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
L S R +HRDL A N L+ K+S +++ +N + ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIPLRWLAPE 188
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVS 734
E FS KSDV+SFGVL+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 22/210 (10%)
Query: 543 LGRGGFGPVHKGKL-------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLV 594
LG G FG V++G +AVK L + + Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLLYL 650
+LLG C+ E + +I E M L ++ D + LL + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 651 HRDSRLRIIHRDLKASNILLDE-----DMNPKISDFGMAR-IFGFNQNEANTNRVVGTYG 704
+ + IHRDL A N L+ E D KI DFG+AR I+ + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE ++G F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 10/197 (5%)
Query: 543 LGRGGFGPVHKG--KLPEGQ--DIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
+G G FG V +G KLP + D+A+K L + S + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G + M+I EYM N SLD F+ + + + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
+HRDL A NIL++ ++ K+SDFG++R ++ T + APE F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 718 VKSDVYSFGVLLLEIVS 734
SDV+SFG+++ E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 17/216 (7%)
Query: 541 NKLGRGGFGPVHKG-KLPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
NK+G+G FG V K + + + A+K+ LS+ + + EE +E ++AKL ++R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLD---WTKRFAIIEGIARGLLYLHRDS 654
+ + ++ EY N L + + L + W RF I I GL +LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAHLHSK- 120
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+I+HRD+K+ N+ LD N KI D G+A++ N N ANT +VGT Y++PE +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDK 176
Query: 715 LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLI 750
++ KSDV++ GV+L E +G+ F +LI
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKH--PFDANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 14/215 (6%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
++G G FG V G E + +A+K + R+ E+F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661
+ L++E+M + L ++ A++ + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 662 DLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGLFSV 718
DL A N L+ E+ K+SDFGM R +Q ++T GT + +PE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 719 KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
KSDV+SFGVL+ E+ S + T + NS ++E +
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-TPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGL-EEFKNEIILIAKLQHRNLVRLLGCC 600
K+G+G FG V+KG L ++AVK L +F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+Q + ++ E +P SL F+ + L K + A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDL A N L+ E+ KISDFGM+R + + APE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 721 DVYSFGVLLLEIVSG 735
DV+S+G+LL E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 90/293 (30%), Positives = 135/293 (46%), Gaps = 36/293 (12%)
Query: 536 YFSEGNKLGRGGFG--------PVHKGKLPEGQDIAVKRLSRKSGQGLEE-FKNEIILIA 586
Y + LG G FG P + G G+ +AVK L R+ GQ +K EI ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILK 61
Query: 587 KLQHRNLVRLLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIA 644
L H N+V+ GCC + K LI EY+P SL ++ P + L FA + I
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFA--QQIC 117
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG-----FNQNEANTNRV 699
G+ YLH IHRDL A N+LLD D KI DFG+A+ + E + V
Sbjct: 118 EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS---GRRNTSFRLEENSSLIEHVWNL 756
+ A E E FS SDV+SFGV L E+++ +++ + EE +I
Sbjct: 175 F----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQ 227
Query: 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+ +EL++ +R +N + C + A +RPT S++ +L+
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 79/290 (27%), Positives = 120/290 (41%), Gaps = 53/290 (18%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRN 592
LG G FG V++G +AVK L S Q +F E ++++K H+N
Sbjct: 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD-------PAKQALLDWTKRFAIIEGIAR 645
+VRL+G + + ++ E M L F+ + P+ + D +A+
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF---CARDVAK 127
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMAR-IFGFNQNEANTNRVVG 701
G YL + IHRD+ A N LL KI+DFGMAR I+ + R +
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-GRAML 183
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-------GRRNTSFRLEENSSLIEHVW 754
+M PE ++G+F+ K+DV+SFGVLL EI S GR N
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------------- 228
Query: 755 NLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+ ME V R + + C Q + RP A+++
Sbjct: 229 ------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 74/194 (38%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
KLG G FG V G +AVK L + ++ F E L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 602 QGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+ E +I EYM SL D D + LL F+ IA G+ Y+ R + IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIERKN---YIH 126
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDL+A+N+L+ E + KI+DFG+AR+ N+ A + APE G F++KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185
Query: 721 DVYSFGVLLLEIVS 734
DV+SFG+LL EIV+
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQD-----IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
LG+G FG V + QD +AVK+L + + L +F+ EI ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 598 GCCIQ-GEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
G C G + L+ EY+P SL ++ + LD K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG---TYGYMAPEYAM 712
R +HRDL NIL++ + KI DFG+ ++ ++ E R G + Y APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184
Query: 713 EGLFSVKSDVYSFGVLLLEIVS 734
E FSV SDV+SFGV+L E+ +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEF----KNEIILIAKLQHRNLVR 595
++G G +G V+K + G+ +A+K++ + E F EI L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 596 LLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQALLDWTK-RFAI--IEGIAR----G 646
L + +++EYM + DL LLD + +F I+ + G
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DL-------TGLLDSPEVKFTESQIKCYMKQLLEG 112
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
L YLH + I+HRD+K SNIL++ D K++DFG+AR + + TNRV+ T Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168
Query: 707 APEYAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
PE + + + D++S G +L E+ G+
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFK----NEIILIAKLQHR 591
+ + KLG G +G V+K + G+ +A+K++ + E EI L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA--IIEGIARGLLY 649
N+V+LL + L++EY + L ++ + K ++ G+A Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----Y 113
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
H RI+HRDLK NIL++ D K++DFG+AR FG T+ VV T Y APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYRAPE 168
Query: 710 YAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
L K D++S G + E+++G+
Sbjct: 169 I----LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 31/219 (14%)
Query: 543 LGRGGFGPVHKGKLP---EGQD---IAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVR 595
+G+G FG V + + P + +AVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-------------------LDWTKR 636
LLG C G+ L++EYM L+ F+ + +A L T++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
I + +A G+ YL S + +HRDL N L+ E+M KI+DFG++R I+ + +A+
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
N + +M PE ++ +SDV+++GV+L EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 72/244 (29%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 537 FSEGNKLGRGGFGPVHKGKL--PEG--QDIAVK--RLSRKSGQGLEEFKNEIILIAKLQH 590
G LG G FG V +G+L +G +AVK +L + +EEF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 591 RNLVRLLGCCIQGEEK------MLIYEYMPNKSLDLFIF------DPAK---QALLDWTK 635
N+++L+G C + M+I +M + L F+ P K Q LL
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL---- 116
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFG---FNQ 691
+F + IA G+ YL S IHRDL A N +L EDM ++DFG+++ I+ + Q
Sbjct: 117 KFMV--DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171
Query: 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751
V ++A E + +++ KSDV++FGV + EI + R T + EN + +
Sbjct: 172 GRIAKMPV----KWIAIESLADRVYTSKSDVWAFGVTMWEIAT-RGQTPYPGVENHEIYD 226
Query: 752 HVWN 755
++ +
Sbjct: 227 YLRH 230
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+KLG G +G V++G + +AVK L ++ +EEF E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
C + +I E+M +L ++ + +Q ++ + I+ + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPEYAMEGLFS 717
HRDL A N L+ E+ K++DFG++R + T + + APE FS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 718 VKSDVYSFGVLLLEIVS 734
+KSDV++FGVLL EI +
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 75/242 (30%), Positives = 119/242 (49%), Gaps = 28/242 (11%)
Query: 542 KLGRGGFGPVHKGK----LPEGQD---IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+LG G FG V + LPE QD +AVK L S ++F+ E L+ LQH+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPE-QDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLF---------IFDPAKQAL---LDWTKRFAIIEG 642
R G C +G ++++EYM + L+ F I + L + AI
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
IA G++YL + L +HRDL N L+ + + KI DFGM+R R +
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762
+M PE + F+ +SD++SFGV+L EI + + ++L N+ IE + +G+
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECI----TQGRE 242
Query: 763 ME 764
+E
Sbjct: 243 LE 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 80/300 (26%), Positives = 127/300 (42%), Gaps = 69/300 (23%)
Query: 543 LGRGGFGPVHKG------KLPEGQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHRNLVR 595
LG+G FG V++G K +A+K ++ S + EF NE ++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 596 LLGCCIQGEEKMLIYEYM-------------PNKSLDLFIFDPAKQALLDWTKRFAIIEG 642
LLG G+ +++ E M P + + P Q + E
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA-----AE- 127
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
IA G+ YL + +HRDL A N ++ ED+ KI DFGM R + E + R G
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 703 ----YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-------GRRNTSFRLEENSSLIE 751
+MAPE +G+F+ KSDV+SFGV+L E+ + G N E
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------------E 228
Query: 752 HVWNLWNEGKAMELVD--PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
V +G ++L + P+ + + +C Q + RPT +V L+
Sbjct: 229 EVLKFVIDGGHLDLPENCPDK-----------LLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/201 (34%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 542 KLGRGGFGPVHKG--KLPEGQDI--AVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLVRL 596
KLG G FG V +G G+ I AVK L +++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWT-KRFAIIEGIARGLLYLHRDSR 655
G + M++ E P SL + A L T +A+ IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYLESK-- 116
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN--EANTNRVVGTYGYMAPEYAME 713
R IHRDL A NILL D KI DFG+ R N++ + V + + APE
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRT 174
Query: 714 GLFSVKSDVYSFGVLLLEIVS 734
FS SDV+ FGV L E+ +
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAK-------L 588
F+ +G+G FG V+K Q +A+K + LEE ++EI I +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID------LEEAEDEIEDIQQEIQFLSQC 56
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKS-LDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+ + + G ++G + +I EY S LDL K LD T I+ + GL
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGL 111
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
YLH + IHRD+KA+NILL E+ + K++DFG++ ++ NT VGT +MA
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMA 166
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
PE + + K+D++S G+ +E+ G
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR----NLVR 595
+LG G G V K P G+ +AVK + + E + +I+ + H+ +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCNSPYIVG 63
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
G + + EYM SLD + + + + A+ + +GL YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEK-- 119
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
+IIHRD+K SNIL++ K+ DFG++ + A T VGT YMAPE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGND 175
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
+SVKSD++S G+ L+E+ +GR
Sbjct: 176 YSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 72/231 (31%), Positives = 106/231 (45%), Gaps = 45/231 (19%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKL------Q 589
F G +G G F V K E ++ A+K L ++ Q ++E K + + I K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNG 60
Query: 590 HRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFI-----FDPAKQALLDWTKRFAIIEGI 643
H +++L Q EE + + EY PN L +I D T RF E I
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD------EKCT-RFYAAE-I 111
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG--------------- 688
L YLH IIHRDLK NILLD+DM+ KI+DFG A++
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 689 FNQNEANTNR---VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+Q E N R VGT Y++PE E SD+++ G ++ ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
G +G G FG V +G+ GQ +AVK + K + F E ++ KL H+NLVRLLG
Sbjct: 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRI 658
I ++ E M +L F+ + + + +F++ +A G+ YL ++
Sbjct: 68 -ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KL 121
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSV 718
+HRDL A NIL+ ED K+SDFG+AR+ + +++ + APE FS
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSS 176
Query: 719 KSDVYSFGVLLLEIVS-GR 736
KSDV+S+GVLL E+ S GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 68/202 (33%), Positives = 115/202 (56%), Gaps = 20/202 (9%)
Query: 543 LGRGGFGPVHKGK-LPEGQDI----AVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRL 596
LG G FG V+KG +PEG+ + A+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDP----AKQALLDWTKRFAIIEGIARGLLYLHR 652
LG C+ + L+ + MP+ L ++ + Q LL+W + IA+G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
R++HRDL A N+L+ + KI+DFG+AR+ ++ E N + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 713 EGLFSVKSDVYSFGVLLLEIVS 734
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 71/226 (31%), Positives = 119/226 (52%), Gaps = 27/226 (11%)
Query: 530 IAVATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQGL-EEFKNEI 582
I ++T F E +LG FG V+KG L + Q +A+K L K+ L EEFK+E
Sbjct: 2 INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 583 ILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIF-------------DPAKQA 629
++ ++LQH N+V LLG + + +I+ Y + L F+ D ++
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 630 LLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFG 688
L+ I+ IA G+ +L S ++H+DL N+L+ + +N KISD G+ R ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ + N ++ +M+PE M G FS+ SD++S+GV+L E+ S
Sbjct: 177 ADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLE-EFKNEIILIAKLQHRNLV 594
E ++LG G G V K +L I A+K ++ L+ + E+ + + +V
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 595 RLLGCCIQGEEKML--IYEYMPNKSLDLFIFDPAKQALLDWTKRFAII---------EGI 643
+ G + + EY SLD I+ K KR I E +
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVK-------KRGGRIGEKVLGKIAESV 114
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
+GL YLH SR +IIHRD+K SNILL K+ DFG++ + A T GT
Sbjct: 115 LKGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTS 167
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YMAPE +S+ SDV+S G+ LLE+ R
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 26/223 (11%)
Query: 543 LGRGGFGPVHKGK-LPEGQDI----AVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRL 596
LG G FG VHKG +PEG I A+K + +SG Q +E + ++ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFI------FDPAKQALLDWTKRFAIIEGIARGLLYL 650
LG C G L+ + P SL + DP Q LL+W + IA+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYYL 125
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
R++HR+L A NILL D +I+DFG+A + + + + +MA E
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS--GRRNTSFRLEENSSLIE 751
+ G ++ +SDV+S+GV + E++S R E L+E
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 19/201 (9%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG-LEEFKNEIILIAKLQH---RNLVRLL 597
+GRG +G V++GK +P G+ +A+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA--IIEGIARGLLYLHRDSR 655
G ++G +I EY S+ + A +++ II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIA-----EKYISVIIREVLVALKYIHKVG- 121
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG- 714
+IHRD+KA+NIL+ N K+ DFG+A + NQN + + VGT +MAPE EG
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 715 LFSVKSDVYSFGVLLLEIVSG 735
+ K+D++S G+ + E+ +G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 70/196 (35%), Positives = 104/196 (53%), Gaps = 7/196 (3%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
KLG G FG V G +AVK L + E F E ++ KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661
E ++ EYM SL F+ D +AL + +A G+ Y+ R + IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIER---MNYIHR 126
Query: 662 DLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSD 721
DL+++NIL+ + + KI+DFG+AR+ N+ A + APE A+ G F++KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 722 VYSFGVLLLEIVSGRR 737
V+SFG+LL E+V+ R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 36/272 (13%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKRLS-----RKSGQGLEEFKNEIILIAKLQHRNL 593
G LG G FG V++G L +G AVK +S + + +++ + EI L++KLQH N+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLD--LFIFDPAKQALLD-WTKRFAIIEGIARGLLYL 650
V+ LG + + + E +P SL L + + ++ +T++ I GL YL
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYL 118
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
H R +HRD+K +NIL+D + K++DFGMA+ + G+ +MAPE
Sbjct: 119 H--DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEV 172
Query: 711 AM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769
+G + + +D++S G +LE+ +G+ S +E V ++ G++ EL P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK--------PPWSQLEGVAAVFKIGRSKEL--PP 222
Query: 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMA 801
I D S ++ I + C+Q RPT A
Sbjct: 223 IPDHLS-DEAKDFI---LKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--EIILIAKLQHRNLVRLLG 598
K+G G +G V+K + G+ +A+K++ + EI L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ L++E+M DL+ +Q L + + + + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE--YAMEGLF 716
+HRDLK N+L++ + K++DFG+AR FG + T+ VV T Y APE +G +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVV-TRWYRAPELLLGDKG-Y 176
Query: 717 SVKSDVYSFGVLLLEIVSGR 736
S D++S G + E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 69/218 (31%), Positives = 112/218 (51%), Gaps = 32/218 (14%)
Query: 539 EGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQG---------LEEFKNEIILIAKL 588
+G +G G FG V+ G G+ +AVK++ S L+ EI L+ +L
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEG 642
QH N+V+ LG + + + EY+P S+ ALL+ F +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQ 114
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN--QNEANTNR-- 698
I +GL YLH +R IIHRD+K +NIL+D KISDFG+++ N + N R
Sbjct: 115 ILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ G+ +MAPE + ++ K+D++S G L++E+++G+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 81/294 (27%), Positives = 126/294 (42%), Gaps = 53/294 (18%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
+LG G FG VH GK +A+K + + E+F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661
Q + ++ E+M N L ++ +Q L ++ + + G+ YL R+S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 662 DLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSD 721
DL A N L+ K+SDFGM R + + +++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 722 VYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLR 781
V+SFGVL+ W ++ EGK M + S +V+
Sbjct: 184 VWSFGVLM------------------------WEVFTEGK-MPF------EKKSNYEVVE 212
Query: 782 CIHVGMLCVQDSAMYRPTMAS-----VVLMLESETPTLPVPRQPTFTSMRSSVD 830
I G +YRP +AS V+ E P +PTF + ++
Sbjct: 213 MISRG------FRLYRPKLASMTVYEVMYSCWHEKPE----GRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 13/202 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLV 594
F++ ++G+G FG V+KG +++ A+K + + + +E+ + EI ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 595 RLLGCCIQGEEKMLIYEYMPNKS-LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
R G ++G + +I EY+ S LDL P ++ + I+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
R IHRD+KA+N+LL E + K++DFG+A Q + NT VGT +MAPE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 714 GLFSVKSDVYSFGVLLLEIVSG 735
+ K+D++S G+ +E+ G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 542 KLGRGGFGPVHKGKL----PEGQD---IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+LG G FG V + PE QD +AVK L S ++F E L+ LQH ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPE-QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL----------LDWTKRFAIIEGIA 644
+ G C++G+ ++++EYM + L+ F+ A+ L ++ I + IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG--- 701
G++YL + +HRDL N L+ E++ KI DFGM+R + + RV G
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTM 183
Query: 702 -TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN 746
+M PE M F+ +SDV+S GV+L EI + + ++L N
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 4e-23
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 543 LGRGGFGPVH------KGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
LG+GGFG V GK+ + + KRL ++ G+ + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
++ L+ M L I++ + + F + I GL +LH+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---R 114
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
RI++RDLK N+LLD+ N +ISD G+A + GT GYMAPE ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 717 SVKSDVYSFGVLLLEIVSGRRNTSFR 742
D ++ G L E+++GR + FR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR--SPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 543 LGRGGFGPVHKGKLPEGQ-DIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
LG+G +G V+ + Q IA+K + + + ++ EI L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 602 QGEEKMLIYEYMPNKSLDLFI---FDPAK---QALLDWTKRFAIIEGIARGLLYLHRDSR 655
+ + E +P SL + + P K Q ++ +TK+ I GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEGLKYLH---D 126
Query: 656 LRIIHRDLKASNILLDEDMNP-KISDFGMA-RIFGFNQNEANTNRVVGTYGYMAPEYAME 713
+I+HRD+K N+L++ KISDFG + R+ G N T GT YMAPE +
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEVIDK 183
Query: 714 GL--FSVKSDVYSFGVLLLEIVSGR 736
G + +D++S G ++E+ +G+
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 543 LGRGGFGPVHKG--KLPEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLL 597
+G G FG V G KLP ++I V + K+G + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G + + M++ EYM N SLD F+ Q + + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMG 126
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMAPEYA 711
+HRDL A NIL++ ++ K+SDFG++R+ + A T R G + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS 734
F+ SDV+S+G+++ E++S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 74/267 (27%), Positives = 120/267 (44%), Gaps = 29/267 (10%)
Query: 542 KLGRGGFGPVHK----------GKLPEGQD-----IAVKRL-SRKSGQGLEEFKNEIILI 585
KLG G FG VH G+ D +AVK L + + +F EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 586 AKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIE---- 641
++L++ N++RLLG C+ + +I EYM N L+ F+ ++ +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 642 -----GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696
IA G+ YL + L +HRDL N L+ KI+DFGM+R
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756
R V +MA E + G F+ SDV++FGV L E+ + + + L + +IE+
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248
Query: 757 W-NEGKAMELVDPNIRDSSSQNQVLRC 782
+ N+G+ + L + S ++RC
Sbjct: 249 FRNQGRQIYLSQTPLCPSPVFKLMMRC 275
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-23
Identities = 76/278 (27%), Positives = 134/278 (48%), Gaps = 37/278 (13%)
Query: 543 LGRGGFGPVHKG--KLPEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLL 597
+G G FG V +G K+P +++AV + K G + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G + + M+I EYM N +LD ++ D + ++ GIA G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMAPEYA 711
+HRDL A NIL++ ++ K+SDFG++R+ E + T G + APE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770
F+ SDV+SFG+++ E++S G R W++ N + M+ ++
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP--------------YWDMSNH-EVMKAINDGF 227
Query: 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
R + + + + C Q RP +V +L+
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
KLG+G FG V G +A+K L + E F E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661
E ++ EYM SL F+ L + + IA G+ Y+ R + +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 662 DLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSD 721
DL+A+NIL+ E++ K++DFG+AR+ N+ A + APE A+ G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185
Query: 722 VYSFGVLLLEIVSGRR 737
V+SFG+LL E+ + R
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
+LG G FG V GK D+A+K + ++ +EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 602 QGEEKMLIYEYMPNKSLDLFIFD----PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+ ++ EYM N L ++ + LL+ K + G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK---Q 120
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPEYAMEGL 715
IHRDL A N L+D+ K+SDFG++R + ++ T+ V + + PE +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 716 FSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHV 753
FS KSDV++FGVL+ E+ S G+ + NS +E V
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKM--PYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 65/213 (30%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGL------EEFKNEIILIAKLQH 590
+++G LG+G +G V+ G +GQ IAVK++ + L E+ + E+ L+ L+H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI--FDPAKQALL-DWTKRFAIIEGIARGL 647
N+V+ LG C+ + E++P S+ + F P + + +TK+ I++G+A
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVA--- 116
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR---IFGFNQNEANTNRVV-GTY 703
YLH + ++HRD+K +N++L + K+ DFG AR G + +N + + GT
Sbjct: 117 -YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+MAPE E + KSD++S G + E+ +G+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 66/207 (31%), Positives = 115/207 (55%), Gaps = 19/207 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFK-NEIILIAKLQ---H 590
+ E ++G G +G V+K + L G+ +A+K++ S +G+ EI L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 591 RNLVRLLGCC--IQGEEKM---LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
N+VRLL C + + ++ L++E++ ++ L ++ K L T + ++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD-LMRQLLR 118
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
G+ +LH RI+HRDLK NIL+ D KI+DFG+ARI+ F A T+ VV T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWY 172
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEI 732
APE ++ ++ D++S G + E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 84/299 (28%), Positives = 132/299 (44%), Gaps = 49/299 (16%)
Query: 540 GNKLGRGGFGPVHKGK------LPEGQDIAVKRLSRKSGQG-LEEFKNEIILIAKLQHRN 592
G LG G FG V K +AVK L + L + +E L+ ++ H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAI 639
+++L G C Q +LI EY SL F+ + K + LD A+
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 640 IEG--------IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691
G I+RG+ YL + ++++HRDL A N+L+ E KISDFG++R +
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVYE 179
Query: 692 NEANTNRVVG--TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSL 749
++ R G +MA E + +++ +SDV+SFGVLL EIV+ N +
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---- 235
Query: 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
E ++NL G ME R + ++ + + C + RPT A + LE
Sbjct: 236 -ERLFNLLKTGYRME------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 543 LGRGGFGPVHKGKL--PEGQDI--AVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLL 597
+G+G FG V+ G L +GQ I AVK L+R + + +E+F E I++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 598 GCCIQGE-EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
G C+ E +++ YM + L FI + F + +A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFN----QNEANTNRVVGTYGYMAPEYA 711
+ +HRDL A N +LDE K++DFG+AR I+ N V +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESL 174
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS 734
F+ KSDV+SFGVLL E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 70/247 (28%), Positives = 101/247 (40%), Gaps = 30/247 (12%)
Query: 544 GRGGFGPVHK-GKLPEGQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRNLVRLLGC 599
G+G FG V K + A+K ++++ +N E ++ +L H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 600 CIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
Q EE M L+ + + L + K + +F I E I L YLH I
Sbjct: 69 -FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHSK---GI 121
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSV 718
IHRD+K NILLDE + I+DF +A + T GT GYMAPE +SV
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 719 KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV--------WNLWNEGKAMELV---- 766
D +S GV E + G+R I W+ +A++ +
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST-EAIDAINKLL 237
Query: 767 --DPNIR 771
DP R
Sbjct: 238 ERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+G G V+ LP + +A+KR+ K ++E + E+ +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ G+E L+ Y+ SL + + LD +++ + +GL YLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 659 IHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANT-NRVVGTYGYMAPEYAMEGL- 715
IHRD+KA NILL ED + KI+DFG+ A + VGT +MAPE ME +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182
Query: 716 -FSVKSDVYSFGVLLLEIVSGR 736
+ K+D++SFG+ +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 29/216 (13%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKRL---SRKSGQG-------LEEFKNEIILIAKL 588
G +G+G +G V+ + G+ +AVK++ + +G+ ++ ++EI + L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 589 QHRNLVRLLGCCIQGEEKMLIY-EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
H N+V+ LG EE + I+ EY+P S+ + + + F E + GL
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFT--EQVLEGL 121
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR----IFGFNQNEANTNRVVGTY 703
YLH I+HRDLKA N+L+D D KISDFG+++ I+ N+ N + + G+
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---NDQNMS-MQGSV 174
Query: 704 GYMAPE--YAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
+MAPE ++ +S K D++S G ++LE+ +GRR
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 76/246 (30%), Positives = 121/246 (49%), Gaps = 35/246 (14%)
Query: 542 KLGRGGFGPVHKGK---LPEGQD---IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
+LG G FG V + L +D +AVK L + ++F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFI--FDPAKQALLDWTKRFA-----------IIEG 642
G C G+ ++++EYM + L+ F+ P L+D R A I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG- 701
IA G++YL + +HRDL N L+ ++ KI DFGM+R + + RV G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 702 ---TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758
+M PE M F+ +SDV+SFGV+L EI + + F+L N+ +IE +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECI----T 239
Query: 759 EGKAME 764
+G+ +E
Sbjct: 240 QGRVLE 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-22
Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 348 TQLQCQRNRSEAGESGGEDGFKVFKNVKLPDFA-DVVSVGQETCKDKCLQNCSCNAYA-D 405
T L C + S DGF +VKLPD A + ++ E C++ CL NCSC AYA +
Sbjct: 1 TPLNCGGDGST-------DGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYN 53
Query: 406 IPGIGCMLWRGELIDVKSFEKGGNLLHVRLP 436
GC+LW G L +++S GG L++RL
Sbjct: 54 NGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 541 NKLGRGGFGPVHK------GKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+G+G FG V K GK+ ++I ++ K Q L +E+ ++ +L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNIV 62
Query: 595 RLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRF---AIIEGIARGLL 648
R I +Y EY L I K+ K I + + LL
Sbjct: 63 RYYDR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLL 116
Query: 649 YLHR-----DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
L+ D ++HRDLK +NI LD + N K+ DFG+A+I G + + A T VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTP 174
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YM+PE + KSD++S G L+ E+ +
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 8e-22
Identities = 59/195 (30%), Positives = 107/195 (54%), Gaps = 10/195 (5%)
Query: 542 KLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
K+G+G G V+ + GQ++A+K+++ + E NEI+++ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+ G+E ++ EY+ SL D + +D + A+ + L +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RD+K+ NILL D + K++DFG Q++ +T +VGT +MAPE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 721 DVYSFGVLLLEIVSG 735
D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 72/220 (32%), Positives = 115/220 (52%), Gaps = 20/220 (9%)
Query: 537 FSEGNKLGRGGFGPV-HKGKLPEGQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRN 592
F++ ++G G FG V + + +A+K++S Q E++++ E+ + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ GC ++ L+ EY + D I + K+ L + + AI G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE--Y 710
R IHRD+KA NILL E K++DFG A + + AN+ VGT +MAPE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVIL 184
Query: 711 AM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSL 749
AM EG + K DV+S G+ +E+ R+ F + S+L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 70/197 (35%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGL-EEFKNEIILIAKLQHRNLVRLLGCC 600
KLG+G FG V G +A+K L K G + E F E ++ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+ E ++ E+M SL L L + + IA G+ Y+ R + IH
Sbjct: 70 VSEEPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RDL+A+NIL+ +++ KI+DFG+AR+ N+ A + APE A+ G F++KS
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184
Query: 721 DVYSFGVLLLEIVSGRR 737
DV+SFG+LL E+V+ R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
KLG+G +G V+K K L + Q A+K L S + E+ NEI ++A + H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL---DWTKRFAIIEGIARGLLYLHRDSR 655
+ G + ++ EY P L I K+ L R I + RGL LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI--QLLRGLQALHE--- 121
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
+I+HRDLK++NILL + KI D G++++ +N A T +GT YMAPE
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QIGTPHYMAPEVWKGRP 177
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
+S KSD++S G LL E+ +
Sbjct: 178 YSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
KLG G FG V + +AVK + + +E F E ++ LQH LV+L +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 602 QGEEKMLIYEYMPNKSL-DLFIFDPAKQA----LLDWTKRFAIIEGIARGLLYLHRDSRL 656
E +I E+M SL D D + L+D++ + IA G+ ++ + +
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN-- 122
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
IHRDL+A+NIL+ + KI+DFG+AR+ N+ A + APE G F
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSF 180
Query: 717 SVKSDVYSFGVLLLEIVS-GR 736
++KSDV+SFG+LL+EIV+ GR
Sbjct: 181 TIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 71/214 (33%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 542 KLGRGGFGPVHKGKL-----PEGQDIAVKRLSR-KSGQGLEEFKNEIILIAKLQHRNLVR 595
+LG FG ++KG L Q +A+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIF--------------DPAKQALLDWTKRFAIIE 641
LLG Q + +++EY+ L F+ D ++ LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANTNRVV 700
IA G+ YL S +H+DL A NIL+ E ++ KISD G++R I+ + ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+M PE M G FS SD++SFGV+L EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 70/236 (29%), Positives = 122/236 (51%), Gaps = 34/236 (14%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDI---AVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
G LG G FG V +G+L + I AVK +++ + +E+F +E + + + H N++
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 595 RLLGCCIQGEEK------MLIYEYMPNKSLDLFI----------FDPAKQALLDWTKRFA 638
RL+G C+Q E ++I +M + L F+ + P Q L+ +
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT-QMLVKF----- 117
Query: 639 IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698
+ IA G+ YL S IHRDL A N +L+E+MN ++DFG+++ +N + R
Sbjct: 118 -MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGR 172
Query: 699 VVGT-YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
+ ++A E + +++ KSDV+SFGV + EI + R T + ENS + +++
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT-RGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLV 594
F++ K+G+G FG V KG Q + A+K + + + +E+ + EI ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 595 RLLGCCIQGEEKMLIYEYMPNKS-LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ G ++ + +I EY+ S LDL P LD T+ I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
+ IHRD+KA+N+LL E K++DFG+A + N VGT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 714 GLFSVKSDVYSFGVLLLEIVSG 735
+ K+D++S G+ +E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 70/199 (35%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ 602
+G+G FG V G G +AVK + K+ + F E ++ +L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV- 69
Query: 603 GEEKMLIY---EYMPNKSLDLFIFDPAKQALL-DWTKRFAIIEGIARGLLYLHRDSRLRI 658
EEK +Y EYM SL ++ + L D +F++ + + YL ++
Sbjct: 70 -EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEANN---F 123
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSV 718
+HRDL A N+L+ ED K+SDFG+ + Q+ + APE E FS
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFST 178
Query: 719 KSDVYSFGVLLLEIVS-GR 736
KSDV+SFG+LL EI S GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 39/242 (16%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQH 590
F+ G LG+G FG V + +L Q +AVK L S +EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 591 RNLVRLLGCCIQGEEK------MLIYEYMPNKSLDLFI---------FDPAKQALLDWTK 635
N+++L+G ++ K M+I +M + L F+ F Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFG---FNQ 691
RF I IA G+ YL S IHRDL A N +L+E+M ++DFG+++ I+ + Q
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751
A+ V ++A E + +++ SDV++FGV + EI++ R T + ENS +
Sbjct: 172 GCASKLPV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT-RGQTPYAGVENSEIYN 226
Query: 752 HV 753
++
Sbjct: 227 YL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 13/202 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLV 594
F++ ++G+G FG V KG Q + A+K + + + +E+ + EI ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 595 RLLGCCIQGEEKMLIYEYMPNKS-LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ G ++G + +I EY+ S LDL P D + +++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 120
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
+ IHRD+KA+N+LL E + K++DFG+A Q + NT VGT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 714 GLFSVKSDVYSFGVLLLEIVSG 735
+ K+D++S G+ +E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 39/224 (17%)
Query: 542 KLGRGGFGPVH----------KGKLPEGQD-------IAVKRLSRKSG--QGLEEFKNEI 582
KLG G FG VH K D +AVK L R E+F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFLKEV 70
Query: 583 ILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI--------FDPAKQALLDWT 634
++++L N+ RLLG C +I EYM N L+ F+ L ++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 635 KRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694
+ IA G+ YL L +HRDL N L+ ++ KI+DFGM+R N +
Sbjct: 131 TLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSS 183
Query: 695 NTNRVVGT----YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ RV G +MA E + G F+ KSDV++FGV L EI++
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 70/220 (31%), Positives = 112/220 (50%), Gaps = 20/220 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRN 592
FS+ ++G G FG V+ + + + +A+K++S Q E++++ E+ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
++ GC ++ L+ EY + DL + L + A+ G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+ +IHRD+KA NILL E K+ DFG A I A N VGT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 713 ---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSL 749
EG + K DV+S G+ +E+ R+ F + S+L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKR-----LSRKSGQGLEEFKNEIILIAKLQHRNL 593
G LG+G FG V+ + G+++AVK+ S ++ + + + EI L+ LQH +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 594 VRLLGCCIQGEEKMLIY-EYMPNKSLDLFIFDPAKQ--ALLDWTKRFAIIEGIARGLLYL 650
V+ GC ++ +E + I+ EYMP S + D K AL + R I G+ YL
Sbjct: 67 VQYYGC-LRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTR-KYTRQILEGVEYL 120
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA-RIFGFNQNEANTNRVVGTYGYMAPE 709
H + I+HRD+K +NIL D N K+ DFG + R+ + V GT +M+PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVS 734
+ K+DV+S G ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 540 GNKLGRGGFGPVHKG------KLPEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKL-QHR 591
G LG G FG V K E +AVK L + + L + +E+ ++ + +H+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 592 NLVRLLGCCIQGEEKMLIYEY----------------MPNKSLDLFIFDPAKQALLDWTK 635
N++ LLG C Q ++ EY S D D
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
FA +ARG+ +L S+ + IHRDL A N+L+ ED KI+DFG+AR
Sbjct: 137 -FAY--QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
T +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 5e-21
Identities = 67/220 (30%), Positives = 112/220 (50%), Gaps = 20/220 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRN 592
F++ ++G G FG V+ + + + +A+K++S Q E++++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ GC ++ L+ EY + DL + L + AI G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+ +IHRD+KA NILL E K++DFG A I + N VGT +MAPE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEVIL 194
Query: 713 ---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSL 749
EG + K DV+S G+ +E+ R+ F + S+L
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 543 LGRGGFGPVH--KGKLPEG----QDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+GRG FG VH + K + + I V+++++ + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
++ + M++ EY P +L +I L + T I+ + LL LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----ILHFFVQILLALHHVHTK 120
Query: 657 RIIHRDLKASNILLDE-DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
I+HRDLK NILLD+ M KI DFG+++I ++++A T VVGT Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEGKP 177
Query: 716 FSVKSDVYSFGVLLLEIVSGRR 737
++ KSD+++ G +L E+ S +R
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-21
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLE-EFKNEIILIAKLQHRNLVRLLGCCI 601
LG+G FG V KG L + +AVK Q L+ +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661
Q + ++ E +P F+ + +FA+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKN---CIHR 117
Query: 662 DLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG----TYGYMAPEYAMEGLFS 717
DL A N L+ E+ KISDFGM+R Q + G + APE G +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 718 VKSDVYSFGVLLLEIVS 734
+SDV+S+G+LL E S
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 45/214 (21%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN--------EIILIAKLQH 590
G KLG G + V+K + E G+ +A+K++ K G+ +E K+ EI L+ +L+H
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKI--KLGE-RKEAKDGINFTALREIKLLQELKH 61
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMP--------NKSLDLFIFDPAKQALLDWTKRFAIIEG 642
N++ LL L++E+M +KS+ + PA K + +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPAD------IK--SYMLM 110
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
RGL YLH + I+HRDLK +N+L+ D K++DFG+AR FG + N T++VV T
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-T 165
Query: 703 YGYMAPEYAMEGLFSVKS-----DVYSFGVLLLE 731
Y APE LF + D++S G + E
Sbjct: 166 RWYRAPEL----LFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.3 bits (231), Expect = 1e-20
Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 10/200 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
++ K+G+G G V + GQ++A+K+++ + E NEI+++ +L++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L + G+E ++ EY+ SL D + +D + A+ + L +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
++IHRD+K+ N+LL D + K++DFG Q++ +T +VGT +MAPE
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 716 FSVKSDVYSFGVLLLEIVSG 735
+ K D++S G++ +E+V G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 543 LGRGGFGPVHKG--KLPEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLL 597
+G G FG V +G KLP ++I V + KSG + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G + M+I E+M N +LD F+ Q + + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---SEMN 126
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMAPEYA 711
+HRDL A NIL++ ++ K+SDFG++R F +++ + + G + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR---FLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS-GRR 737
F+ SDV+S+G+++ E++S G R
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
GNK+G G FG V+ L G+ +AVK R+ + ++E +E+ ++ L+H NLV+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 597 LGCCIQGEEKMLIY-EYMPNKSLDLFIFDPAKQALLD--WTKRFAIIEGIARGLLYLHRD 653
G + EK+ I+ EY +L+ + +LD + + + + GL YLH
Sbjct: 65 YGVEVH-REKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH 118
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT--NRVVGTYGYMAPEYA 711
I+HRD+K +NI LD + K+ DFG A N + GT YMAPE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 712 MEGLFSVK---SDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
G +D++S G ++LE+ +G+R S L+ ++ HV
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE-LDNEFQIMFHV 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS-GQGLEEFK-NEIILIAKLQHRNL 593
+++ K+G G +G V+KG+ GQ +A+K++ +S +G+ EI L+ +LQH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
V L +Q LI+E++ S+DL ++ K +D + + I +G+L+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
R++HRDLK N+L+D K++DFG+AR FG T+ VV T Y APE
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVL 173
Query: 712 MEG-LFSVKSDVYSFGVLLLEIVSGR 736
+ +S D++S G + E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 59/196 (30%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
K+G G G V + G+ +AVK + + Q E NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+ GEE ++ E++ +L D Q L+ + + E + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 661 RDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVK 719
RD+K+ +ILL D K+SDFG A+I +++ +VGT +MAPE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 720 SDVYSFGVLLLEIVSG 735
D++S G++++E+V G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 10/200 (5%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
++ K+G+G G V+ + GQ++A+K+++ + E NEI+++ + ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L + G+E ++ EY+ SL D + +D + A+ + L +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
++IHRD+K+ NILL D + K++DFG Q++ +T +VGT +MAPE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191
Query: 716 FSVKSDVYSFGVLLLEIVSG 735
+ K D++S G++ +E+V G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 542 KLGRGGFGPVHKGKLPEGQD-----------------IAVKRL-SRKSGQGLEEFKNEII 583
KLG G FG VH ++ QD +AVK L + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI---------------FDPAKQ 628
++++L+ N++RLLG C+ + +I EYM N L+ F+ PA
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 629 AL-LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687
+ ++ + IA G+ YL S L +HRDL N L+ E++ KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747
R V +MA E + G F+ SDV++FGV L EI+ + + +
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 748 SLIEHVWNLW-NEGKAMELVDPNIRDSSSQNQVLRC 782
+IE+ + ++G+ + L P +L+C
Sbjct: 249 QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 39/213 (18%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAKLQHRN 592
K+G G +G V+K + G+ +A+K++ LE EI L+ +L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA----IIEG----IA 644
+VRLL + L++E++ LDL + +D + +I+ +
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL---DLDL-------KKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
+G+ Y H S R++HRDLK N+L+D + K++DFG+AR FG T+ VV T
Sbjct: 110 QGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV-TLW 164
Query: 705 YMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGR 736
Y APE + +S D++S G + E+V+ R
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 64/208 (30%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDI----AVKRLSR-KSGQGLEEFKNEIILIAKLQH 590
F + LG G FG V+KG +PEG+ + A+K L S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDP----AKQALLDWTKRFAIIEGIARG 646
++ RLLG C+ + LI + MP L ++ + Q LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+ YL R++HRDL A N+L+ + KI+DFG+A++ G ++ E + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVS 734
A E + +++ +SDV+S+GV + E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 543 LGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601
LG G FG V+K + E G A K + +S + LE+F EI ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661
+ ++ E+ +LD + + L + + + L +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDSIML--ELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 662 DLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS---- 717
DLKA NILL D + K++DFG++ + +T +GT +MAPE F
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPY 185
Query: 718 -VKSDVYSFGVLLLEIVSGR 736
K+D++S G+ L+E+
Sbjct: 186 DYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
K+G+G F V+K L +G+ +A+K++ + ++ EI L+ +L H N+++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQA-LLDWTKRFAIIEGIARGLLYLHRDSRL 656
I+ E ++ E L I KQ L+ + + L ++H S+
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SK- 125
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
RI+HRD+K +N+ + K+ D G+ R F A++ +VGT YM+PE E +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGY 183
Query: 717 SVKSDVYSFGVLLLEI 732
+ KSD++S G LL E+
Sbjct: 184 NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 70/229 (30%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 528 NTIAVATNYFSE---GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--- 580
+ A SE N++G G G V+K P G+ A+K + G + +
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQIC 120
Query: 581 -EIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLD-------LFIFDPAKQALLD 632
EI ++ + H N+V+ E ++ E+M SL+ F+ D A+Q
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ---- 176
Query: 633 WTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692
I+ GIA YLHR I+HRD+K SN+L++ N KI+DFG++RI Q
Sbjct: 177 ------ILSGIA----YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQT 221
Query: 693 EANTNRVVGTYGYMAPEYAMEGLFSVK-----SDVYSFGVLLLEIVSGR 736
N VGT YM+PE L D++S GV +LE GR
Sbjct: 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 539 EGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS----RKSGQG--LEEFKNEIILIAKLQHR 591
+G +LG G F ++ + + G +AVK+++ S Q +E + EI L+A+L H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI--FDPAKQALLDWTKRFAIIEGIARGLLY 649
+++R+LG + L E+M S+ + + K+A++ E + RGL Y
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSY 118
Query: 650 LHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARIFGFNQNEAN--TNRVVGTYGYM 706
LH + +IIHRD+K +N+L+D +I+DFG A A +++GT +M
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
APE + DV+S G +++E+ + +
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 19/199 (9%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
++G G +G V+K + + G+ +A+K + + G E + EI ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 600 CIQGEEKMLIYEYMPNKSL-DLF--IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
++ ++ ++ EY SL D++ P + + + R + +GL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNRVVGTYGYMAPEYA---M 712
IHRD+K +NILL ED + K++DFG+ A++ A +GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 713 EGLFSVKSDVYSFGVLLLE 731
+G + K D+++ G+ +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-20
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 20/220 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKN---EIILIAKLQHRN 592
F +++G G FG V+ ++ AVK++S Q E++++ E+ + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ GC ++ L+ EY + DL + L + AI G +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+ +IHRD+KA NILL E K++DFG A + N VGT +MAPE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVIL 190
Query: 713 ---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSL 749
EG + K DV+S G+ +E+ R+ F + S+L
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 27/204 (13%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
+LG G FG V+K K E G A K + KS + LE++ EI ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL----YLHRDSRL 656
+ ++ E+ P ++D + + LD I+ I R +L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHS---M 129
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGTYGYMAPEYAM- 712
+IIHRDLKA N+LL D + K++DFG++ +N R +GT +MAPE M
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 713 ----EGLFSVKSDVYSFGVLLLEI 732
+ + K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 66/204 (32%), Positives = 112/204 (54%), Gaps = 11/204 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFK-NEIILIAKLQHRNLV 594
F + KLG G + V+KG+ G+ +A+K + + +G EI L+ +L+H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 595 RLLGCCIQGEEK-MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
RL I E K ML++EYM +K L ++ + LD + + +G+ + H +
Sbjct: 62 RLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
R++HRDLK N+L+++ K++DFG+AR FG N +N VV T Y AP+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF-SNEVV-TLWYRAPDVLLG 174
Query: 714 G-LFSVKSDVYSFGVLLLEIVSGR 736
+S D++S G ++ E+++GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 543 LGRGGFGPVHKGKLPEG---QDIAVKRLSRKSGQG-LEEFKNEIILIAKL-QHRNLVRLL 597
+G G FG V K ++ + D A+KR+ + + +F E+ ++ KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFI-------FDPA------KQALLDWTKRFAIIEGIA 644
G C L EY P+ +L F+ DPA + L + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
RG+ YL S+ + IHRDL A NIL+ E+ KI+DFG++R E + +G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 186
Query: 705 --YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MA E +++ SDV+S+GVLL EIVS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 56/201 (27%), Positives = 110/201 (54%), Gaps = 12/201 (5%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
++ K+G+G G V+ + GQ++A+++++ + E NEI+++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L + G+E ++ EY+ SL D + +D + A+ + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
++IHRD+K+ NILL D + K++DFG A+I ++ + +VGT +MAPE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 715 LFSVKSDVYSFGVLLLEIVSG 735
+ K D++S G++ +E++ G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-19
Identities = 32/65 (49%), Positives = 42/65 (64%), Gaps = 6/65 (9%)
Query: 363 GGEDGFKVFKNVKLPDFADVV---SVGQETCKDKCLQNCSCNAYA--DI-PGIGCMLWRG 416
GG DGF N+KLPD + S+G + C+ +CL NCSC AYA DI G GC++W G
Sbjct: 2 GGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTG 61
Query: 417 ELIDV 421
EL+D+
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 536 YFSEGNKLGRGGFGPV---HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
Y K+G G G V G+ +AVK++ + Q E NE++++ QH N
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKS--TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V + + G+E ++ E++ +L D ++ + + + + L +LH
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNRVVGTYGYMAPEYA 711
+IHRD+K+ +ILL D K+SDFG A++ ++ +VGT +MAPE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVI 187
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSG 735
+ + D++S G++++E+V G
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 16/179 (8%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNL 593
+ ++G G G V K K G+ +A+K+ L R G + EI + QH +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD---PAKQALLDWTKRFAIIEGIARGLLYL 650
V+LL G +L+ EYMP+ L + D P +A K + + + +G+ Y+
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQ---VKSYMRM--LLKGVAYM 115
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
H I+HRDLK +N+L+ D KI+DFG+AR+F + +++ V T Y APE
Sbjct: 116 HA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 19/218 (8%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKG-------KLPEGQDIAVKRLSRK-SGQGLEEFKNEII 583
VA + +LG+G FG V++G PE + +A+K ++ S + EF NE
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEAS 61
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIF-------DPAKQALLDWTKR 636
++ + ++VRLLG QG+ ++I E M L ++ + QA K
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696
+ IA G+ YL+ + + +HRDL A N ++ ED KI DFGM R
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ + +M+PE +G+F+ SDV+SFGV+L EI +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 30/268 (11%)
Query: 542 KLGRGGFGPVHKGKLPEGQD-----------------IAVKRLSRKSGQGLE-EFKNEII 583
KLG G FG VH + + +AVK L + + +F EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIF-----DPAKQA---LLDWTK 635
++++L+ N++RLL CI + +I EYM N L+ F+ + A++A + ++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
+ IA G+ YL S L +HRDL N L+ ++ KI+DFGM+R
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
R V +M+ E + G F+ SDV++FGV L EI++ + + + +IE+
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248
Query: 756 LW-NEGKAMELVDPNIRDSSSQNQVLRC 782
+ ++G+ + L P + S +L C
Sbjct: 249 FFRDQGRQVYLPKPALCPDSLYKLMLSC 276
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 31/225 (13%)
Query: 530 IAVATNYFSEGNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKSGQ-GLEEFKNEII 583
IA++ + + + L G FG + G L + +++ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 584 LIAKLQHRNLVRLLGCCIQGEEK-MLIYEYMPNKSLDLFIFDP------AKQALLDWTKR 636
L+ L H+N++ +L CI+ E ++Y YM +L LF+ QAL + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL---STQ 117
Query: 637 ----FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQ 691
AI IA G+ YLH+ +IH+D+ A N ++DE++ KI+D ++R +F +
Sbjct: 118 QLVHMAI--QIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172
Query: 692 N--EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ N NR V +MA E + +S SDV+SFGVLL E+++
Sbjct: 173 HCLGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 28/219 (12%)
Query: 540 GNKLGRGGFGPVHK----GKLPEGQD----IAVKRLS-RKSGQGLEEFKNEIILIAKL-Q 589
G LG G FG V + G D +AVK L + + L + +E+ L+ + +
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI-----------FDPAK--QALLDWTKR 636
H+N++ LLG C Q +I EY +L F+ FD K + L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+ +ARG+ YL +SR R IHRDL A N+L+ ED KI+DFG+AR + + +
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+N + +MAPE + +++ +SDV+SFG+L+ EI +
Sbjct: 194 SNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-19
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 23/288 (7%)
Query: 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEII 583
N I + E N + RG G +KGK + G VK + + +EI
Sbjct: 683 ITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIA 735
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI 643
+ KLQH N+V+L+G C + LI+EY+ K+L + + L W +R I GI
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGI 789
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
A+ L +LH ++ +L I++D P + + +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISS 842
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763
Y+APE + KSD+Y FG++L+E+++G+ + S++E +++
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902
Query: 764 ELVDPNIRD--SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+DP+IR S +QN+++ +++ + C RP V+ LES
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 533 ATNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QH 590
T F +G G +G V+K + + GQ +A+K + EE K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 591 RNLVRLLGCCIQ------GEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFA----- 638
N+ G I+ ++ L+ E S+ DL + L KR
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIA 116
Query: 639 -IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN 697
I+ RGL YLH + ++IHRD+K NILL ++ K+ DFG++ NT
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT- 172
Query: 698 RVVGTYGYMAPE-----YAMEGLFSVKSDVYSFGVLLLEIVSG 735
+GT +MAPE + + +SDV+S G+ +E+ G
Sbjct: 173 -FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 540 GNKLGRGGFGPVHK------GKLPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKL-QHR 591
G LG G FG V + K +AVK L + E +E+ +++ L H
Sbjct: 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
N+V LLG C G ++I EY L L +++ L + +A+G+ +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
+ IHRDL A N+LL KI DFG+AR + N +MAPE
Sbjct: 159 SKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS 734
+++ +SDV+S+G+LL EI S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 543 LGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEE-FKNEIILIAKLQHRNLVRLLG 598
LG GGFG V K+ + + A+K + ++ G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+ ++ + ++ EY +L+ + ++T RF I + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGG--ELWTILRDRGLFDEYTARF-YIACVVLAFEYLHN---RG 113
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
II+RDLK N+LLD + K+ DFG A+ Q T GT Y+APE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 718 VKSDVYSFGVLLLEIVSGR 736
D +S G+LL E+++GR
Sbjct: 171 FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 66/208 (31%), Positives = 110/208 (52%), Gaps = 19/208 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNL 593
F + K+G G +G V+K + G+ +A+K RL ++ EI L+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 594 VRLLGCCIQGEEKM-LIYEYMPNKSLDLFI-FDPAKQALLDWTKR--FAIIEGIARGLLY 649
V+LL I E K+ L++E++ ++ L F+ P L K F +++G+A +
Sbjct: 62 VKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
H R++HRDLK N+L++ + K++DFG+AR FG T+ VV T Y APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPE 170
Query: 710 YAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
+ +S D++S G + E+V+ R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 543 LGRGGFGPVHKGK-LPEGQDI----AVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRL 596
LG G FG V+KG +P+G+++ A+K L S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDP----AKQALLDWTKRFAIIEGIARGLLYLHR 652
LG C+ + L+ + MP L ++ + Q LL+W + IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+R++HRDL A N+L+ + KI+DFG+AR+ ++ E + + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 713 EGLFSVKSDVYSFGVLLLEIVS 734
F+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 540 GNKLGRGGFGPV--------HKGKLPEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-Q 589
G LG G FG V K K + +AVK L + + L + +E+ ++ + +
Sbjct: 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI-----------FDPAK--QALLDWTKR 636
H+N++ LLG C Q ++ EY +L ++ FD K + L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+ +ARG+ YL + + IHRDL A N+L+ ED KI+DFG+AR + + +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
TN + +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 194 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 540 GNKLGRGGFGPV--------HKGKLPEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKL-Q 589
G LG G FG V K K +AVK L S + + L + +E+ ++ + +
Sbjct: 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI-----------FDPAK--QALLDWTKR 636
H+N++ LLG C Q +I EY +L ++ ++P + + L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+ +ARG+ YL + + IHRDL A N+L+ ED KI+DFG+AR I + +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
TN + +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 200 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 65/268 (24%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 543 LGRGGFG-PVHKGKLPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
LG+G FG + + + K L+R S + + NEI++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
+ ++ EY +L I K L + + I + Y+H+ I+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVK 719
HRD+K NI L + K+ DFG+++I G + A T VVGT YM+PE ++ K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFK 181
Query: 720 SDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQV 779
SD+++ G +L E+++ +R +F + ++ + V + + SS +
Sbjct: 182 SDIWALGCVLYELLTLKR--TF---DATNPLNLVVKIVQGNYTPVVS----VYSSELISL 232
Query: 780 LRCIHVGMLCVQDSAMYRPTMASVVLML 807
+ +Q RPT V+
Sbjct: 233 VHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 543 LGRGGFGPVHKGKL-PEGQD----IAVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLVRL 596
LG G FG V + PEG + +AVK L +SG + + K EI ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 597 LGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
G C + LI E++P+ SL ++ P + ++ ++ I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN--EANTNRVVGTYGYMAPEYAM 712
R + +HRDL A N+L++ + KI DFG+ + ++ + + Y APE +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185
Query: 713 EGLFSVKSDVYSFGVLLLEIVS 734
+ F + SDV+SFGV L E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 22/229 (9%)
Query: 537 FSEGNKLGRGGFGPV------HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH 590
F + LG+GGFG V GK+ + + KR+ ++ G+ + NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
R +V L + L+ M L I+ + + F E I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDL 118
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR-VVGTYGYMAPE 709
H++ RI++RDLK NILLD+ + +ISD G+A + E T + VGT GYMAPE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAPE 171
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSG-----RRNTSFRLEENSSLIEHV 753
++ D ++ G LL E+++G +R + EE L++ V
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 542 KLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLE-EFKNEIILIAKLQHRNLVRLLGC 599
++GRG FG V G+L + +AVK L+ +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
C Q + ++ E + + D F + L + ++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG-----TYGYMAPEYAMEG 714
HRDL A N L+ E KISDFGM+R + E G + APE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 715 LFSVKSDVYSFGVLLLEIVS 734
+S +SDV+SFG+LL E S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 543 LGRGGFGPV------HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
LG+GGFG V + GK+ + + KRL +KSG+ + + EI+ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
L+ M L I++ ++ L + + I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
I++RD+K N+LLD+ N ++SD G+A + T R GT GYMAPE E +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRA-GTNGYMAPEILKEEPY 171
Query: 717 SVKSDVYSFGVLLLEIVSGRRNTSFR 742
S D ++ G + E+V+GR T F+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR--TPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 540 GNKLGRGGFGPV--------HKGKLPEGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKL-Q 589
G LG G FG V K K E +AVK L + + L + +E+ ++ + +
Sbjct: 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI-----------FDPAK--QALLDWTKR 636
H+N++ LLG C Q +I EY +L ++ +D A+ + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+ +ARG+ YL + + IHRDL A N+L+ E+ KI+DFG+AR + + +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
TN + +MAPE + +++ +SDV+SFGVL+ EI +
Sbjct: 197 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 47/291 (16%)
Query: 542 KLGRGGFGPVHKG------KLPEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLV 594
+LG+G FG V++G K +AVK ++ S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIF-------DPAKQALLDWTKRFAIIEGIARGL 647
RLLG +G+ +++ E M + L ++ + + + + IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT----Y 703
YL+ + +HRDL A N ++ D KI DFGM R + E + R G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763
+MAPE +G+F+ SD++SFGV+L EI +SL E + +G +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI--------------TSLAEQPY----QGLSN 227
Query: 764 ELVDPNIRDSSSQNQVLRC---IHVGM-LCVQDSAMYRPTMASVVLMLESE 810
E V + D +Q C + M +C Q + RPT +V +L+ +
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 44/217 (20%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL----- 596
LGRG +G V K + +P G +AVKR+ R + E Q R L+ L
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQE------------QKRLLMDLDISMR 55
Query: 597 LGCCIQ---------GEEKMLIYEYMPNKSLDLF---IFDPAKQALLDWTKRFAIIEGIA 644
C E + I + + SLD F ++D D + A+ I
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV--SIV 113
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
+ L YLH S+L +IHRD+K SN+L++ + K+ DFG I G+ + G
Sbjct: 114 KALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDAGCKP 168
Query: 705 YMAPE-----YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YMAPE +G + VKSDV+S G+ ++E+ +GR
Sbjct: 169 YMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQG---LEEFKNEIILIAKLQHRNLVRLLG 598
+ +G +G V K DI A+K + + +++ E ++++ Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALL--------DWTKRFAIIEGIARGLLY 649
QG++ + L+ EY+P DL +LL D + I I L Y
Sbjct: 60 YSFQGKKNLYLVMEYLPGG--DLA-------SLLENVGSLDEDVAR--IYIAEIVLALEY 108
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN-------TNRVVGT 702
LH IIHRDLK NIL+D + + K++DFG+++ G + + N R+VGT
Sbjct: 109 LHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGT 164
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
Y+APE + S D +S G +L E + G
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFK-NEIILIAKLQHRNLVRLLG 598
K+G G +G V+K + + IA+K++ + +G+ EI L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ--ALLDWTKRFAIIEG----IARGLLYLHR 652
+ L++EY LDL D K + D+ K +I+ I RG+ Y H
Sbjct: 69 VVHSEKRLYLVFEY-----LDL---DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH- 119
Query: 653 DSRLRIIHRDLKASNILLDEDMNP-KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
S R++HRDLK N+L+D N K++DFG+AR FG T+ VV T Y APE
Sbjct: 120 -SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEIL 175
Query: 712 MEGL-FSVKSDVYSFGVLLLEIVSGR 736
+ +S D++S G + E+V+ +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 542 KLGRGGFGPVHKG--KLPEGQ-DIAVKRLSRKSGQGL-EEFKNEIILIAKLQHRNLVRLL 597
+LG G FG V KG K+ + Q D+A+K L ++ + + +E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G C + E ML+ E L+ F+ K+ + + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPEYAMEGL 715
+HRDL A N+LL KISDFG+++ G + + R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174
Query: 716 FSVKSDVYSFGVLLLEIVS 734
FS +SDV+S+G+ + E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKRL-----SRKSGQGLEEFKNEIILIAKLQHRNL 593
G LGRG FG V+ G+++AVK++ S+++ + + + EI L+ L+H +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 594 VRLLGCCIQGEEKML--IYEYMPNKSLDLFIFDPAKQALLD-WTKRFAIIEGIARGLLYL 650
V+ GC EEK L EYMP S+ + A AL + T+R+ I +G+ YL
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYT--RQILQGVSYL 122
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA-RIFGFNQNEANTNRVVGTYGYMAPE 709
H + I+HRD+K +NIL D N K+ DFG + RI + V GT +M+PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVS 734
+ K+DV+S ++E+++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 58/183 (31%), Positives = 95/183 (51%), Gaps = 21/183 (11%)
Query: 541 NKLGRGGFGPVHKGKLPEGQDI-AVKRL---SRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
K+G+G FG V K + + + I A+K++ + K G + + EI ++ L+H N+V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 597 LGCC-----IQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARGLLY 649
+ C K Y DL + + + L K+ +++ + GL Y
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKMLLNGLYY 134
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN---TNRVVGTYGYM 706
+HR+ +I+HRD+KA+NIL+ +D K++DFG+AR F ++N TNRVV T Y
Sbjct: 135 IHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYR 190
Query: 707 APE 709
PE
Sbjct: 191 PPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN----- 580
F T+ TN + + +G G FG V + GQ++A+K++ ++ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 581 ----EIILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTK 635
E+ L+ L+H N++ L I E + + E + DL ++ + +
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQ 111
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
F I RGL Y+H ++HRDLK SNIL++E+ + KI DFG+ARI Q+
Sbjct: 112 YFLY--QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQM 162
Query: 696 TNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGR 736
T V Y Y APE + + V+ D++S G + E++ G+
Sbjct: 163 TGYVSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAV-KRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
+LG G FG V+K + E +A K + KS + LE++ EI ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
++ E+ ++D + + ++ L + R + + L YLH + +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIR-VVCKQTLEALNYLHEN---KIIH 126
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGTYGYMAPEYAM----- 712
RDLKA NIL D + K++DFG++ +N R +GT +MAPE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 713 EGLFSVKSDVYSFGVLLLEI 732
+ + K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 543 LGRGGFGPVHK-GKLPEGQDI-AVKRLS----------RKSGQGLEEFKNEIILIAK-LQ 589
LG G FG V+K K GQ++ A+K ++ R+ + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
H N+VR ++ + ++ + + L + F K+ + + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
YLH++ R I+HRDL +NI+L ED I+DFG+A+ Q E+ VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVS 734
E + K+DV++FG +L ++ +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 543 LGRGGFGPVHKG--KLPEGQD--IAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
LG G FG + +G KLP ++ +A+ L + S + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G +G M++ EYM N +LD F+ Q L + ++ G+A G+ YL S +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMAPEYA 711
+H+ L A +L++ D+ KIS F + E + + T + APE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS-GRR 737
FS SDV+SFG+++ E++S G R
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 46/202 (22%)
Query: 536 YFSEGNKLGRGGFGPVHKGKL---PEGQDIAVKRL--SRKSGQGLEEFK-NEIILIAKLQ 589
Y EG +GRG +G V+K K +G++ A+K+ ++ G+ + EI L+ +L+
Sbjct: 2 YEIEG-CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDW------TKRFAIIEGI 643
H N+V L+ ++ +K + Y+ +FD A+ L KR +I +
Sbjct: 61 HENVVSLVEVFLEHADKSV---YL--------LFDYAEHDLWQIIKFHRQAKRVSIPPSM 109
Query: 644 AR--------GLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQ 691
+ G+ YLH + ++HRDLK +NIL+ E KI D G+AR+F
Sbjct: 110 VKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---N 163
Query: 692 NE----ANTNRVVGTYGYMAPE 709
A+ + VV T Y APE
Sbjct: 164 APLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 75/228 (32%), Positives = 106/228 (46%), Gaps = 35/228 (15%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKNEI------ILIAKLQHRNLVR 595
LG+G FG V +L E + AVK L K L++ E IL H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 596 LLGCCIQGEEKML-IYEYMPNKSLDLFI-----FDPAKQALLDWTKRFAIIEGIARGLLY 649
L CC Q +++ + E++ L I FD A+ RF E I L++
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-------ARFYAAE-ITSALMF 111
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR--IFGFNQNEANTNRVVGTYGYMA 707
LH II+RDLK N+LLD + + K++DFGM + IF N T+ GT Y+A
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----NGKTTSTFCGTPDYIA 164
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
PE E L+ D ++ GVLL E++ G + F E L E + N
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG--HAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRL---SRKSGQGLEEFKNEIILIAKLQHRN 592
+ KLG G FG V+K ++ G+ +A+K++ + K G + + EI ++ KL+H N
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPN 68
Query: 593 LVRLLGCCI-----QGEEKMLIYEYMPNKSLDL--------FIFDPAKQALLDWTKRFAI 639
+V L+ + ++ +Y P DL ++
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC--------Y 120
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF---------GFN 690
+ + G+ YLH + I+HRD+KA+NIL+D KI+DFG+AR + G
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 691 QNEAN-TNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
TN VV T Y PE + E ++ D++ G + E+ + R
Sbjct: 178 GGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 581 EIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAII 640
E +L+ + H +++R+ + G ++ +P+ S DL+ + + L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVV 700
+ I GL YLH RIIHRD+K NI +++ I D G A+ F +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLA 217
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
GT APE ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKRL-----SRKSGQGLEEFKNEIILIAKLQHRNL 593
G LG+G FG V+ + G+++A K++ S ++ + + + EI L+ LQH +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 594 VRLLGCCI-QGEEKMLIY-EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
V+ GC + E+ + I+ EYMP S+ + A AL + R I G+ YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLH 123
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMA-RIFGFNQNEANTNRVVGTYGYMAPEY 710
+ I+HRD+K +NIL D N K+ DFG + R+ + V GT +M+PE
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ K+DV+S G ++E+++ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
Y K+G G G V + G+ +AVK++ + Q E NE++++ QH N+
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V + + G+E ++ E++ +L D ++ + A+ + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+IHRD+K+ +ILL D K+SDFG A++ ++ +VGT +MAPE
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELIS 189
Query: 713 EGLFSVKSDVYSFGVLLLEIVSG 735
+ + D++S G++++E+V G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 61/213 (28%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 542 KLGRGGFGPVHKGKLPE--GQDIAVKRL---SRKSGQGLEEFKNEIIL--IAKLQHRNLV 594
++G G +G V K + + G+ +A+KR+ + + G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 595 RLLGCCIQG----EEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
RL C E K+ L++E++ ++ L ++ + + T + + + + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH R++HRDLK NIL+ K++DFG+ARI+ F + VV T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742
++ ++ D++S G + E+ RR FR
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF--RRKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 542 KLGRGGFGPV------HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
K+G G G V H GK +AVK++ + Q E NE++++ H N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGK-----QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
+ + G+E ++ E++ +L D ++ + + + R L YLH
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG- 138
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+IHRD+K+ +ILL D K+SDFG A++ ++ +VGT +MAPE
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 715 LFSVKSDVYSFGVLLLEIVSG 735
+ + D++S G++++E++ G
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 543 LGRGGFGPVHKGKLPE-GQDIAVKRL-SRKSGQGLEEFKNEIILIAKLQH-RNLVRLLGC 599
+GRG FG V+K G +AVKR+ S + + ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 600 CIQGEEKMLIYEYMPNKSLDLF---IFDPAKQALLDWTKRFAIIEGIA----RGLLYLHR 652
+ + + E M + SLD F +++ K + + I+ IA + L YL
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE--- 709
+ L+IIHRD+K SNILLD + N K+ DFG I G + R G YMAPE
Sbjct: 126 E--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERID 180
Query: 710 -YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
A +G + V+SDV+S G+ L E+ +G+
Sbjct: 181 PSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 543 LGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRNLVRLLG 598
+G G +G V + G+ +A+K+LSR Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 599 CCIQGEEKML---IYEYMPNKSLDLF-IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+Y DL I Q L D +F ++ I RGL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKLSDDHIQF-LVYQILRGLKYIHS-- 136
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
IIHRDLK SNI ++ED KI DFG+AR + V T Y APE +
Sbjct: 137 -AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNW 190
Query: 715 LFSVKS-DVYSFGVLLLEIVSGR 736
+ ++ D++S G ++ E+++G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 543 LGRGGFGPVH------KGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
LG+GGFG V GKL + + KRL ++ +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFD--------PAKQALLDWTKRFAIIEGIARGL 647
Q + + L+ M L I++ P +A +T + I GL
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-YTAQ------IISGL 110
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
+LH+ RII+RDLK N+LLD D N +ISD G+A Q++ T GT G+MA
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMA 165
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
PE + D ++ GV L E+++ R
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 73/221 (33%), Positives = 107/221 (48%), Gaps = 46/221 (20%)
Query: 543 LGRGGFGPVHKGKLPEG---QDIAVKRLSR-KSGQGLEEFKNEIILIAKL-QHRNLVRLL 597
+G G FG V + + + + A+K L S +F E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 598 GCCIQGEEKMLIY---EYMPNKSLDLFI-------FDPA------------KQALLDWTK 635
G C E + +Y EY P +L F+ DPA Q LL
Sbjct: 70 GAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL---- 122
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
+FA +A G+ YL S + IHRDL A N+L+ E++ KI+DFG++R E
Sbjct: 123 QFAS--DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVY 172
Query: 696 TNRVVGTYG--YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ +G +MA E +++ KSDV+SFGVLL EIVS
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 47/129 (36%), Positives = 69/129 (53%), Gaps = 15/129 (11%)
Query: 611 EYMPNKSLD--LFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668
E+M SLD P +L I + GL YL+ + RI+HRD+K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVHRIMHRDIKPSNI 135
Query: 669 LLDEDMNPKISDFGMARIFGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGV 727
L++ K+ DFG++ G N A+T VGT YM+PE G ++VKSDV+S G+
Sbjct: 136 LVNSRGQIKLCDFGVS---GELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGI 190
Query: 728 LLLEIVSGR 736
++E+ G+
Sbjct: 191 SIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN--EIILIAKLQ-HRN 592
+ +LG G FG V+ + E G+ +A+K++ +K EE N E+ + KL H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPN 59
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V+L + +E ++EYM +L + D K + +II I +GL ++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV----VGTYGYMAP 708
HRDLK N+L+ KI+DFG+AR E + V T Y AP
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAP 167
Query: 709 EYAME-GLFSVKSDVYSFGVLLLEIVSGR 736
E + +S D+++ G ++ E+ + R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN----EIILIAKLQHRNLVRL 596
+G G +G V K + G+ +A+K+ K + E+ K E+ ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ L++EY+ L+L A L + I + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE----YAM 712
IIHRD+K NIL+ E K+ DFG AR T+ V T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGR 736
G V DV++ G ++ E++ G
Sbjct: 179 YG-KPV--DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 543 LGRGGFGPVHKGKLPEG---QDIAVKRLSRKSGQG-LEEFKNEIILIAKL-QHRNLVRLL 597
+G G FG V K ++ + D A+KR+ + + +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIA-----RGLLYLHR 652
G C L EY P+ +L F+ K +L+ FAI A + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 653 D--------SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
D S+ + IHRDL A NIL+ E+ KI+DFG++R E + +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174
Query: 705 --YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MA E +++ SDV+S+GVLL EIVS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 5e-16
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHRN 592
+G G +G V G+ +A+K++S F + EI L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 593 LVRLLGCCI-QGEEKM----LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
++ LL E ++ E M DL + Q L D ++ + I RGL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQY-FLYQILRGL 116
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN--TNRVVGTYGY 705
YLH + +IHRDLK SNIL++ + + KI DFG+AR +++E T VV T Y
Sbjct: 117 KYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWY 172
Query: 706 MAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
APE + ++ D++S G + E+++ +
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCI 601
+G G +G V+KG+ + +A ++ +G EE K EI ++ K HRN+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 602 Q------GEEKMLIYEYMPNKSLDLFIFDPAKQALLD-WTKRFAIIEGIARGLLYLHRDS 654
+ ++ L+ E+ S+ I + L + W I I RGL +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-- 712
++IHRD+K N+LL E+ K+ DFG++ ++ N +GT +MAPE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 713 ---EGLFSVKSDVYSFGVLLLEIVSG 735
+ + KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 8e-16
Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 47/213 (22%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLVRLL 597
LG G FG V + A+K LS+ K Q +E NE ++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR--------GLL 648
G Q + + L+ EY+P +LF + L + RF E +AR L
Sbjct: 68 GS-FQDDSNLYLVMEYVPGG--ELF-------SHLRKSGRFP--EPVARFYAAQVVLALE 115
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
YLH L I++RDLK N+LLD D KI+DFG A+ + T + GT Y+AP
Sbjct: 116 YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----KGRTYTLCGTPEYLAP 167
Query: 709 E------YAMEGLFSVKSDVYSFGVLLLEIVSG 735
E Y +V D ++ G+L+ E+++G
Sbjct: 168 EIILSKGYGK----AV--DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 542 KLGRGGFGPVHKG--KLPEGQD-IAVKRLSRKSGQGLEEFKNEIILIAK----LQHRNLV 594
+LG G FG V KG K+ + + +AVK L + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
R++G C + E ML+ E L+ F+ K + ++ ++ G+ YL +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN--EANTNRVVGTY--GYMAPEY 710
+HRDL A N+LL KISDFG+++ G ++N +A T+ G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH---GKWPVKWYAPEC 169
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS 734
FS KSDV+SFGVL+ E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 537 FSEGNKLGRGGFGPV------HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH 590
F + LG+GGFG V GK+ + + KR+ ++ G+ + NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
+ +V L + L+ M L I++ + F E I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDL 118
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
HR++ ++RDLK NILLD+ + +ISD G+A + E+ R VGT GYMAPE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEV 172
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742
+++ D + G L+ E++ G+ + FR
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ--SPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 543 LGRGGFGPV------HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
LG+GGFG V GK+ + + KR+ ++ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ L+ M L I++ + F E I GL LHR+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLHRE--- 121
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
RI++RDLK NILLD+ + +ISD G+A + E R VGT GYMAPE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGR-VGTVGYMAPEVVKNERY 178
Query: 717 SVKSDVYSFGVLLLEIVSGR 736
+ D + G L+ E++ G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
K+GRG F V++ L + + +A+K++ + ++ EI L+ +L H N+++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL-----HR 652
I+ E ++ E L I KQ KR + + + L H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQ------KRLIPERTVWKYFVQLCSAVEHM 122
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
SR R++HRD+K +N+ + K+ D G+ R F A++ +VGT YM+PE
Sbjct: 123 HSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIH 179
Query: 713 EGLFSVKSDVYSFGVLLLEIVS 734
E ++ KSD++S G LL E+ +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKRL-----SRKSGQGLEEFKNEIILIAKLQHRNL 593
G LG+G FG V+ G+++AVK++ S ++ + + + EI L+ L H +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 594 VRLLGCCIQGEEKML--IYEYMPNKSLDLFIFDPAKQ--ALLD-WTKRFAIIEGIARGLL 648
V+ GC E+ L E+MP S I D K AL + T+++ I G+
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYT--RQILEGVS 120
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA-RIFGFNQNEANTNRVVGTYGYMA 707
YLH + I+HRD+K +NIL D N K+ DFG + R+ + V GT +M+
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
PE + K+D++S G ++E+++ +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQ-GLE-EFKNEIILIAKLQ---HRNLVR 595
++G G +G V+K + P G +A+K + ++ + GL E+ L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 596 LLGCCIQG----EEKM-LIYEYMPNKSLDLFIFD-PAKQALLDWTKRFAIIEGIARGLLY 649
L+ C E K+ L++E++ ++ L ++ P + K ++ RGL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKD--LMRQFLRGLDF 123
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH + I+HRDLK NIL+ K++DFG+ARI+ + VV T Y APE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPE 177
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741
++ ++ D++S G + E+ RR F
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMF--RRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKS-GQGLEEFK-NEIILIAKLQHRNLVRLLG 598
K+G G +G V K K E + +A+KR+ +G+ EI L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+ ++K+ L++EY DL + + +D + + + +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LF 716
++HRDLK N+L++++ K++DFG+AR FG + V T Y P+ L+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 177
Query: 717 SVKSDVYSFGVLLLEIVSGRR 737
S D++S G + E+ + R
Sbjct: 178 STSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 542 KLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFK---NEIILIAKLQHRNLVRLL 597
++G+GG+G V K + +I A+KR+ + L E + E ++ + LV+LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
Q +E + L EY+P D L + RF + E + LH L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHE---L 120
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
IHRDLK N L+D + K++DFG+++ N VVG+ YMAPE +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAPEVLRGKGY 175
Query: 717 SVKSDVYSFGVLLLEIVSG 735
D +S G +L E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 542 KLGRGGFGPVH--KGKLPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
K+G G FG ++ K K + + +K L++ + E K E+IL+AK++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+ ++ EY L I + + L + + I+ GL ++H +
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHDR---K 121
Query: 658 IIHRDLKASNILLDED-MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
I+HRD+K+ NI L ++ M K+ DFG+AR + A T VGT Y++PE +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPY 179
Query: 717 SVKSDVYSFGVLLLEIVS 734
+ K+D++S G +L E+ +
Sbjct: 180 NNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 541 NKLGRGGFGPVHKG--KLPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
KLG G + V KG KL E +A+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ L++EY+ +K L ++ D + K F + I RGL Y HR
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR--- 123
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-EGL 715
+++HRDLK N+L++E K++DFG+AR + +N VV T Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
+S + D++ G + E+ SGR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 58/213 (27%), Positives = 112/213 (52%), Gaps = 27/213 (12%)
Query: 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRL---SRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
++G G +G V+K + + G+ +A+K++ + K G + + EI ++ +L HRN+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL 71
Query: 597 LGCCIQGEEKM----------LIYEYMPNKSLDLFIFDPAKQALLDWTKRF--AIIEGIA 644
++ + L++EYM + + L + L+ +++ + ++ +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-----ESGLVHFSEDHIKSFMKQLL 126
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
GL Y H+ + L HRD+K SNILL+ K++DFG+AR++ ++ TN+V+ T
Sbjct: 127 EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 705 YMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
Y PE + E + DV+S G +L E+ + +
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 541 NKLGRGGFGPVHKGKLPEGQD-IAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
+KLG G + V+KG+ + +A+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+ L++EY+ +K L ++ D + K F + + RGL Y HR +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---K 124
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL-F 716
++HRDLK N+L++E K++DFG+AR + +N VV T Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDY 182
Query: 717 SVKSDVYSFGVLLLEIVSGR 736
S + D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKNEIILIAKL------QHRNLVR 595
LG+G FG V +L ++ AVK L K L++ E + K +H L +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTK-RFAIIEGIARGLLYLHRD 653
L C Q ++++ + EY+ DL +F + D + RF E I GL +LH
Sbjct: 61 LH-SCFQTKDRLFFVMEYV--NGGDL-MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMAR--IFGFNQNEANTNRVVGTYGYMAPEYA 711
II+RDLK N+LLD + + KI+DFGM + I T+ GT Y+APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL----GGVTTSTFCGTPDYIAPEIL 168
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGR 736
+ D ++ GVLL E+++G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 39/216 (18%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLE---EFKNEIILIAKLQHR- 591
F + +LG G G V K P G +A K + LE +N+II K+ H
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH------LEIKPAIRNQIIRELKVLHEC 56
Query: 592 ---NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
+V G E + E+M SLD + A + + + +I + RGL
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPENILGKISI--AVLRGLT 113
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG--------MARIFGFNQNEANTNRVV 700
YL R+ + +I+HRD+K SNIL++ K+ DFG MA N V
Sbjct: 114 YL-RE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA------------NSFV 159
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
GT YM+PE ++V+SD++S G+ L+E+ GR
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 40/219 (18%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRL---SRKSGQGLEEFKNEIILIAKLQHRN 592
F + N++G G +G V++ + G+ +A+K++ + + G + + EI L+ L+H N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPN 67
Query: 593 LVRLLGCCIQG---EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKR-FA------IIEG 642
+V L + G + L+ EY DL +LLD F+ ++
Sbjct: 68 IVELKEV-VVGKHLDSIFLVMEYCEQ---DL-------ASLLDNMPTPFSESQVKCLMLQ 116
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ RGL YLH + IIHRDLK SN+LL + KI+DFG+AR +G T +VV T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-T 171
Query: 703 YGYMAPEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
Y APE L + D+++ G +L E+++ +
Sbjct: 172 LWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQHRN 592
F K+GRG F V++ L +G +A+K++ + + EI L+ +L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQA-LLDWTKRFAIIEGIARGLLYLH 651
+++ I+ E ++ E L I KQ L+ + + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
SR R++HRD+K +N+ + K+ D G+ R F A++ +VGT YM+PE
Sbjct: 124 --SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 178
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS 734
E ++ KSD++S G LL E+ +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 35/210 (16%)
Query: 543 LGRGGFGPV----HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAK------LQHRN 592
LG+G FG V KG + A+K L K LE+ E ++ + +H
Sbjct: 3 LGKGSFGKVMLAELKGT---NEFFAIKAL--KKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 593 LVRLLGCCIQGEEKML-IYEYMPNKSLDLFI-----FDPAKQALLDWTKRFAIIEGIARG 646
L L C Q +E + + EY+ L I FD A+ RF E I G
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAE-IICG 108
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
L +LH+ II+RDLK N+LLD+D + KI+DFGM + + +A+T GT Y+
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYI 163
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
APE ++ D +SFGVLL E++ G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCC 600
+G G +G V+KG+ + GQ A+K + + EE K EI ++ K HRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 601 I------QGEEKMLIYEYMPNKSLDLFIFDPAKQALL-DWTKRFAIIEGIARGLLYLHRD 653
I ++ L+ E+ S+ + + AL DW I I RGL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM- 712
++IHRD+K N+LL E+ K+ DFG++ ++ N +GT +MAPE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 713 ----EGLFSVKSDVYSFGVLLLEIVSG 735
+ + +SD++S G+ +E+ G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 51/197 (25%), Positives = 104/197 (52%), Gaps = 16/197 (8%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
++G G +G V+K + + G+ A+K + + G+ + EII++ +H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 601 IQGEEKMLIYEYMPNKSL-DLF-IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
++ ++ + E+ SL D++ + P ++ + + R + +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM---EGL 715
+HRD+K +NILL ++ + K++DFG++ A +GT +MAPE A +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 716 FSVKSDVYSFGVLLLEI 732
++ D+++ G+ +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 543 LGRGGFGPV------HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
LG+GGFG V GK+ + + KR+ ++ G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ L+ M L I++ + F E + GL L R+
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQRE--- 121
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR-VVGTYGYMAPEYAMEGL 715
RI++RDLK NILLD+ + +ISD G+A E T R VGT GYMAPE
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
++ D + G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 542 KLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600
++G G +G V+K L G+ AVK + + G + EI ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 601 IQGEEKMLIYEYMPNKSL-DLF-IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ E+ + EY SL D++ + P + + + R + +GL YLH ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM---EGL 715
HRD+K +NILL ++ + K++DFG+A A +GT +MAPE A G
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 716 FSVKSDVYSFGVLLLEI 732
++ D+++ G+ +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKR-LSRKSGQGLEEFK-NEIILIAKLQHRNLVRLLG 598
+G G +G V K K E GQ +A+K+ L + + +++ EI ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ + L++E++ + LD P LD ++ + I RG+ + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-EGLFS 717
IHRD+K NIL+ + K+ DFG AR E T+ V T Y APE + + +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTD-YVATRWYRAPELLVGDTKYG 179
Query: 718 VKSDVYSFGVLLLEIVSG 735
D+++ G L+ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 543 LGRGGFGPV---HKGKLPE-GQDIAVKRLSRKSGQGLEEF--KNEIILIAKLQHRNLVRL 596
LG+G FG V K P+ GQ A+K L + + + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
Q E K+ LI +++ + DLF + + +F + E +A L +LH
Sbjct: 64 -HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS--- 116
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
L II+RDLK NILLDE+ + K++DFG+++ +E GT YMAPE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 716 FSVKSDVYSFGVLLLEIVSG 735
+ +D +SFGVL+ E+++G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-14
Identities = 72/223 (32%), Positives = 103/223 (46%), Gaps = 52/223 (23%)
Query: 541 NKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKL-Q 589
KLG+G +G V K + +A+K++ + F+N EI+ + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 590 HRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIA 644
H N+V+LL I+ E IY EYM DL I L D KR+ I+ +
Sbjct: 66 HPNIVKLLNV-IKAENDKDIYLVFEYMET---DLHAVI---RANILEDVHKRY-IMYQLL 117
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV----V 700
+ L Y+H S +IHRDLK SNILL+ D K++DFG+AR E N V V
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYV 173
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGV-------LLLEIVSGR 736
T Y APE + S Y+ GV +L E++ G+
Sbjct: 174 ATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 542 KLGRGGFGPVH---KGKLPEGQDIAV-KRLSRKSGQGLEEFKN--EIILIAKLQHRNLVR 595
+LG+G FG V+ K + + V K + E + E L++KL H +V+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA---IIEGIARGLLYLHR 652
++ + +I EY + LD + K K + + E + LL +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLD-CKLEELKHT----GKTLSENQVCEWFIQLLLGVHY 121
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+ RI+HRDLKA NI L ++ KI DFG++R+ + + A T GT YM+PE
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178
Query: 713 EGLFSVKSDVYSFGVLLLEI 732
+ KSD++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFK-NEIILIAKLQHRNLVRLL 597
EG K+GRG +G V+K K +G+D L + G G+ EI L+ +L+H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 598 GCCIQGEEKM--LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY-----L 650
+ ++ L+++Y + + F A +A K + G+ + LLY +
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGI 121
Query: 651 HRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNE-ANTNRVVGTYGY 705
H ++HRDLK +NIL+ E KI+D G AR+F A+ + VV T+ Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 706 MAPEYAMEGLFSVKS-DVYSFGVLLLEIVS 734
APE + K+ D+++ G + E+++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 15/216 (6%)
Query: 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLG 598
LG+G FG V +L +G+ AVK L + +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 599 CCIQGEEKML-IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
C Q +E + + E++ L I D + L T F E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT--FYAAE-IVCGLQFLHSKG--- 116
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
II+RDLK N++LD D + KI+DFGM + F N A+T GT Y+APE ++
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYT 174
Query: 718 VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
D +SFGVLL E++ G+ + F ++ L E +
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ--SPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 67/204 (32%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAK------LQHRNLVR 595
LG+G FG V +L Q A+K L K L + E ++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 596 LLGCCIQGEEKML-IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
L C Q +E + + EY+ L I K D + I GL +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMAR--IFGFNQNEANTNRVVGTYGYMAPEYAM 712
I++RDLK NILLD D + KI+DFGM + + G +A T GT Y+APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILL 169
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGR 736
++ D +SFGVLL E++ G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFK-NEIILIAKLQHRNLVRLL 597
EG K+GRG +G V+K K +G+D L + G G+ EI L+ +L+H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 598 GCCIQGEEKM--LIYEYMPNKSLDLFIFDPAKQA-----LLDWTKRFAIIEGIARGLLYL 650
+ ++ L+++Y + + F A +A L + +++ I G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 651 HRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNE-ANTNRVVGTYGY 705
H + ++HRDLK +NIL+ E KI+D G AR+F A+ + VV T+ Y
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 706 MAPEYAMEGLFSVKS-DVYSFGVLLLEIVS 734
APE + K+ D+++ G + E+++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 46/199 (23%)
Query: 559 GQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHRNLVRLLGCCIQGEEKMLI 609
GQ++A+K+LSR F+N E++L+ + H+N++ LL
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 610 YEYMPNKSLDLF--------IFDP----AKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+ P KSL+ F + D Q LD + ++ + G+ +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
IIHRDLK SNI++ D KI DFG+AR G + T VV Y Y APE + +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYK 195
Query: 718 VKSDVYSFGVLLLEIVSGR 736
D++S G ++ E++ G
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 541 NKLGRGGFGPV----HKGKLPEGQDIAVKRLSRKSGQ-----GLEEFKNEIILIAKLQHR 591
+ +G G +G V HK P G +A+K++S Q L E K ++ + +H
Sbjct: 11 SYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKHE 63
Query: 592 NLVRLLGCCIQG-----EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646
N++ +L + ++ E M DL+ + D + F + I RG
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYF--LYQILRG 118
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV---VGTY 703
L Y+H + ++HRDLK SN+LL+ + + KI DFG+ARI + +T + V T
Sbjct: 119 LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATR 173
Query: 704 GYMAPEYAMEGLFSVKS-DVYSFGVLLLEIVSGR 736
Y APE + K+ D++S G +L E++S R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 39/212 (18%)
Query: 543 LGRGGFGPVHKG-KLPEGQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+G G +G V G +AVK+LSR +S + E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 600 CIQGEEKMLIYEYMPNKSLDLF-------------IFDPAK-QALLDWTKRFAIIEGIAR 645
+ P +SL+ F + + K Q L D +F I + I R
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILR 131
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
GL Y+H IIHRDLK SN+ ++ED KI DFG+AR + V T Y
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 183
Query: 706 MAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
APE + + ++ D++S G ++ E+++GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNE- 581
F +AV LGRG FG V + G+ A+K L + + +E E
Sbjct: 1 FRCLAV----------LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK 50
Query: 582 -IILIA-KLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFD---PAKQALLDWTK 635
I A +H LV L C Q E+ + + EY L + I +A
Sbjct: 51 RIFETANSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------ 103
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI-FGFNQNEA 694
F + GL YLH + +I++RDLK N+LLD + KI+DFG+ + GF
Sbjct: 104 VFYAAC-VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--- 156
Query: 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
T+ GT ++APE E ++ D + GVL+ E++ G
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFK-NEIILIAKLQHR----N 592
++LG+G +G V+K P G +A+K RL L+E K N+II+ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V G + EYM SLD + I + +GL +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY-- 710
+ IIHRD+K +N+L++ + K+ DFG++ + A TN +G YMAPE
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPERIK 174
Query: 711 ----AMEGLFSVKSDVYSFGVLLLEIVSGR 736
++V+SDV+S G+ +LE+ GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 40/92 (43%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ARG+ +L SR + IHRDL A NILL E+ KI DFG+AR + +
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE + +++ +SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLVRLL 597
+GRG FG V + + + A+K L + K Q + E ++A +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKLY 67
Query: 598 GCCIQGEEKM-LIYEYMPNKSL-----DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
Q EE + L+ EYMP L +F + RF I E + L +H
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETA-RFYIAE-LVLALDSVH 118
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMA--------------------------- 684
+ L IHRD+K NIL+D D + K++DFG+
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
R Q N VGT Y+APE + ++ D +S GV+L E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 543 LGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLE-EFKNEIILIAKLQHRNLVRLLGCC 600
LG G G V+K L + +AVK + L+ + +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660
+ E+M SLD++ P + L R A+ + +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIP-EHVL----GRIAV--AVVKGLTYLWS---LKILH 118
Query: 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKS 720
RD+K SN+L++ K+ DFG++ + A T VGT YMAPE + + S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKT--YVGTNAYMAPERISGEQYGIHS 174
Query: 721 DVYSFGVLLLEIVSGR 736
DV+S G+ +E+ GR
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 540 GNKLGRGGFGPVHKG--KLPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLV 594
G +G G FG V++G PE + IAV + K S E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 595 RLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIE---GIARGLLYL 650
+L+G E + ++ E P L ++ Q ++I ++ L YL
Sbjct: 71 KLIGVIT--ENPVWIVMELAPLGELRSYL-----QVNKYSLDLASLILYSYQLSTALAYL 123
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAP 708
R +HRD+ A N+L+ K+ DFG++R ++E+ G +MAP
Sbjct: 124 ES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755
E F+ SDV+ FGV + EI+ G + F+ +N+ +I + N
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVK--PFQGVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR--IFGFNQNEANTNRVV 700
IA GL +LH II+RDLK N++LD + + KI+DFGM + IFG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG----GKTTRTFC 162
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQD--IAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLL 597
LG+G FG V +L +G D A+K L + ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 598 GCCIQGEEKML-IYEYMPNKSLDLFIFDPAKQALLDWTK-RFAIIEGIARGLLYLHRDSR 655
CC Q ++++ + EY+ L +F + D + RF E + L++LHR
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG- 116
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
+I+RDLK NILLD + + K++DFGM + G N T GT Y+APE E
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK-EGIL-NGVTTTTFCGTPDYIAPEILQELE 172
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
+ D ++ GVL+ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR---- 591
F ++LG G G V K + P G +A K + + + +N+II ++ H
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI---RNQIIRELQVLHECNSP 63
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
+V G E + E+M SLD + AK+ + + +I + RGL YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYLR 120
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
+ +I+HRD+K SNIL++ K+ DFG++ ++ N VGT YM+PE
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERL 174
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGR 736
+SV+SD++S G+ L+E+ GR
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 543 LGRGGFGPVH------KGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LV 594
+GRGGFG V+ GK+ + + KR+ K G+ L NE I+++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPFI 59
Query: 595 RLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ +K+ I + M DL + RF E I GL ++H
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAE-IILGLEHMH-- 114
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
+R +++RDLK +NILLDE + +ISD G+A F + A+ VGT+GYMAPE +
Sbjct: 115 NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQK 169
Query: 714 GL-FSVKSDVYSFGVLLLEIVSG 735
G+ + +D +S G +L +++ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 545 RGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKN----EIILIAKLQHRNLVRLLGC 599
+G FG V+ K G A+K L + + N I++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL----LDWTKRFAIIEGIARGLLYLHRDSR 655
+ L+ EY+ I + L DW K++ I + G+ LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
IIHRD+K N+L+D+ + K++DFG++R N+ + VGT Y+APE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVG 169
Query: 716 FSVKSDVYSFGVLLLEIVSGRR 737
SD +S G ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 71/279 (25%), Positives = 131/279 (46%), Gaps = 51/279 (18%)
Query: 543 LGRGGFGPV----HKGKLPEGQDIAVKRLSRKSGQGLEE--FKNEIILIAKLQHRNLVRL 596
+G+G +G V H+ +G+ +K+L+ ++ E + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 597 LGCCIQGEEKML-----------IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
+GE+ +L +Y + + L P Q +++W + IA
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL---PENQ-VVEWFVQ------IAM 113
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
L YLH I+HRDLK N+ L K+ D G+AR+ + A+T ++GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765
M+PE ++ KSDV++ G + E+ + + +F ++ +SL+ + EGK
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKH--AFNAKDMNSLVYRII----EGK---- 218
Query: 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+ P +D S + L + ML + RP++ S++
Sbjct: 219 LPPMPKDYSPE---LGELIATMLSKRPEK--RPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
I RGL YLH I+HRD+K N+L++ + KI DFG+AR+ ++++ T VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 703 YGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
Y Y APE M ++ D++S G + E++ R
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 543 LGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRNLVRLLG 598
+G G +G V Q +AVK+LSR Q L + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 599 C---CIQGEEKMLIYEYMPNKSLDLFIFDPAK-QALLDWTKRFAIIEGIARGLLYLHRDS 654
E +Y DL + K Q L D +F I + + RGL Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLN--NIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSAG 138
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
IIHRDLK SN+ ++ED +I DFG+AR Q + V T Y APE +
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNW 190
Query: 715 L-FSVKSDVYSFGVLLLEIVSGR 736
+ ++ D++S G ++ E++ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 543 LGRGGFGPVH------KGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LV 594
+GRGGFG V+ GK+ + + KR+ K G+ L NE I+++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPFI 59
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+ +K+ + N DL + RF E I GL ++H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGG-DLHYHLSQHGVFSEKEMRFYATE-IILGLEHMH--N 115
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
R +++RDLK +NILLDE + +ISD G+A F + A+ VGT+GYMAPE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 715 L-FSVKSDVYSFGVLLLEIVSGRRNTSFR 742
+ +D +S G +L +++ G ++ FR
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG--HSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 533 ATNYFSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFK--NEIILIAKLQ 589
AT+Y + KLG G + V+KG GQ +A+K +S K+ +G+ F E L+ L+
Sbjct: 4 ATSYLNL-EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 590 HRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
H N+V LL I +E + ++EYM I P L + R + + + RGL
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGLA 117
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
Y+H I+HRDLK N+L+ K++DFG+AR ++ ++ VV T Y P
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPP 172
Query: 709 EYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
+ + +S D++ G + +E++ G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIIL----IAKLQHR--NLVR 595
+G G G V+K + G +AVK++ R + EE K IL + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKR--ILMDLDVVLKSHDCPYIVK 78
Query: 596 LLGCCIQGEEKMLIYEYMPN--KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
G I + + E M L I P + +L + I + L YL
Sbjct: 79 CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYL--K 131
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF-NQNEANTNRVVGTYGYMAPEY-- 710
+ +IHRD+K SNILLD N K+ DFG I G ++A T R G YMAPE
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAKT-RSAGCAAYMAPERID 187
Query: 711 --AMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ +++DV+S G+ L+E+ +G+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 543 LGRGGFGPVHKG-KLPEGQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLG- 598
+G G +G V G+ +A+K+LSR +S + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 599 --CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ G+E Y MP DL L K ++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
IIHRDLK N+ ++ED KI DFG+AR +A V T Y APE + +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 717 SVKS-DVYSFGVLLLEIVSGR 736
++ D++S G ++ E+++G+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRL--SRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
K+G G FG K E G+ +K + S+ S + EE + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 599 CCIQGEEKMLIYEYMPNKSLDLF--------IFDPAKQALLDWTKRFAIIEGIARGLLYL 650
+ ++ +Y DL+ + P Q +LDW + I L ++
Sbjct: 67 SFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQ-ILDWFVQ------ICLALKHV 117
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
H +I+HRD+K+ NI L +D K+ DFG+AR+ A T +GT Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS 734
++ KSD+++ G +L E+ +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQG-----LEEFKNEIILIAKLQHRNL 593
N++ G +G V++ + G+ +A+K+L K +G L E I+L KLQH N+
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--KLQHPNI 66
Query: 594 VRL----LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIE------GI 643
V + +G + ++ ++ EY+ + DL K + + F E +
Sbjct: 67 VTVKEVVVGSNL--DKIYMVMEYVEH---DL------KSLMETMKQPFLQSEVKCLMLQL 115
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
G+ +LH + I+HRDLK SN+LL+ KI DFG+AR +G T VV T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TL 170
Query: 704 GYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
Y APE + +S D++S G + E+++ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 40/92 (43%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ARG+ +L SR + IHRDL A NILL E+ KI DFG+AR + +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE + +++ +SDV+SFGVLL EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 541 NKLGRGGFGPVHKG--KLPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+KLG G + V KG KL E +A+K RL + G + E+ L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL 68
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
L++EY+ + L ++ + + K F + RGL Y H+
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHKR--- 122
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL- 715
+I+HRDLK N+L++E K++DFG+AR + +N VV T Y P+ +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
+S D++ G +L E+ +GR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 41/115 (35%), Positives = 59/115 (51%), Gaps = 7/115 (6%)
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
R I E I L +LH+ L II+RD+K NILLD + + ++DFG+++ F + E
Sbjct: 108 RVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEER 162
Query: 696 TNRVVGTYGYMAPEYAM--EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748
GT YMAPE G D +S GVL E+++G + E+NS
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT--NRVV 700
+ RGL Y+H + +IHRDLK SN+L++ED +I DFGMAR + E V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 701 GTYGYMAPE--YAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
T Y APE ++ ++ D++S G + E++ GRR
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKN----EIILIAKLQ 589
N F +G G +G V K + E ++I A+K+ K + EE K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
N+V L + + L++EY+ L+L P + + + I + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSY--IYQLIKAIHW 115
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
H++ I+HRD+K N+L+ + K+ DFG AR + AN V T Y +PE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPE 171
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 39/92 (42%), Positives = 56/92 (60%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+A+G+ +L SR + IHRDL A NILL E+ KI DFG+AR + +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE + +++++SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 543 LGRGGFGPV----HKGKLPEGQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
+G G FG H Q A+K + KS +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVN---SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLFIFDP-----AKQALLDWTKRFAIIEGIARGLLYLH 651
+ + + ++ EY L I + +L W + + G+ ++H
Sbjct: 65 ES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
R++HRD+K+ NI L ++ K+ DFG AR+ A T VGT Y+ PE
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIW 172
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS 734
++ KSD++S G +L E+ +
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 542 KLGRGGFGPVHKGKLPEGQD---IAVKRLSRKSGQGLEEFKNEIILIAKLQ--------- 589
+LG+G +G V + E + +A+K+++ F +I+ L+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59
Query: 590 -HRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
H+N+ L I +Y Y DL + Q L D + I + I GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ-ILCGL 118
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF--GFNQNEANTNRVVGTYGY 705
Y+H + ++HRDLK N+L++ D KI DFG+AR F +N V T Y
Sbjct: 119 KYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 706 MAPEYAMEGLFSVKS-DVYSFGVLLLEIVSGR 736
APE + K+ DV+S G +L E++ +
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 18/191 (9%)
Query: 559 GQDIAVKRLSRKSGQGLEE---FKNEIILIAKLQHRNLVRLLGCCIQGEEKML-IYEYMP 614
G ++A+K L + + + F+ E L A+L H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---D 671
++L + A L + ++ + L H I+HRDLK NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 672 EDMNPKISDFGMARIF-GFNQNEAN----TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFG 726
+ K+ DFG+ + G + T V+GT Y APE + SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 727 VLLLEIVSGRR 737
++ LE ++G+R
Sbjct: 177 LIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+G G FG VH + A+K ++ + + NE ++ ++ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 599 CCIQGEEKML--IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ +++ L + EY+P +LF + + T F E I L YLH
Sbjct: 68 -WTEHDQRFLYMLMEYVPGG--ELFSYLRNSGRFSNSTGLFYASE-IVCALEYLHS---K 120
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
I++RDLK NILLD++ + K++DFG A+ + T + GT Y+APE
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSKGH 175
Query: 717 SVKSDVYSFGVLLLEIVSG 735
+ D ++ G+L+ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 32/191 (16%)
Query: 559 GQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616
G ++AVK+LSR ++ + E++L+ + H+N++ LL + P K
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93
Query: 617 SLDLF-----IFDPAKQAL-------LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664
SL+ F + + L LD + ++ + G+ +LH IIHRDLK
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 665 ASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYS 724
SNI++ D KI DFG+AR N T VV Y Y APE + + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWS 207
Query: 725 FGVLLLEIVSG 735
G ++ E+V G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 543 LGRGGFGPVHKGKLPEGQD----IAVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLV 594
LG+GG+G V + + G D A+K L + ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
L+ G + LI EY+ +LF+ + ++ T F + E I+ L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGIFMEDTACFYLSE-ISLALEHLHQ-- 118
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMAR--IFGFNQNEANTNRVVGTYGYMAPEYAM 712
II+RDLK NILLD + K++DFG+ + I T+ GT YMAPE M
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----GTVTHTFCGTIEYMAPEILM 173
Query: 713 EGLFSVKSDVYSFGVLLLEIVSG 735
D +S G L+ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 541 NKLGRGGFGPVHKGKLPEGQDIA---VKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRL 596
+++G G FG V G+ G A VK L + F E+ +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFI--------FDPAKQALLDWTKRFAIIEGIARGLL 648
LG CI+ +L+ E+ P L ++ K L R A +A GLL
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ----RMAC--EVASGLL 114
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN----TNRVVGTYG 704
+LH+ IH DL N L D++ KI D+G+A Q + +
Sbjct: 115 WLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLR 167
Query: 705 YMAPEYAME---GLFSVK----SDVYSFGVLLLEI 732
++APE L S+++S GV + E+
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 35/212 (16%)
Query: 543 LGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHRN 592
+GRG +G V K E + +A+K+++ F N EI L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 593 LVRLLGCCIQGEEKM------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646
++ + + + ++YE M DL + Q L D ++ + + + RG
Sbjct: 66 VIAIKDI-MPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRG 120
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
L Y+H + ++HRDLK SN+LL+ + + KI DFG+AR + + T VV T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRWYR 175
Query: 707 APEYAME-GLFSVKSDVYSFGVLLLEIVSGRR 737
APE + ++ DV+S G + E++ GR+
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 30/213 (14%)
Query: 542 KLGR----GGFGPVHKGKLPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
+G+ + K K P +AVK+ L S + L+ + EII +LQH N++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
+ I E ++ M S + + + L + F I++ + L Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIH---S 119
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMAR-----------IFGFNQNEANTNRVVGTYG 704
IHR +KAS+ILL D +S + + F ++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK------NLP 173
Query: 705 YMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSG 735
+++PE + L ++ KSD+YS G+ E+ +G
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ARG+ +L + +HRDL A N+LL + KI DFG+AR + N +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE + L++ SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 536 YFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKR--LSRKSGQGLEEFKN------------ 580
Y +G LG G +G V K G+ +A+K+ + S ++ +
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 581 EIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLF-IFDPAKQALLDWTKRFAI 639
E+ ++ +++H N++ L+ ++G+ L+ + M + DL + D K L + + I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS---DLKKVVD-RKIRLTESQVK-CI 124
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN--------- 690
+ I GL LH+ +HRDL +NI ++ KI+DFG+AR +G+
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 691 ----QNEANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
+ E T++VV T Y APE M + D++S G + E+++G+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 542 KLGRGGFGPVHKGKLP-EGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
KLG G + V+KGK G+ +A+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL--DWTKRFAIIEGIARGLLYLHRDSRL 656
E L++EY+ DL + L + K F + RGL Y+H+
Sbjct: 71 IIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLF--QLLRGLSYIHQRY-- 123
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL- 715
I+HRDLK N+L+ + K++DFG+AR + +N VV T Y P+ +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 716 FSVKSDVYSFGVLLLEIVSG 735
+S D++ G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEI----ILIAKLQHRNLVRLL 597
+G+G FG V K +G AVK L +K+ +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
E+ + +Y+ +LF ++ L+ RF E +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LN 116
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
II+RDLK NILLD + ++DFG+ + G + E T+ GT Y+APE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-EGV-EPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 718 VKSDVYSFGVLLLEIVSG 735
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--EIILIAKLQ-HRNLVRL 596
K+G G F V K + G+ A+K + +K + LE+ N EI + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 597 LGCCIQGEEK----------MLIYEYMPNKSLDLFIFDPAKQALLDWT-KRFAIIEGIAR 645
+ + M +YE + + K+ L + K + + + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGR----------KRPLPEKRVKSY--MYQLLK 111
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
L ++HR+ I HRD+K NIL+ +D K++DFG R G T + T Y
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWY 164
Query: 706 MAPEYAM-EGLFSVKSDVYSFGVLLLEIVS 734
APE + +G + K D+++ G + EI+S
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQHRNLVRLLG 598
+GRG + V +L + I ++ +K + ++ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
C Q ++ L+ EY+ DL ++ L + RF E I L +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGG--DLMFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
II+RDLK N+LLD D + K++D+GM + G + T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGD-TTSTFCGTPNYIAPEILRGEEYG 174
Query: 718 VKSDVYSFGVLLLEIVSGR 736
D ++ GVL+ E+++GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 36/95 (37%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV-VG 701
I+ GL +LHR II+RDLK N++LD + + KI+DFGM + + + T R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
T Y+APE + D +++GVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 35/95 (36%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
+ +GL YL + +I+HRD+K SNIL++ K+ DFG++ ++ N VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVG 164
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
T YM+PE +SV+SD++S G+ L+E+ GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 36/194 (18%)
Query: 559 GQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616
G +A+K+L R +S + E+ L+ ++H N++ LL + P+
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV------------FTPDL 87
Query: 617 SLDLF----IFDP---------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDL 663
SLD F + P K L + ++ + +GL Y+H IIHRDL
Sbjct: 88 SLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDL 144
Query: 664 KASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL-FSVKSDV 722
K N+ ++ED KI DFG+AR Q ++ V T Y APE + + ++ D+
Sbjct: 145 KPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDI 199
Query: 723 YSFGVLLLEIVSGR 736
+S G ++ E+++G+
Sbjct: 200 WSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 32/191 (16%)
Query: 560 QDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617
+++A+K+LSR ++ + E++L+ + H+N++ LL + P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 618 L----DLFI--------FDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKA 665
L D++I Q LD + ++ + G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 666 SNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSF 725
SNI++ D KI DFG+AR G + T VV Y Y APE + + D++S
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSV 211
Query: 726 GVLLLEIVSGR 736
G ++ E++ G
Sbjct: 212 GCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEI----ILIAKLQHRNLVRLL 597
+G+G FG V K +G+ AVK L +K+ +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
Q +K+ + +Y+ +LF +++ + RF E IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMAR--IFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
II+RDLK NILLD + ++DFG+ + I ++ T+ GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGI----EHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 715 LFSVKSDVYSFGVLLLEIVSG 735
+ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 13/97 (13%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+A+G+ +L + IHRD+ A N+LL + KI DFG+AR ++N VV
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-----MNDSNYVVKG 272
Query: 703 YG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE + +++V+SDV+S+G+LL EI S
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 43/201 (21%)
Query: 562 IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL- 620
+AVK++ Q ++ EI +I +L H N+V+ +YE + DL
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK-------------VYEVLGPSGSDLT 79
Query: 621 -FIFDPAK-------QALLDWTKRFAIIEG-------------IARGLLYLHRDSRLRII 659
+ + Q ++ + +G + RGL Y+H + ++
Sbjct: 80 EDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VL 136
Query: 660 HRDLKASNILLD-EDMNPKISDFGMARIFG--FNQNEANTNRVVGTYGYMAPEYAMEGLF 716
HRDLK +N+ ++ ED+ KI DFG+ARI ++ + +V + Y +P +
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNN 195
Query: 717 SVKS-DVYSFGVLLLEIVSGR 736
K+ D+++ G + E+++G+
Sbjct: 196 YTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQHRNLVRLLG 598
+GRG + V +L + + I ++ +K + ++ + E + + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 599 CCIQGEEKML-IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
C Q E ++ + EY+ DL ++ L + RF E I+ L YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
II+RDLK N+LLD + + K++D+GM + G + T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGD-TTSTFCGTPNYIAPEILRGEDYG 174
Query: 718 VKSDVYSFGVLLLEIVSGR 736
D ++ GVL+ E+++GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 560 QDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617
+++A+K+LSR ++ + E++L+ + H+N++ LL + P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 618 LDLF--------IFDP----AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKA 665
L+ F + D Q LD + ++ + G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 666 SNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSF 725
SNI++ D KI DFG+AR G + T VV Y Y APE + + D++S
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSV 204
Query: 726 GVLLLEIV 733
G ++ E+V
Sbjct: 205 GCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+A+G+ +L + IHRDL A NILL KI DFG+AR + N
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE +++ +SDV+S+G+LL EI S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKR-LSRKSGQGLEEFK-NEIILIAKLQHRN-LVRLL 597
K+G G +G V+K + G+ +A+K+ +G+ EI L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 598 GCCIQGEEKM------LIYEYMPN---KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
EEK L++EY+ + K +D P + K F + +G+
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY--QLLKGVA 124
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNP-KISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
+ H+ ++HRDLK N+L+D+ KI+D G+ R F ++ T+ +V T Y A
Sbjct: 125 HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIV-TLWYRA 179
Query: 708 PEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSF 741
PE + +S D++S G + E+ R+ F
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 41/249 (16%)
Query: 537 FSEGNKLGRGGFGPV----HKGKLPEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQ 589
F G LG G FG V HKG G+ A+K L ++ + ++ E ++ +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 590 HRNLVRLLGCCIQGEEKM-LIYEYMPN-------KSLDLFIFDPAKQALLDWTKRFAIIE 641
H +V ++ C Q E ++ + E++ + F D AK F E
Sbjct: 77 HPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK---------FYHAE 126
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
+ YLH II+RDLK N+LLD + K++DFG A+ + T + G
Sbjct: 127 -LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCG 177
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR----RNTSFRLEENSSLIEHVWNLW 757
T Y+APE D ++ GVLL E ++G +T FR+ E + W
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW 237
Query: 758 NEGKAMELV 766
+G+A +LV
Sbjct: 238 FDGRARDLV 246
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
IA GL +LH II+RDLK N++LD + + KI+DFGM + ++ T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGT 164
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
Y+APE + D ++FGVLL E+++G+ F E+ L + +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 8/188 (4%)
Query: 561 DIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL 620
D K++ K+ G + EI ++ + HR ++ L+ K + MP DL
Sbjct: 116 DEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY---RWKSTVCMVMPKYKCDL 172
Query: 621 FIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISD 680
F + L + I + L YLH IIHRD+K NI LDE N + D
Sbjct: 173 FTYVDRSGPL-PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGD 228
Query: 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTS 740
FG A + + GT +PE + K+D++S G++L E+ S + T
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM-SVKNVTL 287
Query: 741 FRLEENSS 748
F + SS
Sbjct: 288 FGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-10
Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 521 DLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKN 580
DL F I + S R G ++GK P+ + + KR+ + + + +N
Sbjct: 155 DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGK-PKCERLIAKRV-KAGSRAAIQLEN 212
Query: 581 EIILIAKLQHRNLVRLLGCCIQGEEKMLIYE---YMPNKSLDL----FIFDPA---KQAL 630
EI+ + +L H N++++ E++L E YM + D F++D A K
Sbjct: 213 EILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264
Query: 631 LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690
L R AI++ + + Y+H ++IHRD+K NI L+ D + DFG A F
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-K 319
Query: 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ EA VGT +PE + +D++S G++LL+++S
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQD----IAVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLV 594
LG G +G V + G D A+K L + + + E + E ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 595 RLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
L Q + K+ LI +Y+ +LF ++ + + E I L +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGE-IVLALEHLHK- 123
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM- 712
L II+RD+K NILLD + + ++DFG+++ F ++ E GT YMAP+
Sbjct: 124 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 713 -EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747
+G D +S GVL+ E+++G + E+NS
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 543 LGRGGFGPVHKGKLPEGQD----IAVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLV 594
LG G +G V + G D A+K L + + + +E + E ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 595 RLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
L Q E K+ LI +Y+ ++F + + RF E I L +LH+
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFSEDEVRFYSGE-IILALEHLHK- 123
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM- 712
L I++RD+K NILLD + + ++DFG+++ F ++ + T GT YMAPE
Sbjct: 124 --LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747
+G D +S G+L+ E+++G + E N+
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 32/91 (35%), Positives = 54/91 (59%)
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
LL +H +IHRD+K++NILL + K+ DFG ++++ ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
APE +S K+D++S GVLL E+++ +R
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 543 LGRGGFGPV--HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEI----ILIAKLQHRNLVRL 596
+G+G FG V K KL +G+ AVK L +K +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
Q EK+ N +LF +++ + RF E IA L YLH +
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGG-ELFFHLQRERSFPEPRARFYAAE-IASALGYLHS---I 115
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
I++RDLK NILLD + ++DFG+ + G Q++ T GT Y+APE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTT-FCGTPEYLAPEVIRKQPY 173
Query: 717 SVKSDVYSFGVLLLEIVSG 735
D + G +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+A G+ +L + +HRDL A N+L+ E KI DFG+AR + N +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE L++ SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-09
Identities = 27/77 (35%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 364 GEDGFKVFKNVKLPDFADVVS--VGQETCKDKCLQ-NCSCNAYADIP-GIGCMLWR-GEL 418
+D F N KLP F+ +V E C KCL NCSC ++ GC+LW L
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSL 61
Query: 419 IDVKSFEKGGNLLHVRL 435
D + F GG L+ ++
Sbjct: 62 GDARLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 542 KLGRGGFGPVHKGKLPEG---QDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLL 597
++G G FG V G++ G + VK L + Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL--DWTKRFAIIEGIARGLLYLHRDSR 655
G C + +L+ E+ P L ++ K L+ D T + IA GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-- 713
IH DL N LL D+ KI D+G++ +++ ++APE E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 714 -GLFSV----KSDVYSFGVLLLEI 732
L V +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 543 LGRGGFGPVHKGKLPE---------GQDIAVKRLSRKSGQGL-EEFKNEIILIAKLQHRN 592
LG+G F ++KG L GQ+++V S F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
LV+L G C++ E M + EY+ LD+F+ L W + + + +A L YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 653 DSRLRIIHRDLKASNILL-----DEDMNP--KISDFGMARIFGFNQNEANTNRVVGTYGY 705
+++H ++ NIL+ +E P K+SD G+ E R+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170
Query: 706 MAPEYAMEGLFSVKS--DVYSFGVLLLEIVSG 735
+APE G S+ D +SFG LLEI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 523 AMFNFNTIAVATNYFSEGNKLGRGGFGPVHK-GKLPEGQDIAVKRLSRKSGQGLEEFKNE 581
+M ++ T+ + +G+G +G V+K +G AVK L S EE + E
Sbjct: 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAE 68
Query: 582 IILIAKL-QHRNLVRLLGCCIQ-----GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTK 635
++ L H N+V+ G + G + L+ E S+ + + LL +
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQ 123
Query: 636 RFA------IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689
R I+ G GL +LH + RIIHRD+K +NILL + K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 690 NQNEANTNRVVGTYGYMAPEY-----AMEGLFSVKSDVYSFGVLLLEIVSG 735
+ NT+ VGT +MAPE + + + DV+S G+ +E+ G
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 45/215 (20%)
Query: 542 KLGRGGFGPVHKGKLP-EGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
KLG G + V+KG+ GQ +A+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 599 CCIQGEEKM-LIYEYM-----------PN----KSLDLFIFDPAKQALLDWTKRFAIIEG 642
I ++ + L++EY+ ++ LF+F Q L
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF----QLL------------ 113
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
RGL Y H+ R++HRDLK N+L+ E K++DFG+AR +N VV T
Sbjct: 114 --RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVV-T 166
Query: 703 YGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
Y P+ + +S D++ G + E+ +GR
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 69/242 (28%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 543 LGRGGFGPV----HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEI----ILIAKLQHRNLV 594
+G+G FG V HK E + AVK L +K+ +E K+ + +L+ ++H LV
Sbjct: 3 IGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
L ++ + +Y+ +LF ++ L+ RF E IA L YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAE-IASALGYLHS-- 114
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN--TNRVVGTYGYMAPEYAM 712
L I++RDLK NILLD + ++DFG+ + E N T+ GT Y+APE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772
+ + D + G +L E++ G F + + +++ N K ++L PNI +
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGL--PPFYSRNTAEMYDNILN-----KPLQL-KPNITN 221
Query: 773 SS 774
S+
Sbjct: 222 SA 223
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 56/238 (23%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKS-----GQGLEEFKNEIILIAKLQHRNLVRL 596
+GRG FG V + + I A+K+L RKS Q + + E ++A+ + +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQ-VAHVRAERDILAEADNPWVVKL 66
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
Q E + LI EY+P D+ K + RF I E I L + +
Sbjct: 67 Y-YSFQDENYLYLIMEYLPGG--DMMTLLMKKDTFTEEETRFYIAETI----LAIDSIHK 119
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGM------------ARIFGFNQNEANTNR----- 698
L IHRD+K N+LLD + K+SDFG+ RI + +
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI--LSHALPSNFLDFISK 177
Query: 699 ---------------------VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
VGT Y+APE ++ ++ + D +S GV++ E++ G
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 47/143 (32%), Positives = 75/143 (52%), Gaps = 13/143 (9%)
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L C Q E ++ + E++ DL ++ L + RF E I+ L +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG- 116
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY--AME 713
II+RDLK N+LLD + + K++D+GM + G + T+ GT Y+APE +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDT-TSTFCGTPNYIAPEILRGED 172
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
FSV D ++ GVL+ E+++GR
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 54/242 (22%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN----EIILIAKLQHRNLVRL 596
+G+GG G V+ P + +A+K++ R+ K E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLD--WTKR---------------FAI 639
C G+ +Y MP +I ++LL W K +I
Sbjct: 68 YSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE------ 693
I + Y+H S+ ++HRDLK NILL I D+G A + +
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 694 ----------ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR---RNTS 740
++VGT YMAPE + S +D+Y+ GV+L ++++ R
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 741 FR 742
R
Sbjct: 236 GR 237
|
Length = 932 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN-------EIILIAKLQHRNL 593
K+G G +G V K + E GQ +A+K+ E+ EI ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V L+ + + L++EY + L+ +P + II + + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHK- 118
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
IHRD+K NIL+ + K+ DFG ARI + V T Y APE +
Sbjct: 119 --HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVG 174
Query: 714 GL-FSVKSDVYSFGVLLLEIVSG 735
+ DV++ G + E+++G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKNEI----ILIAKLQHRN--LVR 595
+G+G FG V++ + + + I A+K LS+K +E + I IL+ L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L + L+ +YM +LF + + +F I E + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGG--ELFWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD- 116
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-EG 714
I++RDLK NILLD + + DFG+++ N TN GT Y+APE + E
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKA-NLTDN-KTTNTFCGTTEYLAPEVLLDEK 172
Query: 715 LFSVKSDVYSFGVLLLEIVSG 735
++ D +S GVL+ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 543 LGRGGFGPVHKGKLPEGQD--------IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
LG+G F + KG E D + +K L + E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
G C+ G+E +++ EY+ SLD ++ + W + + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 655 RLRIIHRDLKASNILL--DEDM---NP---KISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+ H ++ A N+LL +ED NP K+SD G++ E R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171
Query: 707 APEYAMEGL-FSVKSDVYSFGVLLLEIVSG 735
PE S+ +D +SFG L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEE----FKNEIILIAKLQHRN 592
F + +GRG FG V + DI ++ +KS +E F+ E +++
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ +L + L+ EY P L L + + + + +F + E + L +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELV----LAIHS 117
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY-- 710
++ +HRD+K N+L+D + K++DFG A N+ N+ VGT Y+APE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLT 176
Query: 711 AMEG----LFSVKSDVYSFGVLLLEIVSGR 736
M G + V+ D +S GV+ E++ GR
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
I L YLH +++RD+K N++LD+D + KI+DFG+ + G + + A GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGIS-DGATMKTFCGT 158
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+APE + + D + GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 581 EIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ--ALLDWTKRFA 638
E ++ + H ++++L G + LI +P DL+ + AK+ A+ D A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 639 IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698
I + R + YLH + RIIHRD+KA NI ++ + + DFG A F + N
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
GT APE + D++S G++L E+ +
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR---IFGFNQNEANTNRV 699
I L YLH +++RDLK N++LD+D + KI+DFG+ + G A
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTF 155
Query: 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
GT Y+APE + + D + GV++ E++ GR
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT--NRVVGT 702
R L Y+H + + HRDLK NIL + D KI DFG+AR+ FN V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVAT 169
Query: 703 YGYMAPEYAMEGLFSVKS----DVYSFGVLLLEIVSGR 736
Y APE G F K D++S G + E+++G+
Sbjct: 170 RWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
A L L + +I+RDLK NILLD + + DFG+ ++ + ++ NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
Y+APE + ++ D ++ GVLL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
I L YLH S +++RDLK N++LD+D + KI+DFG+ + G ++ A GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGI-KDGATMKTFCGT 159
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+APE + + D + GV++ E++ GR
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR-----KSGQGLEEFKNEIILIAKLQHRNLVRL 596
+GRG FG V + Q + A+K LS+ +S F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 108
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFD---PAKQALLDWTKRFAIIEGIARGLLYLHR 652
C Q ++ + ++ EYMP L + + P K W K + A +L L
Sbjct: 109 F-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----AEVVLALDA 157
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY-- 710
+ +IHRD+K N+LLD+ + K++DFG + VGT Y++PE
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD-ETGMVRCDTAVGTPDYISPEVLK 216
Query: 711 --AMEGLFSVKSDVYSFGVLLLEIVSG 735
+G + + D +S GV L E++ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
I L YLH +I++RDLK N++LD+D + KI+DFG+ + G + A GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGIT-DAATMKTFCGT 158
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+APE + + D + GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 24/202 (11%)
Query: 543 LGRGGFGPVHKGKLPEGQ--DIAVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLVRL 596
LG G FG V +A+KR + K Q F IL + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL-NYINHPFCVNL 96
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI---ARGLLYLHRD 653
G L+ E++ + F F L KRF G A+ +L
Sbjct: 97 YGSFKDESYLYLVLEFVIGG--EFFTF-------LRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
L I++RDLK N+LLD+D K++DFG A++ + T + GT Y+APE +
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLN 202
Query: 714 GLFSVKSDVYSFGVLLLEIVSG 735
+D ++ G+ + EI+ G
Sbjct: 203 VGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 543 LGRGGFGPVHK-GKLPEGQDIAVKRLSRKSGQGLEEFKNEI-ILIAKLQHRNLVRLLGC- 599
+G+G +G V K G AVK L EE + E IL A H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 600 ----CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA------IIEGIARGLLY 649
G++ L+ E S + D K L +R I+ GL +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGS----VTDLVK-GFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH + + IHRD+K +NILL + K+ DFG++ + NT+ VGT +MAPE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPE 194
Query: 710 Y-----AMEGLFSVKSDVYSFGVLLLEIVSG 735
++ + + DV+S G+ +E+ G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 37/201 (18%)
Query: 557 PEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614
P G + V+ L + + L+ +NE++L +H N++ G +I +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 615 ----NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670
N L + + +AL+ I+ G RGL YLH++ IHR++KAS+IL+
Sbjct: 83 YGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILI 134
Query: 671 DEDMNPKISDFGMARIFGFNQ-----NEANTNRVVGTYG--------YMAPEYAMEGL-- 715
D G+ + G + +VV + +++PE + L
Sbjct: 135 SGD--------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG 186
Query: 716 FSVKSDVYSFGVLLLEIVSGR 736
++VKSD+YS G+ E+ +GR
Sbjct: 187 YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 67/243 (27%), Positives = 97/243 (39%), Gaps = 59/243 (24%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN---EIILIAKLQHRNLVRLL 597
LG+G G V +L G+ A+K L +K + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR--------GLL 648
Q E + L+ +Y P +LF LL + E +AR L
Sbjct: 68 -ASFQTETYLCLVMDYCPGG--ELF-------RLLQRQPGKCLSEEVARFYAAEVLLALE 117
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDF---------GMARIF-------GFNQN 692
YLH L I++RDLK NILL E + +SDF + N
Sbjct: 118 YLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 693 E-----------ANTNRVVGTYGYMAPEY-AMEG-LFSVKSDVYSFGVLLLEIVSGRRNT 739
+N VGT Y+APE + +G +V D ++ G+LL E++ G T
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGT--T 230
Query: 740 SFR 742
F+
Sbjct: 231 PFK 233
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR-----KSGQGLEEFKNEIILIAKLQHRNLVRL 596
+GRG FG V + + + A+K LS+ +S F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQL 108
Query: 597 LGCCIQGEEKML--IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
++K L + EYMP DL W RF E + L +H
Sbjct: 109 --HYAFQDDKYLYMVMEYMPGG--DLVNLMSNYDIPEKWA-RFYTAE-VVLALDAIHS-- 160
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-- 712
+ IHRD+K N+LLD+ + K++DFG N + VGT Y++PE
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQ 218
Query: 713 --EGLFSVKSDVYSFGVLLLEIVSG 735
+G + + D +S GV L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 13/115 (11%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV-VG 701
IA +L +H +L +HRD+K N+LLD + + +++DFG NQ+ + V VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC--LKMNQDGTVQSSVAVG 165
Query: 702 TYGYMAPEY--AME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751
T Y++PE AME G + + D +S GV + E++ G T F E SL+E
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAE---SLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 19/157 (12%)
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI 643
L++++ H +L + G C++G E +++ E++ + LD+ + + + W + + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNIL-----LDEDMNP--KISDFGMARIFGFNQNEANT 696
A L YL + ++H ++ A NIL L E +P K+SD G++ F E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 697 NRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEI 732
R+ ++APE G S +D +SFG LLEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIA---VKRLSRKSGQGLEEFKNEIILIAK----LQHRNLV 594
++G G FG V ++ +A VK L K+ +E +NE + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFI------FDPAKQALLDWTKRFAIIEGIARGLL 648
+ LG C++ +L++EY L ++ ++ LL +R A IA G+
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMAC--EIAAGVT 113
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT-NRVVGTYGYMA 707
++H + +H DL N L D+ K+ D+G+ + ++ T + ++A
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLA 169
Query: 708 PEYAME---GLFSVK----SDVYSFGVLLLEI 732
PE E GL + + S+V++ GV L E+
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 43/230 (18%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSG----QGLEEFKNEIILIAKLQHRNLVRLLG 598
+GRG FG V + + I ++ RK+ + + + E ++ + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
LI E++P D+ K L + +F I E + L + +L
Sbjct: 69 SFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETV----LAIDAIHQLGF 122
Query: 659 IHRDLKASNILLDEDMNPKISDFGMA--------------------RIFGF----NQNEA 694
IHRD+K N+LLD + K+SDFG+ F F ++ +A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 695 NT---NR------VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
T NR VGT Y+APE M+ ++ D +S GV++ E++ G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 27/81 (33%), Positives = 48/81 (59%)
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
+++HRDLK++NI L K+ DFG ++ + + + + GT Y+APE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 717 SVKSDVYSFGVLLLEIVSGRR 737
S K+D++S GV+L E+++ R
Sbjct: 249 SKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 13/115 (11%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA-RIFGFNQNEANTNRVVG 701
+A +L + +L +HRD+K N+LLD++ + +++DFG R+ +N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL--LADGTVQSNVAVG 165
Query: 702 TYGYMAPEY--AME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751
T Y++PE AME G + + D +S GV + E++ G T F E SL+E
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAE---SLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 49/221 (22%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN-EIILIAKLQHRNLVRLL 597
GN +G G FG V++ + + +A+K++ + ++KN E++++ L H N++ L
Sbjct: 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLK 125
Query: 598 GC----CIQGEEKML----IYEYMP-------------NKSLDLFIFDPAKQALLDWTKR 636
C + EK + + E++P N +L LF+ L
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL------ 179
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP-KISDFGMARIFGFNQNEAN 695
R L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ Q +
Sbjct: 180 -------CRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 696 TNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSG 735
+ + Y APE + ++ D++S G ++ E++ G
Sbjct: 230 ---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEE----FKNEIILIAKLQHRNLVRLLG 598
+GRG FG V + + + ++ RK+ +E + E ++ + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
LI E++P D+ K L + +F I E + L + +L
Sbjct: 69 SFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETV----LAIDSIHQLGF 122
Query: 659 IHRDLKASNILLDEDMNPKISDFGM------ARIFGFNQN------------EANTNR-- 698
IHRD+K N+LLD + K+SDFG+ A F +N N+ R
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 699 -------------VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
VGT Y+APE M+ ++ D +S GV++ E++ G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-06
Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 2/48 (4%)
Query: 809 SETPTLPVPRQPTFTSMRSSVDGDHFMEAH--DTVSSNDLTVTMVVGR 854
SET +P P+QP F RS + D ++ + N +TV+++ R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 72/272 (26%)
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN--- 692
RF I E + + +H+ + IHRD+K NIL+D D + K++DFG+ F + +
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 693 --EANTNRV------------------------------------VGTYGYMAPEYAMEG 714
+ + +R VGT Y+APE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 715 LFSVKSDVYSFGVLLLEIVSGR--------RNTSFRLE--ENSSLIEHVWNLWNEGKAME 764
++ D +S GV+L E++ G+ T ++ E + I L E A +
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSRE--ASD 277
Query: 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTS 824
L+ + R G ++ ++ + L+ + P +P PT TS
Sbjct: 278 LILRLCCGAED-----RLGKNGADEIKAHPFFK-GIDFASLIRRQKAPYIPKITHPTDTS 331
Query: 825 ---------MRSSVDGDHFMEAHDTVSSNDLT 847
+RS G+ + + ++ T
Sbjct: 332 NFDPVDPEKLRSDDSGESSPDRNVKPNNRKRT 363
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 19/157 (12%)
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI 643
++ ++ H+++V L G C++ E +++ E++ LDLF+ K +L +F + + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQL 114
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILL-----DEDMNP--KISDFGMARIFGFNQNEANT 696
A L YL D L +H ++ NILL D + P K+SD G+ I ++ E
Sbjct: 115 ASALSYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQEC-- 168
Query: 697 NRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEI 732
V ++APE + S+ +D +SFG L EI
Sbjct: 169 ---VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 33/253 (13%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR-----KSGQGLEEFKNEIILIAKLQHRNLVRL 596
+GRG FG V + + + A+K LS+ +S F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 108
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFD---PAKQALLDWTKRFAIIEGIARGLLYLHRD 653
++ EYMP L + + P K A RF E + L L
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA------RFYTAEVV----LALDAI 158
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY--- 710
+ IHRD+K N+LLD+ + K++DFG + + VGT Y++PE
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKS 217
Query: 711 -AMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769
+G + + D +S GV L E++ G +T F + SL+ + N ++ D N
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD---SLVGTYSKIMNHKNSLTFPDDN 272
Query: 770 IRDSSSQNQVLRC 782
D S + + L C
Sbjct: 273 --DISKEAKNLIC 283
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 2e-05
Identities = 75/263 (28%), Positives = 121/263 (46%), Gaps = 50/263 (19%)
Query: 542 KLGRGGFGPVHKGKLPEGQDIAV-KRLSRKSGQGLEEFKN-----EIILIAKLQHRNLVR 595
K+G G FG V K Q+ K +S + GL+E + E+ ++ +L+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 596 LLGCCI-QGEEKMLI-YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL----Y 649
+ + + +K+ I E+ L I K + + AI++ I R LL Y
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVD-ITRQLLHALAY 133
Query: 650 LHR----DSRLRIIHRDLKASNILLD-------------EDMN----PKISDFGMARIFG 688
H + R++HRDLK NI L ++N KI DFG+++ G
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSV--KSDVYSFGVLLLEIVSGRRNTSFRLEEN 746
E+ + VGT Y +PE + S KSD+++ G ++ E+ SG+ T F N
Sbjct: 194 I---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANN 248
Query: 747 -SSLIEHVW---NLWNEGKAMEL 765
S LI + +L +GK+ EL
Sbjct: 249 FSQLISELKRGPDLPIKGKSKEL 271
|
Length = 1021 |
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-05
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 1/34 (2%)
Query: 299 DDCELYNFCGNFGIC-NALGSTKCTCMEGFVPKH 331
D+C N C N G C N +GS +C+C G+ ++
Sbjct: 3 DECASGNPCQNGGTCVNTVGSYRCSCPPGYTGRN 36
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 66/269 (24%), Positives = 104/269 (38%), Gaps = 85/269 (31%)
Query: 526 NFNTIAVATNYFSEGNKLGRGGFGPVH-KGKLPEGQDIAVKRLSR----KSGQGLEEFKN 580
+F+T+ V +G+G FG V K G+ A+K L + K Q L K
Sbjct: 2 DFHTVKV----------IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ-LAHVKA 50
Query: 581 EIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL-------DLFIFDPAKQALLDW 633
E ++A+ +V L + LI E++P L D F D
Sbjct: 51 ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--------- 101
Query: 634 TKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN--- 690
RF + E + L + +L IHRD+K NIL+D + K+SDFG++ GF+
Sbjct: 102 VTRFYMAECV----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST--GFHKQH 155
Query: 691 ---------QNEANTNRV-----------------------------------VGTYGYM 706
Q ++N NR+ VGT Y+
Sbjct: 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI 215
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
APE ++ + + D +S G ++ E + G
Sbjct: 216 APEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 20/183 (10%)
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY--AM 712
+L +HRD+K NIL+D + + +++DFG ++ VGT Y++PE AM
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 713 E---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL---- 765
E G + + D +S GV + E++ G T F E SL+E + N + +
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAE---SLVETYGKIMNHKERFQFPAQV 233
Query: 766 --VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESETPTLPVPRQPT 821
V + +D + R +G ++D + P + + E P +P PT
Sbjct: 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH-PFFTGIDWDNIRNCEAPYIPEVSSPT 292
Query: 822 FTS 824
TS
Sbjct: 293 DTS 295
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 41/197 (20%), Positives = 91/197 (46%), Gaps = 24/197 (12%)
Query: 551 VHKGKLPEGQDIAVKRL---SRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607
++KG +++ ++ + ++ +NEI + ++ N++++ G I + +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 608 ----LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRD 662
LI EY L + K+ L + + + +GL L++ ++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148
Query: 663 LKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS---VK 719
L + + L+ E+ KI G+ +I + N N +V Y + + + +FS +K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILS-SPPFKNVNFMV----YFSYKM-LNDIFSEYTIK 202
Query: 720 SDVYSFGVLLLEIVSGR 736
D+YS GV+L EI +G+
Sbjct: 203 DDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI----FGFNQNEANTNR---- 698
L YLH I+HRDLK N+L+ + K++DFG+++I N E + +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 699 -----VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
V GT Y+APE + + D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 21/53 (39%), Positives = 32/53 (60%), Gaps = 4/53 (7%)
Query: 634 TKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686
I E +A L YLHR IIHRDLK N+L+ + + K++DFG++++
Sbjct: 105 MAVKYISE-VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 55/249 (22%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRN 592
F + LG G FG V K+ A+K L +K + + K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V+L + + +Y+P D+ + + RF I E + + +H+
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGG--DMMSLLIRMEVFPEVLARFYIAE-LTLAIESVHK 119
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN-------------------- 692
+ IHRD+K NIL+D D + K++DFG+ F + N
Sbjct: 120 ---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 693 ----------------EANTNR---------VVGTYGYMAPEYAMEGLFSVKSDVYSFGV 727
E + +VGT Y+APE + ++ D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 728 LLLEIVSGR 736
+L E++ G+
Sbjct: 237 ILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 3e-04
Identities = 13/30 (43%), Positives = 17/30 (56%), Gaps = 1/30 (3%)
Query: 299 DDCELYNFCGNFGIC-NALGSTKCTCMEGF 327
D+C N C N G C N +GS +C C G+
Sbjct: 3 DECASGNPCQNGGTCVNTVGSYRCECPPGY 32
|
Length = 39 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 580 NEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAI 639
+E L+ +L H ++ LL + G L+ +P DL+ + A+ L A
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLG----LAQ 261
Query: 640 IEGIARGLL----YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695
+ +AR LL Y+H + IIHRD+K N+L++ + + DFG A + +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLE 731
+ GT APE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 31/197 (15%)
Query: 557 PEGQDIAVKRLSRKSGQGLEEFKNEIIL-------IAKL-QHRNLVRLLGCCIQGEEKML 608
P G+ + V+R++ LE NE++ ++KL H N+V I E +
Sbjct: 23 PTGEYVTVRRIN------LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 76
Query: 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668
+ +M S I + + + I++G+ + L Y+H + +HR +KAS+I
Sbjct: 77 VTSFMAYGSAKDLICTHFMDGMSELAIAY-ILQGVLKALDYIHH---MGYVHRSVKASHI 132
Query: 669 LLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG--------YMAPEYAMEGL--FSV 718
L+ D +S G+ N RVV + +++PE + L +
Sbjct: 133 LISVDGKVYLS--GLRSNLSM-INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189
Query: 719 KSDVYSFGVLLLEIVSG 735
KSD+YS G+ E+ +G
Sbjct: 190 KSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 7e-04
Identities = 12/33 (36%), Positives = 15/33 (45%), Gaps = 1/33 (3%)
Query: 300 DCELYNFCGNFGIC-NALGSTKCTCMEGFVPKH 331
+C N C N G C N GS +C C G+
Sbjct: 1 ECAASNPCSNGGTCVNTPGSYRCVCPPGYTGDR 33
|
Length = 36 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 45/127 (35%)
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN---------------------- 692
++ IHRD+K NIL+D D + K++DFG+ F + +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 693 --------------EANTNR---------VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
E R +VGT Y+APE + ++ D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 730 LEIVSGR 736
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 33/156 (21%)
Query: 607 MLIYEYMPNKSLDLFIFDPA-KQALLDWTKRFA---------IIEGIARGLLYLHRDSRL 656
M I Y N++ + I P LLDW + II L Y H + L
Sbjct: 194 MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH--TEL 251
Query: 657 RIIHRDLKASNILL---DEDMNP-------------KISDFGMARIFGFNQNEANTNRVV 700
++H DLK NIL+ D ++P +I D G G + +V
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-----GCCDERHSRTAIV 306
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
T Y +PE + + +D++S G ++ E+ +G+
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 11/76 (14%)
Query: 639 IIEGIARGLLY-LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA--RIFGFNQNEAN 695
+I+G+ R +L L + R+ I+HRD+K N+L+ D KI DFG A G N N
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-- 367
Query: 696 TNRVVGTYGYMAPEYA 711
YG + P Y+
Sbjct: 368 ------LYGMLDPRYS 377
|
Length = 507 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 854 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.23 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.68 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.97 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.6 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.59 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.33 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.28 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.22 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.68 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=463.79 Aligned_cols=289 Identities=45% Similarity=0.766 Sum_probs=256.4
Q ss_pred cccceeHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeE
Q 003045 521 DLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC 600 (854)
Q Consensus 521 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 600 (854)
....|++.++..+|++|+..+.||+|+||.||+|.+++|+.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred EeCC-eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceec
Q 003045 601 IQGE-EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKIS 679 (854)
Q Consensus 601 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 679 (854)
.+.+ +.+||||||++|+|+++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876554 79999999999999999999999998899999999999999999999999
Q ss_pred ccCcceeccCccCccccccc-ccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCc-ccCchHHHHHHHHh
Q 003045 680 DFGMARIFGFNQNEANTNRV-VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL-EENSSLIEHVWNLW 757 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~-~~~~~l~~~~~~~~ 757 (854)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .....+.+|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999754321 1111112 89999999999999999999999999999999999998887544 34445899999999
Q ss_pred hcCCcccccCCCCC-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 758 NEGKAMELVDPNIR-DSSSQ-NQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 758 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
..+++.+++||.+. ..+.. .++.++..++.+|++.+|.+||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999987 55554 789999999999999999999999999999977643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=388.99 Aligned_cols=256 Identities=32% Similarity=0.481 Sum_probs=210.7
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-eeEEEEEcCCC
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-EKMLIYEYMPN 615 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lV~Ey~~~ 615 (854)
..+.||+|+||+||+|.++....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3456999999999999996555599999976432 22669999999999999999999999999988 79999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceeccCccCcc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 694 (854)
|+|..+++.. ....+++..+++++.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999764 45679999999999999999999999874 99999999999999997 99999999998753221 3
Q ss_pred cccccccccccccceeec--cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAM--EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~--~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
..+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ...+...... ..+.
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~---------~~Rp 265 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVG---------GLRP 265 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhc---------CCCC
Confidence 333478999999999999 56999999999999999999999999874322 1222222212 2223
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
..+......+..++.+||+.||++||++.|++..|+.+...
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 33333556788889999999999999999999999987543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.35 Aligned_cols=250 Identities=27% Similarity=0.356 Sum_probs=208.2
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-eeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-EKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lV~Ey~ 613 (854)
.+..+.||+|..|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||.++|.|.... ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344678999999999999875 5788999999544 4456788999999999999999999999999998 599999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++|+|+.++.. .+.+++...-+|+.+|++||.|||+ .. ||||||||+||||+..|+|||+|||.+..+...
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999843 3558999999999999999999996 55 999999999999999999999999999876422
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+......+.+.....+. -|.+..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p------pP~lP~ 304 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP------PPRLPE 304 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC------CCCCCc
Confidence 456689999999999999999999999999999999999999998865333333333333222211 112211
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ....++..++..||++||.+||++.|+++
T Consensus 305 ~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred c---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 24567899999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=383.51 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=211.4
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 78999999999764 3455778899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
|+|++++|..++. .++++.+.++..+++||+.||.|||+.+ |+|||||..|+||+++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY- 170 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC-
Confidence 9999999999984 5677999999999999999999999998 99999999999999999999999999998743
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......+.+||+.|+|||++.....+..+||||+|||+|.||.|++||+... ..+.+..+ ... +..-|
T Consensus 171 -~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--vkety~~I----k~~---~Y~~P-- 238 (592)
T KOG0575|consen 171 -DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--VKETYNKI----KLN---EYSMP-- 238 (592)
T ss_pred -cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--HHHHHHHH----Hhc---Ccccc--
Confidence 3344556899999999999999999999999999999999999999997421 11122222 111 11111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+++.++|+.+|.+|||+.+|+.
T Consensus 239 -----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 -----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 133346778999999999999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.79 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=205.9
Q ss_pred HhcCcccCcccccCCcccEEEeE-cCCCcEEEEEEecccccc-------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQ-------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 604 (854)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... ......+|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45778889999999999999995 457999999999765221 1233579999999999999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC---CCceeccc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED---MNPKISDF 681 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DF 681 (854)
..|+||||+++|.|.+.+.. .+.+.+.....+++|++.|+.|||+.| |+||||||+|||++.+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999998854 344777788899999999999999999 9999999999999866 67999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL---FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
|+|+..+ ....+.+.+||+.|.|||++..+. +..+.|+||+||+||-+|+|.+||....... .+.+.+ .
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI----~ 395 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQI----L 395 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHH----h
Confidence 9999864 334566789999999999998654 3447899999999999999999997543322 133332 2
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+++.. ....-.+..++..+++.+||..||++|||+.|+++
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222211 11222355678889999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.27 Aligned_cols=198 Identities=31% Similarity=0.525 Sum_probs=179.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.+|...++||+|+||+||+|+++ ++..||||.+.+. .....+.+..||.+|++++|||||++++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56778889999999999999865 5889999999766 45567778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC------CCceecccCcce
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED------MNPKISDFGMAR 685 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~DFGla~ 685 (854)
||.+|+|..|++. .+.+++.....++.|||.||++||+.+ ||||||||+||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999953 346999999999999999999999998 9999999999999865 458999999999
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
.+. ........+|++.|||||++...+|+.|+|+||+|+|||+|++|+.||..
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 874 33445568999999999999999999999999999999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=370.81 Aligned_cols=252 Identities=34% Similarity=0.488 Sum_probs=209.0
Q ss_pred ccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 538 SEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
...+.||+|-||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++..+||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 345799999999999999987889999999764 3456789999999999999999999999999899999999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccc
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN 697 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 697 (854)
|.++|.. ..+..++..+.+.++.|||+||+||++++ +|||||...||||+++..+||+|||+|+....+.. ....
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~~ 362 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TASE 362 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-eecC
Confidence 9999976 34456899999999999999999999998 99999999999999999999999999995432222 1222
Q ss_pred ccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 003045 698 RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776 (854)
Q Consensus 698 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 776 (854)
...-...|.|||.+..+.|+.|+|||||||+||||+| |+.|++.. ...++.+. ++...+-..+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~-------------le~GyRlp~P~ 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLEL-------------LERGYRLPRPE 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHH-------------HhccCcCCCCC
Confidence 2233567999999999999999999999999999999 66665422 11122222 22333344455
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 777 NQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 777 ~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.++..+.+++..|++.+|++|||++.+...|+.+
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 5667899999999999999999999999999886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=341.93 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=209.0
Q ss_pred cCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeee-eEEeCCe-eEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLG-CCIQGEE-KMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~-~~~~~~~-~~lV 609 (854)
..|.+.++||.|.||+|||+. +.+|..+|.|.++-. +....+....|+.+|++|+|||||++++ .+.+.++ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999995 568999999998733 3445667889999999999999999998 4555555 8899
Q ss_pred EEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCC-CCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 610 YEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDS-RLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
|||+..|+|..++..- .....+++..+++++.|++.||.++|..- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998653 34456999999999999999999999832 123999999999999999999999999999987
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.. ........+|||.||+||.+.+..|+.|+||||+||++|||..-++||... .+.+.-. .+.+++...+
T Consensus 179 ~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~-KI~qgd~~~~-- 248 (375)
T KOG0591|consen 179 SS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK-KIEQGDYPPL-- 248 (375)
T ss_pred cc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH-HHHcCCCCCC--
Confidence 43 233345689999999999999999999999999999999999999998743 3333222 2223322111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...-....+..++..|+..||+.||+...+++.+...
T Consensus 249 ------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 249 ------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1134455778889999999999999976666666553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.85 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=200.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.+.|++.++||+|+||.||.++.+ +++.+|+|.+++.. ....+...+|..+|.+++||.||+++..|++.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467899999999999999999654 58899999998652 33566788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
+||+.||.|..+| .++..+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|.++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~- 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL- 176 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc-
Confidence 9999999999999 34556889988889999999999999999 9999999999999999999999999999642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.....+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||... +........... +.
T Consensus 177 -~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~-k~------- 242 (357)
T KOG0598|consen 177 -KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKG-KL------- 242 (357)
T ss_pred -cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcC-cC-------
Confidence 2334455689999999999999999999999999999999999999999743 222222222222 10
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRP 798 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 798 (854)
...+.-...+..+++...|+.||++|.
T Consensus 243 --~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 --PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 011111224667888899999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.07 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=205.5
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
+.|+...++|+|+||+|||++.+ +|+.||||++..... ...+-..+||++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999876 499999999975432 234456899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|++..-|+++-+. ..-++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+..
T Consensus 82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 9999888777533 234788899999999999999999998 99999999999999999999999999998753
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH-----------Hhhc
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN-----------LWNE 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~-----------~~~~ 759 (854)
....-+.++.|..|+|||.+.+ .+|....||||+||++.||++|.+-|+...+-+ ++. .+.. ++..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy-~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLY-LIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHH-HHHHHHcccCHHHHHHhcc
Confidence 2233455789999999999987 689999999999999999999998887543321 221 1211 1111
Q ss_pred C-CcccccCCCC-----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 G-KAMELVDPNI-----RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~-~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ....+.-|.. .+..-......+++++..||+.||.+|++-+|++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 1122222221 11122233447889999999999999999998874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=376.79 Aligned_cols=260 Identities=31% Similarity=0.469 Sum_probs=214.3
Q ss_pred cCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.+....+.||+|.||.||+|+.. +.+.||||.++..... ...+|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455679999999999999643 3467999999887655 7889999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcc-------c----ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 608 LIYEYMPNKSLDLFIFDPA-------K----QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
+|+|||..|+|.+||+... . ..+|+..+.+.||.|||.||+||-++. +|||||..+|.||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996421 1 234889999999999999999999987 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||+++.....+.........-..+|||||.+..++||.++|||||||+|||+++ |+.|+... .+++..+.+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--Sn~EVIe~i-- 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--SNQEVIECI-- 718 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--chHHHHHHH--
Confidence 9999999997654333333323334678999999999999999999999999999998 66666532 222333332
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+.+++ -+++...+.++..|+..||+.+|.+||+++||-..|+....
T Consensus 719 --~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 --RAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --HcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 33333 34556677899999999999999999999999999988633
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.13 Aligned_cols=255 Identities=29% Similarity=0.387 Sum_probs=203.5
Q ss_pred cCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--eeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE--EKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 611 (854)
.++...+.||+|+||+||++...+ |+..|||..........+.+.+|+.+|.+++|||||+.+|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456778899999999999997654 8999999987653333677899999999999999999999855555 6889999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCcceeccC-
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGMARIFGF- 689 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~- 689 (854)
|+++|+|.+++..... .+++..+..+++||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965432 6999999999999999999999998 999999999999999 79999999999987643
Q ss_pred ccCcccccccccccccccceeeccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
...........||+.|||||++..+. ...++|||||||++.||+||+.||... .....++....... ..|
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~-----~~P 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED-----SLP 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC-----CCC
Confidence 11222334578999999999999643 335999999999999999999998742 11222222222222 112
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
..+........+++.+|++.+|++|||+.+++...
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22233445778899999999999999999999843
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=350.01 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=211.6
Q ss_pred cCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
..|...++||+|+-|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456677899999999999995 5578999999998776666777899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+.+ ....+++.++..|+++++.||+|||..+ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999988 3445899999999999999999999999 99999999999999999999999999998754333
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.....+||+.|||||++....|..|.||||||++++||+-|.+|+-.+. -...++.....+. |.+ .
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyLIa~ng~------P~l--k 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYLIATNGT------PKL--K 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHHHhhcCC------CCc--C
Confidence 4456899999999999999999999999999999999999999987521 1222222222221 111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHh
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLE 808 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~ 808 (854)
........+.+++.+||+.|+++||++.|+|+ .|+
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 22233457888999999999999999999998 553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=354.25 Aligned_cols=263 Identities=28% Similarity=0.420 Sum_probs=204.4
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
..++|.+.++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788999999999999999963 235689999987543 23346789999999999 8999999999887654
Q ss_pred -eeEEEEEcCCCCChhhhhcCccc--------------------------------------------------------
Q 003045 605 -EKMLIYEYMPNKSLDLFIFDPAK-------------------------------------------------------- 627 (854)
Q Consensus 605 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 627 (854)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999998864211
Q ss_pred ---ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccc
Q 003045 628 ---QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704 (854)
Q Consensus 628 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 704 (854)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999988 99999999999999999999999999986532222222233456678
Q ss_pred cccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHH
Q 003045 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCI 783 (854)
Q Consensus 705 Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 783 (854)
|+|||++.+..++.++|||||||++|||++ |..|+...... ..+. .....+... .. +......+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~----~~~~~~~~~-----~~----~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFC----QRLKDGTRM-----RA----PENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHH----HHHhcCCCC-----CC----CCCCCHHHH
Confidence 999999999999999999999999999997 99888643211 1111 111111111 11 112234678
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 784 HVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 784 ~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+++.+|++.||++|||+.||++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=341.82 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=204.1
Q ss_pred HhcCcccCcccccCCcccEEEeE-cCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 607 (854)
..+.|+..++||+|.||.||+|+ ..+|+.||+|++.... +....-..+||.||++|+||||++|.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 44667788899999999999996 4579999999997653 34455678999999999999999999998877 6899
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
||+|||++. |.-++. ...-.+++.++..+++||+.||+|||..+ |+|||||.+|||||.+|.+||+|||+|+.+
T Consensus 195 lVFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999874 444442 22345899999999999999999999999 999999999999999999999999999988
Q ss_pred cCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc--
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME-- 764 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-- 764 (854)
....... .+..+-|..|+|||.+.+. .|+.+.|+||.||||.||+.|++.+.... +-+..+.+.++........
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCCCChhccc
Confidence 6444333 3345679999999999865 69999999999999999999998876432 2233344444433221111
Q ss_pred --------ccCCCCC-C----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 --------LVDPNIR-D----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 --------~~d~~l~-~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+.+... . +.-.......++|+..+|..||.+|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111100 0 001122345778899999999999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.39 Aligned_cols=268 Identities=27% Similarity=0.419 Sum_probs=217.6
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
+..-+...+.++||+|-||.|.+++...+.+||||+++.... ..+.+|..||++|.+|+||||++++|+|..++..++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 344566678899999999999999998889999999987643 4468999999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
+|||++|+|.+|+..+.... +.-....+|+.|||.||+||.+.. +|||||.+.|+|++.++++||+|||+++.+..
T Consensus 614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999996653332 456677889999999999999988 99999999999999999999999999997655
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh--CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS--GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
........+.+-...|||||.+..++++.++|||+||+++||+++ ...|+... .+++..+..-.....+...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~~~~~~~~---- 763 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEFFRDQGRQ---- 763 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhhcCCCCcc----
Confidence 555555566677889999999999999999999999999999876 44555432 2223333333332222111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.....+.-+...+.++++.|+..|.++||+.+++...|++.
T Consensus 764 --~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 --VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11222334556788999999999999999999999998775
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.15 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=216.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. .+.+.+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999754 5789999999764 34456779999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+.+ +|..++. ....+++..+..++.+++.||.|||+.. |+|||+||.|||++.++.+|++|||+|+... .
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS--T 152 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--c
Confidence 9988 9999984 4456999999999999999999999998 9999999999999999999999999999764 3
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.....+.+.||+.|||||++.+..|+..+|.||+|||+|||.+|++||.. ..+.+.+..+.. ||..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~--------d~v~- 218 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILK--------DPVK- 218 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhc--------CCCC-
Confidence 34456678999999999999999999999999999999999999999863 233333333222 2221
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhccCCCCCCCCCCcc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESETPTLPVPRQPTF 822 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~~~~~~~p~~~~~ 822 (854)
.+......+..++.-.|++||.+|.|..+++. ..++-......|..+++
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 12244557888888999999999999999987 44443333444444444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=342.91 Aligned_cols=265 Identities=27% Similarity=0.420 Sum_probs=203.4
Q ss_pred cCcccCcccccCCcccEEEeEcCC-----------------CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-----------------GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRL 596 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l 596 (854)
++|.+.++||+|+||.||++..++ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997432 3469999987542 3345678999999999999999999
Q ss_pred eeeEEeCCeeEEEEEcCCCCChhhhhcCcc----------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEE
Q 003045 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPA----------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660 (854)
Q Consensus 597 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 660 (854)
++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999874321 1134788899999999999999999998 999
Q ss_pred cccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 003045 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTS 740 (854)
Q Consensus 661 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~ 740 (854)
|||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||+++..+.+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986532222222333456788999999998899999999999999999998654433
Q ss_pred CCcccCchHHHHHHHHhhcCCcc-cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 741 FRLEENSSLIEHVWNLWNEGKAM-ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 741 ~~~~~~~~l~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
+...........+.......... ....+ ......+.+++.+|++.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRP-------PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 32222223333332222111110 01111 1223578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=358.04 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=216.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcCC----CcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
......+.++||.|.||.|++|+++- ...||||.++.. .+..+.+|..|..||.+++||||++|.|+.......+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 34556778999999999999998653 346999999865 4556778999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|.|||+||+|+.||+.+. +.+.+.+...++++||.||.||-+.+ +|||||..+||||+.+..+|++|||+++.+
T Consensus 707 IiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999998655 34889999999999999999999988 999999999999999999999999999976
Q ss_pred cCccCccccccccc--ccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 688 GFNQNEANTNRVVG--TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 688 ~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
..+. +...+..-| ..+|.|||.+...+++.++|||||||++||.++ |.+|+=.. .+++ +..
T Consensus 782 edd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQd-------------VIk 845 (996)
T KOG0196|consen 782 EDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQD-------------VIK 845 (996)
T ss_pred ccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--chHH-------------HHH
Confidence 4333 222222222 467999999999999999999999999999876 77775311 1122 222
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
.++...+...+++++..+.+|++.|||+|-.+||.+.||+..|.++...
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3445566667788889999999999999999999999999999886443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.26 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=205.8
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (854)
..++|..++.||+|+|++|++|+. ..++++|||++.+. .+.-.+-+..|-+.|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999964 46899999999764 222334467788899999 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|+||+++|.|.+++. +.+.+++.....++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999994 4466999999999999999999999999 999999999999999999999999999988
Q ss_pred cCccCc---------ccc--cccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 688 GFNQNE---------ANT--NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 688 ~~~~~~---------~~~--~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
...... ... ...+||..|.+||++.....+..+|+|+||||||+|+.|.+||... .+..+.+.+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--NeyliFqkI~~- 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--NEYLIFQKIQA- 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--cHHHHHHHHHH-
Confidence 532221 112 4489999999999999999999999999999999999999999742 11112222211
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
++-...... ...+.+|+.+.|..||.+|+|.+||-+.
T Consensus 302 ---------l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 ---------LDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------hcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111122222 2567788889999999999999999873
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=349.41 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=211.9
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
...+.+.+.+.||+|.||+||+|++. ..||||+++... .+..+.|++|+..+++-+|.||+-+.|+|..+.. .+|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 34455567789999999999999984 479999998764 3456789999999999999999999999998887 999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
..++++.+|..+++..+ ..++..+.+.|++|||+||.|||..+ |||||||..||++.+++.|||+|||++..-..
T Consensus 466 TqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999999999997644 45889999999999999999999998 99999999999999999999999999986544
Q ss_pred ccCcccccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
-..........|...|||||++.. .+|+.++||||||+++|||++|..|+... . .+.+..+... -....
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~----~dqIifmVGr--G~l~p 612 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--N----RDQIIFMVGR--GYLMP 612 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--C----hhheEEEecc--cccCc
Confidence 333333445678889999999974 46999999999999999999999998721 1 1111111111 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
|.. .........|.+|+..|+..++++||...+|+.+|+.+.+.
T Consensus 613 d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 613 DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 211 12234556888999999999999999999999999888554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=311.09 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=205.2
Q ss_pred cCcccCcccccCCcccEEEeE-cCCCcEEEEEEecccccc--CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQ--GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|...++||+|.||.||+|+ ..+|+.||||+++..... ......+||+.|+.++|+||+.++++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778899999999999996 457999999999765322 23467899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
||+. +|...+++. ...+.-..+..++.++++||+|||... |+||||||+|+|++.+|.+||+|||+|+.++...
T Consensus 82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 688887653 346888899999999999999999998 9999999999999999999999999999986443
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC---
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD--- 767 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--- 767 (854)
... ...+-|..|+|||.+.+ ..|+...||||.|||+.||+-|.+-++. +.+-+....+.+.+.......+.+
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG--~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG--DSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC--CchHHHHHHHHHHcCCCCcccCccccc
Confidence 322 23377899999999876 4699999999999999999998865542 333333344444443332221111
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 768 -----------PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 768 -----------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.......-.......++++..++..||.+|++++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111222334456899999999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=341.32 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=205.3
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHH--HHHHHHHHhcC-CCceeeeeeeEEeCC-eeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEF--KNEIILIAKLQ-HRNLVRLLGCCIQGE-EKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~ 607 (854)
..++|...++||.|.||.||+|+. ..++.||||+++++-.. .++. .+|+..|++|+ |||||+|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 457888899999999999999964 46899999999876433 4443 68999999999 999999999999988 999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|||||+. +|.+++.+. +..+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 677777554 668999999999999999999999999 999999999999999999999999999976
Q ss_pred cCccCcccccccccccccccceeec-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc---
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM--- 763 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--- 763 (854)
. ....-+.++.|..|+|||++. .+.|+.+.|+|++|||++|+.+-++.|+...+ -+++. .+-..+......
T Consensus 161 ~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~-KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 R---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIY-KICEVLGTPDKDSWP 235 (538)
T ss_pred c---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHH-HHHHHhCCCccccch
Confidence 4 233345578899999999986 56799999999999999999999988764322 11221 111222111111
Q ss_pred ---------cccCCCCC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 764 ---------ELVDPNIR----DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 764 ---------~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.+-=|... ...-.....+.++++.+|+..||.+|||++|.++.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111 11112255678899999999999999999999983
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=344.60 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=205.4
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc----cc-cCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK----SG-QGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~ 605 (854)
...+|...+.||+|+||.|++|.. .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456889999999999999999964 46899999977654 12 23556778999999999 9999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccCcc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMA 684 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla 684 (854)
.++||||+.+|.|.+++.. ...+.+.++.++++|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 456888999999999999999999999 9999999999999999 99999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGL-FS-VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||... ....+... ...+..
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~~~~l~~k----i~~~~~ 240 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--NVPNLYRK----IRKGEF 240 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--cHHHHHHH----HhcCCc
Confidence 9763 2334556689999999999999877 86 6799999999999999999999741 11112221 111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.-|.. .. ...+..++.+||..+|.+|+++.|++.
T Consensus 241 ---~~p~~---~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 ---KIPSY---LL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---cCCCC---cC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11111 10 457888999999999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=328.99 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=207.4
Q ss_pred hcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.+.|+..++||.|.-++||+|+ .+.++.||||++.-..- ...+.+.+|+..|+.++||||++++..|..+...++||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3678888999999999999996 45789999999976533 346889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
||.+|++.++++..... -+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998654333 3899999999999999999999999 9999999999999999999999999876553222
Q ss_pred C-cccc-cccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 692 N-EANT-NRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 692 ~-~~~~-~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
. .... +..+||+.|||||++.. ..|+.|+|||||||+..||.+|..||..... .+.....++. ....+.-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn-~pp~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQN-DPPTLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcC-CCCCccc
Confidence 1 1112 56799999999999654 3599999999999999999999999863221 1111111111 1111111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+..+........+.+++..||++||.+|||+++++.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11122222333457888999999999999999999986
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=350.14 Aligned_cols=260 Identities=30% Similarity=0.437 Sum_probs=203.6
Q ss_pred hcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 605 (854)
.++|++.++||+|+||.||+|+. .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999953 245689999986542 23456788999999999 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc----------------------------------------------------------
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK---------------------------------------------------------- 627 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 627 (854)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854211
Q ss_pred --------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 628 --------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 628 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999988 999999999999999999999999999876432221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++.+..++.++|||||||++|||++ |..|+..... ....... ...+... ..+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-~~~~~~~----~~~~~~~--~~~---- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKM----IKEGYRM--LSP---- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-hHHHHHH----HHhCccC--CCC----
Confidence 22222345678999999999999999999999999999998 7777753211 1112221 1211110 011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
......+.+++.+|++.||++||++.||++.|+..
T Consensus 340 ---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11134688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=381.92 Aligned_cols=262 Identities=27% Similarity=0.477 Sum_probs=216.4
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
...|...+.||+|+||.||+|+. .+++.||||++...... ...|++++++++||||++++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999986 57899999998643322 23568899999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.++++ .++|.++.+++.|||+||+|||....++|+||||||+||+++.++.+++. ||.+....
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 99999999984 27899999999999999999997655679999999999999999888875 66554321
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......++..|+|||++.+..++.++|||||||++|||++|+.|+.........+.+++...........++|+.+..
T Consensus 834 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 834 --TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 112236789999999999999999999999999999999999998654444556667766555455556667776643
Q ss_pred --CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 773 --SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 773 --~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
....++..++.+++.+|++.+|++||+|+||+++|+.+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3455677889999999999999999999999999998744
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=341.99 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=208.4
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
-|+.++.||+|+-|.|-+|++ .+|+.+|||++.+.. ......+.+||-+|+.+.|||++++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467789999999999999976 479999999997652 2335568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|-|.+++. ..+.+.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..- .
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---~ 163 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---V 163 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence 999999999984 4566899999999999999999999998 999999999999999999999999999863 3
Q ss_pred CcccccccccccccccceeeccCCCC-cccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFS-VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......+.+|++.|.|||++.+.+|. .++||||+|||||.||+|+.||+. +++... ...+..|.+.
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~L-LlKV~~G~f~------- 230 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVL-LLKVQRGVFE------- 230 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHH-HHHHHcCccc-------
Confidence 44456678999999999999999986 579999999999999999999972 222222 2222333321
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.+.....+..+|+.+|+..||++|.|++||++ .|.+-
T Consensus 231 ---MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 231 ---MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ---CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 12233346778899999999999999999998 44443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=331.06 Aligned_cols=244 Identities=17% Similarity=0.287 Sum_probs=197.6
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccC---HHHHHHHHHHHHhcCCCceeeeeeeEEe----CCeeEEEEEcC
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQG---LEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEKMLIYEYM 613 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV~Ey~ 613 (854)
..||+|++|.||+|.. +|+.||||++....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999997653333 4678899999999999999999999877 34678999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 99999999854 34588999999999999999999985 5 789999999999999999999999999865321
Q ss_pred cccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+...+ ...+.. +.
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~~~~~~i---~~~~~~-----~~- 242 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKEIYDLI---INKNNS-----LK- 242 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--HHHHHHHH---HhcCCC-----CC-
Confidence 123467889999999976 689999999999999999999999986321 11222221 111110 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1112345688999999999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.50 Aligned_cols=267 Identities=28% Similarity=0.399 Sum_probs=204.3
Q ss_pred ccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHh--cCCCceeeeeeeEEeCC----eeEEEEE
Q 003045 538 SEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAK--LQHRNLVRLLGCCIQGE----EKMLIYE 611 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~~lV~E 611 (854)
...+.||+|+||.||||++ +++.||||++.. +..+.|++|-+|.+. ++|+||+++++.-..+. +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3456899999999999999 459999999865 456678888877766 58999999999877666 8899999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC------CCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS------RLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
|.++|+|.++| +...++|....+|+..+++||+|||+.- +++|+|||||.+||||.++++..|+|||+|.
T Consensus 289 fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999 4557999999999999999999999763 4689999999999999999999999999999
Q ss_pred eccCccCcccccccccccccccceeeccCC-CC-----cccchhhHHHHHHHHHhCCCCCCCC-cccC----------ch
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGL-FS-----VKSDVYSFGVLLLEIVSGRRNTSFR-LEEN----------SS 748 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~~~DVwSlGvil~elltG~~p~~~~-~~~~----------~~ 748 (854)
++.........-..+||.+|||||++.+.. +. .+.||||+|.|||||++........ ..+. ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 987555555555589999999999998653 22 2689999999999999965433210 0000 01
Q ss_pred HHHHHHHH-hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCC
Q 003045 749 LIEHVWNL-WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPV 816 (854)
Q Consensus 749 l~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~ 816 (854)
-.+.++.. .+++....+.+.-... ..+..+.+.+..|++.||+.|.|+.=|.+++.++....+.
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11222222 2222222222221111 3456788899999999999999999999999887444433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=347.89 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=203.5
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
..++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.+ +|+||+++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345788899999999999999863 234579999997543 23356788999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcc----------------------------------------------------------
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPA---------------------------------------------------------- 626 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 626 (854)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999875321
Q ss_pred ---------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccc
Q 003045 627 ---------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN 697 (854)
Q Consensus 627 ---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 697 (854)
....+++.++.+++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0124788899999999999999999988 9999999999999999999999999998653222211222
Q ss_pred ccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 003045 698 RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776 (854)
Q Consensus 698 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 776 (854)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+.. ....+. ....+ .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~----~~~~~~--~~~~~-------~ 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYK----MVKRGY--QMSRP-------D 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHH----HHHccc--CccCC-------C
Confidence 2345678999999999999999999999999999997 99988643221 11111 111110 00011 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 777 NQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 777 ~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.....+.+++.+|++.||++||++.||++.|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1234688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.53 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=207.4
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..|...+.||+|.||.||||.. ..++.||+|++... .....+.+++|+.+|.+++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566678999999999999965 46889999999765 445678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+.+|++.+.+. ....+++....-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999983 3344578888889999999999999998 9999999999999999999999999998875333
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......+||+.|||||++....|+.|+||||||++.+||.+|.+|+..... -++.-++.....+
T Consensus 166 -~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 166 -KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIPKSAPP 229 (467)
T ss_pred -hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEeccCCCCC
Confidence 233668999999999999988999999999999999999999999864222 1222233222222
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+.+++..||+++|+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222244456889999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=307.86 Aligned_cols=265 Identities=25% Similarity=0.277 Sum_probs=214.8
Q ss_pred HhcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-----EK 606 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~ 606 (854)
..++|++.++||+|||+-||+++ ..+++.+|+|++.-...++.+...+|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999997 4578899999998777788899999999999999999999999876544 48
Q ss_pred EEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 607 MLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
||+++|...|+|.+.+... .++..+++.+.+.|+.+|++||++||+.. +++.||||||.|||+++.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999998887653 34457999999999999999999999987 579999999999999999999999999998
Q ss_pred eccCccCcc-------cccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 686 IFGFNQNEA-------NTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 686 ~~~~~~~~~-------~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
.....-... .-.....|..|+|||.+. +...++++|||||||+||+|+.|..||+...+...++.-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA--- 254 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA--- 254 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe---
Confidence 653211100 011235688999999885 4568899999999999999999999997544433333222
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+..+.+.-.-.....+.+.+++.+|++.||.+||++.|++..++.+
T Consensus 255 ---------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 ---------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 2222222222223556889999999999999999999999998875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.01 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=196.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|+..+.||.|+||.|.+++.+ +|..+|+|++++... ...+...+|..+|+.+.||.++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999999765 578899999976532 33456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|.|.++++ +...+++..+..++.+|+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+.+.
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999994 4456899999999999999999999998 9999999999999999999999999999763
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
..+-+.+||+.|+|||++..+.|..++|-|||||++|||+.|..||..... ..+.+.+ -++++
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI----~~~~v-------- 258 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKI----LEGKV-------- 258 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHH----HhCcc--------
Confidence 335678999999999999999999999999999999999999999874322 2333332 12211
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCC
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYR 797 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~R 797 (854)
..+.-....+.+++...|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122222356677778888888888
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=323.79 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=201.5
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc--------------cCHHHHHHHHHHHHhcCCCceeeee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG--------------QGLEEFKNEIILIAKLQHRNLVRLL 597 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~h~niv~l~ 597 (854)
.-+.|++.+.||+|.||.|-+|.. .+++.||||++.+... ...+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 347889999999999999999975 4689999999976421 1346789999999999999999999
Q ss_pred eeEEeC--CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC
Q 003045 598 GCCIQG--EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675 (854)
Q Consensus 598 ~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 675 (854)
.+..+. +..|||+||+..|.+...- .....+.+.++.+++++++.||+|||.++ ||||||||+|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998775 4789999999998775432 22223899999999999999999999999 999999999999999999
Q ss_pred ceecccCcceeccCc---cCcccccccccccccccceeeccCC----CCcccchhhHHHHHHHHHhCCCCCCCCcccCch
Q 003045 676 PKISDFGMARIFGFN---QNEANTNRVVGTYGYMAPEYAMEGL----FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748 (854)
Q Consensus 676 ~kl~DFGla~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~ 748 (854)
+||+|||.+..+... .........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||... ....
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--~~~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--FELE 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--hHHH
Confidence 999999999876322 1222234578999999999987743 356799999999999999999998632 1112
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
+.+. +++..+.-....++-..+.+|+.++|++||++|.+..+|....
T Consensus 327 l~~K------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 LFDK------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHH------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 2222 2222222222234556788999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=335.25 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=201.5
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChh
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLD 619 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 619 (854)
++-||.|+.|.||+|++ .++.||||+++.- -..+|+-|++|+|+||+.+.|+|.....++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 46799999999999999 5789999987542 235788999999999999999999999999999999999999
Q ss_pred hhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccccc
Q 003045 620 LFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699 (854)
Q Consensus 620 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 699 (854)
.+|+ .+.++.-.....+.++||.||.|||.+. |||||||.-||||+.+..|||+|||-++..... ..+-.+
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 9995 3445777888899999999999999998 999999999999999999999999999876321 233347
Q ss_pred ccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 003045 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQV 779 (854)
Q Consensus 700 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 779 (854)
.||..|||||++.+.+.++|.|||||||||||||||..|+..-.... -+ | +.- ...+....+..++
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----II---w--GVG----sNsL~LpvPstcP 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----II---W--GVG----SNSLHLPVPSTCP 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eE---E--ecc----CCcccccCcccCc
Confidence 99999999999999999999999999999999999999976321100 00 0 111 1112223344556
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 780 LRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 780 ~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
+-+.-|+.+||+..|.+||++++++.-|+-..+.+-
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 678888999999999999999999999977644433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=329.04 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=201.1
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
...+.|+.+++||+|+||.||+++.+ +|..+|+|++++.. ....+.++.|-.+|...++|.||+|+..|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35578999999999999999999754 59999999998763 334566788999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
|||||++||++..+| .+...|++..+..++.+++.|+.-||+.| +|||||||+|+|||..|.+||+|||++.-+
T Consensus 218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999 45567999999999999999999999999 999999999999999999999999998543
Q ss_pred cCc--------------------cCccc-------------------------ccccccccccccceeeccCCCCcccch
Q 003045 688 GFN--------------------QNEAN-------------------------TNRVVGTYGYMAPEYAMEGLFSVKSDV 722 (854)
Q Consensus 688 ~~~--------------------~~~~~-------------------------~~~~~gt~~Y~aPE~~~~~~~s~~~DV 722 (854)
... ..+.. ....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 110 00000 012469999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---
Q 003045 723 YSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT--- 799 (854)
Q Consensus 723 wSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs--- 799 (854)
||||||+||||.|.+||..... ......+.. |.+ . +.-........+..++|.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp--~~T~rkI~n-wr~--~-------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETP--QETYRKIVN-WRE--T-------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH-Hhh--h-------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 9999999999999999974322 222222211 100 0 1001111122567788889988 9999986
Q ss_pred HHHHHH
Q 003045 800 MASVVL 805 (854)
Q Consensus 800 ~~eVl~ 805 (854)
+.||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 455543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.18 Aligned_cols=257 Identities=30% Similarity=0.467 Sum_probs=205.3
Q ss_pred cCcccCcccccCCcccEEEeEcCC------CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
+.|++.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999997533 2579999986543 233567899999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC
Q 003045 608 LIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM 674 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 674 (854)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854311 145889999999999999999999998 99999999999999999
Q ss_pred CceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHH
Q 003045 675 NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHV 753 (854)
Q Consensus 675 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~ 753 (854)
.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..|+.... ...+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~~~~~~~- 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--NQEVIEM- 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH-
Confidence 999999999986532222222334566788999999998899999999999999999998 988875321 1122222
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 754 WNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 754 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
+..+... ..+......+.+++.+|++.+|++||+++||++.|+.
T Consensus 239 ---i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ---IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2221111 1122344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=349.83 Aligned_cols=261 Identities=25% Similarity=0.274 Sum_probs=214.0
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcCCC-cEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeee-eEEeC----
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLPEG-QDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLG-CCIQG---- 603 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~-~~~~~---- 603 (854)
.+...++++.+.|.+|||+.||+|+...+ .++|+|++-..++...+.+++||++|++|+ |+|||.+++ .....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34567788899999999999999987665 999999998888888999999999999997 999999999 33321
Q ss_pred --CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 604 --EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 604 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
-+.+|.||||++|.|-+++...... .|.+.++++|+.++++|+++||... ++|||||||-|||||+.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 3678999999999999998654333 3999999999999999999999986 78999999999999999999999999
Q ss_pred CcceeccCccCcc-cc------cccccccccccceee---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHH
Q 003045 682 GMARIFGFNQNEA-NT------NRVVGTYGYMAPEYA---MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751 (854)
Q Consensus 682 Gla~~~~~~~~~~-~~------~~~~gt~~Y~aPE~~---~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~ 751 (854)
|.|...-...... .. -...-|+-|+|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 9997542222110 00 012358999999987 47789999999999999999999999997321
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 752 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
...|++....-........+|.+||..||+.+|++||++.||+..+-.+.
T Consensus 263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 12344444433333567789999999999999999999999999886653
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.19 Aligned_cols=256 Identities=29% Similarity=0.410 Sum_probs=205.7
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.+.|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999988778899999986543 34677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 9999999985433 345899999999999999999999988 99999999999999999999999999987642111
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
........+..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+... ...... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~----~~~~~~---------~ 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQ----VDQGYR---------M 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHH----HHcCCC---------C
Confidence 11111223457999999999999999999999999999999 888875321 1111111 111100 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11112335788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.62 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=205.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 604 (854)
..++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888999999999999999742 23479999996543 233567899999999996 999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCccc---------------------------------------------------------
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAK--------------------------------------------------------- 627 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 627 (854)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988754210
Q ss_pred ------------------------------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 628 ------------------------------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 628 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
...+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999988 99999999999999
Q ss_pred cCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHH
Q 003045 672 EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLI 750 (854)
Q Consensus 672 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~ 750 (854)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ..+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-STFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-HHHH
Confidence 999999999999987643222222333456788999999999999999999999999999997 88887632211 1111
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
. ....+.. + ..+......+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 351 ~----~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 N----KIKSGYR-----M----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HHhcCCC-----C----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 1111110 0 111123457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.44 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=202.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 35788899999999999999865 58899999997542 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3345889999999999999999999998 99999999999999999999999999986532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.. ..... -.+..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~---~~~~~--~~~~~ 222 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWENLKY---WKETL--QRPVY 222 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC--HHHHHHHHHh---ccccc--cCCCC
Confidence 2334678999999999999999999999999999999999999986421 1111121111 00000 00110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
..........+.+++.+||+.+|.+||++.|+++.
T Consensus 223 -~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 -DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001233567888999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.71 Aligned_cols=263 Identities=26% Similarity=0.423 Sum_probs=209.2
Q ss_pred cCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.+|...+.||+|+||.||+|+. .++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3467778999999999999963 2355689999876655556789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC
Q 003045 609 IYEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 675 (854)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1235899999999999999999999998 999999999999999999
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHH
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVW 754 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~ 754 (854)
+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~---- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVI---- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----
Confidence 99999999986533222222233456788999999999999999999999999999999 8888753211 1111
Q ss_pred HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 755 NLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 755 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
.....+..... .......+.+++.+|++.+|++||++.+|+++|+.+....+
T Consensus 236 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 236 ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 11222222111 11223568899999999999999999999999999855433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=358.21 Aligned_cols=259 Identities=31% Similarity=0.490 Sum_probs=207.8
Q ss_pred cCcccCcccccCCcccEEEeEcCC--Cc----EEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE--GQ----DIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.+....+.||+|.||.||.|...+ +. .||||.+.+. +.+...+|.+|..+|++++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 444567799999999999997543 33 4899999765 4566789999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcc----cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 608 LIYEYMPNKSLDLFIFDPA----KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
+++|||++|+|..||++.+ ....+...+.+.++.|||+|+.|||+.. +|||||..+|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997642 2346899999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
|+.+...........-.-...|||||.+..+.|+.|+|||||||+|||++| |..|+... .+.++...+ ...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n~~v~~~~---~~gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SNFEVLLDV---LEGG-- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--chHHHHHHH---HhCC--
Confidence 995432222222222223468999999999999999999999999999999 55565422 222222211 2222
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
+...+..+...+.+|+.+||+.+|++||++..+++.++.+.
T Consensus 922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 22334455678889999999999999999999999887764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=324.74 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=199.5
Q ss_pred cccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 537 FSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999975 468999999986532 22344678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 99999988875422 235889999999999999999999998 999999999999999999999999999875321
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+........ .
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~----------~ 222 (285)
T cd05631 156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKEDQ----------E 222 (285)
T ss_pred -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhccc----------c
Confidence 1223457899999999999999999999999999999999999998743221 11111111111100 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.........+.+++.+||+.||++||+ ++|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346788999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.38 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=200.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.+.||+|+||.||+++.+ +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999875 57899999987542 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988776542 2345889999999999999999999988 9999999999999999999999999998753221
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH------------hhc
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL------------WNE 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~------------~~~ 759 (854)
........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+ ..+... ...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QL-FTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHhhCCCCHHHHHhhhcc
Confidence 112234578999999999999899999999999999999999999986432111 11 111110 000
Q ss_pred CCcccccCCCCCCC------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKAMELVDPNIRDS------SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+..... ........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111111111000 01112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.10 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=208.8
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
...+|++.+.||+|.||.|-+|.. ..|+.||||.+++. ++++.-.+.+||+||+.|+||||+.++.+|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788999999999999999964 67999999999765 34455568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||..+|.|.+|+ ..+..|++.+..++++||..|+.|+|++. ++|||||.+|||+|.|+++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999 44556999999999999999999999998 9999999999999999999999999998763
Q ss_pred CccCcccccccccccccccceeeccCCCC-cccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFS-VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.......++|++-|.+||++.+.+|. +..|-|||||+||.|+.|.-||+... - ..+-+.+..+.+.+--.
T Consensus 205 ---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--h----k~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 205 ---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--H----KRLVRQISRGAYREPET 275 (668)
T ss_pred ---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--H----HHHHHHhhcccccCCCC
Confidence 33445678999999999999999885 67999999999999999999987421 1 11122223333333211
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
.....-++.|||..+|++|-|+.+|..-.
T Consensus 276 -----------PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 -----------PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 12445688899999999999999998743
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.71 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=210.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
....|...++||+|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568888999999999999999888999999999876665677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996543 345899999999999999999999988 99999999999999999999999999986532211
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
......++..|+|||++.+..++.++||||||+++|+|++ |+.|+.... .......+. .+ .+
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~----~~---------~~ 222 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQIT----AG---------YR 222 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHH----hC---------Cc
Confidence 1123345678999999998899999999999999999998 788875322 112222211 11 01
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...+......+.+++.+|++.+|++|||++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111123335688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=299.56 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=209.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
-++|++++.||+|.||.||.|+.+ ++-.||+|++.+. ..+..+++.+|+++-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367899999999999999999764 5678999999764 234567899999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
+||.++|.+...|.+. ....+++.....+++|+|.||.|+|..+ ++||||||+|+|++..+..||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999998643 3345888999999999999999999988 9999999999999999999999999887532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......+||..|.|||...+..++...|+|++|++.||++.|.+||+... ..+.+..+.. .++.+|
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k-------~~~~~p- 242 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRK-------VDLKFP- 242 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHH-------ccccCC-
Confidence 233445899999999999999999999999999999999999999997533 3334433322 122223
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+++.+|+..+|.+|.+..||+.
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 223356788999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.88 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=202.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC----CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999643 35689999987643 2334578899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998543 235889999999999999999999988 9999999999999999999999999876532
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
... ........++..|+|||++.+..++.++||||||+++|||++ |..|+.... .......+ ..+.. .
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--~~~~~~~~----~~~~~--~-- 227 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--GQDVIKAV----EDGFR--L-- 227 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHH----HCCCC--C--
Confidence 111 111112334678999999999999999999999999999875 998875321 11122211 11111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
. .+......+.+++.+|++.+|++||++.|+++.|+..
T Consensus 228 -~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -P----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -C----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 1122345688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.43 Aligned_cols=255 Identities=32% Similarity=0.437 Sum_probs=205.6
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688889999999999999998888899999986532 34678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999988543 2345888999999999999999999988 99999999999999999999999999987642211
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++....++.++||||||+++|+|++ |+.|+.... .......+ ..... .....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~----~~~~~-----~~~~~ 227 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSAL----QRGYR-----MPRME 227 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHH----HcCCC-----CCCCC
Confidence 11222345678999999998899999999999999999998 888875321 11222221 11110 01111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.15 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=205.2
Q ss_pred cCcccCcccccCCcccEEEeEcCC------CcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
+.|.+.+.||+|+||.||+|+..+ ++.||+|.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999997533 478999998765433 4578999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcc-----------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 608 LIYEYMPNKSLDLFIFDPA-----------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2345789999999999999999999998 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+.... .......+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~~~-- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIECI-- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH--
Confidence 9999999986532221122223445788999999999999999999999999999998 998875321 11222221
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
..+.... .+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 238 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 --TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111 111223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.21 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=202.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
.+++|+..++||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998642 35679999986432 2334578899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc-------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK-------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678899999999999999999988 999999999999999999999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHh
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
+|||++................++..|+|||++.+..++.++|||||||++|||++ |..|+.... ....... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--~~~~~~~----~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--NEQVLRF----V 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH----H
Confidence 99999986532222111222345778999999999899999999999999999999 677765321 1111111 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.+..... . +......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 1 11223468889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.56 Aligned_cols=262 Identities=23% Similarity=0.266 Sum_probs=202.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999765 57889999887542 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 9999999999843 345889999999999999999999853 399999999999999999999999999986532
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC---Ccc-----
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---KAM----- 763 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~----- 763 (854)
.......|+..|+|||++.+..++.++|||||||++|||++|+.|+..... ..+...+......+ ...
T Consensus 157 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 157 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCcc
Confidence 223345789999999999999999999999999999999999999864221 11111110000000 000
Q ss_pred -------------------------c-ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 764 -------------------------E-LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 764 -------------------------~-~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
. +................+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000011233568899999999999999999999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.49 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=198.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999765 68899999986532 233556889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 99999999998843 345889999999999999999999998 99999999999999999999999999986531
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+.... ...+...+ ..+.. .+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~i----~~~~~------~~ 217 (291)
T cd05612 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--PFGIYEKI----LAGKL------EF 217 (291)
T ss_pred ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhCCc------CC
Confidence 1223578999999999999999999999999999999999999986421 11122211 11111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
+......+.+++.+||+.||.+||+ +.|+++
T Consensus 218 ----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 218 ----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1112346788999999999999995 778776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.00 Aligned_cols=261 Identities=27% Similarity=0.447 Sum_probs=207.5
Q ss_pred cCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5678889999999999999964 2345689999876655566789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc----------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 609 IYEYMPNKSLDLFIFDPA----------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885422 2235899999999999999999999988 999999999999999999999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHh
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+.... ....... .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--~~~~~~~----i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIEC----I 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH----H
Confidence 99999986532222222233445778999999998899999999999999999998 888775321 1112121 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
..+.... .... ....+.+++.+|++.+|.+|||+.||++.|+.+...
T Consensus 236 ~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2221111 1111 224688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.23 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=201.8
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
+.|++.+.||+|+||.||+++.+++..+|+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999888889999988643 3345788999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....... .
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 999999885432 35889999999999999999999998 99999999999999999999999999986532211 1
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+.... .......+ ..+.. ...+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i----~~~~~--~~~~~~--- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMI----SRGFR--LYRPKL--- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH----HCCCC--CCCCCC---
Confidence 1122334568999999998889999999999999999999 888875321 11222222 11111 111111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
....+.+++.+|++.+|++||+++|+++.|.
T Consensus 226 ----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.93 Aligned_cols=268 Identities=30% Similarity=0.419 Sum_probs=201.6
Q ss_pred CcccCcccccCCcccEEEeE-----cCCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeE
Q 003045 536 YFSEGNKLGRGGFGPVHKGK-----LPEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKM 607 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~-----~~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 607 (854)
+|...+.||+|+||+||++. ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 34778999999999998764 2357889999987543 23456788999999999999999999988764 3578
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
++|||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||++...
T Consensus 85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999843 34899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCccc-ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEAN-TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+..........................+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221111 12234566799999999889999999999999999999999987532211111110000000000111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+.......+......+.+++.+|++.+|++|||+++|+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111122223346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.16 Aligned_cols=241 Identities=21% Similarity=0.256 Sum_probs=194.9
Q ss_pred cccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 468999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 696 (854)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcc
Confidence 99888843 346889999999999999999999998 99999999999999999999999999875321 11223
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 776 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ..+. ..+ +.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~----~~~~------~~~----p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELI----LMEE------IRF----PR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHH----HcCC------CCC----CC
Confidence 34679999999999999999999999999999999999999986321 11111111 1111 111 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 777 NQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 777 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.....+.+++.+||+.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2234678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.88 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=204.3
Q ss_pred cCcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.+.||+|+||+||+|.... ...||+|.+.... .....+|.+|+.++++++|+||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999997642 4579999886543 33456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999985432 36899999999999999999999988 99999999999999999999999999997642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+...+ ...... +
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~----~~~~~~----~ 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAV----EDGYRL----P 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHH----HcCCCC----C
Confidence 222222222345678999999999999999999999999999998 888874321 11122221 111100 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+|++.+|++||++.||++.|+.+
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=323.64 Aligned_cols=267 Identities=27% Similarity=0.399 Sum_probs=202.5
Q ss_pred hcCcccCcccccCCcccEEEeEcCC---------------CcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE---------------GQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLL 597 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~ 597 (854)
.++|++.++||+|+||.||+++..+ ...||+|++... .....+.+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999986532 235899998654 233456789999999999999999999
Q ss_pred eeEEeCCeeEEEEEcCCCCChhhhhcCcc---------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcE
Q 003045 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPA---------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668 (854)
Q Consensus 598 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 668 (854)
+++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885421 1124688999999999999999999998 99999999999
Q ss_pred EEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCch
Q 003045 669 LLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748 (854)
Q Consensus 669 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~ 748 (854)
++++++.+||+|||++................++..|+|||++.++.++.++||||||+++|||+++..+.++.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999998653222212223344567899999999889999999999999999999854433332222222
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
................... .+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2222222221111111000 111123578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=348.81 Aligned_cols=252 Identities=20% Similarity=0.216 Sum_probs=202.6
Q ss_pred CcccCcccccCCcccEEEeEcC-C-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-E-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.|.+.+.||+|+||.||+|... + ++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999643 3 6788888876555445567788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++|+|.+++... .....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 23446889999999999999999999988 99999999999999999999999999987643322
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ..+...... .+.. ++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~-~~~~----~~---- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVL-YGKY----DP---- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH-hCCC----CC----
Confidence 223445679999999999999999999999999999999999999986321 111111111 1111 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+||+.+|++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11112346888999999999999999999874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=325.70 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=196.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999865 688999999875432 234467889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666543 2345888999999999999999999998 9999999999999999999999999997543211
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc---c---c
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA---M---E 764 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---~---~ 764 (854)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+.... ...+......... . .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhCCCChhhccchhh
Confidence 12233567899999998865 45888999999999999999999998743221111 1111111111000 0 0
Q ss_pred --ccCCC-CC--CCCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 --LVDPN-IR--DSSSQ-------NQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 --~~d~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..++. .. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01245678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.23 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=203.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC-C
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG-E 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~ 604 (854)
.++|++.++||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357889999999999999999532 35789999986542 22345678899999999 899999999988654 5
Q ss_pred eeEEEEEcCCCCChhhhhcCccc---------------------------------------------------------
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAK--------------------------------------------------------- 627 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 627 (854)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988753211
Q ss_pred -ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccc
Q 003045 628 -QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706 (854)
Q Consensus 628 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 706 (854)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125889999999999999999999988 9999999999999999999999999998764332222233345677899
Q ss_pred cceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHH
Q 003045 707 APEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHV 785 (854)
Q Consensus 707 aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 785 (854)
|||++.+..++.++|||||||++|||++ |..|+...... ..+. .....+.... .+......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~~~---------~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFC----RRLKEGTRMR---------APEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHH----HHHhccCCCC---------CCccCCHHHHHH
Confidence 9999999999999999999999999998 98887532111 1111 1111111110 111223568899
Q ss_pred HhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 786 GMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 786 ~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+.+|++.+|++||++.||++.|+.+.+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.83 Aligned_cols=250 Identities=35% Similarity=0.540 Sum_probs=193.0
Q ss_pred cCcccccCCcccEEEeEcC-----CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 539 EGNKLGRGGFGPVHKGKLP-----EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..+.||.|.||.||+|++. .+..|+||.++.. ..+..++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999765 3578999999653 233478899999999999999999999999988889999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++... ....+++..++.++.||++||.|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2346899999999999999999999988 99999999999999999999999999987632222
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
............|+|||.+....++.++||||||+++|||++ |+.|+... ....+...+ .++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~----~~~~~~~------- 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKL----KQGQRLP------- 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHH----HTTEETT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc----cccccce-------
Confidence 222233456778999999999999999999999999999999 67776432 222222222 2221111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
.+......+.+++.+||+.+|++||++.+++++|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112234678899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.35 Aligned_cols=257 Identities=32% Similarity=0.436 Sum_probs=202.0
Q ss_pred cCcccCcccccCCcccEEEeEc-----CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
+.|++.++||+|+||.||+|.. ..++.+++|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567778999999999999973 346789999987532 2334678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc--------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC
Q 003045 609 IYEYMPNKSLDLFIFDPA--------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM 674 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 674 (854)
||||+++++|.+++.... ....+++.+.+.++.|++.||+|||+.+ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999885321 1234788999999999999999999998 99999999999999999
Q ss_pred CceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHH
Q 003045 675 NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHV 753 (854)
Q Consensus 675 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~ 753 (854)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+... ....+.+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--~~~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--SNQEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHH
Confidence 999999999986533222222233445678999999988889999999999999999998 88777432 111222221
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 754 WNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 754 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
....... .+......+.+++.+|++.+|++||++.+|++.|..
T Consensus 240 ----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111 111223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=332.01 Aligned_cols=244 Identities=24% Similarity=0.284 Sum_probs=199.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999765 58899999987542 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 99999999998853 345788999999999999999999998 99999999999999999999999999986532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+. ...+.. .+
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~----i~~~~~------~~ 234 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--PFRIYEK----ILAGRL------KF 234 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--HHHHHHH----HhcCCc------CC
Confidence 1223578999999999999999999999999999999999999986321 1111111 112111 01
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.. .....+.+++.+||+.||++||+ ++|++.
T Consensus 235 p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 PN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 12246778999999999999997 677764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.75 Aligned_cols=239 Identities=21% Similarity=0.254 Sum_probs=192.1
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999765 5789999998653 233456778999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 698 (854)
..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccc
Confidence 998853 345889999999999999999999998 999999999999999999999999999854211 122334
Q ss_pred cccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 699 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ .. .+ +...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~-~~------~~----~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQE-PL------RF----PDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcC-CC------CC----CCcC
Confidence 679999999999999999999999999999999999999986321 11222211111 10 11 1122
Q ss_pred HHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRPT---MASVVL 805 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs---~~eVl~ 805 (854)
...+.+++.+||+.||++||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346778999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.71 Aligned_cols=259 Identities=33% Similarity=0.436 Sum_probs=205.0
Q ss_pred CcccCcccccCCcccEEEeEcCC--C---cEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPE--G---QDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~--g---~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
+....++||+|+||.||+|++.. + ..||||..+.. ......+|.+|.++|++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999997543 2 23899998752 3556788999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|||+|.||+|+++|..... .++..+++.++.+.|.||+|||+.+ ++||||..+|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999965333 5999999999999999999999998 999999999999999999999999998854
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
. ..........-...|+|||.+..+.|+.++|||||||++||+++ |..|+... ....+..++ ...+
T Consensus 313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--~~~~v~~kI---~~~~------ 379 (474)
T KOG0194|consen 313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--KNYEVKAKI---VKNG------ 379 (474)
T ss_pred c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--CHHHHHHHH---HhcC------
Confidence 2 11111112234578999999999999999999999999999999 77776532 112222222 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
.+...+......+..++.+|+..+|++||+|.++.+.|+.+.....
T Consensus 380 ---~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 ---YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1112222344567778889999999999999999999998855444
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.73 Aligned_cols=240 Identities=26% Similarity=0.346 Sum_probs=189.6
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999764 57889999997542 23345566677777654 899999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCc
Confidence 999988843 345889999999999999999999988 999999999999999999999999999864221 123
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... .+.+ +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--~~~~~~~i----~~~------~~~~----~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--EDELFDSI----LND------RPHF----P 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HcC------CCCC----C
Confidence 344679999999999999999999999999999999999999986422 11122111 111 0111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMA-SVV 804 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~-eVl 804 (854)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234567888999999999999876 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.79 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=207.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999754 68999999876432 233456889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+++++|..++.... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875422 2345889999999999999999999988 99999999999999999999999999987642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.........+...+ .... .+.
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~-----~~~ 227 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCD-----YPP 227 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCC-----CCC
Confidence 21 112235688899999999988899999999999999999999999854322211122111 1111 111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
. ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1122345688999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.82 Aligned_cols=248 Identities=28% Similarity=0.382 Sum_probs=194.9
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
++||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999764 68899999876432 33456789999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 698 (854)
.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998532 235889999999999999999999998 99999999999999999999999999875432111111111
Q ss_pred cccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 003045 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQN 777 (854)
Q Consensus 699 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 777 (854)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+..... ...... .... .....+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~~~~~----~~~~---------~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREA----IEQG---------VRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HHHHHH----HHcC---------CCCCCccc
Confidence 223457999999999999999999999999999998 7777653211 111111 1111 00111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 778 QVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 778 ~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
....+.+++.+|++.+|++||++.||+++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2357888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.07 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=192.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+.|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999754 68999999986543 23356789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.... ...+..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 3456778899999999999999998 9999999999999999999999999998763221
Q ss_pred cccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 693 EANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ............. . .
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~-~-----~ 293 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMS-Q-----P 293 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhcc-C-----C
Confidence 12234578999999998743 2345689999999999999999999873221 1111111111100 0 0
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+ .........+.+++.+||+.||++||++.|+++
T Consensus 294 ~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111123346889999999999999999999998
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.10 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=197.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|.+.++||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999754 68899999986543 23345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 788777432 235789999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC-----------
Q 003045 693 EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG----------- 760 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------- 760 (854)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhccccc
Confidence 12233567899999998865 5689999999999999999999999864321 11111111111100
Q ss_pred -CcccccCCCCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 -KAMELVDPNIRDSS----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 -~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+...... .......+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111110000 0112245778999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=329.58 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=201.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCc----EEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQ----DIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
..|+..+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888899999999999999753 333 48999986542 33456789999999999999999999999764 5779
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998643 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+ ......+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~~----~~~~~~~~~--~~~ 232 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI----SSILEKGER--LPQ 232 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHH----HHHHhCCCC--CCC
Confidence 3322222222334678999999999999999999999999999998 888875321 1111 111111111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+ . .....+.+++.+|++.+|++||++.+++..|..+..
T Consensus 233 ~---~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 P---P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C---C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1 1 122467889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.32 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=202.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
..|.+.++||+|+||.||+|... .++.||+|++... ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677789999999999999764 5888999998653 334677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 9999999885432 345899999999999999999999988 99999999999999999999999999987542211
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++.+..++.++||||||+++|||++ |..|+.... ...+. ...... ..+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~----~~~~~~-----~~~~--- 225 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY----ELLEKG-----YRME--- 225 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHH----HHHHCC-----CCCC---
Confidence 11112234567999999999999999999999999999998 888875321 11111 111111 0111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus 226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1112235688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.13 Aligned_cols=265 Identities=28% Similarity=0.412 Sum_probs=204.5
Q ss_pred hcCcccCcccccCCcccEEEeEcCC-----------------CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE-----------------GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVR 595 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 595 (854)
.++|++.++||+|+||.||+++..+ +..||+|++.... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999986542 2468999987543 234667899999999999999999
Q ss_pred eeeeEEeCCeeEEEEEcCCCCChhhhhcCcc--------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCc
Q 003045 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPA--------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667 (854)
Q Consensus 596 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 667 (854)
+++++...+..+++|||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 1235899999999999999999999988 9999999999
Q ss_pred EEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh--CCCCCCCCccc
Q 003045 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS--GRRNTSFRLEE 745 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt--G~~p~~~~~~~ 745 (854)
|+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.. ..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~--~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH--LT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC--cC
Confidence 9999999999999999986533222222334556788999999998889999999999999999998 4455532 11
Q ss_pred CchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 746 NSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.......+............. .........+.+++.+|++.+|++|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 222222222211111111111 1111223578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.63 Aligned_cols=199 Identities=27% Similarity=0.352 Sum_probs=173.2
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999765 57889999886542 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++.. ...+++..+..++.++++||.|||+.. .++|+||||+|||++.++.+||+|||++..+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-- 156 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh--
Confidence 9999999999843 345889999999999999999999742 399999999999999999999999999875521
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
.......|+..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred --hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 122345789999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=330.35 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=204.7
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCe
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEE 605 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~ 605 (854)
...-++|...++||+|.||+|+++..+ +++.+|||.+++. ...+.+..+.|-+|+.... ||.++.++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999765 5789999999876 3456777888999888885 9999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.|.||||+.||++..+ .....+++..+.-++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999984332 34456999999999999999999999999 9999999999999999999999999999
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
... .....+.+.+||+.|||||++.+..|+.+.|-|||||+|||||.|..||+.+ +++++.+.+..
T Consensus 517 e~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~---------- 582 (694)
T KOG0694|consen 517 EGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVN---------- 582 (694)
T ss_pred ccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhc----------
Confidence 642 1233566799999999999999999999999999999999999999999743 33344444321
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
|.. .++.....+.+.++.++|.++|++|..+
T Consensus 583 -d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 -DEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 2333444577888889999999999977
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.99 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=200.5
Q ss_pred cccCcccccCCcccEEEeEcCC----CcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe-----
Q 003045 537 FSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE----- 605 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 605 (854)
|.+.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|++.+++++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999997542 3679999987542 2335678999999999999999999998876554
Q ss_pred -eEEEEEcCCCCChhhhhcCcc---cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 606 -KMLIYEYMPNKSLDLFIFDPA---KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 606 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 2346899999999999999999999988 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+... ....+.+.. ..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~--~~~~~~~~~----~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV--ENHEIYDYL----RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH----HcC
Confidence 99987643222222222344678999999998899999999999999999999 77777532 222222222 111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.... .+......+.+++.+|++.||++||++.||++.|+.+
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1112345788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.24 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=194.6
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999754 68999999997542 234567788999999999999999999999999999999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 696 (854)
+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC--ccccc
Confidence 99888743 345889999999999999999999998 99999999999999999999999999875321 11223
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 776 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... .. ... ..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~~---~~-~~~------~~~p~---- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFEL---IL-MED------IKFPR---- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHHHHH---hc-cCC------ccCCC----
Confidence 346799999999999999999999999999999999999999863211 111111 11 110 11111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 777 NQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 777 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.....+.+++.+||+.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1234678899999999999997 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.97 Aligned_cols=256 Identities=28% Similarity=0.412 Sum_probs=201.0
Q ss_pred CcccCcccccCCcccEEEeEcC------CCcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.|++.++||+|+||.||+|... .++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666789999999999999753 2578999999754322 34668899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCc-------------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC
Q 003045 609 IYEYMPNKSLDLFIFDP-------------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 675 (854)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999988421 11235788899999999999999999988 999999999999999999
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHH
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVW 754 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~ 754 (854)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+... ......+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~-- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIEM-- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH--
Confidence 99999999886532222222233456778999999988889999999999999999998 77676432 11122221
Q ss_pred HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 755 NLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 755 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
...+... ..+......+.+++.+|++.+|++||++.||++.|+.
T Consensus 239 --i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 --IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1121111 1112234567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.48 Aligned_cols=241 Identities=21% Similarity=0.260 Sum_probs=193.8
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999754 68999999997542 234456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 696 (854)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCcc
Confidence 99888743 346899999999999999999999998 99999999999999999999999999875321 11222
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCH
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 776 (854)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ......+ . .... .+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~~---~-~~~~------~~p~---- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELI---L-MEEI------RFPR---- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHH---h-cCCC------CCCC----
Confidence 346789999999999999999999999999999999999999863211 1111111 1 1110 1111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 777 NQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 777 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2234677899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.17 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=208.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7899999988643 2233567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+++++|..++... .....+++.++..++.++++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 22345899999999999999999999998 99999999999999999999999999886532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... +...... ...+.. .+.
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~----~~~ 228 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK-IEKCDY----PPL 228 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhh-hhcCCC----CCC
Confidence 21 1123356888999999999888999999999999999999999998543221 1111111 111111 110
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
........+.+++.+|++.+|++||++.+|+++|+++
T Consensus 229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1113345688899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.29 Aligned_cols=260 Identities=30% Similarity=0.437 Sum_probs=204.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
..++|+..+.||+|+||.||++... ....+|+|.+... ......++.+|+++++++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467888899999999999999753 2367999988753 223445688999999999 7999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCc-------------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDP-------------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
..+++|||+++++|..++... .....+++..++.++.|++.||+|||+.+ |+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 22346899999999999999999999988 99999999999999
Q ss_pred cCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHH
Q 003045 672 EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLI 750 (854)
Q Consensus 672 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~ 750 (854)
+++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..|+.... .....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~ 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VEELF 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--HHHHH
Confidence 999999999999987643222112222334678999999999999999999999999999998 888875321 11111
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.....+.. ...+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus 245 ----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 245 ----KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111 011122345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.82 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=201.1
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
+.|.+.+.||+|+||+||+|+..++..+|+|.+... ....+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 356777899999999999998877778999988643 3345779999999999999999999999999889999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....... .
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 999999885432 25899999999999999999999998 99999999999999999999999999886532211 1
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||++.+..++.++||||||+++|||++ |..|+..... ......+ ..+.... .+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~----~~~~~~~--~~----- 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKV----SQGLRLY--RP----- 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH----hcCCCCC--CC-----
Confidence 1112335567999999998889999999999999999998 8888753221 1122211 1111100 01
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112357888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.00 Aligned_cols=257 Identities=29% Similarity=0.431 Sum_probs=200.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCc----EEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQ----DIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
+.|++.+.||+|+||+||+|... +++ ++++|.+..... ....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45777889999999999999753 344 477888754322 23467788899999999999999999875 456789
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+.+ ....+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~----~~~~~~~--~~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVPD----LLEKGER--LAQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHH----HHHCCCc--CCC
Confidence 3222222334556778999999998999999999999999999998 888875321 111111 1222211 111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+.. ....+..++.+|+..+|++|||+.|+++.|+.+..
T Consensus 233 ~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 12356778889999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.32 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=201.8
Q ss_pred CcccCcccccCCcccEEEeEcC------CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
+|.+.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667889999999999999642 235688888865432 335678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc---------------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCc
Q 003045 609 IYEYMPNKSLDLFIFDPA---------------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 667 (854)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999988 9999999999
Q ss_pred EEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccC
Q 003045 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEEN 746 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~ 746 (854)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+... ..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--AP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC--CH
Confidence 9999999999999999986532222112223345678999999988889999999999999999998 88887532 11
Q ss_pred chHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 747 SSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 747 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
..+.+ ...... ... .+......+.+++.+|++.+|++||+++|+++.|+.+.
T Consensus 236 ~~~~~----~~~~~~-----~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 ERLFN----LLKTGY-----RME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHH----HHhCCC-----CCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 12222 211111 011 11122346888999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=329.84 Aligned_cols=245 Identities=22% Similarity=0.266 Sum_probs=198.6
Q ss_pred cCcccCcccccCCcccEEEeEcCC--CcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE--GQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|.+.++||+|+||.||+|.... +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568888999999999999997543 3689999986532 23456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ..+.. .
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i----~~~~~------~ 246 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--PLLIYQKI----LEGII------Y 246 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--HHHHHHHH----hcCCC------C
Confidence 1234679999999999999889999999999999999999999986321 11111111 11111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVLM 806 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~~ 806 (854)
+... ....+.+++.+|++.+|++|+ +++|+++.
T Consensus 247 ~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 123567889999999999995 89988763
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.08 Aligned_cols=241 Identities=25% Similarity=0.343 Sum_probs=193.2
Q ss_pred cccccCCcccEEEeEc----CCCcEEEEEEecccc----ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++||+|+||.||+++. ..++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999964 357899999987532 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++. ....+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 153 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH--E 153 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc--C
Confidence 99999998884 3345788888999999999999999998 99999999999999999999999999875421 1
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... +.. .+
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~-~~~------~~-- 219 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILK-GKL------NL-- 219 (323)
T ss_pred CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHc-CCC------CC--
Confidence 1223346789999999999998899999999999999999999999864211 111111111 110 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 220 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 --PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111234678899999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.20 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=201.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcCC------CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
.+++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678888999999999999997643 5678999876443 2334578999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc----ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC---Ccee
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK----QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM---NPKI 678 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl 678 (854)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999998 99999999999998765 5999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHh
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~~~~~---- 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFV---- 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----
Confidence 99999986532211111122233567999999999999999999999999999997 8888763221 1122111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
..... ...+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11100 01112223578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.86 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=193.5
Q ss_pred cCcccCcccccCCcccEEEeEcC--CCcEEEEEEecccc--ccCHHHHHHHHHHHHhc---CCCceeeeeeeEEe-----
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP--EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKL---QHRNLVRLLGCCIQ----- 602 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~----- 602 (854)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999752 46789999986542 22334567788877766 69999999999853
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346889999997 57888875432 234889999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC--
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG-- 760 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-- 760 (854)
++...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCCh
Confidence 99875422 223346789999999999988999999999999999999999999864321 11222221111100
Q ss_pred -Cc-c------cccCCCCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 -KA-M------ELVDPNIRD---SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 -~~-~------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. . ....+.... .........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0 000000000 000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.44 Aligned_cols=265 Identities=27% Similarity=0.406 Sum_probs=201.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC-----------------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-----------------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVR 595 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~ 595 (854)
.++|++.++||+|+||.||++... ++..+|+|++.... ....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 23468999987542 334567899999999999999999
Q ss_pred eeeeEEeCCeeEEEEEcCCCCChhhhhcCccc--------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCc
Q 003045 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAK--------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667 (854)
Q Consensus 596 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 667 (854)
+++++...+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998864321 134778899999999999999999998 9999999999
Q ss_pred EEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh--CCCCCCCCccc
Q 003045 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS--GRRNTSFRLEE 745 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt--G~~p~~~~~~~ 745 (854)
||++.++.+||+|||++..+.............++..|+|||....+.++.++|||||||++|||++ |..|+... .
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~--~ 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL--S 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc--C
Confidence 9999999999999999986532222122223344678999999888899999999999999999998 55555422 2
Q ss_pred CchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 746 NSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
................. ....+. +......+.+++.+|++.||++||++.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 22222222111111111 001111 11123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.63 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=209.5
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe-eEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE-KMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 610 (854)
++|...++||+|+||.++..+.+ +++.+|+|++.... ...++...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999998764 57789999987543 3445578999999999999999999999999988 99999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
+|++||++.+.+...+ ...+++..+..++.||+.|+.|||+.. |+|||||+.||+++.++.|||.|||+|+..+..
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986543 456899999999999999999999877 999999999999999999999999999987533
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
. .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|... +-..+...+ .+. .++
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--~m~~Li~ki---~~~-----~~~--- 224 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--NMSELILKI---NRG-----LYS--- 224 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--chHHHHHHH---hhc-----cCC---
Confidence 2 2455689999999999999999999999999999999999999988632 222232222 111 122
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
..+......+..++..|++.+|+.||++.+++.+
T Consensus 225 --Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 --PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2333445678888899999999999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=298.63 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=203.5
Q ss_pred HhcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++.|++.+.||+|.|+.||+.. .++|+.+|+|++... ...+.+++.+|++|.+.|+||||++|.+.+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34677888899999999999995 457999999988643 445788999999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccCccee
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFGMARI 686 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~ 686 (854)
+|+|+++.|..-+. .+...++..+-..++||+++|.|+|..+ |||||+||+|+|+.. ..-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999865542 3355778888899999999999999999 999999999999953 34599999999998
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
++ ....-....|||+|||||++...+|+..+|||+.|||||-||.|+.||.. ++...+.+.+. .+... +
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--~~~~rlye~I~----~g~yd--~ 231 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYEQIK----AGAYD--Y 231 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--ccHHHHHHHHh----ccccC--C
Confidence 75 23334457899999999999999999999999999999999999999863 23334555442 11110 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++. .-.....+..+++.+||..||.+|.|+.|.+.
T Consensus 232 ~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 PSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111 11122346678889999999999999988764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.24 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=200.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc-C-HHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ-G-LEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 608 (854)
.+.|+..+.|++|.||.||+|+.+ +++.||+|+++...+. + .=.-.+||.+|.+++|||||.+-.+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356778899999999999999764 6889999999765322 1 12347899999999999999998887654 47999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||++. +|..++.... ..+...++..+..|+++|++|||... |+||||||+|+|++..|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999987 5777774433 45888999999999999999999998 9999999999999999999999999999986
Q ss_pred CccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC---ccc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK---AME 764 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~ 764 (854)
.. ....+..+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++.|... .+-+....+...+.... ...
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHHHHHHHHhCCCccccCCC
Confidence 43 2334456779999999999875 5999999999999999999999877643 22233334444332221 111
Q ss_pred ccCC--------------CCCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVDP--------------NIRDSSSQN-QVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d~--------------~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+... .++..+... ..+.-.+++...|..||.+|-|+.|.+.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1110 111111111 2345667888999999999999999887
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=331.36 Aligned_cols=258 Identities=19% Similarity=0.189 Sum_probs=195.1
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..+|.+.++||+|+||.||++.. .+++.||+|+... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999975 4688999997532 3568899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+. ++|..++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 86 677777643 335889999999999999999999998 999999999999999999999999999753211 1
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc-----CchHHHHHHHHhhcCC------
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE-----NSSLIEHVWNLWNEGK------ 761 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~-----~~~l~~~~~~~~~~~~------ 761 (854)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .......+........
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12223467999999999999999999999999999999999999876432110 0011111111100000
Q ss_pred ----ccc---------ccCCCCCCCC--CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 ----AME---------LVDPNIRDSS--SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ----~~~---------~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...+..+... .......+.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0001001000 0123456888999999999999999999996
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.78 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=196.9
Q ss_pred ccCcccccCCcccEEEeEcCCC-c--EEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------Cee
Q 003045 538 SEGNKLGRGGFGPVHKGKLPEG-Q--DIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------EEK 606 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~ 606 (854)
.+.++||+|+||.||+|+..+. + .+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4678999999999999986543 2 6899988653 233456789999999999999999999987542 246
Q ss_pred EEEEEcCCCCChhhhhcCc---ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 607 MLIYEYMPNKSLDLFIFDP---AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
+++|||+++|+|..++... .....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887432 22345899999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+... ....+.+. ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~----~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDY----LRQGNR 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHH----HHcCCC
Confidence 987642221111122345678999999999999999999999999999999 77777532 11222222 222211
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.. . .......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 233 ~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 0 112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.82 Aligned_cols=251 Identities=29% Similarity=0.416 Sum_probs=199.9
Q ss_pred CcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
.|++.+.||+|+||.||+|+.+++..+|+|.+.... ...+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477788999999999999988777889999986432 3456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999985432 35899999999999999999999998 99999999999999999999999999986532111 11
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .......+ .... ... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~----~~~~-----~~~----~ 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESV----SAGY-----RLY----R 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--HHHHHHHH----HcCC-----cCC----C
Confidence 111223457999999999999999999999999999999 787775321 11222211 1110 001 1
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
+......+.+++.+|++.+|++|||+.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1113447889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.08 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=197.0
Q ss_pred CcccCcccccCCcccEEEeEc----CCCcEEEEEEecccc----ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCee
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 606 (854)
+|++.++||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477789999999999999864 357899999986532 23345678899999999 599999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998843 345889999999999999999999998 99999999999999999999999999986
Q ss_pred ccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
+.... ........||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+......
T Consensus 155 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~------ 225 (332)
T cd05614 155 FLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK------ 225 (332)
T ss_pred ccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc------
Confidence 53221 1223346799999999998865 478899999999999999999999864322111 1111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.++.+... ....+.+++.+||+.||++|| +++|+++
T Consensus 226 ~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11222111 234577889999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=345.66 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=204.9
Q ss_pred HHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-- 604 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 604 (854)
.....++|.+.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++..++|+|++++...+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557899999999999999999964 468999999986542 334567889999999999999999988765432
Q ss_pred ------eeEEEEEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 605 ------EKMLIYEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 605 ------~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3679999999999999886432 2346899999999999999999999988 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHh
Confidence 99999998764333333334567999999999999999999999999999999999999998632 1112221111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+.. ++ .+......+.+++.+||+.+|.+||++.++++
T Consensus 259 -~~~~----~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 259 -AGRY----DP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred -cCCC----CC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111 11 11122346888999999999999999999976
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.91 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=201.9
Q ss_pred cCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++...++||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4566788999999999999963 2356789998876665667789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCccc------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 609 IYEYMPNKSLDLFIFDPAK------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
+|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999988 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~--- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIEC--- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHHH---
Confidence 9999999986532211111222345678999999999999999999999999999998 8888753211 111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
...+... ..+ . .....+.+++.+|++.||++||++.||++.|+
T Consensus 237 -~~~~~~~--~~~---~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -ITQGREL--ERP---R----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHcCccC--CCC---C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111110 011 1 12346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.83 Aligned_cols=253 Identities=25% Similarity=0.301 Sum_probs=202.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||+||+|+.. +++.||+|++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999765 68999999997542 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999865432
Q ss_pred c---------------------------CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 003045 691 Q---------------------------NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL 743 (854)
Q Consensus 691 ~---------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~ 743 (854)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0112234578999999999999999999999999999999999999986432
Q ss_pred ccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 003045 744 EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-MASVVLM 806 (854)
Q Consensus 744 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~eVl~~ 806 (854)
............. .+.-+.. .. ....+.+++.+|++ +|.+||+ +.|+++.
T Consensus 235 -----~~~~~~~i~~~~~--~~~~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -----LQETYNKIINWKE--SLRFPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHHHhccCC--cccCCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111111000 0001110 01 23467788889997 9999999 9999973
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.91 Aligned_cols=240 Identities=27% Similarity=0.362 Sum_probs=191.2
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999765 58899999997542 23445667788888765 899999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCc
Confidence 999888743 345889999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+ ... .+.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~----~~~------~~~~~~~-- 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESI----RVD------TPHYPRW-- 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhC------CCCCCCC--
Confidence 334679999999999999999999999999999999999999986322 11222221 111 1111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMA-SVV 804 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~-eVl 804 (854)
....+.+++.+||+.||++||++. +++
T Consensus 219 --~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 --ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 224577889999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=332.52 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=194.3
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.|...++||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999965 468899999997542 2335678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 345888999999999999999999988 9999999999999999999999999986432100
Q ss_pred C---------------------------------------------cccccccccccccccceeeccCCCCcccchhhHH
Q 003045 692 N---------------------------------------------EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFG 726 (854)
Q Consensus 692 ~---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlG 726 (854)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhh--ccCCCCCCCCCHHHHH
Q 003045 727 VLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGML--CVQDSAMYRPTMASVV 804 (854)
Q Consensus 727 vil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPs~~eVl 804 (854)
|++|||++|+.||...... .... ..........+ +. ....+ ..+.+++.+ |+..++..||++.|++
T Consensus 236 ~il~elltG~~Pf~~~~~~--~~~~---~i~~~~~~~~~--~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT--ETQL---KVINWENTLHI--PP-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH--HHHH---HHHccccccCC--CC-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999998643211 1111 11111100010 00 01122 345566655 5667777799999998
Q ss_pred H
Q 003045 805 L 805 (854)
Q Consensus 805 ~ 805 (854)
.
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 7
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.97 Aligned_cols=254 Identities=30% Similarity=0.441 Sum_probs=201.9
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|++.++||+|+||.||+|+..+...||+|++.... ...+.+.+|++++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999988777789999987532 34567899999999999999999999874 456789999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+..+..... .
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~ 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence 99999998543 2345789999999999999999999988 99999999999999999999999999986642221 1
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||+..+..++.++||||||+++|||++ |..|+.... ........ .... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~----~~~~---------~~~ 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGY---------RMP 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHH----hcCC---------CCC
Confidence 1122345678999999998899999999999999999999 777765321 11111111 1110 001
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
........+.+++.+|++.+|++||+++++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.06 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=206.9
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||.||+++. .+++.+|||.+.... ....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999975 478999999886532 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+++++|.+++... .....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 23356899999999999999999999998 99999999999999999999999999886532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..|+.............+ . ....+.
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~-----~~~~~~ 227 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----E-----QCDYPP 227 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh----h-----cCCCCC
Confidence 21 112235688899999999988899999999999999999999999853222111111111 1 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+. .......+.+++.+|++.+|++||||.+|++.+++.
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 122345788899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.43 Aligned_cols=262 Identities=28% Similarity=0.448 Sum_probs=201.2
Q ss_pred cCcccCcccccCCcccEEEeEc-----CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 607 (854)
++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999963 35789999998776655667899999999999999999999987543 4678
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 245899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCccc-ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC----------chHHHHHHHH
Q 003045 688 GFNQNEAN-TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN----------SSLIEHVWNL 756 (854)
Q Consensus 688 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~----------~~l~~~~~~~ 756 (854)
........ .....++..|+|||++.+..++.++||||||+++|||++|..++....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43221111 111223456999999998899999999999999999999877653211100 0000011111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
... .............+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 239 ~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred Hhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111 111111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.33 Aligned_cols=253 Identities=32% Similarity=0.463 Sum_probs=201.5
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|++.++||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56788899999999999999988888999999875432 4567999999999999999999999875 456889999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999986432 235889999999999999999999998 999999999999999999999999999875422111
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||++.+..++.++||||||+++|||++ |..|+.... .......+ .... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~----~~~~---------~~~ 223 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQV----ERGY---------RMP 223 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH----HcCC---------CCC
Confidence 1112234567999999988889999999999999999999 777775321 11122211 1110 011
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.+......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.30 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=194.1
Q ss_pred cCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----eeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-----EKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~l 608 (854)
-.|...+++|.|+||+||+|...+ ++.||||+.-.+.. --.+|+++|++++|||||+|+-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 346667899999999999997654 68999999865432 2247999999999999999999886543 2358
Q ss_pred EEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccCccee
Q 003045 609 IYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARI 686 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~ 686 (854)
|||||+. +|..+++.. ..+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 566666431 22345777778889999999999999988 9999999999999966 9999999999998
Q ss_pred ccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc---
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA--- 762 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--- 762 (854)
+... ........|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|+.+ +..+....+.+.+.....
T Consensus 176 L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~--s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD--SSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC--CHHHHHHHHHHHhCCCCHHHH
Confidence 7422 222345678899999998864 6999999999999999999999888742 222223333333322211
Q ss_pred -------ccccCCCCCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 -------MELVDPNIRDS-----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 -------~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+...|.+... .......+.++++.++|+++|.+|.++.|+++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 12222333221 22344567889999999999999999999987
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.68 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=205.1
Q ss_pred HhcCcccCcccccCCcccEEEeEc--------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL--------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ 602 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 602 (854)
..++|.+.+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 346778889999999999999963 124579999886532 34456789999999999 89999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEE
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 669 (854)
....++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ ++||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999864321 235788999999999999999999998 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCch
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSS 748 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~ 748 (854)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+... .
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~ 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----P 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----C
Confidence 99999999999999987643222222223445678999999998889999999999999999998 66666421 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
..+.. .....+.... .+......+.+++.+|++.+|++||++.||++.|+.+.
T Consensus 245 ~~~~~-~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 VEELF-KLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHH-HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 11211 1112211110 11123356888999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.40 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=195.6
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----eeE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-----EKM 607 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 607 (854)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999754 6899999998643 2233456889999999999999999999886432 479
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||++ ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 57877774 3345899999999999999999999998 999999999999999999999999999864
Q ss_pred cCccC-cccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-------
Q 003045 688 GFNQN-EANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW------- 757 (854)
Q Consensus 688 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~------- 757 (854)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHH
Confidence 32211 112234578999999999875 6789999999999999999999999864221 01111111100
Q ss_pred ----hcCCccccc---CCCCCCCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 758 ----NEGKAMELV---DPNIRDSSS---QNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 758 ----~~~~~~~~~---d~~l~~~~~---~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
........+ .+....... ......+.+++.+||+.+|++|||++|+++ .+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 000000000 000000000 011245678999999999999999999997 34443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=324.05 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=194.0
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999764 5789999999754 223445678899988877 799999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCc
Confidence 999888743 345899999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc---CchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE---NSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... ......++......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~--- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R--- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C---
Confidence 33467899999999999999999999999999999999999998642211 11122222222222111 1
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPT------MASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs------~~eVl~ 805 (854)
.+......+.+++.+||+.||++||+ +.++++
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11122346778999999999999998 466644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=329.13 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=197.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999764 58999999997532 233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 345899999999999999999999998 999999999999999999999999998765321
Q ss_pred cCcc------------------------------------cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh
Q 003045 691 QNEA------------------------------------NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734 (854)
Q Consensus 691 ~~~~------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt 734 (854)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 003045 735 GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT---MASVVL 805 (854)
Q Consensus 735 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~eVl~ 805 (854)
|+.||..... .+.............+ +. .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~-----~~~~~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP-----QETYRKIINWKETLQF--PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH-----HHHHHHHHcCCCccCC--CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999863221 1111111111110011 10 00112356677788886 8999998 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.89 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=203.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 604 (854)
..++|.+.++||+|+||.||+|++. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456778899999999999999753 346899999975432 23457889999999997 999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcc----------------------------------------------------------
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPA---------------------------------------------------------- 626 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 626 (854)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999885421
Q ss_pred -------------------------------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEE
Q 003045 627 -------------------------------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669 (854)
Q Consensus 627 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 669 (854)
....+++..++.++.||++||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124678888999999999999999987 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCch
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSS 748 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~ 748 (854)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-hHH
Confidence 99999999999999986532222112223456788999999998889999999999999999998 8888753211 111
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+.. ....+.. . ..+......+.+++.+|++.+|++||+++||++.|+.+
T Consensus 351 ~~~----~~~~~~~--~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 FYN----AIKRGYR--M-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHH----HHHcCCC--C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1111110 0 01111235788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.81 Aligned_cols=260 Identities=28% Similarity=0.432 Sum_probs=204.4
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
..++|.+.+.||+|+||.||++.. ..+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 346788899999999999999963 234579999987543 23356789999999999 7999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..+++|||+++++|.+++.... ...+++.++..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999985422 234899999999999999999999988 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 763 (854)
................++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ..... .....+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~----~~~~~~~~- 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFY----KLIKEGYR- 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHH----HHHHcCCc-
Confidence 86543222112223456778999999999999999999999999999998 8888753211 11111 11111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 764 ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 764 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+ .........+.+++.+|++.+|++||++.||++.|+..
T Consensus 263 ----~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ----M----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 01111234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.65 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=205.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcCC-----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPE-----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ-GEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~ 605 (854)
..++|.+.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678888999999999999998655 6889999886542 3345678899999999999999999998876 467
Q ss_pred eEEEEEcCCCCChhhhhcCcccc-----cCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQ-----ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISD 680 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 680 (854)
.++++||+++++|..++...... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998553222 46899999999999999999999988 99999999999999999999999
Q ss_pred cCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhc
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNE 759 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 759 (854)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+... ....+...+ ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~----~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYL----KD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHH----Hc
Confidence 999986532222111222345678999999998889999999999999999999 88887532 112222221 11
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 760 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
+. .+.. .......+.+++.+|++.+|++|||+.||++.|+.+.
T Consensus 235 ~~--~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GY--RLAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC--CCCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 0000 1112346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.70 Aligned_cols=280 Identities=26% Similarity=0.360 Sum_probs=211.6
Q ss_pred ccCCCcccceeHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHH--hcCCCce
Q 003045 516 QVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIA--KLQHRNL 593 (854)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~h~ni 593 (854)
..+|..++.+..+++. ......+.||+|.||.||+|++ .|+.||||++...+ .+.+.+|-++.+ .|+|+||
T Consensus 195 SGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENI 267 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENI 267 (513)
T ss_pred CCCCCCchhHhHHhhh---heeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchh
Confidence 3445566666655554 5566778999999999999999 68999999997643 345566666655 4699999
Q ss_pred eeeeeeEEeCC----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-----CCCCceEEcccC
Q 003045 594 VRLLGCCIQGE----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-----DSRLRIIHRDLK 664 (854)
Q Consensus 594 v~l~~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlk 664 (854)
+.+++.-..++ +.+||.+|.++|||.+|| .+..++....++++..+|.||+|||. ++++.|.|||||
T Consensus 268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred hhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 99998876543 678999999999999999 34678999999999999999999994 477899999999
Q ss_pred CCcEEEccCCCceecccCcceeccCc--cCcccccccccccccccceeeccCC----C-Cc-ccchhhHHHHHHHHHhCC
Q 003045 665 ASNILLDEDMNPKISDFGMARIFGFN--QNEANTNRVVGTYGYMAPEYAMEGL----F-SV-KSDVYSFGVLLLEIVSGR 736 (854)
Q Consensus 665 p~NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~----~-s~-~~DVwSlGvil~elltG~ 736 (854)
..||||..++...|+|+|+|...... ..+...+..+||.+|||||++.+.. | +. .+||||||.|+||+.-..
T Consensus 344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999987543 2334566789999999999997643 2 22 599999999999987632
Q ss_pred ----------CCCCCCcccCchHHHHHHHHhhcCCcccccCCCC-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 737 ----------RNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI-RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 737 ----------~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.||..-.+.+.+..+ ..+.+=.++ +-|.+ ....+.+.+..+.+++..||..+|..|-|+--+-+
T Consensus 424 ~~ggi~eey~~Pyyd~Vp~DPs~ee-MrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 424 ESGGIVEEYQLPYYDVVPSDPSFEE-MRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred hcCCEehhhcCCcccCCCCCCCHHH-Hhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 333322222222222 222111111 11222 12334577889999999999999999999999999
Q ss_pred HHhccC
Q 003045 806 MLESET 811 (854)
Q Consensus 806 ~L~~~~ 811 (854)
.|.++.
T Consensus 499 tl~~l~ 504 (513)
T KOG2052|consen 499 TLAKLS 504 (513)
T ss_pred HHHHHh
Confidence 998873
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.28 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=203.1
Q ss_pred hcCcccCcccccCCcccEEEeEcC--------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG 603 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 603 (854)
.++|.+.++||+|+||.||+++.. +...+|+|.+.... ....+++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999642 23579999987542 33456788999999999 799999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999864321 235889999999999999999999988 9999999999999
Q ss_pred ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchH
Q 003045 671 DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSL 749 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l 749 (854)
+.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..|+... . .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~---~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--P---V 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--C---H
Confidence 9999999999999986532111111122234568999999998899999999999999999998 77776421 1 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 750 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
.+ +.......... ..+......+.+++.+|++.+|++||++.||++.|+.+.
T Consensus 249 ~~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 EE-LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HH-HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 11111121111 111122357788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.52 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=203.1
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCc-eeeeeeeEEeCC------
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRN-LVRLLGCCIQGE------ 604 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~------ 604 (854)
..|...++||+|+||+||+|+. .+|+.||+|++..... .......+|+.++++++|+| |+++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4455667899999999999975 4689999999976543 24456789999999999999 999999999887
Q ss_pred eeEEEEEcCCCCChhhhhcCcccc-cCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQ-ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
..++|+||++ .+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999985 4677777543321 34666888999999999999999999 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
|+.+...... .+..++|..|+|||++.+. .|+...||||+|||++||++++.-|+.. .+.+....+.+.......
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~--se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD--SEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC--cHHHHHHHHHHHcCCCCc
Confidence 9976533322 3446789999999999887 7999999999999999999988776633 334444555555433311
Q ss_pred ---cccc---CC--CCCCCC-----CH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 763 ---MELV---DP--NIRDSS-----SQ---NQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 763 ---~~~~---d~--~l~~~~-----~~---~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.... +- ...... .. .......+++.+||+.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 11 111100 01 111367889999999999999999999985
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.28 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=199.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||+||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36788899999999999999754 68899999997542 234566889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 245899999999999999999999998 999999999999999999999999999876422
Q ss_pred cCcccccccccccccccceeec------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 691 QNEANTNRVVGTYGYMAPEYAM------EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQRFLK 229 (330)
T ss_pred Cc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCCccC
Confidence 21 1223357899999999986 45678999999999999999999999863211 111222221111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+ .......+.+++..|++ +|.+||++.++++
T Consensus 230 ~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 FPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111 01123457778888997 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.57 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=204.2
Q ss_pred hcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888899999999999999653 24689999986543 23345788999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcc-------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceec
Q 003045 607 MLIYEYMPNKSLDLFIFDPA-------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKIS 679 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 679 (854)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 1234789999999999999999999988 9999999999999999999999
Q ss_pred ccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhh
Q 003045 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... ........+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~----~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFV----I 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHH----h
Confidence 9999986543222222233456788999999998889999999999999999998 88887532 111222221 1
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.+.... ... .....+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 236 ~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLD-----LPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCC-----CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 111 124578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=323.17 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=195.3
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+++.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999764 58899999997542 23345678899999998 699999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCc
Confidence 999888743 346899999999999999999999998 99999999999999999999999999874311 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc---CchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE---NSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....++.......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 33467999999999999999999999999999999999999999643211 11122222222222111 1111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPT------MASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs------~~eVl~ 805 (854)
. ....+.+++.+||+.||++||+ ++|+++
T Consensus 227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 2346788999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.57 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=194.8
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|+||+||++... +++.+|+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999754 68899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccc
Q 003045 619 DLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN 697 (854)
Q Consensus 619 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 697 (854)
..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 8887542 23346899999999999999999999998 9999999999999999999999999998654222 2223
Q ss_pred ccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 003045 698 RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQN 777 (854)
Q Consensus 698 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 777 (854)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... ..... ..+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~---------~~~~~--~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRI---------LNDSV--TYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhh---------cccCC--CCccc
Confidence 4578999999999999999999999999999999999999986432211 111111110 00000 11122
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 778 QVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 778 ~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
....+.+++.+||+.||++|| +++|+++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 345678899999999999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=328.57 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=198.9
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
..++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999764 58899999986532 2334557889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788889999999999999999988 9999999999999999999999999998653
Q ss_pred CccCcccccccccccccccceeeccC----CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEG----LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...............
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSLT 267 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCcCC
Confidence 221 1122345799999999998653 478999999999999999999999864221 111111111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY--RPTMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~eVl~ 805 (854)
+.+ .......+.+++.+||+.+|.+ ||++.|++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 268 FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 111 0112346778889999999988 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.10 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=202.7
Q ss_pred hcCcccCcccccCCcccEEEeEcCC-C---cEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE-G---QDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|+..+.||+|+||.||+|+.+. + ..+|+|++.... ....+.+.+|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567788999999999999997642 3 368999886542 3345678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++++|..++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 245899999999999999999999998 9999999999999999999999999998664
Q ss_pred CccCcccc-cccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 689 FNQNEANT-NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 689 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
........ .....+..|+|||++....++.++||||||+++|||++ |+.|+..... ..+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~----i~~~~----- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKA----INDGF----- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHH----HhcCC-----
Confidence 32211111 11223457999999998889999999999999999997 9999853211 111111 11110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.34 Aligned_cols=246 Identities=29% Similarity=0.419 Sum_probs=194.3
Q ss_pred ccccCCcccEEEeEc---CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 542 KLGRGGFGPVHKGKL---PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+||+|+||.||+|.. .+++.+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999954 357889999986543 234567899999999999999999999875 55778999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc-
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN- 695 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 695 (854)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 345889999999999999999999988 99999999999999999999999999987643322111
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+.... ...+...+ ..+... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i----~~~~~~-----~~~~-- 221 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMI----ESGERM-----ECPQ-- 221 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HCCCCC-----CCCC--
Confidence 112234578999999988889999999999999999998 888886321 11222221 221111 1111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.....+.+++.+|++.+|++||++.+|.+.|++
T Consensus 222 --~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 --RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.23 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=200.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCc----EEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQ----DIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.+.|...++||+|+||+||+|+. .+++ .||+|.+.... ....+++.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35677889999999999999974 3444 48999986542 3345678899999999999999999999875 4578
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998543 245899999999999999999999988 999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+...+ ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~----~~~~~~~-- 231 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLL----EKGERLP-- 231 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH----HCCCcCC--
Confidence 43222211222344678999999998899999999999999999998 888875321 11222221 1111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
........+.+++.+|++.||++||++.|++..|+.+.
T Consensus 232 -------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 -------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01122346788999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.18 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=202.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578899999999999999999643 24579999876442 2234467889999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcc-------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 606 KMLIYEYMPNKSLDLFIFDPA-------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
.++||||+++|+|.+++.... ....+.+..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986422 1234577888999999999999999988 999999999999999999999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHh
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.... ....... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--~~~~~~~---~- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--NEQVLKF---V- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH---H-
Confidence 99999986532221111222345678999999999999999999999999999999 676764211 1111111 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+... .. +......+.+++.+|++.+|++||++.|+++.|+..
T Consensus 235 ~~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGYL-----DQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCCC-----CC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111110 01 111235788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=321.69 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=192.5
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHH---HhcCCCceeeeeeeEEeCCeeEEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILI---AKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999754 68999999997542 23345667776655 566799999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 235899999999999999999999998 99999999999999999999999999875321
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ . .+.. .
T Consensus 154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--~~~~~~~i---~-~~~~------~ 219 (324)
T cd05589 154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--EEEVFDSI---V-NDEV------R 219 (324)
T ss_pred --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHH---H-hCCC------C
Confidence 1122334679999999999999999999999999999999999999986321 11111111 1 1111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
... .....+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111 1234677899999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.56 Aligned_cols=262 Identities=25% Similarity=0.429 Sum_probs=202.0
Q ss_pred cCcccCcccccCCcccEEEeEc-----CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
..|.+.++||+|+||.||+++. .+++.||+|.+.... ....+.+.+|++++++++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567889999999999999963 357889999986543 33456789999999999999999999998875 567
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc---------cCchHHHHHHHH
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE---------ENSSLIEHVWNL 756 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~---------~~~~l~~~~~~~ 756 (854)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6432211 112234567789999999988899999999999999999998766432110 000001111111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...+.. ..........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 011112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=322.49 Aligned_cols=241 Identities=25% Similarity=0.317 Sum_probs=192.3
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCC-ceeeeeeeEEeCCeeEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHR-NLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 610 (854)
+|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3677899999999999999765 5789999999754 233456788899999999765 6888999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF- 153 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence 99999999988843 345889999999999999999999998 99999999999999999999999999875321
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ . ... ..+
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i---~-~~~------~~~ 220 (324)
T cd05587 154 -GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQSI---M-EHN------VSY 220 (324)
T ss_pred -CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHH---H-cCC------CCC
Confidence 1122334679999999999999999999999999999999999999986321 11122211 1 111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
+......+.+++.+||+.+|++||+.
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 ----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11123467889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=311.33 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=200.3
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|++.++||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5688899999999999999985 468899999997655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 99999998843 345889999999999999999999988 9999999999999999999999999998763221
Q ss_pred ccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.......++..|+|||.+. ...++.++||||||+++|||++|+.|+....... ... ..... .+..+..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----~~~-~~~~~---~~~~~~~ 231 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALF-LMSKS---NFQPPKL 231 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----hhe-eeecC---CCCCCCC
Confidence 1122356888999999884 3457889999999999999999999875321110 000 00000 0111111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.. .......+.+++.+||+.+|++||+++++++.
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11 11223578899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=322.41 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=193.3
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999765 57899999987542 33445677899999876 799999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc--CCcc
Confidence 999888743 345889999999999999999999998 99999999999999999999999999875421 1222
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... . ...+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~~~~~~i---~~~-~---~~~p---~--- 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--EDDLFESI---LHD-D---VLYP---V--- 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--HHHHHHHH---HcC-C---CCCC---C---
Confidence 334678999999999999999999999999999999999999986432 11222221 111 1 0111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRP-------TMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RP-------s~~eVl~ 805 (854)
.....+.+++.+||+.||++|| ++.++++
T Consensus 218 -~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 -WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1124677889999999999999 7888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=327.36 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=194.1
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
+|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888899999999999999754 58899999986532 2345668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999843 345888899999999999999999998 9999999999999999999999999985331100
Q ss_pred C-----------------------------------------cccccccccccccccceeeccCCCCcccchhhHHHHHH
Q 003045 692 N-----------------------------------------EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLL 730 (854)
Q Consensus 692 ~-----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ 730 (854)
. ........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 003045 731 EIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP---TMASVVLM 806 (854)
Q Consensus 731 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---s~~eVl~~ 806 (854)
||++|+.||..... ..... ....... ....+. .... ...+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~~--~~~~~---~i~~~~~--~~~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTP--AETQL---KVINWET--TLHIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCH--HHHHH---HHhccCc--cccCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999864321 11111 1111100 000110 1112 234556666665 5999999 88888863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.99 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=199.5
Q ss_pred cCcccCcccccCCcccEEEeEcCC-Cc--EEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQ--DIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999997643 33 4788887642 233456789999999999 799999999999999999999
Q ss_pred EEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 610 YEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
+||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1135889999999999999999999988 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..|+.... ...+...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--~~~~~~~--- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--CAELYEK--- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---
Confidence 99999998643211 11111223457999999998899999999999999999998 988875321 1111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
...+. .+ ..+......+.+++.+|++.+|.+||+++++++.|+.+..
T Consensus 231 -~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 -LPQGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HhcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11110 01 1111223467889999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.04 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=202.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|++.+.||+|+||.||++..+ ++..+|+|++.... ....+++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999753 46789999987542 23456789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcc-------------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCc
Q 003045 607 MLIYEYMPNKSLDLFIFDPA-------------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 667 (854)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1134788899999999999999999988 9999999999
Q ss_pred EEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccC
Q 003045 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEEN 746 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~ 746 (854)
||+++++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886532221111222334567999999998899999999999999999998 7777642111
Q ss_pred chHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 747 SSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 747 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.+.. .....+.... .+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 239 ---~~~~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ---EEVI-YYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHH-HHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 1111221111 111223578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=328.68 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=195.1
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3678889999999999999965 468999999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 345888999999999999999999998 999999999999999999999999999643210
Q ss_pred cCc---------------------------------------------ccccccccccccccceeeccCCCCcccchhhH
Q 003045 691 QNE---------------------------------------------ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSF 725 (854)
Q Consensus 691 ~~~---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSl 725 (854)
... .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHH
Q 003045 726 GVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYR---PTMAS 802 (854)
Q Consensus 726 Gvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Ps~~e 802 (854)
||++|||++|+.||..... ...... .........+.+. ......+.+++.+|++ +|.+| |++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~--~~~~~~---i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS--HETYRK---IINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCH--HHHHHH---HHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999864221 111111 1111111111110 0112456778888997 66665 59999
Q ss_pred HHHH
Q 003045 803 VVLM 806 (854)
Q Consensus 803 Vl~~ 806 (854)
+++.
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.04 Aligned_cols=261 Identities=29% Similarity=0.417 Sum_probs=203.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC--------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG 603 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 603 (854)
..+|.+.+.||+|+||.||+++.. .+..||+|.+.... ....+++.+|+++++++ +|+||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 356888999999999999999632 12368999886532 33456889999999999 799999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
+..+++|||+++++|.+++.... ....+.+.++..++.||+.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999986422 2235889999999999999999999988 9999999999999
Q ss_pred ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchH
Q 003045 671 DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSL 749 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l 749 (854)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----V 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----H
Confidence 9999999999999986542221112222334567999999999999999999999999999998 777764321 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 750 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.+.. .....+.... ........+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 243 ~~~~-~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELF-KLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHH-HHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1111 1111111111 111223468889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=329.04 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=191.8
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
+|+..++||+|+||+||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999754 68899999987542 2334578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 345788899999999999999999998 9999999999999999999999999975431000
Q ss_pred ---------------------------------------------CcccccccccccccccceeeccCCCCcccchhhHH
Q 003045 692 ---------------------------------------------NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFG 726 (854)
Q Consensus 692 ---------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlG 726 (854)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00011235789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHH
Q 003045 727 VLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT---MASV 803 (854)
Q Consensus 727 vil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~eV 803 (854)
|++|||++|+.||..... .+.............+ |. .... ...+.+++.+++ .+|++|++ +.|+
T Consensus 236 vil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~--p~-~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP-----LETQMKVINWQTSLHI--PP-QAKL----SPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCH-----HHHHHHHHccCCCcCC--CC-cccC----CHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999864221 1111111111110000 10 0112 234455555655 49999997 7777
Q ss_pred HH
Q 003045 804 VL 805 (854)
Q Consensus 804 l~ 805 (854)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.77 Aligned_cols=241 Identities=22% Similarity=0.257 Sum_probs=193.1
Q ss_pred cccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 468999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GAT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccc
Confidence 99888743 3458999999999999999999997 56 999999999999999999999999998753211 112
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+ .... ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i----~~~~------~~~p~~-- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELI----LMEE------IRFPRT-- 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHH----hcCC------CCCCCC--
Confidence 2345799999999999999999999999999999999999999863211 1111111 1111 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
....+.+++.+||+.||++|+ ++.++++
T Consensus 219 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 219 --LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred --CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 234677889999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=326.27 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=198.8
Q ss_pred HHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
+....++|++.++||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3345578999999999999999999765 5789999998643 22334567899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998843 24788899999999999999999998 9999999999999999999999999998
Q ss_pred eccCccCcccccccccccccccceeeccC----CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEG----LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
..... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .............
T Consensus 191 ~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~~~~~~~i~~~~~ 264 (370)
T cd05621 191 KMDET-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----LVGTYSKIMDHKN 264 (370)
T ss_pred ecccC-CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCc
Confidence 76321 11122346799999999998754 37889999999999999999999986321 1111122211111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY--RPTMASVVLM 806 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~eVl~~ 806 (854)
...+. ........+.+++..|++.++.+ ||++.|+++.
T Consensus 265 ~~~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11110 01112345667778888765544 8899999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=321.74 Aligned_cols=236 Identities=27% Similarity=0.390 Sum_probs=189.9
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||+||+|+.+ +++.||+|++... .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999765 5889999998753 233456677888888877 699999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCc
Confidence 999988743 345889999999999999999999998 99999999999999999999999999875421 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ..+.. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i----~~~~~---~~~------- 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAI----LNDEV---VYP------- 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHH----hcCCC---CCC-------
Confidence 334679999999999999999999999999999999999999986321 11122211 11111 011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123467889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.60 Aligned_cols=262 Identities=28% Similarity=0.415 Sum_probs=201.2
Q ss_pred hcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC-C
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG-E 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~ 604 (854)
.++|++.++||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46789999999999999999962 357889999997543 23345688999999999 689999999988654 4
Q ss_pred eeEEEEEcCCCCChhhhhcCccc---------------------------------------------------------
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAK--------------------------------------------------------- 627 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 627 (854)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998853210
Q ss_pred -------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccccc
Q 003045 628 -------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVV 700 (854)
Q Consensus 628 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 700 (854)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124678888999999999999999988 9999999999999999999999999998653222212222334
Q ss_pred cccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 003045 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQV 779 (854)
Q Consensus 701 gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 779 (854)
++..|+|||++.+..++.++||||||+++|||++ |..|+...... ..+. .....+..... +. . ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~--~~---~----~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC----RRLKEGTRMRA--PD---Y----TT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHH----HHHhccCCCCC--CC---C----CC
Confidence 5678999999999899999999999999999997 88887532111 1111 11112111110 11 1 12
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 780 LRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 780 ~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
..+.+++.+|++.+|++||++.||++.|+.+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 367889999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=307.51 Aligned_cols=247 Identities=29% Similarity=0.376 Sum_probs=197.0
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChh
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLD 619 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 619 (854)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999875432 23446889999999999999999999999999999999999999999
Q ss_pred hhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccccc
Q 003045 620 LFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699 (854)
Q Consensus 620 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 699 (854)
+++... ...+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 988542 235789999999999999999999988 99999999999999999999999999976432111 111122
Q ss_pred ccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 700 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
.++..|+|||++....++.++||||||+++|||++ |..|+.... .......+ ..+.. .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--~~~~~~~~----~~~~~---------~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--NQQAREQV----EKGYR---------MSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHH----HcCCC---------CCCCCCC
Confidence 34567999999998899999999999999999998 888875321 11111111 11111 1111123
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 779 VLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
...+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.75 Aligned_cols=238 Identities=25% Similarity=0.276 Sum_probs=191.2
Q ss_pred cccccCCcccEEEeEc----CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 541 NKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
+.||+|+||.||+++. .+|+.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 357899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EK 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CC
Confidence 9999988843 345899999999999999999999998 999999999999999999999999998864321 12
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+.... .......+ . .... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~i---~-~~~~----------~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--RKETMTMI---L-KAKL----------GM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--HHHHHHHH---H-cCCC----------CC
Confidence 2334678999999999999889999999999999999999999986321 11111111 1 1111 01
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTMAS 802 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~e 802 (854)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112346778899999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=325.02 Aligned_cols=201 Identities=24% Similarity=0.346 Sum_probs=173.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|+..++||+|+||+||+++.. +++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36788899999999999999754 58899999997532 233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 346899999999999999999999998 999999999999999999999999998754311
Q ss_pred cC---------------------------------cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCC
Q 003045 691 QN---------------------------------EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737 (854)
Q Consensus 691 ~~---------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~ 737 (854)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 000123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 003045 738 NTSF 741 (854)
Q Consensus 738 p~~~ 741 (854)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.42 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=192.4
Q ss_pred cccccCCcccEEEeEcCC---CcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE---GQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+.||+|+||.||+|...+ +..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999997543 45799998865432 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCccc--ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 617 SLDLFIFDPAK--QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 617 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|.+++..... ....++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 234677788899999999999999988 9999999999999999999999999997543222212
Q ss_pred cccccccccccccceeeccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 695 NTNRVVGTYGYMAPEYAMEG-------LFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~-------~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+...... ...... ..+....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~----~~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYT----VREQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHH----hhcccCCCC
Confidence 22334577889999998642 35789999999999999996 99888643211 111111 111222233
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
++.+.... ...+.+++..|+ .+|++|||+.||++.|+
T Consensus 232 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 33332222 234667888898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=309.00 Aligned_cols=250 Identities=32% Similarity=0.479 Sum_probs=203.7
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 5677889999999999999987 488999999976543 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999985432 235899999999999999999999998 99999999999999999999999999986532111
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
....+..|+|||++....++.++||||||+++|||++ |+.|+.... ...+...+ ..+... .
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~----~~~~~~---------~ 219 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHV----EKGYRM---------E 219 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH----hcCCCC---------C
Confidence 2334567999999998899999999999999999997 888875321 11122211 111110 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112235788899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=309.14 Aligned_cols=254 Identities=34% Similarity=0.470 Sum_probs=203.3
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.+.|.+.++||+|+||.||+|..++++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45688889999999999999998889999999987543 34578899999999999999999999874 56789999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999885432 346889999999999999999999988 99999999999999999999999999987542111
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++....++.++||||||+++|||++ |+.|+.... ...+.... ..+.. .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~----~~~~~-----~---- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNL----ERGYR-----M---- 222 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHH----HcCCC-----C----
Confidence 11122345678999999998899999999999999999999 898886321 11122111 11110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.........+.+++.+|++.+|++||++++++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.01 Aligned_cols=251 Identities=27% Similarity=0.349 Sum_probs=199.8
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999754 68899999986532 2223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 99999999887543 2245899999999999999999999998 999999999999999999999999999865321
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+....... .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~~~~~~~~~~~~~~----------~ 221 (285)
T cd05605 156 --ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--KVKREEVERRVKED----------Q 221 (285)
T ss_pred --CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--hhHHHHHHHHhhhc----------c
Confidence 112235789999999999988999999999999999999999999874321 11111111111110 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
..........+.+++.+|++.||++|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111222345678899999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=320.48 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=192.5
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 610 (854)
+|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3677889999999999999765 57899999987542 22344567788888877 5899999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW- 153 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC-
Confidence 99999999888743 345889999999999999999999998 99999999999999999999999999975421
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+. .... .
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~----~~~~------~- 219 (323)
T cd05616 154 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIM----EHNV------A- 219 (323)
T ss_pred -CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--HHHHHHHHH----hCCC------C-
Confidence 1122334678999999999999999999999999999999999999986421 122222221 1111 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
.+......+.+++.+|++.+|++|++.
T Consensus 220 ---~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ---YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111223467889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.92 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=202.5
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.+|...+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999975 468899999997765556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 170 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence 99999998842 34789999999999999999999998 9999999999999999999999999988653221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .........+ . +.+ .
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~-----~~~--~ 237 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNG-T-----PEL--Q 237 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHHHhcCC-C-----CCC--C
Confidence 1122346888999999999888999999999999999999999998643211 1111111110 0 011 0
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11223356788999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.90 Aligned_cols=241 Identities=27% Similarity=0.348 Sum_probs=191.5
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||+||+|+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 57899999997542 23345567788888764 899999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|+|..++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCc
Confidence 999998843 345889999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i----~~~------~~~~~~--- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSI----RMD------NPCYPR--- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhC------CCCCCc---
Confidence 334678999999999999999999999999999999999999986321 11222221 111 111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMA-SVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~-eVl~ 805 (854)
.....+.+++.+||+.+|++||++. ++.+
T Consensus 218 -~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 -WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1224577889999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.46 Aligned_cols=250 Identities=34% Similarity=0.493 Sum_probs=202.6
Q ss_pred cccccCCcccEEEeEcCC----CcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+|.... +..+++|.+...... ..+.+.+|++++++++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999997653 788999999765433 367889999999999999999999999999999999999999
Q ss_pred CChhhhhcCccc------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 616 KSLDLFIFDPAK------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 616 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
++|.+++..... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 356899999999999999999999988 99999999999999999999999999987653
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
...........++..|+|||.+....++.++||||||+++|||++ |..|+... ....+.... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~----~~~~~~----- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYL----RKGYRL----- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH----HcCCCC-----
Confidence 322223334567889999999998899999999999999999999 58887643 111222221 111110
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
..+......+.+++.+|++.+|++||++.|++..|+
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122457888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.04 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=203.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-----CCcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-----EGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 606 (854)
++|...+.||+|+||.||+|+.. .++.+|||.+...... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45667789999999999999743 3688999999765433 46789999999999999999999999887 5578
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 25899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCc---------hHHHHHHHH
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS---------SLIEHVWNL 756 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~---------~l~~~~~~~ 756 (854)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6422111 111123445679999999888999999999999999999999988753221110 001111111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...+ .....+......+.+++.+|++.+|++||++.||+++|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 11111122235788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.26 Aligned_cols=250 Identities=27% Similarity=0.359 Sum_probs=202.9
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...+.||+|++|.||+|+.. +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999764 6889999998643 234567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 9999999998643 2346889999999999999999999988 9999999999999999999999999998764321
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......|++.|+|||++.+..++.++||||||++++||++|+.|+.... ....... ...+.. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~----~~~~~~---------~ 219 (256)
T cd08529 156 -NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILK----IIRGVF---------P 219 (256)
T ss_pred -chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHH----HHcCCC---------C
Confidence 12233568889999999999999999999999999999999999986432 1111111 111111 1
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.........+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111334578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.04 Aligned_cols=277 Identities=25% Similarity=0.331 Sum_probs=206.8
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecc--ccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe-----C
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ-----G 603 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~ 603 (854)
....+|...+.||+|+||.|..+.. .+|+.||||++.. ......++..+|+.+|+.++|+||+.+.+.+.- -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3456666678999999999999965 4689999999973 244456678899999999999999999998865 3
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
+..|+|+|+| +.+|...++ .+..|+......++.||++||.|+|+.+ ++||||||+|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 5689999999 567877773 3344888999999999999999999999 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-----
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW----- 757 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~----- 757 (854)
|+...........+..+.|..|+|||++.. ..|+.+.||||.|||+.||++|+.-|+....- .....+....
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSE 249 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCH
Confidence 998754323344566888999999998864 57999999999999999999999888743211 1111111111
Q ss_pred ------hcCCcccccCC---CCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhccCCCCCCC
Q 003045 758 ------NEGKAMELVDP---NIRDS---SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESETPTLPVP 817 (854)
Q Consensus 758 ------~~~~~~~~~d~---~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~~~~~~~p 817 (854)
..+.....+.. ..+.. .-.......++++.+||..||.+|+|++|.++ -|+........|
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11111111110 00000 00112235778888999999999999999998 455554444444
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=319.18 Aligned_cols=260 Identities=29% Similarity=0.430 Sum_probs=202.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC--------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG 603 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 603 (854)
.++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357788899999999999999632 24578999887542 23456788999999999 699999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
...+++|||+++++|.+++.... ....+++.++..++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999985432 1245889999999999999999999988 9999999999999
Q ss_pred ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchH
Q 003045 671 DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSL 749 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l 749 (854)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+... ....+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~~~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEEL 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CHHHH
Confidence 9999999999999986542221111222234567999999999899999999999999999999 77777432 11112
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 750 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
.. ....+.... .+......+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 246 ~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 FK----LLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH----HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22 112211111 11122346778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.02 Aligned_cols=253 Identities=32% Similarity=0.451 Sum_probs=200.8
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|++.++||+|++|.||+|....+..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999988777789999876432 34567899999999999999999999875 456889999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence 99999998643 2335789999999999999999999988 99999999999999999999999999986532211 1
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||+..+..++.++||||||+++|||++ |..|+.... .......+ ..+.. + .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~----~~~~~-----~----~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQV----ERGYR-----M----P 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCC-----C----C
Confidence 1122345678999999998889999999999999999999 888875321 11122211 11100 0 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.+......+.+++.+|++.+|++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112234578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.91 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=186.3
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEII-LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999764 58899999986532 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+.+..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCc
Confidence 999887742 345788899999999999999999988 99999999999999999999999999875321 1222
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+. .. .... . .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~---i~-~~~~------~----~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQMYDN---IL-HKPL------Q----LP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--HHHHHHH---Hh-cCCC------C----CC
Confidence 344678999999999999999999999999999999999999986421 1111111 11 1110 0 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMA 801 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~ 801 (854)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=290.94 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=202.4
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-----cc---CHHHHHHHHHHHHhcC-CCceeeeeeeEEe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-----GQ---GLEEFKNEIILIAKLQ-HRNLVRLLGCCIQ 602 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~---~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 602 (854)
.-++|...+.||.|..++|.+... ++|+++|+|++.... ++ -.+.-..|+.||+++. ||+|+.+.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 346677888999999999999855 468899999996432 11 1334567999999985 9999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
+.-.++|+|.|+.|.|.++|. ..-.+++++..+|++|+.+|++|||..+ ||||||||+|||++++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999993 4456899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeec------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAM------EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
++..+. ........+||++|+|||.+. ...|+...|+|++|||+|.||.|.+||--. -.-...+.
T Consensus 169 Fa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR------kQmlMLR~ 239 (411)
T KOG0599|consen 169 FACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR------KQMLMLRM 239 (411)
T ss_pred eeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH------HHHHHHHH
Confidence 999874 223455689999999999985 345888999999999999999999997411 01112233
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+++.+- -.|. =.+......+++.+||+.||.+|.|++|+++
T Consensus 240 ImeGkyqF-~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQF-RSPE-----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhccccc-CCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 33333311 1111 1233456789999999999999999999987
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.53 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=209.9
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCC-CcEEEEEEecccccc---CHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCee
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQ---GLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~ 606 (854)
.....|.+.+.||.|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999998665 999999999776433 4568999999999998 99999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC----CCceecccC
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED----MNPKISDFG 682 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFG 682 (854)
++|||++.+|.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999988654 2899999999999999999999988 9999999999999643 479999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||....+... ... ...++.
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~~~----i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--FLA----ILRGDF 255 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--HHH----HHcCCC
Confidence 9998753 4456678999999999999999999999999999999999999999975432211 111 112211
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......-......+.+++..++..||.+|+|+.++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222233457788899999999999999999999
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.82 Aligned_cols=256 Identities=32% Similarity=0.464 Sum_probs=205.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..++|.+.++||+|+||.||+|..++++.+|+|.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999987533 3467899999999999999999999999988999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+....
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 99999999986532 235899999999999999999999998 9999999999999999999999999998764211
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........++..|+|||.+.+..++.++||||||+++|||++ |+.|+... ........+ ..+. ..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~----~~~~--~~------ 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQV----ERGY--RM------ 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH----HcCC--CC------
Confidence 111112234568999999998899999999999999999999 88887532 111122211 1110 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111123568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.29 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=196.5
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.|...++||+|+||.||+|.. .+++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999975 46889999998654 2333467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---- 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---- 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc----
Confidence 999996653 3678888999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCch-HHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS-LIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.|+......... ............. .+.+.
T Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~- 221 (279)
T cd06619 148 SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP- 221 (279)
T ss_pred ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC-
Confidence 1223457899999999999999999999999999999999999998643221111 1111111111111 11110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.+++.+|++.+|++||++.|+++
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1112246788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.69 Aligned_cols=248 Identities=29% Similarity=0.391 Sum_probs=197.6
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChh
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLD 619 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 619 (854)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998877999999998765333 4568899999999999999999999999999999999999999999
Q ss_pred hhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccccc
Q 003045 620 LFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699 (854)
Q Consensus 620 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 699 (854)
+++... ...+++..+..++.+++.+|.|||+.+ ++||||||+|||++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988543 235789999999999999999999998 999999999999999999999999999865321111111222
Q ss_pred ccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 700 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......+ .... ....+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~----~~~~---------~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERI----ESGY---------RMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHH----hcCC---------CCCCCccC
Confidence 34567999999998899999999999999999999 7777643211 1111111 1110 01111223
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 779 VLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
...+.+++.+|++.+|++||++.||++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 457888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.76 Aligned_cols=247 Identities=26% Similarity=0.302 Sum_probs=192.9
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|+||.||+++.+ +|+.+|+|++.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999764 58999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 698 (854)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...... .....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeec
Confidence 88875432 234889999999999999999999988 999999999999999999999999999865321 12233
Q ss_pred cccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 699 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
..|+..|+|||++.+..++.++||||+||++|||++|+.|+....... ...+...... .... .. . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~----~~--~---~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTL-EDEV----KF--E---HQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhh-cccc----cc--c---cccC
Confidence 568999999999998889999999999999999999999986422211 1111111111 1110 00 0 0112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
...+.+++.+||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 34678899999999999999998776533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=311.62 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=200.0
Q ss_pred CcccCcccccCCcccEEEeEcCC-C---cEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPE-G---QDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.|++.+.||+|+||.||+|+... + ..||+|.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999997643 3 36999998754 2334568999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 345889999999999999999999988 999999999999999999999999998765332
Q ss_pred cCcccccc-cc--cccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 691 QNEANTNR-VV--GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 691 ~~~~~~~~-~~--gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
........ .. .+..|+|||++....++.++||||||+++|||++ |..|+.... .......+ .... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i----~~~~--~-- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAI----EQDY--R-- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHH----HcCC--c--
Confidence 22111111 11 1357999999999999999999999999999886 988875321 11222222 1110 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.. ...+....+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 230 -~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -LP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 1112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.23 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=200.4
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
+.+++++.....||+|+||.||+|+.. +++.|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445666767789999999999999754 5788999998776656677899999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~ 688 (854)
+||+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322212278888999999999999999988 999999999999986 6789999999987653
Q ss_pred CccCcccccccccccccccceeeccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
... .......++..|+|||++.+.. ++.++||||||+++|+|++|+.|+........ ..+...... .
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~-------~ 229 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFK-------I 229 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhc-------c
Confidence 211 1222346789999999986643 78899999999999999999999853211110 010000000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+ ..+......+.+++.+|++.+|++|||+.|+++
T Consensus 230 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11 112223356788999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.47 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=193.4
Q ss_pred ccccCCcccEEEeEcC---CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 542 KLGRGGFGPVHKGKLP---EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999653 35579999986543 233567899999999999999999999885 457899999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc-c
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN-T 696 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 696 (854)
|.+++... ...+++..+++++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988532 345899999999999999999999988 99999999999999999999999999986532221111 1
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
....++..|+|||++....++.++||||||+++|||++ |..|+..... .... .....+.. ...+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~----~~~~~~~~---------~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVM----SFIEQGKR---------LDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHH----HHHHCCCC---------CCCC
Confidence 11233568999999988889999999999999999996 9988753211 1111 11122111 1111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
......+.+++.+|++.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22235777899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=318.74 Aligned_cols=241 Identities=25% Similarity=0.323 Sum_probs=193.6
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||+||+++.. +++.||+|++.+.. ....+.+..|+++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999765 57899999997542 33456678899999888 699999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCc
Confidence 999888743 345899999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ..... .. +
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i----~~~~~------~~----~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQSI----LEDEV------RY----P 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHH----HcCCC------CC----C
Confidence 334578999999999999999999999999999999999999986321 11111111 11111 11 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTM-----ASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~-----~eVl~ 805 (854)
......+.+++.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1123467889999999999999999 88865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.07 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=200.3
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc-----cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG-----QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|...+.||+|++|.||++.. .+++++|+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999975 4689999999864321 124568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345888999999999999999999998 9999999999999999999999999998653
Q ss_pred CccCcc-cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEA-NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.|+.... . ............ .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~-~~~~~~~~~~~~-----~ 225 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----A-MAAIFKIATQPT-----N 225 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----h-HHHHHHHhccCC-----C
Confidence 221111 1133567889999999999889999999999999999999999975321 1 111111111100 1
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
+ ..+......+.+++.+|++.+|++||++.|+++.
T Consensus 226 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 P----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 1122233467889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=327.95 Aligned_cols=260 Identities=19% Similarity=0.217 Sum_probs=194.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
...|.+.++||+|+||.||++... .++.||||... ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 446888999999999999999765 47889999642 23467899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+. ++|..++... ...+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6777776432 236899999999999999999999998 99999999999999999999999999987643222
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc--CchHHHHHHHHhhcCCc--cccc--
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE--NSSLIEHVWNLWNEGKA--MELV-- 766 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~--~~~~-- 766 (854)
........||..|+|||++.+..++.++|||||||++|||++|..++...... .......+.+....... .++.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22233467999999999999999999999999999999999988765322111 11111111111111110 0000
Q ss_pred -----------------CCCC-CCCCC--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 -----------------DPNI-RDSSS--QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 -----------------d~~l-~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+.. ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000 00000 011235778999999999999999999987
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=332.51 Aligned_cols=260 Identities=18% Similarity=0.290 Sum_probs=190.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-------- 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------- 603 (854)
...+|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999764 68899999885432 2345799999999999999999887432
Q ss_pred CeeEEEEEcCCCCChhhhhcC-cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-Cceeccc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFD-PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDF 681 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DF 681 (854)
...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 55555432 233456899999999999999999999998 99999999999999665 6999999
Q ss_pred CcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
|+++.+... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||..... ......+.......
T Consensus 216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC
Confidence 999865321 12223578999999999865 4699999999999999999999999864321 11111111111110
Q ss_pred C----------cccccCCCC-----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 K----------AMELVDPNI-----RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ~----------~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ...+.-+.. ....+......+.+++.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 000000110 00111122356889999999999999999999986
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=321.08 Aligned_cols=244 Identities=27% Similarity=0.425 Sum_probs=204.7
Q ss_pred ccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhh
Q 003045 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL 620 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 620 (854)
+||+|.||+||.|+..+ ...+|||.+..+..+..+-+.+||.+.++|+|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999998765 55789999988777777788999999999999999999999999999999999999999999
Q ss_pred hhcCcccccCC--CHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCceecccCcceeccCccCccccc
Q 003045 621 FIFDPAKQALL--DWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEANTN 697 (854)
Q Consensus 621 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 697 (854)
+|+..= +++ ++...-.+.+||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++++. .....+.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE 734 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence 996432 344 78888899999999999999998 99999999999996 67899999999999873 3445566
Q ss_pred ccccccccccceeeccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 698 RVVGTYGYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 698 ~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
...||.-|||||++..++ |..++|||||||++.||.||++||-....... + ++.-+ +--+ .+..+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----A--MFkVG--myKv----HP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----A--MFKVG--MYKV----HPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----h--hhhhc--ceec----CCCCc
Confidence 788999999999998764 99999999999999999999999863322111 0 11111 1112 23456
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+...+...++++|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677888999999999999999999999998
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=314.64 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=191.4
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999764 57899999997642 23445678999999888 699999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCc
Confidence 999888742 345899999999999999999999998 99999999999999999999999999875321 1122
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc-CchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE-NSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.+......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~----~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------R----I 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------C----C
Confidence 33467999999999999999999999999999999999999999643221 11122222222211111 0 1
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
+......+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.20 Aligned_cols=240 Identities=24% Similarity=0.280 Sum_probs=188.5
Q ss_pred cccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEII-LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||+||+|+. .+|+.+|+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4799999999999975 468999999986542 223345555655 56779999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCC
Confidence 99988874 3346889999999999999999999998 99999999999999999999999999875321 1222
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ . ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~~-~------~~~~~~-- 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILHK-P------LVLRPG-- 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHcC-C------ccCCCC--
Confidence 334679999999999999999999999999999999999999986321 11111111111 1 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl 804 (854)
....+.+++.+|++.+|++||++++.+
T Consensus 219 --~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 --ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 224567889999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.11 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=200.3
Q ss_pred HHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 003045 528 NTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603 (854)
Q Consensus 528 ~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 603 (854)
..+....++|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999765 57899999986432 22345578899999999999999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...++||||+++|+|..++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998843 24788889999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccC----CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEG----LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE 759 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 759 (854)
+....... ........||+.|+|||++... .++.++|||||||++|||++|+.||.... ...........
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTYSKIMNH 262 (371)
T ss_pred eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-----HHHHHHHHHcC
Confidence 98763221 1122346799999999998754 37899999999999999999999986321 11122222222
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 003045 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY--RPTMASVVLM 806 (854)
Q Consensus 760 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~eVl~~ 806 (854)
.....+.+. ......+.+++.+|+..++.+ ||++.|+++.
T Consensus 263 ~~~~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111111111 122345677888999854443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=317.30 Aligned_cols=255 Identities=30% Similarity=0.444 Sum_probs=198.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCc--EEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQ--DIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.+.||+|+||.||+|..+ ++. .+++|.+... .....+.+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999764 344 4577777543 233456788999999999 899999999999999999999
Q ss_pred EEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 610 YEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235889999999999999999999988 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..|+.... .......+
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~-- 236 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL-- 236 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHH--
Confidence 99999998643111 11111234567999999988889999999999999999998 888875321 11111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+. ...........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 237 --~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 --PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --hcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1110 0001111234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.62 Aligned_cols=237 Identities=24% Similarity=0.297 Sum_probs=187.4
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEII-LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||+||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999764 68999999997542 222344555554 56789999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCc
Confidence 999888843 346889999999999999999999998 99999999999999999999999999875321 1222
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+... .. .+. ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~---i~-~~~------~~~~~~~- 219 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--TAEMYDN---IL-NKP------LRLKPNI- 219 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--HHHHHHH---HH-cCC------CCCCCCC-
Confidence 334679999999999999999999999999999999999999986321 1111111 11 111 1111112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMA 801 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~ 801 (854)
...+.+++.+||+.||++||++.
T Consensus 220 ---~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 ---SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CHHHHHHHHHHhhcCHHhCCCCC
Confidence 34678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=342.45 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=202.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||.||+|... +++.||+|++..... ...+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999764 589999999975422 23457899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcc--------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 611 EYMPNKSLDLFIFDPA--------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234567788999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccC----------------cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC
Q 003045 683 MARIFGFNQN----------------EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN 746 (854)
Q Consensus 683 la~~~~~~~~----------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~ 746 (854)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 01112357999999999999999999999999999999999999998642111
Q ss_pred chHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhccC
Q 003045 747 SSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-TMASVVLMLESET 811 (854)
Q Consensus 747 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~eVl~~L~~~~ 811 (854)
.... ... +.++.... ........+.+++.+|++.||++|| +++++++.|+...
T Consensus 238 -ki~~-------~~~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 238 -KISY-------RDV---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred -hhhh-------hhh---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0100 000 01110000 0012234677899999999999996 6677777777653
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=325.38 Aligned_cols=262 Identities=19% Similarity=0.234 Sum_probs=198.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC---CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
...+|.+.++||+|+||.||++... .++.||+|.+... +.+.+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999643 3578999987542 2456899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||++. ++|..++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99986 5677776 23456899999999999999999999998 99999999999999999999999999987643
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc-CchHHHHHHHHhhcCCccc----
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE-NSSLIEHVWNLWNEGKAME---- 764 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~---- 764 (854)
...........||..|+|||++....++.++|||||||++|||++|+.|+...... .......+...........
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 33323333567999999999999999999999999999999999999998543221 1111111111111100000
Q ss_pred ---------ccCCCCCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 765 ---------LVDPNIRDSSS-------QNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 765 ---------~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
......+.... ......+.+++.+||+.||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0112456788899999999999999999983
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.80 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=198.1
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEE-eCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI-QGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lV~Ey~ 613 (854)
++|.+.+.||+|+||.||++.. .+..+|+|.+... ...+.+.+|+.++++++|+|++++++++. +.+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4677889999999999999976 4788999988643 33567899999999999999999999765 456789999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 9999999985432 235889999999999999999999988 999999999999999999999999998864321
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+... .+.+..... ..+.. +.
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~-~~~~~-----~~--- 219 (256)
T cd05082 156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV-EKGYK-----MD--- 219 (256)
T ss_pred --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH-hcCCC-----CC---
Confidence 112334568999999998899999999999999999998 88887532 111111111 11111 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112335778899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.08 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=187.8
Q ss_pred cccccCCcccEEEeEcCC-------------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 541 NKLGRGGFGPVHKGKLPE-------------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997432 2358899886655555567889999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC-------ceecc
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN-------PKISD 680 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~D 680 (854)
+||||+++++|+.++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999887532 345899999999999999999999988 999999999999987664 89999
Q ss_pred cCcceeccCccCcccccccccccccccceeec-cCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhh
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
||++.... ......++..|+|||.+. +..++.++|||||||++|||++ |..|+..... .+. ....
T Consensus 156 ~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~-~~~~- 222 (262)
T cd05077 156 PGIPITVL------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AEK-ERFY- 222 (262)
T ss_pred CCCCcccc------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hHH-HHHH-
Confidence 99987542 112345778899999886 5678999999999999999984 7766543211 111 0111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
.+.. ... . .....+.+++.+|++.||++||++.++++.|+
T Consensus 223 ~~~~-~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-MLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 011 1 11246788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.76 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=196.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|.+.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999765 57889999987543 23345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 986 676666432 335789999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc---------
Q 003045 693 EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA--------- 762 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~--------- 762 (854)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+....+.........
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--EDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhhcch
Confidence 12223467899999998865 4688999999999999999999999864321 1111111111111000
Q ss_pred ccccC---CCCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVD---PNIRD----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d---~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+ +.... .........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00000 000112345678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=305.58 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=188.4
Q ss_pred cccccCCcccEEEeEcCC---CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE---GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
++||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999996433 4568888775432 233457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCccc--ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 617 SLDLFIFDPAK--QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 617 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|.+++..... .....+.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567888999999999999999998 9999999999999999999999999987542221111
Q ss_pred cccccccccccccceeecc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 695 NTNRVVGTYGYMAPEYAME-------GLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+..... .. ........ ....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~---~~~~~~~~-~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQ---VLKQVVRE-QDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HH---HHHHHhhc-cCccCC
Confidence 1223445678999998743 457889999999999999999 6667653211 11 11111111 122233
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
.+.+....+ ..+.+++..|+ .||++||+++||++.|.
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 333322222 34556677787 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.51 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=201.6
Q ss_pred cCcccCcccccCCcccEEEeEcC----CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.+|++.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999753 23479999886532 23356789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 235889999999999999999999988 99999999999999999999999999987643
Q ss_pred ccCccc-ccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 690 NQNEAN-TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 690 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
...... .....++..|+|||++.+..++.++||||||+++||+++ |..|+..... ......+ .++. ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~----~~~~--~~-- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAI----EEGY--RL-- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHH----hCCC--cC--
Confidence 221111 111223567999999998899999999999999999887 9988753211 1122221 1110 00
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+ ........+.+++.+|++.+|++||+|.++++.|+.+
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 1112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.93 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=195.2
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----eeE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-----EKM 607 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 607 (854)
.|+..++||+|+||.||++.. .+++.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367789999999999999975 46899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|+||+. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46666663 2345899999999999999999999998 999999999999999999999999999865
Q ss_pred cCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc---
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM--- 763 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--- 763 (854)
..... .......++..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..........
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHH
Confidence 32211 122334678999999998774 589999999999999999999999864321 11111111111100000
Q ss_pred --------ccc----CCC-C--CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 764 --------ELV----DPN-I--RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 764 --------~~~----d~~-l--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+. .+. . ...........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 000 0 00011112356788999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.85 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=196.5
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|++.++||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3677889999999999999764 68999999986432 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++ ++|.+++........+++..+..++.||++||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 578777755444456899999999999999999999988 9999999999999999999999999998653221
Q ss_pred cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-------hc----C
Q 003045 693 EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW-------NE----G 760 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~-------~~----~ 760 (854)
.......++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ..+........ .. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhH
Confidence 112234568899999988654 5788999999999999999999888632211 11111100000 00 0
Q ss_pred Ccc----cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 KAM----ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ~~~----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ......+ .........++.+++.+||+.||++|||+.||+.
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000000 0000112346678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=308.53 Aligned_cols=252 Identities=30% Similarity=0.441 Sum_probs=198.9
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCH--HHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGL--EEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
|+..++||+|+||+||+++.. +++.+|+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999765 467899999987643322 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|..++. ....+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||++... ....
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence 9999999985 4556899999999999999999999998 999999999999999999999999999864 1222
Q ss_pred ccccccccccccccceeec-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++. +..++.++||||+|+++|+|++|..|+.... .............. .. ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~-~~---~~~~~~- 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKR-PL---PSSSQQ- 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHT-HH---HHHTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhcccc-cc---cccccc-
Confidence 3344567899999999998 8889999999999999999999999987431 01111111111100 00 000000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.+++.+||+.||++||++.|+++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001167889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.88 Aligned_cols=249 Identities=31% Similarity=0.428 Sum_probs=198.5
Q ss_pred cccccCCcccEEEeEcCC--C--cEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE--G--QDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 479999999999997543 3 3689999977655 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc-
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA- 694 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 694 (854)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999998 9999999999999999999999999998764322111
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||++....++.++||||||+++|||++ |..|+.... .......+. .... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~---~~~~--~~~~------ 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--GSQILKKID---KEGE--RLER------ 222 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH---hcCC--cCCC------
Confidence 1223456788999999998899999999999999999999 999875321 111222211 1110 0101
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
+......+.+++.+|++.+|++||++.||++.|.
T Consensus 223 -~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 -PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1122357888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.00 Aligned_cols=249 Identities=30% Similarity=0.458 Sum_probs=193.5
Q ss_pred cccccCCcccEEEeEcCC-Cc--EEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE-GQ--DIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||.||+|..++ +. .+++|.+... .....+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998654 43 4688887643 234456788999999999 799999999999999999999999999
Q ss_pred CChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 616 KSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 616 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 1234789999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||.... .......+ ..+.
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~----~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL----PQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--HHHHHHHH----hCCC
Confidence 98632211 11111233567999999988889999999999999999997 888875321 11111111 1110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.. .........+.+++.+|++.+|.+|||+.|+++.|+.+
T Consensus 229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 01111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.65 Aligned_cols=251 Identities=31% Similarity=0.483 Sum_probs=197.0
Q ss_pred cccccCCcccEEEeEcCC-------CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPE-------GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999997542 2578999886543 23466789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcc----cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-----CceecccCc
Q 003045 613 MPNKSLDLFIFDPA----KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-----NPKISDFGM 683 (854)
Q Consensus 613 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~DFGl 683 (854)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234789999999999999999999988 99999999999999877 899999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
+................++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ......+ ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV----TAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH----hcCCc
Confidence 986533222222223345678999999999999999999999999999998 8888753211 1111111 11110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
..........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 ---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01112234567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.96 Aligned_cols=260 Identities=25% Similarity=0.276 Sum_probs=198.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|.+.++||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 35888899999999999999754 57888999886542 23345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 152 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 152 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc--
Confidence 999999999853 34588999999999999999999974 5 99999999999999999999999999875421
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc--------
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM-------- 763 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-------- 763 (854)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ..................
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 153 --SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred --cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccC
Confidence 12234578899999999988889999999999999999999999985322 111111110000000000
Q ss_pred ------------c----ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 764 ------------E----LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 764 ------------~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
+ +................+.+++.+|++.+|++||++.||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000000000123458899999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.64 Aligned_cols=248 Identities=31% Similarity=0.456 Sum_probs=195.5
Q ss_pred cccccCCcccEEEeEcCC----CcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999996422 36899999876543 24567899999999999999999999875 5678999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 35889999999999999999999988 99999999999999999999999999987643222111
Q ss_pred -ccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 696 -TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 696 -~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+.... ...+...+ ...... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~----~~~~~~---------~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAML----ESGERL---------P 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHH----HcCCcC---------C
Confidence 111223567999999998999999999999999999998 888875321 12222222 111111 0
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111234678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.70 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=200.9
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
..|.+.+.||+|+||.||+|...+++.+|+|++... ....+++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 356677899999999999998877889999988643 2345678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++... ...+++..+..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999988542 235789999999999999999999988 999999999999999999999999999865322111
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||++.++.++.++||||||+++|||++ |+.|+..... ....+.. .++ .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~--~~~~~~~~--- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETI----NAG--FRLYKPRL--- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHH----hCC--CCCCCCCC---
Confidence 1112234568999999998899999999999999999998 8888753211 1111111 111 11111211
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
....+.+++.+|++.+|++||++.||++.|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.22 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=200.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 66888899999999999999765 48899999998766666778899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|..++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~ 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence 999998877432 235899999999999999999999988 999999999999999999999999998764221 1
Q ss_pred ccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 694 ANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.......++..|+|||++. ...++.++|||||||++|||++|..|+..... ........ .... +
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~-~~~~-----~ 233 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIA-KSEP-----P 233 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHh-cCCC-----c
Confidence 1223456788999999985 34578899999999999999999998753211 11111111 1111 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .+......+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 110 11122346788999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=306.18 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=198.3
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
.|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++...+..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3667789999999999999765 477889999876655566788999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|..++.. ....+++..+..++.|+++||.|||+.+ ++|+||||+|||++.++.+||+|||++...... ..
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 9999888753 2346899999999999999999999988 999999999999999999999999998765321 11
Q ss_pred cccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 695 NTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
......++..|+|||++. +..++.++|||||||++|||++|+.|+..... .+........ .......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~-~~~~~~~-- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKS-EPPTLAQ-- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHHHhhc-CCCCCCC--
Confidence 223356889999999984 45578899999999999999999998753211 1111111111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+......+.+++.+|++.+|++||++.++++
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346788999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.09 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=202.2
Q ss_pred cCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|+..++||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999998764 78999999875433 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 99999998843 2346899999999999999999999988 9999999999999999999999999998764221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......++..|+|||++.+..++.++||||||+++|+|++|+.|+....... .... .... ..+.+ .
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~-----~~~~~--~ 220 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIFM-IPNK-----PPPTL--S 220 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhhh-hccC-----CCCCC--C
Confidence 12233557889999999999899999999999999999999999986422110 0000 0000 00111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+|++.+|++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11223356888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.44 Aligned_cols=254 Identities=30% Similarity=0.440 Sum_probs=202.5
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999998877888999988643 2345678999999999999999999999887 7789999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 999999998543 2345788999999999999999999988 99999999999999999999999999986532211
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++....++.++|+||||+++|+|++ |+.|+.... ...+...+ ..+...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~----~~~~~~--------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRAL----ERGYRM--------- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHH----hCCCCC---------
Confidence 11122345677999999998889999999999999999999 888875321 11122211 111110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=311.91 Aligned_cols=196 Identities=29% Similarity=0.441 Sum_probs=159.4
Q ss_pred CcccccCCcccEEEeEcC---CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCeeEEEEEcCC
Q 003045 540 GNKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEKMLIYEYMP 614 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~ 614 (854)
.++||+|+||+||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999754 46789999986532 23467899999999999999999998864 356789999987
Q ss_pred CCChhhhhcCc------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE----ccCCCceecccCcc
Q 003045 615 NKSLDLFIFDP------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMA 684 (854)
Q Consensus 615 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla 684 (854)
+ +|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666655321 12235889999999999999999999998 9999999999999 45678999999999
Q ss_pred eeccCccC-cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 685 RIFGFNQN-EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 685 ~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
+.+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643221 122334678999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.66 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=186.1
Q ss_pred ccccCCcccEEEeEcCC-------------------------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeee
Q 003045 542 KLGRGGFGPVHKGKLPE-------------------------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 596 (854)
+||+|+||.||+|.... ...|++|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13588998866544445678899999999999999999
Q ss_pred eeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC--
Q 003045 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-- 674 (854)
Q Consensus 597 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-- 674 (854)
++++.+....++||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988542 345889999999999999999999988 99999999999998654
Q ss_pred -----CceecccCcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCcccCc
Q 003045 675 -----NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIV-SGRRNTSFRLEENS 747 (854)
Q Consensus 675 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~ell-tG~~p~~~~~~~~~ 747 (854)
.+|++|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+..... .
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~ 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP--S 228 (274)
T ss_pred cCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--H
Confidence 379999998864321 112356788999998875 56899999999999999995 68887753221 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 748 SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 748 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
...... .... .+... ....+.+++.+|++.+|++||++.+|++.|.
T Consensus 229 ~~~~~~----~~~~-------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFY----EKKH-------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH----Hhcc-------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111 1100 00011 1135788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=310.25 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=202.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999975 47899999999766555567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999998842 34789999999999999999999988 9999999999999999999999999998653222
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ +.. ....+ .+.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~~~----~~~~~------~~~~-- 235 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL----IATNG------TPEL-- 235 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-eee----eccCC------CCCC--
Confidence 122335688899999999998899999999999999999999999853221110 000 00000 0000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+......+.+++.+|++.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111223345778999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.18 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=202.4
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.+|...++||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999974 578999999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|..++.. ..+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 169 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence 99999998842 35899999999999999999999998 9999999999999999999999999988653221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.|+...... ......... ....+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~~~~~-~~~~~~~------ 237 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATN-GTPELQN------ 237 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc-CCcccCC------
Confidence 1223356888999999999888999999999999999999999998643211 111111111 1101101
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+......+.+++.+|++.+|++||++.+++.
T Consensus 238 -~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 -PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1122346778899999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=315.68 Aligned_cols=193 Identities=23% Similarity=0.345 Sum_probs=164.3
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
....+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999765 4678999975332 2356999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV- 209 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence 9995 577777643 2346899999999999999999999998 99999999999999999999999999975321
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
........||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 --APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 12223457899999999999999999999999999999999976654
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.53 Aligned_cols=240 Identities=23% Similarity=0.401 Sum_probs=188.3
Q ss_pred cccccCCcccEEEeEcCC--------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPE--------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+.||+|+||.||+|.... ..++++|.+........+.+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999996532 235888888655555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC--------ceecccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN--------PKISDFGMA 684 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~DFGla 684 (854)
+++|+|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986432 35889999999999999999999988 999999999999987765 589999988
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCC-CCCCCcccCchHHHHHHHHhhcCCc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRR-NTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|.. |+... . ...... .... .
T Consensus 156 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~-~~~~~~----~~~~-~- 221 (258)
T cd05078 156 ITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-D-SQKKLQ----FYED-R- 221 (258)
T ss_pred cccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-c-HHHHHH----HHHc-c-
Confidence 6542 1223567889999999986 458999999999999999999964 43321 1 101000 0010 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
.. .+......+.+++.+|++.+|++|||++++++.|+
T Consensus 222 -----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----HQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01 11112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=303.20 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=199.8
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|.+.++||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35677888999999999999975 46889999998766555566788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 999999998843 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
........|+..|+|||++. ...++.++|||||||++|||++|..|+...... ..+ ... ..... ..+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~----~~~-~~~~~---~~~~ 230 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RAL----FLM-TKSNF---QPPK 230 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhH----Hhh-hccCC---CCCc
Confidence 12223457899999999874 456889999999999999999999987532211 011 110 01110 0111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..... .....+.+++.+|++.+|++||++.+|++
T Consensus 231 ~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11100 11235778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.31 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=187.9
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHH-HHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEI-ILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||+||+|+.. +++.+|+|++.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999765 57889999987532 12233444444 457888999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+.+.....++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCC
Confidence 999988843 345778888899999999999999998 99999999999999999999999999975421 1222
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ... .. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i---~~~-~~------~~~~~-- 218 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNI---LNK-PL------QLKPN-- 218 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--HHHHHHHH---HhC-Cc------CCCCC--
Confidence 344679999999999999999999999999999999999999986321 11111111 111 10 11111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+.+++.+|++.+|.+||++.+.+.
T Consensus 219 --~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 --ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2346778889999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=318.28 Aligned_cols=260 Identities=24% Similarity=0.267 Sum_probs=194.4
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE----- 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 604 (854)
..++|.+.++||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999754 5899999998653 2234567889999999999999999999986543
Q ss_pred -eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 605 -EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 605 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 468999999865 444442 23778889999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHH------------
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE------------ 751 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~------------ 751 (854)
++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..
T Consensus 170 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 170 ARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHH
Confidence 975421 12233457899999999999999999999999999999999999998643210 00000
Q ss_pred ------HHHHHhhcC-Ccc-----cccCCCC---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 752 ------HVWNLWNEG-KAM-----ELVDPNI---RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 752 ------~~~~~~~~~-~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+....... ... +...... ...........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000 0000000 00011112346788999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=315.70 Aligned_cols=196 Identities=27% Similarity=0.348 Sum_probs=168.2
Q ss_pred cCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-C-----CceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-H-----RNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~~~~~ 607 (854)
-+|++.+.||+|.||.|-+|. .++++.||||+++... .-..+...|+.+|..|+ | -|+|+++++|...++.+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 388999999999999999995 4569999999997643 34566688999999997 4 38999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC--CceecccCcce
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM--NPKISDFGMAR 685 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DFGla~ 685 (854)
||+|.++ -+|.+++....- ..++...+..++.||+.||..||+.+ |||+|||||||||.+-. .+||+|||.+.
T Consensus 265 iVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999985 578888865443 34899999999999999999999998 99999999999997543 69999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
.... ... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|+.
T Consensus 340 ~~~q----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQ----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCC----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 7532 111 46678899999999999999999999999999999999766653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.63 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=201.6
Q ss_pred cCcccCcccccCCcccEEEeEcCC-Cc----EEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQ----DIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.+|.+.++||+|+||+||+|..+. |+ .+|+|.+..... ...+++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567778999999999999997542 33 589998865533 345678899999999999999999999987 78899
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234899999999999999999999987 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
............++..|+|||.+....++.++||||||+++|||++ |+.|+.... ...+...+ ..+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~----~~~~~--~~~ 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDLL----EKGER--LPQ 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHH----hCCCC--CCC
Confidence 3222111112223567999999988899999999999999999998 998876321 11222221 11111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+ ......+.+++.+|+..+|++||++.++++.|+.+..
T Consensus 233 ~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 P-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 1122467788999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.02 Aligned_cols=240 Identities=24% Similarity=0.324 Sum_probs=191.1
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 611 (854)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.+++.+. |++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 667789999999999999754 68899999987542 234456788999998886 5778889999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|..++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 9999999988843 345899999999999999999999998 999999999999999999999999998754211
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ...+...+. .... .
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~----~~~~------~-- 219 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--EDELFQSIM----EHNV------S-- 219 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHH----hCCC------C--
Confidence 122334578999999999999999999999999999999999999986421 112222211 1111 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 --~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 --YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111123467789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=319.60 Aligned_cols=252 Identities=20% Similarity=0.289 Sum_probs=193.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
+.|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35778899999999999999764 58899999996532 334567888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 345889999999999999999999998 999999999999999999999999998754211
Q ss_pred cC---------------------------------cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCC
Q 003045 691 QN---------------------------------EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737 (854)
Q Consensus 691 ~~---------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~ 737 (854)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 001123579999999999999999999999999999999999999
Q ss_pred CCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 003045 738 NTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT---MASVVL 805 (854)
Q Consensus 738 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~eVl~ 805 (854)
||..... ...... ......... +.+.. . ....+.+++.+++. +|.+|++ +.|+++
T Consensus 235 Pf~~~~~--~~~~~~---i~~~~~~~~-~p~~~--~----~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETP--QETYRK---VMNWKETLV-FPPEV--P----ISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCH--HHHHHH---HHcCCCcee-cCCCC--C----CCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9863221 111111 111110000 11110 1 12356667777664 9999995 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=302.79 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=199.2
Q ss_pred CcccCcccccCCcccEEEeEcCCCcEEEEEEeccccc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.|...+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667889999999999999888899999998864321 2235688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 235789999999999999999999988 99999999999999999999999999886532
Q ss_pred cc----CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 690 NQ----NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 690 ~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
.. .........|+..|+|||++.+..++.++||||||+++|+|++|+.|+..... ... ........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~-~~~~~~~~----~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAA-MFYIGAHR----G 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHH-HHHhhhcc----C
Confidence 11 11112235688999999999998999999999999999999999999863211 111 11110000 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.+.. .....+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111212 22346788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=313.70 Aligned_cols=255 Identities=21% Similarity=0.260 Sum_probs=193.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||+||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999764 5889999998653 2233456889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998432 345889999999999999999999998 999999999999999999999999999765322
Q ss_pred cCcccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 691 QNEANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ...+.............+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKEHFQF 229 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCCcccC
Confidence 11 12223568999999999863 45788999999999999999999998632 111222222211111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQD--SAMYRPTMASVVLM 806 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPs~~eVl~~ 806 (854)
+..... ....+.+++.+|+.. ++..||++.+++..
T Consensus 230 --~~~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 --PPDVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --CCccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111 223456666666544 44458899998874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.47 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=189.4
Q ss_pred cccccCCcccEEEeEcCCC---cEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKLPEG---QDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
++||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999965433 346677765433 334578999999999999999999999999999999999999999
Q ss_pred ChhhhhcCccc-ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 617 SLDLFIFDPAK-QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 617 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
+|.+++..... ...+.+..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865322 234667778899999999999999988 99999999999999999999999999864321111122
Q ss_pred ccccccccccccceeecc-------CCCCcccchhhHHHHHHHHHhC-CCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 696 TNRVVGTYGYMAPEYAME-------GLFSVKSDVYSFGVLLLEIVSG-RRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+... ........ .. .+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--~~~~~~~~---~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--SDREVLNH---VI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHH---HH-hhcccccCC
Confidence 234567889999998753 2457899999999999999975 4455321 11112221 11 122233444
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
+.+....+ ..+.+++..|+ .+|++||+++||++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44433333 35666777898 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=302.53 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=188.0
Q ss_pred cccccCCcccEEEeEcCCCc-----------EEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 541 NKLGRGGFGPVHKGKLPEGQ-----------DIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999875433 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-------CceecccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-------NPKISDFG 682 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~DFG 682 (854)
|||+++++|++++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 25889999999999999999999988 99999999999999887 79999999
Q ss_pred cceeccCccCcccccccccccccccceeeccC--CCCcccchhhHHHHHHHHHhC-CCCCCCCcccCchHHHHHHHHhhc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEG--LFSVKSDVYSFGVLLLEIVSG-RRNTSFRLEENSSLIEHVWNLWNE 759 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~ 759 (854)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+.... ........ ..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~----~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFY----QD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHH----hc
Confidence 9986532 2234566789999999876 789999999999999999995 55554221 11111111 10
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 760 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
.. ....+ ....+.+++.+|++.+|.+||++.||++.|+
T Consensus 222 ~~--~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH--RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00000 0157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=302.70 Aligned_cols=251 Identities=28% Similarity=0.389 Sum_probs=191.0
Q ss_pred cccccCCcccEEEeEcC----CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCeeEEEEEcCC
Q 003045 541 NKLGRGGFGPVHKGKLP----EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ-GEEKMLIYEYMP 614 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lV~Ey~~ 614 (854)
+.||+|+||.||+|... +...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47999999999999743 2457999988543 23345678899999999999999999998764 456789999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC--
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN-- 692 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 692 (854)
+++|.+++... ...+.+..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234678888999999999999999988 99999999999999999999999999986532111
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
........++..|+|||++.+..++.++||||||+++|||++|+.|+.... ....+...+ . .+.. +..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~---~-~~~~-----~~~-- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYL---L-QGRR-----LLQ-- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH---h-cCCC-----CCC--
Confidence 011122345678999999988899999999999999999999655432211 111122211 1 1110 000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+......+.+++.+|++.+|++||++.||++.|+.+
T Consensus 224 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111234688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.92 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=201.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999765 58899999986543 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998432 6899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++.+..++.++||||||+++|+|++|+.|+.... .. .... ..... ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~---~~~~-~~~~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--PM---RVLF-LIPKN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hH---HHHH-Hhhhc-----CCCCCcc
Confidence 12234568889999999999889999999999999999999999985321 11 1111 11111 1111111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .....+.+++.+|+..+|++||+++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 02346778999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=307.77 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=192.1
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhc---CCCceeeeeeeEEeC-----C
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKL---QHRNLVRLLGCCIQG-----E 604 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~-----~ 604 (854)
+|++.+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999765 68899999987532 22234566788777766 699999999988642 4
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..+++|||+++ +|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 777776432 2234899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc-
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM- 763 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~- 763 (854)
...... .......|+..|+|||++.+..++.++|||||||++|||++|++||..... ......+..........
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCChhh
Confidence 865321 122335678999999999998999999999999999999999988753221 11111121111110000
Q ss_pred ---------cccCCCCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 764 ---------ELVDPNIR---DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 764 ---------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0011123346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.14 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=200.9
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+|.+.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3677889999999999999754 6889999998643 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++... ....+++.....++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 999998887532 2345789999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......|+..|+|||++.+..++.++|+||||+++|+|++|+.|+.... ........ ..+....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~-~~~~~~~--------- 219 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKV-CQGSYKP--------- 219 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHH-hcCCCCC---------
Confidence 12233568889999999998899999999999999999999999986321 11111111 1111111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.+......+.+++.+||+.+|++||++.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=306.74 Aligned_cols=250 Identities=27% Similarity=0.346 Sum_probs=197.2
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
|+..++||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999754 688999999865422 2234577899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|..++.... ...+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 155 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC--
Confidence 99999998885422 235889999999999999999999988 999999999999999999999999998764321
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..+........ . ....
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~--~----~~~~-- 224 (285)
T cd05630 156 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKE--V----QEEY-- 224 (285)
T ss_pred -ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhh--h----hhhc--
Confidence 11223478999999999999999999999999999999999999986432211 01111111100 0 0011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.......+.+++.+||+.||++||| +.|+++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112345778999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.50 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=198.4
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc---------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ---------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999754 5789999988654322 12567899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345888999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccCc----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 686 IFGFNQNE----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 686 ~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
........ .......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... . ..+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~-~~~~~~~-~-- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----L-QAIFKIG-E-- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----H-HHHHHHh-c--
Confidence 76421111 111234578899999999988899999999999999999999999864211 1 1111111 1
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+.+ +......+.+++.+|++.+|.+||++.||++
T Consensus 227 ---~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111 1223356788899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.01 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=202.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+.|++.++||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777889999999999999754 58899999886543 33457889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
+++++|..++.. ...+++..+..++.+++.+|.|||+. + ++|+||||+||++++++.++|+|||++.....
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-- 156 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-- 156 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh--
Confidence 999999988743 34589999999999999999999974 5 99999999999999999999999999875421
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC------chHHHHHHHHhhcCCcccc
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN------SSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~------~~l~~~~~~~~~~~~~~~~ 765 (854)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.|+....... ..+.+.........
T Consensus 157 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 157 --SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred --hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 12234578999999999988899999999999999999999999987433211 11112211111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
.+.+ ........+.+++.+|++.||++|||+.||++..
T Consensus 230 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111 0112335688899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.81 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=203.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|++.++||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999764 57889999998765566788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 999999987542 245889999999999999999999988 9999999999999999999999999998653211
Q ss_pred ccccccccccccccceeeccC---CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEG---LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~---~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ...... .... +..+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-----~~~~~~-~~~~---~~~~~~ 226 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-----RALFLI-SKSN---FPPPKL 226 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-Hhcc---CCCccc
Confidence 122335678899999999876 8899999999999999999999998632211 111111 1110 001111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+.+++.+|++.+|.+||++.+|+.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.30 Aligned_cols=256 Identities=28% Similarity=0.375 Sum_probs=201.2
Q ss_pred cCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
++|.+.+.||+|+||.||+|+.+ +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999753 3467999988654433 4578999999999999999999999999989999
Q ss_pred EEEEcCCCCChhhhhcCcccc------cCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQ------ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654322 25899999999999999999999998 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
|++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..|+.... ...+... ...+
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~~~----~~~~ 234 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEVLNR----LQAG 234 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHHHHH----HHcC
Confidence 998754211 1112223456778999999988889999999999999999999 666764211 1111111 1111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
.... .. .......+.+++.+|++.+|++||++.|++..|.
T Consensus 235 ~~~~-~~-------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL-PV-------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC-CC-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111 00 1122347888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.80 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=197.9
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC------
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG------ 603 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~------ 603 (854)
.++..|+..+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999764 57889999986543 4456789999999999 699999999998753
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988542 2345889999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
+...... ........|+..|+|||++. +..++.++|||||||++|||++|+.|+..... .... .....
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~-~~~~~ 230 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRAL-FLIPR 230 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHH-HHHhc
Confidence 9865321 12233467889999999986 34588899999999999999999999853211 1111 11111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... +.+. .......+.+++.+|+..+|.+|||+.|++.
T Consensus 231 -~~~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -NPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCC-----CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 1111 1112246788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.25 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=198.0
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556678999999999999754 57889999886443 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~ 155 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--Q 155 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc--c
Confidence 99999988742 35889999999999999999999988 999999999999999999999999999865321 1
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+...... .... ..... ..+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~----~~~~~-----~~~~~--- 221 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLF----LIPKN-----SPPTL--- 221 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHh----hhhcC-----CCCCC---
Confidence 1222346788999999999989999999999999999999999987532111 1110 01111 01111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.+++.+|++.+|++||++.||++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 -EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1223456888999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.02 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=201.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..|...++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667789999999999999764 58899999987542 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 999999998842 35788999999999999999999988 9999999999999999999999999998764221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++.+..++.++|+||||+++|||++|..|+..... ...... . ......
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~----~---------~~~~~~ 219 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--MRVLFL----I---------PKNNPP 219 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--HhHhhh----h---------hcCCCC
Confidence 122334678899999999988899999999999999999999998753211 111100 0 011111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233455678899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.62 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=207.9
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.-|...+.||+|.|++|-+|++ -.|++||||++.+..- .....+.+|++-|+.++|||||+|+.+.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4567778999999999999964 4899999999987643 344578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCceecccCcceeccCc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~ 690 (854)
.-++|+|.+|+..+..+ +.+....+++.||+.|+.|+|+.. +|||||||+||.+- .-|-|||+|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 99999999999765544 889999999999999999999988 99999999999875 56789999999998763
Q ss_pred cCcccccccccccccccceeeccCCCC-cccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFS-VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.....+..+|+..|.|||++.+..|. ++.||||||||||.|++|+.||....+. +.+..++|..
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------------ETLTmImDCK 235 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------------ETLTMIMDCK 235 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------------hhhhhhhccc
Confidence 22345568999999999999999887 4799999999999999999999743221 1122234443
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ..+.....++.+++..||..||.+|-+.+||+.
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 334556678999999999999999999999987
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.26 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=201.5
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEE--
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCI-- 601 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~-- 601 (854)
.+..+..+.++|++.+.||+|+||.||++... +++.+|+|++... ....+++.+|+.+++++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455667889999999999999999999754 5789999987643 22346788999999999 6999999999884
Q ss_pred ---eCCeeEEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 602 ---QGEEKMLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 602 ---~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 345689999999999999887532 23346889999999999999999999988 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEH 752 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~ 752 (854)
|+|||++...... ........|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ..
T Consensus 165 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----~~ 237 (286)
T cd06638 165 LVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----RA 237 (286)
T ss_pred EccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----HH
Confidence 9999999865322 112233568999999998853 45788999999999999999999998632110 11
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 753 VWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 753 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
... ........+.++. .....+.+++.+|++.+|++||++.||++.
T Consensus 238 ~~~-~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFK-IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhh-ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 111 0111111111111 112468889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.50 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=199.1
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999865 6899999988653 2233567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++++|..++........+++..+..++.+|+.||.|||+. + ++|+||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999886543334689999999999999999999964 5 999999999999999999999999999765321
Q ss_pred cccccccccccccccceeeccC------CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 693 EANTNRVVGTYGYMAPEYAMEG------LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+..... ........... ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~-~~~----- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIV-DGD----- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHh-hcC-----
Confidence 22234678899999998544 358899999999999999999999864211 11111111111 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+ .........+.+++.+|++.+|++||++.+++.
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01 112224456788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.39 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=198.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCc----EEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQ----DIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.+.|+..+.||+|+||.||+|... +++ .+|+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356777889999999999999753 344 478888865432 2344788999999999999999999998754 567
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999988542 235889999999999999999999988 999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.............++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ....... ...+.. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~----~~~~~~--~~ 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDL----LEKGER--LP 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH----HHCCCC--CC
Confidence 43222222223445678999999998999999999999999999997 888875321 1112221 111111 10
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+ . .....+.+++.+|+..+|++||++.++++.|+.+
T Consensus 232 ~~---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 QP---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1 1224678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.35 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=209.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+-|.+.++||+|+||.||+|.++ .|+.+|||++... .+.+++..||.++++++.+++|+++|.|.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34667789999999999999765 5999999998653 56789999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
..|+..+.++. ++++|.+.++..+++..++||+|||... -||||||..|||++.+|.+||+|||.|-.+. +.-
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTM 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhH
Confidence 99999999864 4567999999999999999999999987 8999999999999999999999999998763 333
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
...+.+.||+.|||||++.+-.|..++||||||++..||.-|++|+.....-. . -.+-...|...-.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-----A--------IFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-----A--------IFMIPTKPPPTFK 250 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-----e--------eEeccCCCCCCCC
Confidence 45567899999999999999999999999999999999999999986321100 0 0011112222233
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+..-...+.+++.+||-+.|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 45566678999999999999999999998876
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.67 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=201.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|.+.++||+|+||.||++... +++.+|+|.+........+.+.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 466888899999999999999764 5889999999766555667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 9999999988532 245899999999999999999999998 999999999999999999999999998764321
Q ss_pred cccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 693 EANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
........++..|+|||++. ...++.++||||||+++|||++|+.|+..... ....... .......+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~~~- 229 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLKI-LKSEPPTLD- 229 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHHH-hcCCCCCcC-
Confidence 11223456889999999875 34577899999999999999999999863211 1111111 111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+|++.+|.+||++.+|++
T Consensus 230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 ------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11122346778899999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.28 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=196.9
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
|+..++||+|+||+||+|... +++.+|+|.+.... ......+.+|++++++++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999764 68899999986542 22344578899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--
Confidence 99999998875432 235899999999999999999999988 999999999999999999999999999765321
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......|+..|+|||++.+..++.++|+||||+++|||++|..||..... ....+.+........ +..
T Consensus 156 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--~~~~~~~~~~~~~~~------~~~-- 224 (285)
T cd05632 156 -ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--KVKREEVDRRVLETE------EVY-- 224 (285)
T ss_pred -CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhhccc------ccc--
Confidence 112235789999999999989999999999999999999999999864321 111111111111110 011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.......+.+++..|++.+|++||+ +.|++.
T Consensus 225 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 --SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122345678999999999999999 556665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=301.20 Aligned_cols=247 Identities=31% Similarity=0.463 Sum_probs=197.2
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
+.|.+.+.||+|+||.||++.. +++.+|+|++... ...+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 6788999998653 2346789999999999999999999998654 5799999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 235889999999999999999999988 999999999999999999999999999864211
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.|+.... ...... ....+... .
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~----~~~~~~~~---------~ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--LKEVKE----CVEKGYRM---------E 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--HHHHHH----HHhCCCCC---------C
Confidence 112234567999999998899999999999999999998 888875321 111111 11111111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
........+.+++.+|++.+|++||+++++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=303.94 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=197.8
Q ss_pred cccCcccccCCcccEEEeEcC----CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 604 (854)
|.+.+.||+|+||.||+|... .++.||+|++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999643 36889999986542 334567889999999999999999999886543
Q ss_pred eeEEEEEcCCCCChhhhhcCc---ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDP---AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
..++++||+++++|..++... .....+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247889999999998887432 12234788999999999999999999988 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+... ....+...+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--~~~~~~~~~~----~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--ENSEIYNYLI----KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--CHHHHHHHHH----cC
Confidence 99987643222222223345678999999998889999999999999999999 77776532 1112222211 11
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 0112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.07 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=200.0
Q ss_pred cCcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|.+.++||+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999997543 3468999886554 3456688999999999999999999998865 567899
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 235899999999999999999999988 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
... .......++..|+|||.+....++.++||||||+++|||++ |..||..... ......+ ..+...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~----~~~~~~----- 227 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRI----ENGERL----- 227 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH----HcCCcC-----
Confidence 211 11122334567999999988889999999999999999996 9998853321 1111111 111111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
.... .....+.+++.+|+..+|++|||+.+++..|+.+.
T Consensus 228 ~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 PMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 22346888999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.99 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=199.2
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999865 58999999986542 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999887632 335899999999999999999999988 9999999999999999999999999998764322
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-----------hc
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW-----------NE 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~-----------~~ 759 (854)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... +....+.... ..
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV--DQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhccc
Confidence 1 2223457889999999876 56889999999999999999999998643211 1111111100 00
Q ss_pred CCc-ccccCCCCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKA-MELVDPNIRDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~-~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .....+......+ ......+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0011111111111 112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.92 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=202.6
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|+..+.||+|+||.||.++. .+++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999864 45889999998654 234456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 345899999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......++..|+|||++.+..++.++||||||+++|||++|..|+.... ..+...... .+....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~-~~~~~~-------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIV-QGNYTP-------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHH-cCCCCC--------
Confidence 2234568999999999998889999999999999999999999885321 112221111 111111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
........+.+++.+|++.+|++||++.|+++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 012223568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.74 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=192.6
Q ss_pred cCcccccC--CcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 539 EGNKLGRG--GFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 539 ~~~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.++||+| +|++||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7889999965 468999999987542 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234889999999999999999999988 999999999999999999999999876543211100
Q ss_pred -----ccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 694 -----ANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 694 -----~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....... .+.....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~-----~~~~~~~~ 231 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKL-----NGTVPCLL 231 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh-HHHHHHh-----cCCccccc
Confidence 01122356778999999976 45899999999999999999999998632211 0011100 00000000
Q ss_pred C-------------------CCC-----------------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 D-------------------PNI-----------------RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 000 00111223356889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=308.75 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=196.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|.+.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999764 57899999986543 33345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++ ++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 5787777432 335789999999999999999999988 9999999999999999999999999997643221
Q ss_pred cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc------------
Q 003045 693 EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE------------ 759 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------------ 759 (854)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhcc
Confidence 11223456889999998865 4578899999999999999999999864321 1111111111110
Q ss_pred CCcccccCCCCCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKAMELVDPNIRDS----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......-.+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000111100 01112345788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=316.36 Aligned_cols=261 Identities=23% Similarity=0.263 Sum_probs=195.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------ 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 603 (854)
..++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999754 58899999987542 23345678899999999999999999988643
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...++||||++++ |...+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 3568999999764 544442 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHH---------
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVW--------- 754 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~--------- 754 (854)
++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+.
T Consensus 166 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 986432 12223457899999999999999999999999999999999999998643210 00100000
Q ss_pred ---------HHhhc-CCcccccCCCC--------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 755 ---------NLWNE-GKAMELVDPNI--------RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 755 ---------~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
..... .....+..+.. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00000000000 001111223567899999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=315.68 Aligned_cols=240 Identities=22% Similarity=0.249 Sum_probs=185.1
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc---CCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL---QHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
||+|+||+||+|+.. +++.||+|++.... ......+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999764 58999999986532 12233455677777665 699999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCC
Confidence 999888743 345889999999999999999999998 99999999999999999999999999875421 1222
Q ss_pred ccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.. .....+.. .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~-~~i~~~~~-~~~~----~-- 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMY-RNIAFGKV-RFPK----N-- 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHH-HHHHcCCC-CCCC----c--
Confidence 3346799999999998764 48999999999999999999999986321 11111 11111111 0100 1
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRP----TMASVVL 805 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RP----s~~eVl~ 805 (854)
.....+.+++.+||+.||.+|| ++.|+++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1224567889999999999999 4566655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.48 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=203.1
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+|+..+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999765 58899999987653 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 9999999985432 568899999999999999999999 77 9999999999999999999999999987653211
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........+.+....... .+.+..
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 226 (265)
T cd06605 156 ---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP------PPRLPS 226 (265)
T ss_pred ---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC------CCCCCh
Confidence 11266788999999999999999999999999999999999998654322222333322222111 011111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+.+++.+|+..+|++||++.|++.
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 ---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113456888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.57 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=199.2
Q ss_pred CcccCcccccCCcccEEEeEcCC--CcEEEEEEecccc----------ccCHHHHHHHHHHHHh-cCCCceeeeeeeEEe
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPE--GQDIAVKRLSRKS----------GQGLEEFKNEIILIAK-LQHRNLVRLLGCCIQ 602 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~ 602 (854)
+|.+.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999998754 6889999885321 2234557788888875 799999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCCceecc
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISD 680 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~D 680 (854)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887432 233468899999999999999999996 45 99999999999999999999999
Q ss_pred cCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+... ......... .+.
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~-~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKI-VEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHH-hhc
Confidence 99998754222 333467889999999999988999999999999999999999987532 111111111 111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
... +... ......+.+++.+|++.||++||++.||.++|+
T Consensus 229 ~~~----~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 1111 112346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.72 Aligned_cols=250 Identities=34% Similarity=0.519 Sum_probs=198.2
Q ss_pred ccCcccccCCcccEEEeEcCC-----CcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 538 SEGNKLGRGGFGPVHKGKLPE-----GQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.+.+.||.|+||.||+++..+ +..||+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456899999999999997654 478999999655433 56789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999854222 12899999999999999999999998 9999999999999999999999999998764321
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
... .....++..|+|||.+.+..++.++||||+|+++++|++ |+.|+... ....+...+ ....... .
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~----~~~~~~~-----~ 225 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYL----KKGYRLP-----K 225 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH----hcCCCCC-----C
Confidence 111 112336789999999988889999999999999999998 66666431 111222221 1111111 1
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
.......+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111345688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=333.94 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=199.4
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
...+.|.+.++||+|+||+||+++.. .++.+|+|.+... .......+..|+.++++++||||+++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34468999999999999999999764 4678899988643 233456789999999999999999999988654 468
Q ss_pred EEEEEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCC----CceEEcccCCCcEEEccC--------
Q 003045 607 MLIYEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSR----LRIIHRDLKASNILLDED-------- 673 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlkp~NILl~~~-------- 673 (854)
+|||||+++++|..++.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999885422 23468999999999999999999998542 349999999999999642
Q ss_pred ---------CCceecccCcceeccCccCcccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003045 674 ---------MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742 (854)
Q Consensus 674 ---------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~ 742 (854)
..+||+|||++..+... .......||+.|+|||++.+ ..++.++||||||||||||++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34899999999865322 12234578999999999854 45899999999999999999999998632
Q ss_pred cccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 743 LEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 743 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
. .....+. ...... ...+ .. ....+.+|+..||+.+|.+||++.|++. .+..+
T Consensus 247 ~----~~~qli~-~lk~~p-----~lpi-~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 247 N----NFSQLIS-ELKRGP-----DLPI-KG----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred C----cHHHHHH-HHhcCC-----CCCc-CC----CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 1 1111111 111110 0000 11 1246788999999999999999999994 55544
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.82 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=194.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||+||+++.+ .++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999765 4778999998643 2223445888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235889999999999999999999988 999999999999999999999999999765321
Q ss_pred cCcccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 691 QNEANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
. ........||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+.............+
T Consensus 156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 156 G-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKERFQF 229 (332)
T ss_pred C-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHHHHHhCCCccccC
Confidence 1 12223457999999999986 346889999999999999999999998632 122222222221111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCC--CCCCCHHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSA--MYRPTMASVVLM 806 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp--~~RPs~~eVl~~ 806 (854)
+.... .....+.+++.+|+..++ ..||++.|+++.
T Consensus 230 --p~~~~----~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 --PAQVT----DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CCccc----cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111 122456667777775444 447899999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.31 Aligned_cols=196 Identities=29% Similarity=0.442 Sum_probs=158.6
Q ss_pred CcccccCCcccEEEeEcC---CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCeeEEEEEcCC
Q 003045 540 GNKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEKMLIYEYMP 614 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~ 614 (854)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999854 35789999886532 23467899999999999999999998854 456789999988
Q ss_pred CCChhhhhcCc------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE----ccCCCceecccCcc
Q 003045 615 NKSLDLFIFDP------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMA 684 (854)
Q Consensus 615 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla 684 (854)
+ +|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 555554321 12235889999999999999999999998 9999999999999 56678999999999
Q ss_pred eeccCccCc-ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 685 RIFGFNQNE-ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 685 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
+........ .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876432221 12234578999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.07 Aligned_cols=259 Identities=23% Similarity=0.272 Sum_probs=194.4
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------ 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 603 (854)
..++|.+.++||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999754 58899999987532 23456778999999999999999999987543
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5555542 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh------
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW------ 757 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~------ 757 (854)
++.... ........+|..|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 173 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 986532 1222345789999999999999999999999999999999999999864321 01111110000
Q ss_pred -------------hc-CCcccc----cCCCC----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 -------------NE-GKAMEL----VDPNI----RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 -------------~~-~~~~~~----~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ...... ..+.. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 000000 00000 00111112346789999999999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.32 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=193.6
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG----- 603 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----- 603 (854)
...++|.+.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999975 468899999986532 22345678899999999999999999987543
Q ss_pred -CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 604 -EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 604 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 778877763 235899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
+++.... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+........
T Consensus 164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIMEVVGTPS 236 (343)
T ss_pred cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence 9986532 1234578999999999876 5689999999999999999999999863211 111111111100000
Q ss_pred -----------cccccC--CCCCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 -----------AMELVD--PNIRDS----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 -----------~~~~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+. +..... ........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000 00001124678999999999999999999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.32 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=197.9
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc----------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG----------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 604 (854)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999654 688999998853211 11346788999999999999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 46889999999999999999999988 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
................++..|+|||.+.... ++.++|+||||+++|||++|..|+.... . ........... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~-~~~~~~~~~~~-~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----A-IAAMFKLGNKR-S 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----h-HHHHHHhhccc-c
Confidence 8653222222233456888999999987654 8899999999999999999999985211 1 11111111111 1
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+... ........+.+++.+|++.+|++||++.||++
T Consensus 230 ~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 11223457888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.26 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=204.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999754 67899999986542 33567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999988 99999999999999999999999999987643322
Q ss_pred cc--cccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 693 EA--NTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 693 ~~--~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. ......|+..|+|||++... .++.++|+||||+++|||++|+.|+...... +......... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcCC------CCC
Confidence 21 22345688999999998877 7899999999999999999999998632111 1111111110 111
Q ss_pred CCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSS-SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1123456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.96 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=199.0
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-----ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-----GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999875 78999999986543 22456789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 235889999999999999999999998 99999999999999999999999999886532
Q ss_pred ccCcccccccccccccccceeeccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+.... -............. +
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~-----~ 221 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGRSKEL-----P 221 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHhcccC-----C
Confidence 22 223456888999999988776 8999999999999999999999986422 11111111110111 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 222 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122356778999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.24 Aligned_cols=254 Identities=19% Similarity=0.236 Sum_probs=194.5
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||.||+++.. +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999765 5788999998653 2223455788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245889999999999999999999988 999999999999999999999999999876422
Q ss_pred cCcccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 691 QNEANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
.. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||.... ..+.............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHEERFQ- 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHHHHHHHHcCCCccc-
Confidence 11 12223579999999999875 568889999999999999999999986321 1122212111111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY--RPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~eVl~ 805 (854)
+ +.... .....+.+++.+|+..++.+ |++++++++
T Consensus 229 ~-p~~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 F-PSHIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred C-CCccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 11111 12346777888888765544 468888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.26 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=199.1
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-EEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lV~E 611 (854)
.|++.+.||+|++|.||++..+ +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778899999999999999754 57889999986542 23456788999999999999999999987644 46789999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988643 2345899999999999999999999998 9999999999999999999999999998763221
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......+++.|+|||++.+..++.++||||||+++++|++|+.|+.... ......... .+.. +
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~-~~~~-----~--- 220 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRII-EGKL-----P--- 220 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHH-hcCC-----C---
Confidence 22334568899999999999999999999999999999999999876321 111111111 1111 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=325.32 Aligned_cols=263 Identities=19% Similarity=0.188 Sum_probs=192.3
Q ss_pred HHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC------ceeeeeeeE
Q 003045 528 NTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR------NLVRLLGCC 600 (854)
Q Consensus 528 ~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~~~~ 600 (854)
+++...+++|++.++||+|+||+||+|... .++.||||+++... ...+++..|++++++++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999999999999764 57889999986432 2344567788888887654 588899988
Q ss_pred EeC-CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCC----
Q 003045 601 IQG-EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDM---- 674 (854)
Q Consensus 601 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~---- 674 (854)
... .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||+. + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 765 4688999988 6677777643 34689999999999999999999974 6 99999999999998765
Q ss_pred ------------CceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003045 675 ------------NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742 (854)
Q Consensus 675 ------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~ 742 (854)
.+||+|||.+.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999876421 2233468999999999999999999999999999999999999998643
Q ss_pred cccCchHHHHHHHHhhc-----------CCccccc------CCCCCC-----------CCCHHHHHHHHHHHhhccCCCC
Q 003045 743 LEENSSLIEHVWNLWNE-----------GKAMELV------DPNIRD-----------SSSQNQVLRCIHVGMLCVQDSA 794 (854)
Q Consensus 743 ~~~~~~l~~~~~~~~~~-----------~~~~~~~------d~~l~~-----------~~~~~~~~~l~~l~~~Cl~~dp 794 (854)
.. ......+...... .....+. .+.... .........+.+|+.+||+.||
T Consensus 349 ~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 349 DN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred Ch--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 21 1111111111000 0000000 000000 0000112457799999999999
Q ss_pred CCCCCHHHHHH
Q 003045 795 MYRPTMASVVL 805 (854)
Q Consensus 795 ~~RPs~~eVl~ 805 (854)
++|||++|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999997
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.48 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=203.7
Q ss_pred ceeHHHHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 003045 524 MFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCI 601 (854)
Q Consensus 524 ~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 601 (854)
.+....+..++++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 345566667789999999999999999999976 468899999986432 2346678899999999 7999999999987
Q ss_pred eC-----CeeEEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC
Q 003045 602 QG-----EEKMLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675 (854)
Q Consensus 602 ~~-----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 675 (854)
.. +..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 3579999999999999987532 23346899999999999999999999988 999999999999999999
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHH
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-----LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLI 750 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~ 750 (854)
+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.|+..... .
T Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----V 239 (291)
T ss_pred EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----H
Confidence 99999999886532211 12235678899999987643 368899999999999999999999863211 1
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+... .......+.++ ......+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~-~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 KTLFKI-PRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHH-hcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 11111111111 122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.84 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=197.4
Q ss_pred cCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 539 EGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
...+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3458999999999999764 689999999976555566788999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccc
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN 697 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 697 (854)
|..++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ....
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 988773 245889999999999999999999998 9999999999999999999999999987553221 1223
Q ss_pred ccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHH
Q 003045 698 RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQN 777 (854)
Q Consensus 698 ~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 777 (854)
...|+..|+|||++.+..++.++||||||+++|||++|+.|+..... . +..... ..... +.... ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~---~~~~~~-~~~~~-----~~~~~--~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--V---QAMKRL-RDSPP-----PKLKN--AHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHH-hccCC-----CCccc--cCC
Confidence 35688999999999988999999999999999999999999863221 1 111111 11110 00000 011
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 778 QVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 778 ~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+.+++.+|++.+|++||++.|+++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 2245778899999999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.06 Aligned_cols=258 Identities=22% Similarity=0.243 Sum_probs=206.3
Q ss_pred cCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|+..+.||.|.-|+||++++.+ +..+|+|++.+..- ....+.+.|-+||+.++||.+..|+..++.++..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567778899999999999998765 58899999987533 33445678999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC-
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF- 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~- 689 (854)
|||+||+|..+++. +..+.+++..+..++..++-||+|||-.| ||.|||||+||||-++|.+-|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999888754 34456899999999999999999999999 99999999999999999999999998765411
Q ss_pred --------------------------------c-c--------------------CcccccccccccccccceeeccCCC
Q 003045 690 --------------------------------N-Q--------------------NEANTNRVVGTYGYMAPEYAMEGLF 716 (854)
Q Consensus 690 --------------------------------~-~--------------------~~~~~~~~~gt~~Y~aPE~~~~~~~ 716 (854)
. . ........+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0011234679999999999999999
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCC
Q 003045 717 SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY 796 (854)
Q Consensus 717 s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~ 796 (854)
+.+.|-|+|||+|||||.|.-||...... . -+ ..++...+.-.........+.+||.+.|.+||.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~--~---Tl---------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK--E---TL---------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch--h---hH---------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999999743221 1 11 1222222222222244567889999999999999
Q ss_pred CCC----HHHHHH--HHhcc
Q 003045 797 RPT----MASVVL--MLESE 810 (854)
Q Consensus 797 RPs----~~eVl~--~L~~~ 810 (854)
|.. ++||-+ ..+++
T Consensus 379 Rlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hhccccchHHhhcCccccCC
Confidence 998 888876 44443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.29 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=192.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-----cCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-----QGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
.+|...+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999764 588999998864321 2235688899999999999999999988753 567
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 335889999999999999999999988 99999999999999999999999999986
Q ss_pred ccCccC-cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQN-EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
...... ........++..|+|||++.+..++.++||||||+++|||++|+.|+.... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-----~~~~~~~~~~~~----- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-----AMAAIFKIATQP----- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-----hHHHHHHHhcCC-----
Confidence 532111 111223457889999999998889999999999999999999999986321 111111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.+ +......+..++ +|+..+|++||+++||++
T Consensus 226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11211 112223344454 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.01 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=198.9
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
.|.....||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444568999999999999754 688999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++.. ..+++.++..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++....... .
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 9999998732 34889999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... ......+. . .+.+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~----~-----~~~~~~~~-- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIR----D-----NLPPRVKD-- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH----h-----cCCCcccc--
Confidence 22335688999999999988899999999999999999999999863211 11111111 0 11111111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.......+.+++.+|++.+|++|||++|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11123357788889999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.14 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=194.7
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|+..++||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999764 68899999986532 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++ +|..++... ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 666665432 345899999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC------cccc
Q 003045 693 EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK------AMEL 765 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 765 (854)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+...... ......+........ ....
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhHHhhhc
Confidence 112234678899999998764 4789999999999999999999986432221 111111111111000 0000
Q ss_pred cCC----CCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDP----NIRD-----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~----~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+. .... .........+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 0000 011122356778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=297.31 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=200.3
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
+|+..+.||+|+||.||+|+. .+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999975 5689999999865321 134678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceec
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIF 687 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 687 (854)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 346889999999999999999999998 99999999999998776 5999999999876
Q ss_pred cCccCc--ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 688 GFNQNE--ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 688 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|..|+...... .....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~------ 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASA------ 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhcc------
Confidence 432111 1123356788999999998888999999999999999999999998632211 111111111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+......+.+++.+|++.+|++||++.|++.
T Consensus 227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011222334457888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=300.08 Aligned_cols=260 Identities=26% Similarity=0.302 Sum_probs=200.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 610 (854)
++|+..++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999864 588999999875432 3456789999999999999999999998654 3689999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998886432 23345889999999999999999999988 99999999999999999999999999875432
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...........+...... ......+.+.
T Consensus 158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~- 231 (287)
T cd06621 158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDE- 231 (287)
T ss_pred c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccC-
Confidence 1 112345788999999999999999999999999999999999998754321111112111111 1111111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ........+.+++.+|++.+|++|||+.||++
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 01123457889999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=301.12 Aligned_cols=260 Identities=24% Similarity=0.302 Sum_probs=197.4
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc-----CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ-----GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
+|...+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999764 6899999999754322 234567899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985432 36899999999999999999999998 99999999999999999999999999987643
Q ss_pred ccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC--------
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG-------- 760 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-------- 760 (854)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|..++..... ..............
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhc
Confidence 21 12222356788999998854 4678999999999999999999766653221 11111111111000
Q ss_pred -CcccccCCCCCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 -KAMELVDPNIRDS-----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 -~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
............. ........+.+++.+|++.+|++|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000011 11223457889999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=294.71 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=200.6
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|+..++||+|+||.||+++.. +++.+|+|++... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999754 6889999998643 233456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 99999998875322 234789999999999999999999988 9999999999999999999999999998653221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......|+..|+|||++.+..++.++|+||||+++++|++|+.|+.... ..+.+..... +.. +
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~-~~~-----~---- 219 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIR-GSY-----P---- 219 (256)
T ss_pred -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhc-CCC-----C----
Confidence 11223467889999999998899999999999999999999999986321 1122211111 111 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+......+.+++.+|++.+|++||++.||++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111223456888999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.96 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=198.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|+..++||+|+||.||+|..+ +++.+|+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778899999999999999875 589999999865432 235678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..+... ...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234899999999999999999999988 9999999999999999999999999998753222
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc-----------
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE----------- 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~----------- 759 (854)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.|+..... ......+......
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhcc
Confidence 22233567889999999875 4578899999999999999999988753221 1111111110000
Q ss_pred CCc-ccccCCCCCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKA-MELVDPNIRDS-----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~-~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .....+..... ........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00001111000 01122456889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=298.08 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=194.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-----ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-----GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
++|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999764 58899999885321 12245788899999999999999999998764 457
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998843 235788899999999999999999998 99999999999999999999999999986
Q ss_pred ccCcc-CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQ-NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... .........++..|+|||++.+..++.++||||||+++|||++|+.|+.... ... .+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~-~~~~~~~~~----- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMA-AIFKIATQP----- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHH-HHHHHhcCC-----
Confidence 53211 1112233568889999999988889999999999999999999999985321 111 111111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111233344567778888885 8999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=299.52 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=199.6
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999764 68999999987643 33456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885433 45899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC----------
Q 003045 693 EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK---------- 761 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---------- 761 (854)
.......++..|+|||++.+. .++.++||||+|+++|||++|.+++.... .......+........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--DIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC--HHHHHHHHHHHcCCCChHHHhhccCc
Confidence 122335688999999998654 46899999999999999999977664322 1111111111111100
Q ss_pred --cccccCCCCC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 --AMELVDPNIR----DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 --~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+..+... .....+....+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0001122367889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=300.80 Aligned_cols=262 Identities=21% Similarity=0.331 Sum_probs=195.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|+..++||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999765 688999999865432 2234577899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++ +|.+++.... ..+++.....++.|+++||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8888775432 35889999999999999999999998 99999999999999999999999999875432111
Q ss_pred cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc-------
Q 003045 693 EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME------- 764 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------- 764 (854)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.|+....... .....+.+.........
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346788999998875 458899999999999999999999986432111 11111111111100000
Q ss_pred ---------ccC-CCCCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 ---------LVD-PNIRDSS-SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ---------~~d-~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ..+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 0011256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.04 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=195.5
Q ss_pred CcccCcccccCCcccEEEeEcC---CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKM 607 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 607 (854)
+|.+.++||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999764 47899999997643 33456778899999999999999999999988 7899
Q ss_pred EEEEcCCCCChhhhhcCc-cc-ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc----CCCceeccc
Q 003045 608 LIYEYMPNKSLDLFIFDP-AK-QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE----DMNPKISDF 681 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~-~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 681 (854)
+||||+++ +|..++... .. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 455544322 22 236889999999999999999999998 999999999999999 899999999
Q ss_pred CcceeccCccC-cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccC--------chHHH
Q 003045 682 GMARIFGFNQN-EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN--------SSLIE 751 (854)
Q Consensus 682 Gla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~--------~~l~~ 751 (854)
|++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|+.|+....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643222 122234567889999998866 458899999999999999999999986433221 00111
Q ss_pred HHHHHhhcC------------CcccccCCCCCCCCC-----H------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 752 HVWNLWNEG------------KAMELVDPNIRDSSS-----Q------NQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 752 ~~~~~~~~~------------~~~~~~d~~l~~~~~-----~------~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ...+... ......+.......+ . .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 I-FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred H-HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 0100000 000000000000001 0 22346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=293.91 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=204.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|++.+.||+|++|.||+|+.. +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35778899999999999999876 489999999876543 4467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998532 568999999999999999999999 88 9999999999999999999999999998764222
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ....+........ .. +.+
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~-~~-----~~~- 223 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG-PP-----PSL- 223 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC-CC-----CCC-
Confidence 1 12245678899999999999999999999999999999999999864332 1111111111111 11 111
Q ss_pred CCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQN-QVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.. ....+.+++.+|++.+|++||++.|+++
T Consensus 224 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 ---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 3457888999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=302.80 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=200.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|...+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999765 57899999987543 233457889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 345889999999999999999999988 999999999999999999999999998742110
Q ss_pred cC-------------cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 691 QN-------------EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 691 ~~-------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|..|+... ....+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~---~~ 229 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQ---VI 229 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHH---HH
Confidence 00 00112245788999999999889999999999999999999999998532 11111111 11
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+. ...+.... .....+.+++.+|++.+|++||+..++.+.|+..
T Consensus 230 -~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 230 -SDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred -hcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111 11111111 1234678899999999999999987777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.92 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=200.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|+..++||+|+||.||+|..+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999765 5889999988653 23345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|++++.+..+.. +...+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999988876653 2344889999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh-----------c
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN-----------E 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~ 759 (854)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+...... ..+.. ...... .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYL-IQKCLGPLPPSHQELFSS 231 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHHHhhhccc
Confidence 2 122335678899999999888 8899999999999999999999888632211 11111 101000 0
Q ss_pred -CCcc--cccCCCC----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 -GKAM--ELVDPNI----RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 -~~~~--~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... +..+... ....+......+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 0000000 00111122567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=294.01 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=199.7
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc--CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ--GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...++||+|+||.||+|... +++.+++|.+...... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999754 6889999998765443 567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 334788999999999999999999998 99999999999999999999999999987643222
Q ss_pred ccc--ccccccccccccceeeccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 693 EAN--TNRVVGTYGYMAPEYAMEGL---FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 693 ~~~--~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
... .....++..|+|||++.... ++.++||||||+++|||++|+.||...... ... .... ..+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~---~~~~-~~~~-----~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQI---MFHV-GAGH-----K 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHH---HHHH-hcCC-----C
Confidence 111 12356788999999998766 889999999999999999999998632211 111 1111 1110 1
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 1112345678899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=300.13 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=202.0
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788889999999999999975 467899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 99999998843 34789999999999999999999998 9999999999999999999999999987653222
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .+...... ......
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-----~~~~~~~~--------~~~~~~ 236 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATN--------GTPELQ 236 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-----heeehhcC--------CCCCCC
Confidence 12233468889999999998889999999999999999999999986432110 00000000 000011
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
........+.+++.+|++.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233467789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.29 Aligned_cols=253 Identities=23% Similarity=0.250 Sum_probs=200.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc---CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ---GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|...+.||+|+||.||++... +++.+|+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999765 4899999999765322 4557889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 2346899999999999999999999988 999999999999999999999999998765321
Q ss_pred cCc---------------------------ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 003045 691 QNE---------------------------ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL 743 (854)
Q Consensus 691 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~ 743 (854)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 11123467889999999999889999999999999999999999986322
Q ss_pred ccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 003045 744 EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT----MASVVL 805 (854)
Q Consensus 744 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----~~eVl~ 805 (854)
.. ......... .............+.+++.+|++.+|++||+ +.|++.
T Consensus 237 ~~-----~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD-----ETFSNILKK---------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH-----HHHHHHhcC---------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 111111111 1100011113467889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=294.68 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=199.4
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCeeEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEKMLIY 610 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 610 (854)
+|++.+.||.|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 367788999999999999965 467899999986532 3345678899999999999999999998764 34678999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCC--CCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDS--RLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
||+++++|.+++... .....+++..++.++.||+.||.|||..+ ...++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 22456899999999999999999999332 234999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.... .......++..|+|||++.+..++.++||||||+++++|++|+.|+.... ...+... ...+..
T Consensus 161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~----~~~~~~----- 227 (265)
T cd08217 161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASK----IKEGKF----- 227 (265)
T ss_pred cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHH----HhcCCC-----
Confidence 4322 11233568999999999999889999999999999999999999986432 1112221 111111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+......+.+++.+|++.+|++||++.||++
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1112233457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.81 Aligned_cols=246 Identities=30% Similarity=0.451 Sum_probs=198.5
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccccc---CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQ---GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.+.|...+.||.|+||.||.|+. .+.+.||||++.-...+ -+..+..|+..|++++|||++.+.|+|......+||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34577788999999999999975 46789999999755443 356789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||||-| +-.+++. -..+++-+.++..|..+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|...
T Consensus 105 MEYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~-- 176 (948)
T KOG0577|consen 105 MEYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM-- 176 (948)
T ss_pred HHHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc--
Confidence 999965 4455542 23356888999999999999999999998 999999999999999999999999999865
Q ss_pred ccCcccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
...+.++|||.|||||++. .+.|+-|+|||||||+..||.-.++|.. ..+.-..++.-+ .+.
T Consensus 177 ----~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF-nMNAMSALYHIA-----QNe----- 241 (948)
T KOG0577|consen 177 ----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIA-----QNE----- 241 (948)
T ss_pred ----CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc-CchHHHHHHHHH-----hcC-----
Confidence 2345689999999999985 6789999999999999999999877753 222222222211 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.|.+. ..+-...+..++..||++-|.+|||.++++.
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12222 3455678899999999999999999988765
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.29 Aligned_cols=247 Identities=26% Similarity=0.446 Sum_probs=198.2
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCeeEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 610 (854)
.|+..++||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999975 46899999998654 3344567889999999997 999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998743 26889999999999999999999998 999999999999999999999999999876432
Q ss_pred cCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
. .......|+..|+|||.+.++ .++.++||||||+++|+|++|..|+..... ..... .... ...+.
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~-~~~~-----~~~~~ 221 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMM-LIPK-----SKPPR 221 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhh-cccc-----CCCCC
Confidence 2 222335688999999988654 578999999999999999999999863211 11110 0000 01111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+... .....+.+++.+|++.+|++||++.|++.
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 13356788999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.30 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=194.9
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++++|.+.+.||+|+||.||+|.. .+++.+|+|++..... .....+.+|+.++++++|+||+++.+++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357788899999999999999975 4688999999865432 23346788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+. ++|..++... ...+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666655332 234778888999999999999999998 999999999999999999999999999764321
Q ss_pred cCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC---------
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG--------- 760 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------- 760 (854)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.|+.........+.+ ++......
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhhhhhh
Confidence 1 112234578899999998764 5788999999999999999999998643221111111 11111000
Q ss_pred ---Cc-ccccCCCCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 ---KA-MELVDPNIRDSS-----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ---~~-~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ............ .......+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 000000000000 0011346778899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.10 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=204.3
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKMLIY 610 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 610 (854)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 688999999876542 4567889999999999999999999999988 8899999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998533 26899999999999999999999988 999999999999999999999999999876533
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ........... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~---------~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGS---------SGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccc---------cCC
Confidence 22112334578889999999998889999999999999999999999986433 11112211111 011
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122223467888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=299.71 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=195.0
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|+..+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999764 68899999886432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 57888775432 345899999999999999999999988 9999999999999999999999999988653221
Q ss_pred cccccccccccccccceeeccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC-----------
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG----------- 760 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------- 760 (854)
.......++..|+|||++.+.. ++.++||||||+++|||++|+.|+...... ..+.... ......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIF-RTLGTPDEVVWPGVTSL 231 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH-HHhCCCChhhhhhhhHH
Confidence 1122345678999999887644 688999999999999999999988643211 1111111 100000
Q ss_pred -----CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 -----KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 -----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+ ..........+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000112245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=297.11 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=199.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~------ 604 (854)
++++|++.+.||+|++|.||+|..+ +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999864 57889999886543 2456789999999999 6999999999997654
Q ss_pred eeEEEEEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999875422 2356899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
+....... .......|+..|+|||++.. ..++.++||||||+++|+|++|+.|+..... ...+. .. .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~----~~-~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MRALF----KI-P 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-HHHHH----Hh-h
Confidence 98653221 12233568899999998753 3477899999999999999999999863211 11111 11 1
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .+.+ .........+.+++.+|+..||++|||+.|+++
T Consensus 232 ~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 1111 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=297.33 Aligned_cols=246 Identities=27% Similarity=0.432 Sum_probs=197.9
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
-|...++||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999975 468899999886432 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|..++. ...+++..+..++.+++.++.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999998874 235889999999999999999999988 9999999999999999999999999988653221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..|+..... ...... ..... .+.+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~-----~~~~~-- 222 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFL-IPKNN-----PPTLE-- 222 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHH-HhcCC-----CCCCC--
Confidence 122234678899999999988899999999999999999999998753211 111111 11111 01111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+.+++.+|++.+|++||++.++++
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 223 --GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 122346778999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=298.04 Aligned_cols=262 Identities=23% Similarity=0.359 Sum_probs=198.3
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+|+..++||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999875 588999999875432 33567788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++ +|..++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 78777755444456899999999999999999999988 9999999999999999999999999997653221
Q ss_pred ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC---Ccccc----
Q 003045 694 ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---KAMEL---- 765 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~~---- 765 (854)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+..... ......+....... ....+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 112234578899999988654 578899999999999999999998864321 11111111111000 00000
Q ss_pred -cCCCCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 -VDPNIR-------DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 -~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...... ..........+.+++.+|++.+|.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0011122356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=297.50 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=192.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHH-HHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIIL-IAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999765 68999999987542 2234456667665 666789999999999999999999999
Q ss_pred cCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 612 YMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 612 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|++ ++|..++... .....+++..+..++.||+.||+|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6777776432 2335689999999999999999999986 6 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeecc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAME----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
. .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... .+........ .
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~-~---- 224 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQVVEE-P---- 224 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHHHhc-C----
Confidence 1 12233567889999998864 45688999999999999999999998532211 1111111111 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+.+. .......+.+++.+|++.+|++||++.|+++
T Consensus 225 -~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11110 0112346788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.75 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=202.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecc--ccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV 609 (854)
....|++.++||+||.+.||++...+.+.+|+|++.. .+.+..+-|.+|+.+|.+|+ |.+||+|++|-..++..|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456888899999999999999988889999998754 35667788999999999996 99999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||- +.+|..+|..... ....| .+..+.+||+.++.++|+++ |||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9985 5678888854322 22334 77788999999999999999 999999999999865 6899999999999876
Q ss_pred ccCcccccccccccccccceeeccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGL-----------FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-----------~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
+.........+||+.||+||.+.... .+.++||||+|||||+|+.|+.||.. +...+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~a---- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQIA---- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHHH----
Confidence 66666667789999999999986432 56789999999999999999999862 221111
Q ss_pred cCCcccccCCCCCCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQ-NQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++..+.||.-.-+++. ..-..+++++..||+.||.+||+.-|+|+
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2334555533111111 01122889999999999999999999998
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.39 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=198.6
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477788999999999999965 46889999998654 233456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 691 (854)
+++++|.+++.... ...+++..+..++.+++++|.|||+.+ ++|+||||+||++++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK- 155 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence 99999999985432 345889999999999999999999988 99999999999998654 5899999999876422
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... ....... .... .... +
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~---~~~~-~~~~-----~- 221 (256)
T cd08220 156 --SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPALVLK---IMSG-TFAP-----I- 221 (256)
T ss_pred --ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--hHHHHHH---HHhc-CCCC-----C-
Confidence 12223567889999999998889999999999999999999999875321 1111111 1111 1111 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 222 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112346788999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.35 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=198.8
Q ss_pred cccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 537 FSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999975 46889999998765555566789999999999999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence 999998843 35889999999999999999999998 9999999999999999999999999887553221 11
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... ........ ..... +.+.. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~-~~~~~-----~~~~~--~ 238 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRI-RDNLP-----PKLKN--L 238 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHH-HhcCC-----CCCcc--c
Confidence 223568899999999998889999999999999999999999975321 11111111 11111 11111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+.+++.+|++.+|++||++.|+++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112347889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=286.19 Aligned_cols=248 Identities=28% Similarity=0.458 Sum_probs=202.2
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999875 6889999999776555667899999999999999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999885432 46899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....++..|+|||.+....++.++||||||+++|+|++|+.|+..... ....... .......+..+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~~~~~------- 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKI-ATNGPPGLRNP------- 220 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHH-HhcCCCCcCcc-------
Confidence 3446788999999999988899999999999999999999998863211 1111111 11111111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111356888999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.12 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=203.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.+++|+..+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999876 688999999976443 56778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985432 36899999999999999999999988 9999999999999999999999999987653221
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......++..|+|||++.+..++.++||||||+++|+|++|+.|+..... ...... . .........+
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--~~~~~~---~-~~~~~~~~~~---- 238 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--LRALFL---I-TTKGIPPLKN---- 238 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHHHH---H-HhcCCCCCcc----
Confidence 122234578899999999988899999999999999999999999753211 111111 1 1111111101
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.+++.+|++.+|.+||++.+|++
T Consensus 239 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 ---PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112356888999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.16 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=196.5
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV 609 (854)
++|+..+.||+|+||.||+|+.+ +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999875 588999999975432 2234567899999999999999999999877 889999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++ +|..++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8887774322 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred ccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc---------
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE--------- 759 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--------- 759 (854)
.. .......++..|+|||.+.+. .++.++|+||||+++|||++|..|+...... .....+......
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHh
Confidence 22 122234578899999988754 4689999999999999999999988643211 111111110000
Q ss_pred --------CCcccccCCCCCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 --------GKAMELVDPNIRDSSSQN-QVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 --------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..........+....+.. ....+.+++.+|++.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111111111 2456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.18 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=203.8
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcE-EEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQD-IAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~-vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.|++...||.|+||.||+|..++... .|.|.+...+....+.|.-||+||..++||+||+|++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 556777899999999999998776444 4678887778888999999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
.||-.+.++... ...|.+.++..+++|++.||.|||+.. |||||||..|||++-+|.++|+|||.+-... ...
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 999999987543 346899999999999999999999998 9999999999999999999999999886532 223
Q ss_pred ccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 694 ANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.....+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|.... .....+.. +..-....++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllK-iaKSePPTLlq- 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLK-IAKSEPPTLLQ- 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHH-HhhcCCCcccC-
Confidence 3445689999999999874 578999999999999999999999886421 11111111 11111111222
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+..-...+.+++..||..+|..||+++++++
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2334557889999999999999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=297.33 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=194.8
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
|++.++||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999754 68999999987543 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888874322 135899999999999999999999987 99999999999999999999999999976532211
Q ss_pred ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC-----------C
Q 003045 694 ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG-----------K 761 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-----------~ 761 (854)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ...+........... .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 12223568899999988664 578999999999999999999998864221 111111111000000 0
Q ss_pred ----cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 ----AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+.. ..........+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0111122256788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=298.12 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=199.9
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe-
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ- 602 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~- 602 (854)
++.++..+...|++.+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444555678899999999999999999976 458899999886543 3446788999999999 69999999999853
Q ss_pred -----CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 603 -----GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 603 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
....+++|||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 457899999999999999885432 234788889999999999999999998 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEH 752 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~ 752 (854)
|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.|+...... ..
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----~~ 234 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-----RA 234 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----hh
Confidence 99999987653211 1223456889999999876 346888999999999999999999998532110 10
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 753 VWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 753 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... .....+.+. .......+.+++.+||+.||.+||++.|+++
T Consensus 235 ~~~~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 LFLI------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhH------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1000 000011111 1122346888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.69 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=205.7
Q ss_pred ccCcccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 538 SEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
...++||-|.||.||.|.++. .-.||||.++.. ....++|..|..+|+.++|||+|+|+|+|..+...|||.|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 345799999999999998875 567999999764 456789999999999999999999999999999999999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 696 (854)
+|.+||++-.+ ..++-...+.++.||..||+||...+ +|||||...|.||.++..|||+|||+++.+..+.. ...
T Consensus 349 NLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAH 423 (1157)
T KOG4278|consen 349 NLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAH 423 (1157)
T ss_pred cHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecc
Confidence 99999976433 34677788899999999999999988 99999999999999999999999999998743222 111
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
....-...|.|||-+....++.|+|||+|||+||||.| |..|++.. +-.+ +..++ ....+.+.+
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSq----VY~LL---------EkgyRM~~P 488 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQ----VYGLL---------EKGYRMDGP 488 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHH----HHHHH---------hccccccCC
Confidence 11223467999999999999999999999999999988 66665521 1112 22222 223334445
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+.+...+.+|+++||+..|.+||+++|+-+.+|.+
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 55667899999999999999999999999888764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.52 Aligned_cols=250 Identities=28% Similarity=0.403 Sum_probs=204.4
Q ss_pred ccCcccccCCcccEEEeEcC--CCc--EEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 538 SEGNKLGRGGFGPVHKGKLP--EGQ--DIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
...++||+|.||+|++|.+. +|+ .||||.+...... ....|.+|+.+|-+|+|+|+++|+|+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 44579999999999999764 454 5799999866443 67899999999999999999999999987 778899999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++.|+|.+.|++ ..+..|-......++.|||.||.||..+. +|||||...||||-....|||+|||+.+.++....
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999987 45567888888999999999999999988 99999999999999999999999999998865433
Q ss_pred ccc-ccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 693 EAN-TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 693 ~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
... .....-...|+|||.+....|+.++|||+|||+||||+| |..||... ...++.+ .+|..-
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~-------------~iD~~e 332 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILK-------------NIDAGE 332 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHH-------------hccccc
Confidence 332 223334567999999999999999999999999999999 45566521 1122222 233222
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
+...+..+.+++.+++.+||..+|++|||+..+.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3344556678999999999999999999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.29 Aligned_cols=253 Identities=29% Similarity=0.414 Sum_probs=205.3
Q ss_pred cCcccccCCcccEEEeEc-CCCc----EEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 539 EGNKLGRGGFGPVHKGKL-PEGQ----DIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..++||+|+||+||+|.+ ++|+ +||+|++... ..+...++.+|.-+|.+++|||++||+++|.... ..||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 457999999999999953 4544 6899988765 4456788999999999999999999999998766 8899999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
|+.|+|.++++.+ +..+..+..+.|..|||+||.|||++. +|||||..+||||.+-..+||.|||+++....+..
T Consensus 779 mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999764 345888999999999999999999988 99999999999999999999999999998865555
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
+.......-.+.|||-|.+....|+.++|||||||++||++| |..|+.... .+.+.+.++.+. +
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------~~eI~dlle~ge---------R 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------AEEIPDLLEKGE---------R 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------HHHhhHHHhccc---------c
Confidence 444443444567999999999999999999999999999988 777765321 122222222222 2
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
...+......+..++.+||..|+..||+++++...+.+-..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 23334455678889999999999999999999988866543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.09 Aligned_cols=244 Identities=26% Similarity=0.292 Sum_probs=198.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778899999999999999764 58999999986532 234567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998843 346889999999999999999999988 999999999999999999999999999875322
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.... ....... ...+. ..+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~----~~~~~------~~~ 217 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEK----ILEGK------VRF 217 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH----HhcCC------ccC
Confidence 234568899999999988889999999999999999999999986322 1111111 11111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.. .....+.+++.+|++.+|.+|| +++|+++
T Consensus 218 ~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred Cc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11 1235778899999999999999 6677664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.16 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=195.4
Q ss_pred ccCcccccCCcccEEEeEcC-CCcEEEEEEecc----ccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe--eEEEE
Q 003045 538 SEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE--KMLIY 610 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 610 (854)
+...+||+|+|-+||||.+. +|-+||=-.++. ..+...+.|..|+.+|+.|+|+||+++++++.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999654 466665322221 134556889999999999999999999999987765 77899
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~ 689 (854)
|.|..|+|..|+.. ...++......|++||++||.|||++. +||||||||-+||+|+. -|.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999854 345888999999999999999999987 78999999999999985 48999999999997642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
. ......|||.|||||... ..|++..||||||+.++||+|+..|+.... ...++ .+.+..|....-+..
T Consensus 199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-n~AQI----YKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-NPAQI----YKKVTSGIKPAALSK- 267 (632)
T ss_pred c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-CHHHH----HHHHHcCCCHHHhhc-
Confidence 2 223379999999999877 789999999999999999999999986322 22233 333333322111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.. ...+.++|.+||.. .++|||+.|+|. +|...
T Consensus 268 ----V~---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 ----VK---DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----cC---CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11 12567889999999 999999999998 55553
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=290.66 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=194.1
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|++|.||+++.. +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999865 488999999875432 3446789999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 698 (854)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 234889999999999999999999988 9999999999999999999999999998764321 2233
Q ss_pred cccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 699 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+. .+........ ......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~---------~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKG---------NGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhcc---------CCCCCCCccc
Confidence 567889999999988889999999999999999999999986543211 1111111110 0011111122
Q ss_pred HHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
...+.+++.+|++.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=299.24 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=194.2
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.+.|...++||+|+||+||+|... +++.||+|++..... ...+++.+|++++++++||||+++.+++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999764 689999999864432 2345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++ ++.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 56555532 2235899999999999999999999988 99999999999999999999999999875421
Q ss_pred ccCcccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.....++..|+|||++. ...++.++||||||+++|||++|+.|+.... ......... ....
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~~-~~~~---- 231 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIA-QNDS---- 231 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHh-cCCC----
Confidence 12346788999999884 4568899999999999999999999875321 111111111 1000
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
+.+ ........+.+++.+|++.+|++||++.+|+..
T Consensus 232 -~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 111234568899999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=293.29 Aligned_cols=247 Identities=25% Similarity=0.275 Sum_probs=199.9
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
+|.+.++||.|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777899999999999999865 58999999997543 2346788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..++... ..+++..+..++.||++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988432 46889999999999999999999988 9999999999999999999999999988653221
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ........... . .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~--------~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET--A--------D 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc--c--------c
Confidence 223356788999999999888999999999999999999999998743321 11111111110 0 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTM--ASVV 804 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~--~eVl 804 (854)
...+......+.+++.+|++.+|.+||+. +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11111223678889999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.73 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=193.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCe-----
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEE----- 605 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~----- 605 (854)
++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999764 68999999886542 223467889999999995 6999999999987665
Q ss_pred eEEEEEcCCCCChhhhhcCccc--ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccC
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK--QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFG 682 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFG 682 (854)
.++||||+++ +|..++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 68777654322 346899999999999999999999988 999999999999998 8899999999
Q ss_pred cceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..|+...... ..+.. +........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH-HHHHhCCCC
Confidence 9986532211 1122356788999998865 45789999999999999999999888642211 11111 111110000
Q ss_pred cc---cc---c----CCCCC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AM---EL---V----DPNIR----DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~---~~---~----d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. .. . -+... ..........+.+++.+||+++|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00 0 00000 0001123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=280.40 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=198.9
Q ss_pred cccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
+.||+|+|+.|--+. +.+|.++|||++.+.....+..+.+|++++.+.+ |+||++|+++|+++...|||||.|.+|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 589999999999884 6789999999998887778889999999999996 99999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecccCcceeccCc--cCc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISDFGMARIFGFN--QNE 693 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~~~~~--~~~ 693 (854)
..++. ++..+++.++.++.++|+.||.+||..+ |.||||||+|||...... +||+||.+..-.... -+.
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99984 4556999999999999999999999999 999999999999986654 899999988754321 111
Q ss_pred ---ccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC--------chH-HHHHHHH
Q 003045 694 ---ANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN--------SSL-IEHVWNL 756 (854)
Q Consensus 694 ---~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~--------~~l-~~~~~~~ 756 (854)
......+|+..|||||+.. ...|+.++|.||||||||-||+|+.||...-..+ ... ...+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1223578999999999874 3458999999999999999999999996432111 111 1122222
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++++.. ++.|..- -.......+++...+..++.+|.++.+++.
T Consensus 318 IQEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 333322 1211110 122345567777888899999999999987
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=293.75 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=196.5
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEEEEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKMLIYE 611 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 611 (854)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556789999999999999765 48899999997653 33446788999999999999999999999988 78999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787777432 246899999999999999999999988 9999999999999999999999999998764332
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC---Ccccc--
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---KAMEL-- 765 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~~-- 765 (854)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ......+....... ....+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhcccccc
Confidence 1 12233456788999998765 4688999999999999999999998864321 11112221111110 00000
Q ss_pred ------cCCC------CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 ------VDPN------IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ------~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+. +...........+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 000000112457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=319.34 Aligned_cols=269 Identities=22% Similarity=0.259 Sum_probs=186.4
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcCC--CcEEEEE------------------EeccccccCHHHHHHHHHHHHhcCC
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLPE--GQDIAVK------------------RLSRKSGQGLEEFKNEIILIAKLQH 590 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~h 590 (854)
....++|++.++||+|+||+||++..+. +...++| ++. ........+.+|+.++++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999986432 2222222 111 112234568899999999999
Q ss_pred CceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCccc--ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcE
Q 003045 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAK--QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668 (854)
Q Consensus 591 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 668 (854)
+||+++++++...+..++|+|++.. +|..++..... .......+...++.||+.||.|||+.+ |+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999999999999999999864 55555533211 122345667789999999999999988 99999999999
Q ss_pred EEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc-c-C
Q 003045 669 LLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE-E-N 746 (854)
Q Consensus 669 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~-~-~ 746 (854)
|++.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..++..... . .
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 99999999999999998764221 1222346799999999999999999999999999999999998764432211 1 1
Q ss_pred chHHHHHHHHhh-cCCc-------ccccCCC-C---CCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 747 SSLIEHVWNLWN-EGKA-------MELVDPN-I---RDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 747 ~~l~~~~~~~~~-~~~~-------~~~~d~~-l---~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.+.+..... .+.. ...++.. + ..... ......+.+++.+||+.||.+|||+.|+++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 112111110000 0000 0000000 0 00000 001234667788999999999999999987
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=295.47 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=194.3
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 608 (854)
.++|++.++||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367888999999999999999764 589999999865422 2233567899999999999999999998765 46899
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677776432 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc----
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM---- 763 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~---- 763 (854)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.... .......+..........
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhhchh
Confidence 321 11222345788999999865 568899999999999999999999886322 112222221111100000
Q ss_pred -------cc--cCCCCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 764 -------EL--VDPNIRDSS---SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 764 -------~~--~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ......... .......+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000000 0012345678999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=291.85 Aligned_cols=242 Identities=24% Similarity=0.292 Sum_probs=186.2
Q ss_pred ccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHh---cCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 542 KLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAK---LQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~---l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 588999998865421 122334455544443 479999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 9999988843 345899999999999999999999998 999999999999999999999999998755321
Q ss_pred cccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......|+..|+|||.+.+ ..++.++||||+||++|||++|..||........ ..+...... ....+
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~------~~~~~--- 218 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT------VNVEL--- 218 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH---HHHHHHhhc------CCcCC---
Confidence 1223468999999999864 5689999999999999999999999864322111 111111000 11111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVLM 806 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~~ 806 (854)
+......+.+++.+|++.||++|| +++|+++.
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 222345788899999999999999 59998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=288.87 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=199.0
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...+.||+|+||.||+|..+ +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999765 57899999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC-ceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN-PKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~ 691 (854)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999885432 235789999999999999999999988 999999999999998864 6999999998664221
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......|+..|+|||++....++.++||||||++++||++|+.|+... ...+.+...... .. .+ .
T Consensus 157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~-~~----~~-~- 222 (257)
T cd08225 157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQG-YF----AP-I- 222 (257)
T ss_pred --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcc-cC----CC-C-
Confidence 1222346888999999998888999999999999999999999997532 122222222111 11 11 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112246888899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=302.02 Aligned_cols=259 Identities=24% Similarity=0.280 Sum_probs=195.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------ 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 603 (854)
..++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999754 6899999998643 223345678899999999999999999988643
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...++||||+.+ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999965 66666532 2788899999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH--------
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN-------- 755 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~-------- 755 (854)
++..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+..
T Consensus 165 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 9875322 122334678899999999999999999999999999999999999864321 000000000
Q ss_pred -----------HhhcCC------cccccCCCC----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 756 -----------LWNEGK------AMELVDPNI----RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 756 -----------~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...... ...+....+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 001111100 01111223456789999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=294.61 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=193.4
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...++||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999754 58999999987543 234567889999999996 99999999999999999999999
Q ss_pred CCCCChhhhhcC--cccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 613 MPNKSLDLFIFD--PAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 613 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
+.. ++..+... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 874 44443211 11234689999999999999999999975 5 99999999999999999999999999976532
Q ss_pred ccCcccccccccccccccceeeccC---CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEG---LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
. .......|+..|+|||++.+. .++.++||||||+++|||++|+.|+.... ...+.+...... .
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~------~ 227 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKG------D 227 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCC------C
Confidence 1 112234678899999998766 68999999999999999999999986422 122222211111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+.+...........+.+++.+|++.+|++|||+.||++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112222222234457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=299.37 Aligned_cols=275 Identities=24% Similarity=0.319 Sum_probs=200.9
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC--Cee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~--~~~ 606 (854)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4577888999999999999999765 5889999988543 223445677899999999 999999999998654 367
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 488777743 26889999999999999999999988 99999999999999999999999999987
Q ss_pred ccCccCc---ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-----
Q 003045 687 FGFNQNE---ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW----- 757 (854)
Q Consensus 687 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~----- 757 (854)
....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.|+...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL--NQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCH
Confidence 6432211 22334578999999998765 55788999999999999999999998642211 1111110000
Q ss_pred ------hcCCcccccC----CCCC--CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HhccCCCCCCC
Q 003045 758 ------NEGKAMELVD----PNIR--DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM--LESETPTLPVP 817 (854)
Q Consensus 758 ------~~~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~--L~~~~~~~~~p 817 (854)
.......+++ .... ..........+.+++.+|++.+|++|||+.++++. ++........+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~ 308 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP 308 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence 0000000111 0000 00001124568899999999999999999999983 55543333333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=304.80 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=197.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-----EK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~ 606 (854)
+++|.+.++||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999975 46899999998643 2334566888999999999999999999876543 57
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++++||+++ +|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 6666652 235899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCcc-cccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC---C
Q 003045 687 FGFNQNEA-NTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---K 761 (854)
Q Consensus 687 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~ 761 (854)
........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|+..... ......+....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence 54221111 1233568899999998754 5689999999999999999999998853211 11111111111100 0
Q ss_pred cccccCCC---------CCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HhccCC
Q 003045 762 AMELVDPN---------IRDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVLM--LESETP 812 (854)
Q Consensus 762 ~~~~~d~~---------l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~--L~~~~~ 812 (854)
...+.+.. .....+ ......+.+++.+|++.+|++|||+.|+++. ++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000000 000000 1123468899999999999999999999985 555433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=292.10 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=195.3
Q ss_pred cccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChh
Q 003045 541 NKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLD 619 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 619 (854)
.+||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5899999999999976 468999999986655555677899999999999999999999999999999999999999999
Q ss_pred hhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccccc
Q 003045 620 LFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699 (854)
Q Consensus 620 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 699 (854)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... ......
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 88732 34789999999999999999999988 9999999999999999999999999987653221 112335
Q ss_pred ccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHH
Q 003045 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQV 779 (854)
Q Consensus 700 ~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 779 (854)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..|+..... ......+ .... .+.+.. .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~----~~~~-----~~~~~~--~~~~~ 243 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMI----RDNL-----PPKLKN--LHKVS 243 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhhC-----CcccCC--cccCC
Confidence 688999999999888899999999999999999999999763211 1111111 1100 011100 01123
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 780 LRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 780 ~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.+++.+|++.+|.+||++.|+++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 35778899999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=292.16 Aligned_cols=261 Identities=16% Similarity=0.166 Sum_probs=182.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCC----cEEEEEEeccccccCH-----------HHHHHHHHHHHhcCCCceeeee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEG----QDIAVKRLSRKSGQGL-----------EEFKNEIILIAKLQHRNLVRLL 597 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~l~ 597 (854)
..++|.+.++||+|+||+||+|...++ ..+|+|+......... .....++..+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346789999999999999999986543 4556665432221111 1122334455667899999999
Q ss_pred eeEEeCC----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC
Q 003045 598 GCCIQGE----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED 673 (854)
Q Consensus 598 ~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 673 (854)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9776543 34677787644 44444421 223567888999999999999999988 9999999999999999
Q ss_pred CCceecccCcceeccCccC-----cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCch
Q 003045 674 MNPKISDFGMARIFGFNQN-----EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748 (854)
Q Consensus 674 ~~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~ 748 (854)
+.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-N 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-H
Confidence 9999999999987642211 111223569999999999999999999999999999999999999997542221 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
......... ...+..+.+.. ......+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDF----IKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHH----HHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111000 00011111100 011356888999999999999999999998763
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=298.15 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=206.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcC---CCc--EEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP---EGQ--DIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~---~g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.-+.....++||+|-||.||+|... .|+ .||||..+.+ .....+.|..|.-+|++++||||++++|.|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3344455678999999999999642 343 5888988764 45568899999999999999999999999964 678
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++|||.++-|.|..||..++ ..|+......++.||..||+|||+.. +|||||..+||||....-|||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999996543 45888889999999999999999987 99999999999999999999999999998
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
+...... ......-...|||||-+.-..++.++|||-|||.+||+++ |..||..-.+ .++...
T Consensus 541 ~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------------sDVI~~ 604 (974)
T KOG4257|consen 541 LEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------------SDVIGH 604 (974)
T ss_pred ccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---------------cceEEE
Confidence 7533222 2223344667999999999999999999999999999876 8888763211 112222
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
+...-+...+..++..+..++.+||.++|.+||...|+...|+.+.
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 2333344556666778899999999999999999999988886653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=286.42 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=203.6
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...+.||+|+||.||++... +++.+|+|++..... ...+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999764 588999999976533 4567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886432 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+.... ..+...... ..... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~~-----~-- 222 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKIL-KGQYP-----P-- 222 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHh-cCCCC-----C--
Confidence 12233578889999999998889999999999999999999999975322 112211111 11111 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+|+..+|++||++.|+++
T Consensus 223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11123356788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=285.53 Aligned_cols=246 Identities=22% Similarity=0.252 Sum_probs=189.2
Q ss_pred HHHhcCcccCccc--ccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCee
Q 003045 531 AVATNYFSEGNKL--GRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 531 ~~~~~~f~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 606 (854)
....++|++.+.+ |+|+||.||++..+ +++.+|+|.+....... .|+.....+ +|+|++++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344677777776 99999999999754 67889999886532221 123222222 699999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcce
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMAR 685 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~ 685 (854)
++||||+++++|.+++... ..+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998432 36899999999999999999999998 99999999999999998 99999999988
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... ....++..|+|||++.+..++.++||||||+++|||++|+.|+............+.... .. ..
T Consensus 159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~---~~ 227 (267)
T PHA03390 159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QK---KL 227 (267)
T ss_pred ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cc---cC
Confidence 65321 224678899999999999999999999999999999999999874322221122221111 00 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-MASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~eVl~ 805 (854)
.........+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011123356888999999999999996 688874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=301.44 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=204.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc--CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ--GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
....|.+.+.||+|.|++|.+|++. ++..||+|.+++.... ..+.+.+|+++|..++|||||+++.+.+.....|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467888999999999999999754 6999999999876433 345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+.+|.+.+++..+ ..+.+..+..++.|+..|++|||+.+ |||||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 9999999999999543 33566888899999999999999998 9999999999999999999999999999874
Q ss_pred ccCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
........+|++.|.|||++.+..| .+++|+||+|++||.|+.|..||+... +.++-+.
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------------lk~Lr~r 266 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------------LKELRPR 266 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------------------cccccch
Confidence 3345566899999999999998776 568999999999999999999997321 1111111
Q ss_pred CCCCC--CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDS--SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.++.. .+.-....+.+++.++|-.+|.+|+++.++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 12111 11222346778899999999999999999976
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=290.14 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=191.0
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeC--CeeEEEEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQG--EEKMLIYE 611 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 611 (854)
|++.++||+|+||.||+|... +++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999754 68899999987542 222234457899999985 99999999999987 88999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++ +|.+++... ...+++.++..++.||+.||.|||+.+ ++|+||||+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~- 152 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK- 152 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC-
Confidence 9974 666666432 246899999999999999999999998 999999999999999 99999999999865322
Q ss_pred Ccccccccccccccccceeec-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-----------hc
Q 003045 692 NEANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW-----------NE 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~-----------~~ 759 (854)
.......++..|+|||++. +..++.++|||||||++|||++|..|+..... ........... ..
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcc
Confidence 1122345788999999764 45678899999999999999999998864321 11111111111 01
Q ss_pred CCcccccCCCCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKAMELVDPNIRD----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+.... .........+.+++.+||+++|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111111111000 001123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=305.23 Aligned_cols=255 Identities=26% Similarity=0.339 Sum_probs=200.4
Q ss_pred cccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------eeEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------EKML 608 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~l 608 (854)
+...+.||+|+||.||+|++ ..|+.||||.++... ....+...+|+++|++++|+|||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457899999999999985 469999999997653 445677889999999999999999998865543 5689
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc--cCC--CceecccCcc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD--EDM--NPKISDFGMA 684 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~DFGla 684 (854)
|||||.+|+|...+....+..-|++.+.+.++.++..||.|||+.+ ||||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888888999999999999999999999988 99999999999994 334 3799999999
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 763 (854)
+.+.. .......+||..|++||.+.. +.|+..+|.|||||++|+..||..||...... ....+.++....++..-
T Consensus 172 rel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p-k~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP-KNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc-cccchhhhhhhccCCCc
Confidence 97742 235667899999999999984 88999999999999999999999999754332 22223333332221110
Q ss_pred c--ccCCCC------------CCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 003045 764 E--LVDPNI------------RDSSSQNQVLRCIHVGMLCVQDSAMYRP 798 (854)
Q Consensus 764 ~--~~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 798 (854)
. ..++.. ..........++.+++..+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 011111 1123345566777888888889999988
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=292.41 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=196.7
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC---
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE--- 604 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 604 (854)
+...++|++.++||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999875 58899999987542 233456788999999999999999999987655
Q ss_pred -------eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 605 -------EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 605 -------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
..++|+||+++ ++..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999987 555555332 335899999999999999999999998 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+.... .......+...
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRL 233 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHH
Confidence 999999987642221 11122345778999998864 457899999999999999999998886321 11112222221
Q ss_pred hhcCCc---ccc--------cCC------CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 WNEGKA---MEL--------VDP------NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ~~~~~~---~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...... ..+ .++ ..+... ......+.+++.+|++.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111100 000 000 000000 012356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=287.74 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=195.5
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc-----cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK-----SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
.+|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999754 5899999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++++||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 335789999999999999999999998 99999999999999999999999999986
Q ss_pred ccCcc-CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQ-NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... .........++..|+|||++.+..++.++|+||||+++|||++|+.|+.... .. ..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~-~~~~~~~~~------ 224 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE----AM-AAIFKIATQ------ 224 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC----HH-HHHHHHHcC------
Confidence 53211 1112223568899999999998889999999999999999999999985321 11 111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+......+.+++.+|++ +|.+||+..+++.
T Consensus 225 ---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 ---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111222334568888999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=284.06 Aligned_cols=247 Identities=29% Similarity=0.420 Sum_probs=200.6
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|+..++||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999765 578999999976543 4567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988432 56899999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......++..|+|||...+..++.++||||+|+++|+|++|+.|+.... .... .+... .... +.+
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~-~~~~~-~~~~-----~~~-- 219 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAA-LFRIV-QDDH-----PPL-- 219 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHH-HHHHh-ccCC-----CCC--
Confidence 1233567889999999988889999999999999999999999876322 1111 11111 1111 111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+......+.+++.+|++.+|++||++.|++.
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 --PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122356788999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=290.40 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=193.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|+..++||+|++|+||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999765 68899999986542 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCcceeccCc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGMARIFGFN 690 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~ 690 (854)
|+++ +|..++... ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 666665332 2223678888899999999999999988 999999999999985 557999999999865322
Q ss_pred cCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc---cc--
Q 003045 691 QNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA---ME-- 764 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---~~-- 764 (854)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|+.|+...... ..+... ......... ..
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKI-FRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HHHhCCCChhhccccc
Confidence 1 11223467889999998866 45789999999999999999999998643211 111111 111111000 00
Q ss_pred -ccC-----CCCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 -LVD-----PNIRD----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 -~~d-----~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000 001112345788999999999999999999987
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=290.59 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=195.9
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999865433 3456789999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC------
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN------ 692 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~------ 692 (854)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988532 36899999999999999999999988 99999999999999999999999999886432211
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
........++..|+|||......++.++||||||+++|||++|..|+..... ...... . ..+... .. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~---~-~~~~~~----~~--~ 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--EEIFQN---I-LNGKIE----WP--E 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH---H-hcCCcC----CC--c
Confidence 1122345678899999999888899999999999999999999999863321 111111 1 111110 00 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
. ......+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus 223 ~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 D--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred c--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0 0124577889999999999999999776666643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-34 Score=330.56 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=201.6
Q ss_pred HHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
...+-++....+||.|.||.||-|.. .+|+-.|+|.+... .......+.+|+.++..++|||+|+++|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34556677788999999999999964 56888999987543 3445677899999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
|.||||++|+|.+++. .....++.....+..|++.|++|||+++ ||||||||+||+|+.+|.+|+.|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999984 3334556666778899999999999999 999999999999999999999999999987
Q ss_pred cCcc--CcccccccccccccccceeeccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 688 GFNQ--NEANTNRVVGTYGYMAPEYAMEGL---FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 688 ~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
.... -....+...||+.|||||++.+.. ...++||||+|||++||.||++||.....+ -.+.- .+..+..
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy----~V~~gh~ 1459 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMY----HVAAGHK 1459 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHh----HHhccCC
Confidence 5331 112234578999999999997644 566899999999999999999999743221 11111 1111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.++......=.+++.+||+.||++|-++.|+++
T Consensus 1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2233344556678899999999999988887776
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=290.23 Aligned_cols=249 Identities=29% Similarity=0.361 Sum_probs=202.9
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
...+.|+..++||+||||.||-++.+ +|+.+|.|++.++ ...+..-..+|-.+|.+++.+.||.+-..|+..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34467888899999999999998654 6899999998654 2345556789999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|+..|.+|+|.-+|++... ..+++..+..++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|.|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999987654 56999999999999999999999998 999999999999999999999999999987
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
...+ .....+||.+|||||++.++.|+...|-|||||+||||+.|+.||....+.... +.+.+.. +-|
T Consensus 338 ~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~-------~~~ 405 (591)
T KOG0986|consen 338 PEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRT-------LED 405 (591)
T ss_pred CCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHH-------hcc
Confidence 4322 223358999999999999999999999999999999999999999754322110 0111100 111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT 799 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 799 (854)
+ .+++....+....+....|+.||++|..
T Consensus 406 ~---~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 406 P---EEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred h---hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 1 2334444556777888899999999974
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=318.45 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=190.3
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe-------
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ------- 602 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------- 602 (854)
.-...|++.+.||+||||.||+++.+ ||+.+|||++..+. ......+.+|+..|++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34466788899999999999999865 89999999997653 3445678899999999999999998654321
Q ss_pred --------------------------------------------------------------------------------
Q 003045 603 -------------------------------------------------------------------------------- 602 (854)
Q Consensus 603 -------------------------------------------------------------------------------- 602 (854)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHh
Q 003045 603 ------------------------G--------EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650 (854)
Q Consensus 603 ------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 650 (854)
. ...|+=||||+..+|+.++..+.-.. .-...++++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 12356788888888888775432111 3667899999999999999
Q ss_pred hcCCCCceEEcccCCCcEEEccCCCceecccCcceecc----------------CccCcccccccccccccccceeeccC
Q 003045 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG----------------FNQNEANTNRVVGTYGYMAPEYAMEG 714 (854)
Q Consensus 651 H~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~aPE~~~~~ 714 (854)
|+.+ ||||||||.||+++++..|||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 01111234457899999999999765
Q ss_pred C---CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccC
Q 003045 715 L---FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQ 791 (854)
Q Consensus 715 ~---~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 791 (854)
. |+.|+|+||||||++||+. ||....+. +. +...++.+.+..- ..........-.+++.++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----a~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER----AS-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHH----HH-HHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 4 9999999999999999985 45432221 11 1112222222211 12233344456788999999
Q ss_pred CCCCCCCCHHHHHH
Q 003045 792 DSAMYRPTMASVVL 805 (854)
Q Consensus 792 ~dp~~RPs~~eVl~ 805 (854)
.||.+|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999987
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.75 Aligned_cols=244 Identities=26% Similarity=0.326 Sum_probs=190.8
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|+||+||++... +|+.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999654 68899999986532 22344567899999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 698 (854)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCcccc
Confidence 998854332 35899999999999999999999998 99999999999999999999999999876532 112223
Q ss_pred cccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 699 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
..++..|+|||++.+..++.++||||||+++|+|++|+.|+....... ....+...... . .. ..+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~----~--~~----~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--EKEELKRRTLE----M--AV----EYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--cHHHHHhcccc----c--cc----cCCccC
Confidence 467889999999988889999999999999999999999986432211 01111110000 0 00 111122
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34678899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=294.91 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=193.8
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.|...+.||+|+||.||+|+.. +++.+|+|++..... ...+.+.+|++++++++|+|++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999754 688999999864422 234578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++ +|.+++.. ....+++.++..++.+|+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 66666532 2345899999999999999999999998 99999999999999999999999999875421
Q ss_pred Ccccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.....++..|+|||++. .+.++.++|||||||++|||++|+.|+.... . ........... . +
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~---~~~~~~~~~~~-~-----~ 242 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--A---MSALYHIAQNE-S-----P 242 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--H---HHHHHHHHhcc-C-----C
Confidence 22346788999999974 4568999999999999999999999875321 1 11111111111 0 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.. ........+.+++.+|++.+|.+||++.||++.+-.
T Consensus 243 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 TL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 01 111223467889999999999999999999985543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=296.12 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=191.5
Q ss_pred cccccC--CcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRG--GFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
..||+| +||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 89999999764 78999999986532 22346788999999999999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc-
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA- 694 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 694 (854)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885432 234889999999999999999999988 9999999999999999999999998654332111100
Q ss_pred ----cccccccccccccceeeccC--CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH------------
Q 003045 695 ----NTNRVVGTYGYMAPEYAMEG--LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL------------ 756 (854)
Q Consensus 695 ----~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~------------ 756 (854)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ..+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhcCCCCCCccccccch
Confidence 01112345679999999764 4789999999999999999999998643211 1111100000
Q ss_pred ----h----------------hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 ----W----------------NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ----~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .........+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000000111111222223345567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.38 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=197.6
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
|...+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999764 688999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++ +|..++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 86 777776432 246899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC---CcccccC--
Q 003045 694 ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---KAMELVD-- 767 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d-- 767 (854)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+..... ......+....... ....+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhh
Confidence 112234577889999998876 789999999999999999999988854221 11111111111110 0000000
Q ss_pred -------CC----CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 -------PN----IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 -------~~----l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+. ............+.+++.+|++.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 001111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=287.47 Aligned_cols=248 Identities=29% Similarity=0.368 Sum_probs=201.5
Q ss_pred CcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|++.++||+|+||.||+++. .+++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 467788999999999999965 468899999987542 23456778999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885422 2346899999999999999999999998 999999999999999999999999999876432
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ..+... ......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~----~~~~~~--------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYK----VQRGKY--------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HhcCCC---------
Confidence 22234678899999999999999999999999999999999999863221 111111 111111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..........+.+++.+|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112234467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=299.24 Aligned_cols=263 Identities=20% Similarity=0.297 Sum_probs=197.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 606 (854)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478888999999999999999754 68999999987542 2345677889999999999999999998763 3468
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578887743 344899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCccCc--ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh-----
Q 003045 687 FGFNQNE--ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN----- 758 (854)
Q Consensus 687 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----- 758 (854)
....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHHHHHhCCChhH
Confidence 5432211 11223578899999998865 4688999999999999999999999853211 111111111100
Q ss_pred ------cCCcccccCC-CCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 ------EGKAMELVDP-NIRDSS-----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ------~~~~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+...+..+. ...... .......+.+++.+|++.+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011111100 000001 1123467889999999999999999999988
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.99 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=191.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-------
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------- 604 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------- 604 (854)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56888899999999999999764 68899999986542 222345678999999999999999999987654
Q ss_pred -eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 605 -EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 605 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
..++||||+.+ +|..++.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999975 66666632 2235899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCc--ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc-
Q 003045 684 ARIFGFNQNE--ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE- 759 (854)
Q Consensus 684 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~- 759 (854)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.... .......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~--~~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT--EQHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCC
Confidence 9876432211 112234578889999988664 47889999999999999999998875322 11112222111110
Q ss_pred --CCcc-----c-------------ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 --GKAM-----E-------------LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 --~~~~-----~-------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... . .+...+... .....+.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 0 000000000 01235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.52 Aligned_cols=244 Identities=20% Similarity=0.227 Sum_probs=188.2
Q ss_pred cccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHH-HhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILI-AKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999764 588999999865422 1223344555444 445899999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 345889999999999999999999988 99999999999999999999999999886432
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...... ....... ..+.. .
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~~~~~~--~~~~~----~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DAVFDN----ILSRRIN--WPEEV----K 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHhcccC--CCCcc----c
Confidence 2235678899999999888899999999999999999999999863211 111111 1111110 01111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
......+.+++.+|++.+|++||++.++.+.|+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123356889999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=291.75 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=192.0
Q ss_pred cCcccCcccccCCcccEEEeEcCC-CcEEEEEEecccc-ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.+.||+|+||.||+|..++ ++.||||+++... .....++..|+.++.+.+ |+||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999998764 8999999997543 233456677888777775 9999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
|+++ ++..++... ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9864 666655332 23689999999999999999999974 6 999999999999999999999999998765322
Q ss_pred cCcccccccccccccccceeeccCC----CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGL----FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... .+......... ...+.
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-~~~~~ 240 (296)
T cd06618 169 K---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLTKILQEE-PPSLP 240 (296)
T ss_pred C---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHHHHhcCC-CCCCC
Confidence 1 122345788999999987553 888999999999999999999998532111 11111111111 11110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
. .......+.+++.+|++.+|++||++.++++.
T Consensus 241 ~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 P-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 01123468889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=289.55 Aligned_cols=255 Identities=23% Similarity=0.282 Sum_probs=198.6
Q ss_pred cccCcccccCCcccEEEeEc----CCCcEEEEEEecccc----ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeE
Q 003045 537 FSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (854)
|.+.+.||+|++|.||+++. .+++.+|||.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 66778999999999999863 357889999986432 23345688999999999 5999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999988843 345889999999999999999999988 999999999999999999999999998865
Q ss_pred cCccCcccccccccccccccceeeccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..|+....... ...+........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~------ 227 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS------ 227 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc------
Confidence 32211 1122356889999999987655 7889999999999999999999986432211 111111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+.... .....+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 228 -~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111111 1224577889999999999999999998877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=300.08 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=198.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Ce
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 605 (854)
.++|.+.++||+|+||+||+|+. .+++.||+|.+... .......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999975 46899999998653 223345678899999999999999999988654 34
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 677777742 345899999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC----
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---- 760 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---- 760 (854)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.|+.... .......+.......
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--YVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHHhCCCChHH
Confidence 653221 22233567889999998865 468999999999999999999999986421 111111111111000
Q ss_pred -------Cccccc-------CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhcc
Q 003045 761 -------KAMELV-------DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM--LESE 810 (854)
Q Consensus 761 -------~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~--L~~~ 810 (854)
.....+ ++... .........+.+++.+||+.+|++|||++|+++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 00000 0011234567899999999999999999999985 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.22 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=192.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 604 (854)
.++|++.++||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478899999999999999999764 588999999865422 22346788999999999999999999875543
Q ss_pred --eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 605 --EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 605 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
..++|+||+.. +|...+.. ....+++..+..++.||++||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999976 45555532 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccCc---------ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHH
Q 003045 683 MARIFGFNQNE---------ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEH 752 (854)
Q Consensus 683 la~~~~~~~~~---------~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~ 752 (854)
++......... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~--~~~~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD--IDQLHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 99865322111 11123456888999998765 4588999999999999999999988853221 111222
Q ss_pred HHHHhhcCC---------cccccCCCCCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 753 VWNLWNEGK---------AMELVDPNIRDSSS-------QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 753 ~~~~~~~~~---------~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+........ .....+.......+ ......+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 221111100 00000000000000 112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.62 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=193.3
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhc---CCCceeeeeeeEEeCCe-----
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKL---QHRNLVRLLGCCIQGEE----- 605 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~----- 605 (854)
|++.++||+|+||.||+|+.+ +++.+|+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999876 489999999975422 2234567788877766 59999999999988776
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7877774322 235899999999999999999999988 9999999999999999999999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc-
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME- 764 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~- 764 (854)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.|+.... .......+...........
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--EADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--hHHHHHHHHHHcCCCChHhc
Confidence 764321 1223457889999999999999999999999999999999988875322 1111221111111000000
Q ss_pred ---------ccCCCCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 ---------LVDPNIR---DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ---------~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....... ..........+.+++.+||+.||.+||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 1111223456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=290.49 Aligned_cols=261 Identities=21% Similarity=0.235 Sum_probs=192.1
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+++.+|.|+++.||+++. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555556666666655 7899999998754 3445678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC----
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN---- 692 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 692 (854)
+|.+++.... ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999986432 235788999999999999999999998 99999999999999999999999999876532111
Q ss_pred -cccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh----hcC-----
Q 003045 693 -EANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW----NEG----- 760 (854)
Q Consensus 693 -~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~----~~~----- 760 (854)
........++..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.+...... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCccccccCchhhh
Confidence 111223456778999999876 35889999999999999999999998642211 11111111000 000
Q ss_pred --Cccc----ccCCCC----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 --KAME----LVDPNI----RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 --~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... ..++.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 001100 01112233457888999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=285.47 Aligned_cols=241 Identities=25% Similarity=0.305 Sum_probs=185.8
Q ss_pred ccccCCcccEEEeEcC-CCcEEEEEEecccccc---CHHHHHHHHH---HHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 542 KLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ---GLEEFKNEII---LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~Ei~---~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
.||+|+||.||++... +++.||+|.+...... ....+..|.. .++..+||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999754 5889999998754221 1223444444 3444579999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|..++. ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++..+...
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 999998874 3346899999999999999999999988 999999999999999999999999998755321
Q ss_pred cccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......|+..|+|||++.++ .++.++||||+|+++|||++|+.|+......... ........ ..+.+..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~------~~~~~~~- 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT------MAVELPD- 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---HHHHHhhc------cCCCCCC-
Confidence 12235789999999998754 6899999999999999999999998643221111 11111100 1111111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.....+.+++.+|+..+|++|| ++.|+++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1235788889999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=286.86 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=194.5
Q ss_pred CcccCcccccCCcccEEEeEc----CCCcEEEEEEecccc----ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCee
Q 003045 536 YFSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 606 (854)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999975 368899999987532 22346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345788999999999999999999988 99999999999999999999999999986
Q ss_pred ccCccCcccccccccccccccceeeccC--CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEG--LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
...... .......|+..|+|||.+... .++.++||||||+++|+|++|..|+...... ....+........
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~----- 227 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS----- 227 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc-----
Confidence 532211 122235688999999998753 4778999999999999999999998643221 1122222111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.+. .+......+.+++.+|++.+|++|| ++.+++.
T Consensus 228 --~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111 1112234677899999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=287.64 Aligned_cols=259 Identities=24% Similarity=0.278 Sum_probs=193.6
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
|.+.+.||+|++|+||+|... +++.|++|++..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999875 478899999865432 22234567999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--- 152 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--- 152 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC---
Confidence 788888775432 246899999999999999999999988 999999999999999999999999999865321
Q ss_pred ccccccccccccccceeec-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh-------------c
Q 003045 694 ANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN-------------E 759 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-------------~ 759 (854)
.......++..|+|||++. ...++.++|+||||++++||++|+.|+...... ........... .
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1122356788999999885 455889999999999999999999888643211 11111000000 0
Q ss_pred CCcccccCCCCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKAMELVDPNIR---DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+..... ..........+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 0000111357889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=294.34 Aligned_cols=262 Identities=22% Similarity=0.329 Sum_probs=194.1
Q ss_pred cCcc-cCcccccCCcccEEEeEcC-CCcEEEEEEeccccccC--------------HHHHHHHHHHHHhcCCCceeeeee
Q 003045 535 NYFS-EGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQG--------------LEEFKNEIILIAKLQHRNLVRLLG 598 (854)
Q Consensus 535 ~~f~-~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~~ 598 (854)
++|. +.+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4567999999999999754 68999999986542211 124778999999999999999999
Q ss_pred eEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 599 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
++...+..++||||++ ++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 57888773 2345889999999999999999999988 999999999999999999999
Q ss_pred cccCcceeccCcc------------CcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCccc
Q 003045 679 SDFGMARIFGFNQ------------NEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE 745 (854)
Q Consensus 679 ~DFGla~~~~~~~------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~ 745 (854)
+|||++....... .........++..|+|||++.+. .++.++||||||+++|||++|+.|+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~- 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE- 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 9999998764110 01111223467889999998764 478999999999999999999998864322
Q ss_pred CchHHHHHHHHhhcCCcccc-----------cCCCCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 746 NSSLIEHVWNLWNEGKAMEL-----------VDPNIRD---SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~-----------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+...........+ ..+.... .........+.+++.+|++.+|++||++.|++.
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1222222221111100000 0000000 001112356788999999999999999999997
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=287.43 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=200.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV 609 (854)
++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999765 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 336999999999999999999999988 99999999999999999999999999987643
Q ss_pred ccCc------------------ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHH
Q 003045 690 NQNE------------------ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751 (854)
Q Consensus 690 ~~~~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~ 751 (854)
.... .......++..|+|||++....++.++||||||++++++++|+.|+..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTFQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHHH
Confidence 2211 222335678899999999888899999999999999999999999874321 11111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 003045 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM----ASVVL 805 (854)
Q Consensus 752 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~----~eVl~ 805 (854)
. .... ....+......+.+++.+|++.+|++||++ +|+++
T Consensus 233 ~---~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 K---ILKL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHhc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 1100 011111224578899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.17 Aligned_cols=267 Identities=23% Similarity=0.286 Sum_probs=202.2
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----eeE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-----EKM 607 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 607 (854)
+|.+.++||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999865 48999999987643 344567899999999999999999999998775 789
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
++|||+++ +|..++.. ...+++..+..++.+|+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 77777743 236899999999999999999999998 999999999999999999999999999976
Q ss_pred cCccC-cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC-----
Q 003045 688 GFNQN-EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG----- 760 (854)
Q Consensus 688 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 760 (854)
..... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ......+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhcCCCChhHh
Confidence 43321 0122335678899999999887 799999999999999999999999864321 11111111111000
Q ss_pred ------CcccccCC-CCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhccC
Q 003045 761 ------KAMELVDP-NIRD-----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESET 811 (854)
Q Consensus 761 ------~~~~~~d~-~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~~ 811 (854)
.....+.. .... .........+.+++.+||+.+|++||++.++++ .+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000 0000 001112356788999999999999999999998 466653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=291.49 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=195.0
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCeeE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ-GEEKM 607 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~ 607 (854)
..+++|.+.++||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46788999999999999999999754 7899999988643 22335678899999999999999999999876 45788
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+++||+ +++|..++. ...+++.....++.||++||.|||+.+ ++|+||||+|||+++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 457877763 234778888899999999999999998 999999999999999999999999998754
Q ss_pred cCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh--------
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN-------- 758 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-------- 758 (854)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.|+..... ......+.+...
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHH
Confidence 21 1123467889999998766 5689999999999999999999998864321 011111111000
Q ss_pred ---cCCccccc-CCCCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 759 ---EGKAMELV-DPNIRDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 759 ---~~~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
.....+++ ........+ ......+.+++.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000001111 1123578889999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=289.71 Aligned_cols=243 Identities=28% Similarity=0.428 Sum_probs=189.9
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
|...++||+|+||+||+|+.. +++.|++|++..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999754 688999999865322 2345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+.+ ++..++.. ....+++.++..++.||+.+|.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 964 56565532 2345899999999999999999999998 9999999999999999999999999986431
Q ss_pred cccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
......|+..|+|||++. ...++.++||||||+++|||++|..|+.... ........... .. +.
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~-~~-----~~ 239 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQN-DS-----PT 239 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhc-CC-----CC
Confidence 122456888999999984 4568889999999999999999999875321 11111111111 11 11
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. .......+.+++.+|++.+|++||++.++++
T Consensus 240 ~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 LQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1112235788999999999999999999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=295.25 Aligned_cols=264 Identities=25% Similarity=0.281 Sum_probs=196.3
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 603 (854)
..++..++++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455667889999999999999999999974 468999999987532 22345678899999999999999999988643
Q ss_pred ------CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 604 ------EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 604 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
...+++++++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467788876 7788777632 34889999999999999999999998 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
|+|||++..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+..... ......+...
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~ 233 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRL 233 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence 999999875421 2233567889999998866 5688999999999999999999999853221 1111111110
Q ss_pred hhc-----------CCcccc---cCCCCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 WNE-----------GKAMEL---VDPNIRDSS---SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ~~~-----------~~~~~~---~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...... +........ .......+.+++.+|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000 000000 000000000 0012346789999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=284.22 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=196.3
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999865 48999999997653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
+ ++|.+++.... ..+++..+..++.++++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988885432 35899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc------ccc-
Q 003045 694 ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA------MEL- 765 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------~~~- 765 (854)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ......+......... ..+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 12223457789999998776 789999999999999999999888754221 1111111111100000 000
Q ss_pred -cC---CCCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 -VD---PNIRD----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 -~d---~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+ +.... .........+.+++.+|++.+|++||++.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 00000 000112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=295.74 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=192.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC---------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--------- 603 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------- 603 (854)
..+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367888999999999999999754 6889999999776666677889999999999999999999876544
Q ss_pred -----CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCce
Q 003045 604 -----EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPK 677 (854)
Q Consensus 604 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 677 (854)
...++||||++ ++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47877763 235889999999999999999999998 99999999999997 456789
Q ss_pred ecccCcceeccCccCc-ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 678 ISDFGMARIFGFNQNE-ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 678 l~DFGla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
|+|||++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 9999999865322111 11123457889999998654 56888999999999999999999998633210 000000000
Q ss_pred Hhh-----cCCc-----ccccCCCCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 756 LWN-----EGKA-----MELVDPNIRDSS-----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 756 ~~~-----~~~~-----~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .... ............ .......+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000 000000000000 0112346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=290.79 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=197.4
Q ss_pred HHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-- 604 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-- 604 (854)
+....++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 444678899999999999999999974 468999999986432 223456889999999999999999999987653
Q ss_pred ----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecc
Q 003045 605 ----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISD 680 (854)
Q Consensus 605 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 680 (854)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 458999998 678887763 235889999999999999999999988 99999999999999999999999
Q ss_pred cCcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHH------
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV------ 753 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~------ 753 (854)
||++..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|+...... ..+....
T Consensus 162 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~ 235 (343)
T cd07880 162 FGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTP 235 (343)
T ss_pred ccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence 999986532 1223467889999999876 45889999999999999999999998643210 0111100
Q ss_pred ----HHHhhcCCcccccC--CCCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 754 ----WNLWNEGKAMELVD--PNIRD----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 754 ----~~~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
...+........+. +.... .........+.+++.+|++.||++|||+.+++. .++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000000000 00000 000112235788999999999999999999995 44544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=289.82 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=192.2
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
+.|...+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|++++++++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666789999999999999764 5788999998643 2233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+. +++..++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9997 5676665432 235889999999999999999999988 99999999999999999999999999876531
Q ss_pred cCcccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+..... ....... .....
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~-~~~~~----- 231 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHI-AQNES----- 231 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HHHHHHH-hhcCC-----
Confidence 12346788999999974 35688899999999999999999998753211 0111111 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
+... .......+.+++.+||+.+|++||++.+|+...
T Consensus 232 ~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111 112334678899999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=293.26 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=194.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 604 (854)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478888999999999999999754 68999999986532 223456889999999999999999999987543
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++|+||+.. +|..+. ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 565544 124889999999999999999999998 999999999999999999999999998
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh-----
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN----- 758 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~----- 758 (854)
+.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 75421 1223467889999999876 4688999999999999999999999864211 111111111000
Q ss_pred ------cCCcccccC--CCC-CCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhccCC
Q 003045 759 ------EGKAMELVD--PNI-RDSS---SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESETP 812 (854)
Q Consensus 759 ------~~~~~~~~d--~~l-~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~~~ 812 (854)
.......+. +.. .... .......+.+++.+||+.||++||+++|++. .++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000 000 0000 0012245789999999999999999999996 4666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=282.85 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=193.5
Q ss_pred CcccCcccccCCcccEEEeEcCC-CcEEEEEEeccc-----cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK-----SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999997643 444555555432 122344577899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
|||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23356899999999999999999999988 999999999999975 569999999998653
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.. ........|+..|+|||.+.+..++.++|+||||+++|+|++|..|+... .......... .+. .+
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~-~~~-----~~ 223 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIV-EGP-----TP 223 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHH-cCC-----CC
Confidence 22 12223456788999999998888999999999999999999999998531 1122211111 111 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .+......+.+++.+|++.+|++||++.|+++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 12233457888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=266.18 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=192.2
Q ss_pred cCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 539 EGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
....||.|.-|+|++++.+ .|..+|||.+.+.. .+..+.+...++++.+.+ +|.||+.+|||......++.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3457999999999999865 48899999998764 344567788888887776 89999999999999999999999854
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
.++.++.. -..++++..+-++...+++||.||.+.. .|+|||+||+|||+|+.|++||+|||++-++- ....
T Consensus 176 -C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dSkA 247 (391)
T KOG0983|consen 176 -CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKA 247 (391)
T ss_pred -HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee---cccc
Confidence 34555533 2345888888899999999999998764 59999999999999999999999999998763 2233
Q ss_pred ccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.++..|-+.|||||.+.- ..|+.++|||||||.|+||.||+.|+.....+-. ... ...+++ -|.+..
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~lt---kvln~e------PP~L~~ 317 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLT---KVLNEE------PPLLPG 317 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHH---HHHhcC------CCCCCc
Confidence 445678999999999864 4688999999999999999999999875332211 111 112211 122222
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. .....+.+++..||++|+.+||...++++
T Consensus 318 ~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 13457888999999999999999999887
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=269.24 Aligned_cols=271 Identities=22% Similarity=0.311 Sum_probs=196.5
Q ss_pred HhcCcccCcccccCCcccEEEeEcC---C--CcEEEEEEecccccc--CHHHHHHHHHHHHhcCCCceeeeeeeEEe-CC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP---E--GQDIAVKRLSRKSGQ--GLEEFKNEIILIAKLQHRNLVRLLGCCIQ-GE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~ 604 (854)
.-..|+...+||+|.||.||+|.-. + .+.+|+|+++..... .-....+|+.+++.++|||++.|..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456888899999999999999422 2 337899999765322 23467899999999999999999999988 77
Q ss_pred eeEEEEEcCCCCChhhhhcC-cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC----CCceec
Q 003045 605 EKMLIYEYMPNKSLDLFIFD-PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED----MNPKIS 679 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~ 679 (854)
..+|++||.+...+.-.-+. ..+...++-..+..|+.||+.|+.|||+.- |+||||||.||||..+ |.|||+
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 89999999988544333222 233356888999999999999999999987 9999999999999877 899999
Q ss_pred ccCcceeccCccCcc-cccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcc---cC----chHH
Q 003045 680 DFGMARIFGFNQNEA-NTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLE---EN----SSLI 750 (854)
Q Consensus 680 DFGla~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~---~~----~~l~ 750 (854)
|||+++.+...-... ....++-|..|+|||.+.+. .|+.+.|||+.|||+.||++-.+.|.-... .. .+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999986443222 44557779999999998875 699999999999999999998877643221 11 1122
Q ss_pred HHHHHHhhcCCcccccCCCCCC------------CCCHH-----------HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 751 EHVWNLWNEGKAMELVDPNIRD------------SSSQN-----------QVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~------------~~~~~-----------~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
..+.+.+.......+.+-.-.. .+... ......+++.++|+.||-+|.|+++.++-
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 2333333222111111100000 00000 01125678889999999999999998873
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=268.14 Aligned_cols=271 Identities=22% Similarity=0.210 Sum_probs=204.6
Q ss_pred HhcCccc-CcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe----CCe
Q 003045 533 ATNYFSE-GNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ----GEE 605 (854)
Q Consensus 533 ~~~~f~~-~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~ 605 (854)
.++.|.+ -++||-|--|.|-.+.. .+++++|+|++.. ....++|+++.-+. .|||||+++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3455544 36899999999999865 4689999999854 24567889887776 49999999998864 356
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccC
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFG 682 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFG 682 (854)
+.+|||.|+||.|...+.+.. ...+.+.++..|++||+.|+.|||..+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999999886543 345899999999999999999999998 999999999999974 4569999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
+|+.- .........+-|+.|.|||++...+|+..+|+||+||++|-||+|.+||..... ..+..-.+..+..+..
T Consensus 210 FAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccCc
Confidence 99964 233445567889999999999999999999999999999999999999864322 2222222222222221
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCCCCCCcccc
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTS 824 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~p~~~~~~~ 824 (854)
++.+++ =....+...+++...|..+|.+|.|+.|++..- =+.....+|..|..++
T Consensus 285 -~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp-wi~~~~~vp~tpl~t~ 339 (400)
T KOG0604|consen 285 -EFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP-WINQYEAVPQTPLSTS 339 (400)
T ss_pred -cCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc-hhcccccCCCCCchhh
Confidence 111111 123345677889999999999999999998721 1223445666665544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=271.64 Aligned_cols=242 Identities=22% Similarity=0.264 Sum_probs=195.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHH---HHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLE---EFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~---~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.-++|...++||+|.||.|.+++.+ .++.+|+|++++.-.-..+ .-..|-++|+..+||.+..|-..|...++.++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999754 6899999999876433333 34568899999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||..+|.|.-+|. ....+++.....+...|+.||.|||+.+ ||.||||.+|.|+|.+|.+||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-
Confidence 999999999988883 4456888888889999999999999988 999999999999999999999999999853
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
-.....+...+||+.|+|||++....|..+.|-|.+||++|||++|+.||..... ..+.+.+. . .
T Consensus 319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl----~--------e 383 (516)
T KOG0690|consen 319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELIL----M--------E 383 (516)
T ss_pred -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHH----h--------h
Confidence 1233455679999999999999999999999999999999999999999974321 22333221 0 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRP 798 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 798 (854)
.+ .++.....+...++.-.|.+||.+|.
T Consensus 384 d~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 DL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11 11222223556677778899999997
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=286.11 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=189.8
Q ss_pred CcccCcccccCCcccEEEeEcC-C--CcEEEEEEecccc--ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC----Ce
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-E--GQDIAVKRLSRKS--GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG----EE 605 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~ 605 (854)
+|++.+.||+|+||.||+++.. . ++.+|+|++.... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999754 3 7789999986432 22345678899999999 599999999876433 45
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++++||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 57877774 3345889999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccC--cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh-----
Q 003045 686 IFGFNQN--EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW----- 757 (854)
Q Consensus 686 ~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~----- 757 (854)
.+..... ........|+..|+|||++.+ ..++.++||||+|+++|+|++|+.|+..... ......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HHHHHHHHHHhCCCCH
Confidence 7642211 111234578999999998765 4689999999999999999999988764221 01111110000
Q ss_pred ------hcCCcccc---cC--CCC-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 ------NEGKAMEL---VD--PNI-RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ------~~~~~~~~---~d--~~l-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........ .. +.. ...........+.+++.+|++.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00 000 00000112346788999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=287.09 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=192.4
Q ss_pred CcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 540 GNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
.+.||+|.||+||-|+. ++|+.||||++.+. ......++++|+.||++++||.||.+.-.|+..+..++|||.+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999975 47999999999764 3445678999999999999999999999999999999999999766
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC---CCceecccCcceeccCccCc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED---MNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 693 (854)
-|+-.|..+ .+.|++.....++.||+.||.|||..+ |+|+||||+|||+... -++||+|||+|+.++. .
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---k 720 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---K 720 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---h
Confidence 665555432 345888888889999999999999998 9999999999999644 4799999999999853 2
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......+||+.|+|||++.++.|...-|+||.|||+|--|+|..||... +++.+.+.+ ... ...+..-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQN----AaF--MyPp~PW-- 788 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQN----AAF--MYPPNPW-- 788 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhc----ccc--ccCCCch--
Confidence 2344589999999999999999999999999999999999999998632 233333211 111 1111111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl 804 (854)
.+.....++++...|+..-++|-|..+-+
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 12334567778888888888888876544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=290.31 Aligned_cols=258 Identities=25% Similarity=0.316 Sum_probs=194.5
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe----
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE---- 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---- 605 (854)
..++|.+.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578889999999999999999765 5789999998653 22234567789999999999999999998876654
Q ss_pred --eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 606 --KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 606 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688887742 45899999999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc---
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE--- 759 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~--- 759 (854)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ......+......
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCH
Confidence 9865321 223467888999998865 4688999999999999999999999863221 1111111111000
Q ss_pred --------CCcccccCCCC-C--CC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 --------GKAMELVDPNI-R--DS---SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 --------~~~~~~~d~~l-~--~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.....++.... . .. ........+.+++.+|++.+|++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 0 00 00112457889999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=272.84 Aligned_cols=236 Identities=27% Similarity=0.327 Sum_probs=191.4
Q ss_pred cccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 543 LGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999765 588999999876432 2456789999999999999999999999999999999999999999
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccc
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 698 (854)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998432 35899999999999999999999988 9999999999999999999999999998753221 22334
Q ss_pred cccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 699 ~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.|+..... ......+ . .. .. ..+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~---~-~~------~~----~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI---L-KD------PL----RFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---h-cC------CC----CCCCCC
Confidence 5678899999999888899999999999999999999999863221 1111111 1 10 01 111112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRPTMAS 802 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs~~e 802 (854)
...+.+++.+|+..||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 457788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.70 Aligned_cols=258 Identities=26% Similarity=0.319 Sum_probs=195.3
Q ss_pred HhcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccc-------cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK-------SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG- 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~- 603 (854)
..++|-..++||+|||+.||+|. +.+.+.||||+-..+ .....+...+|.+|.+.|+||.||++++++.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34667778899999999999994 556788999976433 122344567899999999999999999999755
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISD 680 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~D 680 (854)
+..+-|.||+++.+|+-+|. ....+++.++..|+.||+.||.||.+.. +||||-||||.||||.+ .|.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 45778999999999999994 4456899999999999999999999876 78999999999999964 57899999
Q ss_pred cCcceeccCccCc-----ccccccccccccccceeecc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHH
Q 003045 681 FGMARIFGFNQNE-----ANTNRVVGTYGYMAPEYAME----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751 (854)
Q Consensus 681 FGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~ 751 (854)
||+++++..+... ..+....||..|++||.+.- .+++.|.||||.|||+|..+.|+.||.-.....+-+.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999988543322 23455789999999998853 35888999999999999999999999743222111111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003045 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 752 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl 804 (854)
. .++..-.+.....|. ...+...++.+||++.-++|-...++.
T Consensus 697 N--TIlkAtEVqFP~KPv--------VsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N--TILKATEVQFPPKPV--------VSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h--chhcceeccCCCCCc--------cCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 011111111111221 123566788899999999998766654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=306.75 Aligned_cols=145 Identities=26% Similarity=0.383 Sum_probs=129.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.++||+|+||.||+|... +++.||||++.... ....+.+..|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999765 68999999987542 223467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
||+++++|..++.. ...+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 235788999999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=290.62 Aligned_cols=240 Identities=23% Similarity=0.265 Sum_probs=193.2
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++.|.....+|.|+|+.|-++.. .+++..++|++.+.. .+-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356777888899999999999864 468899999997652 2335677666666 6999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE-ccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL-DEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~ 689 (854)
|.+.++-+.+.+.... ....++..|+.+|+.++.|||.++ +|||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877764322 223777889999999999999998 9999999999999 5889999999999987642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
. ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ ..+...+..+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~--------- 529 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMP--------- 529 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCC---------
Confidence 2 33456688999999999999999999999999999999999998754332 1122222222
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+........+++.+||+.||.+||+|.++..
T Consensus 530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 222344457788999999999999999999987
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=303.05 Aligned_cols=261 Identities=28% Similarity=0.399 Sum_probs=204.6
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC--------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCI 601 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 601 (854)
...++..+.+.||+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34455566679999999999999632 14579999997653 34567899999999999 5999999999999
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCcc-------c----c--cCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcE
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPA-------K----Q--ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 668 (854)
..+..++|.||++.|+|..+++..+ . . ..+...+.+.++.|||.||+||++.. +|||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999997654 0 0 23889999999999999999999987 99999999999
Q ss_pred EEccCCCceecccCcceeccCccCcccccccc--cccccccceeeccCCCCcccchhhHHHHHHHHHhC-CCCCCCCccc
Q 003045 669 LLDEDMNPKISDFGMARIFGFNQNEANTNRVV--GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG-RRNTSFRLEE 745 (854)
Q Consensus 669 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG-~~p~~~~~~~ 745 (854)
|+.++..+||+|||+|+........... ... -...|||||.+....|+.|+|||||||+||||+|. ..|++. ...
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~~ 527 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IPP 527 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CCc
Confidence 9999999999999999965322221111 111 23459999999999999999999999999999994 445542 111
Q ss_pred CchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 746 NSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..++.+ .+.++.. .+.+..+..++.+++..|++.+|++||+..|+++.++..
T Consensus 528 ~~~l~~----~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEELLE----FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHH----HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 222322 2223222 223334456788999999999999999999999999885
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=268.57 Aligned_cols=220 Identities=20% Similarity=0.130 Sum_probs=174.6
Q ss_pred CCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcC
Q 003045 546 GGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD 624 (854)
Q Consensus 546 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 624 (854)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999764 68899999986542 234555666667799999999999999999999999999999998843
Q ss_pred cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccc
Q 003045 625 PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704 (854)
Q Consensus 625 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 704 (854)
...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 234899999999999999999999988 999999999999999999999999988755321 122345678
Q ss_pred cccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 003045 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIH 784 (854)
Q Consensus 705 Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 784 (854)
|+|||.+....++.++||||+|+++|||++|+.|+...... ... ..... .+......+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~~-----~~~~~----~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------INT-----HTTLN----IPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------ccc-----ccccC----CcccCCHHHHH
Confidence 99999998888999999999999999999999775421110 000 00001 11122346788
Q ss_pred HHhhccCCCCCCCCCHH
Q 003045 785 VGMLCVQDSAMYRPTMA 801 (854)
Q Consensus 785 l~~~Cl~~dp~~RPs~~ 801 (854)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=266.70 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=193.7
Q ss_pred cccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 537 FSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
......||.|.||+|+|-.+ +.|+.+|||+++... +.+..++..|.+...+- +.||||+++|.+..++..++.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 33456899999999999865 469999999997653 35567788888865554 6999999999999999999999999
Q ss_pred CCCChhhhhcC--cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 614 PNKSLDLFIFD--PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 614 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
+ .||+.+-.. ..+...+++.-.-+|....++||.||.+.- .|||||+||+|||++..|.+||+|||++-.+-
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--- 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--- 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH---
Confidence 5 456554321 123345888888899999999999998764 69999999999999999999999999987652
Q ss_pred Ccccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.....+...|-..|||||.+.. ..|..++||||||++|||+.||+.|+.... ++.+.+.... .+....+..+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----svfeql~~Vv-~gdpp~l~~~- 293 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----SVFEQLCQVV-IGDPPILLFD- 293 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----HHHHHHHHHH-cCCCCeecCc-
Confidence 2233445678889999999864 348999999999999999999999986432 2333332222 2222222111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+..++..|+.+|..+||...++.+
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 112334567899999999999999999998876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=300.92 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=207.1
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ 602 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 602 (854)
..++....++|++.++||+|+||.|..++.+ .++.+|.|++.+- ......-|..|-.+|..-+.+=|+++...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455566788999999999999999999875 5788999999763 23445678899999999999999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
..++|+|||||+||+|-.++. +...+++.-+..++..|+-||.-||+.| +|||||||+|||||..|.+||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999984 3336889988899999999999999999 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeec----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAM----E-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
.+-.+.. +........+|||.|++||++. + +.|+..+|-||+||++|||+.|.-||.. +.+.+-..+++
T Consensus 221 sClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-----dslveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-----DSLVETYGKIM 294 (1317)
T ss_pred hHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-----HHHHHHHHHHh
Confidence 9987753 2334455679999999999995 3 6799999999999999999999999863 34555544555
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT---MASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~eVl~ 805 (854)
+.+....+.+... ......++|.+.+ .+|+.|.. +.++-.
T Consensus 295 ~hk~~l~FP~~~~-------VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFPDETD-------VSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCCcccc-------cCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 5444444432211 2234455555544 46788887 777765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=269.79 Aligned_cols=242 Identities=25% Similarity=0.316 Sum_probs=195.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 608 (854)
...|....+||+|+||.|-+|..+ +.+.+|||++++.- ..+.+--..|-++|+.. +-|.++++..+|...+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 356778899999999999999654 46779999997652 22333445677777776 46889999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+.+|+|-.++. +-+.+.+..+..++..||-||-+||+.+ ||.||||.+||||+.+|.+||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn- 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN- 500 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc-
Confidence 999999999987774 3445778888999999999999999999 999999999999999999999999999853
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
-.....+...+||+.|+|||++...+|+..+|-|||||+||||+.|++||+.+ ++.++...+.+ .
T Consensus 501 -i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~e------------h 565 (683)
T KOG0696|consen 501 -IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIME------------H 565 (683)
T ss_pred -ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHH------------c
Confidence 23345566799999999999999999999999999999999999999999743 33344444321 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT 799 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 799 (854)
. -.++.....+.+.++...|...|.+|..
T Consensus 566 n--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 N--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred c--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1 1234444556677777888889998863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=236.87 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=191.3
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+|...++||+|.||+||+|+.. +++.||+|+.+.. ++.-.....+||-+++.++|.|||++++....++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999765 4788999998654 333456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+.. .|..+.. .-.+.++...+..++.|+++||.++|++. +.||||||+|.|++.+|+.|++|||+++.++....
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 4444432 23345888889999999999999999998 99999999999999999999999999998864322
Q ss_pred cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh---cCCcc---cc
Q 003045 693 EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN---EGKAM---EL 765 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~~~---~~ 765 (854)
-. ...+-|..|++|+++.+. .|+...|+||.|||+.|+....+|.....+..+++ ..+..... ++... .+
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql-krif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH-HHHHHHhCCCccccCCccccC
Confidence 11 123558899999999875 58999999999999999988666643322222333 33333332 22221 22
Q ss_pred cCCCCCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQ---------NQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~---------~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.|-.....++. ....+=.+++.+.+..+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22222221111 11112235555677789999999988765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=293.33 Aligned_cols=259 Identities=20% Similarity=0.214 Sum_probs=166.9
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-C----CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeee------EE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-E----GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC------CI 601 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------~~ 601 (854)
..++|...++||+|+||.||+|++. + +..||+|++..... .+...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999764 4 68999998764321 1111111 1122222222222211 24
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCcccc-----------------cCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccC
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQ-----------------ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 664 (854)
.....++||||+++++|.+++...... .......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999888542110 01123345679999999999999988 9999999
Q ss_pred CCcEEEcc-CCCceecccCcceeccCccCcccccccccccccccceeeccC----------------------CCCcccc
Q 003045 665 ASNILLDE-DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG----------------------LFSVKSD 721 (854)
Q Consensus 665 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~~~D 721 (854)
|+|||+++ ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998653222 1223446789999999965322 2445679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC----cccccCCCCCCC----C--CHHHHHHHHHHHhhccC
Q 003045 722 VYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK----AMELVDPNIRDS----S--SQNQVLRCIHVGMLCVQ 791 (854)
Q Consensus 722 VwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~l~~l~~~Cl~ 791 (854)
||||||+||||+++..+.... +..........+. ....+.+..... . .........+++.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999976554311 1111100000000 000111110000 0 00011234579999999
Q ss_pred CCCCCCCCHHHHHH
Q 003045 792 DSAMYRPTMASVVL 805 (854)
Q Consensus 792 ~dp~~RPs~~eVl~ 805 (854)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=261.70 Aligned_cols=238 Identities=28% Similarity=0.340 Sum_probs=192.3
Q ss_pred CcccEEEeEcC-CCcEEEEEEeccccccC-HHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcC
Q 003045 547 GFGPVHKGKLP-EGQDIAVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD 624 (854)
Q Consensus 547 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 624 (854)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48999999997665444 78899999999999999999999999999999999999999999998854
Q ss_pred cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccc
Q 003045 625 PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704 (854)
Q Consensus 625 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 704 (854)
.. .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2889999999999999999999998 9999999999999999999999999998764321 2334567889
Q ss_pred cccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 003045 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIH 784 (854)
Q Consensus 705 Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 784 (854)
|+|||.+.+..++.++||||||+++++|++|..|+.... ......+.. ........ .........+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~----~~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKI----GKPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHH----hccCCCCc-------cccccCCHHHHH
Confidence 999999998889999999999999999999998876421 111111211 11111100 000002357888
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 003045 785 VGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 785 l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=265.85 Aligned_cols=266 Identities=19% Similarity=0.205 Sum_probs=201.8
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCC--C----ceeeeeee
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH--R----NLVRLLGC 599 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~----niv~l~~~ 599 (854)
++.....+++|.+...+|+|.||.|-..... .+..||||+++.- ....+..+-|+++|+++.+ | -+|.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3444455899999999999999999998543 4788999998643 3445667889999999942 3 37888899
Q ss_pred EEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc--------
Q 003045 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-------- 671 (854)
Q Consensus 600 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-------- 671 (854)
|.-.++.++|+|.+ +-|+.+++..+ +..+++...+..++.|+++++++||+.. ++|-||||+|||+.
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 99999999999998 45788888543 3346888999999999999999999998 99999999999994
Q ss_pred ------------cCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 672 ------------EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 672 ------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
++..+||+|||.|..-. .....++.|..|+|||++.+-.++..+||||+||||+||.+|...|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 13358999999998642 2235678899999999999999999999999999999999999877
Q ss_pred CCCcccCchHHHHHHHHh-----------------hcCCcc-----------cccCCC----CCCCCCHHHHHHHHHHHh
Q 003045 740 SFRLEENSSLIEHVWNLW-----------------NEGKAM-----------ELVDPN----IRDSSSQNQVLRCIHVGM 787 (854)
Q Consensus 740 ~~~~~~~~~l~~~~~~~~-----------------~~~~~~-----------~~~d~~----l~~~~~~~~~~~l~~l~~ 787 (854)
....+. +.+ ....+.. ..+++. ...++- ........+..++.+++.
T Consensus 310 qtHen~-EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 310 QTHENL-EHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ccCCcH-HHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 643311 111 1111111 111110 000000 011233467778999999
Q ss_pred hccCCCCCCCCCHHHHHH
Q 003045 788 LCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 788 ~Cl~~dp~~RPs~~eVl~ 805 (854)
.||..||.+|+|+.|+++
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=282.40 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=178.8
Q ss_pred HhcCcccCcccccCCcccEEEeEc-----------------CCCcEEEEEEeccccccCHHH--------------HHHH
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-----------------PEGQDIAVKRLSRKSGQGLEE--------------FKNE 581 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E 581 (854)
..++|++.++||+|+||+||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999953 235689999986543222223 3457
Q ss_pred HHHHHhcCCCce-----eeeeeeEEe--------CCeeEEEEEcCCCCChhhhhcCccc---------------------
Q 003045 582 IILIAKLQHRNL-----VRLLGCCIQ--------GEEKMLIYEYMPNKSLDLFIFDPAK--------------------- 627 (854)
Q Consensus 582 i~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 627 (854)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888877654 677777753 3568999999999999998864211
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccccccccccccccc
Q 003045 628 QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707 (854)
Q Consensus 628 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 707 (854)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++....... ........+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence 123567788899999999999999988 9999999999999999999999999997643211 111112334789999
Q ss_pred ceeeccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCcccCchHHH-----HHHHHhhc
Q 003045 708 PEYAMEGL--------------------F--SVKSDVYSFGVLLLEIVSGRR-NTSFRLEENSSLIE-----HVWNLWNE 759 (854)
Q Consensus 708 PE~~~~~~--------------------~--s~~~DVwSlGvil~elltG~~-p~~~~~~~~~~l~~-----~~~~~~~~ 759 (854)
||.+.... | ..+.||||+||++|+|++|.. |+.........+.. ..|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99885432 1 234799999999999999875 44321100001100 01111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 003045 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSA---MYRPTMASVVL 805 (854)
Q Consensus 760 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPs~~eVl~ 805 (854)
... +-.. .........+++.++|..+| .+|+|++|+++
T Consensus 459 ~~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111 1111 11123456778888888765 78999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=281.47 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=212.8
Q ss_pred eeHHHHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 003045 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ 602 (854)
Q Consensus 525 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 602 (854)
..++.+...++.|++.+.||.|.+|.||+++. ++++.+|+|++... ....+++..|+++|+.+ +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34455556678899999999999999999975 46888999988654 34457788999999998 59999999999864
Q ss_pred -----CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 603 -----GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 603 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
+++++||||||.+|+..+++..-. ...+.|..+..|++.++.||.+||... ++|||||=.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 468999999999999999986644 566899999999999999999999988 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEH 752 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~ 752 (854)
|+|||.+..+. .+....+...||+.|||||++.- ..|+..+|+||||++..||--|.+|......-
T Consensus 164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------- 234 (953)
T KOG0587|consen 164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------- 234 (953)
T ss_pred Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence 99999998774 33445566899999999999963 34788999999999999999999886522110
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 753 VWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 753 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..++ .-.-+|......+..-.+++.+++..||.+|-++||++.++++
T Consensus 235 -raLF-----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 -RALF-----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hhhc-----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0000 1112344444456677789999999999999999999999886
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=259.94 Aligned_cols=265 Identities=22% Similarity=0.314 Sum_probs=205.5
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeee
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGC 599 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 599 (854)
..++..-..+++....+-+|.||.||+|.+. +.+.|-+|.++... .-....+..|--++..+.|||++.+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455566677888889999999999999543 34567778776543 2345667889999999999999999999
Q ss_pred EEeC-CeeEEEEEcCCCCChhhhhc-----CcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC
Q 003045 600 CIQG-EEKMLIYEYMPNKSLDLFIF-----DPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED 673 (854)
Q Consensus 600 ~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 673 (854)
+.+. +..+.+|.++.-|+|..||. +......+...+...++.|++.||+|||+++ +||.||..+|.++++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 46788999999999999997 4444456788888999999999999999999 9999999999999999
Q ss_pred CCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHH
Q 003045 674 MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEH 752 (854)
Q Consensus 674 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~ 752 (854)
.++||+|=.+++.+-..+....-...-....||+||.+.+..|+.++|||||||++|||+| |+.|+..- ++.+....
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--DPfEm~~y 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--DPFEMEHY 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--CHHHHHHH
Confidence 9999999999886532233322223344678999999999999999999999999999988 66665421 11112222
Q ss_pred HHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 753 VWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 753 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
+ ..+ .+-..+.++++++..++.-||...|++||+.+|++.-|.+
T Consensus 511 l----kdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 L----KDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred H----hcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 111 1112233456788999999999999999999999998865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=252.17 Aligned_cols=263 Identities=21% Similarity=0.346 Sum_probs=188.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--------C
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--------G 603 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~ 603 (854)
..|+...+||+|.||.||+|+.+ +|+.||+|+.-.. .+.-.....+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34556679999999999999765 4788899876432 22223455789999999999999999988753 2
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...++||.+++. +|.-+|.+. ...++..++.++++++..||.|+|... |+|||+|++|+|++.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999986 344555332 234788899999999999999999988 99999999999999999999999999
Q ss_pred ceeccCccCccc--ccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc-
Q 003045 684 ARIFGFNQNEAN--TNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE- 759 (854)
Q Consensus 684 a~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~- 759 (854)
++.+........ -+..+-|..|++||.+.+ ..|+++.|||..|||+.||+++.+-+.... +......+..+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccC
Confidence 987753322222 223455899999999876 569999999999999999999987765322 22222222222211
Q ss_pred --CCccc--------cc--CCCCCCCC--CHHHH------HHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 --GKAME--------LV--DPNIRDSS--SQNQV------LRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 --~~~~~--------~~--d~~l~~~~--~~~~~------~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+...+ -+ .|...+.. -.+.+ ...++++.+++..||.+|+.+.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111 11 11000000 01111 25678888999999999999998875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.16 Aligned_cols=248 Identities=23% Similarity=0.268 Sum_probs=199.9
Q ss_pred cCcccCcccccCCcccEEEeEcCCCc-EEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQ-DIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++.....||-||||.|=+...+... .+|+|++++. .....+.+..|-++|...+.|.||+++..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34445567999999999998765433 4888888765 2334566788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
|-|-+|.|-..|+ .++.++......++..+.+|++|||..+ ||.|||||+|.|++.+|-+||.|||+|+.++
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-- 571 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-- 571 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence 9999999999995 4455888888889999999999999998 9999999999999999999999999999875
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
....+.+.+||+.|.|||++.++..+.++|.||||+++|||++|.+||..... ...+..+.+- +|
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn~ILkG---------id--- 636 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYNLILKG---------ID--- 636 (732)
T ss_pred -cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHhh---------hh---
Confidence 33456779999999999999999999999999999999999999999974321 1122222110 01
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.-..+........+++.+.+..+|.+|.. +.||-.
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 01223344456778888889999999986 566654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=281.72 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=188.2
Q ss_pred CcccCcccccCCccc-EEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcC
Q 003045 536 YFSEGNKLGRGGFGP-VHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
-|...+.+|.|+-|+ ||+|.. +|+.||||++-. ...+...+||..|+.-+ |||||++++.-.+....|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899999886 799998 788999998854 33446689999999984 999999999988889999999999
Q ss_pred CCCChhhhhcCccc-ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---C--CCceecccCcceec
Q 003045 614 PNKSLDLFIFDPAK-QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---D--MNPKISDFGMARIF 687 (854)
Q Consensus 614 ~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~~kl~DFGla~~~ 687 (854)
..+|++++..... .....-...+.+..|+++||++||+.+ ||||||||+||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 4689998865311 111111445778899999999999987 999999999999976 2 46999999999998
Q ss_pred cCccCccc-ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhC-CCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 688 GFNQNEAN-TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG-RRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 688 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
........ .....||.+|+|||++....-+.++||||+||++|+.++| .+||......+.++.. ...-...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceee
Confidence 65544332 4457899999999999999889999999999999999997 8898743222111111 1100001
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+ ..+. ...+++.+|+.++|..||++.+|+.
T Consensus 735 L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 1111 6778999999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=266.59 Aligned_cols=239 Identities=21% Similarity=0.307 Sum_probs=186.6
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
...-|-..+.||-|+||.|.++.. ++...+|.|.+++.+. ......+.|-+||...+.+=||+|+..|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 335577788999999999999954 4466789999977543 334457889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||+|+++|++-.+|. +.+.+++..+..++..+..|+++.|+.| +|||||||+|||||.+|.+||+|||++.-+.
T Consensus 707 VMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999998884 3456788888888889999999999998 9999999999999999999999999987542
Q ss_pred CccC--------c--------------------------------ccccccccccccccceeeccCCCCcccchhhHHHH
Q 003045 689 FNQN--------E--------------------------------ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVL 728 (854)
Q Consensus 689 ~~~~--------~--------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvi 728 (854)
.... . ......+||+.|+|||++....|+..+|-||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 0 00012569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHH
Q 003045 729 LLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHV 785 (854)
Q Consensus 729 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 785 (854)
||||+.|+.||-.....+..... ..+...++-......+.+...-+.+|
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv--------~nw~~~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKV--------INWRNFLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeee--------eehhhccccccccccCHHHHHHHHHH
Confidence 99999999999754332211111 12233444445555666655555553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=235.04 Aligned_cols=210 Identities=28% Similarity=0.353 Sum_probs=170.6
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCe
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 605 (854)
.++...+.......||+|++|.|-+-++ .+|+..|+|++... ..+..++..+|+++..+. .+|.+|.++|.......
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3455556666678999999999988765 47999999999765 344556778888876665 69999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 606 KMLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
.++.||.|. .||+.+-..- .+...+++...-+|+..+.+||.|||++- .++|||+||+|||++.+|++|++|||++
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999995 4677665432 34556889999999999999999999874 6999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeecc----CCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE 744 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~~DVwSlGvil~elltG~~p~~~~~~ 744 (854)
-.+.. ....+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|++....
T Consensus 197 G~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 197 GYLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eeehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 87631 122233467788999998853 3689999999999999999999999875443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=243.84 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=195.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
+.|...++||+|+|+.|-+++++ +.+.+|+|++++. ..+.++-.+.|-.+..+. +||.+|.+..+|..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 67888999999999999999875 4778999998764 344566677777777766 699999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
.||+++|+|--++ .++..++++.+..+...|..||.|||+.+ ||.||||.+|||+|..|.+||+|+|+++.--
T Consensus 330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l- 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL- 402 (593)
T ss_pred EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-
Confidence 9999999986665 44556889888889999999999999999 9999999999999999999999999998532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc--cCchHHHHHHHHhhcCCcccccC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE--ENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.....+...+||+.|+|||++.+..|....|-|++||+++||+.|+.||+.-.. .+.+..+++...+-+
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------- 473 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------- 473 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------
Confidence 223345668999999999999999999999999999999999999999986442 222223333322222
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP 798 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 798 (854)
..++- +.....+...++..-|.+||.+|.
T Consensus 474 kqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 KQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 11211 112223455667778889998875
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=227.76 Aligned_cols=110 Identities=46% Similarity=0.825 Sum_probs=82.8
Q ss_pred CCceEEeecCCCCCCCC--CceEEEeccCCeEEEcCCCcEEEEe-cccccc-ccceeEeccCCceEEEcCCCcCCcccee
Q 003045 78 EKAVVWVANRNRPISDE--RGTLTIGNDGNLMVLNGNSIAVWSS-NASVVS-NNTAALLEDDGNLILTNSEDIGNLGKAY 153 (854)
Q Consensus 78 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~l~l~~~~~~~vW~t-~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~ 153 (854)
++|+||+|||++|+... ..+|.|+.||+|+|+++++.++|++ ++.+.+ ....|.|+|+|||||++.. +++|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEE
Confidence 36999999999999553 4799999999999999999999999 555544 5788999999999999965 7999
Q ss_pred eeeccCCCCCcCCCCeEeEEecCCCceeEEeccCCCCCC
Q 003045 154 WQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPS 192 (854)
Q Consensus 154 WqsFd~PTDtllpg~kl~~~~~~g~~~~L~sw~s~~dps 192 (854)
||||||||||+||||+|+.+..++.+..++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988887778899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=234.88 Aligned_cols=210 Identities=34% Similarity=0.541 Sum_probs=182.8
Q ss_pred cccCCcccEEEeEcCC-CcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhh
Q 003045 543 LGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL 620 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 620 (854)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 899999998765332 35779999999999999999999999999999999999999999999
Q ss_pred hhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCcceeccCccCccccccc
Q 003045 621 FIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGMARIFGFNQNEANTNRV 699 (854)
Q Consensus 621 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 699 (854)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985322 35889999999999999999999998 999999999999999 89999999999987642211 22335
Q ss_pred ccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHH
Q 003045 700 VGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778 (854)
Q Consensus 700 ~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 778 (854)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 888999999999999999
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467788999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=216.75 Aligned_cols=110 Identities=40% Similarity=0.935 Sum_probs=103.3
Q ss_pred EecCCCcceeeecccccccccccceeeeeccCCCCCceEEEEEecCCceEEEEEEeecCcEEEEEEcCCCCceEEEEecc
Q 003045 218 WRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQP 297 (854)
Q Consensus 218 w~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p 297 (854)
||+|+|||..|+|+|++... ..+.+.|+. ++++.+|+|...+.+.++|++|+++|+++++.|+++++.|.+.|++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~--~~~~~~fv~--~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p 76 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSN--SLYNYSFVS--NNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAP 76 (110)
T ss_pred CCccccCCeEECCccccccc--ceeEEEEEE--CCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEec
Confidence 89999999999999999866 566777776 88899999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCCCCCccccCCCCcccCCCCCCccCc
Q 003045 298 ADDCELYNFCGNFGICNALGSTKCTCMEGFVPKH 331 (854)
Q Consensus 298 ~~~Cd~~~~CG~~giC~~~~~~~C~C~~Gf~p~~ 331 (854)
.|+||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 77 ~d~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 77 KDQCDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred ccCCCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999999988889999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=228.85 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=193.7
Q ss_pred hcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC--eeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGE--EKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~~lV 609 (854)
.++|++.+++|+|.++.||.|. ..+.++++||+++.- ..+.+.+|+.+|+.|. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999996 457889999999753 3467899999999998 999999999987764 46799
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~~ 688 (854)
+||+.+.+...+- ..+....+..++.++++||.|+|+.| |.|||+||.||++|.. ..++|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876654 34677788889999999999999999 9999999999999965 569999999999864
Q ss_pred CccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc-----
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA----- 762 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~----- 762 (854)
... .-+-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||.-..+..+++..-+ ..+....+
T Consensus 185 p~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa-kVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA-KVLGTDELYAYLN 260 (338)
T ss_pred CCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH-HHhChHHHHHHHH
Confidence 221 1222456778899998865 5688999999999999999999999875544444444332 22211111
Q ss_pred --ccccCCCCCC---------------CCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 --MELVDPNIRD---------------SSSQN-QVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 --~~~~d~~l~~---------------~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.--+||...+ ..+.. ...+.++++.+.|..|-.+|||++|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0012221110 00111 1246778888999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=257.18 Aligned_cols=196 Identities=27% Similarity=0.379 Sum_probs=164.9
Q ss_pred cCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccc--------cCHHHHHHHHHHHHhcC---CCceeeeeeeEEe
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSG--------QGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQ 602 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 602 (854)
..|...++||+|+||.|+++.++. ...|+||.+.+... ...-.+-.||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 347788999999999999997654 56788998865421 11223567999999997 9999999999999
Q ss_pred CCeeEEEEEcCC-CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 603 GEEKMLIYEYMP-NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 603 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
.+.+||+||-.. +-+|.+++ ...+.+++.++..|++||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 44666666 33455899999999999999999999999 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcc-cchhhHHHHHHHHHhCCCCCC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVK-SDVYSFGVLLLEIVSGRRNTS 740 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-~DVwSlGvil~elltG~~p~~ 740 (854)
|.+... ........+||..|.|||++.+.+|--| -|||++|++||.++....|+.
T Consensus 715 gsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999754 3344556899999999999999887654 899999999999998777764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=242.52 Aligned_cols=133 Identities=27% Similarity=0.379 Sum_probs=107.5
Q ss_pred hcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-----C---CceeeeeeeEEe--
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-----H---RNLVRLLGCCIQ-- 602 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~~-- 602 (854)
..+|.+.++||.|.|++||++- ....+.||+|+.+.. ....+....||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3788899999999999999995 456788999998543 334566789999999984 3 369999999975
Q ss_pred --CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 603 --GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 603 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
+.+.+||+|++-...|..+.+... .-++...+..|++||+.||.|||..+ .|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 458999999995544444333322 34888999999999999999999987 699999999999994
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=237.69 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=186.0
Q ss_pred ccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----CeeEEE
Q 003045 538 SEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EEKMLI 609 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~lV 609 (854)
+..+.||.|+||+||..+.+ +|+.||+|++..- .-...+.+.+|+.+|..++|.|++..++...-. ++.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34579999999999999764 6999999998643 122346788999999999999999988765433 356778
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
.|.|.. +|...+. ....++-..+.-++.||++||.|||+.+ |.||||||.|.|++.|-..||+|||+++....
T Consensus 136 TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 888753 4555553 2334666777778999999999999998 99999999999999999999999999997543
Q ss_pred ccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc-----
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM----- 763 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~----- 763 (854)
.+.. ..+..+-|..|+|||++.+. .|+.+.||||.|||+.||+..+..|... ...+..+.+.+++......
T Consensus 209 d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq--~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 RDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA--GPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc--ChHHHHHHHHHHhCCCcHHHHHHH
Confidence 3322 33445668899999999864 6999999999999999999877655432 2222223332222221110
Q ss_pred ------ccc-----CCC---CCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 003045 764 ------ELV-----DPN---IRD-SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 764 ------~~~-----d~~---l~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L 807 (854)
-++ .|. +.. ..+...-.+.+.+..+++..||.+|.+..+.+.-+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000 111 110 11112233456677789999999999999988755
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-27 Score=248.89 Aligned_cols=272 Identities=19% Similarity=0.212 Sum_probs=206.2
Q ss_pred ceeHHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcC------CCceeee
Q 003045 524 MFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ------HRNLVRL 596 (854)
Q Consensus 524 ~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l 596 (854)
.|.+.-.+....+|.+....|+|-|++|-+|... .|+.||||++..+.. -.+.=+.|+++|++|+ .-|.+++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3566667788899999999999999999999754 488999999976532 2344468999999996 3489999
Q ss_pred eeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-C
Q 003045 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-N 675 (854)
Q Consensus 597 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~ 675 (854)
+-.|...++++||+|-+ .-+|.++|.......-|....+..++.|+.-||..|...+ |+|.||||+||||++.. .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 99999999999999987 4578888876666666888899999999999999999988 99999999999998764 5
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHH--
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV-- 753 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~-- 753 (854)
+||||||.|...+. ...+ .+.-+..|.|||++.+-.|+...|+||.||+||||.||+..|+..... ..|.-..
T Consensus 576 LKLCDfGSA~~~~e---neit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-~MLrl~me~ 650 (752)
T KOG0670|consen 576 LKLCDFGSASFASE---NEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-QMLRLFMEL 650 (752)
T ss_pred eeeccCcccccccc---cccc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH-HHHHHHHHh
Confidence 89999999987532 1222 233456799999999999999999999999999999999887643321 1111110
Q ss_pred -----HHHhhcCC---------------------------cccccCC------CC-----CCCCCHHHHHHHHHHHhhcc
Q 003045 754 -----WNLWNEGK---------------------------AMELVDP------NI-----RDSSSQNQVLRCIHVGMLCV 790 (854)
Q Consensus 754 -----~~~~~~~~---------------------------~~~~~d~------~l-----~~~~~~~~~~~l~~l~~~Cl 790 (854)
..++..+. ++..+.| .+ ...-....+..+.+|+.+|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 00111110 0111222 01 11223345677889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 003045 791 QDSAMYRPTMASVVL 805 (854)
Q Consensus 791 ~~dp~~RPs~~eVl~ 805 (854)
..||++|.|..|.|+
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=231.04 Aligned_cols=199 Identities=35% Similarity=0.460 Sum_probs=172.0
Q ss_pred cccCcccccCCcccEEEeEcCC-CcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
|+..+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998765 889999999865544 57789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999998853221 1789999999999999999999997 99999999999999999999999999987643321 1
Q ss_pred cccccccccccccceee-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYA-MEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~-~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678889999998 667788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=254.37 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=203.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|+....+|.|.||.|||++.. .++..|+|.++........-+++|+-+++..+|+||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888899999999999999754 6899999999888778888889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+.+|+|++.-+ ...++++.++..+.+..++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+-.++ ..
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--at 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--AT 165 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--hh
Confidence 99999988763 3456899999999999999999999998 8999999999999999999999999987764 23
Q ss_pred cccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
........||+.|||||+.. .+.|.+++|||++|+...|+---++|...... ..+..+... ...+|.
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTk----S~~qpp 235 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTK----SGFQPP 235 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhc----cCCCCC
Confidence 34445678999999999874 56799999999999999999776666431111 111111111 122222
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
-..+ ...-...+.+++..|+..+|.+||++..+++
T Consensus 236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1223456778899999999999999987765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=238.26 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=201.2
Q ss_pred HHHHhcCcccCcccccCCcccEEEeEcC----CCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGE 604 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 604 (854)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4456678889999999999999999653 46789999987653 3456899999999996 999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGM 683 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGl 683 (854)
...+|+||+++....++... ++..++..+++.+.+||.++|..| ||||||||+|+|.+. .+.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888742 668899999999999999999999 999999999999985 46789999999
Q ss_pred ceeccCcc-------------Cc-----------------------------ccccccccccccccceeeccC-CCCccc
Q 003045 684 ARIFGFNQ-------------NE-----------------------------ANTNRVVGTYGYMAPEYAMEG-LFSVKS 720 (854)
Q Consensus 684 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~~~ 720 (854)
|....... .. .......||++|+|||++... ..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321000 00 001124599999999998764 578899
Q ss_pred chhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH---------HhhcCC--ccc---------------ccC-CCCC--
Q 003045 721 DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN---------LWNEGK--AME---------------LVD-PNIR-- 771 (854)
Q Consensus 721 DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~---------~~~~~~--~~~---------------~~d-~~l~-- 771 (854)
||||.|||++-+++++.||....++...+.+.+.- ....+. +.+ -++ ..+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999997766555544443210 001111 000 010 0000
Q ss_pred -------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 -------DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 -------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.....-....+.+++.+|++.||.+|.|++|.|+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0111122346889999999999999999999886
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=202.77 Aligned_cols=115 Identities=44% Similarity=0.789 Sum_probs=103.3
Q ss_pred CccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCcEEEE
Q 003045 39 QSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWS 118 (854)
Q Consensus 39 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~vW~ 118 (854)
++|.+|++|+|++|.|++|||++..+...+++|||...+ .++||.||++.|. ...+.|.|+.||+|+|+|.+|.+||+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 578999999999999999999987665589999999876 8999999999984 66789999999999999999999999
Q ss_pred eccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCC
Q 003045 119 SNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHP 160 (854)
Q Consensus 119 t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 160 (854)
|++.+......++|+|||||||++.+ +++||||||||
T Consensus 80 S~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 99876345678899999999999987 68999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-26 Score=229.55 Aligned_cols=259 Identities=25% Similarity=0.267 Sum_probs=188.8
Q ss_pred hcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------C
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------E 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 604 (854)
..+|-..+.+|.|.. .|-.+. .-.+++||+|++... .....+...+|...+..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356666788999988 555553 336899999998654 233456678999999999999999999998633 3
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
+.|+|||+|. .+|...+. -.++-.....|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 5799999995 46666664 23666788899999999999999999 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc-------------Cch---
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE-------------NSS--- 748 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~-------------~~~--- 748 (854)
+.-+ ..-..+.++.|..|.|||++.+..|.+.+||||+||++.||++|..-|.....- ...
T Consensus 166 r~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 8632 223556678899999999999988999999999999999999999776532110 000
Q ss_pred -HHHHHHHHhh-cCCcc-----c-ccCCCCCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 749 -LIEHVWNLWN-EGKAM-----E-LVDPNIRD--SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 749 -l~~~~~~~~~-~~~~~-----~-~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+...+..... .++.+ + +.|..... +.+........+++.+||-.+|++|-++.++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1111111111 00010 1 11111111 111223344567888999999999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=218.63 Aligned_cols=252 Identities=18% Similarity=0.281 Sum_probs=186.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeee-EEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGC-CIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~-~~~~~~~~lV 609 (854)
..+.|.+.+.||+|.||.+-+++++ ..+.+|+|-+.+. .....+|.+|...--.| .|.||+..++. |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4467888899999999999999876 4678999988653 34567899998876666 48999988764 5666778899
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc--cCCCceecccCcceec
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD--EDMNPKISDFGMARIF 687 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~ 687 (854)
+||++.|+|.+-+-. ..+.+....+++.|++.|+.|+|+.+ +||||||.+||||- +..++||+|||..+..
T Consensus 101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999887732 34778888999999999999999998 99999999999994 4458999999999865
Q ss_pred cCccCcccccccccccccccceeeccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEG-----LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
+.. ..+..-+..|.|||+.... ...+.+|||.||+|+|.++||..|+.........+.+|. .|..+..
T Consensus 174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~--~w~~rk~ 246 (378)
T KOG1345|consen 174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE--QWLKRKN 246 (378)
T ss_pred Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH--HHhcccC
Confidence 421 2223345679999987533 245679999999999999999999985544444555543 3333322
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+ |..-... ..++.++..+-+.+++++|=...++..
T Consensus 247 ~~~--P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 247 PAL--PKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccC--chhhccc----CHHHHHHHHHhcCCcccccchhHHHHH
Confidence 221 1111112 235566666889999999954444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=267.34 Aligned_cols=197 Identities=18% Similarity=0.258 Sum_probs=139.2
Q ss_pred HhcCC-CceeeeeeeE-------EeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 003045 586 AKLQH-RNLVRLLGCC-------IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657 (854)
Q Consensus 586 ~~l~h-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 657 (854)
+.++| +||++++++| .+.+..++++||+ +++|.+++... ...+++.+++.++.||++||+|||+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34555 5777888877 2334567888987 55899998532 345899999999999999999999998
Q ss_pred eEEcccCCCcEEEcc-------------------CCCceecccCcceeccCccC--------------cccccccccccc
Q 003045 658 IIHRDLKASNILLDE-------------------DMNPKISDFGMARIFGFNQN--------------EANTNRVVGTYG 704 (854)
Q Consensus 658 ivH~Dlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 704 (854)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 45567777777764311000 000112457889
Q ss_pred cccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 003045 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIH 784 (854)
Q Consensus 705 Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 784 (854)
|||||++.+..|+.++|||||||+||||++|..|+.... ...... ... ...+.. .........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~----~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSL----RHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHH----HHh----hcChhh-----hhcCHHHHH
Confidence 999999999999999999999999999999887754211 111111 000 111111 111234567
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 003045 785 VGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 785 l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++.+||+++|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999986
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=192.13 Aligned_cols=113 Identities=42% Similarity=0.774 Sum_probs=100.7
Q ss_pred CccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCcEEEE
Q 003045 39 QSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWS 118 (854)
Q Consensus 39 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~vW~ 118 (854)
+.|..|+.|+|+++.|++|||.+..+ ..+++|||+..+ .++||+||++.|+.+ .+.|.|+.||+|+|++.+|.+||+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEE
Confidence 56889999999999999999988654 678999999877 899999999999854 489999999999999999999999
Q ss_pred eccccccccceeEeccCCceEEEcCCCcCCccceeeeeccC
Q 003045 119 SNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNH 159 (854)
Q Consensus 119 t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 159 (854)
|++........++|+|||||||++.. +++|||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 99873345678899999999999987 6899999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=205.86 Aligned_cols=167 Identities=22% Similarity=0.144 Sum_probs=124.9
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCccc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|+|.+++... ...+++.+++.++.||++||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 6788888532 345999999999999999999999975 999999999999999 9999865321
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+.........+...... ... .++..+ ...
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~------~~~~~~-~~~ 132 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MPA------DDPRDR-SNL 132 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hcc------CCcccc-ccH
Confidence 1268899999999999999999999999999999999999986432222222221111 110 001100 011
Q ss_pred HHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 776 QNQVL--RCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 776 ~~~~~--~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..... .+.+++.+|++.+|++||++.|+++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 12222 589999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=221.36 Aligned_cols=176 Identities=23% Similarity=0.242 Sum_probs=134.1
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC--CCcEEEEEEeccc-----cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP--EGQDIAVKRLSRK-----SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 604 (854)
...+.|...+.||+|+||+||+|... +++.+|||++... .....+.|.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45578999999999999999999764 5777899987532 11235668999999999999999853322 24
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEccc-CCCcEEEccCCCceecccCc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDL-KASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFGl 683 (854)
..++||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 689999999999996321 11 1 1467889999999999998 999999 99999999999999999999
Q ss_pred ceeccCccCccc------ccccccccccccceeeccCC------CCcccchh
Q 003045 684 ARIFGFNQNEAN------TNRVVGTYGYMAPEYAMEGL------FSVKSDVY 723 (854)
Q Consensus 684 a~~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~------~s~~~DVw 723 (854)
++.+........ .....++..|+|||++.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 998753221111 13467888999999986433 23346666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=208.52 Aligned_cols=259 Identities=19% Similarity=0.193 Sum_probs=190.5
Q ss_pred CcccCcccccCCcccEEEeEcCCC--cEEEEEEeccccccCHHHHHHHHHHHHhcCC----CceeeeeeeE-EeCCeeEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPEG--QDIAVKRLSRKSGQGLEEFKNEIILIAKLQH----RNLVRLLGCC-IQGEEKML 608 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~~l 608 (854)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999986553 4788887765433333378899999999973 5888888888 47778899
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-----CCceecccCc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-----MNPKISDFGM 683 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DFGl 683 (854)
||+.+ +.+|.++..... ...++....++|+.|++.+|++||+.+ ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99986 778888764433 456999999999999999999999999 9999999999999865 4589999999
Q ss_pred ceecc--CccC----cc-c-ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 684 ARIFG--FNQN----EA-N-TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 684 a~~~~--~~~~----~~-~-~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
++.+. .... .. . .....||..|++++.+.+...+.+.|+||++.++.|++.|..|+........ ...+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~ 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEK 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHH
Confidence 99432 1111 11 1 2235699999999999999999999999999999999999999854321111 111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.... ..... ....... .+.++...+-..+...+|....+...|+..
T Consensus 252 ~~~~----~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 252 DPRK----LLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred Hhhh----hcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111 11111 1112223 344444444458889999999999887665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-20 Score=200.55 Aligned_cols=260 Identities=27% Similarity=0.367 Sum_probs=197.7
Q ss_pred cccCcccccCCcccEEEeEcCCCcEEEEEEecccccc---CHHHHHHHHHHHHhcCCC-ceeeeeeeEEeCCeeEEEEEc
Q 003045 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ---GLEEFKNEIILIAKLQHR-NLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lV~Ey 612 (854)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999876 88999999765433 367899999999999988 799999999777778999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceeccCcc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFGFNQ 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 691 (854)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||++..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643221135888999999999999999999998 99999999999999998 79999999998654332
Q ss_pred Ccc----cccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCccc--CchHHHHHHHHhhcCCc
Q 003045 692 NEA----NTNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE--NSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 692 ~~~----~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~ 762 (854)
... ......|+..|+|||.+.. ..+....|+||+|++++++++|..|+...... .......+.. ...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCC
Confidence 221 3456789999999999987 57888999999999999999999995533221 1122222211 111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
. .................+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 000011111002223567788889999999999999887763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-22 Score=230.23 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=189.8
Q ss_pred ccCcccccCCcccEEEeEcC-CCcEEEEEEecc---cc--c-cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 538 SEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSR---KS--G-QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~--~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
...+.+|.|.+|.|+..... ..+..+.|.+.. .. . .....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 44678999999988877432 334344444321 11 1 11122566788888899999998888777777666679
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||++. +|..++.. ...+...++-.+++|++.|+.|||..+ |.|||||++|++++.++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 89888743 235778889999999999999999999 999999999999999999999999999987654
Q ss_pred cCc--ccccccccccccccceeeccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 691 QNE--ANTNRVVGTYGYMAPEYAMEGLFSVK-SDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 691 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~-~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
... ......+|+..|+|||++.+..|.+. .||||.|+++..|++|+.||.............. ..........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----~~~~~~~~~~ 549 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----YSDQRNIFEG 549 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----cccccccccC
Confidence 444 45566899999999999999999876 8999999999999999999987654433321110 0000000000
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..........+...++.++|+.+|.+|-|+++|++
T Consensus 550 ---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 ---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11122344556788899999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=194.03 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=187.4
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
..+|.+...|..|+|+++ |..+++|++.... ....+.|..|.-.|+-+.||||+.+++.|..+.+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 357889999999999994 5667778876542 2334578999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceec--ccCcceeccCccCccc
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKIS--DFGMARIFGFNQNEAN 695 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~--DFGla~~~~~~~~~~~ 695 (854)
|..+|++. ..-..+-.++.+++.+||+|++|||+..+. |----|....|++|++.+++|. |--++...
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfqe-------- 343 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------- 343 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeeec--------
Confidence 99999764 334578889999999999999999998732 3334689999999999988774 32222110
Q ss_pred ccccccccccccceeeccCCC---CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLF---SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~---s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
....-.+.||+||.+...+- -.++|+|||+++||||.|...||.....-+.. +.+.-..++.
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkialeglrv 408 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIALEGLRV 408 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhhccccc
Confidence 01223678999999987653 35799999999999999999998643221110 1111122344
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+......+.+++.-|+..||.+||....|+-.||..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 44555556888999999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.7e-20 Score=183.46 Aligned_cols=139 Identities=16% Similarity=0.108 Sum_probs=108.7
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEecccccc--C-------HH-----------------HHHHHHHHHHhcCCCce
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--G-------LE-----------------EFKNEIILIAKLQHRNL 593 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~h~ni 593 (854)
...||+|+||.||+|..++|+.||||+++..... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999654211 1 11 22359999999988776
Q ss_pred eeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHh-hcCCCCceEEcccCCCcEEEcc
Q 003045 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL-HRDSRLRIIHRDLKASNILLDE 672 (854)
Q Consensus 594 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILl~~ 672 (854)
.....+. ....++||||++++++..... ....++......++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 223489999999987765432 224588899999999999999999 6887 99999999999998
Q ss_pred CCCceecccCcceec
Q 003045 673 DMNPKISDFGMARIF 687 (854)
Q Consensus 673 ~~~~kl~DFGla~~~ 687 (854)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-20 Score=188.42 Aligned_cols=174 Identities=13% Similarity=0.158 Sum_probs=136.1
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHH---------HHHHHHHHHhcCCCceeeeeeeEE
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEE---------FKNEIILIAKLQHRNLVRLLGCCI 601 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~h~niv~l~~~~~ 601 (854)
.....+|+..++||.|+||.||+... ++..+|+|.+.......... +.+|++.+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34678899999999999999999766 57789999997543322222 689999999999999999998866
Q ss_pred eC--------CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC
Q 003045 602 QG--------EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED 673 (854)
Q Consensus 602 ~~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 673 (854)
.. ...+++|||+++.+|.++.. ++. ....+++.+|..||..+ ++|||+||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 35789999999999977631 222 24568999999999998 9999999999999998
Q ss_pred CCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh
Q 003045 674 MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734 (854)
Q Consensus 674 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt 734 (854)
+ ++|+|||......... .. ..++....|..++|+|+||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 9999999887542111 11 013445567789999999999876643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=185.11 Aligned_cols=200 Identities=22% Similarity=0.305 Sum_probs=167.5
Q ss_pred hcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 611 (854)
.-+|+++++||+|.||+.+.|+ +-+++.||||.-.+.+ ..-++..|.+..+.|. .++|...+.|-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3579999999999999999996 4579999999865543 3356788999999885 6899999988888889999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-----CCceecccCccee
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-----MNPKISDFGMARI 686 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DFGla~~ 686 (854)
.+ +-+|+++..- -...++.+.+..+|+|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 5677776421 2234889999999999999999999998 9999999999999743 3489999999998
Q ss_pred ccCccCcc-----cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 687 FGFNQNEA-----NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 687 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
+....+.. ......||..||+-..+.+...+.+.|+-|||-+++..|-|..||..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 86443322 13346799999999999999999999999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.9e-20 Score=178.61 Aligned_cols=202 Identities=19% Similarity=0.258 Sum_probs=165.7
Q ss_pred HhcCcccCcccccCCcccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH-RNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 610 (854)
...+|...++||.|+||.+|.|. ..+|++||||.-.... ...++..|..+.+.|+| ..|..+.-|..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34678899999999999999995 5689999999875543 33467789999999986 67777888888888999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC---CCceecccCcceec
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED---MNPKISDFGMARIF 687 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~~ 687 (854)
+.+ +-+|+++..--. ..++..+++-++-|++.-++|+|..+ +|||||||+|+|..-+ ..+.++|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 667777653222 23778899999999999999999999 9999999999999744 46899999999987
Q ss_pred cCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003045 688 GFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742 (854)
Q Consensus 688 ~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~ 742 (854)
....+. .......||..|.+-..+.+...+.+.|+-|+|.+|..+.-|..||...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 432221 1223467999999999888888999999999999999999999999743
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-20 Score=213.29 Aligned_cols=252 Identities=17% Similarity=0.197 Sum_probs=182.5
Q ss_pred CcccCcccccCCcccEEEeEcCCCcEEEEEEecccc-ccCHHHHHHHHHH--HHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS-GQGLEEFKNEIIL--IAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.+...+.||.+.|=.|.+|+.++|. |+||++-+.. ....+.|.++++- ...++|||.+++...-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566789999999999999998887 9999986654 4455666655544 4445899999998887777788899999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc-c
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN-Q 691 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~-~ 691 (854)
..+. |.+.+ ..+..+...+...|+.|+++||..+|+.+ |+|+|||.+||||+.-.-+.|+||..-+..... +
T Consensus 103 vkhn-LyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKHN-LYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhhh-hhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8664 44544 45667888899999999999999999999 999999999999999999999999877654322 2
Q ss_pred Cccccc----ccccccccccceeeccC-----------CCCcccchhhHHHHHHHHHhC-CCCCCCCcccCchHHHHHHH
Q 003045 692 NEANTN----RVVGTYGYMAPEYAMEG-----------LFSVKSDVYSFGVLLLEIVSG-RRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 692 ~~~~~~----~~~gt~~Y~aPE~~~~~-----------~~s~~~DVwSlGvil~elltG-~~p~~~~~~~~~~l~~~~~~ 755 (854)
...... +...-..|+|||.+... ..+++.||||+||++.||++- +++|.. .+....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aY 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAY 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhH
Confidence 222211 22334579999988531 167899999999999999885 555542 221111
Q ss_pred HhhcC-CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 756 LWNEG-KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 756 ~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
.-.+. ....++ +..+. ..+..+++.|++.||++|.++.+.++.-+++.
T Consensus 248 r~~~~~~~e~~L-----e~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 RSGNADDPEQLL-----EKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred hccCccCHHHHH-----HhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11100 000000 00111 15667899999999999999999999876653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-19 Score=177.24 Aligned_cols=140 Identities=18% Similarity=0.219 Sum_probs=111.1
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEecccccc---------------------C-----HHHHHHHHHHHHhcCCCce
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ---------------------G-----LEEFKNEIILIAKLQHRNL 593 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~h~ni 593 (854)
...||+|+||.||+|...+|+.||||+++..... . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998878999999998754211 0 1123678999999999987
Q ss_pred eeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEcc
Q 003045 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDE 672 (854)
Q Consensus 594 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~ 672 (854)
.....+... ..++||||++++++..... ....++..+...++.+++.+|.+||. .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 3489999999886543321 22346788899999999999999999 88 99999999999999
Q ss_pred CCCceecccCcceecc
Q 003045 673 DMNPKISDFGMARIFG 688 (854)
Q Consensus 673 ~~~~kl~DFGla~~~~ 688 (854)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=168.16 Aligned_cols=184 Identities=20% Similarity=0.155 Sum_probs=137.9
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEecccccc----CHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcC
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ----GLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999998866 6788888877654321 1225789999999995 5789999886 4569999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEccc-CCCcEEEccCCCceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDL-KASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
.+.+|...+. . ....++.|++.+|.++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998865431 0 11357789999999999999 999999 79999999999999999999986542221
Q ss_pred c----cc-------ccccccccccccceeeccC-CCC-cccchhhHHHHHHHHHhCCCCCC
Q 003045 693 E----AN-------TNRVVGTYGYMAPEYAMEG-LFS-VKSDVYSFGVLLLEIVSGRRNTS 740 (854)
Q Consensus 693 ~----~~-------~~~~~gt~~Y~aPE~~~~~-~~s-~~~DVwSlGvil~elltG~~p~~ 740 (854)
. .. +.....++.|++|+...-- ..+ ...+-++.|.-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 1112357788888754322 222 56788899999999999997753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-18 Score=189.43 Aligned_cols=217 Identities=24% Similarity=0.379 Sum_probs=164.3
Q ss_pred HHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccC
Q 003045 585 IAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664 (854)
Q Consensus 585 l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 664 (854)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+... .-.+++.....++++|++||.|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 45789999999999999999999999999999999999652 335889999999999999999999976 12999999
Q ss_pred CCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCC-------CCcccchhhHHHHHHHHHhCCC
Q 003045 665 ASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL-------FSVKSDVYSFGVLLLEIVSGRR 737 (854)
Q Consensus 665 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~~~DVwSlGvil~elltG~~ 737 (854)
+.|.+++....+||+|||+.................-..-|.|||.+.... .+++.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988753211111111122345699999987632 4678999999999999999999
Q ss_pred CCCCCcccCc--hHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 738 NTSFRLEENS--SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 738 p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
||........ ++...+.. ......-|.+.... +....+..++.+|+..+|++||++.+|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9986543322 33333222 11122222221110 233368889999999999999999999999887744
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.1e-18 Score=202.00 Aligned_cols=201 Identities=19% Similarity=0.233 Sum_probs=164.8
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCe
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQGEE 605 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~ 605 (854)
+.+...+.|.+.+.||+|+||.||+|...+|+.||+|.-+... .-+|.--.+++.+|+ -+.|+.+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3455667899999999999999999998889999999865432 223333344555555 2345555566666788
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-------cCCCcee
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-------EDMNPKI 678 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl 678 (854)
.+||+||.+.|+|.+++. ..+.++|.....++.|+++.+++||..+ |||+||||+|.||. ++..++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999984 5567999999999999999999999998 99999999999995 3345899
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCC
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRN 738 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p 738 (854)
+|||.+..+..-.........++|-.+-.+|...+..++.++|.|.++-+++-||.|++.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999876544444566677889999999999999999999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.9e-18 Score=177.11 Aligned_cols=233 Identities=19% Similarity=0.240 Sum_probs=149.9
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCC----------CceeeeeeeE-
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQH----------RNLVRLLGCC- 600 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~~- 600 (854)
.....+.||.|+++.||.++.. +++++|||++.... ....+++++|.-.+..+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455679999999999999876 48999999986442 3346677777655555322 1222222221
Q ss_pred --------EeCC--------eeEEEEEcCCCCChhhhhcC---c-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEE
Q 003045 601 --------IQGE--------EKMLIYEYMPNKSLDLFIFD---P-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660 (854)
Q Consensus 601 --------~~~~--------~~~lV~Ey~~~gsL~~~l~~---~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 660 (854)
.... ..+++|+-+ .++|..++.. . .....+....++.+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1111 236778877 5677766532 1 11223556667788899999999999999 999
Q ss_pred cccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeecc--------CCCCcccchhhHHHHHHHH
Q 003045 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME--------GLFSVKSDVYSFGVLLLEI 732 (854)
Q Consensus 661 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~~DVwSlGvil~el 732 (854)
+||||+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998886542111 1234577999997743 2478899999999999999
Q ss_pred HhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 003045 733 VSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYR 797 (854)
Q Consensus 733 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R 797 (854)
++|+.|+........... .-..+. +..+.+..++..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999875432211100 112344 667788899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=167.55 Aligned_cols=136 Identities=23% Similarity=0.300 Sum_probs=106.5
Q ss_pred ccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhc-----CCCceeeeeeeEEeCC---eeE-E
Q 003045 538 SEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-----QHRNLVRLLGCCIQGE---EKM-L 608 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 608 (854)
...++||+|+||.||. +++....+||++........+.+.+|+.+++++ .||||+++++++.+.. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 444333479988765455667899999999999 5799999999998874 333 7
Q ss_pred EEEc--CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHH-HHhhcCCCCceEEcccCCCcEEEcc----CCCceeccc
Q 003045 609 IYEY--MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL-LYLHRDSRLRIIHRDLKASNILLDE----DMNPKISDF 681 (854)
Q Consensus 609 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 681 (854)
|+|| +++++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6689999999432 24444 35677888777 9999998 999999999999974 347999994
Q ss_pred Ccc
Q 003045 682 GMA 684 (854)
Q Consensus 682 Gla 684 (854)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-18 Score=188.48 Aligned_cols=233 Identities=23% Similarity=0.246 Sum_probs=178.6
Q ss_pred ccccCCcccEEEeE----cCCCcEEEEEEecccccc--CHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 542 KLGRGGFGPVHKGK----LPEGQDIAVKRLSRKSGQ--GLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
.+|+|.||.|++.+ ...+.-+|.|.+.+.... .......|-.++...+ ||.+|++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999863 334677888887654211 1224567888899997 9999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|.|...+. +...+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+.+..-...
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999887773 3444666677777788999999999999 9999999999999999999999999998652111
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
..+||..|||||++. ....++|-||||++.+||+||..||.. +....+ .. .....
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~I---l~-----------~~~~~ 206 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRI---LK-----------AELEM 206 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHH---hh-----------hccCC
Confidence 128999999999998 567899999999999999999999863 111111 11 11223
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCH--HHHHHHHh
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTM--ASVVLMLE 808 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~--~eVl~~L~ 808 (854)
+.+......+++.+++..+|.+|--. ..+.+.++
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 44455566677778888999998855 34444443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.1e-17 Score=171.23 Aligned_cols=197 Identities=21% Similarity=0.253 Sum_probs=133.5
Q ss_pred CCCceeeeeeeEEe---------------------------CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHH
Q 003045 589 QHRNLVRLLGCCIQ---------------------------GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIE 641 (854)
Q Consensus 589 ~h~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 641 (854)
+|||||++.++|.+ +...|+||.-.+ .+|..++.. ...+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999988754 234577877654 366676632 2245566677889
Q ss_pred HHHHHHHHhhcCCCCceEEcccCCCcEEEc--cCC--CceecccCcceeccCc--cCcccc--cccccccccccceeecc
Q 003045 642 GIARGLLYLHRDSRLRIIHRDLKASNILLD--EDM--NPKISDFGMARIFGFN--QNEANT--NRVVGTYGYMAPEYAME 713 (854)
Q Consensus 642 ~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~DFGla~~~~~~--~~~~~~--~~~~gt~~Y~aPE~~~~ 713 (854)
|+++|+.|||+++ |.|||+|.+|||+. +++ ...|+|||++-.-... +-.... -..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999995 333 4789999998753211 000111 12346788999999875
Q ss_pred CC------CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHh
Q 003045 714 GL------FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGM 787 (854)
Q Consensus 714 ~~------~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 787 (854)
.+ .=.|+|.|+.|.+.||++....||....+-.-+... .++.+. |.+ +......+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qL-----Pal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQL-----PAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhC-----CCC----cccCChHHHHHHH
Confidence 43 124899999999999999999998753321111111 111111 222 2233345678888
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 003045 788 LCVQDSAMYRPTMASVVLML 807 (854)
Q Consensus 788 ~Cl~~dp~~RPs~~eVl~~L 807 (854)
..|+.||++||+..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=164.87 Aligned_cols=148 Identities=16% Similarity=0.168 Sum_probs=113.6
Q ss_pred HHHHhcCcccCcccccCCcccEEEeE--cCCCcEEEEEEecccccc------------------------CHHHHHHHHH
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGK--LPEGQDIAVKRLSRKSGQ------------------------GLEEFKNEII 583 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~Ei~ 583 (854)
+..-...|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33334457888999999999999998 568999999998753210 0123568999
Q ss_pred HHHhcCCCc--eeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEc
Q 003045 584 LIAKLQHRN--LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHR 661 (854)
Q Consensus 584 ~l~~l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 661 (854)
++.++.+.. +.+++++ ...++||||+++.+|...... ...+...+...++.||+.++.+||+.+ .++||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 999997633 3344432 245899999999888665421 223556667889999999999999986 49999
Q ss_pred ccCCCcEEEccCCCceecccCcceec
Q 003045 662 DLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 662 Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
||||+||+++ ++.++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999998854
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=161.91 Aligned_cols=134 Identities=22% Similarity=0.300 Sum_probs=113.9
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEecccccc--------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986543211 124578899999999999998888887778889999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887421 12 78899999999999999998 99999999999999 78999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=160.17 Aligned_cols=146 Identities=20% Similarity=0.210 Sum_probs=114.5
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccccc----------------------CHHHHHHHHHH
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ----------------------GLEEFKNEIIL 584 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~Ei~~ 584 (854)
..++......|.+.+.||+|+||.||++..++|+.||||++...... ....+..|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 34555555568888999999999999999888999999987543200 11236778999
Q ss_pred HHhcCCCc--eeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcc
Q 003045 585 IAKLQHRN--LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRD 662 (854)
Q Consensus 585 l~~l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 662 (854)
+.++.|++ +.+.++ ....++||||+++++|..+... .....++.+++.++.++|+.+ ++|+|
T Consensus 87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 99998874 444443 2456899999999998765420 234578899999999999988 99999
Q ss_pred cCCCcEEEccCCCceecccCcceecc
Q 003045 663 LKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 663 lkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
|||+||++++++.++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5e-17 Score=177.33 Aligned_cols=175 Identities=23% Similarity=0.315 Sum_probs=132.9
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++.|++++..+|.+++.........++.....+++|++.|+.| .+ .+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666678899999999999999999 55 999999999999999999999999999
Q ss_pred eeccCcc----CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCC-CCCCCCcccCchHHHHHHHHhhc
Q 003045 685 RIFGFNQ----NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR-RNTSFRLEENSSLIEHVWNLWNE 759 (854)
Q Consensus 685 ~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~-~p~~~~~~~~~~l~~~~~~~~~~ 759 (854)
....... .....+...||..||+||.+.+..|+.|+||||||+||+||+.-- -+++ .......++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~d~r~ 474 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLTDIRD 474 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhhhhhc
Confidence 8765333 223455678999999999999999999999999999999999821 1111 1111111111
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003045 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803 (854)
Q Consensus 760 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eV 803 (854)
..++|....+++. -..++.+++...|.+||+..++
T Consensus 475 ----g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 ----GIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----CCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 2233333333332 2467779999999999944443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=157.47 Aligned_cols=130 Identities=24% Similarity=0.346 Sum_probs=107.4
Q ss_pred ccccCCcccEEEeEcCCCcEEEEEEecccccc--------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.||+|+||.||+|.. ++..+++|+....... ..+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6788999986543211 1255778999999999988766666666777789999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|+||+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773211 078999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.9e-16 Score=181.41 Aligned_cols=139 Identities=21% Similarity=0.303 Sum_probs=113.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccc--cc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 604 (854)
....|...++||+|+||+||+|..... .+++|+.... .. ...+.+.+|++++++++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556778999999999999987544 4444433211 11 12356889999999999999998888888878
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999988873 35678999999999999998 9999999999999 6789999999999
Q ss_pred eec
Q 003045 685 RIF 687 (854)
Q Consensus 685 ~~~ 687 (854)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=138.57 Aligned_cols=135 Identities=21% Similarity=0.202 Sum_probs=114.9
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCC--CceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH--RNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
+.+.||+|.++.||+++..+ +.+++|....... ...+.+|+.+++.++| .++.+++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999998754 7899998865433 5678999999999987 58899998888888899999999988
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
.+..+ +......++.+++++|++||......++|+||||+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566677899999999999997555699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-15 Score=175.53 Aligned_cols=216 Identities=20% Similarity=0.243 Sum_probs=143.0
Q ss_pred hcCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
...|+..+.|..|+||.||..+++. .+.+|.|+-+.+. +.+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 3567778999999999999998764 6778885432210 0000 22222333333
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc--
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN-- 690 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~-- 690 (854)
|+-...+.. .+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+.+...+.
T Consensus 136 ---gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 332333321 122221 3378999999998 999999999999999999999999999864211
Q ss_pred -----------cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc
Q 003045 691 -----------QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE 759 (854)
Q Consensus 691 -----------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 759 (854)
..+......+||+.|+|||++....|....|-|++|+|+||.+-|..||..+. .++|...+... .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--peelfg~visd--~ 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVISD--D 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--HHHHHhhhhhh--h
Confidence 11112335689999999999999999999999999999999999999987432 22333332211 1
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.+- | .....+..+++.+.|+.+|..|--...-++
T Consensus 275 i~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 275 IEWPEE-D--------EALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred cccccc-C--------cCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 111111 1 122235667778899999999985444333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=146.07 Aligned_cols=136 Identities=20% Similarity=0.240 Sum_probs=98.9
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEecccccc--CHHH----------------------HHHHHHHHHhcCCCc--e
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--GLEE----------------------FKNEIILIAKLQHRN--L 593 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~h~n--i 593 (854)
.+.||+|+||+||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998653211 1111 135666676665443 3
Q ss_pred eeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEcc
Q 003045 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDE 672 (854)
Q Consensus 594 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~ 672 (854)
.+.+++ ...++||||++++.+......... . ..+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999999654322111000 1 15677899999999999999 77 99999999999999
Q ss_pred CCCceecccCcceec
Q 003045 673 DMNPKISDFGMARIF 687 (854)
Q Consensus 673 ~~~~kl~DFGla~~~ 687 (854)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-15 Score=120.98 Aligned_cols=57 Identities=53% Similarity=1.067 Sum_probs=50.5
Q ss_pred CCcceEeecccCCCcccc---cccChhhHHHHHhccCCeeeeecc---CCceeeEeeeccccc
Q 003045 365 EDGFKVFKNVKLPDFADV---VSVGQETCKDKCLQNCSCNAYADI---PGIGCMLWRGELIDV 421 (854)
Q Consensus 365 ~~~f~~~~~~~lpd~~~~---~~~s~~~C~~~Cl~nCsC~Aya~~---~g~gC~~w~~~l~~~ 421 (854)
+|+|+.+++|++|+.... .++++++|++.||+||||+||||. ++++|++|+++|+|+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 799999999999996422 368999999999999999999995 478899999999985
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-15 Score=176.57 Aligned_cols=256 Identities=22% Similarity=0.263 Sum_probs=191.6
Q ss_pred cCcccCcccccCCcccEEEeEcCC--CcEEEEEEecccc--ccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE--GQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV 609 (854)
..|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666789999999998886543 3456667665543 233344556888888887 99999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhh-cCCCCceEEcccCCCcEEEccCC-CceecccCcceec
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH-RDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIF 687 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 687 (854)
.||..++++...+.. ......+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998877731 11113455667789999999999999 777 99999999999999999 9999999999988
Q ss_pred cC-ccCccccccccc-ccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 688 GF-NQNEANTNRVVG-TYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 688 ~~-~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+............|.... .
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-----~-- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-----G-- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-----c--
Confidence 76 455555666788 9999999999885 456779999999999999999999886654443333332110 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...-........++..+++..+|..|.+.+++..
T Consensus 249 ~~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccc----cCccccCChhhhhcccccccCCchhccccccccc
Confidence 000 0111112234566777888899999999888765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.8e-14 Score=146.19 Aligned_cols=136 Identities=22% Similarity=0.267 Sum_probs=105.8
Q ss_pred Ccccc-cCCcccEEEeEcCCCcEEEEEEecccc-------------ccCHHHHHHHHHHHHhcCCCce--eeeeeeEEeC
Q 003045 540 GNKLG-RGGFGPVHKGKLPEGQDIAVKRLSRKS-------------GQGLEEFKNEIILIAKLQHRNL--VRLLGCCIQG 603 (854)
Q Consensus 540 ~~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~ 603 (854)
...|| .||.|+||+... .+..++||++.... ......+.+|++++.+++|+++ .+.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 899999999987 47789999885421 1223467889999999998875 6777765443
Q ss_pred Ce----eEEEEEcCCC-CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 604 EE----KMLIYEYMPN-KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 604 ~~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
.. .++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688888743 234433 3578999999999999 999999999999999999999
Q ss_pred cccCcceec
Q 003045 679 SDFGMARIF 687 (854)
Q Consensus 679 ~DFGla~~~ 687 (854)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.3e-14 Score=119.80 Aligned_cols=67 Identities=15% Similarity=0.193 Sum_probs=60.9
Q ss_pred CCcceEeecccCCCcccccccChhhHHHHHhc---cCCeeeeeccC-CceeeEeeecc-ccceecccCCeEEEEe
Q 003045 365 EDGFKVFKNVKLPDFADVVSVGQETCKDKCLQ---NCSCNAYADIP-GIGCMLWRGEL-IDVKSFEKGGNLLHVR 434 (854)
Q Consensus 365 ~~~f~~~~~~~lpd~~~~~~~s~~~C~~~Cl~---nCsC~Aya~~~-g~gC~~w~~~l-~~~~~~~~~~~~ly~r 434 (854)
+.+|+.+.+|++||.. .+++++|+++|++ ||||+||||.. +.||++|+++| .|++++.+++.+||+|
T Consensus 8 ~g~fl~~~~~klpd~~---~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 8 AGTTLIKIALKIKTTK---ANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred CCeEEEeecccCCccc---ccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 6789999999999976 4789999999999 99999999953 57999999999 9999998889999998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.2e-13 Score=149.93 Aligned_cols=145 Identities=24% Similarity=0.294 Sum_probs=102.3
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccC--------------------------H-------------
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQG--------------------------L------------- 575 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------~------------- 575 (854)
..|+ .+.||.|++|.||+|++++|+.||||+.+...... .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 36899999999999999999999999986431110 0
Q ss_pred -HHHHHHHHHHHhcC----CCceeeeeeeEE-eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHH-HHH
Q 003045 576 -EEFKNEIILIAKLQ----HRNLVRLLGCCI-QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR-GLL 648 (854)
Q Consensus 576 -~~~~~Ei~~l~~l~----h~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~ 648 (854)
-.|.+|...+.+++ |.+-+.+-..+. .....+|||||+++++|.++...... .. .+..++..++. .+.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLN 271 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHH
Confidence 02445555555552 333333333332 34567999999999999887632111 11 23456666666 478
Q ss_pred HhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 649 yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
.+|..+ ++|+|+||.||+++++++++++|||++..+.
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 889888 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.6e-12 Score=132.00 Aligned_cols=206 Identities=22% Similarity=0.227 Sum_probs=141.5
Q ss_pred HHHHHHhcCCCceeeeeeeEEeC-----CeeEEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCC
Q 003045 581 EIILIAKLQHRNLVRLLGCCIQG-----EEKMLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDS 654 (854)
Q Consensus 581 Ei~~l~~l~h~niv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 654 (854)
-+..|-++.|.|||++..|+.+. .+..++.|||+.|++..+|+.- ..+..+....-.+++-||..||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34566677899999999887654 3567899999999999999763 33445777778899999999999999975
Q ss_pred CCceEEcccCCCcEEEccCCCceecccCcceec--cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHH
Q 003045 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIF--GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEI 732 (854)
Q Consensus 655 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~--~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~el 732 (854)
++|+|+++..+-|++..++-+|+.--...... -.......+....+-++|.|||.=.....+.++|||+||+..+||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 78999999999999999998887431111100 001111122234567899999988777888899999999999999
Q ss_pred HhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 733 VSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 733 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.-+..-... ........+.+.+ .+..+-++.. ..++..|++..|..||+|++++.
T Consensus 276 ailEiq~tn-seS~~~~ee~ia~-----~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTN-SESKVEVEENIAN-----VIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCC-Ccceeehhhhhhh-----heeeccCccc------------cCcCcccccCCCCCCcchhhhhc
Confidence 887643211 1111111111111 1111112211 23556899999999999999875
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.2e-12 Score=108.87 Aligned_cols=72 Identities=44% Similarity=0.886 Sum_probs=61.0
Q ss_pred CCcceEeecccCCCcccc-cccChhhHHHHHhccCCeeeeeccC-CceeeEeeeccccceecccCCeEEEEecC
Q 003045 365 EDGFKVFKNVKLPDFADV-VSVGQETCKDKCLQNCSCNAYADIP-GIGCMLWRGELIDVKSFEKGGNLLHVRLP 436 (854)
Q Consensus 365 ~~~f~~~~~~~lpd~~~~-~~~s~~~C~~~Cl~nCsC~Aya~~~-g~gC~~w~~~l~~~~~~~~~~~~ly~rlp 436 (854)
.++|..+.++++|+.... .++++++|++.||+||+|+||+|.. +++|.+|.+++.+.++....+..+|+|+|
T Consensus 11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 368999999999986432 4789999999999999999999954 57899999999998876656789999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.6e-11 Score=121.51 Aligned_cols=130 Identities=22% Similarity=0.141 Sum_probs=98.3
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceee-eeeeEEeCCeeEEEEEcCCCCChh
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR-LLGCCIQGEEKMLIYEYMPNKSLD 619 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~~~~lV~Ey~~~gsL~ 619 (854)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+.+++.+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 57899999999999874 78899998754422 2335688999999997655543 4433 234568999999998875
Q ss_pred hhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC--CCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 620 LFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS--RLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 620 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
... .....++.+++++|+.||..+ ...++|+|++|+||+++ ++.++++|||.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 011345678999999999987 23469999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.6e-11 Score=139.20 Aligned_cols=144 Identities=19% Similarity=0.222 Sum_probs=95.3
Q ss_pred hcCcccCcccccCCcccEEEeEcCC-CcEEEEEEecccccc----------------------------------CHHH-
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQ----------------------------------GLEE- 577 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~~- 577 (854)
...|+. +.||+|++|.||+|++++ |+.||||+++..... ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 799999999999999887 999999999743110 0111
Q ss_pred -----HHHHHHHHHhcC----CCceeeeeeeEEe-CCeeEEEEEcCCCCChhhhhcCcccc---cCCCHHHHHHHHHHHH
Q 003045 578 -----FKNEIILIAKLQ----HRNLVRLLGCCIQ-GEEKMLIYEYMPNKSLDLFIFDPAKQ---ALLDWTKRFAIIEGIA 644 (854)
Q Consensus 578 -----~~~Ei~~l~~l~----h~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia 644 (854)
|.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-...+ ..+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 334444444442 4444444444433 45778999999999997753211111 112222233333333
Q ss_pred HHHHHhhcCCCCceEEcccCCCcEEEccCC----CceecccCcceecc
Q 003045 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDM----NPKISDFGMARIFG 688 (854)
Q Consensus 645 ~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGla~~~~ 688 (854)
+..+ ++|+|+||.||+++.++ +++++|||++..+.
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3455 99999999999999888 99999999998774
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-11 Score=135.74 Aligned_cols=249 Identities=21% Similarity=0.239 Sum_probs=178.1
Q ss_pred cCcccCccccc--CCcccEEEeEc---CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCee
Q 003045 535 NYFSEGNKLGR--GGFGPVHKGKL---PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~ 606 (854)
..|-+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+....+++ |+|.++....++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44556678999 99999999976 35788999985433 2233333356777777774 99999988889999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHH----HHHHhhcCCCCceEEcccCCCcEEEccC-CCceeccc
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR----GLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDF 681 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DF 681 (854)
++-.|++. .+|..+.+. ....++....+.++.+... ||.++|... ++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 667676643 2334677788888888888 999999988 9999999999999999 88999999
Q ss_pred CcceeccCccCcc---cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 682 GMARIFGFNQNEA---NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 682 Gla~~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
|+...++...-.. ...+..|...|++||.. ++.++.+.|+|++|.++.+-.+|.+........ .| .
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W--~--- 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-----SW--S--- 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-----Cc--c---
Confidence 9999875432111 12233678889999964 566789999999999999999988766532111 01 0
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+-.. +..+.... ...++..++.++++.+|..|++.+.+..
T Consensus 337 ~~r~~~-ip~e~~~~----~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGY-IPLEFCEG----GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccc-CchhhhcC----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000 11111111 1123334788999999999998776654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.7e-10 Score=110.01 Aligned_cols=136 Identities=13% Similarity=0.098 Sum_probs=99.1
Q ss_pred cccccCCcccEEEeEcCC-------CcEEEEEEecccc------------c----------cCHHHHH----HHHHHHHh
Q 003045 541 NKLGRGGFGPVHKGKLPE-------GQDIAVKRLSRKS------------G----------QGLEEFK----NEIILIAK 587 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~------------~----------~~~~~~~----~Ei~~l~~ 587 (854)
..||.|--+.||.|...+ +..+|||+.+... . ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999997543 4799999875320 0 0122333 79999999
Q ss_pred cCC--CceeeeeeeEEeCCeeEEEEEcCCCCChhh-hhcCcccccCCCHHHHHHHHHHHHHHHHHh-hcCCCCceEEccc
Q 003045 588 LQH--RNLVRLLGCCIQGEEKMLIYEYMPNKSLDL-FIFDPAKQALLDWTKRFAIIEGIARGLLYL-HRDSRLRIIHRDL 663 (854)
Q Consensus 588 l~h--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dl 663 (854)
+.. -++.+++++ ...++||||+.+..+.. .+. ...++..+...+..+++.+|..| |+.+ +||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 964 345555543 56789999998754422 221 12244556677889999999999 8887 999999
Q ss_pred CCCcEEEccCCCceecccCcceecc
Q 003045 664 KASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 664 kp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
++.|||+. ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.3e-10 Score=114.14 Aligned_cols=142 Identities=17% Similarity=0.230 Sum_probs=110.7
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCC--ceeeeeeeEEeCC---eeEEEEEcCC
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHR--NLVRLLGCCIQGE---EKMLIYEYMP 614 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~---~~~lV~Ey~~ 614 (854)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999998765322 2456789999999999764 4566777765532 5689999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS---------------------------------------- 654 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 654 (854)
+.++...+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 24677778888888888888888531
Q ss_pred -------------CCceEEcccCCCcEEEcc--CCCceecccCccee
Q 003045 655 -------------RLRIIHRDLKASNILLDE--DMNPKISDFGMARI 686 (854)
Q Consensus 655 -------------~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~ 686 (854)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=122.55 Aligned_cols=169 Identities=17% Similarity=0.224 Sum_probs=126.8
Q ss_pred EcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHH
Q 003045 555 KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWT 634 (854)
Q Consensus 555 ~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 634 (854)
+..++.+|.|...+.......+...+-++.|+.++||||++++..++..+..|||.|-+. -|..++.. +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence 344688999988877655444567788999999999999999999999999999999874 34455422 2244
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccC
Q 003045 635 KRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714 (854)
Q Consensus 635 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 714 (854)
.....+.||+.||.+||+.+ .++|++|....|+|++.|..||.+|.++...... ........--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~--~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF--NAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC--CcccccchhhhcccChhhcCcc
Confidence 55567889999999999776 5999999999999999999999999988754211 1111112223346677654332
Q ss_pred CCCcccchhhHHHHHHHHHhCCC
Q 003045 715 LFSVKSDVYSFGVLLLEIVSGRR 737 (854)
Q Consensus 715 ~~s~~~DVwSlGvil~elltG~~ 737 (854)
. -..|.|-||++++|++.|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c--cchhhhhHHHHHHHHhCccc
Confidence 2 34699999999999999943
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.8e-09 Score=104.23 Aligned_cols=131 Identities=21% Similarity=0.286 Sum_probs=103.8
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEecccccc--------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..|++|+-+.+|.+.+. |.++++|.-..+... ..+.-.+|.+++.+++--.|.-.+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999763 445777755433211 123457899999999877776666677788899999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+++..|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 3567788888899999999 99999999999998776 99999999984
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.5e-10 Score=124.53 Aligned_cols=248 Identities=22% Similarity=0.227 Sum_probs=175.0
Q ss_pred HhcCcccCcccccCCcccEEEeEc--CCCcEEEEEEeccccccCHHHH--HHHHHHHHhc-CCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL--PEGQDIAVKRLSRKSGQGLEEF--KNEIILIAKL-QHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (854)
-...|.....||.|.|+.|++... .++..+++|.+.+.......++ ..|+.+...+ .|.++++....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 345677888999999999999753 4578899998876543332222 4566666666 4889999888888888888
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccCccee
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARI 686 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~ 686 (854)
+=-||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||++..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 889999999887766 22335778888999999999999999887 9999999999999886 7889999999875
Q ss_pred ccCccCcccccccccccccc--cceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 687 FGFNQNEANTNRVVGTYGYM--APEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
+..... ......+++ +|+......+-.+.|++|||.-+.|.+++..-..... .+. ....+.
T Consensus 417 ~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~--~i~~~~--- 479 (524)
T KOG0601|consen 417 LAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSL--TIRSGD--- 479 (524)
T ss_pred cceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cce--eeeccc---
Confidence 321111 112223333 5666667778999999999999999999875432110 000 000000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
-+.+ +... +.+..++..++..++..||.+.++....+.+
T Consensus 480 --~p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 --TPNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --ccCC----CchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0111 1111 4555666678899999999998887755443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.8e-09 Score=100.60 Aligned_cols=143 Identities=24% Similarity=0.294 Sum_probs=108.3
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEecccc--------ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--------GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
....|-+|+-+.|+++.. .|+..+||.-..+. .-..+..++|.+.|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456889999999999988 67887777543221 113455688999999998777776666777788889999
Q ss_pred EcCCC-CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecccCccee
Q 003045 611 EYMPN-KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISDFGMARI 686 (854)
Q Consensus 611 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~ 686 (854)
||+++ .++.+++....... ........+++.|-+.+.-||..+ |||+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46777775432222 222233678889999999999998 999999999999976553 58999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-07 Score=102.84 Aligned_cols=169 Identities=21% Similarity=0.299 Sum_probs=127.9
Q ss_pred cccEEEeE-cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCeeEEEEEcCCCC-Chhhh
Q 003045 548 FGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEKMLIYEYMPNK-SLDLF 621 (854)
Q Consensus 548 fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV~Ey~~~g-sL~~~ 621 (854)
-.+.||+. ..+|..+++|+++....+.......-+++.+++.|+|+|++.+++.. ....++||+|.++. +|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35778985 44899999999965544444444566889999999999999998873 34678999999864 55444
Q ss_pred hcCc------------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 622 IFDP------------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 622 l~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
-+.. ......++...|.++.|++.||.++|+.| +.-+-|.|.+||++.+.+++|...|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3321 12235778899999999999999999999 88899999999999999999988887766532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRN 738 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p 738 (854)
+.. |-+. --++-|.=-||.+++.|.||...
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 220 1111 12357899999999999999654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-07 Score=101.69 Aligned_cols=258 Identities=16% Similarity=0.147 Sum_probs=157.8
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeee------EEeC-CeeEEEE
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGC------CIQG-EEKMLIY 610 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~------~~~~-~~~~lV~ 610 (854)
.++.||+|+-+-+|-.- +-...+.|+.+........+. +..|... .||-+-.-+.+ --++ ...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45789999999999642 223456788876544332222 2223332 35433221111 0112 2255777
Q ss_pred EcCCCCChhhhhcC----cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 611 EYMPNKSLDLFIFD----PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 611 Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+.+++.----.++. .......+|.-.+++++.+|.+.+.||+.| .+-+|+.++|+||++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 87776532222222 123345899999999999999999999999 89999999999999999999998654433
Q ss_pred ccCccCcccccccccccccccceeeccC-----CCCcccchhhHHHHHHHHHhC-CCCCCCCc---ccCchHHHHHHHHh
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEG-----LFSVKSDVYSFGVLLLEIVSG-RRNTSFRL---EENSSLIEHVWNLW 757 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~~DVwSlGvil~elltG-~~p~~~~~---~~~~~l~~~~~~~~ 757 (854)
. .........+|.+.|.+||...-+ .-+...|.|.|||+++++|.| ++|+.... .....+...+.
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--- 240 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--- 240 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh---
Confidence 2 222334457889999999976522 345679999999999999887 88986422 12222221211
Q ss_pred hcCCcccc------cCCCCCCCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHhccC
Q 003045 758 NEGKAMEL------VDPNIRDSSSQNQVLRCIHVGMLCVQD--SAMYRPTMASVVLMLESET 811 (854)
Q Consensus 758 ~~~~~~~~------~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPs~~eVl~~L~~~~ 811 (854)
.+..... ..+..+.-.-......+..+..+|+.. .+.-|||++-.+..|..+.
T Consensus 241 -~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 241 -HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred -cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 1111111 111111111112223455566677765 3678999999998886654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.7e-08 Score=95.63 Aligned_cols=125 Identities=25% Similarity=0.297 Sum_probs=82.2
Q ss_pred cEEEeEcCCCcEEEEEEecccc-------------cc-------------CHHHHHHHHHHHHhcCCCc--eeeeeeeEE
Q 003045 550 PVHKGKLPEGQDIAVKRLSRKS-------------GQ-------------GLEEFKNEIILIAKLQHRN--LVRLLGCCI 601 (854)
Q Consensus 550 ~Vy~~~~~~g~~vavK~~~~~~-------------~~-------------~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~ 601 (854)
.||.|...+|..+|||+.+... .. .....++|++.|.++..-+ +.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998899999999885320 00 1223578999999998664 4555544
Q ss_pred eCCeeEEEEEcCC--CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHH-hhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 602 QGEEKMLIYEYMP--NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY-LHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 602 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
....+||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 25579999999 55554433111 1123345677778775555 57887 9999999999999988 9999
Q ss_pred cccCcceec
Q 003045 679 SDFGMARIF 687 (854)
Q Consensus 679 ~DFGla~~~ 687 (854)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.9e-08 Score=100.97 Aligned_cols=139 Identities=19% Similarity=0.130 Sum_probs=99.7
Q ss_pred cccCCcccEEEeEcCCCcEEEEEEeccccc-----------cCHHHHHHHHHHHHhcCCCce--eeeeeeEEe-----CC
Q 003045 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRKSG-----------QGLEEFKNEIILIAKLQHRNL--VRLLGCCIQ-----GE 604 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~-----~~ 604 (854)
+-+-....|.+.+. +|+.+.||+...... .....+.+|...+.++...+| .+++++.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667666 678899997743321 111247899999999864443 345556543 23
Q ss_pred eeEEEEEcCCCC-ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-------CCCc
Q 003045 605 EKMLIYEYMPNK-SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-------DMNP 676 (854)
Q Consensus 605 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~ 676 (854)
..+||+|++++. +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 578999999986 7888874221 223456677889999999999999999 999999999999985 4678
Q ss_pred eecccCccee
Q 003045 677 KISDFGMARI 686 (854)
Q Consensus 677 kl~DFGla~~ 686 (854)
.|+||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-08 Score=118.73 Aligned_cols=250 Identities=18% Similarity=0.183 Sum_probs=162.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
..+.+.+.+.+-+|.++.++.++-. .|...+.|..... .....+....+-.++-.-+||-+++...-+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4466777778899999999987533 2322333322211 11222333333334444456777766655556678899
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
+++|..+++|...++... ..+.......+..+..+++|||... +.|+|++|.|+|...++..+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988875432 3444444445556788999999986 8999999999999999999999998544321
Q ss_pred Cc-------------------------cCc----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 689 FN-------------------------QNE----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 689 ~~-------------------------~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
.- ... .......||+.|.+||...+......+|.|++|++++|.++|..|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 10 000 0122356899999999999999999999999999999999999998
Q ss_pred CCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 003045 740 SFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMA 801 (854)
Q Consensus 740 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ 801 (854)
.....+ ...+.+ ....+.. ...+.....+..+++...+..+|.+|-.|.
T Consensus 1036 na~tpq--~~f~ni----~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQ--QIFENI----LNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchh--hhhhcc----ccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 643221 111111 1111100 111222233455666677778888887765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.2e-07 Score=95.11 Aligned_cols=146 Identities=21% Similarity=0.220 Sum_probs=102.7
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccc----------c------------ccCHHHHHHHHHH
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK----------S------------GQGLEEFKNEIIL 584 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----------~------------~~~~~~~~~Ei~~ 584 (854)
+..+..-..-..++++||-|--+.||.|..++|.++|||.=+.. . .-.+...++|+++
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 33444333445677899999999999999999999999954211 0 0123346789999
Q ss_pred HHhcCCC--ceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcc
Q 003045 585 IAKLQHR--NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRD 662 (854)
Q Consensus 585 l~~l~h~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 662 (854)
|++|... .+.+.+++ +...+||||+++-.|...- ++-...-.++..|+.-+..+-..| |||+|
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGD 227 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGD 227 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccC
Confidence 9999755 66666654 5678999999987664432 122223334444555554444556 99999
Q ss_pred cCCCcEEEccCCCceecccCcceec
Q 003045 663 LKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 663 lkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+++-||+++++|.+.++||-.+...
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999776643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.7e-07 Score=101.88 Aligned_cols=140 Identities=21% Similarity=0.302 Sum_probs=92.6
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEecccccc--------------------------CH----HH----------HHH
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--------------------------GL----EE----------FKN 580 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~----~~----------~~~ 580 (854)
+.|+.++-|.||+|++++|+.||||+.+..-.. .. ++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 689999999999999999999999998653110 00 11 233
Q ss_pred HHHHHHhcC----CCceeeeeeeEE-eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHH-HHHhhcCC
Q 003045 581 EIILIAKLQ----HRNLVRLLGCCI-QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG-LLYLHRDS 654 (854)
Q Consensus 581 Ei~~l~~l~----h~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~ 654 (854)
|...+.+++ +..-+++=..|. -.+...|+|||++|-.+.+...... ..++.+ .++..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 444444442 222233333333 3567899999999999988753222 223422 233333332 22232344
Q ss_pred CCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 655 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999998764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.8e-07 Score=83.79 Aligned_cols=88 Identities=28% Similarity=0.468 Sum_probs=63.6
Q ss_pred eEEEeccCCeEEEcCC-CcEEEEecccccc-ccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 97 TLTIGNDGNLMVLNGN-SIAVWSSNASVVS-NNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 97 ~l~~~~~g~l~l~~~~-~~~vW~t~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
++.++.||+||+++.. +.+||++++.... ....+.|+++|||||++.+ +.++|+| +|-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S-----~t~---------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS-----NTT---------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe-----ccc----------
Confidence 4566789999999875 5899999986532 2367889999999999877 5789997 111
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecC
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSG 221 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg 221 (854)
...|.|.+.|+++|...++-. ...+.|.|.
T Consensus 83 ----------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 83 ----------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 134678899999997544322 235678663
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.6e-06 Score=88.60 Aligned_cols=107 Identities=25% Similarity=0.279 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHHhcCCC--ceeeeeeeEEeCC----eeEEEEEcCCCC-ChhhhhcCcccccCCCHHHHHHHHHHHHHHH
Q 003045 575 LEEFKNEIILIAKLQHR--NLVRLLGCCIQGE----EKMLIYEYMPNK-SLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647 (854)
Q Consensus 575 ~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 647 (854)
.....+|...+.++... ...+++++..... ..++|+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 44678899988888643 3456666665532 458999999984 78888843221 55667788999999999
Q ss_pred HHhhcCCCCceEEcccCCCcEEEccCC---CceecccCcceec
Q 003045 648 LYLHRDSRLRIIHRDLKASNILLDEDM---NPKISDFGMARIF 687 (854)
Q Consensus 648 ~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~~ 687 (854)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-06 Score=80.40 Aligned_cols=88 Identities=25% Similarity=0.418 Sum_probs=63.2
Q ss_pred eEEEec-cCCeEEEcCC-CcEEEEeccccc-cccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEE
Q 003045 97 TLTIGN-DGNLMVLNGN-SIAVWSSNASVV-SNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVN 173 (854)
Q Consensus 97 ~l~~~~-~g~l~l~~~~-~~~vW~t~~~~~-~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~ 173 (854)
++.++. ||+||+++.. +.+||++++... .....+.|+++|||||++.+ +.++|+|= |-
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~-----~~--------- 83 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSN-----TT--------- 83 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEec-----cc---------
Confidence 345665 9999999765 589999998653 34567889999999999987 57899971 10
Q ss_pred ecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecC
Q 003045 174 SALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSG 221 (854)
Q Consensus 174 ~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg 221 (854)
...+.+.+.|+++|...++-. .....|.|.
T Consensus 84 -----------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 113 (116)
T cd00028 84 -----------------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSF 113 (116)
T ss_pred -----------------CCCCceEEEEeCCCCEEEECC-CCCEEEcCC
Confidence 024678899999996444322 245678765
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.1e-07 Score=105.91 Aligned_cols=153 Identities=19% Similarity=0.241 Sum_probs=101.5
Q ss_pred HHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC----ccc---ccccccccccccceeec
Q 003045 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN----EAN---TNRVVGTYGYMAPEYAM 712 (854)
Q Consensus 640 ~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~----~~~---~~~~~gt~~Y~aPE~~~ 712 (854)
+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++........ ... ..-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999876 699999999999999999999999998875432111 011 11123456799999999
Q ss_pred cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCC
Q 003045 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQD 792 (854)
Q Consensus 713 ~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 792 (854)
+...+.++|+||+|+++|-+..|+.+....... ........ ..+..-...++.....++.+=+.+.+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~----------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSR----------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhh----------cccccccccccccCcHHHHHHHHHHhcC
Confidence 988999999999999999999665543211111 11111110 0111111122233444566666678889
Q ss_pred CCCCCCCHHHHHH
Q 003045 793 SAMYRPTMASVVL 805 (854)
Q Consensus 793 dp~~RPs~~eVl~ 805 (854)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999997776654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-06 Score=73.67 Aligned_cols=70 Identities=37% Similarity=0.753 Sum_probs=55.5
Q ss_pred CCcceEeecccCCCccc--ccccChhhHHHHHhc-cCCeeeeeccC-CceeeEee-eccccceecccCCeEEEEe
Q 003045 365 EDGFKVFKNVKLPDFAD--VVSVGQETCKDKCLQ-NCSCNAYADIP-GIGCMLWR-GELIDVKSFEKGGNLLHVR 434 (854)
Q Consensus 365 ~~~f~~~~~~~lpd~~~--~~~~s~~~C~~~Cl~-nCsC~Aya~~~-g~gC~~w~-~~l~~~~~~~~~~~~ly~r 434 (854)
...|..++++.+++... ....++++|++.|++ +|+|.||+|.. +.+|.+|. +.+.+.......+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEEe
Confidence 45688899999986542 236799999999999 99999999964 57899999 8888877556666677765
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.8e-06 Score=84.76 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=86.4
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce--eeeeeeEEeCCeeEEEEEcCCCCC-
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL--VRLLGCCIQGEEKMLIYEYMPNKS- 617 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~~~~~lV~Ey~~~gs- 617 (854)
.+||+|..+.||+. .+..+++|..... .......+|.++++.+..-.+ .+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 3556888887543 234567899999999975444 567777777777889999999963
Q ss_pred hhhhh---------------------cCcccccCCCHHHHHH-HHH----------HHHH-HHHHhhcC-CCCceEEccc
Q 003045 618 LDLFI---------------------FDPAKQALLDWTKRFA-IIE----------GIAR-GLLYLHRD-SRLRIIHRDL 663 (854)
Q Consensus 618 L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~-~~~~ivH~Dl 663 (854)
+...+ +.... .......... +.. .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 10000 0011111100 000 0011 11122111 2245799999
Q ss_pred CCCcEEEccCCCceecccCccee
Q 003045 664 KASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 664 kp~NILl~~~~~~kl~DFGla~~ 686 (854)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-05 Score=81.18 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=102.6
Q ss_pred cccCCcccEEEeEcCCCcEEEEEEeccc------cccCHHHHHHHHHHHHhcCCC--ceeeeeeeEEeC-----CeeEEE
Q 003045 543 LGRGGFGPVHKGKLPEGQDIAVKRLSRK------SGQGLEEFKNEIILIAKLQHR--NLVRLLGCCIQG-----EEKMLI 609 (854)
Q Consensus 543 LG~G~fg~Vy~~~~~~g~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~-----~~~~lV 609 (854)
-|.||-+-|++-.. +|+.+-+|+-... .+.....|.+|+..|.++... .+.+++ ++... -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35688888999876 4557888987521 144677899999999999633 244444 33211 135799
Q ss_pred EEcCCC-CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC--ceecccCccee
Q 003045 610 YEYMPN-KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN--PKISDFGMARI 686 (854)
Q Consensus 610 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~ 686 (854)
+|-+++ .+|.+++.+. .....+...+..++.++++.+.-||+.+ +.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5777777432 1224577788899999999999999999 999999999999986666 99999987764
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.5e-05 Score=73.02 Aligned_cols=99 Identities=23% Similarity=0.398 Sum_probs=66.6
Q ss_pred CeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEee-cCCCCCCCCCceEEEeccCCeEEEcCCCcEEEEecccc
Q 003045 45 ESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVA-NRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASV 123 (854)
Q Consensus 45 ~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~ 123 (854)
+.+.+.+|.+.|-|...++ -+.|. ...+++|.. +...... ..+.+.|+.||||||+|..+.++|+|..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn------Lvl~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-- 80 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN------LVLYD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD-- 80 (114)
T ss_dssp EEEEECETTEEEEEETTSE------EEEEE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--
T ss_pred cccccccccccceECCCCe------EEEEc--CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--
Confidence 4566655888998876664 23333 335779999 4343321 5689999999999999999999999942
Q ss_pred ccccceeEecc--CCceEEEcCCCcCCccceeeeeccCC
Q 003045 124 VSNNTAALLED--DGNLILTNSEDIGNLGKAYWQSFNHP 160 (854)
Q Consensus 124 ~~~~~~~~l~d--~gnlvl~~~~~~~~~~~~~WqsFd~P 160 (854)
....+.+..++ +||++ +... ..+.|.|=+.|
T Consensus 81 ~ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dp 113 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDP 113 (114)
T ss_dssp SSS-EEEEEET--TSEEE-EEST-----SSEEEESS---
T ss_pred CCccEEEeccCcccCCCc-cccc-----eEEeECCCCCC
Confidence 23456677777 89999 6544 46789886655
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-05 Score=80.83 Aligned_cols=151 Identities=17% Similarity=0.215 Sum_probs=101.3
Q ss_pred eHHHHHHHhcCcccCc---ccccCCcccEEEeEcCCCcEEEEEEecccccc-------------------CHHH-----H
Q 003045 526 NFNTIAVATNYFSEGN---KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ-------------------GLEE-----F 578 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~---~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~-----~ 578 (854)
+.+++.....+..+.. .|..|.-+.||+|...++..+|||++...... ..++ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4455555555554444 45667778899999888999999998643110 1111 2
Q ss_pred HHHHHHHHhcC--CCceeeeeeeEEeCCeeEEEEEcCCCCChhh-hhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CC
Q 003045 579 KNEIILIAKLQ--HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL-FIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DS 654 (854)
Q Consensus 579 ~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~ 654 (854)
..|+.-|.++. +-.+.+.+++. .-.|||||+.....-. .| +...+...+...+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 45777787774 44455555543 4579999997652111 11 11122333566777888888887776 45
Q ss_pred CCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 655 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
+||+||+.-|||+. ++.+.|+|||.|....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.3e-07 Score=101.37 Aligned_cols=190 Identities=19% Similarity=0.146 Sum_probs=137.8
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc-eeeeeeeEEeCCeeEEE
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN-LVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lV 609 (854)
+..+..+...+.+++++++.++|.+-...+....+.+... .+..-++++|.+++||| .++.++-+..+....++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3445556666788999999999987544444445554332 45677899999999999 77777777777788999
Q ss_pred EEcCCCC--ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 610 YEYMPNK--SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 610 ~Ey~~~g--sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
++++..+ +..... ...-.+..-+...+.+.-+++++|||+.- -+|+| ||+..+ +..|..||+.+..+
T Consensus 313 ~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 313 MRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 9999887 221111 01111233334455666778899999864 58998 777766 67899999998876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
.... ..+...+++.++|||+..+..+..+-|+|++|+-..++--|-+|.
T Consensus 382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4322 344578899999999999999999999999999877887777664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=80.03 Aligned_cols=139 Identities=16% Similarity=0.177 Sum_probs=91.3
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHH---------HHHHHHHHHhcCCCcee---eeeee
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEE---------FKNEIILIAKLQHRNLV---RLLGC 599 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~h~niv---~l~~~ 599 (854)
....+|...+.+-......|.+-.. +|+.+++|..........+. ..+++..+.+++...+. .++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456677767777766666766665 67899999876543222222 23445555555433322 22222
Q ss_pred EE-----eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC
Q 003045 600 CI-----QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM 674 (854)
Q Consensus 600 ~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 674 (854)
.+ .....+++|||++|..|.++.. ++. .++..+++++.-||+.| ++|+|..|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 21 2235568999999988866531 222 24566788899999999 99999999999999655
Q ss_pred CceecccCccee
Q 003045 675 NPKISDFGMARI 686 (854)
Q Consensus 675 ~~kl~DFGla~~ 686 (854)
++++||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.7e-05 Score=88.99 Aligned_cols=147 Identities=16% Similarity=0.228 Sum_probs=91.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccC-------------------------------HH-----
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQG-------------------------------LE----- 576 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------~~----- 576 (854)
.-..|+ .+.||..+.|.||+|++++|+.||||+-+..-... .+
T Consensus 160 if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 160 IFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred HHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 334444 36899999999999999999999999876531110 01
Q ss_pred -HHHHHHHHHHh----cCCCc---eeeeeeeEEe-CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHH
Q 003045 577 -EFKNEIILIAK----LQHRN---LVRLLGCCIQ-GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647 (854)
Q Consensus 577 -~~~~Ei~~l~~----l~h~n---iv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 647 (854)
.|.+|.+-..+ +.|-+ -|.+-.++.+ ...+.|+||||+|..+.+...-.+. .++-..+..-+.++..-+
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ 316 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH
Confidence 13334433333 34555 2223333332 3578999999999988776532221 244333333222222222
Q ss_pred HHhhcCCCCceEEcccCCCcEEEcc----CCCceecccCcceec
Q 003045 648 LYLHRDSRLRIIHRDLKASNILLDE----DMNPKISDFGMARIF 687 (854)
Q Consensus 648 ~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DFGla~~~ 687 (854)
-+ ..| ++|+|-+|.||++.. ++++.+.|||+....
T Consensus 317 If--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HH--hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 22 224 999999999999984 668999999998865
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.7e-05 Score=80.90 Aligned_cols=143 Identities=22% Similarity=0.210 Sum_probs=84.8
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeeeeEEeC---CeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLGCCIQG---EEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~---~~~~lV~Ey~~~ 615 (854)
+.|+.|..+.||+....+ +.+++|..... .....+..|..+++.+.... +.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999998866 69999987543 44567889999999886433 44566544332 346899999999
Q ss_pred CChhh----------------hhc---Cc-ccccCCCHHHH---------HHH------------HHHHHH-HHHHhhc-
Q 003045 616 KSLDL----------------FIF---DP-AKQALLDWTKR---------FAI------------IEGIAR-GLLYLHR- 652 (854)
Q Consensus 616 gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~- 652 (854)
..+.. .+. .. ........... ... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 110 00 00001111100 000 111222 2333332
Q ss_pred ---CCCCceEEcccCCCcEEEc-cCCCceecccCccee
Q 003045 653 ---DSRLRIIHRDLKASNILLD-EDMNPKISDFGMARI 686 (854)
Q Consensus 653 ---~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~ 686 (854)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 556668999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-05 Score=80.60 Aligned_cols=141 Identities=14% Similarity=0.121 Sum_probs=86.0
Q ss_pred ccccCCc-ccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcCCCCChh
Q 003045 542 KLGRGGF-GPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYMPNKSLD 619 (854)
Q Consensus 542 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 619 (854)
.|-.|.. ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4455555 788999764 4788888875432 345778999998885 434556777776666789999999998876
Q ss_pred hhhc-------------------Cccc-ccCCC--HHHHHHHHH--------------------HHHHHHHHhhc----C
Q 003045 620 LFIF-------------------DPAK-QALLD--WTKRFAIIE--------------------GIARGLLYLHR----D 653 (854)
Q Consensus 620 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 653 (854)
.... .... ...+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 00111 000000000 01111122211 1
Q ss_pred CCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 654 ~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.9e-05 Score=77.84 Aligned_cols=105 Identities=22% Similarity=0.232 Sum_probs=84.1
Q ss_pred HHHHHHHHhcCC-CceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 003045 579 KNEIILIAKLQH-RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657 (854)
Q Consensus 579 ~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 657 (854)
.+|.-+++.+++ +++.+++|+| ..++|.||...+++...-.....-...+|..|.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999986 6999999999 34779999988765321100011123689999999999999999999876556
Q ss_pred eEEcccCCCcEEEccCCCceecccCcceec
Q 003045 658 IIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 658 ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=6.7e-05 Score=72.41 Aligned_cols=129 Identities=20% Similarity=0.234 Sum_probs=89.5
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
..+.|++|.+|.||+|.+. |..+|+|+-..+ ..+..+..|.++|..++-.++-+=+-.+ +.-++.|||+.+-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 3568999999999999984 558899986543 4567889999999999877766543333 233455999999888
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccC-CCcEEEccCCCceecccCccee
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK-ASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kl~DFGla~~ 686 (854)
...-... + .+-+..+++.-.-|...+ |-|..|. |..++|..++.+.|+||..|..
T Consensus 100 ~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6664211 1 122334455544455556 9999987 5555555555999999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00012 Score=76.47 Aligned_cols=73 Identities=16% Similarity=0.243 Sum_probs=46.5
Q ss_pred cccccCCccc-EEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC---ceeeeeeeEEeC---CeeEEEEEcC
Q 003045 541 NKLGRGGFGP-VHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR---NLVRLLGCCIQG---EEKMLIYEYM 613 (854)
Q Consensus 541 ~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~---~~~~lV~Ey~ 613 (854)
+.|+.|+... ||+. +..+++|..... .....+.+|.++++.+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 5678777774 8975 235777865432 2345789999999888632 233334333222 1347899999
Q ss_pred CCCChh
Q 003045 614 PNKSLD 619 (854)
Q Consensus 614 ~~gsL~ 619 (854)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00029 Score=87.18 Aligned_cols=79 Identities=15% Similarity=0.318 Sum_probs=58.3
Q ss_pred CcccccCCcccEEEeEcCCC---cEEEEEEecccc-ccCHHHHHHHHHHHHhcC-CCce--eeeeeeEEeC---CeeEEE
Q 003045 540 GNKLGRGGFGPVHKGKLPEG---QDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ-HRNL--VRLLGCCIQG---EEKMLI 609 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 609 (854)
.++|+.|.+..+|+.+..++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876554 467888764322 223457889999999996 6664 6777777654 467899
Q ss_pred EEcCCCCCh
Q 003045 610 YEYMPNKSL 618 (854)
Q Consensus 610 ~Ey~~~gsL 618 (854)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00041 Score=75.12 Aligned_cols=77 Identities=9% Similarity=0.035 Sum_probs=57.0
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCC---CceeeeeeeEEeC---CeeEEEEEc
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH---RNLVRLLGCCIQG---EEKMLIYEY 612 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~---~~~~lV~Ey 612 (854)
..+.||+|..+.||+....++ .+++|..+. ......+..|.+.|+.+.. ..+.++++++..+ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999877555 466676432 1234578999999999853 3577788777543 568999999
Q ss_pred CCCCCh
Q 003045 613 MPNKSL 618 (854)
Q Consensus 613 ~~~gsL 618 (854)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00029 Score=73.53 Aligned_cols=74 Identities=20% Similarity=0.325 Sum_probs=49.4
Q ss_pred cccccCCcccEEEeEcCC--CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEcCCCCC
Q 003045 541 NKLGRGGFGPVHKGKLPE--GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
+.|..|-...+|+....+ ++.+++|+....... .-...+|+.+++.+...+++ +++.... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999998764 678999977543221 12335799999998654444 3333322 248999999877
Q ss_pred hh
Q 003045 618 LD 619 (854)
Q Consensus 618 L~ 619 (854)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00053 Score=69.18 Aligned_cols=128 Identities=16% Similarity=0.239 Sum_probs=91.0
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEecccc----------------ccCHHHHHHHHHHHHhcC------CCceeeee
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS----------------GQGLEEFKNEIILIAKLQ------HRNLVRLL 597 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~l~ 597 (854)
...||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45899999999996 5667778889886544 223566777887766666 78899999
Q ss_pred eeEEeCCeeEEEEEcCCCC------ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 598 GCCIQGEEKMLIYEYMPNK------SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 598 ~~~~~~~~~~lV~Ey~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
|+.++....-+|+|.+.+. +|.+++. ...++. +.... +-+-..||-+.. |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 9999998899999987542 4666662 223444 33333 334445666666 99999999999996
Q ss_pred cCC----Cceecc
Q 003045 672 EDM----NPKISD 680 (854)
Q Consensus 672 ~~~----~~kl~D 680 (854)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 433 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0003 Score=74.61 Aligned_cols=139 Identities=16% Similarity=0.093 Sum_probs=80.1
Q ss_pred ccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEcCCCCChhh
Q 003045 542 KLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEYMPNKSLDL 620 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~gsL~~ 620 (854)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....+. +++... ...+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456677889999874 5678889876443222112357899999999654443 333332 2468999999877642
Q ss_pred h-----------------hcCcc-cccCCCHHHH-HHHHHH---------HHHHHHHhhcC-----CCCceEEcccCCCc
Q 003045 621 F-----------------IFDPA-KQALLDWTKR-FAIIEG---------IARGLLYLHRD-----SRLRIIHRDLKASN 667 (854)
Q Consensus 621 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlkp~N 667 (854)
- ++... ....++.... ..+..+ +...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11110 0111222211 111111 11112222111 12358999999999
Q ss_pred EEEccCCCceecccCccee
Q 003045 668 ILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~ 686 (854)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00047 Score=68.97 Aligned_cols=136 Identities=24% Similarity=0.341 Sum_probs=95.6
Q ss_pred CCcccceeHHHHHHHhcCcccCcccccCCc-ccEEEeEcCCCcEEEEEEeccc---cc------------------cCHH
Q 003045 519 GTDLAMFNFNTIAVATNYFSEGNKLGRGGF-GPVHKGKLPEGQDIAVKRLSRK---SG------------------QGLE 576 (854)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~---~~------------------~~~~ 576 (854)
+..+..|.. .+..++..+.||.|.- |.||++++ +|+.+|+|.+..- .. ...+
T Consensus 26 gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 26 GPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 344555655 2277888899999999 99999998 6789999994321 00 1123
Q ss_pred HHHHHHHHHHhcC---CCce--eeeeeeEEeC------------------CeeEEEEEcCCCCChhhhhcCcccccCCCH
Q 003045 577 EFKNEIILIAKLQ---HRNL--VRLLGCCIQG------------------EEKMLIYEYMPNKSLDLFIFDPAKQALLDW 633 (854)
Q Consensus 577 ~~~~Ei~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~ 633 (854)
-|..|.+...+|+ +.++ |+.+||..-. ..+.||.||++...
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------- 163 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------- 163 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------
Confidence 4778888877775 4566 8999987422 12356777765542
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 634 TKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 634 ~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
.....-+.+|.+-|..+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 164 ~~~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 PLQIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccchhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 112334567788888999998 999999999986 5689999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00078 Score=73.04 Aligned_cols=143 Identities=17% Similarity=0.121 Sum_probs=87.3
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeeee------EEeCCeeEEEEE
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLGC------CIQGEEKMLIYE 611 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E 611 (854)
.+.|..|....+|+....+ ..+++|+... ...+.+..|++++..+++.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987644 4788898754 33456778898888885433 3444331 123456689999
Q ss_pred cCCCCChhhh----h----------cCcc----c----ccCCCHHHHH----------HHHHHHHHHHHHhhcC----CC
Q 003045 612 YMPNKSLDLF----I----------FDPA----K----QALLDWTKRF----------AIIEGIARGLLYLHRD----SR 655 (854)
Q Consensus 612 y~~~gsL~~~----l----------~~~~----~----~~~l~~~~~~----------~i~~~ia~gL~yLH~~----~~ 655 (854)
|++|..+... . +... . .....|.... .....+...+.++.+. .+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776321 0 1000 0 0111222211 0111233344444431 12
Q ss_pred CceEEcccCCCcEEEccCCCceecccCccee
Q 003045 656 LRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 656 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0014 Score=73.12 Aligned_cols=74 Identities=15% Similarity=0.180 Sum_probs=53.8
Q ss_pred cccccCCcccEEEeEcCCC-cEEEEEEeccc-----c--ccCHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCeeEEE
Q 003045 541 NKLGRGGFGPVHKGKLPEG-QDIAVKRLSRK-----S--GQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV 609 (854)
+.||.|-+..||+....+| +.++||.-... . +...+.+..|.+.|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998777 58999985321 1 234567788888888873 2345566655 44668899
Q ss_pred EEcCCCC
Q 003045 610 YEYMPNK 616 (854)
Q Consensus 610 ~Ey~~~g 616 (854)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0014 Score=71.37 Aligned_cols=141 Identities=26% Similarity=0.336 Sum_probs=83.5
Q ss_pred cccccCCcccEEEeEcCC-------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPE-------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey 612 (854)
+.|..|--..+|+.+..+ ++.+++|+..... .......+|++++..+....+. ++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 355566667889887654 5789999975543 2234567899999888644443 3444442 2358999
Q ss_pred CCCCChhhhh-----------------cCccccc------CCC--HHHHHH--------------------------HHH
Q 003045 613 MPNKSLDLFI-----------------FDPAKQA------LLD--WTKRFA--------------------------IIE 641 (854)
Q Consensus 613 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 641 (854)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 1100000 000 111100 111
Q ss_pred HHHHHHHHhhc------CCCCceEEcccCCCcEEEccC----CCceecccCccee
Q 003045 642 GIARGLLYLHR------DSRLRIIHRDLKASNILLDED----MNPKISDFGMARI 686 (854)
Q Consensus 642 ~ia~gL~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~ 686 (854)
.+..-+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 234569999999999999985 8899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0062 Score=66.79 Aligned_cols=142 Identities=18% Similarity=0.196 Sum_probs=79.5
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeee------eEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLG------CCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~Ey 612 (854)
+.|+.|....+|+.+..+| .+++|++.. ...+....|+.++..|...+ +.+++. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4577787789999887555 688998752 22344555667776664222 223332 12234567899999
Q ss_pred CCCCChhh-----------hh---cCccc--------ccCCCH-HHHHH------------HHHH-HHHHHHHhhcC---
Q 003045 613 MPNKSLDL-----------FI---FDPAK--------QALLDW-TKRFA------------IIEG-IARGLLYLHRD--- 653 (854)
Q Consensus 613 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~~~-ia~gL~yLH~~--- 653 (854)
++|..+.. .+ +.... ...+.| ..... .+.+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11 10000 001112 11111 1111 11122333211
Q ss_pred -CCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 654 -SRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 654 -~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
-+..+||+|+.|.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999766568999998863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.012 Score=64.17 Aligned_cols=143 Identities=18% Similarity=0.191 Sum_probs=83.7
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeeee------EEeCCeeEEEEE
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLGC------CIQGEEKMLIYE 611 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E 611 (854)
.+.++.|-...+|+.+..++ .+++|+.... ...+++..|++++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876544 6888876542 12445667788888875322 3343332 122456789999
Q ss_pred cCCCCChhhh--------------hcCcccc---------cCCCHHHHH------------HHHHHHHHHHHHhhc----
Q 003045 612 YMPNKSLDLF--------------IFDPAKQ---------ALLDWTKRF------------AIIEGIARGLLYLHR---- 652 (854)
Q Consensus 612 y~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~gL~yLH~---- 652 (854)
|++|..+... ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654211 0110000 001111110 011123344555542
Q ss_pred CCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 653 ~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.-+..++|+|+++.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0052 Score=65.91 Aligned_cols=73 Identities=15% Similarity=0.203 Sum_probs=48.9
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
.+.|+.|....+|+.+ .+++.+.||.-. ......|..|.+-|+.|. -..+.+++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3578889999999988 478899999865 234457889999888884 345778888887777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0058 Score=67.69 Aligned_cols=140 Identities=21% Similarity=0.278 Sum_probs=81.5
Q ss_pred ccccCCcccEEEeEcCC-----CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEcCCC
Q 003045 542 KLGRGGFGPVHKGKLPE-----GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
.|-.|-.-.+|+....+ ++.+++|+.........+. .+|+.+++.+...++. ++++++..+ .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45456667788876432 3678999876544333333 7799999998755554 455555322 58999988
Q ss_pred CChhhhh-----------------cCcc--c-ccCCCHHHHHHHHHHH-----------------HHHHHHh----hc-C
Q 003045 616 KSLDLFI-----------------FDPA--K-QALLDWTKRFAIIEGI-----------------ARGLLYL----HR-D 653 (854)
Q Consensus 616 gsL~~~l-----------------~~~~--~-~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~ 653 (854)
.++.... +... . .....+.+..++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 7764210 1100 0 0011122222222111 1111122 21 2
Q ss_pred CCCceEEcccCCCcEEEcc-CCCceecccCccee
Q 003045 654 SRLRIIHRDLKASNILLDE-DMNPKISDFGMARI 686 (854)
Q Consensus 654 ~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~ 686 (854)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2345899999999999986 46899999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0026 Score=77.25 Aligned_cols=196 Identities=19% Similarity=0.168 Sum_probs=131.1
Q ss_pred HHHHHHHHHhcCCCceeeeeeeEEeCCeeE----EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC
Q 003045 578 FKNEIILIAKLQHRNLVRLLGCCIQGEEKM----LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653 (854)
Q Consensus 578 ~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 653 (854)
..-|+..+.++.|+|+++++.|-.+....- +..|++..-++...+. .-..++......+..++.+||+|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677888899999999999887654433 3456777777766663 334577888888999999999999998
Q ss_pred CCCceEEcccCCC---cEEEccCCCceec--ccCcceeccCccCcccccccccccccccceeeccCCCCcc--cchhhHH
Q 003045 654 SRLRIIHRDLKAS---NILLDEDMNPKIS--DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVK--SDVYSFG 726 (854)
Q Consensus 654 ~~~~ivH~Dlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~--~DVwSlG 726 (854)
. ..|.-|..+ +..++..+.+.+. ||+..+.+.... ......-+..+-+||......++.+ .|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 445444443 4444556666666 888887653211 1112233556888888777665554 7999999
Q ss_pred HHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 727 VLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 727 vil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
..+..+..|..+..... ... .+++.. . ...+.+...+|+..++++|++..+++..
T Consensus 380 ll~~~~~~~~~i~~~~~-----~~~------------~~l~~~----~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA-----VPV------------SLLDVL----S----TSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCccccccc-----chh------------hhhccc----c----chhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999999876543110 000 011110 0 0144566678999999999999999984
Q ss_pred H
Q 003045 807 L 807 (854)
Q Consensus 807 L 807 (854)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 3
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.013 Score=62.78 Aligned_cols=31 Identities=32% Similarity=0.598 Sum_probs=26.0
Q ss_pred CceEEcccCCCcEEEccCCC-ceecccCccee
Q 003045 656 LRIIHRDLKASNILLDEDMN-PKISDFGMARI 686 (854)
Q Consensus 656 ~~ivH~Dlkp~NILl~~~~~-~kl~DFGla~~ 686 (854)
..++|+|++|.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0019 Score=68.24 Aligned_cols=137 Identities=17% Similarity=0.178 Sum_probs=94.3
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEecc--cc--------------cc------CHHHHHHHHHHHHhcCC--
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSR--KS--------------GQ------GLEEFKNEIILIAKLQH-- 590 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~--------------~~------~~~~~~~Ei~~l~~l~h-- 590 (854)
.-++++++||-|.-+-||.+-..+|++.++|.-.. .+ .. .+-...+|+..|+.|..
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 34678899999999999999999999999884321 00 00 11234678888888853
Q ss_pred CceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 591 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
--+.+.+++ +..++|||++.+-.|...-+ ..+... +...+..-+.-|..+| +||+|..-=||++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 224445544 46688999998877755431 112222 3333344445566677 9999999999999
Q ss_pred ccCCCceecccCcceec
Q 003045 671 DEDMNPKISDFGMARIF 687 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~ 687 (854)
++++.++++||-.....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999766544
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0029 Score=47.51 Aligned_cols=44 Identities=39% Similarity=0.592 Sum_probs=38.3
Q ss_pred CCCCCCCCCCccccccCCCCCCCCcccC--CCCCCCceeeeeeccC
Q 003045 811 TPTLPVPRQPTFTSMRSSVDGDHFMEAH--DTVSSNDLTVTMVVGR 854 (854)
Q Consensus 811 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 854 (854)
...+|.|++|+|...+.....++.+... +.++.|++|+|+++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 3578999999999988887777776666 7899999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.0031 Score=52.66 Aligned_cols=34 Identities=24% Similarity=0.505 Sum_probs=28.7
Q ss_pred ccChhhHHHHHhccCCeeeeeccC-CceeeEeeec
Q 003045 384 SVGQETCKDKCLQNCSCNAYADIP-GIGCMLWRGE 417 (854)
Q Consensus 384 ~~s~~~C~~~Cl~nCsC~Aya~~~-g~gC~~w~~~ 417 (854)
..+.++|++.|+.+|+|.||.|.. ...|+++.+.
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 568899999999999999999964 3559988764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.01 Score=60.79 Aligned_cols=31 Identities=39% Similarity=0.563 Sum_probs=22.2
Q ss_pred CceEEcccCCCcEEE-ccCCCceecccCccee
Q 003045 656 LRIIHRDLKASNILL-DEDMNPKISDFGMARI 686 (854)
Q Consensus 656 ~~ivH~Dlkp~NILl-~~~~~~kl~DFGla~~ 686 (854)
..++|+||.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.035 Score=60.05 Aligned_cols=135 Identities=16% Similarity=0.270 Sum_probs=77.5
Q ss_pred cEEEeEcCCCcEEEEEEecc--ccccCHHHHHHHHHHHHhcCC--CceeeeeeeEEeCC--eeEEEEEcCCCCChhhhhc
Q 003045 550 PVHKGKLPEGQDIAVKRLSR--KSGQGLEEFKNEIILIAKLQH--RNLVRLLGCCIQGE--EKMLIYEYMPNKSLDLFIF 623 (854)
Q Consensus 550 ~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--~~~lV~Ey~~~gsL~~~l~ 623 (854)
.+|..... +++++++ ... ..........+|+.+|+.+.- .-.-+.++.|.++. ..+.||+|.++..+...+.
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 34444443 7888888 331 223344556788888888853 23344566666655 6699999999853322221
Q ss_pred Cccc-----------------------------------ccCCCHHHHHHHHH--------HHHHHHHHhhcC-----CC
Q 003045 624 DPAK-----------------------------------QALLDWTKRFAIIE--------GIARGLLYLHRD-----SR 655 (854)
Q Consensus 624 ~~~~-----------------------------------~~~l~~~~~~~i~~--------~ia~gL~yLH~~-----~~ 655 (854)
.... +..-.|...++.++ ....-..+|+.. +.
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 0000 00001111111000 111223333332 23
Q ss_pred CceEEcccCCCcEEEccCCCceecccCccee
Q 003045 656 LRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 656 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
..++|+|+.+.||+++.++-+-|+||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 5799999999999999998899999999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.03 Score=60.43 Aligned_cols=141 Identities=16% Similarity=0.152 Sum_probs=97.3
Q ss_pred cCcccccCCcccEEEeEcCCCcEEEEEEecccc----------------------ccCHH----HHHHHHHHHHhcCCCc
Q 003045 539 EGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS----------------------GQGLE----EFKNEIILIAKLQHRN 592 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~----~~~~Ei~~l~~l~h~n 592 (854)
+...|..|--+.||.+...+|..+|||+++... ...++ -...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788899999999999999999999885320 00111 1346888888887555
Q ss_pred eeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc
Q 003045 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE 672 (854)
Q Consensus 593 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 672 (854)
|...--.. -....|||+|+..... -....+...++...+..+-.+++.-|.-|.+.+ .+||.||.--|+|+-+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 33221111 1234699999864322 211223344667778888888999999888887 5999999999999854
Q ss_pred CCCceecccCcceec
Q 003045 673 DMNPKISDFGMARIF 687 (854)
Q Consensus 673 ~~~~kl~DFGla~~~ 687 (854)
|.+.|+|-+.+...
T Consensus 301 -G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEH 314 (520)
T ss_pred -CEEEEEEccccccC
Confidence 57899998877644
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.035 Score=61.17 Aligned_cols=140 Identities=16% Similarity=0.247 Sum_probs=78.9
Q ss_pred ccccCCcccEEEeEcCC----CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEcCCCC
Q 003045 542 KLGRGGFGPVHKGKLPE----GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
.|..|=--.+|+....+ +..|++|+......... .-.+|..+++.+...++- ++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 45446666778875432 34788998765433222 236799999999765554 4555552 22 589999877
Q ss_pred Chhhh-------h----------cCcc---cccCCCHHHHHHHHHHH----------------------HHHHH----Hh
Q 003045 617 SLDLF-------I----------FDPA---KQALLDWTKRFAIIEGI----------------------ARGLL----YL 650 (854)
Q Consensus 617 sL~~~-------l----------~~~~---~~~~l~~~~~~~i~~~i----------------------a~gL~----yL 650 (854)
.+..- + +... ....--|....++..++ .+-+. .+
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 1 1100 00011233222222111 11111 12
Q ss_pred hc-CCCCceEEcccCCCcEEEcc-CCCceecccCccee
Q 003045 651 HR-DSRLRIIHRDLKASNILLDE-DMNPKISDFGMARI 686 (854)
Q Consensus 651 H~-~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~ 686 (854)
.. .....++|.|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12235899999999999975 57899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.062 Score=58.98 Aligned_cols=73 Identities=18% Similarity=0.137 Sum_probs=48.9
Q ss_pred ccccCCcccEEEeEcCCC-cEEEEEEeccc-------cccCHHHHHHHHHHHHhcC--CCceeeeeeeEEeCCeeEEEEE
Q 003045 542 KLGRGGFGPVHKGKLPEG-QDIAVKRLSRK-------SGQGLEEFKNEIILIAKLQ--HRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lV~E 611 (854)
.||.|-...||++..++| +.|+||.-... -+-..++..-|...|+... .|..++-+-+ .+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence 579999999999988655 58999975321 1234455667888887764 3544443322 24566679999
Q ss_pred cCCC
Q 003045 612 YMPN 615 (854)
Q Consensus 612 y~~~ 615 (854)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.11 Score=58.14 Aligned_cols=73 Identities=10% Similarity=0.010 Sum_probs=49.8
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccc----cc---cCHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCeeEEE
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK----SG---QGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV 609 (854)
.+.||.|-...||+.... ++.++||+-... .. ...+.-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357899999999998864 557999976521 11 13344455667666654 246777877775 557889
Q ss_pred EEcCCC
Q 003045 610 YEYMPN 615 (854)
Q Consensus 610 ~Ey~~~ 615 (854)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 854 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-18 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-18 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 448 bits (1156), Expect = e-152
Identities = 113/309 (36%), Positives = 163/309 (52%), Gaps = 18/309 (5%)
Query: 516 QVNGTDLAMFNFNTIAVATNYFSE------GNKLGRGGFGPVHKGKLPEGQDIAVKRLS- 568
+V+ T F+F + TN F E GNK+G GGFG V+KG + +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 569 ---RKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDP 625
+ + ++F EI ++AK QH NLV LLG G++ L+Y YMPN SL +
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 626 AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685
L W R I +G A G+ +LH + IHRD+K++NILLDE KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE 745
T+R+VGT YMAPE + G + KSD+YSFGV+LLEI++G E
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 746 NSSLIEHVWNLWNEGKAME-LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
L++ + +E K +E +D + D+ S V V C+ + RP + V
Sbjct: 241 Q-LLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 805 LMLESETPT 813
+L+ T +
Sbjct: 299 QLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-146
Identities = 121/291 (41%), Positives = 177/291 (60%), Gaps = 6/291 (2%)
Query: 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLE-EFKNEII 583
F+ + VA++ FS N LGRGGFG V+KG+L +G +AVKRL + QG E +F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 584 LIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAK-QALLDWTKRFAIIEG 642
+I+ HRNL+RL G C+ E++L+Y YM N S+ + + + Q LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
ARGL YLH +IIHRD+KA+NILLDE+ + DFG+A++ + T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL---EENSSLIEHVWNLWNE 759
G++APEY G S K+DV+ +GV+LLE+++G+R +++ L++ V L E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810
K LVD +++ + +V + I V +LC Q S M RP M+ VV MLE +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-128
Identities = 108/306 (35%), Positives = 165/306 (53%), Gaps = 5/306 (1%)
Query: 505 SGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAV 564
+ + + S + + + ATN F +G G FG V+KG L +G +A+
Sbjct: 9 TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68
Query: 565 KRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD 624
KR + +S QG+EEF+ EI ++ +H +LV L+G C + E +LIY+YM N +L ++
Sbjct: 69 KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 625 PAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683
+ + W +R I G ARGL YLH + IIHRD+K+ NILLDE+ PKI+DFG+
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL 743
++ + V GT GY+ PEY ++G + KSDVYSFGV+L E++ R L
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 744 -EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMAS 802
E +L E N G+ ++VDPN+ D + + + C+ S+ RP+M
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 803 VVLMLE 808
V+ LE
Sbjct: 306 VLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 4e-97
Identities = 72/308 (23%), Positives = 128/308 (41%), Gaps = 29/308 (9%)
Query: 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIIL 584
+ + RG FG V K + + +AVK + Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 585 IAKLQHRNLVRLLGCCIQGE----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAII 640
+ ++H N+++ +G +G + LI + SL F+ K ++ W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 641 EGIARGLLYLHRD-------SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693
E +ARGL YLH D + I HRD+K+ N+LL ++ I+DFG+A F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 694 ANTNRVVGTYGYMAPEYAMEGL-----FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS- 747
+T+ VGT YMAPE + ++ D+Y+ G++L E+ S ++E
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 748 SLIEHVWNLWNEGKAMELV-----DPNIRDSSSQNQVLRCI-HVGMLCVQDSAMYRPTMA 801
E + + E+V P +RD ++ + + C A R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 802 SVVLMLES 809
V +
Sbjct: 308 CVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 6e-78
Identities = 70/336 (20%), Positives = 122/336 (36%), Gaps = 44/336 (13%)
Query: 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNE--I 582
+ ++ + +GRG +G V+KG L + + +AVK S + Q F NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 583 ILIAKLQHRNLVRLLGCCIQGE-----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF 637
+ ++H N+ R + + E +L+ EY PN SL ++ DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 638 AIIEGIARGLLYLHRD------SRLRIIHRDLKASNILLDEDMNPKISDFGMARIF---- 687
+ + RGL YLH + + I HRDL + N+L+ D ISDFG++
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 688 --GFNQNEANTNRVVGTYGYMAPEYAMEGL-------FSVKSDVYSFGVLLLEIVSGRRN 738
+ + VGT YMAPE + + D+Y+ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 739 TSFRLEENSSLIEHVWNLWNEGKAMELVD--------PNIRDSSSQNQVLRCIHVGML-- 788
+ + N ++ P ++ +N + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 789 CVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTS 824
C A R T + + + T+
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-62
Identities = 64/199 (32%), Positives = 108/199 (54%), Gaps = 6/199 (3%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLL 597
K+G G FG VH+ + G D+AVK L + + + EF E+ ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G Q ++ EY+ SL + + LD +R ++ +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
I+HR+LK+ N+L+D+ K+ DFG++R+ ++ GT +MAPE + +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 718 VKSDVYSFGVLLLEIVSGR 736
KSDVYSFGV+L E+ + +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-61
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
G LG+G FG K G+ + +K L R + F E+ ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ + I EY+ +L I Q W++R + + IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR------------VVGTYGYM 706
IHRDL + N L+ E+ N ++DFG+AR+ + + R VVG +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
APE + K DV+SFG++L EI+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-60
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+GRG FG V K K +D+A+K++ +S + F E+ ++++ H N+V+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
G C+ L+ EY SL + + ++G+ YLH
Sbjct: 67 YGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 657 RIIHRDLKASNILLDEDMN-PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
+IHRDLK N+LL KI DFG A + + G+ +MAPE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 716 FSVKSDVYSFGVLLLEIVSGRR 737
+S K DV+S+G++L E+++ R+
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG-------LEEFKNEIILIAKL 588
++G+GGFG VHKG+ + + +A+K L +G +EF+ E+ +++ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
H N+V+L G ++ E++P L + D A + W+ + ++ IA G+
Sbjct: 81 NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIE 136
Query: 649 YLHRDSRLRIIHRDLKASNILLDE-----DMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
Y+ + I+HRDL++ NI L + K++DFG+++ + + + ++G +
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNF 190
Query: 704 GYMAPE--YAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761
+MAPE A E ++ K+D YSF ++L I++G F E + I+ + + EG
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG--PFD-EYSYGKIKFINMIREEGL 247
Query: 762 AMEL---VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+ P +R+ V LC RP + +V L
Sbjct: 248 RPTIPEDCPPRLRN------------VIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 7e-58
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRL----SRKSGQGLEEFKNEIILIAKLQHRNLVR 595
+G GGFG V++ G ++AVK Q +E + E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L G C++ L+ E+ L+ + + IARG+ YLH ++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 656 LRIIHRDLKASNILLDEDMNP--------KISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
+ IIHRDLK+SNIL+ + + KI+DFG+AR + G Y +MA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMA 182
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
PE +FS SDV+S+GVLL E+++G
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-57
Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLL 597
G ++G G FG V+KGK D+AVK L+ + Q L+ FKNE+ ++ K +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G + ++ ++ SL + + + K I ARG+ YLH
Sbjct: 87 GYSTA-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 140
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE---YAMEG 714
IIHRDLK++NI L ED KI DFG+A ++ G+ +MAPE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 715 LFSVKSDVYSFGVLLLEIVSGR 736
+S +SDVY+FG++L E+++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 5e-57
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLL 597
KL G + KG+ +G DI VK L + S + +F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 598 GCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
G C LI +MP SL + + ++D ++ +ARG+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG- 714
L I L + ++++DEDM +IS + F + + ++APE A++
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKK 183
Query: 715 ---LFSVKSDVYSFGVLLLEIVSGR 736
+D++SF VLL E+V+
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 9e-54
Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 36/284 (12%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLL 597
G +G+G FG V+ G+ ++A++ + + + L+ FK E++ + +H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G C+ +I ++L + D LD K I + I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGTYGYMAPE----- 709
I+H+DLK+ N+ D + I+DFG+ I G Q ++ G ++APE
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 710 ----YAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765
+ FS SDV++ G + E+ + F+ + ++I + G L
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEAIIWQM----GTGMKPNL 263
Query: 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+ + +L C + RPT ++ MLE
Sbjct: 264 SQIGM-GKEISDILLFCWA------FEQEE-RPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-53
Identities = 73/296 (24%), Positives = 119/296 (40%), Gaps = 35/296 (11%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNE--IILIAKLQHRNLVRLL 597
++G+G +G V GK G+ +AVK + E I ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 598 GCCIQGEEK----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
I+G LI +Y N SL ++ K LD + GL +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 654 SRLR-----IIHRDLKASNILLDEDMNPKISDFGMARIF--GFNQNEANTNRVVGTYGYM 706
I HRDLK+ NIL+ ++ I+D G+A F N+ + N VGT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 707 APEYAMEGLFSV-------KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE 759
PE ++ + +D+YSFG++L E+ + E + V + +
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 760 GKAMELVD-----PNIRDSSSQNQVLRCIHVGML-CVQDSAMYRPTMASVVLMLES 809
E+V P+ + S ++ LR + M C + R T V L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-53
Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 33/295 (11%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNE--IILIAKLQHRNLVRLL 597
+G+G +G V +G +G+++AVK S + + + E + L+H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 598 GCCIQGEEK----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ LI Y SL ++ + LD I+ IA GL +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 654 SRLR-----IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT--NRVVGTYGYM 706
I HRDLK+ NIL+ ++ I+D G+A + + N+ + N VGT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 707 APE------YAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760
APE + D+++FG++L E+ + + + V N +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 761 KAMELVD-----PNIRDSSSQNQVLRCIHVGM-LCVQDSAMYRPTMASVVLMLES 809
++V PNI + + L + M C + R T + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 8e-51
Identities = 65/296 (21%), Positives = 119/296 (40%), Gaps = 35/296 (11%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNE--IILIAKLQHRNLVRLL 597
+G+G FG V +GK G+++AVK S + + E I L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 598 GCCIQGEEK----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ L+ +Y + SL ++ + + + A GL +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 654 -----SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT--NRVVGTYGYM 706
+ I HRDLK+ NIL+ ++ I+D G+A + + N VGT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 707 APEYAMEGLFSV-------KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE 759
APE ++ ++ ++D+Y+ G++ EI + + V + +
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 760 GKAMELVD-----PNIRDSSSQNQVLRCIHVGM-LCVQDSAMYRPTMASVVLMLES 809
+ ++V PNI + + LR + M C + R T + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-48
Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLP-----EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKL 588
+ LG G FG V + G+ +AVK L +SG + + K EI ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 589 QHRNLVRLLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEG 642
H N+V+ G C + LI E++P+ SL ++ + L +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------Q 134
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
I +G+ YL + +HRDL A N+L++ + KI DFG+ + ++ V
Sbjct: 135 ICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKD 187
Query: 703 YG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNL 756
+ APE M+ F + SDV+SFGV L E+++ ++S + +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
Query: 757 WNEGKAMELVDPNIRDSSSQNQVLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
+ + + R N C ++ M C + R + +++ E+
Sbjct: 248 TVT-RLVNTLKEGKRLPCPPN----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-47
Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 38/291 (13%)
Query: 540 GNKLGRGGFGPVHKGKLP-----EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+LG+G FG V + G+ +AVK+L + + L +F+ EI ++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 595 RLLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLL 648
+ G C + LI EY+P SL ++ ++ LL +T I +G+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGME 159
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG---- 704
YL R IHRDL NIL++ + KI DFG+ ++ ++ V G
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPI 212
Query: 705 -YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKA 762
+ APE E FSV SDV+SFGV+L E+ + ++ S E +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 763 MELVDPNIRDSSSQNQVLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
+EL+ N R C I++ M C ++ RP+ + L ++
Sbjct: 273 IELLKNNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 38/291 (13%)
Query: 540 GNKLGRGGFGPVHKGKLP-----EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+LG+G FG V + G+ +AVK+L + + L +F+ EI ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 595 RLLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLL 648
+ G C + LI EY+P SL ++ ++ LL +T I +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGME 128
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG---- 704
YL R IHRDL NIL++ + KI DFG+ ++ ++ V G
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPI 181
Query: 705 -YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKA 762
+ APE E FSV SDV+SFGV+L E+ + ++ S E +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 763 MELVDPNIRDSSSQNQVLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
+EL+ N R C I++ M C ++ RP+ + L ++
Sbjct: 242 IELLKNNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 76/310 (24%), Positives = 133/310 (42%), Gaps = 39/310 (12%)
Query: 540 GNKLGRGGFGPVHKGKLP-----EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
++LG+G FG V + G +AVK+L +F+ EI ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 595 RLLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLL 648
+ G + L+ EY+P+ L F+ + LL ++ I +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGME 141
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG---- 704
YL R +HRDL A NIL++ + + KI+DFG+A++ +++ VV G
Sbjct: 142 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPI 194
Query: 705 -YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKA 762
+ APE + +FS +SDV+SFGV+L E+ + ++ S E + +
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS-RL 253
Query: 763 MELVDPNIRDSSSQNQVLRC---IHVGML-CVQDSAMYRPTMASVVLMLESETPTLPVPR 818
+EL++ R + C +H M C S RP+ +++ L+
Sbjct: 254 LELLEEGQRLPAPPA----CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
Query: 819 QPTFTSMRSS 828
FT+
Sbjct: 310 THAFTAHPEG 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-47
Identities = 79/290 (27%), Positives = 121/290 (41%), Gaps = 38/290 (13%)
Query: 540 GNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNL 593
LG G FG V G+ +AVK L +G Q +K EI ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 594 VRLLGCCIQGEEK--MLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFAIIEGIARGLLY 649
++ GCC L+ EY+P SL ++ LL + + I G+ Y
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAY 149
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG----- 704
LH IHRDL A N+LLD D KI DFG+A+ V G
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVF 202
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAM 763
+ APE E F SDV+SFGV L E+++ + S + + + +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-RLT 261
Query: 764 ELVDPNIRDSSSQNQVLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
EL++ R C ++ M C + A +RPT +++ +L++
Sbjct: 262 ELLERGERLPRPDK----CPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+G+G FG V G G +AVK + K+ + F E ++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 600 CIQGEEK-MLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLR 657
++ + ++ EYM SL ++ + L D +F++ + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYL---EGNN 137
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY--MAPEYAMEGL 715
+HRDL A N+L+ ED K+SDFG+ + EA++ + G APE E
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 190
Query: 716 FSVKSDVYSFGVLLLEIVS-GRR 737
FS KSDV+SFG+LL EI S GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-45
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+G+G FG V G G +AVK + K+ + F E ++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 600 CIQGEEK-MLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLR 657
++ + ++ EYM SL ++ + L D +F++ + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYL---EGNN 309
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY--MAPEYAMEGL 715
+HRDL A N+L+ ED K+SDFG+ + EA++ + G APE E
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKK 362
Query: 716 FSVKSDVYSFGVLLLEIVS-GRR 737
FS KSDV+SFG+LL EI S GR
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRV 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-45
Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 31/276 (11%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+KLG G +G V++G +AVK L ++ +EEF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLR 657
C + +I E+M +L ++ + +Q + A I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT--QISSAMEYL---EKKN 338
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
IHR+L A N L+ E+ K++DFG++R+ + A+ + APE FS
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 397
Query: 718 VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQN 777
+KSDV++FGVLL EI + + + + S + E + + ME P
Sbjct: 398 IKSDVWAFGVLLWEIATYGM-SPYPGIDLSQVYELL----EKDYRMER--PE-------- 442
Query: 778 QVLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
C ++ M C Q + RP+ A + E+
Sbjct: 443 ---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 62/197 (31%), Positives = 90/197 (45%), Gaps = 7/197 (3%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQDIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
G ++GRG FG V G+L + +AVK +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
G C Q + ++ E + F+ + L ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS 717
IHRDL A N L+ E KISDFGM+R A+ + APE G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 718 VKSDVYSFGVLLLEIVS 734
+SDV+SFG+LL E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-45
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+LG G FG V + + +AVK L + ++F+ E L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLF-------------IFDPAKQALLDWTKRFAII 640
V+ G C G+ ++++EYM + L+ F + L ++ I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVV 700
IA G++YL + +HRDL N L+ ++ KI DFGM+R + + RV
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV- 191
Query: 701 GTYG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
G + +M PE M F+ +SDV+SFGV+L EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 31/214 (14%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQ----DIAVKRL-SRKSGQGLEEFKNEIILIAKLQHRNL 593
LG G FG V+KG PEG+ +A+K L S + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLLY 649
RLLG C+ LI + MP L ++ + LL+W IA+G+ Y
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 132
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG----- 704
L R++HRDL A N+L+ + KI+DFG+A++ G + E + G
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIK 184
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
+MA E + +++ +SDV+S+GV + E+++ G +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+LG G FG V + + +AVK L S ++F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLF------------IFDPAKQALLDWTKRFAIIE 641
VR G C +G ++++EYM + L+ F + L + A+
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
+A G++YL + L +HRDL N L+ + + KI DFGM+R + + R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217
Query: 702 TYG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+M PE + F+ +SDV+SFGV+L EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+KLG G +G V++G +AVK L ++ +EEF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
C + +I E+M +L ++ + +Q + + I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN-----RVVGTYGYMAPEYAME 713
IHRDL A N L+ E+ K++DFG++R+ + A+ + + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 714 GLFSVKSDVYSFGVLLLEIVS-GRR 737
FS+KSDV++FGVLL EI + G
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
++G G FG VH G +A+K + R+ E+F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
C++ L+ E+M + L ++ + + + G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL--DVCEGMAYL---EEACVI 126
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGLF 716
HRDL A N L+ E+ K+SDFGM R +Q ++T GT + +PE +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182
Query: 717 SVKSDVYSFGVLLLEIVS-GRR 737
S KSDV+SFGVL+ E+ S G+
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKI 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+LG G FG V GK D+A+K + ++ +EF E ++ L H LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
C + +I EYM N L ++ + + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK--DVCEAMEYL---ESKQFL 142
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGLF 716
HRDL A N L+++ K+SDFG++R ++ ++ G+ + PE M F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198
Query: 717 SVKSDVYSFGVLLLEIVS-GRR 737
S KSD+++FGVL+ EI S G+
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKM 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 540 GNKLGRGGFGPVHKG--KLPEGQDI--AVKRL---SRKSGQGLEEFKNEIILIAKLQHRN 592
KLG G FG V +G P G+ + AVK L + +++F E+ + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLL 648
L+RL G + ++ E P SL + L + +A G+
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGY 705
YL R IHRDL A N+LL KI DFG+ R N + + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
APE FS SD + FGV L E+ + G+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-44
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 26/212 (12%)
Query: 540 GNKLGRGGFGPVHKGKL--PEGQDI--AVKRLSRKSG---QGLEEFKNEIILIAKLQHRN 592
+G G G V G+L P +D+ A+K L K+G + +F +E ++ + H N
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
++RL G +G M++ EYM N SLD F+ Q + ++ G+ G+ YL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL-- 167
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YM 706
S L +HRDL A N+L+D ++ K+SDFG++R+ + + A T T G +
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWT 221
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
APE FS SDV+SFGV++ E+++ G R
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-44
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+LG G FG V GK D+AVK + ++ +EF E + KL H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRII 659
C + ++ EY+ N L ++ K + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY--DVCEGMAFL---ESHQFI 126
Query: 660 HRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGLF 716
HRDL A N L+D D+ K+SDFGM R + VGT + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 717 SVKSDVYSFGVLLLEIVS-GRR 737
S KSDV++FG+L+ E+ S G+
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 9e-44
Identities = 74/202 (36%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+LG G FG V G +AVK L ++ + F E L+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRI 658
Q E +I EYM N SL F+ P+ L ++ A IA G+ ++
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA--QIAEGMAFI---EERNY 130
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY--MAPEYAMEGLF 716
IHRDL+A+NIL+ + ++ KI+DFG+AR+ ++ T R + APE G F
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 717 SVKSDVYSFGVLLLEIVS-GRR 737
++KSDV+SFG+LL EIV+ GR
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 69/220 (31%), Positives = 108/220 (49%), Gaps = 33/220 (15%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRN 592
+LG FG V+KG L + Q +A+K L K G EEF++E +L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLF-------------IFDPAKQALLDWTKRFAI 639
+V LLG + + +I+ Y + L F D ++ L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699
+ IA G+ YL S ++H+DL N+L+ + +N KISD G+ R A+ ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 700 VGTYG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE M G FS+ SD++S+GV+L E+ S
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRN 592
+LG+G FG V++G +A+K ++ S + EF NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIAR 645
+VRLLG QG+ ++I E M L + + + A +K + IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
G+ YL + + +HRDL A N ++ ED KI DFGM R + E + R G G
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK-GGKGL 201
Query: 706 -----MAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
M+PE +G+F+ SDV+SFGV+L EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-43
Identities = 69/203 (33%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
KLG G FG V + +AVK + + +E F E ++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ E +I E+M SL F+ L F+ IA G+ ++ +
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA--QIAEGMAFI---EQRNY 305
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPEYAMEGL 715
IHRDL+A+NIL+ + KI+DFG+AR+ N+ A G + APE G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGS 361
Query: 716 FSVKSDVYSFGVLLLEIVS-GRR 737
F++KSDV+SFG+LL+EIV+ GR
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-43
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQDI----AVKRLSRKSG-QGLEEFKNEIILIAKLQHRNL 593
LG G FG VHKG PEG+ I +K + KSG Q + + ++ I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLLY 649
VRLLG C L+ +Y+P SL + LL+W IA+G+ Y
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG----- 704
L ++HR+L A N+LL +++DFG+A + + + +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
+MA E G ++ +SDV+S+GV + E+++ G
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 540 GNKLGRGGFGPVHKGKL--PEGQDI--AVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLV 594
+GRG FG V+ G L +G+ I AVK L+R + +F E I++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 595 RLLGCCIQGEEK-MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
LLG C++ E +++ YM + L FI + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL--- 144
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMA 707
+ + +HRDL A N +LDE K++DFG+AR + V G +MA
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMA 200
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVS 734
E F+ KSDV+SFGVLL E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 27/213 (12%)
Query: 540 GNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHR 591
+G G FG V+KG L + +A+K L K+G + +F E ++ + H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
N++RL G + + M+I EYM N +LD F+ + + + ++ GIA G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL- 163
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------Y 705
+ + +HRDL A NIL++ ++ K+SDFG++R+ + T T G +
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRW 216
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
APE F+ SDV+SFG+++ E+++ G R
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-43
Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 540 GNKLGRGGFGPVHKG--KLPEGQDI--AVKRLSRKSG---QGLEEFKNEIILIAKLQHRN 592
+G G FG V G KLP ++I A+K L K G + +F E ++ + H N
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
++RL G + + M++ EYM N SLD F+ Q + ++ GIA G+ YL
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL-- 163
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT---YGYMAPE 709
S + +HRDL A NIL++ ++ K+SDFG+ R+ + A T R G + +PE
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPE 220
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
F+ SDV+S+G++L E++S G R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 540 GNKLGRGGFGPVHKGKL---PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKL-QHRN 592
+ +G G FG V K ++ D A+KR+ K +F E+ ++ KL H N
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIE---- 641
++ LLG C L EY P+ +L F DPA + +
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 642 --GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699
+ARG+ YL S+ + IHRDL A NIL+ E+ KI+DFG++R Q V
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY----V 196
Query: 700 VGTYG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
T G +MA E +++ SDV+S+GVLL EIVS
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 539 EGNKLGRGGFGPVHKGKLPEG----QDIAVKRLSRKSGQG-LEEFKNEIILIAKLQHRNL 593
+G+G FG V+ G+ + A+K LSR + +E F E +L+ L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 594 VRLLGCCIQGEE-KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ L+G + E ++ YM + L FI P + + F + +ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL-- 140
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YM 706
+ + +HRDL A N +LDE K++DFG+AR + V +
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHRHARLPVKWT 195
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVS 734
A E F+ KSDV+SFGVLL E+++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 31/214 (14%)
Query: 540 GNKLGRGGFGPVHKGKL-PEGQ----DIAVKRLSRKSGQG-LEEFKNEIILIAKLQHRNL 593
LG G FG V+KG PEG+ +A+K L + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLLY 649
RLLG C+ LI + MP L ++ + LL+W IA+G+ Y
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 132
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG----- 704
L R++HRDL A N+L+ + KI+DFG+A++ G + E + G
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIK 184
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
+MA E + +++ +SDV+S+GV + E+++ G +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 539 EGNKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKSG----QGLEEFKNEIILIAKLQHR 591
E +LG G FG V KG + +AVK L K+ +E E ++ +L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAEANVMQQLDNP 78
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAK---QALLDWTKRFAIIEGIARGLL 648
+VR++G C + E ML+ E L+ ++ + +++ + ++ G+
Sbjct: 79 YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMK 131
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG---- 704
YL +HRDL A N+LL KISDFG+++ ++N
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWP 183
Query: 705 --YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
+ APE FS KSDV+SFGVL+ E S G++
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 540 GNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNL 593
G LG G FG V +G L +AVK + S + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 594 VRLLGCCIQGE-----EKMLIYEYMPNKSLDLFI---FDPAKQALLDWTKRFAIIEGIAR 645
+RLLG CI+ + M+I +M L ++ + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANTN-----RV 699
G+ YL S +HRDL A N +L +DM ++DFG+++ I+ + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
++A E + +++ KSDV++FGV + EI +
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 21/263 (7%)
Query: 484 CKNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKL 543
C + K + F G + + +D S +N + I ++ +
Sbjct: 38 CSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVI 97
Query: 544 GRGGFGPVHKGKL--PEGQDI--AVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLVRLLG 598
GRG FG V+ G L +G+ I AVK L+R + G + +F E I++ H N++ LLG
Sbjct: 98 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157
Query: 599 CCIQGEEK-MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
C++ E +++ YM + L FI + +A+G+ +L + +
Sbjct: 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMAPEYA 711
+HRDL A N +LDE K++DFG+AR + + V G +MA E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 712 MEGLFSVKSDVYSFGVLLLEIVS 734
F+ KSDV+SFGVLL E+++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 72/214 (33%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRN 592
LG G FG V++G++ P +AVK L S Q +F E ++I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFI----FDPAKQALLDWTKRFAIIEGIARGLL 648
+VR +G +Q + ++ E M L F+ P++ + L + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 649 YLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
YL IHRD+ A N LL KI DFGMAR + A+ R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206
Query: 706 -----MAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
M PE MEG+F+ K+D +SFGVLL EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 540 GNKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-Q 589
G LG G FG V + E +AVK L + + L + +E+ ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSL-------------DLFIFDPAKQALLDWTKR 636
H+N++ LLG C Q +I EY +L + + + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+ +ARG+ YL + + IHRDL A N+L+ E+ KI+DFG+AR I + +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 696 TN-----RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
TN + +MAPE + +++ +SDV+SFGVL+ EI +
Sbjct: 217 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 542 KLGRGGFGPVHKGKLPEGQ---DIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVR 595
+LG G FG V +G + D+A+K L K G EE E ++ +L + +VR
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
L+G C Q E ML+ E L F+ ++ + + ++ ++ G+ YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EE 128
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG------YMAPE 709
+HRDL A N+LL KISDFG+++ G + + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPE 183
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
FS +SDV+S+GV + E +S G++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 540 GNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNL 593
G LG+G FG V + +L +AVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 594 VRLLGCCIQGEEK------MLIYEYMPNKSLDLFIFD---PAKQALLDWTKRFAIIEGIA 644
+L+G ++ K M+I +M + L F+ L + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANTN-----R 698
G+ YL S IHRDL A N +L EDM ++DFG++R I+ + +
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
++A E + L++V SDV++FGV + EI++
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-42
Identities = 83/275 (30%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
KLG+G FG V G +A+K L + E F E ++ KL+H LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ E ++ EYM SL F+ + L L A IA G+ Y+ R+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA--QIASGMAYV---ERMNY 301
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSV 718
+HRDL+A+NIL+ E++ K++DFG+AR+ N+ A + APE A+ G F++
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 360
Query: 719 KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778
KSDV+SFG+LL E+ + R + N +++ V G M P
Sbjct: 361 KSDVWSFGILLTELTTKGR-VPYPGMVNREVLDQV----ERGYRMPC--PP--------- 404
Query: 779 VLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
C +H M C + RPT + LE
Sbjct: 405 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-42
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 540 GNKLGRGGFGPVHKGKL--------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-Q 589
G LG G FG V + E +AVK L + + L + +E+ ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSL-------------DLFIFDPAKQALLDWTKR 636
H+N++ LLG C Q +I EY +L + + + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+ +ARG+ YL + + IHRDL A N+L+ E+ KI+DFG+AR I + +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 696 TN-----RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
TN + +MAPE + +++ +SDV+SFGVL+ EI +
Sbjct: 263 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHR 591
G LG G FG V + +AVK L E +E+ +++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG--------- 642
N+V LLG C G ++I EY L F+ + T + +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 643 ------IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEAN 695
+A+G+ +L + IHRDL A NILL KI DFG+AR I +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 696 TN-----RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
N + +MAPE +++ +SDV+S+G+ L E+ S
Sbjct: 205 GNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 83/275 (30%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
KLG+G FG V G +A+K L + E F E ++ KL+H LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRI 658
+ E ++ EYM SL F+ + L L A IA G+ Y+ R+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA--QIASGMAYV---ERMNY 384
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSV 718
+HRDL+A+NIL+ E++ K++DFG+AR+ N+ A + APE A+ G F++
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 443
Query: 719 KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQ 778
KSDV+SFG+LL E+ + R + N +++ V G M P
Sbjct: 444 KSDVWSFGILLTELTTKGR-VPYPGMVNREVLDQV----ERGYRMPC--PP--------- 487
Query: 779 VLRC---IHVGML-CVQDSAMYRPTMASVVLMLES 809
C +H M C + RPT + LE
Sbjct: 488 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRN 592
G LG G FG V K +AVK L S L + +E ++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSL---------------------DLFIFDPAKQALL 631
+++L G C Q +LI EY SL + D + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 632 DWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691
+ I++G+ YL + ++++HRDL A NIL+ E KISDFG++R +
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DV 200
Query: 692 NEANTNRVVGTYG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
E ++ + G +MA E + +++ +SDV+SFGVLL EIV+
Sbjct: 201 YEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 72/214 (33%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRN 592
LG G FG V++G++ P +AVK L S Q +F E ++I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFI----FDPAKQALLDWTKRFAIIEGIARGLL 648
+VR +G +Q + ++ E M L F+ P++ + L + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 649 YLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
YL IHRD+ A N LL KI DFGMAR + A R G
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAM 247
Query: 706 -----MAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
M PE MEG+F+ K+D +SFGVLL EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 41/228 (17%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRN 592
+G G FG V + + +AVK L + S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLF---------------------IFDPAKQALL 631
+V+LLG C G+ L++EYM L+ F L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 632 DWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691
++ I +A G+ YL S + +HRDL N L+ E+M KI+DFG++R N
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 692 NEANTNRVVGTYGY-----MAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
A+ + M PE ++ +SDV+++GV+L EI S
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 41/222 (18%)
Query: 540 GNKLGRGGFGPVHKGKL--------PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR 591
LG+G F + KG ++ +K L + E F +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
+LV G C+ G+E +L+ E++ SLD ++ + W A +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK--QLAAAMHFL- 129
Query: 652 RDSRLRIIHRDLKASNILLDEDMNP--------KISDFGMARIFGFNQNEANTNRVVGTY 703
+IH ++ A NILL + + K+SD G++ V+
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKD 175
Query: 704 GY------MAPEYAMEG-LFSVKSDVYSFGVLLLEIVS-GRR 737
+ PE ++ +D +SFG L EI S G +
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 38/222 (17%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKL-Q 589
G LG G FG V + +AVK L KS E +E+ +++ L Q
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQ 108
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSL-----------DLFIFDPAKQALLDWTKRFA 638
H N+V LLG C G ++I EY L + +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 639 IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANTN 697
+A+G+ +L + IHRD+ A N+LL KI DFG+AR I + N
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 698 -----RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ +MAPE + +++V+SDV+S+G+LL EI S
Sbjct: 226 ARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 540 GNKLGRGGFGPVHKG--KLPEGQDI--AVKRLSRKSG---QGLEEFKNEIILIAKLQHRN 592
G +G G FG VH+G PE + A+K K+ E+F E + + + H +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V+L+G + +I E L F+ L +A ++ L YL
Sbjct: 78 IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY--QLSTALAYL-- 132
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPEY 710
R +HRD+ A N+L+ + K+ DFG++R ++ G +MAPE
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 188
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
F+ SDV+ FGV + EI+ G +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 540 GNKLGRGGFGPVHKGKL--PEGQDI--AVKRLSRKSG---QGLEEFKNEIILIAKLQHRN 592
LG G FG V++G +G+ I AVK K E+F +E +++ L H +
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ----ALLDWTKRFAIIEGIARGLL 648
+V+L+G + E +I E P L ++ L+ ++ I + +
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMA 127
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYM 706
YL + +HRD+ NIL+ K+ DFG++R ++E V +M
Sbjct: 128 YL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWM 181
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
+PE F+ SDV+ F V + EI+S G++
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHR 591
G LGRG FG V + + +AVK L + +E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 592 NLVRLLGCCIQ-GEEKMLIYEYMPNKSL-------------DLFIFDPAKQALLDWTKRF 637
N+V LLG C + G M+I E+ +L + + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 638 AIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFGFNQNEANT 696
+A+G+ +L + + IHRDL A NILL E KI DFG+AR I+
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 697 N-----RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ + +MAPE + +++++SDV+SFGVLL EI S
Sbjct: 209 DARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 47/231 (20%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKL-Q 589
G LG G FG V +AVK L K E +E+ ++ +L
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGS 107
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSL--------DLFIFDPAKQALLDWTKRFAIIE 641
H N+V LLG C LI+EY L + F D + + +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 642 G------------IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR-IFG 688
+A+G+ +L +HRDL A N+L+ KI DFG+AR I
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 689 FNQNEANTN-----RVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+ N + +MAPE EG++++KSDV+S+G+LL EI S
Sbjct: 225 DSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-40
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 540 GNKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-Q 589
G LG G FG V + +AVK L + + L + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSL-------------DLFIFDPAKQALLDWTKR 636
H+N++ LLG C Q +I EY +L + + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 637 FAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696
+ +ARG+ YL + + IHRDL A N+L+ ED KI+DFG+AR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHID 245
Query: 697 NRVVGTYG-----YMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
T G +MAPE + +++ +SDV+SFGVLL EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-40
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 23/279 (8%)
Query: 467 WLLWRFRALCKDSTISCCKNNDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFN 526
L + ++ K + + D S D ++ L +
Sbjct: 275 STLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFL-- 332
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQ---DIAVKRL-SRKSGQGLEEFKNEI 582
N +LG G FG V +G + D+A+K L EE E
Sbjct: 333 -----KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 583 ILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG 642
++ +L + +VRL+G C Q E ML+ E L F+ ++ + + ++
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 444
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
++ G+ YL +HR+L A N+LL KISDFG+++ G + +
Sbjct: 445 VSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAG 499
Query: 703 ---YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
+ APE FS +SDV+S+GV + E +S G++
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 9/204 (4%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+ K+G G FG K +G+ +K +SR S + EE + E+ ++A ++H N+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V+ + ++ +Y L I + K L + I L ++H
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
+I+HRD+K+ NI L +D ++ DFG+AR+ A +GT Y++PE
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICEN 199
Query: 714 GLFSVKSDVYSFGVLLLEIVSGRR 737
++ KSD+++ G +L E+ + +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKH 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
F E +G GGFG V K K +G+ +KR+ + E+ + E+ +AKL H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 596 LLGC-------------CIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAI 639
GC + ++ E+ +L+ +I + + LD +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699
E I +G+ Y+H ++I+RDLK SNI L + KI DFG+ +N+ R
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRS 181
Query: 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
GT YM+PE + + D+Y+ G++L E++
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 27/220 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHRNLV 594
F LGRGGFG V + K + + A+KR+ E+ E+ +AKL+H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 595 RLLGCCI---------QGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG 642
R + K+ +Y + ++L ++ + + I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV--- 699
IA + +LH ++HRDLK SNI D K+ DFG+ ++ E
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 700 -------VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEI 732
VGT YM+PE +S K D++S G++L E+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 536 YFSEGNKLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRN 592
+ ++GRG F V+KG ++A + + + + FK E ++ LQH N
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 593 LVRLLGCCIQGEEKM----LIYEYMPNKSLDLFIFDPAK---QALLDWTKRFAIIEGIAR 645
+VR + L+ E M + +L ++ + L W ++ I +
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILK 140
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
GL +LH IIHRDLK NI + + KI D G+A + + A V+GT
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA--VIGTPE 195
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+MAPE E + DVY+FG+ +LE+ +
Sbjct: 196 FMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRL---SRKSGQGLEEFKNEIILIAKLQHRN 592
F K+GRG F V++ L +G +A+K++ + + EI L+ +L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEGIARG 646
+++ I+ E ++ E L I + + +
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
L ++H R++HRD+K +N+ + K+ D G+ R F A++ +VGT YM
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
+PE E ++ KSD++S G LL E+ + +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 37/228 (16%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
F E LG+G FG V K + + + A+K++ + L +E++L+A L H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 596 LLGC----------CIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFAII 640
++K ++ EY N +L +D ++ + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLF 122
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT---- 696
I L Y+H IIHRDLK NI +DE N KI DFG+A+ + +
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 697 --------NRVVGTYGYMAPE-YAMEGLFSVKSDVYSFGVLLLEIVSG 735
+GT Y+A E G ++ K D+YS G++ E++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 540 GNKLGRGGFGPVHKG--KLPEGQDI--AVKRLSRKSG---QGLEEFKNEIILIAKLQHRN 592
G +G G FG VH+G PE + A+K K+ E+F E + + + H +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V+L+G + +I E L F+ LD ++ L YL
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL-- 507
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY--GYMAPEY 710
R +HRD+ A N+L+ + K+ DFG++R ++ G +MAPE
Sbjct: 508 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVS-GRR 737
F+ SDV+ FGV + EI+ G +
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIIL 584
F +++V +S ++G GG V + + Q A+K ++ + Q L+ ++NEI
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 585 IAKLQHRNL--VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG 642
+ KLQ + +RL I + ++ E ++DL + K+++ W ++ +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG---NIDLNSWLKKKKSIDPWERKS-YWKN 135
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ + +H+ I+H DLK +N L+ + K+ DFG+A + + VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 703 YGYMAPE-----------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YM PE + S KSDV+S G +L + G+
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+G G +G K + +G+ + K + + +E+ L+ +L+H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 599 CCIQGEEKML--IYEYMPNKSLDLFIFDPAKQA-------LLDWTKRFAIIEGIARGLLY 649
I L + EY L I K+ +L + + L
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ------LTLALKE 126
Query: 650 LH--RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
H D ++HRDLK +N+ LD N K+ DFG+ARI + + A T VGT YM+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMS 184
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
PE ++ KSD++S G LL E+ +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 528 NTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILI 585
I+V +S ++G GG V + + Q A+K ++ + Q L+ ++NEI +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 586 AKLQHRNL--VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI 643
KLQ + +RL I + ++ E ++DL + K+++ W ++ + +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKS-YWKNM 117
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
+ +H+ I+H DLK +N L+ D K+ DFG+A + + VGT
Sbjct: 118 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 704 GYMAPE-----------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YM PE + S KSDV+S G +L + G+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 528 NTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILI 585
I+V +S ++G GG V + + Q A+K ++ + Q L+ ++NEI +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 586 AKLQHRNL--VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI 643
KLQ + +RL I + ++ E ++DL + K+++ W ++ + +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKS-YWKNM 164
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
+ +H+ I+H DLK +N L+ D K+ DFG+A + + VG
Sbjct: 165 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 704 GYMAPE-----------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YM PE + S KSDV+S G +L + G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 539 EGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
+ LG+G +G V+ G+ L IA+K + + + + EI L L+H+N+V+ L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 598 GCCIQGEEKMLIY-EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR--------GLL 648
G + I+ E +P SL L E GL
Sbjct: 86 GSF-SENGFIKIFMEQVPGGSL--------SALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
YLH + +I+HRD+K N+L++ KISDFG ++ T GT YMA
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMA 191
Query: 708 PE---YAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
PE G + +D++S G ++E+ +G+
Sbjct: 192 PEIIDKGPRG-YGKAADIWSLGCTIIEMATGKP 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 35/232 (15%)
Query: 529 TIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAK 587
+ + ++ KLG GGF V + L +G A+KR+ Q EE + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 588 LQHRNLVRLLGCCIQGEEKM----LIYEYMPNKSLDLFIFDPAKQALLDWTKRF------ 637
H N++RL+ C++ L+ + +L I + L D
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQIL 137
Query: 638 AIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN 697
++ GI RGL +H HRDLK +NILL ++ P + D G + +
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 698 RVV-------GTYGYMAPE------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ T Y APE + + ++DV+S G +L ++ G
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE 243
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFK-NEIILIAKLQHR 591
++ + ++GRG FG VH+ K G AVK++ LE F+ E++ A L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF--AIIEGIAR---- 645
+V L G +G + E + SL L+
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALE 161
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNP-KISDFGMARIF---GFNQNEANTNRVVG 701
GL YLH RI+H D+KA N+LL D + + DFG A G ++ + + G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
T +MAPE M K D++S ++L +++G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 56/203 (27%), Positives = 109/203 (53%), Gaps = 10/203 (4%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
++ K+G+G G V+ + GQ++A+++++ + E NEI+++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V L + G+E ++ EY+ SL D + +D + A+ + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+ ++IHRD+K+ NILL D + K++DFG Q++ +T +VGT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 713 EGLFSVKSDVYSFGVLLLEIVSG 735
+ K D++S G++ +E++ G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 46/222 (20%), Positives = 92/222 (41%), Gaps = 24/222 (10%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ 589
+ + + + LG+G V +G+ G A+K + S + ++ E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 590 HRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646
H+N+V+L + E+ P SL + +P+ L ++ ++ + G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 647 LLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ +L I+HR++K NI+ D K++DFG AR + + + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
Query: 703 YGYMAPE--------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+ P+ + + D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
K+G G G V + G+ +AVK + + Q E NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V + + GEE ++ E++ +L D Q L+ + + E + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+IHRD+K+ +ILL D K+SDFG + + + +VGT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 713 EGLFSVKSDVYSFGVLLLEIVSG 735
L++ + D++S G++++E+V G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 529 TIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSG-QGLEEFKNEI-ILI 585
++ V + +LGRG +G V K + +P GQ +AVKR+ Q + ++ I +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 586 AKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AI 639
+ V G + + + E M + SLD F + ++D + I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699
I + L +LH S+L +IHRD+K SN+L++ K+ DFG++ G+ ++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDID 169
Query: 700 VGTYGYMAPE----YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
G YMAPE + +SVKSD++S G+ ++E+ R
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 11/201 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG-LEEFKNEIILIAKLQHRNLV 594
F++ K+G+G FG V KG + +A+K + + + +E+ + EI ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+ G ++ + +I EY+ S D + LD T+ I+ I +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+ IHRD+KA+N+LL E K++DFG+A Q + NT VGT +MAPE +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 715 LFSVKSDVYSFGVLLLEIVSG 735
+ K+D++S G+ +E+ G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFK---NEIILIAKLQHRN 592
F + ++LG G G V K P G +A K + + E+ ++ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPY 92
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEGIARG 646
+V G E + E+M SLD +L R + + +G
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
L YL + +I+HRD+K SNIL++ K+ DFG++ + AN+ VGT YM
Sbjct: 144 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSF--VGTRSYM 197
Query: 707 APEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+PE +SV+SD++S G+ L+E+ GR
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 30/212 (14%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEE---FKNEIILIAKL-QHR 591
F ++LG G +G V K +G+ AVKR S +G ++ E+ K+ QH
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 592 NLVRLLGCCIQGEEKMLIY-EYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEGIA 644
VRL + + + E L Q W +
Sbjct: 118 CCVRLEQA-WEEGGILYLQTELCGP---SLQ------QHCEAWGASLPEAQVWGYLRDTL 167
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
L +LH ++H D+K +NI L K+ DFG+ G G
Sbjct: 168 LALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPR 221
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YMAPE ++G + +DV+S G+ +LE+
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSG-QGLEEFKNEI-ILIAKLQHRNLVRLLG 598
++GRG +G V+K P GQ +AVKR+ + ++ ++ +++ +V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEGIARGLLYLHR 652
+ + + E M + S D F K I + L +L
Sbjct: 89 ALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLK- 142
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE--- 709
L+IIHRD+K SNILLD N K+ DFG++ G + R G YMAPE
Sbjct: 143 -ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERID 198
Query: 710 -YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
A + V+SDV+S G+ L E+ +GR
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 46/222 (20%), Positives = 92/222 (41%), Gaps = 24/222 (10%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQ 589
+ + + + LG+G V +G+ G A+K + S + ++ E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 590 HRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646
H+N+V+L + E+ P SL + +P+ L ++ ++ + G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 647 LLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ +L I+HR++K NI+ D K++DFG AR + + + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
Query: 703 YGYMAPE--------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+ P+ + + D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKS--GQGLEE-FKNEIILIAKLQHRNLVR 595
G LG+GGF + + + A K + + E EI + L H+++V
Sbjct: 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFD--PAKQALLDWTKRFAIIEGIARGLLYLHR 652
G + + + ++ E +SL + ++AL + R+ + I G YLHR
Sbjct: 106 FHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR 159
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
R+IHRDLK N+ L+ED+ KI DFG+A ++ + GT Y+APE
Sbjct: 160 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 214
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGR 736
+ S + DV+S G ++ ++ G+
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKS--GQGLEE-FKNEIILIAKLQHRNLVR 595
G LG+GGF + + + A K + + E EI + L H+++V
Sbjct: 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFD--PAKQALLDWTKRFAIIEGIARGLLYLHR 652
G + + + ++ E +SL + ++AL + R+ + I G YLHR
Sbjct: 80 FHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR 133
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGTYGYMAPE 709
R+IHRDLK N+ L+ED+ KI DFG+A + E + R + GT Y+APE
Sbjct: 134 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPE 185
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ S + DV+S G ++ ++ G+
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS--GQGLEE-FKNEIILIAKLQHRNLVR 595
GN LG+G F V++ + + G ++A+K + +K+ G+ + +NE+ + +L+H +++
Sbjct: 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQ---ALLDWTKRFAIIEGIARGLLYLH 651
L + + L+ E N + K + R + I G+LYLH
Sbjct: 76 LYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARH-FMHQIITGMLYLH 129
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGTYGYMAP 708
I+HRDL SN+LL +MN KI+DFG+A Q + + + GT Y++P
Sbjct: 130 S---HGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISP 181
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
E A ++SDV+S G + ++ GR
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQHRNLVRLL 597
KLG GG V+ + +A+K + R+ + L+ F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 598 GCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
EE Y EY+ +L +I L I G+ + H
Sbjct: 78 D---VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD-- 129
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+RI+HRD+K NIL+D + KI DFG+A+ + TN V+GT Y +PE A
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 715 LFSVKSDVYSFGVLLLEIVSGRR 737
+D+YS G++L E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
F KLG G +G V+K GQ +A+K++ + L+E EI ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
+V+ G + + ++ EY S+ D+ L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH 142
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
R IHRD+KA NILL+ + + K++DFG+A + NT V+GT +MAPE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSG 735
E ++ +D++S G+ +E+ G
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEG 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-33
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEI-ILIAKLQHRNLVR 595
F + LG G G + + + +D+AVKR+ + E+ +L +H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 596 LLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+++ Y E + K + +++ GL +LH
Sbjct: 83 YFCTE---KDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLH- 135
Query: 653 DSRLRIIHRDLKASNILLDE-----DMNPKISDFGMARIFGFNQNE-ANTNRVVGTYGYM 706
L I+HRDLK NIL+ + ISDFG+ + ++ + + V GT G++
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 707 APEY---AMEGLFSVKSDVYSFGVLLLEIVSG 735
APE + + D++S G + ++S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
+ +LG G FG V+K K G A K + KS + LE++ EI ++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 596 LLGCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRF------AIIEGIARGLL 648
LLG + ++ E+ P ++ + +L+ + + + L
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAI---------MLELDRGLTEPQIQVVCRQMLEALN 131
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
+LH RIIHRDLKA N+L+ + + +++DFG++ + ++ +GT +MAP
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAP 186
Query: 709 E-----YAMEGLFSVKSDVYSFGVLLLEIVSG 735
E + + K+D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKLQHRNLVRLL 597
+LG GGFG V + G+ +A+K+ ++ E + EI ++ KL H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 598 GCCIQGEEKM-------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
G +K+ L EY L ++ L ++ I+ L YL
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 651 HRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
H RIIHRDLK NI+L + + KI D G A+ VGT Y+A
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQYLA 191
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
PE + ++V D +SFG L E ++G R
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 60/264 (22%), Positives = 92/264 (34%), Gaps = 72/264 (27%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHRNLV 594
F +GRGGFG V + K + + A+KR+ E+ E+ +AKL+H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 595 RLLGCCIQGE------------------------EKMLIYEYMPNKSLDLFIFDPA---- 626
R ++ + + + +D F
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 627 -----------------KQALLDWTKR------------FAIIEGIARGLLYLHRDSRLR 657
K+ L DW R I IA + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKG 184
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN----------RVVGTYGYMA 707
++HRDLK SNI D K+ DFG+ ++ E VGT YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLE 731
PE +S K D++S G++L E
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 28/232 (12%), Positives = 54/232 (23%), Gaps = 43/232 (18%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRL---SRKSGQGLEEFKNEIILIAKLQHRNLVR 595
L G V + + +D A+K + S LE A+L +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 596 LLGCC----------IQGEEKML-------------IYEYMPNKSLDLFIF------DPA 626
+Q + MP S+DL +
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 627 KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686
+ + + R L ++H N+ + D + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 687 FGFNQNEANTNRVVGTYGYMAPEYAM--EGLFSVKSDVYSFGVLLLEIVSGR 736
G Y E+ F+ + + G+ + +
Sbjct: 244 VG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 542 KLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQG---LEEFKNEIILIAKLQHRNLVRLL 597
+GRGG G V++ + + +A+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 598 GCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
GE +Y + L + +Q L + AI+ I L H
Sbjct: 101 D---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
HRD+K NIL+ D + DFG+A ++ VGT YMAPE E
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 715 LFSVKSDVYSFGVLLLEIVSGRR 737
+ ++D+Y+ +L E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 69/327 (21%), Positives = 119/327 (36%), Gaps = 45/327 (13%)
Query: 529 TIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAK 587
T+ + L GGF V++ + + G++ A+KRL + E+ + K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 588 LQ-HRNLVRLLGCCIQGEEKM-------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAI 639
L H N+V+ G+E+ L+ + L F+ + L I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR- 698
R + ++HR + IIHRDLK N+LL K+ DFG A + + + +
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 699 ---------VVGTYGYMAPEYAMEGLFS-----VKSDVYSFGVLLLEIVSGRRNTSFRLE 744
T Y PE + L+S K D+++ G +L + + F E
Sbjct: 201 RALVEEEITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPF--E 254
Query: 745 ENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+ + L + +I +Q V + ML V + R ++A VV
Sbjct: 255 DGAKL------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQV--NPEERLSIAEVV 300
Query: 805 LMLESETPTLPVPRQPTFTSMRSSVDG 831
L+ V + T + G
Sbjct: 301 HQLQEIAAARNVNPKSPITELLEQNGG 327
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHRNLV 594
+ +G G V P+ + +A+KR++ K ++E EI +++ H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAIIEGIAR----GLLY 649
+ +E L+ + + S+ D+ AK + I I R GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM-ARIFGFNQNEANTNR--VVGTYGYM 706
LH++ IHRD+KA NILL ED + +I+DFG+ A + N R VGT +M
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 707 APEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
APE + + K+D++SFG+ +E+ +G
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSG-QGLEEFKNEI-ILIAKLQHRNLVRLLG 598
++G G G V K + G IAVK++ R + + ++ +++ +V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
I + + E M + + + I + L YL + +
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK--EKHGV 146
Query: 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-----YAME 713
IHRD+K SNILLDE K+ DFG++ G ++ +R G YMAPE +
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
+ +++DV+S G+ L+E+ +G+
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 43/215 (20%), Positives = 83/215 (38%), Gaps = 16/215 (7%)
Query: 534 TNYFSEGNKLGRG--GFGPVHKGK-LPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKL 588
+ +G+G V+ + P G+ + V+R L S + + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
H N+V I E ++ +M S + ++ I++G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT-----NRVVGTY 703
Y+H +HR +KAS+IL+ D +S + V
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 704 GYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGR 736
+++PE + L + KSD+YS G+ E+ +G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQHRN 592
FS+ ++G G FG V+ + + + +A+K++S ++S + ++ E+ + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
++ GC ++ L+ EY + DL L + A+ G +GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 172
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE--- 709
+IHRD+KA NILL E K+ DFG A I AN+ VGT +MAPE
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVGTPYWMAPEVIL 223
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSG 735
EG + K DV+S G+ +E+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 41/226 (18%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK-----------------SGQGLEEFKNEI 582
L +G F + + + + A+K+ + ++FKNE+
Sbjct: 36 IRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 583 ILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFD-PAKQALLDWTKRFAII 640
+I +++ + G I +++ +IYEYM N S+ +LD I
Sbjct: 95 QIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIP 149
Query: 641 EGIAR--------GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692
+ + Y+H + I HRD+K SNIL+D++ K+SDFG +
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDK 205
Query: 693 EANTNRVVGTYGYMAPE-YAMEGLFS-VKSDVYSFGVLLLEIVSGR 736
+ GTY +M PE ++ E ++ K D++S G+ L +
Sbjct: 206 KIKG--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQHRNLVR 595
G LG GG VH + L + +D+AVK L + F+ E A L H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 596 LLGCCIQGEEKM-------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
+ GE + ++ EY+ +L + + + + +I + L
Sbjct: 77 VYD---TGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALN 130
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE-ANTNRVVGTYGYMA 707
+ H+ IIHRD+K +NI++ K+ DFG+AR + N T V+GT Y++
Sbjct: 131 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
PE A +SDVYS G +L E+++G
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 59/231 (25%), Positives = 87/231 (37%), Gaps = 40/231 (17%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEI-ILIAKLQHRNL 593
N LG G G V +G+ +AVKR+ + EI +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 594 VRLLGCCIQGEEKMLIY---EYMPNKSLDLFI----FDPAKQALLDWTKRFAIIEGIARG 646
+R +Y E N +L + L +++ IA G
Sbjct: 72 IRYYCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 647 LLYLHRDSRLRIIHRDLKASNILLD-------------EDMNPKISDFGMARIFGFNQN- 692
+ +LH L+IIHRDLK NIL+ E++ ISDFG+ + Q+
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 693 -EANTNRVVGTYGYMAPEYAMEGLFSV-------KSDVYSFGVLLLEIVSG 735
N N GT G+ APE E D++S G + I+S
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 34/209 (16%)
Query: 542 KLGRGGFGPVHKGK---LPEGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRL 596
+ GG G ++ + G+ + +K L SG + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 597 LGCCIQGEEKM--------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
E ++ EY+ +SL L + A + I L
Sbjct: 145 FN---FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALS 196
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
YLH + +++ DLK NI+L E+ K+ D G + + GT G+ AP
Sbjct: 197 YLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQAP 246
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
E G +V +D+Y+ G L +
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEE-FKNEIILIAKLQHRN 592
F G LG+G FG V+ + +A+K L + G+E + E+ + + L+H N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 593 LVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEGIAR 645
++RL G ++ LI EY P ++ + L +F I +A
Sbjct: 71 ILRLYGY-FHDATRVYLILEYAPLGTV----YR-----ELQKLSKFDEQRTATYITELAN 120
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGT 702
L Y H R+IHRD+K N+LL KI+DFG + A ++R + GT
Sbjct: 121 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGT 170
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+ PE + K D++S GVL E + G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 45/331 (13%), Positives = 87/331 (26%), Gaps = 68/331 (20%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQH-- 590
G LG+ + G+ V R +++ K E++ + L+
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 591 --------------RNLVRLLGCCIQGEEK--------MLIYEYMPNKSLDLFIF----- 623
+LV+ + + + P +L F
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 624 -DPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682
+ L R + + R L LH ++H L+ +I+LD+ ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 683 MARIFGFNQNEANTNRVVGTYGYMAPE-----YAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
G + R A L + D ++ G+ + I
Sbjct: 257 HLVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD- 314
Query: 738 NTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQ------ 791
+ E ++ + +R +L G L
Sbjct: 315 -LPNTDDAALGGSEWIFRSCKN------IPQPVRA------LLE----GFLRYPKEDRLL 357
Query: 792 -DSAMYRPTMASVVLMLESETPTLPVPRQPT 821
AM P + L + P +PT
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQTDGEPT 388
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 53/232 (22%), Positives = 81/232 (34%), Gaps = 48/232 (20%)
Query: 537 FSEGNKLGRGGFGPVHKG-KLPEGQDIAVKR--LSRKSGQGLEEFKNEIILIAKL-QHRN 592
F E K+G G FG V K K +G A+KR + E+ A L QH +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 593 LVRLLGCCIQGEEKMLIY-EYMPNKSLDLFIFDPAKQA-------LLDWTKRFAIIEGIA 644
+VR + + MLI EY SL I + + L D + +
Sbjct: 73 VVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ------VG 125
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNP-------------------KISDFGMAR 685
RGL Y+H ++H D+K SNI + P KI D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
+ G ++A E E K+D+++ + ++
Sbjct: 183 RIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHR 591
F +G G +G V+KG+ + GQ A+K + G EE K EI ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHR 81
Query: 592 NLVRLLGCCIQGEEKM------LIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAIIEGIA 644
N+ G I+ L+ E+ S+ DL K L I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREIL 139
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
RGL +LH+ ++IHRD+K N+LL E+ K+ DFG++ NT +GT
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 705 YMAPE-----YAMEGLFSVKSDVYSFGVLLLEIVSG 735
+MAPE + + KSD++S G+ +E+ G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQH 590
+ + KLG G +G V + + A+K + + S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 591 RNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGI 643
N+++L E+K Y E L FD + + A II+ +
Sbjct: 96 PNIMKLYDFF---EDKRNYYLVMECYKGGEL----FDEIIHRMKF---NEVDAAVIIKQV 145
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVV 700
G+ YLH+ I+HRDLK N+LL ++D KI DFG++ +F + +
Sbjct: 146 LSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERL 199
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
GT Y+APE + + K DV+S GV+L +++G
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQH 590
++ LG+G FG V K K Q+ AVK +++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 591 RNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRF------AIIE 641
N+++L E+ Y E L FD + KRF II+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIK-----RKRFSEHDAARIIK 128
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNR 698
+ G+ Y+H+ I+HRDLK NILL ++D + KI DFG++ F N
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKD 182
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
+GT Y+APE + G + K DV+S GV+L ++SG
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
N +GRG +G V A K++ + + ++ FK EI ++ L H N++RL
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 599 CCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLLYLH 651
E+ IY E L F+ K+ + A I++ + + Y H
Sbjct: 74 TF---EDNTDIYLVMELCTGGEL----FERVVHKRVF---RESDAARIMKDVLSAVAYCH 123
Query: 652 RDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
+L + HRDLK N L D K+ DFG+A F + VGT Y++P
Sbjct: 124 ---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSP 177
Query: 709 EYAMEGLFSVKSDVYSFGVLL 729
+ +EGL+ + D +S GV++
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMM 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLS-RKSGQGLEEFKNEIILIAKLQHR 591
+ F KLG G FG VH + G + +K ++ +S +E+ + EI ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 592 NLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRF------AIIEG 642
N++++ E+ +Y E L + + K +++
Sbjct: 81 NIIKIFEVF---EDYHNMYIVMETCEGGEL----LE-RIVSAQARGKALSEGYVAELMKQ 132
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRV 699
+ L Y H ++H+DLK NIL KI DFG+A +F ++ ++
Sbjct: 133 MMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNA 186
Query: 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
GT YMAPE + + K D++S GV++
Sbjct: 187 AGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 31/217 (14%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQ 589
++ + LG+G FG V K GQ+ AVK +S++ E E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 590 HRNLVRLLGCCIQGEEKM---LIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEG 642
H N+++L E+K L+ E L FD +++ ++ A II
Sbjct: 85 HPNIMKLYEFF---EDKGYFYLVGEVYTGGEL----FDEIISRKRF---SEVDAARIIRQ 134
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRV 699
+ G+ Y+H+ +I+HRDLK N+LL +D N +I DFG++ F ++
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDK 188
Query: 700 VGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+GT Y+APE + G + K DV+S GV+L ++SG
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 33/245 (13%), Positives = 69/245 (28%), Gaps = 54/245 (22%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLS---RKSGQGLEEFKNEIILIAKLQ--- 589
G LG+ + E G+ V R +++ K E++ + L+
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 590 ----------------------HRNLVRLLGCCIQGEEKM--LIYEYMPNKSLDLF--IF 623
+ ++R+ +Y M + +
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 624 D-PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682
+ L R + + R L LH ++H L+ +I+LD+ ++ F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 683 MARIFGFNQNEANTNRVVGTYGYMAPEY-----------AMEGLFSVKSDVYSFGVLLLE 731
G + G+ PE L + D ++ G+++
Sbjct: 252 HLVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 732 IVSGR 736
I
Sbjct: 306 IWCAD 310
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLV 594
G+ LG G +G V + AVK L + + G K EI L+ +L+H+N++
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 595 RLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKR--FA-IIEGIARGLL 648
+L+ + EEK +Y EY ++ P K+ F +I+G+
Sbjct: 70 QLVDV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLE---- 123
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
YLH I+H+D+K N+LL KIS G+A + G+ + P
Sbjct: 124 YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 709 EYAM-EGLFS-VKSDVYSFGVLLLEIVSGR 736
E A FS K D++S GV L I +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEE-FKNEIILIAKLQHRNLVR 595
G LG+G FG V+ + +A+K L + +G+E + EI + + L+H N++R
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+ +++ L+ E+ P +L+ + + E +A L Y H
Sbjct: 79 MYNY-FHDRKRIYLMLEFAPRG--ELYKELQKHGRFDEQRSATFMEE-LADALHYCHE-- 132
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR---VVGTYGYMAPEYA 711
++IHRD+K N+L+ KI+DFG + A + R + GT Y+ PE
Sbjct: 133 -RKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMI 184
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGR 736
K D++ GVL E + G
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 523 AMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFK 579
N ++ LG+G FG V K K Q+ AVK +++ +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 580 NEIILIAKLQHRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWT 634
E+ L+ KL H N+++L E+ Y E L FD ++ +
Sbjct: 70 REVELLKKLDHPNIMKLFEIL---EDSSSFYIVGELYTGGEL----FDEIIKRKRF---S 119
Query: 635 KRFA--IIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGF 689
+ A II+ + G+ Y+H+ I+HRDLK NILL ++D + KI DFG++ F
Sbjct: 120 EHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
N +GT Y+APE + G + K DV+S GV+L
Sbjct: 177 NT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 25/205 (12%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVK-----RLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+G+G F V + E GQ AVK + + G E+ K E + L+H ++
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 594 VRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAK-QALLDWTKRFA--IIEGIARGL 647
V LL ++Y E+M DL + A +++ A + I L
Sbjct: 89 VELLETY---SSDGMLYMVFEFMDGA--DLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 648 LYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYG 704
Y H IIHRD+K +LL + K+ FG+A G + A VGT
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPH 198
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLL 729
+MAPE + DV+ GV+L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAKL 588
+ + K+G G +G V+K K +G+ +A+KR+ L+ EI L+ +L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKEL 76
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARG 646
H N+V L+ L++E+M DL + + K + + RG
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLY--QLLRG 131
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+ + H+ RI+HRDLK N+L++ D K++DFG+AR FG + T+ VV T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYR 186
Query: 707 APEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
AP+ L K D++S G + E+++G+
Sbjct: 187 APDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 32/256 (12%), Positives = 72/256 (28%), Gaps = 29/256 (11%)
Query: 529 TIAVATNYFSEGNKLGRGGFGPVHKGK------LPEGQDIAVKRLSRKSGQGLEEFKNEI 582
+ + + LG G F V++ Q +K + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 583 ILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI--FDPAKQALLDWTKRFAII 640
+ ++ + +L+ E +L I + + ++ +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILL-----------DEDMNPKISDFGMARIFGF 689
+ + +H IIH D+K N +L D + D G +
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR------RNTSFRL 743
T G+ E ++ + D + + ++ G +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
Query: 744 EENSSLIEHVWNLWNE 759
E + H+ ++WNE
Sbjct: 296 EGLFRRLPHL-DMWNE 310
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAKL 588
+ K+G G +G V+K + G+ A+K++ LE+ EI ++ +L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKEL 57
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARG 646
+H N+V+L + +L++E++ DL + K F + + G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLL--QLLNG 112
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+ Y H R++HRDLK N+L++ + KI+DFG+AR FG T+ +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYR 167
Query: 707 APEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
AP+ L K D++S G + E+V+G
Sbjct: 168 APDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK-------------SGQGLEEFK 579
+ + KLG G +G V K + A+K + + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 580 NEIILIAKLQHRNLVRLLGCCIQGEEKM---LIYEYMPNKSLDLFIFDPAKQALLDWTKR 636
NEI L+ L H N+++L E+K L+ E+ L F+ +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGEL----FEQIIN-----RHK 142
Query: 637 F------AIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIF 687
F I++ I G+ YLH+ I+HRD+K NILL + +N KI DFG++ F
Sbjct: 143 FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
+ +GT Y+APE ++ ++ K DV+S GV++ ++ G
Sbjct: 200 SKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAK 587
+ + K+G G +G V K K + +A+KR+ L++ EI L+ +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKE 57
Query: 588 LQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIAR 645
L+H+N+VRL ++ L++E+ DL + + K F + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLF--QLLK 112
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
GL + H ++HRDLK N+L++ + K+++FG+AR FG + VV T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWY 167
Query: 706 MAPEYAMEGLFSVKS-----DVYSFGVLLLEIVSGRR 737
P+ LF K D++S G + E+ + R
Sbjct: 168 RPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 39/254 (15%)
Query: 501 STDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQ 560
+ +G +D LA Y + +G G FG V + KL E
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAY-TNCKVIGNGSFGVVFQAKLVESD 65
Query: 561 DIAVKRLSRKSGQGLEEFKN-EIILIAKLQHRNLVRLLGCCIQGEEKM------LIYEYM 613
++A+K++ + + FKN E+ ++ ++H N+V L +K L+ EY+
Sbjct: 66 EVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120
Query: 614 PNKSLDL--FI--FDPAKQAL-LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668
P + + KQ + + K + + + R L Y+H + I HRD+K N+
Sbjct: 121 P---ETVYRASRHYAKLKQTMPMLLIKLY--MYQLLRSLAYIHS---IGICHRDIKPQNL 172
Query: 669 LLDEDMNP-KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF-----SVKSDV 722
LLD K+ DFG A+I E N + + Y Y APE +F + D+
Sbjct: 173 LLDPPSGVLKLIDFGSAKI--LIAGEPNVSYICSRY-YRAPEL----IFGATNYTTNIDI 225
Query: 723 YSFGVLLLEIVSGR 736
+S G ++ E++ G+
Sbjct: 226 WSTGCVMAELMQGQ 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 51/234 (21%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--------------------------SG 572
+++G+G +G V + A+K LS+K
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 573 QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD-PAKQ 628
+E+ EI ++ KL H N+V+L+ + + +Y E + + + P +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132
Query: 629 ALLDWTKRF---AIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685
L + RF +I+GI YLH +IIHRD+K SN+L+ ED + KI+DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 686 IFGFNQNEANTNRVVGTYGYMAPE--YAMEGLFS-VKSDVYSFGVLLLEIVSGR 736
F ++A + VGT +MAPE +FS DV++ GV L V G+
Sbjct: 186 E--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 506 GPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAV 564
GP + G Q G + + NY +LG+G F V + G + A
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 565 KRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY---EYMPNKSLD 619
K ++ K S + ++ + E + KLQH N+VRL +E+ Y + + L
Sbjct: 60 KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI---QEESFHYLVFDLVTGGEL- 115
Query: 620 LFIFD--PAKQALLDWTKRFA--IIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DE 672
F+ A++ ++ A I+ I + Y H I+HR+LK N+LL +
Sbjct: 116 ---FEDIVAREFY---SEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 166
Query: 673 DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
K++DFG+A ++ + GT GY++PE + +S D+++ GV+L
Sbjct: 167 GAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-26
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 41/220 (18%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN-EIILIAKLQHRNLV 594
+++ +G G FG V++ KL + G+ +A+K++ + + FKN E+ ++ KL H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 595 RLLGCCIQGEEKM------LIYEYMPNKSLDLF----IFDPAKQALLDWTKRFAIIEGIA 644
RL EK L+ +Y+P ++ + AKQ L + + +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKL-YMYQLF 166
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNP-KISDFGMARIFGFNQNEANTNRVVGTY 703
R L Y+H I HRD+K N+LLD D K+ DFG A+ + E N + + Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY 221
Query: 704 GYMAPE-------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y APE Y + DV+S G +L E++ G+
Sbjct: 222 -YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRL 596
+LG+G F V + G + A K ++ K S + ++ + E + KLQH N+VRL
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 597 LGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLLY 649
+E+ Y + + L F+ A++ ++ A I+ I + Y
Sbjct: 71 HDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADASHCIQQILESIAY 120
Query: 650 LHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
H I+HR+LK N+LL + K++DFG+A ++ + GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYL 174
Query: 707 APEYAMEGLFSVKSDVYSFGVLL 729
+PE + +S D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 52/255 (20%), Positives = 85/255 (33%), Gaps = 58/255 (22%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVK-----RLSRKSGQGLEEFKNEIILIAK 587
+ +G+G +G V + A+K ++ + + + +E K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 588 LQHRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFDPAKQALLDWTKRFA------ 638
L H N+ RL E++ I E L + +
Sbjct: 85 LHHPNIARLYEVY---EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 639 -------------------------------IIEGIARGLLYLHRDSRLRIIHRDLKASN 667
I+ I L YLH I HRD+K N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPEN 198
Query: 668 ILL--DEDMNPKISDFGMARIFGFNQNEANT--NRVVGTYGYMAPE--YAMEGLFSVKSD 721
L ++ K+ DFG+++ F N GT ++APE + K D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 722 VYSFGVLLLEIVSGR 736
+S GVLL ++ G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 15/201 (7%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
+Y+ +LG G FG VH+ G+ K ++ KNEI ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA--IIEGIARGLLYL 650
L+ L E +LI E++ +LF A+ + ++ + GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFL--SGGELFDRIAAEDYKM--SEAEVINYMRQACEGLKHM 165
Query: 651 HRDSRLRIIHRDLKASNILL--DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
H I+H D+K NI+ + + KI DFG+A ++ T + AP
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 709 EYAMEGLFSVKSDVYSFGVLL 729
E +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAK 587
+ + + LG G F V+K + Q +A+K++ E K+ EI L+ +
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLLQE 68
Query: 588 LQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIAR 645
L H N++ LL L++++M DL I D + K + ++ +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLM--TLQ 123
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
GL YLH+ I+HRDLK +N+LLDE+ K++DFG+A+ FG + N A T++VV T Y
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWY 178
Query: 706 MAPEYAMEGLF-----SVKSDVYSFGVLLLEIVSGR 736
APE LF V D+++ G +L E++
Sbjct: 179 RAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 513 DGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKR-LSRK 570
GS + + A + F G+G FG V GK G +A+K+ +
Sbjct: 2 PGSMM-SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP 60
Query: 571 SGQGLEEFKN----EIILIAKLQHRNLVRLLGC-CIQGEEKM------LIYEYMPNKSLD 619
F+N + +A L H N+V+L GE ++ EY+P
Sbjct: 61 R------FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DT 111
Query: 620 L--FI--FDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675
L + + A + + + R + LH S + + HRD+K N+L++E
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG 169
Query: 676 P-KISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-------YAMEGLFSVKSDVYSFGV 727
K+ DFG A+ + +E N + Y Y APE Y + D++S G
Sbjct: 170 TLKLCDFGSAKK--LSPSEPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGC 220
Query: 728 LLLEIVSGR 736
+ E++ G
Sbjct: 221 IFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 38/219 (17%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAKLQHR 591
K+G+G FG V K + GQ +A+K++ +E K EI ++ L+H
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHE 76
Query: 592 NLVRLLGCCIQGEEKM--------LIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIE 641
N+V L+ C L++++ DL + + + L KR ++
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRV--MQ 131
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN---TNR 698
+ GL Y+HR+ +I+HRD+KA+N+L+ D K++DFG+AR F +N TNR
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 699 VVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGR 736
VV T Y PE + E + D++ G ++ E+ +
Sbjct: 189 VV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKLQHRNLVRLL 597
LG G +G V + +AVK + K E K EI + L H N+V+
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 598 GCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA---IIEGIARGLLY 649
G E + Y EY L FD + + + ++ G+ Y
Sbjct: 72 GHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH + I HRD+K N+LLDE N KISDFG+A +F +N E N++ GT Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 710 YAMEGLFS-VKSDVYSFGVLLLEIVSGR 736
F DV+S G++L +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 28/201 (13%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
LG G F V K G+ A+K + + +NEI ++ K++H N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 599 CCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLLYLH 651
E Y + + L FD + T++ A +I+ + + YLH
Sbjct: 74 IY---ESTTHYYLVMQLVSGGEL----FDRILERGVY---TEKDASLVIQQVLSAVKYLH 123
Query: 652 RDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
I+HRDLK N+L +E+ I+DFG++++ + GT GY+AP
Sbjct: 124 E---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAP 176
Query: 709 EYAMEGLFSVKSDVYSFGVLL 729
E + +S D +S GV+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN-----EIILIAKLQH 590
+ + +KLG G + V+KGK +A+K + + +G E+ L+ L+H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKH 59
Query: 591 RNLVRLLGCCIQGEEKM-LIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARGL 647
N+V L I E+ + L++EY+ DL ++ D + K F + + RGL
Sbjct: 60 ANIVTLH-DIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGL 113
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
Y HR +++HRDLK N+L++E K++DFG+AR + N VV T Y
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYRP 168
Query: 708 PEYAMEGLF-----SVKSDVYSFGVLLLEIVSGR 736
P+ L S + D++ G + E+ +GR
Sbjct: 169 PDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 35/228 (15%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGK---LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL 588
V + EG K+GRG +G V+K K + +D A+K++ +G + + EI L+ +L
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLREL 75
Query: 589 QHRNLVRLLGCCIQGEEK--MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG---- 642
+H N++ L + ++ L+++Y DL+ +A K + G
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 643 ----IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP----KISDFGMARIFGF-NQNE 693
I G+ YLH + ++HRDLK +NIL+ + KI+D G AR+F +
Sbjct: 133 LLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 694 ANTNRVVGTYGYMAPEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
A+ + VV T+ Y APE L + D+++ G + E+++
Sbjct: 190 ADLDPVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 11/199 (5%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
+++ +LG G FG VH+ G + A K + E + EI ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
LV L E ++IYE+M +LF + + + + + +GL ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFM--SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272
Query: 653 DSRLRIIHRDLKASNILL--DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
+H DLK NI+ K+ DFG+ + + GT + APE
Sbjct: 273 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEV 327
Query: 711 AMEGLFSVKSDVYSFGVLL 729
A +D++S GVL
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLG 598
LG+GGFG V ++ + A K+L +K +G NE ++ K+ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLF--IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
+ ++ + L+ M DL I+ + + F E I GL LHR
Sbjct: 251 YAYETKDALCLVLTLMNGG--DLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR--- 304
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
RI++RDLK NILLD+ + +ISD G+A Q VGT GYMAPE
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 361
Query: 716 FSVKSDVYSFGVLLLEIVSGR-----RNTSFRLEE 745
++ D ++ G LL E+++G+ R + EE
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 20/203 (9%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
+ LGRG FG VH+ + K + + G K EI ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLL 648
++ L EE ++I+E++ + F+ L +R + + L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFEL--NEREIVSYVHQVCEALQ 116
Query: 649 YLHRDSRLRIIHRDLKASNILL--DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+LH I H D++ NI+ KI +FG AR N + Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYY 170
Query: 707 APEYAMEGLFSVKSDVYSFGVLL 729
APE + S +D++S G L+
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKLQHRNLVRLL 597
LG G +G V + +AVK + K E K EI + L H N+V+
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 598 GCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA---IIEGIARGLLY 649
G E + Y EY L FD + + + ++ G+ Y
Sbjct: 72 GHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----Y 120
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH + I HRD+K N+LLDE N KISDFG+A +F +N E N++ GT Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 710 YAMEGLFS-VKSDVYSFGVLLLEIVSGR 736
F DV+S G++L +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 45/216 (20%)
Query: 540 GNKLGRGGFGPV----HKGKLPEGQDIAVKRLSRKSGQG--------LEEFKNEI-ILIA 586
+ +GRG V H+ G + AVK + + + E + E IL
Sbjct: 99 KDVIGRGVSSVVRRCVHRAT---GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 587 KLQHRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--I 639
H +++ L+ E ++ + M L FD K AL +++ I
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMFLVFDLMRKGEL----FDYLTEKVAL---SEKETRSI 205
Query: 640 IEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV 699
+ + + +LH I+HRDLK NILLD++M ++SDFG + + +
Sbjct: 206 MRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLREL 259
Query: 700 VGTYGYMAPE------YAMEGLFSVKSDVYSFGVLL 729
GT GY+APE + + D+++ GV+L
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKS---GQGLEEFKNEIILIAKLQHRN 592
F G LG G F V + A+K L ++ + E ++++L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 593 LVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
V+L Q +EK+ Y N +L + + + RF E I L YLH
Sbjct: 92 FVKLYFTF-QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTAE-IVSALEYLH 147
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
IIHRDLK NILL+EDM+ +I+DFG A++ +A N VGT Y++PE
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGR 736
E SD+++ G ++ ++V+G
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 40/214 (18%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGL---------EEFKNEI-ILIAKL 588
LGRG V + ++ AVK + G E E+ IL
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 589 QHRNLVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIE 641
H N+++L E + + M L FD K L +++ I+
Sbjct: 82 GHPNIIQLKDTY---ETNTFFFLVFDLMKKGEL----FDYLTEKVTL---SEKETRKIMR 131
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
+ + LH+ L I+HRDLK NILLD+DMN K++DFG + + V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCG 185
Query: 702 TYGYMAPE------YAMEGLFSVKSDVYSFGVLL 729
T Y+APE + + D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
S+ LG G FG VHK + G +A K + + + EE KNEI ++ +L H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA--IIEGIARGLLYLHRD 653
L + +L+ EY+ L FD + T+ ++ I G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 654 SRLRIIHRDLKASNILL--DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
+ I+H DLK NIL + KI DFG+AR + + GT ++APE
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVV 260
Query: 712 MEGLFSVKSDVYSFGVLL 729
S +D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKS------GQGLEEFKNEIILIA 586
+++ G +LG G F V K + G + A K + ++ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 587 KLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEG 642
++ H N++ L + +LI E + L FD K++L ++ A I+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESL---SEEEATSFIKQ 123
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNEANTNR 698
I G+ YLH +I H DLK NI+L + K+ DFG+A
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
+ GT ++APE +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEE--------FKNEIILIAKLQH 590
LG G G V + + +A+K +S++ + EI ++ KL H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARG 646
++++ E+ ++ E M L FD + L + +
Sbjct: 75 PCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRL---KEATCKLYFYQMLLA 126
Query: 647 LLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
+ YLH IIHRDLK N+LL +ED KI+DFG ++I G + + GT
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTP 180
Query: 704 GYMAPE---YAMEGLFSVKSDVYSFGVLL 729
Y+APE ++ D +S GV+L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK------SGQGLEEFKNEIILIA 586
+++ G +LG G F V K + G + A K + ++ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 587 KLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEG 642
++ H N++ L + +LI E + L FD K++L ++ A I+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESL---SEEEATSFIKQ 123
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNEANTNR 698
I G+ YLH +I H DLK NI+L + K+ DFG+A
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
+ GT ++APE +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN----EIILIAKLQHRNLVR 595
+G G +G V K + + G+ +A+K+ + K EI L+ +L+H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
LL C + + L++E++ + + +++ + I G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKY--LFQIINGIGFCHSH 143
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE---- 709
IIHRD+K NIL+ + K+ DFG AR E + V T Y APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAPELLVG 198
Query: 710 ---YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y +V DV++ G L+ E+ G
Sbjct: 199 DVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 540 GNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEE--------FKNEIILIAKLQH 590
LG G G V + + +A++ +S++ + EI ++ KL H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFA--IIEGIARGLL 648
++++ E+ ++ E M +LF + L + + +
Sbjct: 200 PCIIKIKNF-FDAEDYYIVLELMEGG--ELFDKVVGNKRL---KEATCKLYFYQMLLAVQ 253
Query: 649 YLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
YLH IIHRDLK N+LL +ED KI+DFG ++I G + + GT Y
Sbjct: 254 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTY 307
Query: 706 MAPE---YAMEGLFSVKSDVYSFGVLL 729
+APE ++ D +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK------SGQGLEEFKNEIILIA 586
+Y+ G +LG G F V K + G A K + ++ G E+ + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 587 KLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEG 642
++QH N++ L + +LI E + L FD K++L T+ A ++
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESL---TEEEATEFLKQ 122
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNEANTNR 698
I G+ YLH L+I H DLK NI+L KI DFG+A F
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
+ GT ++APE +++D++S GV+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK------SGQGLEEFKNEIILIA 586
+++ G +LG G F V K + G++ A K + ++ G EE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 587 KLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEG 642
+++H N++ L + +LI E + L FD K++L T+ A ++
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESL---TEDEATQFLKQ 116
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMARIFGFNQNEANTNR 698
I G+ YLH RI H DLK NI+L + K+ DFG+A
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKN 170
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
+ GT ++APE +++D++S GV+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 36/212 (16%)
Query: 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKN--------EIILIAKLQHR 591
K+G G +G V K + + GQ +A+K+ E EI ++ +L+H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIARGLLY 649
NLV LL + L++EY + + + K + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSI--TWQTLQAVNF 117
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
H+ IHRD+K NIL+ + K+ DFG AR+ ++ + V T Y +PE
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWYRSPE 172
Query: 710 YAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
L DV++ G + E++SG
Sbjct: 173 L----LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN-----EIILIAKLQHRNLV 594
KLG G + V+KG G +A+K + S +G EI L+ +L+H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMKELKHENIV 66
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIA---------- 644
RL + L++E+M DL + +D G+
Sbjct: 67 RLYDVIHTENKLTLVFEFM---DNDL-------KKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 645 --RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+GL + H + +I+HRDLK N+L+++ K+ DFG+AR FG ++ VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-T 171
Query: 703 YGYMAPE-------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y AP+ Y S D++S G +L E+++G+
Sbjct: 172 LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 50/221 (22%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN--------EIILIAKLQHR 591
KLG G +G V+K + +A+KR+ LE + E+ L+ +LQHR
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG------IAR 645
N++ L LI+EY DL + +D ++ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA---ENDL-------KKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNP-----KISDFGMARIFGFNQNEANTNRVV 700
G+ + H R +HRDLK N+LL KI DFG+AR FG T+ ++
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199
Query: 701 GTYGYMAPEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
T Y PE L + D++S + E++
Sbjct: 200 -TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE--FKNEIILIAKLQHRNLVRL 596
+LG+G F V + + GQ+ A ++ K + + E + L+H N+VRL
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 597 LGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLLY 649
E+ Y + + L F+ A++ ++ A I+ I +L+
Sbjct: 76 HDSI---SEEGHHYLIFDLVTGGEL----FEDIVAREYY---SEADASHCIQQILEAVLH 125
Query: 650 LHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
H+ + ++HR+LK N+LL + K++DFG+A Q GT GY+
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 707 APEYAMEGLFSVKSDVYSFGVLL 729
+PE + + D+++ GV+L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 45/217 (20%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRL 596
+G+G F V + + G+++A+K + + + L++ E+ ++ L H N+V+L
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFD--------PAKQALLDWTKRFA--IIEGIAR 645
I+ E+ + LI EY + FD K+A + I+ +
Sbjct: 80 FEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEA-----RSKFRQIVSAVQ- 128
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
Y H+ RI+HRDLKA N+LLD DMN KI+DFG + F + G Y
Sbjct: 129 ---YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPY 179
Query: 706 MAPEYAMEGLFS------VKSDVYSFGVLLLEIVSGR 736
APE LF + DV+S GV+L +VSG
Sbjct: 180 AAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRK---SGQGLEEFKNE-IIL--IAKLQHRNLVR 595
+GRGGFG V+ + + + A+K L +K QG NE I+L ++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 596 LLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+ +K+ I + M DL + RF E I GL ++H
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAE-IILGLEHMHN-- 310
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+++RDLK +NILLDE + +ISD G+A F + + VGT+GYMAPE +G
Sbjct: 311 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKG 365
Query: 715 L---FSVKSDVYSFGVLLLEIVSGR 736
+ S D +S G +L +++ G
Sbjct: 366 VAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--------SGQGLEEFKNEIILIAKLQH 590
+ LG G FG V + +++ VK + ++ L + EI ++++++H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 591 RNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
N++++L + + L+ E + LDLF F L + I + + Y
Sbjct: 89 ANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSAVGY 145
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
L IIHRD+K NI++ ED K+ DFG A + GT Y APE
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAPE 199
Query: 710 -YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ +++S GV L +V
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 30/202 (14%)
Query: 540 GNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+G G + + + AVK + + EE IL+ QH N++ L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKD 83
Query: 599 CCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLLYLH 651
++ +Y E M L D ++ ++R A ++ I + + YLH
Sbjct: 84 VY---DDGKYVYVVTELMKGGEL----LDKILRQKFF---SEREASAVLFTITKTVEYLH 133
Query: 652 RDSRLRIIHRDLKASNILL---DEDMNP-KISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
++HRDLK SNIL + +I DFG A+ T T ++A
Sbjct: 134 A---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVA 188
Query: 708 PEYAMEGLFSVKSDVYSFGVLL 729
PE + D++S GVLL
Sbjct: 189 PEVLERQGYDAACDIWSLGVLL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLG 598
LGRGGFG V ++ + A K+L++K +G + E ++AK+ R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLF--IFDPAKQA--LLDWTKRFAIIEGIARGLLYLHRD 653
+ + + L+ M D+ I++ + + F + I GL +LH+
Sbjct: 252 YAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQ- 307
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
II+RDLK N+LLD+D N +ISD G+A Q + GT G+MAPE +
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLG 363
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
+ D ++ GV L E+++ R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVK--RLSRKSGQGLEEFKNEIILIAKL 588
Y +LGRG F V + GQ+ A K + R+ E +EI ++
Sbjct: 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA 85
Query: 589 QHR-NLVRLLGCCIQGEEKMLIYEYMPNKSLDLF--IFDPAKQALLDWTKRFA--IIEGI 643
+ ++ L E +LI EY ++F + + ++ +I+ I
Sbjct: 86 KSCPRVINLHEVYENTSEIILILEYAAGG--EIFSLCLPELAEMV---SENDVIRLIKQI 140
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVV 700
G+ YLH+ I+H DLK NILL + KI DFGM+R G ++
Sbjct: 141 LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIM 194
Query: 701 GTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
GT Y+APE + +D+++ G++
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCC 600
LG G V L Q+ AVK + ++ G E+ ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 601 IQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIARGLLYLHRD 653
EE+ Y E M S+ ++ + A +++ +A L +LH
Sbjct: 81 ---EEEDRFYLVFEKMRGGSI----LSHIHKRRHF---NELEASVVVQDVASALDFLHN- 129
Query: 654 SRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNR-----VVGTYGY 705
I HRDLK NIL ++ KI DF + N + + + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 706 MAPE-----YAMEGLFSVKSDVYSFGVLL 729
MAPE ++ + D++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
+++F ++LGRG V++ K + A+K L + + + + EI ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 593 LVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIAR 645
+++L E I E + L FD K ++R A ++ I
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGEL----FDRIVEKGYY---SERDAADAVKQILE 159
Query: 646 GLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ YLH I+HRDLK N+L D KI+DFG+++I V GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGT 213
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLL 729
GY APE + + D++S G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK------SGQGLEEFKNEIILIAKLQHR- 591
G LG GGFG V+ G + + +A+K + + E++L+ K+
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 592 -NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL-DWTKRFA--IIEGIARGL 647
++RLL + + +LI E P DLF F + AL + + F ++E +
Sbjct: 108 SGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVR--- 163
Query: 648 LYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+ H ++HRD+K NIL+D + K+ DFG + + GT Y
Sbjct: 164 -HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 215
Query: 707 APEYAMEGLFS-VKSDVYSFGVLLLEIVSGR 736
PE+ + + V+S G+LL ++V G
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 535 NYFSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRN 592
+ + LG G F K Q AVK +S++ + EI + + H N
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPN 67
Query: 593 LVRLLGCCIQGEEKMLIY---EYMPNKSLDLFIFD--PAKQALLDWTKRFA--IIEGIAR 645
+V+L +++ + E + L F+ K+ ++ A I+ +
Sbjct: 68 IVKLHEVF---HDQLHTFLVMELLNGGEL----FERIKKKKHF---SETEASYIMRKLVS 117
Query: 646 GLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ ++H + ++HRDLK N+L ++++ KI DFG AR+ + T T
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLL 729
Y APE + + D++S GV+L
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 48/226 (21%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE--GQDIAVKRLSRKSGQGLEEFKN--------EIILIA 586
+ ++G G +G V K + + G+ +A+KR+ ++ + E+ ++
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLR 66
Query: 587 KLQ---HRNLVRLL----GCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFA 638
L+ H N+VRL E K+ L++E++ DL LD
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDL-------TTYLDKVPEPG 116
Query: 639 IIEG--------IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690
+ + RGL +LH R++HRDLK NIL+ K++DFG+ARI+ F
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173
Query: 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
T+ VV T Y APE ++ ++ D++S G + E+ +
Sbjct: 174 MAL--TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK------SGQGLEEFKNEIILIAKL---- 588
G LG+GGFG V G L + +A+K + R E+ L+ K+
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALL-DWTKRFA--IIEGIAR 645
H ++RLL E ML+ E P + DLF + K L ++ F ++ I
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ- 153
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNP-KISDFGMARIFGFNQNEANTNRVVGTYG 704
+ H ++HRD+K NIL+D K+ DFG + ++ GT
Sbjct: 154 ---HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRV 203
Query: 705 YMAPEYAMEGLFS-VKSDVYSFGVLLLEIVSGR 736
Y PE+ + + + V+S G+LL ++V G
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS-RKSGQGLEEFKN----EIILIAKLQ- 589
+ ++G G +G V+K + G +A+K + G G E+ L+ +L+
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 590 --HRNLVRLLGCCIQGEEK-----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG 642
H N+VRL+ C L++E++ DL + LD +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDL-------RTYLDKAPPPGLPAE 120
Query: 643 --------IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694
RGL +LH + I+HRDLK NIL+ K++DFG+ARI+ +
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 175
Query: 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
T VV T Y APE ++ ++ D++S G + E+ +
Sbjct: 176 LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 535 NYFSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEI-ILIAKLQHRN 592
+Y LG G G V + + A+K L + + E+ + Q +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 116
Query: 593 LVRLLGCC---IQGEEKM-LIYEYMPNKSLDLF--IFDPAKQALLDWTKRFA--IIEGIA 644
+VR++ G + + ++ E + +LF I D QA T+R A I++ I
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECL--DGGELFSRIQDRGDQAF---TEREASEIMKSIG 171
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
+ YLH + I HRD+K N+L + K++DFG A+ + N T
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTT--PCY 225
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
T Y+APE + D++S GV++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 40/219 (18%)
Query: 529 TIAVATNYFSEGNKLGRGGFGPVHKG-KLPEGQDIAVKRLSRKSGQGLEEFKNEI-ILIA 586
AV +Y LG G G V + GQ A+K L + + E+
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77
Query: 587 KLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI----------FDP-AKQALLDWTK 635
++V +L +YE M + L I F ++ +T+
Sbjct: 78 ASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 636 RFA--IIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFN 690
R A I+ I + +LH I HRD+K N+L ++D K++DFG A+
Sbjct: 128 REAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-- 182
Query: 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLL 729
QN T T Y+APE + D++S GV++
Sbjct: 183 QNALQT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 36/212 (16%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKN---EIILIAKLQHRNLVRLLG 598
+G+G FG V + + + + A+K ++++ E +N E+ ++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIARGLLYL 650
Q EE M ++ + + DL F + T + I E + L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGG--DLRYHLQQNVHFK-------EETVKLFICE-LVMALDYL 131
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE- 709
RIIHRD+K NILLDE + I+DF +A + E + GT YMAPE
Sbjct: 132 QN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAPEM 185
Query: 710 -YAMEGL---FSVKSDVYSFGVLLLEIVSGRR 737
+ +G F+V D +S GV E++ GRR
Sbjct: 186 FSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 54/222 (24%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSR---KSGQGLEEFKNEIILIAKLQHRNLVR 595
G+ LG G FG V G+ G +AVK L+R +S + + K EI + +H ++++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFI----------FD--PAKQALLDWTKR--FA-II 640
L Y+ + + D F+ FD + + R F I+
Sbjct: 76 L-------------YQVISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVV 700
+ Y HR ++HRDLK N+LLD MN KI+DFG++ + +
Sbjct: 122 SAVD----YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSC 171
Query: 701 GTYGYMAPE------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
G+ Y APE YA G + D++S GV+L ++ G
Sbjct: 172 GSPNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGT 208
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-21
Identities = 53/253 (20%), Positives = 102/253 (40%), Gaps = 65/253 (25%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN-EIILIAKLQ 589
++ +S G LG G FG V + + G+ A+K++ + +KN E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 590 HRNLVRLLGCCIQGEEKM--------------------------------------LIYE 611
H N+++L+ ++ +I E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 612 YMPNKSLDLF----IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667
Y+P L F + +++ I + R + ++H L I HRD+K N
Sbjct: 119 YVP---DTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQN 171
Query: 668 ILLD-EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY---AMEGLFSVKSDVY 723
+L++ +D K+ DFG A+ +E + + + Y APE A E ++ D++
Sbjct: 172 LLVNSKDNTLKLCDFGSAKK--LIPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLW 226
Query: 724 SFGVLLLEIVSGR 736
S G + E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 53/221 (23%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSR---KSGQGLEEFKNEIILIAKLQHRNLVR 595
LG G FG V Q +A+K +SR K + EI + L+H ++++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFI---------FD--PAKQALLDWTKR--FA-IIE 641
L Y+ + + D+ + FD K+ + + R F II
Sbjct: 74 L-------------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG 701
I Y HR +I+HRDLK N+LLD+++N KI+DFG++ I + N T+ G
Sbjct: 120 AIE----YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS--CG 169
Query: 702 TYGYMAPE------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ Y APE YA + DV+S G++L ++ GR
Sbjct: 170 SPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGR 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+A+G+ +L + + IHRDL A NILL E KI DFG+AR + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS 734
+MAPE + +++++SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 38/163 (23%), Positives = 60/163 (36%), Gaps = 19/163 (11%)
Query: 540 GNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQG-LEEFKNEI-ILIAKLQHR 591
G LGRG FG V + + +AVK L + +E+ ILI H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 592 NLVRLLGCCIQ-GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
N+V LLG C + G M+I E+ +L ++ +KR + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693
+ I DLK + + S F + + E
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 53/235 (22%), Positives = 90/235 (38%), Gaps = 34/235 (14%)
Query: 526 NFNTIAVATNYFSEGNK------LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEE-- 577
+ + + + G +G V G EG +A+KR+ G
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 578 FKN---------EIILIAKLQHRNLVRLLGCCI-QGEEKM----LIYEYMPNKSLDLF-I 622
+ EI L+ H N++ L + E M L+ E M DL +
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQV 123
Query: 623 FDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682
+ + ++ + I GL LH ++HRDL NILL ++ + I DF
Sbjct: 124 IHDQRIVISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFN 179
Query: 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGR 736
+AR + T+ V Y APE M+ F+ D++S G ++ E+ + +
Sbjct: 180 LAR--EDTADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN----- 580
++ + +G G G V +++A+K+LSR F+N
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAK 69
Query: 581 ----EIILIAKLQHRNLVRLL------GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL 630
E++L+ + H+N++ LL + ++ ++ E M +L I + L
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMEL 124
Query: 631 LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690
+ ++ + G+ +LH IIHRDLK SNI++ D KI DFG+AR
Sbjct: 125 DHERMSY-LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 178
Query: 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ T VV T Y APE + + D++S G ++ E++ G
Sbjct: 179 TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 62/226 (27%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSR---KSGQGLEEFKNEIILIAKLQHRNLVR 595
G+ LG G FG V GK G +AVK L+R +S + + + EI + +H ++++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFI----------FD--------PAKQALLDWTKRF 637
L Y+ + S D+F+ FD K++ + F
Sbjct: 81 L-------------YQVISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESR----RLF 122
Query: 638 A-IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696
I+ G+ Y HR ++HRDLK N+LLD MN KI+DFG++ + +
Sbjct: 123 QQILSGVD----YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFL 172
Query: 697 NRVVGTYGYMAPE------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
G+ Y APE YA + D++S GV+L ++ G
Sbjct: 173 RTSCGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGT 213
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 39/212 (18%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLG 598
KLGRG + V + + + + VK L + + K EI ++ L+ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLA- 97
Query: 599 CCIQGEEKM---LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
++ L++E++ N Q L D+ RF + E I + L Y H S
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDYCH--SM 149
Query: 656 LRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE----- 709
I+HRD+K N+++D E ++ D+G+A ++ + RV Y + PE
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELLVDY 205
Query: 710 ----YAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
Y++ D++S G +L ++ +
Sbjct: 206 QMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN----- 580
T + +G G +G V G+ +A+K+LSR F++
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAK 68
Query: 581 ----EIILIAKLQHRNLVRLLGCCIQGEEKM------LIYEYMPNKSLDLFIFDPAKQAL 630
E++L+ +QH N++ LL L+ +M L +
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKF 123
Query: 631 LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690
+ ++ ++ + +GL Y+H ++HRDLK N+ ++ED KI DFG+AR
Sbjct: 124 SEEKIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH---- 175
Query: 691 QNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGR 736
+ T VV T Y APE + ++ D++S G ++ E+++G+
Sbjct: 176 ADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEE---FKNEIILIAKLQHRNLVRLLG 598
+GRG FG V KL + A+K L++ E F+ E ++ + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
Q + + L+ +Y L L + + L + RF + E + + +H+ L
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQ---LH 195
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-----YAM 712
+HRD+K NIL+D + + +++DFG + ++ VGT Y++PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGR 736
+G + + D +S GV + E++ G
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN----- 580
++ + +G G G V +++A+K+LSR F+N
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAK 106
Query: 581 ----EIILIAKLQHRNLVRLL------GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL 630
E++L+ + H+N++ LL + ++ L+ E M L I + L
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMEL 161
Query: 631 LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690
+ + + + G+ +LH IIHRDLK SNI++ D KI DFG+AR
Sbjct: 162 DHERMSYLLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 215
Query: 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ T VV T Y APE + + D++S G ++ E+V +
Sbjct: 216 TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLG 598
+GRG F V K+ + + A+K +++ + F+ E ++ R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLF--IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
Q E + L+ EY DL + ++ + RF + E I + +HR
Sbjct: 128 FAFQDENYLYLVMEYYVGG--DLLTLLSKFGERIPAEMA-RFYLAE-IVMAIDSVHR--- 180
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
L +HRD+K NILLD + +++DFG + + VGT Y++PE
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVG 239
Query: 716 FSVKSDVY-------SFGVLLLEIVSGR 736
+ Y + GV E+ G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 61/225 (27%), Positives = 90/225 (40%), Gaps = 62/225 (27%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKLQHRNLVRLL 597
+G G FG + + +AVK + R G ++E + EII L+H N+VR
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF- 81
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFI----------FDPAKQALLDWTKRFAIIEGIAR-- 645
E + + L I ++ A RF+ E AR
Sbjct: 82 ------------KEVILTPT-HLAIIMEYASGGELYERICNA-----GRFS--EDEARFF 121
Query: 646 ------GLLYLHRDSRLRIIHRDLKASNILLDED--MNPKISDFGMARIFGFNQNEANTN 697
G+ Y H ++I HRDLK N LLD KI DFG ++ + ++ +
Sbjct: 122 FQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS- 176
Query: 698 RVVGTYGYMAPE------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
VGT Y+APE Y G +DV+S GV L ++ G
Sbjct: 177 -TVGTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 47/234 (20%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN----- 580
+ ++ + +G G +G V +A+K++S F++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70
Query: 581 ----EIILIAKLQHRNLVRLLGCCI-QGEEKM----LIYEYMPNKSLDL--FIFDPAKQA 629
EI ++ + +H N++ + E+M ++ + M DL + Q
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLL---KTQH 124
Query: 630 LLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689
L + + + I RGL Y+H S ++HRDLK SN+LL+ + KI DFG+AR+
Sbjct: 125 LSNDHICY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 690 NQNEAN--TNRVVGTYGYMAPEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
+ + T V T Y APE + + K D++S G +L E++S R
Sbjct: 181 DHDHTGFLTEYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 42/187 (22%), Positives = 81/187 (43%), Gaps = 29/187 (15%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHR 591
+G G +G V + E + +A+K++ R F++ EI ++ +L H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHD 112
Query: 592 NLVRLLGCCI-QGEEKM----LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646
++V++L I + EK ++ E D L + + ++ + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKT-LLYNLLVG 168
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
+ Y+H S I+HRDLK +N L+++D + K+ DFG+AR + +N + + M
Sbjct: 169 VKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 707 APEYAME 713
Sbjct: 226 NLVTFPH 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 72/251 (28%), Positives = 108/251 (43%), Gaps = 50/251 (19%)
Query: 506 GPSDMVVDGSQVNGTD---LAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI 562
GP + +G+ + L + NF I V LG+G FG V ++ E D+
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRV----------LGKGSFGKVMLARVKETGDL 50
Query: 563 -AVKRLSRKSGQGLEEFKNEI--------ILIAKLQHRNLVRLLGCCIQGEEKM-LIYEY 612
AVK L + +++ IL H L +L CC Q +++ + E+
Sbjct: 51 YAVKVLKKDVILQ----DDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 613 MPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKA 665
+ DL F +A RF E I L++LH II+RDLK
Sbjct: 106 VNGG--DLMFHIQKSRRF-DEARA------RFYAAE-IISALMFLHD---KGIIYRDLKL 152
Query: 666 SNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSF 725
N+LLD + + K++DFGM + N T GT Y+APE E L+ D ++
Sbjct: 153 DNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 726 GVLLLEIVSGR 736
GVLL E++ G
Sbjct: 211 GVLLYEMLCGH 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEE---FKNEIILIAKLQHRNLVRLLG 598
+GRG FG V + + + A+K LS+ + F E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 599 CCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
Q + + ++ EYMP DL + + + RF E + L +H +
Sbjct: 136 YAFQDDRYLYMVMEYMPGG--DLV-NLMSNYDVPEKWARFYTAE-VVLALDAIHS---MG 188
Query: 658 IIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE----YAME 713
IHRD+K N+LLD+ + K++DFG + VGT Y++PE +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGD 247
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
G + + D +S GV L E++ G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGD 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 543 LGRGGFGPV----HKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRL 596
LG+G FG V Q A+K L + + + K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIARGLL 648
Q E K+ LI +++ DLF +F + +F + E +A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFT------EEDV-KFYLAE-LALALD 140
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
+LH L II+RDLK NILLDE+ + K++DFG+++ ++ +A + GT YMAP
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 195
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
E + +D +SFGVL+ E+++G
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 50/264 (18%)
Query: 494 MSKGQEISTDFSGPSDMVVDGSQVN-----GTDLAMFNFNTIAVATNYFSEGNKLGRGGF 548
+S+ QE + P+ Q+N +F+ + V +G+G F
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKV----------IGKGSF 51
Query: 549 GPV----HKGKLPEGQDIAVKRLSRKSGQGLEEFKNEI----ILIAKLQHRNLVRLLGCC 600
G V HK E AVK L +K+ +E K+ + +L+ ++H LV L
Sbjct: 52 GKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FS 107
Query: 601 IQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
Q +K+ + +Y+ +LF F +A RF E IA L YLH
Sbjct: 108 FQTADKLYFVLDYINGG--ELFYHLQRERCF-LEPRA------RFYAAE-IASALGYLHS 157
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
L I++RDLK NILLD + ++DFG+ + + + +T GT Y+APE
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLH 212
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGR 736
+ + D + G +L E++ G
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKNEI-- 582
+F + LG+G FG V + + A+K L + ++ + +
Sbjct: 18 DFILHKM----------LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 583 --ILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLD 632
+L +H L + C Q +E + + EY+ DL F +A
Sbjct: 68 KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGG--DLMYHIQSCHKF-DLSRA--- 120
Query: 633 WTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692
F E I GL +LH I++RDLK NILLD+D + KI+DFGM +
Sbjct: 121 ---TFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ NT GT Y+APE + ++ D +SFGVLL E++ G+
Sbjct: 174 KTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLVRLL 597
LG G FG V K E + A+K L + K Q +E NE ++ + LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLE 107
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+ + ++ EY+ ++F + RF + I YLH L
Sbjct: 108 FSF-KDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---L 160
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
+I+RDLK N+L+D+ +++DFG A+ + + T + GT +APE + +
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGY 215
Query: 717 SVKSDVYSFGVLLLEIVSGR 736
+ D ++ GVL+ E+ +G
Sbjct: 216 NKAVDWWALGVLIYEMAAGY 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHR 591
LG GG G V + +A+K++ + EI +I +L H
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHD 68
Query: 592 NLVRLL----------GCCIQGEEKM----LIYEYMPNKSLDL--FIFDPAKQALLDWTK 635
N+V++ + ++ ++ EYM DL + + LL+
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVL---EQGPLLEEHA 122
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEA 694
R + + RGL Y+H + ++HRDLK +N+ ++ ED+ KI DFG+ARI + +
Sbjct: 123 RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 695 N--TNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
+ +V T Y +P + ++ D+++ G + E+++G+
Sbjct: 179 GHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 23/207 (11%), Positives = 54/207 (26%), Gaps = 55/207 (26%)
Query: 542 KLGRGGFGPVHKG---KLPEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVR 595
G + L + +A+ + + L+E + + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 596 LLGCCIQGEEKMLIY---EYMPNKSLDLFIFDP--AKQALLDWTKRFAIIEGIARGLLYL 650
+L + E++ SL A+ ++ +A
Sbjct: 96 VLD---VVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI-------RAMQSLAAAADAA 145
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
HR + S + + D G V+ M
Sbjct: 146 HRAG---VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA- 179
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGRR 737
+ + D+ G L ++ R
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRW 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 45/213 (21%)
Query: 543 LGRGGFGPVHKGKLPEGQDI-AVKRLSR----KSGQGLEEFKNEIILIAKLQHRNLVRLL 597
LG G FG VH + A+K L + + Q +E +E ++++ + H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRMW 72
Query: 598 GCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIARGLLY 649
G Q +++ +I +Y+ +LF F +F E + L Y
Sbjct: 73 GTF-QDAQQIFMIMDYIEGG--ELFSLLRKSQRFPNP-------VAKFYAAE-VCLALEY 121
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH II+RDLK NILLD++ + KI+DFG A+ T + GT Y+APE
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE 173
Query: 710 ------YAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y S+ D +SFG+L+ E+++G
Sbjct: 174 VVSTKPYNK----SI--DWWSFGILIYEMLAGY 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHRN 592
+G G +G V G +A+K+L R F++ E+ L+ ++H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHEN 85
Query: 593 LVRLLGCCIQGEEKM------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646
++ LL E L+ +M L + + L + +F ++ + +G
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF-LVYQMLKG 140
Query: 647 LLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYM 706
L Y+H IIHRDLK N+ ++ED KI DFG+AR + T VV T Y
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTGYVV-TRWYR 192
Query: 707 APEYAME-GLFSVKSDVYSFGVLLLEIVSGR 736
APE + ++ D++S G ++ E+++G+
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 40/214 (18%)
Query: 543 LGRGGFGPVHKGKLPEGQDI----AVKRLSRKSGQGLEEFKNEI--------ILIAKLQH 590
LG+GG+G V + + G + A+K L + + + IL +++H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNIL-EEVKH 80
Query: 591 RNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEG 642
+V L+ Q K+ LI EY+ +LF IF T F + E
Sbjct: 81 PFIVDLI-YAFQTGGKLYLILEYLSGG--ELFMQLEREGIFMED-------TACFYLAE- 129
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
I+ L +LH+ II+RDLK NI+L+ + K++DFG+ + + +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
YMAPE M + D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 24/248 (9%)
Query: 494 MSKGQEISTDFSGPSDMVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHK 553
M +D SG +M V ++ + M F + + LG+G FG V
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAK-PKHRVTMNEFEYLKL----------LGKGTFGKVIL 166
Query: 554 GKLPEGQDI-AVKRLSRKSGQGLEEF---KNEIILIAKLQHRNLVRLLGCCIQGEEKM-L 608
K A+K L ++ +E E ++ +H L L Q +++
Sbjct: 167 VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCF 225
Query: 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668
+ EY +LF ++ + RF E I L YLH S +++RDLK N+
Sbjct: 226 VMEYANGG--ELFFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVYRDLKLENL 280
Query: 669 LLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVL 728
+LD+D + KI+DFG+ + + T GT Y+APE + + D + GV+
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338
Query: 729 LLEIVSGR 736
+ E++ GR
Sbjct: 339 MYEMMCGR 346
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKNEI-- 582
+FN + V LG+G FG V + ++ AVK L + +++
Sbjct: 21 DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVEC 66
Query: 583 ------ILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQ 628
+L + L +L C Q +++ + EY+ DL F
Sbjct: 67 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRF-KEPH 122
Query: 629 ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688
A F E IA GL +L II+RDLK N++LD + + KI+DFGM +
Sbjct: 123 A------VFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172
Query: 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
++ T GT Y+APE + D ++FGVLL E+++G+
Sbjct: 173 WDGVTTKT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 38/215 (17%)
Query: 543 LGRGGFGPVHKGKLPEGQDI----AVKRLSRKS----GQGLEEFKNE-IILIAKLQHRNL 593
LG G +G V + G D A+K L + + + E + E +L Q L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 594 VRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGIAR 645
V L Q E K+ LI +Y+ +LF F + + E I
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGG--ELFTHLSQRERFTEH-------EVQIYVGE-IVL 170
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
L +LH+ L II+RD+K NILLD + + ++DFG+++ F ++ E GT Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 226
Query: 706 MAPEYAMEGL----FSVKSDVYSFGVLLLEIVSGR 736
MAP+ G +V D +S GVL+ E+++G
Sbjct: 227 MAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 52/225 (23%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQHR 591
LG G +G V P G+ +A+K++ F EI ++ +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 592 NLVRLLGCCI-QGEEKM----LIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGIA 644
N++ + E +I E M DL I + Q L D ++ I
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT---DLHRVI---STQMLSDDHIQY-FIYQTL 122
Query: 645 RGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRV----- 699
R + LH +IHRDLK SN+L++ + + K+ DFG+ARI + + +
Sbjct: 123 RAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 700 ---VGTYGYMAPEYAMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
V T Y APE + + DV+S G +L E+ R
Sbjct: 180 VEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 45/227 (19%)
Query: 526 NFNTIAVATNYFSEGNKLGRGGFGPV----HKGKLPEGQDIAVKRLSRK---SGQGLEEF 578
+F+ + V +GRG + V K + A+K + ++ + ++
Sbjct: 10 DFDLLRV----------IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWV 56
Query: 579 KNE-IILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQA 629
+ E + H LV L C Q E ++ + EY+ DL P + A
Sbjct: 57 QTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKL-PEEHA 112
Query: 630 LLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689
RF E I+ L YLH II+RDLK N+LLD + + K++D+GM +
Sbjct: 113 ------RFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162
Query: 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ +T GT Y+APE + D ++ GVL+ E+++GR
Sbjct: 163 PGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 44/220 (20%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 510 MVVDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLS 568
M +G + F + + + +GRG +G V+ +++A+K+++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 569 RKSGQGLEEFKN---------EIILIAKLQHRNLVRLLGCCI-----QGEEKMLIYEYMP 614
R F++ EI ++ +L+ ++RL I + +E ++ E
Sbjct: 61 R-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM 674
+ DL L + + I+ + G ++H IIHRDLK +N LL++D
Sbjct: 114 S---DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDC 166
Query: 675 NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+ K+ DFG+AR ++ N + ++
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 67/229 (29%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN----- 580
TI + + +G G +G V G +AVK+LSR F++
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAK 73
Query: 581 ----EIILIAKLQHRNLVRLLGCCIQGEEKM------LIYEYMPNKSLDL--FIFDPAKQ 628
E+ L+ ++H N++ LL L+ M DL + Q
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIV---KCQ 127
Query: 629 ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688
L D +F +I I RGL Y+H S IIHRDLK SN+ ++ED KI DFG+AR
Sbjct: 128 KLTDDHVQF-LIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 689 FNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGR 736
T V T Y APE + ++ D++S G ++ E+++GR
Sbjct: 184 DEM----TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 52/273 (19%)
Query: 487 NDTQLIDMSKGQEISTDFSGPSDMVVDGSQVNGTD-------LAMFNFNTIAVATNYFSE 539
+ D+ + + + S + + +N + L + +F+ + V
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRV------- 59
Query: 540 GNKLGRGGFGPV----HKGKLPEGQDIAVKRLSRK---SGQGLEEFKNE-IILIAKLQHR 591
+GRG + V K + A++ + ++ + ++ + E + H
Sbjct: 60 ---IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 592 NLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDWTKRFAIIEGI 643
LV L C Q E ++ + EY+ DL P + A RF E I
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGG--DLMFHMQRQRKL-PEEHA------RFYSAE-I 162
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
+ L YLH II+RDLK N+LLD + + K++D+GM + + +T GT
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTP 217
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y+APE + D ++ GVL+ E+++GR
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEF---KNE 581
+F+ + + LG+G FG V + A+K L ++ +E E
Sbjct: 6 DFDYLKL----------LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 582 IILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQALLDW 633
++ +H L L Q +++ + EY +LF +F ++A
Sbjct: 56 SRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGG--ELFFHLSRERVF-TEERA---- 107
Query: 634 TKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693
RF E I L YLH +++RD+K N++LD+D + KI+DFG+ + +
Sbjct: 108 --RFYGAE-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
T GT Y+APE + + D + GV++ E++ GR
Sbjct: 162 MKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 1e-16
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 47/228 (20%)
Query: 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDI-AVKRLSRKSGQGLEEFKNEI-- 582
+FN + V LG+G FG V + ++ AVK L +K + +++
Sbjct: 342 DFNFLMV----------LGKGSFGKVMLSERKGTDELYAVKIL-KK---DVVIQDDDVEC 387
Query: 583 ------ILIAKLQHRNLVRLLGCCIQGEEKM-LIYEYMPNKSLDLF-------IFDPAKQ 628
+L + L +L C Q +++ + EY+ DL F
Sbjct: 388 TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGG--DLMYHIQQVGRF-KEPH 443
Query: 629 ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688
A F E IA GL +L II+RDLK N++LD + + KI+DFGM +
Sbjct: 444 A------VFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493
Query: 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
++ T GT Y+APE + D ++FGVLL E+++G+
Sbjct: 494 WDGVTTKT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 24/173 (13%)
Query: 524 MFNFNTIAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEI 582
A+ +Y LG G G V + + A+K L + + E+
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREV 61
Query: 583 -ILIAKLQHRNLVRLLGCC---IQGEEKM-LIYEYMPNKSLDLFIFDP-AKQALLDWTKR 636
+ Q ++VR++ G + + ++ E + L F + +T+R
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTER 117
Query: 637 FA--IIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMA 684
A I++ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 118 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 8e-15
Identities = 27/130 (20%), Positives = 51/130 (39%), Gaps = 20/130 (15%)
Query: 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPI 91
VN+++ S+ G SL + L N L G W +N
Sbjct: 1 VNSLSSPNSLFTGHSLEVGPS-YRLIMQGDCNFVLYDSGKPV---------WASNTGGLG 50
Query: 92 SDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGK 151
S R TL N+GNL++ + ++ +W + + ++ +L+ D N+++ G
Sbjct: 51 SGCRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY--------GP 100
Query: 152 AYWQSFNHPT 161
W + + P
Sbjct: 101 VVWATGSGPA 110
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 56/233 (24%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKN---------EIILIAKLQ- 589
KLG+G +G V K G+ +AVK++ F+N EI+++ +L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSG 67
Query: 590 HRNLVRLLGCCIQGEEKM----LIYEYMPNKSLDL--FIFDPAKQALLDWTKRFAIIEGI 643
H N+V LL + + L+++YM DL I L K++ ++ +
Sbjct: 68 HENIVNLLN--VLRADNDRDVYLVFDYMET---DLHAVI---RANILEPVHKQY-VVYQL 118
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTY 703
+ + YLH S ++HRD+K SNILL+ + + K++DFG++R F + N +
Sbjct: 119 IKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 704 GYMAP--------EY-------AMEGLFSVKS-----DVYSFGVLLLEIVSGR 736
+Y A E L D++S G +L EI+ G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 6e-14
Identities = 31/201 (15%), Positives = 57/201 (28%), Gaps = 46/201 (22%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRL--------SRKSGQGLEEFKNEII 583
+ T K+G G FG V + + +A+K + + + EE EII
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 584 LIAKLQ---------HRNLVRLLGCCI-------------------QGEEKMLIYEYMPN 615
+ +L + L +G + +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 616 KSLDLFIFDPAKQALLDWTKRF-------AIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668
+ + F+ L + +I+ + L LR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 669 LLDEDMNPKISDFGMARIFGF 689
LL + K+ +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI 214
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-13
Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 20/127 (15%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
N +T G+ + G+SL + N L W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLVLYDHSTSV---------WASNTGIL-G 49
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
+ + +DGN +V + ++W+S++ + N +L++DGN+++ S
Sbjct: 50 KKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------D 101
Query: 153 YWQSFNH 159
W + +
Sbjct: 102 IWSTGTY 108
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-13
Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 21/124 (16%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
N + G+++ GE L +NG + N L V W N
Sbjct: 2 NILYSGETLSPGEFL-NNGR-YVFIMQEDCNLVLYDVDKPI---------WATNTGGL-- 48
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
D R L++ +DGNL+V + + +W+SN + N +L+ D N+++ G A
Sbjct: 49 DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVI--------YGTA 100
Query: 153 YWQS 156
W +
Sbjct: 101 RWAT 104
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 48/225 (21%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ----------- 589
KLG G F V K + +A+K + R E ++EI L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI-FDPAKQALLDWTKRF-------AIIE 641
++++LL + + + + + F+ + LL K++ ++
Sbjct: 85 ANHILKLLDH----------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 642 GIAR----GLLYLHRDSRLRIIHRDLKASNILLDEDMNP------KISDFGMARIFGFNQ 691
I++ GL Y+HR R IIH D+K N+L++ +P KI+D G A +
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYD 189
Query: 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ T Y +PE + + +D++S L+ E+++G
Sbjct: 190 EHYTN--SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-12
Identities = 28/127 (22%), Positives = 52/127 (40%), Gaps = 19/127 (14%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
+ + G + G SL G + + N L VW + N S
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNNR---------AVWASGTNGKAS 50
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
L + NDGNL++ +G+ A+W+SN + + N +L+ D N+++ ++ A
Sbjct: 51 G--CVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNA 102
Query: 153 YWQSFNH 159
W + +
Sbjct: 103 IWATHTN 109
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-12
Identities = 33/137 (24%), Positives = 51/137 (37%), Gaps = 29/137 (21%)
Query: 31 AVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRP 90
N + GQ++ L NG+ F+L N L Y G W
Sbjct: 2 GTNYLLSGQTLDTEGHL-KNGD-FDLVMQDDCNLVL-YNGNWQSNTANNGRDC------- 51
Query: 91 ISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLG 150
LT+ + G L++ NG+ VW S A V N AA++ DG L++ G
Sbjct: 52 ------KLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV--------FG 97
Query: 151 KAYWQSFNHPTDTHLPG 167
+ ++ D + G
Sbjct: 98 PSVFKI-----DPWVRG 109
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 9e-12
Identities = 27/124 (21%), Positives = 46/124 (37%), Gaps = 21/124 (16%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
N + GQ++ SL + + L + N G W +N +R
Sbjct: 3 NVLLSGQTLHADHSLQAGA--YTLTIQNKCNLVKYQNGRQI---------WASNTDR--R 49
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
LT+ +DGNL++ + N+ VW S + A +L+ DG ++ G
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY--------GPV 101
Query: 153 YWQS 156
W
Sbjct: 102 LWSL 105
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-11
Identities = 23/124 (18%), Positives = 45/124 (36%), Gaps = 22/124 (17%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
N + GQ + L + +L N L W +N + +
Sbjct: 7 NLLFSGQVLYGDGRLTAKN--HQLVMQGDCNLVLYGGKY----------GWQSNTHG--N 52
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
E L + + G L++ + + +WSS +S +L+DDG ++ G A
Sbjct: 53 GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI--------YGPA 104
Query: 153 YWQS 156
+++
Sbjct: 105 IFET 108
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 22/127 (17%), Positives = 42/127 (33%), Gaps = 19/127 (14%)
Query: 30 RAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNR 89
R N + Q + D L + + L N L G + +VW
Sbjct: 4 RVRNVLFSSQVMYDNAQLATRD--YSLVMRDDCNLVL-TKG------SKTNIVW--ESGT 52
Query: 90 PISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNL 149
+ + +G+ G L + + V+ SN + +L+ +G ++
Sbjct: 53 SGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV--------Y 104
Query: 150 GKAYWQS 156
G A W +
Sbjct: 105 GPAVWST 111
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-09
Identities = 17/80 (21%), Positives = 33/80 (41%), Gaps = 10/80 (12%)
Query: 77 DEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDG 136
D +W N + R + DG L+V+ ++ VW S + + + +L+ D
Sbjct: 46 DNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDR 103
Query: 137 NLILTNSEDIGNLGKAYWQS 156
N+++ G A W +
Sbjct: 104 NVVIY--------GDALWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-08
Identities = 18/77 (23%), Positives = 32/77 (41%), Gaps = 7/77 (9%)
Query: 81 VVWVANRNRPISDERG-TLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLI 139
++ + + D NL VL N+ +W++N + N A+L+ DG L+
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNL-VLYDNNNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 140 LTNSEDIGNLGKAYWQS 156
+ +E WQS
Sbjct: 75 VITNE-----NVTVWQS 86
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 48/217 (22%)
Query: 543 LGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR------NLVR 595
+G+G FG V K Q +A+K + R + + EI ++ L+ + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 596 LLGC-------CIQGEEKML---IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
+L C+ E +L +YE + F L ++FA I +
Sbjct: 164 MLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFS--------LPLVRKFAH--SILQ 211
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNP--KISDFGMARIFGFNQNEANTNRVVGTY 703
L LH+ RIIH DLK NILL + K+ DFG + ++ V TY
Sbjct: 212 CLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---------EHQRVYTY 259
Query: 704 ----GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y APE + + + D++S G +L E+++G
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 52/222 (23%)
Query: 541 NKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHR----- 591
+ +G+G FG V K E + +A+K + K Q E+ L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 592 -NLVRLLGC-------CIQGEEKML---IYEYMPNKSLDLFIFDPAKQALLDWTKRFAII 640
+V L C+ E ML +Y+ + N + L+ T++FA
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVS--------LNLTRKFAQ- 164
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP--KISDFGMARIFGFNQNEANTNR 698
+ LL+L L IIH DLK NILL KI DFG + +
Sbjct: 165 -QMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---------LGQ 213
Query: 699 VVGTY----GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
+ Y Y +PE + + + D++S G +L+E+ +G
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 53/266 (19%), Positives = 90/266 (33%), Gaps = 88/266 (33%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ--------HRN 592
KLG G F V + + +A+K + + + E +EI L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 593 LVRLLGC-CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRF-----------AII 640
+V+LL I G N + +F+ LL W + II
Sbjct: 103 VVQLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILL------------------------------ 670
+ + +GL YLH ++ RIIH D+K NILL
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 671 -------------------DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
E + KI+D G A + E + T Y + E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVL 265
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGRR 737
+ ++ +D++S + E+ +G
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDY 291
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 37/169 (21%), Positives = 62/169 (36%), Gaps = 25/169 (14%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDI------AVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
G +G+GGFG ++ + + + VK +G E K Q +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 594 VRLLGCCIQGEEKMLIY--EYMPNKSLDLFIFD---PAKQALLDWT-KRFAI-------I 640
+R G K KS I D Q + + KRF+ +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI--SDFGMARIF 687
+ L Y+H +H D+KASN+LL+ ++ D+G+A +
Sbjct: 160 RILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 31/166 (18%), Positives = 59/166 (35%), Gaps = 22/166 (13%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIA---VKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
G K+G GGFG ++ + + A VK +++G E K + K + +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLD--LFIFD---PAKQALLDWTKRFAI-------IEGI 643
G K + + Q + F I +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI--SDFGMARIF 687
L Y+H + +H D+KA+N+LL ++ +D+G++ +
Sbjct: 162 DV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 37/171 (21%), Positives = 62/171 (36%), Gaps = 37/171 (21%)
Query: 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
F G K+G G FG + GK L + +A+K KS + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGI 67
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSL-DLFIFDP-----------AKQALLDWTKRFAIIE 641
++ G+ ++ E + SL DLF A Q + + +E
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLI-------SRME 119
Query: 642 GIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK-----ISDFGMARIF 687
Y+H + +I+RD+K N L+ N I DF +A+ +
Sbjct: 120 -------YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 29/161 (18%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH-RNLVRLL 597
G K+G G FG ++ G + G+++A+K K+ E + +Q + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIR 71
Query: 598 GCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAI-------IEGIARGLLY 649
C +G+ +++ E + SL DLF F ++F++ + I+R + Y
Sbjct: 72 WCGAEGDYNVMVMELL-GPSLEDLFNFCS---------RKFSLKTVLLLADQMISR-IEY 120
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPK---ISDFGMARIF 687
+H + IHRD+K N L+ I DFG+A+ +
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 3e-07
Identities = 27/145 (18%), Positives = 53/145 (36%), Gaps = 12/145 (8%)
Query: 29 GRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVG--IWYHQIDEKAVVWVAN 86
G + + Q++ G+ L+S + F+L N ++ G +W + +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPL 70
Query: 87 RNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAAL-----LEDDGNLILT 141
RN+ L + + + VW ++ S ++N L+DDGN++L
Sbjct: 71 RNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLV 125
Query: 142 NSEDIGNLGKAYWQSFNHPTDTHLP 166
+S + N A L
Sbjct: 126 DSLALWNGTPAIPLVPGAIDSLLLA 150
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.9 bits (102), Expect = 1e-04
Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 9/70 (12%)
Query: 97 TLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156
DGNL+V + +W S+ + + L+ +G++ + + K W
Sbjct: 198 RAVFQGDGNLVVYGAGNAVLWHSH-TGGHASAVLRLQANGSIAILD-------EKPVWAR 249
Query: 157 F-NHPTDTHL 165
F PT H+
Sbjct: 250 FGFQPTYRHI 259
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 29/161 (18%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLL 597
G K+G G FG ++ G + +++A+K + K+ E + LQ + +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVR 69
Query: 598 GCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAI-------IEGIARGLLY 649
++G+ +L+ + + SL DLF F ++ ++ + I R + +
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINR-VEF 118
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPK---ISDFGMARIF 687
+H S +HRD+K N L+ I DFG+A+ +
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 29/172 (16%), Positives = 57/172 (33%), Gaps = 31/172 (18%)
Query: 540 GNKLGRGGFGPVHKGK---------LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH 590
+ R G +++ P+ Q ++K L K G+ E LQ
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 591 RNLVRLLGC---CI---------QGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRF 637
+L I Q + + L+ + +SL P +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164
Query: 638 AIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI--SDFGMARIF 687
A + L +LH + +H ++ A NI +D + ++ + +G A +
Sbjct: 165 AC-RLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 35/164 (21%), Positives = 70/164 (42%), Gaps = 33/164 (20%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRL 596
G ++G G FG + +G L Q +A+K R+S Q +E++ +L + +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNV 71
Query: 597 LGCCIQGEEKMLIYEYMPNKSL-DLFIFDPAKQALLDWTKRFAI-------IEGIARGLL 648
+G +L+ + + SL DL ++F++ + +AR +
Sbjct: 72 YYFGQEGLHNVLVIDLLG-PSLEDLLDLCG---------RKFSVKTVAMAAKQMLAR-VQ 120
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNPK-----ISDFGMARIF 687
+H S +++RD+K N L+ + + DFGM + +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 1e-06
Identities = 22/80 (27%), Positives = 32/80 (40%), Gaps = 10/80 (12%)
Query: 77 DEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDG 136
D VW N + R L +G + VL +IAVW+S S + +L+ D
Sbjct: 166 DRDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDR 223
Query: 137 NLILTNSEDIGNLGKAYWQS 156
NL + G A W +
Sbjct: 224 NLAIY--------GGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 6/92 (6%)
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAA 130
I Y + + + L++ D NL VL VWS+N + A
Sbjct: 127 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNL-VLFDRDDRVWSTNTAGKGTGCRA 185
Query: 131 LLEDDGNLILTNSEDIGNLGKAYWQSFNHPTD 162
+L+ +G + + ++ A W S N +
Sbjct: 186 VLQPNGRMDVLTNQ-----NIAVWTSGNSRSA 212
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 25/196 (12%), Positives = 58/196 (29%), Gaps = 30/196 (15%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
+ + Q++ +SL + F + Q D V++ ++ S
Sbjct: 9 HEGSHPQTLHAAQSLELSSFRFTM------------------QSDCNLVLFDSDVRVWAS 50
Query: 93 DERG----TLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGN 148
+ G + +DG L++L + WSS N +L+ D + +
Sbjct: 51 NTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPG---- 106
Query: 149 LGKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQI 208
W S + + + + S + + +
Sbjct: 107 ----LWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNL 162
Query: 209 VIWEQLKRRWRSGQWN 224
V++++ R W +
Sbjct: 163 VLFDRDDRVWSTNTAG 178
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 4/74 (5%)
Query: 91 ISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLG 150
+S E + D NL++ N + SN + L + G L + ++ N
Sbjct: 17 LSYESAAFVMQGDCNLVLYNEA--GGFQSNTHGRGVDCTLRLNNRGQLEIHSAN--SNTP 72
Query: 151 KAYWQSFNHPTDTH 164
+ + +
Sbjct: 73 VWVYPRSVNTVRGN 86
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 23/117 (19%), Positives = 39/117 (33%), Gaps = 29/117 (24%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQID------EKAVVWVAN 86
N + G I L F + Q D +A + +N
Sbjct: 3 NVLLTGDVIHTDNQLSYESAAFVM------------------QGDCNLVLYNEAGGFQSN 44
Query: 87 RNRPISDERGTLTIGNDGNLMVLNGNS---IAVWSSNASVVSNNTAALLEDDGNLIL 140
+ TL + N G L + + NS + V+ + + V N AA L D ++ +
Sbjct: 45 THG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTI 99
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 62/235 (26%)
Query: 542 KLGRGGFGPVHKGK-LPEGQDIAVK-----RLSRKSGQGLEEFKNEIILIAKLQHR---- 591
K+G G FG V + + + AVK + +S K E ++ K+Q+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA------KIEADILKKIQNDDINN 95
Query: 592 -NLVRLLGC-------CIQGEEKML---IYEYMPNKSLDLFIFDPAKQALLDWTKRFAII 640
N+V+ G C+ E L +YE + + ++ ++ K + I
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNN-----YNGFH---IEDIKLYCI- 144
Query: 641 EGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR-- 698
I + L YL + + + H DLK NILLD+ K G T
Sbjct: 145 -EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 699 ------------------VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
++ T Y APE + + V SD++SFG +L E+ +G
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 51/236 (21%), Positives = 83/236 (35%), Gaps = 68/236 (28%)
Query: 542 KLGRGGFGPVHKG--KLPEGQDIAVK-----RLSRKSGQGLEEFKNEIILIAKLQHR--- 591
LG G FG V + +A+K R++ + EI ++ K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA------RLEINVLKKIKEKDKE 79
Query: 592 ---NLVRLLGC-------CIQGEEKML---IYEYMPNKSLDLFIFDPAKQALLDWTKRFA 638
V + CI E +L +E++ + F P L + A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENN-----FQPYP---LPHVRHMA 129
Query: 639 IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP-------------------KIS 679
+ L +LH ++ H DLK NIL +++
Sbjct: 130 Y--QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
DFG A F+ T +V T Y PE +E ++ DV+S G +L E G
Sbjct: 185 DFGSA---TFDHEHHTT--IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 57/239 (23%), Positives = 90/239 (37%), Gaps = 74/239 (30%)
Query: 542 KLGRGGFGPV-----HKGKLPEGQDIAVK-----RLSRKSGQGLEEFKNEIILIAKLQHR 591
LG G FG V HK G+ +AVK ++ ++EI ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAG---GRHVAVKIVKNVDRYCEAA------RSEIQVLEHLNTT 71
Query: 592 ------NLVRLLGC-------CIQGEEKML---IYEYMPNKSLDLFIFDPAKQALLDWTK 635
V++L CI E +L Y+++ F P + LD +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG-----FLPFR---LDHIR 121
Query: 636 RFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP------------------- 676
+ A I + + +LH ++ H DLK NIL +
Sbjct: 122 KMAY--QICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSG 735
K+ DFG A ++ +T +V T Y APE + +S DV+S G +L+E G
Sbjct: 177 KVVDFGSA---TYDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 854 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.8 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.72 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.71 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.59 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.58 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.54 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.35 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.23 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.2 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.14 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.18 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.96 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.33 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.33 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.03 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 81.82 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 80.84 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 80.81 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.15 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=444.95 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=214.4
Q ss_pred cCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999753 477899999987666677889999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc----------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 609 IYEYMPNKSLDLFIFDPA----------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
|||||++|+|.++++... ....++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996432 2346999999999999999999999988 999999999999999999999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHh
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..++...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~~~~~i---- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIECI---- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH----
Confidence 99999987643333333444679999999999999999999999999999999999 899986421 22222222
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
..+.... .+......+.+++.+||+.||++|||++||++.|+.+...
T Consensus 244 ~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2222111 1122335788999999999999999999999999987443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=447.66 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=207.6
Q ss_pred cCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999753 478899999987766677889999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 609 IYEYMPNKSLDLFIFDPA------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
|||||++|+|.++++... ....++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999996542 2246999999999999999999999988 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ...+...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--~~~~~~~i-- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--NTEAIDCI-- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--HHHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--HHHHHHHH--
Confidence 9999999997654333334455789999999999999999999999999999999999 899986421 12222222
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
..+... . .+......+.+++.+||+.||++||||+||++.|+.+...
T Consensus 274 --~~g~~~-----~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 --TQGREL-----E----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHTCCC-----C----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HcCCCC-----C----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222111 1 1112235688899999999999999999999999987544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=440.80 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=211.3
Q ss_pred CcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.+++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455689999999999999752 46789999997543 3456789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC
Q 003045 609 IYEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 675 (854)
|||||++|+|.++|.... ....++|.++++|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996432 1346999999999999999999999988 999999999999999999
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHH
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVW 754 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~ 754 (854)
+||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |+.||... ...++...+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~~i- 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVEMI- 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHHHH-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHHHH-
Confidence 99999999987654444444556789999999999999999999999999999999999 88888632 122222222
Q ss_pred HHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 755 NLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 755 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+.... .+......+.+++.+||+.||++||||+||++.|+..
T Consensus 261 ---~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 ---RNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222211 1223345788999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=433.50 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=203.5
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
+.+.+.++||+|+||+||+|++++ .||||+++.. ..+..++|.+|++++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456778899999999999998753 6999998643 23456789999999999999999999998864 568999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
|++|+|.+++... ...+++.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999643 345999999999999999999999988 99999999999999999999999999987654333
Q ss_pred cccccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||..... . ..+......+. ..|.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~---~~~~~~~~~~~----~~p~ 258 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--R---DQIIFMVGRGY----ASPD 258 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--H---HHHHHHHHTTC----CCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--H---HHHHHHHhcCC----CCCC
Confidence 344456789999999999864 4699999999999999999999999863211 1 11111222211 1121
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCC
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTL 814 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~ 814 (854)
+. .........+.+++.+||+.||++||||.||++.|+.+...+
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11 112233457888999999999999999999999998874433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=428.71 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=209.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999764 69999999998766667778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+++.. ..+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--C
Confidence 99999998842 45899999999999999999999998 999999999999999999999999999976432 2
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+. .+. .+.+ .
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~----~~~-----~~~~--~ 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIR----DNL-----PPRL--K 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHH----HSS-----CCCC--S
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHH----cCC-----CCCC--C
Confidence 3344579999999999999999999999999999999999999998632 1112222221 111 1111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+.+++.+||+.||++|||++|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122346788999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=425.89 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=201.6
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999975 46999999999754 23346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|.+++... +...+++.++..|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 99999999998542 2345789999999999999999999998 99999999999999999999999999987632
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||... . ..+.+...... .. +.+.
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--~---~~~~~~~i~~~-~~-----~~~~ 246 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--S---MKNLVLKIISG-SF-----PPVS 246 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--S---HHHHHHHHHHT-CC-----CCCC
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--C---HHHHHHHHHcC-CC-----CCCC
Confidence 112234578999999999999999999999999999999999999999632 1 22222222221 11 1111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222 346788999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=420.76 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=209.5
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||+||+|+. .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999975 46899999999753 3445678999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999987544
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||... ....+...+. .+.. .+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~----~~~~------~~ 253 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKII----KLEY------DF 253 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHH----HTCC------CC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHH----cCCC------CC
Confidence 4444556689999999999999999999999999999999999999999632 2222222221 1111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl 804 (854)
.... ...+.+++.+||+.||++|||++|++
T Consensus 254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1222 24678899999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=424.85 Aligned_cols=254 Identities=23% Similarity=0.291 Sum_probs=204.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.|...++||+|+||+||+|+.+ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56788889999999999999764 689999999975422 247999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceeccCccC
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFGFNQN 692 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 692 (854)
++|+|.+++. +...+++.++..++.||+.||+|||+.+ ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999994 3456999999999999999999999998 99999999999999987 699999999997643221
Q ss_pred c---ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 693 E---ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 693 ~---~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+...+.. ..... ..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~---~~~~~----~~ 277 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR--GPLCLKIAS---EPPPI----RE 277 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC--SCCHHHHHH---SCCGG----GG
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHHc---CCCCc----hh
Confidence 1 123346899999999999999999999999999999999999999964322 223322221 11100 01
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+.. .....+.+++.+||+.||++|||+.|+++.|...+.
T Consensus 278 ~~~----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 IPP----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp SCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 112 223467889999999999999999999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=412.95 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=197.0
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCeeEEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEKMLI 609 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV 609 (854)
|+..++||+|+||+||+|... +++.||+|++... .....+.|.+|++++++++|||||++++++.+ .+..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 456678999999999999754 6889999999654 23345679999999999999999999999875 3457999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~ 688 (854)
||||++|+|.+++. +...+++..+..++.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999994 3456999999999999999999999976 4699999999999998 47999999999998532
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .. .+......+......+
T Consensus 184 ----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~-~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AA-QIYRRVTSGVKPASFD- 252 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HH-HHHHHHTTTCCCGGGG-
T ss_pred ----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HH-HHHHHHHcCCCCCCCC-
Confidence 223445789999999998865 699999999999999999999999863211 11 1122222221111111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...+.+++.+||+.||++|||++|+++
T Consensus 253 ---~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 235788999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=427.99 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=210.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999764 69999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+++. ...+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~ 301 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V 301 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--C
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--C
Confidence 9999999884 235899999999999999999999998 999999999999999999999999999976432 2
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+ ..+.. +.+..
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i----~~~~~-----~~~~~- 369 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMI----RDNLP-----PRLKN- 369 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHH----HHSCC-----CCCSC-
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHH----HcCCC-----CCCcc-
Confidence 3345579999999999999999999999999999999999999998632 111222222 11111 11110
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLES 809 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~ 809 (854)
.......+.+++.+||+.||++|||+.|+++ .+.+
T Consensus 370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 1112246788999999999999999999987 4544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=426.88 Aligned_cols=266 Identities=27% Similarity=0.394 Sum_probs=214.3
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcCC------CcEEEEEEeccccc-cCHHHHHHHHHHHHhcCC-CceeeeeeeE
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQH-RNLVRLLGCC 600 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h-~niv~l~~~~ 600 (854)
.-+...++|++.++||+|+||+||+|+... ++.||||++..... ...++|.+|+++|.+++| ||||+++++|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 334556789999999999999999997432 46799999976533 345679999999999965 8999999999
Q ss_pred EeC-CeeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCC
Q 003045 601 IQG-EEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKAS 666 (854)
Q Consensus 601 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 666 (854)
.+. +..++|||||++|+|.++|+.... ...+++.+++.++.|||+||+|||+.+ ||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcc
Confidence 765 568999999999999999965322 345899999999999999999999998 999999999
Q ss_pred cEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCccc
Q 003045 667 NILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEE 745 (854)
Q Consensus 667 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~ 745 (854)
|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~- 293 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI- 293 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999997754444444556789999999999999999999999999999999998 8999864221
Q ss_pred CchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 746 NSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
...+.. ....+.... .+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 294 ~~~~~~----~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 294 DEEFCR----RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp SHHHHH----HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH----HHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 122222 222222111 11122346888999999999999999999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=413.45 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=201.6
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----eeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE----EKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 610 (854)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567788999999999999988 6899999999654221 222345666777899999999999998764 579999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS-----RLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
|||++|+|.+++.. ..++|..+.+++.|+++||+|||+.. .++||||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 35899999999999999999999872 3359999999999999999999999999998
Q ss_pred eccCccCc--ccccccccccccccceeeccC------CCCcccchhhHHHHHHHHHhCCCCCCCCcccC---------ch
Q 003045 686 IFGFNQNE--ANTNRVVGTYGYMAPEYAMEG------LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN---------SS 748 (854)
Q Consensus 686 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvil~elltG~~p~~~~~~~~---------~~ 748 (854)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76433221 223346899999999999764 46789999999999999999988764322111 01
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDS-SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
..+.+......+ ..+|.+... .+.+....+.+++.+||+.||++||||.||++.|+.+.
T Consensus 237 ~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 112222222111 122322211 22356678899999999999999999999999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=402.83 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=189.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999764 6999999999754 2334567999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+ +|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999 678888874 3456999999999999999999999998 99999999999999999999999999986532
Q ss_pred cCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......+||+.|||||++.+..| +.++||||+||++|||++|+.||... ....+...+ ..+.. .
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i----~~~~~------~ 230 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNI----SNGVY------T 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH----HHTCC------C
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHH----HcCCC------C
Confidence 223345789999999999998876 57999999999999999999999632 112222222 11111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.... ...+.+++.+||+.||++|||++|+++
T Consensus 231 ~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11112 246788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=410.85 Aligned_cols=247 Identities=24% Similarity=0.271 Sum_probs=196.1
Q ss_pred cCcccCcccccCCcccEEEeEc----CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|++.++||+|+||+||+|+. ..++.||||++++.. ......+.+|+++|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5689999999999999999964 247889999997542 2334568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 3456999999999999999999999998 9999999999999999999999999998653
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
. ........+||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+ .. +..
T Consensus 178 ~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i---~~-~~~------ 243 (304)
T 3ubd_A 178 D--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMI---LK-AKL------ 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH---HH-CCC------
T ss_pred C--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--CHHHHHHHH---Hc-CCC------
Confidence 2 223334578999999999999999999999999999999999999999632 222222222 11 111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
...... ...+.+++.+||+.||++||| ++|+++
T Consensus 244 ~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 GMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111122 346788999999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=401.83 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=190.0
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--------
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-------- 604 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 604 (854)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4588899999999999999975 468999999997543 334567899999999999999999999987654
Q ss_pred ----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecc
Q 003045 605 ----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISD 680 (854)
Q Consensus 605 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 680 (854)
..++||||+++|+|.+++.........++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976555455677888999999999999999998 99999999999999999999999
Q ss_pred cCcceeccCccCc----------ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHH
Q 003045 681 FGMARIFGFNQNE----------ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLI 750 (854)
Q Consensus 681 FGla~~~~~~~~~----------~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~ 750 (854)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||... .+..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHH
Confidence 9999976432211 11234679999999999999999999999999999999996 55321 1111
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.. ....... .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~-~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTD-VRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH-HHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH-HhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 1111110 011122345677999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.65 Aligned_cols=283 Identities=38% Similarity=0.607 Sum_probs=244.4
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
.+.+++.++++|+..+.||+|+||.||+|+.++++.||||++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445567789999999999999999999988899999999887666677889999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc-ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK-QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999865432 235899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc-cCchHHHHHHHHhhcCCcc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE-ENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~ 763 (854)
................||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .......+.......+...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 875433333333446789999999999999999999999999999999999999875432 2334555555555666777
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 764 ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 764 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
.++++.+...........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 788888888888889999999999999999999999999999998864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=385.34 Aligned_cols=289 Identities=42% Similarity=0.703 Sum_probs=247.4
Q ss_pred cccceeHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeee
Q 003045 521 DLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGC 599 (854)
Q Consensus 521 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 599 (854)
....|++.++....++|++.++||+|+||.||+|+..+++.||||++.... ......+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456788999999999999999999999999999998889999999997643 2233478999999999999999999999
Q ss_pred EEeCCeeEEEEEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 600 CIQGEEKMLIYEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 600 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
+.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||+....+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997643 3345999999999999999999999992223999999999999999999999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCc---ccCchHHHHHHH
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL---EENSSLIEHVWN 755 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~---~~~~~l~~~~~~ 755 (854)
+|||++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+..++..
T Consensus 176 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999998764322 222334569999999999999999999999999999999999999996322 233445566666
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.........+.+..+...........+.+++.+|++.||++|||+.||++.|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 6666677778888888888899999999999999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=391.67 Aligned_cols=201 Identities=23% Similarity=0.315 Sum_probs=171.7
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcC----CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCe
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 605 (854)
....++|++.++||+|+||+||+|+.+ .++.||+|++... .....+.+|+++|+++ +||||+++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345688999999999999999999642 4678999998654 3346788999999998 69999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccCcc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMA 684 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla 684 (854)
.++||||+++|+|.+++. .+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999882 3889999999999999999999998 9999999999999877 79999999999
Q ss_pred eeccCccCc--------------------------ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCC
Q 003045 685 RIFGFNQNE--------------------------ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRR 737 (854)
Q Consensus 685 ~~~~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~ 737 (854)
+........ ......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 865322110 112345799999999999875 58999999999999999999999
Q ss_pred CCCCC
Q 003045 738 NTSFR 742 (854)
Q Consensus 738 p~~~~ 742 (854)
||...
T Consensus 246 Pf~~~ 250 (361)
T 4f9c_A 246 PFYKA 250 (361)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 98643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=394.79 Aligned_cols=268 Identities=20% Similarity=0.290 Sum_probs=203.1
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe------CC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ------GE 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~ 604 (854)
.++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999975 469999999997542 2334678899999999999999999998764 35
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..|||||||+ |+|..++.. ...+++.++..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 678888843 456999999999999999999999998 999999999999999999999999999
Q ss_pred eeccCc--cCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 685 RIFGFN--QNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 685 ~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
+.+... .........+||+.|||||++.+. .|+.++||||+|||+|||++|+.||... ........+........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--NYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhcCCCC
Confidence 876432 122334457999999999998875 5799999999999999999999999642 22222333322221111
Q ss_pred cccc-----------cCC-CCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 762 AMEL-----------VDP-NIRDSSSQ-----NQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 762 ~~~~-----------~d~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.... +.. ......+. .....+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0000 000 00000010 11246788999999999999999999987 44443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=366.66 Aligned_cols=284 Identities=37% Similarity=0.559 Sum_probs=233.5
Q ss_pred cccceeHHHHHHHhcCcccC------cccccCCcccEEEeEcCCCcEEEEEEecccc----ccCHHHHHHHHHHHHhcCC
Q 003045 521 DLAMFNFNTIAVATNYFSEG------NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQH 590 (854)
Q Consensus 521 ~~~~~~~~~~~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h 590 (854)
+...|++.++..++++|... ++||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999877 8999999999999987 68899999986532 2345778999999999999
Q ss_pred CceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 591 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999876555567999999999999999999999998 9999999999999
Q ss_pred ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHH
Q 003045 671 DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLI 750 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~ 750 (854)
+.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|+.|+...... ..+.
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHH
Confidence 9999999999999987653333333445679999999998765 5889999999999999999999998753322 1122
Q ss_pred HHHHHHhh-cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 751 EHVWNLWN-EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 751 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
........ .......+++.+ ..........+.+++.+|++.+|++|||+.||++.|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22211111 122333444443 3356677888999999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=404.68 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=207.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|++.+.||+|+||+||+|+.+ +|+.||+|++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 67999999999999999999764 69999999997766566778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC--CCceecccCcceeccCcc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED--MNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 691 (854)
++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 999999988542 345899999999999999999999998 9999999999999854 8999999999998642
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+ . .... . ..+...
T Consensus 310 -~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--~~~~~~~i---~-~~~~-~-~~~~~~ 380 (573)
T 3uto_A 310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNV---K-SCDW-N-MDDSAF 380 (573)
T ss_dssp -TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHH---H-TTCC-C-CCSGGG
T ss_pred -CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHH---H-hCCC-C-CCcccc
Confidence 223345689999999999999999999999999999999999999986321 11222222 1 1111 0 011111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 381 ~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SG----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 2246788999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=398.92 Aligned_cols=248 Identities=26% Similarity=0.282 Sum_probs=198.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHH---HHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNE---IILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E---i~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
++|++.++||+|+||+||+|+.. +|+.||+|++.+.. ......+.+| +.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67899999999999999999764 69999999996531 2233334444 56677779999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++|+|..++. +...+++..+..++.||+.||+|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999994 3456999999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.. ......+||+.|||||++.+ ..|+.++|+|||||++|||++|+.||...... ...+........ .
T Consensus 343 ~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~i~~~-~----- 410 (689)
T 3v5w_A 343 SK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTM-A----- 410 (689)
T ss_dssp SS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHHHHHC-C-----
T ss_pred CC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCC-C-----
Confidence 42 22345789999999999975 57999999999999999999999999643222 111211111111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
..+.... ...+.+++.+||+.||++|++ ++||++
T Consensus 411 -~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111122 346788999999999999998 678765
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.92 Aligned_cols=232 Identities=18% Similarity=0.261 Sum_probs=180.0
Q ss_pred cccccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCC----CceEEEeccCC
Q 003045 30 RAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDE----RGTLTIGNDGN 105 (854)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~g~ 105 (854)
.+.|+|++|++|++|++|+|++|.|+||||.++ .+|+ |+ +.+ +||+|||++|++++ +++|+|+.||+
T Consensus 12 ~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 12 VGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp TTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred ccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 467999999999999999999999999999443 5676 66 777 99999999999875 78999999999
Q ss_pred eEE--EcCCCcEEEEeccccc-----cccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEecCCC
Q 003045 106 LMV--LNGNSIAVWSSNASVV-----SNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSALGE 178 (854)
Q Consensus 106 l~l--~~~~~~~vW~t~~~~~-----~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~~~g~ 178 (854)
||| .|++|.+||+|+++.. ..+..|+|+|+|||||++ +++|||| |||||||||||||.+.++|.
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccCc
Confidence 999 7888999999997642 346789999999999997 2689999 99999999999999988765
Q ss_pred ceeEEeccCCCCCCCCceEeeecCCCCCeEEEEec-ceeEEecCCCcceeeecccccccccccceeeeeccCCCCCceEE
Q 003045 179 NRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQ-LKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYF 257 (854)
Q Consensus 179 ~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~-~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (854)
. | ++.+||++|.|+++|+++|. +++|+. ...||++|+|++....- .++.. -.+.+.+. ++..+..
T Consensus 154 ~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l--~l~~d----GnLvl~d~-~~~~vWs 219 (276)
T 3m7h_A 154 E--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRA--VFQGD----GNLVVYGA-GNAVLWH 219 (276)
T ss_dssp E--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEE--EECTT----SCEEEECT-TSCEEEE
T ss_pred c--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEE--EEcCC----CeEEEEeC-CCcEEEE
Confidence 4 5 67899999999999999984 566654 58999999997632110 11111 11222221 1223333
Q ss_pred EEEecCCceEEEEEEeecCcEEEEEEcCCCCceEEEEeccC
Q 003045 258 TYVPANASYLLRFRIGWDGNEEQLRWDGSAKKWSVIQKQPA 298 (854)
Q Consensus 258 ~~~~~~~~~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~ 298 (854)
++.. .....|++|+.||++++|.| ...|..++.+|.
T Consensus 220 S~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 220 SHTG--GHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CSCT--TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred ecCC--CCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 3222 22348999999999999999 356777776664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=367.20 Aligned_cols=264 Identities=28% Similarity=0.445 Sum_probs=205.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
..++|++.++||+|+||+||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456888999999999999999987 68899999987543 233567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 191 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS- 191 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc-
Confidence 99999999999976544445999999999999999999999986 3599999999999999999999999999986432
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+ ...... ..+
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~~---~~~~~~-----~~~ 260 (309)
T 3p86_A 192 -TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAV---GFKCKR-----LEI 260 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHHHH---HHSCCC-----CCC
T ss_pred -cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH---HhcCCC-----CCC
Confidence 11223346799999999999999999999999999999999999999864321 1111111 111111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCC
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTL 814 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~ 814 (854)
+......+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 261 ----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 ----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1122346888999999999999999999999999875543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.47 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=208.1
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|+..++||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999975 56899999999876666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 999999999843 35899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. ..
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~-~~------- 236 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTP-EL------- 236 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSC-CC-------
T ss_pred -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC-CC-------
Confidence 233446799999999999999999999999999999999999999864221 1111111111110 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111223346788999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=373.01 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=211.3
Q ss_pred hcCcccCcccccCCcccEEEeEc--------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL--------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG 603 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 603 (854)
.++|.+.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788999999999999999964 235679999997543 33456789999999999 899999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999864321 235899999999999999999999998 9999999999999
Q ss_pred ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchH
Q 003045 671 DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSL 749 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l 749 (854)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.... ...+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~--~~~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEEL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH
Confidence 9999999999999997654333333344567889999999999999999999999999999999 888886432 1222
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 750 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
...+ ..+.. ...+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 315 ~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 FKLL----KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHH----HTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2221 11111 1111223346888999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.64 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=211.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|.+.++||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367888999999999999999764 6899999999776666778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998542 345899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cc------------cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 693 EA------------NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 693 ~~------------~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+..................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence 11 111457999999999999999999999999999999999999988653322111111010000
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+....... ...+.+++.+|++.||++|||+.|+++.|+.+..
T Consensus 241 ------~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 241 ------DRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------HHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------cccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00111111 2357789999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.59 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=214.1
Q ss_pred cceeHHHHHHHhcC----------cccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC
Q 003045 523 AMFNFNTIAVATNY----------FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR 591 (854)
Q Consensus 523 ~~~~~~~~~~~~~~----------f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ 591 (854)
..++++++..+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777887777764 667789999999999999865 7999999999877667788899999999999999
Q ss_pred ceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 592 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999998842 35899999999999999999999998 99999999999999
Q ss_pred cCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHH
Q 003045 672 EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751 (854)
Q Consensus 672 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~ 751 (854)
.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH
T ss_pred CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 99999999999998764321 223446799999999999999999999999999999999999999864211 11111
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 752 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+ .... .+.+. ........+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~----~~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RL----RDSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HH----HHSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----hcCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111 11111 11122346788999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=363.05 Aligned_cols=264 Identities=27% Similarity=0.380 Sum_probs=207.9
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----eeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE----EKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lV 609 (854)
.++|.+.++||+|+||+||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468899999999999999999874 7899999996543 23445667999999999999999999998754 36999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC----------CCCceEEcccCCCcEEEccCCCceec
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD----------SRLRIIHRDLKASNILLDEDMNPKIS 679 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~Dlkp~NILl~~~~~~kl~ 679 (854)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999843 3489999999999999999999998 6 9999999999999999999999
Q ss_pred ccCcceeccCccCcccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCch-H----
Q 003045 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS-L---- 749 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~-l---- 749 (854)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999988754433333445689999999999986 35667899999999999999999998653321111 0
Q ss_pred -----HHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 750 -----IEHVWNLWNEGKAMELVDPNIRDS-SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 750 -----~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
............ ..+.+... ........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111111 11111111 1234566799999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=366.24 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=208.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC----CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|++.++||+|+||.||+|+.. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999864 3456999999764 33445679999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 245899999999999999999999998 9999999999999999999999999999764
Q ss_pred CccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 689 FNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 689 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+..... ..+...+ ..+..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~----~~~~~---- 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSV----EEGYR---- 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHH----HTTCC----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCC----
Confidence 32221 12223456778999999999999999999999999999999 9999853211 1122211 11110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
...+......+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 273 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11111233578889999999999999999999999999854433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=359.54 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=204.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 67899999999999999999765 78999999986543 23346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999984 3345899999999999999999999998 99999999999999999999999999987643333
Q ss_pred cccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+. ..... ..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~---~~---- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTY---LN---- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCTT---ST----
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----ccccc---CC----
Confidence 334445789999999999988775 7789999999999999999999975433322222221 11000 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01122346778999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.27 Aligned_cols=266 Identities=27% Similarity=0.428 Sum_probs=207.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-----CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
.++|++.++||+|+||+||+|+. .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999973 36889999999876666677899999999999999999999998654 458
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 234899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc----------CchHHHHHHH
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE----------NSSLIEHVWN 755 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~----------~~~l~~~~~~ 755 (854)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6432221 1223345777899999999999999999999999999999999887532110 0011111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
....+ .....+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 244 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 LLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 11111222345788899999999999999999999999887433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.99 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=204.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35789999999999999999976 57999999999754 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred cCcccccccccccccccceeeccCCCC-cccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFS-VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......||+.|+|||++.+..+. .++|||||||++|||++|+.||.... ...+...+ . .+.. .
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i---~-~~~~------~ 232 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERV---L-RGKY------R 232 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---H-HCCC------C
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHH---H-hCCC------C
Confidence 233456899999999999988775 78999999999999999999986421 11222221 1 1111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+ +......+.+++.+||+.||.+|||++|+++
T Consensus 233 ~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 1112346778999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.06 Aligned_cols=261 Identities=26% Similarity=0.341 Sum_probs=203.5
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHh--cCCCceeeeeeeEEeC----CeeE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAK--LQHRNLVRLLGCCIQG----EEKM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----~~~~ 607 (854)
.++|.+.++||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46889999999999999999987 6899999998653 34566677777776 7899999999987653 4578
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceEEcccCCCcEEEccCCCceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH--------RDSRLRIIHRDLKASNILLDEDMNPKIS 679 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 679 (854)
+||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 235899999999999999999999 666 9999999999999999999999
Q ss_pred ccCcceeccCccCc--ccccccccccccccceeeccC------CCCcccchhhHHHHHHHHHhC----------CCCCCC
Q 003045 680 DFGMARIFGFNQNE--ANTNRVVGTYGYMAPEYAMEG------LFSVKSDVYSFGVLLLEIVSG----------RRNTSF 741 (854)
Q Consensus 680 DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~~~DVwSlGvil~elltG----------~~p~~~ 741 (854)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876432221 112335799999999999876 455799999999999999999 777654
Q ss_pred CcccCchHHHHHHHHhhcCCcccccCCCCC-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 742 RLEENSSLIEHVWNLWNEGKAMELVDPNIR-DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 742 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
........... ......... .+.+. ..........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDM-RKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHH-HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhh-hHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 33222222222 221111111 11111 112345677899999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=367.19 Aligned_cols=269 Identities=27% Similarity=0.414 Sum_probs=213.9
Q ss_pred eeHHHHHHHhcCcccCcccccCCcccEEEeE------cCCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeee
Q 003045 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGK------LPEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRL 596 (854)
Q Consensus 525 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l 596 (854)
+.....+...++|.+.++||+|+||.||+|+ ..+++.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3445556677899999999999999999996 2346899999997643 23456789999999999 79999999
Q ss_pred eeeEEeCCe-eEEEEEcCCCCChhhhhcCccc------------------------------------------------
Q 003045 597 LGCCIQGEE-KMLIYEYMPNKSLDLFIFDPAK------------------------------------------------ 627 (854)
Q Consensus 597 ~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 627 (854)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999865432
Q ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 628 ---------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 628 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999998 99999999999999999999999999987643333
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........||+.|+|||++.+..++.++||||||+++|||++ |+.|+...... ..+...+ ..+.... ..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~----~~~~~~~-----~~ 318 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRL----KEGTRMR-----AP 318 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHH----HHTCCCC-----CC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHH----HcCCCCC-----CC
Confidence 333445678999999999999999999999999999999998 99998643221 1122211 1111111 11
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
. .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 319 ~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1 1224688899999999999999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=349.70 Aligned_cols=270 Identities=20% Similarity=0.251 Sum_probs=216.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--eeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE--EKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV 609 (854)
.++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367889999999999999999765 48999999997543 345677889999999999999999999998765 77999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE----ccCCCceecccCcce
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMAR 685 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla~ 685 (854)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 777889999999998
Q ss_pred eccCccCcccccccccccccccceeec--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAM--------EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
..... .......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ....+.+....
T Consensus 165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-RRNKEVMYKII 240 (319)
T ss_dssp ECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-GGCHHHHHHHH
T ss_pred ecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-chhHHHHHHHh
Confidence 76422 2223467999999999986 577999999999999999999999998643221 11222222222
Q ss_pred hcCC---cccc---------c--CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 758 NEGK---AMEL---------V--DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 758 ~~~~---~~~~---------~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.... ...+ . +..............+.+++.+||+.||++|||++|+++.....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2111 1000 0 11112345567778899999999999999999999999988876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=372.54 Aligned_cols=257 Identities=28% Similarity=0.364 Sum_probs=207.3
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999875 68999999987542 2334578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998532 335899999999999999999999998 9999999999999999999999999998653221
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.........++..|+|||++....++.++||||||+++|||++ |..|+..... ...... ...+...
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~------- 334 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREF----VEKGGRL------- 334 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHH----HHTTCCC-------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCC-------
Confidence 1111222345778999999999999999999999999999998 8888864221 112211 1121111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+......+.+++.+||+.||++|||++||++.|+.+
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11112234678899999999999999999999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.97 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=208.8
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|.+.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5788889999999999999998889999999997543 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 99999998543 345899999999999999999999998 9999999999999999999999999998653221 11
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..... ......+ ..+. ....+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~~~~----~~~~--~~~~~----- 229 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDI----STGF--RLYKP----- 229 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTTC--CCCCC-----
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHH----hcCc--cCCCC-----
Confidence 2233456788999999999999999999999999999999 8888864221 1122211 1110 11111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
......+.+++.+|++.||++||++.|+++.|+++
T Consensus 230 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11234688899999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.06 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=205.0
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|++.++||+|+||.||+|+. .++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5688889999999999999987 4789999998643 34578999999999999999999999886 45899999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC-ceecccCcceeccCccCc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN-PKISDFGMARIFGFNQNE 693 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 693 (854)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 9999999976555556889999999999999999999943234999999999999998887 79999999976532
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ...+... .+.. +.....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~-~~~~-----~~~~~~ 228 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWAVH-NGTR-----PPLIKN 228 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHHHH-TTCC-----CCCBTT
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHHHh-cCCC-----CCcccc
Confidence 12234689999999999999999999999999999999999999864322211 1111111 1111 111112
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCCCCCCc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPT 821 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~p~~~~ 821 (854)
. ...+.+++.+|++.||++|||+.|+++.|+.+....+.+..|.
T Consensus 229 ~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 229 L----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred c----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 2 3467889999999999999999999999998866655554443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.10 Aligned_cols=268 Identities=25% Similarity=0.376 Sum_probs=211.0
Q ss_pred hcCcccCcccccCCcccEEEeE-----cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEE--eCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-----LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI--QGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~ 606 (854)
.++|++.++||+|+||.||+|+ ..+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3678889999999999999997 3468899999998766666778999999999999999999999987 44568
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999998542 235899999999999999999999998 99999999999999999999999999997
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc---------CchHHHHHHHH
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE---------NSSLIEHVWNL 756 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~---------~~~l~~~~~~~ 756 (854)
....... .......||..|+|||++.+..++.++||||||+++|+|++|+.|+...... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 1223356788899999999999999999999999999999999997532211 00001111111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
.. .......+......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 257 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LE---------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hh---------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11 111112222334578899999999999999999999999999855443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.42 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=209.9
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.++|++.+.||+|+||.||+|+.+++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788899999999999999998888899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 999999998542 335899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..... ..... .. ..+. ....+.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~---~~-~~~~--~~~~~~--- 228 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--SEVVL---KV-SQGH--RLYRPH--- 228 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH---HH-HTTC--CCCCCT---
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--HHHHH---HH-HcCC--CCCCCC---
Confidence 12223456778999999999899999999999999999999 9988863221 11111 11 1111 111111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
. ....+.+++.+|++.||++|||+.|+++.|+.+..
T Consensus 229 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 L----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp T----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred c----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1 12468889999999999999999999999998843
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=368.53 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=197.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC----CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|.+.++||+|+||.||+|+.. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467899999999999999999764 5778999999754 23445679999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcc-cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 689 FNQNEA-NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 689 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+...+ ..+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~~~i----~~~~----- 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKAV----DEGY----- 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--HHHHHHHH----HTTE-----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCC-----
Confidence 322111 1222345778999999999999999999999999999998 999885321 11122211 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
....+......+.+++.+|++.||++||++.||++.|+.+.
T Consensus 268 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 ----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 01111123357889999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=367.97 Aligned_cols=266 Identities=29% Similarity=0.403 Sum_probs=214.2
Q ss_pred HhcCcccCcccccCCcccEEEeEc--------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL--------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ 602 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 602 (854)
..++|.+.++||+|+||.||+|+. ..++.||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457889999999999999999974 234679999997643 33456789999999999 89999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEE
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 669 (854)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999864321 235899999999999999999999998 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCch
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSS 748 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~ 748 (854)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+.... ...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--~~~ 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEE 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHH
Confidence 99999999999999987654333333444567889999999999999999999999999999999 998886321 111
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCC
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPV 816 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~ 816 (854)
+.. ....+.... . +......+.+++.+||+.||++|||+.||++.|+.+......
T Consensus 302 ~~~----~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 LFK----LLKEGHRMD-----K----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHH----HHHTTCCCC-----C----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHH----HHHcCCCCC-----C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 222 222221111 1 112234688899999999999999999999999998544433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.43 Aligned_cols=261 Identities=31% Similarity=0.434 Sum_probs=209.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|.+.++||+|+||+||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888999999999999999742 4678999999654 334456789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcc----cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC---Cceec
Q 003045 607 MLIYEYMPNKSLDLFIFDPA----KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM---NPKIS 679 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~ 679 (854)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986432 2245899999999999999999999998 99999999999999555 59999
Q ss_pred ccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhh
Q 003045 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|+.... ...+...+ .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~~~~~~i----~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFV----T 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH----H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----H
Confidence 9999986543333333445678999999999999999999999999999999998 888886421 11222221 1
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.+... ..+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 301 ~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 301 SGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 1111223468889999999999999999999999988744
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=356.39 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=211.3
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
..++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457888999999999999999964 345789999997543 3345678999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc---------------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccC
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK---------------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 664 (854)
.++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999865332 234889999999999999999999998 9999999
Q ss_pred CCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 003045 665 ASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRL 743 (854)
Q Consensus 665 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~ 743 (854)
|+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.|+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654333333344567889999999999999999999999999999999 998886432
Q ss_pred ccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 744 EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 744 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
. ..+...+ ..+.. +. .+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 258 ~--~~~~~~~----~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 P--ERLFNLL----KTGHR-----ME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp G--GGHHHHH----HTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--HHHHHHh----hcCCc-----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2 2222222 11111 11 1112235688899999999999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=348.94 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=205.8
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|++.++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46789999999999999999975 468999999986543 23356789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999984 3346899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
. .........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........... .... ...
T Consensus 164 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~-~~~~-~~~ 235 (294)
T 4eqm_A 164 T-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIKHIQDS-VPNV-TTD 235 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHHHHSSC-CCCH-HHH
T ss_pred c-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhhcc-CCCc-chh
Confidence 2 11223346799999999999999999999999999999999999999864221 11111111111 1110 011
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhccCC
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRP-TMASVVLMLESETP 812 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~eVl~~L~~~~~ 812 (854)
.... ....+.+++.+|++.||++|| +++++.+.|+....
T Consensus 236 ~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 236 VRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp SCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1122 235688899999999999999 99999999998744
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=359.09 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=200.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCc----EEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQ----DIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.++|+..++||+|+||+||+|+.. +++ +||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367888999999999999999753 444 3688887543 3455678999999999999999999999998754 78
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998643 345899999999999999999999998 999999999999999999999999999877
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.............+|..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+...+ ..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~~---- 237 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSIL----EKGER---- 237 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----HTTCC----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHH----HcCCC----
Confidence 54443333444567889999999999999999999999999999999 9999864321 2222222 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
...+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111223346888999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=350.87 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=202.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
..++|++.++||+|+||+||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999998889999999997542 223467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 67666643 2345899999999999999999999998 999999999999999999999999999876422
Q ss_pred cCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc---
Q 003045 691 QNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV--- 766 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~--- 766 (854)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+...........+.
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSGGGT
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhhhhh
Confidence 222334578999999999876 56899999999999999999999998743322 2222222222211110000
Q ss_pred ------CCC--CCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 ------DPN--IRDSS-----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 ------d~~--l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.. ..... .......+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00000 0112246788999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.17 Aligned_cols=266 Identities=27% Similarity=0.400 Sum_probs=210.3
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
..++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999975 24568999999754 234457899999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccc--------------------cCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccC
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQ--------------------ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLK 664 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 664 (854)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34899999999999999999999998 9999999
Q ss_pred CCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 003045 665 ASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRL 743 (854)
Q Consensus 665 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~ 743 (854)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987653333333444667889999999999999999999999999999998 998886432
Q ss_pred ccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 744 EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 744 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
.. ..+.. ....+.. +. .+......+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 280 ~~-~~~~~----~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VD-ANFYK----LIQNGFK-----MD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CS-HHHHH----HHHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cH-HHHHH----HHhcCCC-----CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 21 11111 1112111 11 111223568889999999999999999999999998855443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=360.67 Aligned_cols=264 Identities=27% Similarity=0.435 Sum_probs=212.7
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 603 (854)
....++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 445688999999999999999999764 34789999997643 33456789999999999999999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCccc---------------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAK---------------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRD 662 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 662 (854)
+..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999865321 256899999999999999999999998 99999
Q ss_pred cCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 003045 663 LKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSF 741 (854)
Q Consensus 663 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~ 741 (854)
|||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987643322233344578899999999999999999999999999999999 9988863
Q ss_pred CcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 742 RLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 742 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.. ...+.. ....+.... .+......+.+++.+||+.||++||++.||++.|+.+..
T Consensus 280 ~~--~~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MA--HEEVIY----YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SC--HHHHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CC--hHHHHH----HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 21 111111 112222111 111223468889999999999999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=351.97 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=204.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67888999999999999999765 6899999999754 3345677899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 157 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc-
Confidence 9999999999884 3446899999999999999999999998 99999999999999999999999999986421
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... .. .+
T Consensus 158 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i---~~~-~~------~~ 224 (337)
T 1o6l_A 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELI---LME-EI------RF 224 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---HHC-CC------CC
T ss_pred -CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHH---HcC-CC------CC
Confidence 1223345789999999999999999999999999999999999999986321 11222221 111 11 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.. .....+.+++.+||+.||++|| ++.|+++
T Consensus 225 p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 PR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11 1234678899999999999999 8999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.72 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=196.2
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc----ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|+..++||+|+||.||+|.. .++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5788889999999999999987 48899999986542 234578899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc--------CCCceecccC
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE--------DMNPKISDFG 682 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~DFG 682 (854)
||+++++|.+++. ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999983 346899999999999999999999998666999999999999986 7789999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+..... ............
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~- 231 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----LAVAYGVAMNKL- 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHHHHHTSCC-
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHhhhcCCC-
Confidence 99865322 22245789999999999999999999999999999999999999864221 111111111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
....+......+.+++.+|++.||++|||+.|+++.|+.+
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 --------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111122235688999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=356.39 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=205.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
..++|.+.+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467899999999999999999765 689999999976432 235789999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC----Cceeccc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM----NPKISDF 681 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 681 (854)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 346899999999999999999999998 99999999999998877 7999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+...+ ....
T Consensus 164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--~~~~~~~i----~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANI----TAVS 234 (361)
T ss_dssp SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHH----HTTC
T ss_pred CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhcC
Confidence 999876422 22344679999999999999999999999999999999999999986421 11222211 1111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. .++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0000001 11246788999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.49 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=201.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE------ 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------ 605 (854)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999875 78999999997543 3346789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEEcCCCCChhhhhcCcccccCCCHH
Q 003045 606 ---------------------------------------------------KMLIYEYMPNKSLDLFIFDPAKQALLDWT 634 (854)
Q Consensus 606 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 634 (854)
.++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999776655667888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc----------ccccccccccc
Q 003045 635 KRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE----------ANTNRVVGTYG 704 (854)
Q Consensus 635 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 704 (854)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999987533211 12234579999
Q ss_pred cccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 003045 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIH 784 (854)
Q Consensus 705 Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 784 (854)
|+|||++.+..++.++||||||+++|||++|..|+.. ..... ........ ..........+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~-~~~~~~~~---------~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRII-TDVRNLKF---------PLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHH-HHHHTTCC---------CHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHH-HHhhccCC---------CcccccCChhHHH
Confidence 9999999999999999999999999999998765421 11111 11111111 1111233356788
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 003045 785 VGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 785 l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++.+||+.||++|||+.|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=360.40 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=195.3
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCCCc----EEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPEGQ----DIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
...++|++.+.||+|+||.||+|+..... .||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34578999999999999999999865432 7999999754 33456789999999999999999999999988766
Q ss_pred e------EEEEEcCCCCChhhhhcCcc---cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 606 K------MLIYEYMPNKSLDLFIFDPA---KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 606 ~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
. ++||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999985432 2225899999999999999999999998 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+...+
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~-- 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYL-- 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH--
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHHHHHH--
Confidence 9999999987643332223334556789999999999999999999999999999999 8888864321 2222221
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
... .. . .........+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 253 -~~~-~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 -IGG-NR-----L----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -HTT-CC-----C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -hcC-CC-----C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111 11 0 11112235688999999999999999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=358.95 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=203.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcE----EEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQD----IAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|++.++||+|+||+||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999754 4444 7888875432 334567789999999999999999999886 567889
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998643 345889999999999999999999998 9999999999999999999999999999875
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
............++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...+...+ ..+... ..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~----~~~~~~--~~ 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDLL----EKGERL--AQ 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHHH----HTTCBC--CC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHHH----HcCCCC--CC
Confidence 4444344455678889999999999999999999999999999999 999986432 12222222 111111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+. .....+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 239 ~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 PQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 112246778999999999999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.98 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=206.5
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..++|++.++||+|+||+||+|+..++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346788899999999999999999888899999997543 3457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 9999999998643 345899999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..... ......+ ..+. ....+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~----~~~~--~~~~~--- 243 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHI----AQGL--RLYRP--- 243 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHH----HTTC--CCCCC---
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--hHHHHHH----hccc--CCCCC---
Confidence 112223456788999999999999999999999999999998 9999864221 1111111 1110 00111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
. .....+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 244 ~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 H----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp T----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1 1124688899999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=374.01 Aligned_cols=258 Identities=27% Similarity=0.375 Sum_probs=211.0
Q ss_pred hcCcccCcccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.+.|.+.++||+|+||.||+|+... ++.||||+++... ...++|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999998764 8899999997543 4578899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 99999999986432 345899999999999999999999998 9999999999999999999999999998763221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........++..|+|||++....++.++|||||||++|||++ |..|+.... ...+...+ ..+ .+
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~~~~~~----~~~---------~~ 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELL----EKD---------YR 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHH----HTT---------CC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcC---------CC
Confidence 112223456788999999999999999999999999999999 888876422 12222222 111 11
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
...+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11122233578889999999999999999999999998743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=350.51 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=204.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
..++|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467899999999999999999764 689999999975432 246789999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC----Cceeccc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM----NPKISDF 681 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 681 (854)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999843 346899999999999999999999998 99999999999999887 8999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
|++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+. .. .
T Consensus 163 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~---~~-~ 233 (326)
T 2y0a_A 163 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVS---AV-N 233 (326)
T ss_dssp TTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHH---HT-C
T ss_pred CCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHHH---hc-C
Confidence 999876422 223346799999999999999999999999999999999999999863211 11111111 11 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .. .+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-~~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y-EF-EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CC-CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-Cc-Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00 000001 11246788999999999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.00 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=201.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999764 68999999997543 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 998754444432 2346899999999999999999999998 999999999999999999999999999876422
Q ss_pred CcccccccccccccccceeeccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc------
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME------ 764 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------ 764 (854)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.|+..... .......+...........
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22233467899999999998765 89999999999999999999988643322 2222222222221111000
Q ss_pred ccC---------CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVD---------PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+ ..............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00001111223456788999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=353.98 Aligned_cols=263 Identities=25% Similarity=0.422 Sum_probs=206.8
Q ss_pred hcCcccCcccccCCcccEEEeE-----cCCCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Ce
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-----LPEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-----~~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 605 (854)
.++|++.++||+|+||.||+|+ ..+++.||+|++... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3568888999999999999997 346899999999754 334567899999999999999999999999877 66
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998532 345899999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc---------cCchHHHHHHH
Q 003045 686 IFGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE---------ENSSLIEHVWN 755 (854)
Q Consensus 686 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~---------~~~~l~~~~~~ 755 (854)
........ .......||..|+|||++.+..++.++||||||+++|||++|..|+..... ........+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76433221 223345688889999999999999999999999999999999988642210 00111111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
....+. ....+......+.+++.+||+.||++|||+.|++++|+.+
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111111 1111222335788999999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.72 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=194.9
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc--------------------------cCHHHHHHHHHHHHh
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG--------------------------QGLEEFKNEIILIAK 587 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~ 587 (854)
++|.+.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6788999999999999999975 4688999999865421 123568999999999
Q ss_pred cCCCceeeeeeeEEe--CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCC
Q 003045 588 LQHRNLVRLLGCCIQ--GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKA 665 (854)
Q Consensus 588 l~h~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 665 (854)
++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.||+.||+|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999987 56789999999999998865 2346899999999999999999999998 99999999
Q ss_pred CcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCC---CCcccchhhHHHHHHHHHhCCCCCCCC
Q 003045 666 SNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL---FSVKSDVYSFGVLLLEIVSGRRNTSFR 742 (854)
Q Consensus 666 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvil~elltG~~p~~~~ 742 (854)
+|||++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999876422 22233467999999999998765 478899999999999999999998632
Q ss_pred cccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 743 LEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 743 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ...+...+ ...... . + .... ....+.+++.+||+.||++|||+.|+++
T Consensus 244 ~--~~~~~~~~----~~~~~~-~--~-~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R--IMCLHSKI----KSQALE-F--P-DQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S--HHHHHHHH----HHCCCC-C--C-SSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--HHHHHHHH----hcccCC-C--C-Cccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 11111111 111110 0 0 0111 2246888999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.95 Aligned_cols=261 Identities=22% Similarity=0.328 Sum_probs=199.7
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|.+.++||+|+||+||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999998889999999996542 23356788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 888877532 245889999999999999999999998 9999999999999999999999999998654221
Q ss_pred cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc-------
Q 003045 693 EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME------- 764 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------- 764 (854)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+...........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhhhcc
Confidence 22234578999999999876 458999999999999999999999986432 1122222222211111000
Q ss_pred -ccCCCCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 -LVDPNIR-------DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 -~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..++... ..........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111110 0011122356788999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=358.87 Aligned_cols=270 Identities=28% Similarity=0.395 Sum_probs=205.5
Q ss_pred cCcccCcccccCCcccEEEeEc-----CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-----PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 606 (854)
++|++.++||+|+||+||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 3458899999999999988753 268899999997643 23456789999999999999999999999884 578
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 999999999999999843 34899999999999999999999998 99999999999999999999999999997
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
....... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+..........................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 6432221 123345678889999999999999999999999999999999999864221100000000000000000111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
+........+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111222233457889999999999999999999999998864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.09 Aligned_cols=255 Identities=28% Similarity=0.508 Sum_probs=202.7
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccccc-------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQ-------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999976 47899999998654322 1267899999999999999999999986554
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC-----ceecc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN-----PKISD 680 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~D 680 (854)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888543 346899999999999999999999986 35999999999999988776 99999
Q ss_pred cCcceeccCccCcccccccccccccccceee--ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYA--MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
||+++... .......||+.|+|||++ ....++.++||||||+++|||++|+.||.............. ..
T Consensus 173 fg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~ 244 (287)
T 4f0f_A 173 FGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---RE 244 (287)
T ss_dssp CTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH---HH
T ss_pred CCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH---hc
Confidence 99998542 123346789999999998 455688999999999999999999999874332221112211 11
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+ ..+.+.. .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 245 ~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EG-----LRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SC-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cC-----CCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1111112 2235788999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=372.22 Aligned_cols=258 Identities=30% Similarity=0.422 Sum_probs=210.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..++|.+.++||+|+||.||+|+.++++.||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788899999999999999999888999999997543 45788999999999999999999999986 6678999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999996432 235889999999999999999999998 99999999999999999999999999987532111
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......++..|+|||++....++.++|||||||++|||++ |+.|+.... ...+...+ ..+.. .
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i----~~~~~--~------ 404 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRAL----ERGYR--M------ 404 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH----HHTCC--C------
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCC--C------
Confidence 11223446788999999999999999999999999999999 999986321 11222222 11111 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
..+......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1111233578889999999999999999999999999844
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.60 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=196.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCC--CceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQH--RNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~l 608 (854)
..++|++.++||+|+||.||++...+++.||||++.... ....+.+.+|+.++++++| +||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346789999999999999999998889999999987542 3345778999999999986 999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999853 346899999999999999999999998 99999999999997 5789999999998765
Q ss_pred CccCcccccccccccccccceeecc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAME-----------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~ 234 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAII 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHHHHHHh
Confidence 4333333445689999999999865 67899999999999999999999998642221 11111111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++......+......+.+++.+||+.||++|||+.|+++
T Consensus 235 ---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 235 ---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111111111112246788999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=345.16 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=204.0
Q ss_pred hcCcccCcccccCCcccEEEeEcCC-C-------cEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE-G-------QDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
.++|.+.+.||+|+||+||+|+... + ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3678889999999999999997543 3 4799999987666777889999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC--------ce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN--------PK 677 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~k 677 (854)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998543 234899999999999999999999998 999999999999998887 99
Q ss_pred ecccCcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
|+|||++.... ......||..|+|||++.+ ..++.++||||||+++|||++|..|+....... ......
T Consensus 162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ----RKLQFY 231 (289)
T ss_dssp ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHH
T ss_pred eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH----HHHHHh
Confidence 99999987542 1233568899999999987 779999999999999999999766544222111 111111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
...... .... ...+.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 232 ~~~~~~--------~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 EDRHQL--------PAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HTTCCC--------CCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hccCCC--------CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111111 1111 13467899999999999999999999999998543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=369.78 Aligned_cols=260 Identities=29% Similarity=0.425 Sum_probs=205.8
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..++|.+.++||+|+||.||+|+..++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999998888889999997543 346789999999999999999999999876 778999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 334 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence 9999999999532 2345899999999999999999999998 9999999999999999999999999998764221
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........++..|+|||++....++.++||||||+++|||++ |+.|+.... ...+...+ ..+..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i----~~~~~--------- 399 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGYR--------- 399 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTTCC---------
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCC---------
Confidence 112223456788999999999999999999999999999999 888886321 11122211 11111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCC
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTL 814 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~ 814 (854)
...+......+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1111223357888999999999999999999999999985443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=349.74 Aligned_cols=262 Identities=28% Similarity=0.422 Sum_probs=211.6
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccccc-cCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
..++|.+.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788999999999999999973 3568899999975432 3457789999999999 8999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCccc---------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEE
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAK---------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 669 (854)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999865322 224899999999999999999999998 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCch
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSS 748 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~ 748 (854)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..... ...
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-hhH
Confidence 99999999999999987654333333344567889999999999999999999999999999999 8888864322 112
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
....+ .... .+.... .....+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 257 ~~~~~----~~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 FYKMI----KEGF-----RMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHH----HHTC-----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh----ccCC-----CCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 22221 1111 011111 22356888999999999999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=356.49 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=201.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 608 (854)
.++|++.++||+|+||.||+|+.+ +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367889999999999999999765 57899999997642 23345688999999887 89999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999884 3356999999999999999999999998 9999999999999999999999999998532
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC---chHHHHHHHHhhcCCcccc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN---SSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~ 765 (854)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.........
T Consensus 205 ~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 R--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp C--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred c--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 1 2223445789999999999999999999999999999999999999996432111 1111222222111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM------ASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~------~eVl~ 805 (854)
.+.. .....+.+++.+||+.||++||++ +||++
T Consensus 280 ---~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 ---RIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ---CCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ---CCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1111 123467889999999999999985 56654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=354.92 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=199.5
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (854)
..++|++.++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|..+++++ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999764 5899999999754 234566788999999998 6999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999843 356899999999999999999999998 999999999999999999999999999854
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... ..
T Consensus 175 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i---~~~-~~----- 241 (353)
T 3txo_A 175 IC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAI---LND-EV----- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---HHC-CC-----
T ss_pred cc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--HHHHHHHH---HcC-CC-----
Confidence 21 2233445789999999999999999999999999999999999999986432 12222222 111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM------ASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~------~eVl~ 805 (854)
.. +......+.+++.+||+.||++||++ .|+++
T Consensus 242 -~~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -VY----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -CC----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01 11123467889999999999999998 77765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.74 Aligned_cols=268 Identities=24% Similarity=0.314 Sum_probs=209.5
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~ 607 (854)
..++|++.++||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999976 5789999999977666667889999999999999999999999873 34788
Q ss_pred EEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 608 LIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+||||+++++|.+++... .....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988542 22456899999999999999999999998 99999999999999999999999999886
Q ss_pred ccCccCcc-------cccccccccccccceeeccCC---CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 687 FGFNQNEA-------NTNRVVGTYGYMAPEYAMEGL---FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 687 ~~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~---~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.........+.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence 53211110 112346799999999987554 789999999999999999999998642222222222111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCC
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPV 816 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~ 816 (854)
.. . .. + ........+.+++.+||+.||.+|||+.||++.|+.+.+..+.
T Consensus 262 --~~-~-~~--~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 262 --NQ-L-SI--P-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp --CC----C--C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred --cc-C-CC--C-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 10 0 00 0 0111234688899999999999999999999999998544443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.23 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=204.4
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-----ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-----GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
..++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999754 68999999986431 22467899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecccC
Q 003045 607 MLIYEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISDFG 682 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFG 682 (854)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988775432 2345899999999999999999999998 999999999999987655 9999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...+ ..+..
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~i----~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEGI----IKGKY 249 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHHH----HHTCC
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHHH----HcCCC
Confidence 99876432 222344679999999999999999999999999999999999999986421 1122111 11111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000011 1246788999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=344.90 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=204.3
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|.+.+.||+|+||.||+|... +++.+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467899999999999999999765 5889999998654 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc--CCCceecccCcceeccCc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE--DMNPKISDFGMARIFGFN 690 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~ 690 (854)
+++++|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998532 235899999999999999999999998 999999999999987 789999999999876422
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.......||+.|+|||++.+..++.++||||||+++|||++|..||.... .......+ ... ... .++..
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i---~~~-~~~--~~~~~ 226 (321)
T 1tki_A 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENI---MNA-EYT--FDEEA 226 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHH---HHT-CCC--CCHHH
T ss_pred ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHH---HcC-CCC--CChhh
Confidence 22344678999999999999889999999999999999999999986422 11222222 111 110 00000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 12346788999999999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.26 Aligned_cols=260 Identities=17% Similarity=0.182 Sum_probs=207.1
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999975 578999999986543 235688999999999 99999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC-----ceecccCccee
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN-----PKISDFGMARI 686 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFGla~~ 686 (854)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 346999999999999999999999998 999999999999998887 99999999997
Q ss_pred ccCccCcc-----cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 687 FGFNQNEA-----NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 687 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+.+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~- 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA--DTLKERYQKIGDTK- 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--SSHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc--ccHHHHHHHHHhhh-
Confidence 64322211 12456899999999999999999999999999999999999999975322 12222211111000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.. .....+... .. .+.+++.+|++.||.+||++.+|++.|+.+
T Consensus 237 ~~-~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 RA-TPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HH-SCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cc-CCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 000000111 12 788899999999999999999999999765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=353.37 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=209.7
Q ss_pred HhcCcccCcccccCCcccEEEeEc--------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL--------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ 602 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 602 (854)
..++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 347889999999999999999975 346789999997543 33456789999999999 89999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEE
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 669 (854)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999865432 234899999999999999999999998 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCch
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSS 748 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~ 748 (854)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEE 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC--HHH
Confidence 99999999999999987653332223334567889999999999899999999999999999999 998886321 112
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+...+ ..+.. +.... .....+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 268 ~~~~~----~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 LFKLL----KEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHH----HHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----hcCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22221 11111 11111 223468889999999999999999999999998743
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.63 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=204.0
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
...++|++.++||+|+||+||+|.. .+|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3567899999999999999999965 468999999997543 2345678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc---cCCCceecccCcce
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMAR 685 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~ 685 (854)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999888853 345899999999999999999999998 99999999999998 46789999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...+...+ ..+.. .+
T Consensus 162 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i----~~~~~-~~ 232 (444)
T 3soa_A 162 EVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQI----KAGAY-DF 232 (444)
T ss_dssp CCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH----HHTCC-CC
T ss_pred EecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHH----HhCCC-CC
Confidence 76422 222334689999999999999999999999999999999999999986321 11222222 11111 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~-~~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSPE-WDT----VTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTTT-TTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Cccc-ccc----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111 111 2346788999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=365.41 Aligned_cols=250 Identities=29% Similarity=0.398 Sum_probs=204.6
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-eeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE-EKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lV~Ey 612 (854)
.++|.+.++||+|+||.||+|+.. ++.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888899999999999999884 7899999997543 5678999999999999999999999987765 78999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999643 2234789999999999999999999998 999999999999999999999999999864311
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+...+ ..+..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i----~~~~~--------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV----EKGYK--------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHH----HTTCC---------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCC---------
Confidence 122356889999999999999999999999999999998 9998864321 2222222 11111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111122335788899999999999999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.47 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=197.2
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcC--CCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQ--HRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lV 609 (854)
.++|.+.++||+|+||.||++...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35689999999999999999998889999999986542 344578899999999996 59999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 578899999853 346889999999999999999999998 99999999999995 58999999999987643
Q ss_pred ccCcccccccccccccccceeecc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAME-----------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~~~~- 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAII- 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHH-
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----HHHHHHHh-
Confidence 333333445689999999999865 46899999999999999999999998642221 11111111
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++......+......+.+++.+||+.||++|||+.|+++
T Consensus 282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111111346788999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.16 Aligned_cols=265 Identities=27% Similarity=0.407 Sum_probs=211.9
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 601 (854)
+.+...++|.+.+.||+|+||.||+|+.. .++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445688999999999999999999653 36789999997543 234557899999999999999999999999
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCccc-------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPAK-------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM 674 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 674 (854)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999864321 145789999999999999999999998 99999999999999999
Q ss_pred CceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHH
Q 003045 675 NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHV 753 (854)
Q Consensus 675 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~ 753 (854)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+.... ...+...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~- 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRF- 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHH-
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--HHHHHHH-
Confidence 999999999986643322223334567889999999999999999999999999999999 788875321 1111111
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 754 WNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 754 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
...+.... . .......+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 253 ---~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 253 ---VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ---HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11211111 1 1122346888999999999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.39 Aligned_cols=261 Identities=30% Similarity=0.468 Sum_probs=196.1
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||+||+|+.. ..||+|++.... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467888999999999999999864 369999987543 33456789999999999999999999965 5567899999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999998543 345899999999999999999999998 9999999999999999999999999998654333
Q ss_pred Ccccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.........||+.|+|||++. +..++.++||||||+++|||++|+.||...... ..+... ...+...... .
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~-~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEM----VGRGSLSPDL-S 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHH----HHHTSCCCCT-T
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHH----hcccccCcch-h
Confidence 333344567999999999986 667889999999999999999999998643221 122222 2222111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.+.. .....+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 249 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 KVRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 223578899999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.02 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=205.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999765 68999999997543 3345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998843 345899999999999999999999998 9999999999999999999999999998764333
Q ss_pred CcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.........|++.|+|||++.+..+ +.++||||||+++|||++|+.|+.........+..+. ..... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~--~~--- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKTY--LN--- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCTT--ST---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcccc--cC---
Confidence 2233445678999999999987765 7789999999999999999999875433222222211 11100 00
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+.+++.+||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122346778999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=353.49 Aligned_cols=252 Identities=22% Similarity=0.250 Sum_probs=205.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|.+.++||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999764 6889999999766555566889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc--CCCceecccCcceeccCc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE--DMNPKISDFGMARIFGFN 690 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~ 690 (854)
+++++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988532 235899999999999999999999998 999999999999974 467999999999876422
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ... .. ..++..
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i---~~~-~~--~~~~~~ 273 (387)
T 1kob_A 205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNV---KRC-DW--EFDEDA 273 (387)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHH---HHC-CC--CCCSST
T ss_pred ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--HHHHHHHH---HhC-CC--CCCccc
Confidence 22334579999999999999999999999999999999999999986421 11122211 111 11 011111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSS----VSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 112 2346789999999999999999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.66 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=199.9
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999985 57899999998653 2334567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+ +|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6788887743 346899999999999999999999998 999999999999999999999999999865322
Q ss_pred cCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... + ...+....
T Consensus 162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~------------~~~i~~~~ 224 (336)
T 3h4j_B 162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--L------------FKKVNSCV 224 (336)
T ss_dssp ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--C------------BCCCCSSC
T ss_pred ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--H------------HHHHHcCC
Confidence 22344679999999999988776 789999999999999999999986422110 0 00000000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+......+.+++.+||+.||.+|||++|+++
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111122346788999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.11 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=204.5
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
...++|.+.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999764 68999999997543 2345678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC---CceecccCcce
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM---NPKISDFGMAR 685 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~ 685 (854)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999988843 346899999999999999999999998 99999999999998654 59999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...+...+ ..+... .
T Consensus 180 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i----~~~~~~-~ 249 (362)
T 2bdw_A 180 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQI----KAGAYD-Y 249 (362)
T ss_dssp CCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHTCCC-C
T ss_pred EecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH----HhCCCC-C
Confidence 76421 22334679999999999999999999999999999999999999986321 11222222 111110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00112346788999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=351.84 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=202.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67888999999999999999754 5889999998653 2345678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 99999999999853 345899999999999999999999998 99999999999999999999999999987642
Q ss_pred cCcccccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..+...... ....
T Consensus 168 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~-~~~~----- 237 (384)
T 4fr4_A 168 --ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFE-TTVV----- 237 (384)
T ss_dssp --TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHH-HCCC-----
T ss_pred --CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh-hccc-----
Confidence 223345789999999999874 458999999999999999999999997433221 111111111 1100
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-MASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~eVl~ 805 (854)
. .+......+.+++.+||+.||++||+ +++|++
T Consensus 238 -~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -T----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -C----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -C----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 11122346888999999999999998 777764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.69 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=203.2
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999764 6899999999754 2345677889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999853 345899999999999999999999998 99999999999999999999999999987532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .+........ .. ..
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~---~~~~~~i~~~-~~------~~ 222 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--T---MKTYEKILNA-EL------RF 222 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--H---HHHHHHHHHC-CC------CC
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--H---HHHHHHHHhC-CC------CC
Confidence 2334689999999999999999999999999999999999999986321 1 1111122211 11 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
... ....+.+++.+||+.||++|| +++|+++
T Consensus 223 p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111 224678899999999999999 8899885
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=339.69 Aligned_cols=262 Identities=15% Similarity=0.173 Sum_probs=209.8
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46789999999999999999975 578999999986542 345688999999999 79999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC-----ceecccCccee
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN-----PKISDFGMARI 686 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFGla~~ 686 (854)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 235899999999999999999999998 999999999999987766 99999999997
Q ss_pred ccCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc-CchHHHHHHHHhhcC
Q 003045 687 FGFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE-NSSLIEHVWNLWNEG 760 (854)
Q Consensus 687 ~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~ 760 (854)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6533221 1234567999999999999999999999999999999999999999753321 112222221111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.... +.... ...+.+++.+|++.||++||++.+|++.|+.+..
T Consensus 241 ~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 241 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 1111 11112 2478889999999999999999999999988743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=347.80 Aligned_cols=246 Identities=24% Similarity=0.275 Sum_probs=193.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 608 (854)
..++|++.++||+|+||+||+|+.. +++.||||++.... ......+..|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999875 68999999986542 22334455666666665 89999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+ +++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 66888877542 345999999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+... .. +.....+... +
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~----~~~~~~~~~~----~ 271 (311)
T 3p1a_A 209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EG----WQQLRQGYLP----P 271 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HH----HHHHTTTCCC----H
T ss_pred cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cH----HHHHhccCCC----c
Confidence 22 22334569999999998876 7999999999999999999998765421 11 1111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... .....+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 12356888999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=348.99 Aligned_cols=269 Identities=27% Similarity=0.407 Sum_probs=213.6
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccccc-cCHHHHHHHHHHHHhc-CCCceeeee
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSG-QGLEEFKNEIILIAKL-QHRNLVRLL 597 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~ 597 (854)
.........++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444555678999999999999999999963 3568999999976432 3456789999999999 799999999
Q ss_pred eeEEeCC-eeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEccc
Q 003045 598 GCCIQGE-EKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDL 663 (854)
Q Consensus 598 ~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 663 (854)
+++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988765 48999999999999999965432 123789999999999999999999998 999999
Q ss_pred CCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 003045 664 KASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFR 742 (854)
Q Consensus 664 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~ 742 (854)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..|+...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987643333333445677899999999999999999999999999999998 99888643
Q ss_pred cccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 743 LEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 743 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
... ..+...+ ..+... ..... ....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 255 ~~~-~~~~~~~----~~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KID-EEFCRRL----KEGTRM-----RAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCS-HHHHHHH----HHTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chh-HHHHHHh----ccCccC-----CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 1222211 111111 11111 2346888999999999999999999999998763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=342.27 Aligned_cols=258 Identities=32% Similarity=0.445 Sum_probs=208.2
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788899999999999999998888899999996543 45678999999999999999999999986 45689999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 999999998542 2236899999999999999999999998 99999999999999999999999999987643211
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
.......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+...+ ..+.. ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~~-----~~~-- 231 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNL----ERGYR-----MVR-- 231 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HTTCC-----CCC--
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHHH----hcccC-----CCC--
Confidence 12223456788999999998899999999999999999999 8888763211 1122111 11110 111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
+......+.+++.+|++.||++|||+.++++.|+.+...
T Consensus 232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 112235788899999999999999999999999887443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.70 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=189.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
..++|++.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999875 57899999997542 34678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~~~ 688 (854)
|+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998853 345899999999999999999999998 999999999999975 8899999999998653
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..+... . ..... ....+
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~---i-~~~~~-~~~~~ 273 (349)
T 2w4o_A 203 H---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRR---I-LNCEY-YFISP 273 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-HHHHHH---H-HTTCC-CCCTT
T ss_pred c---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-HHHHHH---H-HhCCC-ccCCc
Confidence 2 12233467899999999999999999999999999999999999998643221 111111 1 11111 01111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ......+.+++.+||+.||++|||+.|+++
T Consensus 274 -~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -WW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hh----hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 122346788999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.25 Aligned_cols=269 Identities=16% Similarity=0.174 Sum_probs=204.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcCC------CcEEEEEEecccccc-----------CHHHHHHHHHHHHhcCCCceee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKSGQ-----------GLEEFKNEIILIAKLQHRNLVR 595 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~ 595 (854)
..++|.+.++||+|+||.||+|.... ++.||||++...... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999997654 478999998654321 1122345666777788999999
Q ss_pred eeeeEEeC----CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 596 LLGCCIQG----EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 596 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4589999999 99999998542 346999999999999999999999998 99999999999999
Q ss_pred --cCCCceecccCcceeccCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 003045 672 --EDMNPKISDFGMARIFGFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE 744 (854)
Q Consensus 672 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~ 744 (854)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432211 112335699999999999999999999999999999999999999974322
Q ss_pred cCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 745 ENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 745 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.. .......... ......++++.+... .....+.+++.+|++.+|++||++.+|++.|+.+..
T Consensus 267 ~~-~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DP-KYVRDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CH-HHHHHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CH-HHHHHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 21 1221111111 112223333322111 112467889999999999999999999999988654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=344.24 Aligned_cols=271 Identities=26% Similarity=0.341 Sum_probs=204.5
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhc--CCCceeeeeeeEEeC---
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL--QHRNLVRLLGCCIQG--- 603 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~--- 603 (854)
......++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445678999999999999999999874 899999998643 234455566666555 899999999999887
Q ss_pred -CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceEEcccCCCcEEEccCCCce
Q 003045 604 -EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS-----RLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 604 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 688999999999999999842 35899999999999999999999881 11299999999999999999999
Q ss_pred ecccCcceeccCccCcc--cccccccccccccceeeccCCCCcc------cchhhHHHHHHHHHhC----------CCCC
Q 003045 678 ISDFGMARIFGFNQNEA--NTNRVVGTYGYMAPEYAMEGLFSVK------SDVYSFGVLLLEIVSG----------RRNT 739 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~------~DVwSlGvil~elltG----------~~p~ 739 (854)
|+|||++..+....... ......||+.|+|||++.+..+..+ +|||||||++|||++| +.|+
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998764322211 1234579999999999988776665 9999999999999999 5555
Q ss_pred CCCcccCchHHHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 740 SFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS-SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 740 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
........... .......... ..+..... ........+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 263 ~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 263 HDLVPSDPSYE-DMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTSCSSCCHH-HHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhcCCCCchh-hhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 43222222211 1111111111 11111111 123667789999999999999999999999999998743
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=340.91 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=208.0
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5788889999999999999998888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 99999998542 345899999999999999999999998 9999999999999999999999999998653211 11
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+.... .......+ ..+.. ...+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~i----~~~~~--~~~~----- 227 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDI----STGFR--LYKP----- 227 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH----HTTCC--CCCC-----
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--HHHHHHHH----hcCCc--CCCC-----
Confidence 2223456788999999998999999999999999999999 888876321 11111111 11110 0111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
......+.+++.+|++.||++||++.|+++.|+.+
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11234678899999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.21 Aligned_cols=267 Identities=16% Similarity=0.185 Sum_probs=200.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC----CCcEEEEEEecccccc-----------CHHHHHHHHHHHHhcCCCceeeeee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKSGQ-----------GLEEFKNEIILIAKLQHRNLVRLLG 598 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~ 598 (854)
.++|.+.++||+|+||.||+|... .+..+|+|++...... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367889999999999999999865 5788999998754321 2234667888999999999999999
Q ss_pred eEEe----CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC
Q 003045 599 CCIQ----GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM 674 (854)
Q Consensus 599 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 674 (854)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998532 36999999999999999999999998 99999999999999887
Q ss_pred --CceecccCcceeccCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCc
Q 003045 675 --NPKISDFGMARIFGFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747 (854)
Q Consensus 675 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~ 747 (854)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 112346799999999999999999999999999999999999999964322222
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 748 SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 748 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
........ ........+....... .....+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 269 ~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTN-LLDELPQSVLKWAPSG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHH-HHHTTTHHHHHHSCTT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHh-hcccccHHHHhhcccc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 22211111 1111110000000000 122478889999999999999999999999998743
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=358.30 Aligned_cols=259 Identities=20% Similarity=0.241 Sum_probs=206.6
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ 602 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 602 (854)
++.+....++|++.++||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556788999999999999999999765 5889999999653 22334568899999999999999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
.+..++||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999998842 35899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCC----CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL----FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~ 758 (854)
+++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+. .
T Consensus 214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~---~ 287 (410)
T 3v8s_A 214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIM---N 287 (410)
T ss_dssp TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHH---T
T ss_pred eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--hhhHHHHHH---h
Confidence 998764221 12233578999999999998765 8899999999999999999999986321 112222221 1
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY--RPTMASVVL 805 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~eVl~ 805 (854)
......+.+ .... ...+.+++.+||+.+|.+ ||+++||++
T Consensus 288 ~~~~~~~p~---~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HKNSLTFPD---DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHCCCCT---TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccccccCCC---cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 100000000 0112 246788899999999998 999999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.54 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=190.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999764 58999999997543 3345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcc---cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPA---KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875321 2235899999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc---cc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA---ME 764 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---~~ 764 (854)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......... ..
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND--EEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCTTTCGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHhhh
Confidence 221 22334578999999999976 4689999999999999999999999864321 2222222222111100 00
Q ss_pred c-----cCCCCCC------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 L-----VDPNIRD------------SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~-----~d~~l~~------------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ..+.+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000 000112346889999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=352.82 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=199.3
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcE----EEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQD----IAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.++|++.++||+|+||.||+|+.. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367888999999999999999753 4544 577777543 3456788999999999999999999999998754 78
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+ ..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~----~~~~~---- 237 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSIL----EKGER---- 237 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHH----HTTCC----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCC----
Confidence 54333333344567889999999999999999999999999999999 9999864322 2222222 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
...+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 01111223468889999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.92 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=210.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
..++|.+.++||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4577888999999999999999865 4888999999653 3446789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 2345899999999999999999999998 9999999999999999999999999998764222
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..|+.... .......+. .. .
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~~----~~---------~ 229 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLE----KD---------Y 229 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHH----TT---------C
T ss_pred -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHh----cc---------C
Confidence 122333567889999999999999999999999999999999 888876432 122222221 11 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
....+......+.+++.+|++.||++|||+.|+++.|+.+
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111112235788999999999999999999999999876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=350.40 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=194.1
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|.+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467899999999999999999765 68999999997543 3346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC--ceecccCcceeccCc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN--PKISDFGMARIFGFN 690 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~~~~~ 690 (854)
+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 999999998843 345899999999999999999999998 999999999999987765 9999999997532
Q ss_pred cCcccccccccccccccceeeccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVK-SDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.........||+.|+|||++.+..+..+ +|||||||++|+|++|+.||...... ......+....... . .+
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~-~-~~---- 241 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVK-Y-SI---- 241 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTC-C-CC----
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCC-C-CC----
Confidence 1122334679999999999988887766 89999999999999999998743222 12222222221111 0 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+.+++.+||+.||++|||+.|+++
T Consensus 242 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 ---PDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000112246788999999999999999999997
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=351.01 Aligned_cols=247 Identities=25% Similarity=0.322 Sum_probs=195.7
Q ss_pred cCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 539 EGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 539 ~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
..+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356899999999999975 4689999999987655667789999999999999999999999999999999999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE--ccCCCceecccCcceeccCccCccc
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL--DEDMNPKISDFGMARIFGFNQNEAN 695 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 695 (854)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+... ..
T Consensus 173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~ 244 (373)
T 2x4f_A 173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EK 244 (373)
T ss_dssp EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CB
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cc
Confidence 98888532 335899999999999999999999998 9999999999999 56678999999999876422 22
Q ss_pred ccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 696 TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 696 ~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ........ + .+.....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~---~i~~~~~~--~-~~~~~~~-- 314 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLN---NILACRWD--L-EDEEFQD-- 314 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH---HHHHTCCC--S-CSGGGTT--
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHHhccCC--C-Chhhhcc--
Confidence 2345799999999999999999999999999999999999999864221 11111 11111100 0 0111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+.+++.+||+.||++|||+.|+++
T Consensus 315 --~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 --ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2346888999999999999999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.98 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=204.0
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCee
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 606 (854)
...++|.+.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999865 58899999997542 34566788999999987 899999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999843 346899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+. .+.
T Consensus 168 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~----~~~----- 234 (345)
T 1xjd_A 168 NML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIR----MDN----- 234 (345)
T ss_dssp CCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH----HCC-----
T ss_pred ccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHH----hCC-----
Confidence 422 1223445789999999999999999999999999999999999999986321 122222221 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMA-SVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-eVl~ 805 (854)
+..... ....+.+++.+||+.||++||++. |+++
T Consensus 235 -~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 -PFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -CCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111111 234678899999999999999997 6653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=342.62 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=194.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
..++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34688899999999999999997643 4579999987542 33456789999999999999999999998 456789
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998532 335899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.... ........+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+. .+...
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~i~----~~~~~--- 236 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIE----NGERL--- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH----TTCCC---
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHHHH----cCCCC---
Confidence 4221 112233456788999999999999999999999999999997 8888864321 22222221 11110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+ +......+.+++.+|++.||++|||+.|+++.|+.+
T Consensus 237 --~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 --PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 112235688899999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=347.03 Aligned_cols=244 Identities=22% Similarity=0.245 Sum_probs=203.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999765 6899999999654 2345678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999853 345899999999999999999999998 99999999999999999999999999987532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ . .+.. .+
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i---~-~~~~------~~ 257 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKI---V-SGKV------RF 257 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH---H-HCCC------CC
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHH---H-cCCC------CC
Confidence 223468999999999999999999999999999999999999998632 111222221 1 1111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
... ....+.+++.+||+.||++||+ ++||++
T Consensus 258 p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111 2346788999999999999998 888876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=353.89 Aligned_cols=272 Identities=20% Similarity=0.245 Sum_probs=216.1
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--eeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE--EKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV 609 (854)
.++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367889999999999999999765 58999999997543 345677889999999999999999999998765 67999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE----ccCCCceecccCcce
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPKISDFGMAR 685 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla~ 685 (854)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555455999999999999999999999998 9999999999999 777789999999998
Q ss_pred eccCccCcccccccccccccccceeecc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAME--------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+.+....
T Consensus 165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYKII 240 (396)
T ss_dssp ECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-TCHHHHHHHH
T ss_pred EccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-chHHHHHHHh
Confidence 76422 22234679999999999875 567889999999999999999999986433211 1222222222
Q ss_pred hcCCcc---cc---------c--CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 758 NEGKAM---EL---------V--DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 758 ~~~~~~---~~---------~--d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
...... .+ . +..............+.+++.+||+.||++||++.|+++.|+.++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 221110 00 0 1111223456777889999999999999999999999999988643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.32 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=200.7
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788999999999999999975 578999999997532 334567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988542 22456899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.|+.........+... .........
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~---- 258 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDYPPL---- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----HHTTCSCCC----
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----hhcccCCCC----
Confidence 21 22234578999999999999999999999999999999999999986432221112111 111111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCCCC
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPR 818 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~p~ 818 (854)
.... ....+.+++.+||+.||++|||+.||++.|+.+.+....|+
T Consensus 259 ~~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 259 PSDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred cccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1111 23468889999999999999999999999999865544443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=359.24 Aligned_cols=263 Identities=17% Similarity=0.202 Sum_probs=208.7
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCI 601 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 601 (854)
.+.++....++|++.++||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555667789999999999999999999865 4788999999753 2223445889999999999999999999999
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
+.+..++||||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999642 345899999999999999999999998 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
|+++...... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+...
T Consensus 220 Gla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~ 296 (437)
T 4aw2_A 220 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNH 296 (437)
T ss_dssp TTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTH
T ss_pred hhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhhc
Confidence 9998764222 12233468999999999997 5679999999999999999999999986421 11222222111
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMY--RPTMASVVL 805 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~eVl~ 805 (854)
... +.-|...... ...+.+++.+||..+|++ ||+++|+++
T Consensus 297 ~~~-----~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KER-----FQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHH-----CCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccc-----ccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 0111111112 246778889999888888 999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=344.44 Aligned_cols=270 Identities=24% Similarity=0.318 Sum_probs=211.7
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHh--cCCCceeeeeeeEEeC
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAK--LQHRNLVRLLGCCIQG 603 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~ 603 (854)
.........++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3444556678999999999999999999987 5899999998643 34677889999888 7899999999999887
Q ss_pred C----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceEEcccCCCcEEEc
Q 003045 604 E----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH--------RDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 604 ~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~ 671 (854)
. ..++||||+++|+|.+++.. ..+++.+++.++.||+.||.||| +.+ |+||||||+|||++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 6 78999999999999999843 35899999999999999999999 666 99999999999999
Q ss_pred cCCCceecccCcceeccCccCcc--cccccccccccccceeeccCC------CCcccchhhHHHHHHHHHhC--------
Q 003045 672 EDMNPKISDFGMARIFGFNQNEA--NTNRVVGTYGYMAPEYAMEGL------FSVKSDVYSFGVLLLEIVSG-------- 735 (854)
Q Consensus 672 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~------~s~~~DVwSlGvil~elltG-------- 735 (854)
.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999998764322211 234457999999999997652 34689999999999999999
Q ss_pred --CCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 736 --RRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS-SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 736 --~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
..|+.............. ....... ..+.+... ........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMR-KVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHH-HHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHH-HHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 566654332222222222 2211111 11221111 23356778999999999999999999999999998863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=341.21 Aligned_cols=264 Identities=22% Similarity=0.347 Sum_probs=200.0
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-----ccCHHHHHHHHHHHHhcC---CCceeeeeeeEEe
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-----GQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQ 602 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 602 (854)
...++|++.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3567899999999999999999985 468999999986432 122456778888887775 9999999999987
Q ss_pred CC-----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCce
Q 003045 603 GE-----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPK 677 (854)
Q Consensus 603 ~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 677 (854)
.. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 5789999997 59988885432 234899999999999999999999998 99999999999999999999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
|+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 161 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLI 235 (308)
T ss_dssp ECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHHHHH
T ss_pred EeeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHh
Confidence 999999986532 223345688999999999999999999999999999999999999986432 222222222222
Q ss_pred hcCCcccccC------CCC--CCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 NEGKAMELVD------PNI--RDS-----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d------~~l--~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+.. ... ... ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111100000 000 000 00122356788999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=353.30 Aligned_cols=272 Identities=18% Similarity=0.235 Sum_probs=205.3
Q ss_pred hcCcccCcccccC--CcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRG--GFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999865 68999999997543 3345678889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999985432 245899999999999999999999998 9999999999999999999999999987642
Q ss_pred Ccc-----Ccccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh---
Q 003045 689 FNQ-----NEANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN--- 758 (854)
Q Consensus 689 ~~~-----~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~--- 758 (854)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT-HHHHC---------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCccc
Confidence 111 1112233578999999999987 679999999999999999999999986432211 11111100000
Q ss_pred -c-----CC-------------ccccc---CCC------CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hh
Q 003045 759 -E-----GK-------------AMELV---DPN------IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM--LE 808 (854)
Q Consensus 759 -~-----~~-------------~~~~~---d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~--L~ 808 (854)
. .. ..... .+. ............+.+++.+||+.||++|||+.|+++. ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 0 00 00000 000 0001112233568889999999999999999999863 55
Q ss_pred cc
Q 003045 809 SE 810 (854)
Q Consensus 809 ~~ 810 (854)
.+
T Consensus 339 ~~ 340 (389)
T 3gni_B 339 QI 340 (389)
T ss_dssp GC
T ss_pred HH
Confidence 54
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.69 Aligned_cols=263 Identities=20% Similarity=0.192 Sum_probs=199.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc---CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ---GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|.+.++||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999864 6889999999764322 346789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999853 346899999999999999999999998 99999999999999999999999999986542
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. ........|++.|+|||++.+..++.++||||||+++|||++|+.||..... ............ .. ..
T Consensus 187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~-~~--~~ 256 (309)
T 2h34_A 187 EK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMGAHINQAIP-RP--ST 256 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHHHHHHSCCC-CG--GG
T ss_pred cc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHHHHhccCCC-Cc--cc
Confidence 21 1222345789999999999999999999999999999999999999864221 111111111110 00 01
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhccCCCCCC
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRP-TMASVVLMLESETPTLPV 816 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~eVl~~L~~~~~~~~~ 816 (854)
.... ....+.+++.+||+.||++|| +++++++.|+........
T Consensus 257 ~~~~----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 257 VRPG----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp TSTT----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred cCCC----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 1111 223678899999999999999 999999999987555443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.98 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=198.3
Q ss_pred HHHhcCcccCcccccCCcccEEEeEcC----CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE 604 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 604 (854)
....++|.+.+.||+|+||.||+|+.. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345578899999999999999999653 34589999987542 334567899999999999999999999998765
Q ss_pred e-----eEEEEEcCCCCChhhhhcCc---ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 605 E-----KMLIYEYMPNKSLDLFIFDP---AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 605 ~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
. .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3 49999999999999988432 23356999999999999999999999998 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... ......+.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~- 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLL- 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHH-
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHH-
Confidence 9999999987643322222334567889999999999999999999999999999999 8888764321 22222211
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.+.. + ..+......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 264 ---~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 ---HGHR-----L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---TTCC-----C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCC-----C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 0 1111223468889999999999999999999999988743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.26 Aligned_cols=262 Identities=28% Similarity=0.403 Sum_probs=209.4
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCC------CcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQG 603 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 603 (854)
...++|.+.+.||+|+||.||+|.... .+.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345788999999999999999997532 2479999997643 23456789999999999 899999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCccc-----------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAK-----------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE 672 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 672 (854)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999864321 235799999999999999999999998 999999999999999
Q ss_pred CCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHH
Q 003045 673 DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIE 751 (854)
Q Consensus 673 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~ 751 (854)
++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+...... ..+..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHH
Confidence 99999999999987643333223344567889999999999999999999999999999999 88887643211 11222
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 752 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+ ..+.. +.. +......+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 279 ~~----~~~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LV----KDGYQ-----MAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HH----HHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----hcCCC-----CCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11 11110 001 111134678899999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=347.62 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=202.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999865 58899999997643 23345688999999988 899999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999998843 346899999999999999999999998 99999999999999999999999999986421
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC---chHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN---SSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~ 766 (854)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.........
T Consensus 163 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred --CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 1223445689999999999999999999999999999999999999996432111 0111112222111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM------ASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~------~eVl~ 805 (854)
.+.. .....+.+++.+||+.||++||++ .|+++
T Consensus 237 --~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 --RIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp --CCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred --CCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1111 223467889999999999999995 56664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.10 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=195.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee---
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK--- 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~--- 606 (854)
.++|++.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999975 5789999999976432 2345788999999999999999999998776543
Q ss_pred -EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 607 -MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 607 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 686 IFGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 686 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIPP 239 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCCCc
Confidence 76432221 223346789999999999999999999999999999999999999864221 111122222211110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHhcc
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV-LMLESE 810 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl-~~L~~~ 810 (854)
. ..... ....+.+++.+||+.||++||+..+++ ..|...
T Consensus 240 ~---~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 S---ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H---HHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c---cccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 00111 234678899999999999999666555 455554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=345.01 Aligned_cols=266 Identities=21% Similarity=0.218 Sum_probs=204.1
Q ss_pred HHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc-----cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK-----SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 603 (854)
+....++|.+.++||+|+||+||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456778999999999999999999976 46889999998654 234567899999999999999999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCcc-------------------------------------cccCCCHHHHHHHHHHHHHH
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPA-------------------------------------KQALLDWTKRFAIIEGIARG 646 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 646 (854)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01124567788999999999
Q ss_pred HHHhhcCCCCceEEcccCCCcEEEccCC--CceecccCcceeccCccCc--ccccccccccccccceeecc--CCCCccc
Q 003045 647 LLYLHRDSRLRIIHRDLKASNILLDEDM--NPKISDFGMARIFGFNQNE--ANTNRVVGTYGYMAPEYAME--GLFSVKS 720 (854)
Q Consensus 647 L~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~~~ 720 (854)
|+|||+.+ |+||||||+|||++.++ .+||+|||++..+...... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 8999999999876432211 12345679999999999875 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 721 DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 721 DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
||||||+++|||++|+.||..... .+............ ..+. .......+.+++.+||+.||++||++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLCF--ENPN-----YNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCT--TSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhccccc--CCcc-----cccCCHHHHHHHHHHcCCChhHCCCH
Confidence 999999999999999999864221 11222222211110 0110 11123467889999999999999999
Q ss_pred HHHHH--HHhcc
Q 003045 801 ASVVL--MLESE 810 (854)
Q Consensus 801 ~eVl~--~L~~~ 810 (854)
.|+++ .+++.
T Consensus 326 ~~~l~hp~~~~~ 337 (345)
T 3hko_A 326 MRALQHPWISQF 337 (345)
T ss_dssp HHHHHSHHHHTT
T ss_pred HHHhcChhhccC
Confidence 99988 44443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=353.75 Aligned_cols=264 Identities=23% Similarity=0.248 Sum_probs=192.4
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEE--------
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCI-------- 601 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~-------- 601 (854)
....+|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3456899999999999999999985 468999999997666566778899999999996 999999999984
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
.....++||||++ |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3345789999996 788888865444556999999999999999999999975 35999999999999999999999999
Q ss_pred CcceeccCccCcc----------cccccccccccccceee---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCch
Q 003045 682 GMARIFGFNQNEA----------NTNRVVGTYGYMAPEYA---MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748 (854)
Q Consensus 682 Gla~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~---~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~ 748 (854)
|++.......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998764322111 11135689999999998 5677899999999999999999999998632110
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
... . +.. ........ ...+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 260 --~~~----~-~~~----~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 --RIV----N-GKY----SIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------C----CCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --Hhh----c-Ccc----cCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 000 0 000 00011111 1246788999999999999999999999988754333
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=345.17 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=193.7
Q ss_pred hcCcccCcccccCCcccEEEeEc----CCCcEEEEEEecccc----ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
.++|++.++||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36788999999999999999975 478999999997642 2345567899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999884 3346889999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+ ... ..
T Consensus 170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i---~~~-~~--- 238 (327)
T 3a62_A 170 ESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKI---LKC-KL--- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH---HHT-CC---
T ss_pred ccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHH---HhC-CC---
Confidence 64321 122344679999999999999999999999999999999999999986421 11122221 111 10
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.+.. .....+.+++.+||+.||++|| ++.|+++
T Consensus 239 ---~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ---NLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 1234678899999999999999 7788876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.18 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=205.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe---------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--------- 602 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 602 (854)
...+|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4577899999999999999999875 78999999997543 457889999999999999999998864
Q ss_pred -------CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC
Q 003045 603 -------GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN 675 (854)
Q Consensus 603 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 675 (854)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44579999999999999998543 2346899999999999999999999998 999999999999999999
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+... .. ...
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~-~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SK-FFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HH-HHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HH-HHH
Confidence 9999999998764321 223457899999999999999999999999999999999999876311 11 111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
....+. +....+ ..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 230 ~~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 DLRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred Hhhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 111111 111222 357789999999999999999999999998855443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=348.59 Aligned_cols=254 Identities=13% Similarity=0.099 Sum_probs=206.3
Q ss_pred HHhcCcccCcccccCCcccEEEeE------cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC---CCceeeeeeeEEe
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGK------LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQ 602 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~ 602 (854)
...++|.+.++||+|+||+||+|. ..+++.||||++... ...++..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999993 456889999998653 4567888888888887 9999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcc--cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc--------
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPA--KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-------- 672 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------- 672 (854)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999986422 3456999999999999999999999998 999999999999998
Q ss_pred ---CCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchH
Q 003045 673 ---DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSL 749 (854)
Q Consensus 673 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l 749 (854)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999987643333344455789999999999999999999999999999999999999985322110
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHhccC
Q 003045 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYR-PTMASVVLMLESET 811 (854)
Q Consensus 750 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Ps~~eVl~~L~~~~ 811 (854)
..+...+..... ...+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 293 --------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 --------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 011111211122 3456677889999999998 57888888887753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=356.43 Aligned_cols=251 Identities=26% Similarity=0.420 Sum_probs=206.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999865 79999999997542 234567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999853 346899999999999999999999998 999999999999999999999999999876422
Q ss_pred cCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||... ....+...+ ..+.. ..+
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i----~~~~~---~~p- 236 (476)
T 2y94_A 170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD--HVPTLFKKI----CDGIF---YTP- 236 (476)
T ss_dssp ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS--SSHHHHHHH----HTTCC---CCC-
T ss_pred ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC--CHHHHHHHH----hcCCc---CCC-
Confidence 22334679999999999988775 68999999999999999999998632 122222222 11111 001
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.. ....+.+++.+||+.||++|||+.|+++ .+...
T Consensus 237 --~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 --QY----LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --TT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --cc----CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 11 1246788999999999999999999997 45543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.76 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=204.6
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
..++|.+.++||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999765 477899999987766778899999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 688 (854)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988843 345899999999999999999999998 9999999999999 788999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.. .......||+.|+|||++.+. ++.++||||||+++|||++|+.|+..... ......+ ..+.... ...
T Consensus 161 ~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~----~~~~~~~-~~~ 229 (277)
T 3f3z_A 161 PG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLKI----REGTFTF-PEK 229 (277)
T ss_dssp TT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHCCCCC-CHH
T ss_pred Cc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--HHHHHHH----HhCCCCC-Cch
Confidence 22 223345789999999988654 89999999999999999999999864221 1111111 1111100 000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 230 -~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 -DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 12346788999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=347.35 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=203.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (854)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467899999999999999999875 4789999999754 234567788999999988 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999843 345899999999999999999999998 999999999999999999999999999864
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ... ..
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i---~~~-~~----- 238 (353)
T 2i0e_A 172 IW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSI---MEH-NV----- 238 (353)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH---HHC-CC-----
T ss_pred cc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHH---HhC-CC-----
Confidence 21 122344578999999999999999999999999999999999999998632 212222222 111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.... .....+.+++.+||+.||++||+ ++|+++
T Consensus 239 -~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -AYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 22346788999999999999995 577765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=334.03 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=182.5
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5788899999999999999976 578999999996542 234578899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999998542 245899999999999999999999998 999999999999999999999999999876422
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... . .... .. .+...
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~----~~---~~~~~ 231 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--T---LNKV----VL---ADYEM 231 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C----CS---SCCCC
T ss_pred C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--H---HHHH----hh---cccCC
Confidence 1 12234578999999999999999999999999999999999999986432110 0 0000 00 01111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11 12346788999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.71 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=203.8
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG--EEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 610 (854)
++|.+.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788889999999999999998 48899999997543 33456799999999999999999999999887 7789999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.... ...+++..++.++.||+.||+|||+.+ .+++||||||+|||++.++.++|.|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 9999999999996532 235899999999999999999999875 459999999999999999999999998876432
Q ss_pred cCcccccccccccccccceeeccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSV---KSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.....||+.|+|||++.+..++. ++||||||+++|||++|+.|+..... ..........+. .
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~-----~ 229 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEGL-----R 229 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHHSCC-----C
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHhcCC-----C
Confidence 12356899999999998765544 79999999999999999999863211 111111111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
+.+.. .....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 230 ~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11112 22346888999999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.17 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=206.2
Q ss_pred cCcccCc-ccccCCcccEEEeEcC---CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGN-KLGRGGFGPVHKGKLP---EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|.+.+ .||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 9999999999999743 57789999997643 34567789999999999999999999999 56678999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 2345899999999999999999999998 99999999999999999999999999987643
Q ss_pred ccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 690 NQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 690 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+...+ ..+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i----~~~~~----- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFI----EQGKR----- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHH----HTTCC-----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHH----hcCCc-----
Confidence 2221 12223456889999999998899999999999999999998 999986422 12222221 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
+ ..+......+.+++.+|++.||++||++.|+++.|+.+...
T Consensus 232 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 232 M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11122335788899999999999999999999999887443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.25 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=208.0
Q ss_pred hcCcccCcccccCCcccEEEeE-----cCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--ee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-----LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE--EK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~ 606 (854)
.++|++.++||+|+||.||+++ ..+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4678889999999999999997 3468899999998766666778999999999999999999999987654 78
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc----------cCchHHHHHHH
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE----------ENSSLIEHVWN 755 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~----------~~~~l~~~~~~ 755 (854)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+..... ........+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6433221 112234567789999999998899999999999999999999988753210 00011111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
....+. ....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1111122335788899999999999999999999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=372.04 Aligned_cols=259 Identities=29% Similarity=0.429 Sum_probs=209.5
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
..++|.+.++||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788889999999999999999888899999997543 346789999999999999999999999876 778999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 9999999999532 2245899999999999999999999998 9999999999999999999999999998653211
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........++..|+|||++....++.++|||||||++|||++ |+.|+.... ...+...+ ..+..
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--~~~~~~~i----~~~~~--------- 482 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGYR--------- 482 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--HHHHHHHH----HTTCC---------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCC---------
Confidence 111223456788999999999999999999999999999999 888886321 11222221 12111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
...+......+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 111122335688899999999999999999999999998543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=344.47 Aligned_cols=243 Identities=24% Similarity=0.289 Sum_probs=201.3
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc--------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG--------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 603 (854)
..++|++.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999974 5688999999976421 1345678899999999999999999999999
Q ss_pred CeeEEEEEcCCCC-ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 604 EEKMLIYEYMPNK-SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 604 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
+..++||||+..| +|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 99888843 345899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
++...... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99876422 22334679999999999988876 88999999999999999999998631110
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
......+ +......+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011 01122467889999999999999999999983
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=339.37 Aligned_cols=260 Identities=28% Similarity=0.393 Sum_probs=201.1
Q ss_pred cCcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEE-eCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCI-QGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~l 608 (854)
.+|.+.++||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 567888999999999999997543 2358999987543 334567899999999999999999999865 4567899
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999999542 345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CccC--cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 689 FNQN--EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 689 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ........ .+.. ..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~~~~----~~~~--~~ 252 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLL----QGRR--LL 252 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHHHHH----TTCC--CC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHHh----cCCC--CC
Confidence 3221 12233456788999999999999999999999999999999965544322221 12222211 1111 01
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
.+ .. ....+.+++.+|++.||++|||+.|+++.|+.+...
T Consensus 253 ~~---~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 253 QP---EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC---cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11 224688899999999999999999999999987443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.12 Aligned_cols=248 Identities=22% Similarity=0.264 Sum_probs=179.7
Q ss_pred CcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 540 GNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
.++||+|+||.||+|... +++.||||++... ....+.+|+.++++++ ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999764 6899999998653 4567889999999997 9999999999999999999999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC---CceecccCcceeccCccCcc
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM---NPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~ 694 (854)
|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQ 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CC
Confidence 9999853 356899999999999999999999998 99999999999998765 7999999999865322 22
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc--CchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE--NSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. .....+... ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~------~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFS------FEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCC------CCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCC------CCc
Confidence 234467899999999999999999999999999999999999998753321 11112221 222221110 000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000112356888999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.14 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=198.2
Q ss_pred cCccc-CcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSE-GNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 611 (854)
+.|.+ .++||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 56776 478999999999999754 6899999999876666778899999999995 79999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~~~ 688 (854)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999853 346899999999999999999999998 999999999999998776 9999999998653
Q ss_pred CccC-----cccccccccccccccceeecc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCc---------hH
Q 003045 689 FNQN-----EANTNRVVGTYGYMAPEYAME-----GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS---------SL 749 (854)
Q Consensus 689 ~~~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~---------~l 749 (854)
.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2111 111223569999999999875 5689999999999999999999999875432110 00
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 750 IEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 750 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+......+... +.... .. .....+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~i~~~~~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDKD-WA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHHH-HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCcc-cCchh-cc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111111111110 00000 00 12246889999999999999999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=340.29 Aligned_cols=261 Identities=22% Similarity=0.275 Sum_probs=197.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.++||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999865 589999999865432 235668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 155 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP- 155 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-
Confidence 9999999988743 345899999999999999999999998 999999999999999999999999999876422
Q ss_pred Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhh-----------c
Q 003045 692 NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN-----------E 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~ 759 (854)
........||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+...... .....+..... .
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 156 -SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHT
T ss_pred -ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhccccccccccccc
Confidence 122334578999999999876 67899999999999999999999998643221 11111111111 1
Q ss_pred CCc---ccccCCCCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKA---MELVDPNIRDSS---SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~---~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ..+.++...... .......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 100 011111100000 0112345788999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.73 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=198.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
..++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3467889999999999999999764 68899999997653 345688999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCccee
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARI 686 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~ 686 (854)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988543 22356999999999999999999999998 9999999999999 4567899999999986
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.... .......||+.|+|||++. ..++.++||||||+++|||++|+.||..... ..+.... ........ .
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~~~~~~---~~~~~~~~-~ 246 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQQKA---TYKEPNYA-V 246 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---HHCCCCCC-C
T ss_pred cCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HHHHhhh---ccCCcccc-c
Confidence 5322 2234467899999999875 5689999999999999999999999864221 1111111 11110000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 247 ~---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011 1246778999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.94 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=199.1
Q ss_pred cccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 537 FSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
|.....||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 44456899999999999975 46889999999876666678899999999999999999999999999999999999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-CCCceecccCcceeccCccCcc
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-DMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 694 (854)
++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||++...... ..
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~ 178 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NP 178 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--CC
Confidence 999999865444446789999999999999999999998 999999999999987 899999999999876421 12
Q ss_pred cccccccccccccceeeccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.|+............ ... .. ..+.+..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~-~~-----~~~~~~~ 249 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGM-FK-----VHPEIPE 249 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHH-HC-----CCCCCCT
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hcc-cc-----ccccccc
Confidence 233467899999999997654 889999999999999999999998632211111111 000 00 1112222
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ....+.+++.+||+.||++||++.|+++
T Consensus 250 ~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 S----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp T----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 2346788999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=337.37 Aligned_cols=258 Identities=28% Similarity=0.360 Sum_probs=203.7
Q ss_pred CcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee-EEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK-MLI 609 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~lV 609 (854)
.|...++||+|+||+||+|+..+ +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999997432 2379999987543 23457889999999999999999999999877665 999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+.+++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999998642 345889999999999999999999998 99999999999999999999999999986532
Q ss_pred cc--CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 690 NQ--NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 690 ~~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.. .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ...+...+. ....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~----~~~~----- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLA----QGRR----- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHH----TTCC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhh----cCCC-----
Confidence 21 12223345778999999999999999999999999999999997766543222 222222221 1110
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.. .+......+.+++.+|++.||++|||+.|+++.|+.+..
T Consensus 247 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 247 LP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 111123468889999999999999999999999988743
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=355.20 Aligned_cols=263 Identities=19% Similarity=0.216 Sum_probs=207.0
Q ss_pred eeHHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeE
Q 003045 525 FNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCC 600 (854)
Q Consensus 525 ~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 600 (854)
+.+++.....++|++.++||+|+||.||+++.+ +++.||+|++.+.. ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344555566789999999999999999999864 68999999997532 23345688999999999999999999999
Q ss_pred EeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecc
Q 003045 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISD 680 (854)
Q Consensus 601 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 680 (854)
.+.+..++||||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999998532 236899999999999999999999998 99999999999999999999999
Q ss_pred cCcceeccCccCcccccccccccccccceeec-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHH
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-------EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 753 (854)
||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i 282 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--TAETYGKI 282 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHH
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--HHHHHHHH
Confidence 999987642211 1223468999999999997 4578999999999999999999999986422 11222222
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 003045 754 WNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYR---PTMASVVL 805 (854)
Q Consensus 754 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Ps~~eVl~ 805 (854)
...... +.-|...... ...+.+++.+||+ +|++| |+++|+++
T Consensus 283 ~~~~~~-----~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYKEH-----LSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHHHH-----CCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhcccC-----cCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 110000 0011111122 3467889999999 99998 58999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=338.95 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=204.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999765 689999999976432 146789999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC----Cceeccc
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM----NPKISDF 681 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 681 (854)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999853 345889999999999999999999998 99999999999999888 7999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
|++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.|+..... ......+ . ...
T Consensus 164 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i---~-~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANI---T-SVS 234 (321)
T ss_dssp TTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH---H-TTC
T ss_pred ccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---H-hcc
Confidence 999876422 223346789999999999999999999999999999999999999863211 1111111 1 111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. -.++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000011 1246788999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=343.84 Aligned_cols=266 Identities=26% Similarity=0.322 Sum_probs=197.0
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHH--HHhcCCCceeeeeeeEEe-----CCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIIL--IAKLQHRNLVRLLGCCIQ-----GEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~-----~~~~~ 607 (854)
++|++.++||+|+||.||+|+. +++.||||++... ..+.+..|.++ +..++|+||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 6788899999999999999987 6899999998653 23444445444 455899999999986543 23568
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC---------CCCceEEcccCCCcEEEccCCCcee
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD---------SRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
+||||+++|+|.+++.. ...++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 99999999999999843 2358999999999999999999998 6 999999999999999999999
Q ss_pred cccCcceeccCccC------cccccccccccccccceeecc-------CCCCcccchhhHHHHHHHHHhCCCCCCCCccc
Q 003045 679 SDFGMARIFGFNQN------EANTNRVVGTYGYMAPEYAME-------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE 745 (854)
Q Consensus 679 ~DFGla~~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~ 745 (854)
+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987643211 112234579999999999986 45678999999999999999998776432211
Q ss_pred Cc---h---------HHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 746 NS---S---------LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 746 ~~---~---------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
.. . ................-+... -.........+.+++.+||+.||++|||++||++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 10 0 011111111111111111111 111234566799999999999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.94 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=202.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcCC----CcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
..++|.+.+.||+|+||.||+|+..+ +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999997432 346999998764 23346788999999999999999999999864 5678
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999853 2345899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+..... ......+. .+...
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~----~~~~~--- 233 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLE----KGDRL--- 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHH----HTCCC---
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHh----cCCCC---
Confidence 42211 12233456889999999999999999999999999999998 9999864322 12222221 11110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.... .....+.+++.+|++.||++||++.|+++.|+.+
T Consensus 234 --~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 --PKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0111 1234688899999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=329.23 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=203.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999754 58999999996543 334567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecccCcceec
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISDFGMARIF 687 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~~ 687 (854)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988874 3356899999999999999999999998 999999999999987655 999999999876
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.|+.... .......+ ..+... ...
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~----~~~~~~-~~~ 228 (284)
T 3kk8_A 159 NDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQI----KAGAYD-YPS 228 (284)
T ss_dssp CSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHTCCC-CCT
T ss_pred ccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--hhHHHHHH----Hhcccc-CCc
Confidence 422 22234678999999999999999999999999999999999999986421 11222221 111110 011
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~-~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PE-WDT----VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TT-TTT----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hh-hcc----cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 111 2246788999999999999999999988
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.56 Aligned_cols=262 Identities=17% Similarity=0.218 Sum_probs=202.1
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeE-EeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC-IQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 610 (854)
..++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999975 578999999875542 234688999999999988877666655 6677889999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCcceec
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIF 687 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~ 687 (854)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 335899999999999999999999998 9999999999999 78999999999999976
Q ss_pred cCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc-cCchHHHHHHHHhhcCC
Q 003045 688 GFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE-ENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 688 ~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~ 761 (854)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 533221 122356789999999999999999999999999999999999999975332 11222222211110100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
. +.+.... ...+.+++.+|++.||++|||+.||++.|+.+.
T Consensus 239 ~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred h-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0 0011112 247889999999999999999999999998864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.34 Aligned_cols=262 Identities=31% Similarity=0.439 Sum_probs=204.6
Q ss_pred HhcCcccCcccccCCcccEEEeEc------CCCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 605 (854)
..++|.+.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 347889999999999999999974 34778999999644 33445678999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc----ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCcee
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK----QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKI 678 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl 678 (854)
.++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999865321 245899999999999999999999998 999999999999994 446999
Q ss_pred cccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHh
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
+|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+...+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~---- 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFV---- 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH----
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHHHHHH----
Confidence 99999986543332233344677899999999999999999999999999999998 888876321 11122211
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
..+... .... .....+.+++.+||+.||++||++.||++.|+.+..
T Consensus 259 ~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 TSGGRM-----DPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCC-----CCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111111 1111 223467889999999999999999999999988643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.08 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=199.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467889999999999999999754 5779999998653 223456789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999998843 345899999999999999999999988 99999999999999999999999999865421
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.|+.... .......+. .. ...
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~----~~------~~~ 225 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRIS----RV------EFT 225 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHH----HT------CCC
T ss_pred ----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--HHHHHHHHH----hC------CCC
Confidence 22234678999999999999999999999999999999999999986321 111111111 11 011
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 FPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCC----cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 12246778999999999999999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.02 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=205.5
Q ss_pred eHHHHHHHhcCcccC-cccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcC-CCceeeeeeeE
Q 003045 526 NFNTIAVATNYFSEG-NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQ-HRNLVRLLGCC 600 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 600 (854)
.+...+...++|.+. ++||+|+||.||+|... +++.||+|++... .......+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344556667778776 89999999999999765 6899999999754 2345678999999999995 69999999999
Q ss_pred EeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCce
Q 003045 601 IQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPK 677 (854)
Q Consensus 601 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~k 677 (854)
.+.+..++||||+++++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999988543 2346899999999999999999999998 999999999999997 78999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
|+|||++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..
T Consensus 175 L~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~-- 247 (327)
T 3lm5_A 175 IVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--QETYLNISQ-- 247 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH--
T ss_pred EeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHh--
Confidence 9999999876422 223346799999999999999999999999999999999999999864221 111111111
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .. .............+.+++.+||+.||++|||++|+++
T Consensus 248 -~-~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 -V-NV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -T-CC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -c-cc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 00 0011111122346788999999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=345.86 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=199.4
Q ss_pred cCcccCcccccCCcccEEEeEcCC-----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
++|...++||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778999999999999997542 2359999997542 2345678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998542 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 689 FNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 689 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
..... .......+|..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+... ...+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~~~~----~~~~~~---- 268 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA----INDGFR---- 268 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH----HHTTCC----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--HHHHHHH----HHCCCc----
Confidence 32211 12223456788999999999999999999999999999999 999885321 1112221 111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
. ..+......+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 269 -~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 -L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 011122356888999999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=359.33 Aligned_cols=248 Identities=22% Similarity=0.266 Sum_probs=194.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|++.++||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46789999999999999999975 46899999999754 334456778999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
|||+++++|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999884 34468999999999999999999998 77 9999999999999999999999999998542
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... ..
T Consensus 301 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i---~~~-~~------ 366 (446)
T 4ejn_A 301 K--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELI---LME-EI------ 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---HHC-CC------
T ss_pred C--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHH---HhC-CC------
Confidence 2 2223345789999999999999999999999999999999999999986421 11222221 111 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.+... ....+.+++.+||+.||++|| +++|+++
T Consensus 367 ~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 RFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11111 224678899999999999999 9999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=340.34 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=202.6
Q ss_pred hcCcccCc-ccccCCcccEEEeEc---CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 534 TNYFSEGN-KLGRGGFGPVHKGKL---PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 534 ~~~f~~~~-~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
.++|.+.+ .||+|+||.||+|.. ..++.||||++.... ....+++.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999943 346889999997543 22357899999999999999999999999 667889
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999853 345899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccCcc-cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 688 GFNQNEA-NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 688 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+... ...+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~-- 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAM----LEKGERM-- 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCCCC--
Confidence 4322211 1223456788999999998889999999999999999999 9999864221 112221 1221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
..+......+.+++.+|++.||++||++.||++.|+.+.
T Consensus 240 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223357888999999999999999999999998864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.58 Aligned_cols=271 Identities=24% Similarity=0.270 Sum_probs=208.4
Q ss_pred ccceeHHHHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-----CCceee
Q 003045 522 LAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-----HRNLVR 595 (854)
Q Consensus 522 ~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~ 595 (854)
...+++++.....++|.+.++||+|+||+||+|+. .+++.||||++... ....+.+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455566666778999999999999999999976 46889999998642 234566788999999997 999999
Q ss_pred eeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---
Q 003045 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE--- 672 (854)
Q Consensus 596 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--- 672 (854)
+++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 999999885432 234899999999999999999999998 999999999999975
Q ss_pred ----------------------CCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHH
Q 003045 673 ----------------------DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLL 730 (854)
Q Consensus 673 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ 730 (854)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 78999999999986432 223467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCcccCchHHHHHHHHhhcC-----------CcccccCC-CCC-----CCCCHH---------------H
Q 003045 731 EIVSGRRNTSFRLEENSSLIEHVWNLWNEG-----------KAMELVDP-NIR-----DSSSQN---------------Q 778 (854)
Q Consensus 731 elltG~~p~~~~~~~~~~l~~~~~~~~~~~-----------~~~~~~d~-~l~-----~~~~~~---------------~ 778 (854)
||++|+.||..... ......+....... .....++. .+. ...... .
T Consensus 251 ell~g~~pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 251 ELYTGSLLFRTHEH--MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHSSCSCCCSSH--HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHCCCCCCCCcH--HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 99999999864321 11111111111000 00000000 000 000000 1
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 779 VLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 779 ~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+.+++.+||+.||++|||++|+++
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 146779999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=354.45 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=206.1
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|...+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999865 6899999999654 234567789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986543 2346999999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+....... ...
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~-~~~------ 410 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLE-QAV------ 410 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHH-CCC------
T ss_pred CC--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhh-ccc------
Confidence 22 122334689999999999999999999999999999999999999997543211 11111111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM-----ASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~eVl~ 805 (854)
. .+......+.+++.+||+.||++||++ .||++
T Consensus 411 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 T----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred C----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 111223467889999999999999975 66664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=359.03 Aligned_cols=254 Identities=28% Similarity=0.347 Sum_probs=206.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
..++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999764 6899999999653 23456678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|..++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986532 234899999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+........ .
T Consensus 338 ~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~~------~ 406 (576)
T 2acx_A 338 EG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEVP------E 406 (576)
T ss_dssp TT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHCC------C
T ss_pred cC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhccc------c
Confidence 22 223346899999999999999999999999999999999999999975432111 111111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.... .....+.+++.+||+.||++|| +++||++
T Consensus 407 ~~p~----~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSE----RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCc----cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111 2234678899999999999999 7888875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.89 Aligned_cols=265 Identities=23% Similarity=0.347 Sum_probs=191.6
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC--e
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGE--E 605 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~ 605 (854)
...++|.+.++||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999975 46899999998643 2334567789999999997 999999999997654 6
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 578888742 46889999999999999999999998 9999999999999999999999999998
Q ss_pred eccCcc-------------------Ccccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCccc
Q 003045 686 IFGFNQ-------------------NEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE 745 (854)
Q Consensus 686 ~~~~~~-------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~ 745 (854)
.+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-- 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-- 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 753211 1112334689999999999986 679999999999999999999999986432
Q ss_pred CchHHHHHHHHhhcCCcccc---c------------------CCCCCCCCC------------HHHHHHHHHHHhhccCC
Q 003045 746 NSSLIEHVWNLWNEGKAMEL---V------------------DPNIRDSSS------------QNQVLRCIHVGMLCVQD 792 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~---~------------------d~~l~~~~~------------~~~~~~l~~l~~~Cl~~ 792 (854)
.......+...........+ . ......... ......+.+++.+||+.
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 11122222111111100000 0 000000000 01124678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003045 793 SAMYRPTMASVVLM 806 (854)
Q Consensus 793 dp~~RPs~~eVl~~ 806 (854)
||++|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=334.72 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=204.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
..++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999764 689999999986655556678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 688 (854)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999988843 346899999999999999999999998 9999999999999 788999999999997542
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.... ...+...+ ..+.. .. ..
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i----~~~~~-~~-~~ 228 (304)
T 2jam_A 161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKI----KEGYY-EF-ES 228 (304)
T ss_dssp C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHH----HHCCC-CC-CT
T ss_pred C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH----HcCCC-CC-Cc
Confidence 1 22334578999999999999999999999999999999999999986422 11222222 11111 00 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.... .....+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 229 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 PFWD----DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTT----TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred cccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1111 22346888999999999999999999997 45543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=330.65 Aligned_cols=262 Identities=17% Similarity=0.217 Sum_probs=205.7
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeE-EeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCC-IQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lV~E 611 (854)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++++++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999985 578999999986543 335689999999999988866666555 56678899999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 688 (854)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 345899999999999999999999998 9999999999999 488999999999998765
Q ss_pred CccCcc-----cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcc-cCchHHHHHHHHhhcCCc
Q 003045 689 FNQNEA-----NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLE-ENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 689 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~ 762 (854)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 332211 12446799999999999999999999999999999999999999975332 222222222211111000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+.+.... ...+.+++.+|++.||++|||+.||++.|+.+..
T Consensus 240 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0011112 2468889999999999999999999999988643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=342.30 Aligned_cols=257 Identities=29% Similarity=0.408 Sum_probs=202.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcE--EEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQD--IAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
++|.+.+.||+|+||.||+|+.. +++. +|+|++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67888999999999999999764 4554 499988753 334566789999999999 899999999999999999999
Q ss_pred EEcCCCCChhhhhcCcc-------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 610 YEYMPNKSLDLFIFDPA-------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
|||+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999998 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.|+.... ..+.. .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~-~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELY-E 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHH-H
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HHHHH-H
Confidence 9999999975321 112233456889999999998899999999999999999998 999986321 11111 1
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
....+. .+.. +......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 253 ~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 253 KLPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HGGGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhcCC-----CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1111 11223468889999999999999999999999988643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.11 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=203.2
Q ss_pred hcCcccCcccccCCcccEEEeEc----CCCcEEEEEEecccc----ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRKS----GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999976 468999999987532 23456778899999999 6999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999853 346899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC---
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc---
Confidence 87642221 22334679999999999985 347899999999999999999999987543221 112222111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVLML 807 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~~L 807 (854)
.+.... .....+.+++.+||+.||++|| ++.|+++..
T Consensus 282 ----~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111111 2234678899999999999999 999998743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.49 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=201.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc------cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|++.++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467889999999999999999765 689999999875421 2467899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC----CceecccC
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM----NPKISDFG 682 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFG 682 (854)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 346899999999999999999999998 99999999999998877 89999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.|+..... ......+ .....
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~----~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--QETLTNI----SAVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH----HTTCC
T ss_pred cceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--HHHHHHh----Hhccc
Confidence 99876322 122345789999999999999999999999999999999999999864221 1111111 11110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ..+.... .....+.+++.+|++.||++|||+.|+++
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000001 12246788999999999999999999997
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.41 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=198.4
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.+.|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688899999999999999975 5789999999975432 2346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||++ |+|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 567666642 2346899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.....||+.|+|||++. ...++.++|||||||++|||++|+.|+.... ....+....... .
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~-~---- 270 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNE-S---- 270 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC-C----
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcC-C----
Confidence 23457899999999984 5679999999999999999999999986321 111122222211 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 271 -~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 -PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11111 111245778999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=348.85 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=193.9
Q ss_pred CcccCcccccCCcccEEEeEcC--CC--cEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCeeEEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP--EG--QDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ-GEEKMLI 609 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lV 609 (854)
.|...++||+|+||.||+|+.. ++ ..||+|.+.... ....+++.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999753 22 368999986542 3446789999999999999999999998755 4578999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999543 345789999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCc--ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNE--ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+.... .......+ ..+.. ..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~----~~~~~--~~ 316 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL----LQGRR--LL 316 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHH----HTTCC--CC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHH----HcCCC--CC
Confidence 2111 12233567889999999999999999999999999999999 555554322 12222222 11111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
.+ ......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 317 ~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 QP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11 1123468889999999999999999999999998754433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.87 Aligned_cols=246 Identities=22% Similarity=0.265 Sum_probs=191.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHH-HHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIIL-IAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367889999999999999999765 58899999997653 2234456677776 577899999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998843 346889999999999999999999998 9999999999999999999999999998642
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ... ..
T Consensus 191 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i---~~~-~~------ 256 (373)
T 2r5t_A 191 E--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNI---LNK-PL------ 256 (373)
T ss_dssp C--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--HHHHHHHH---HHS-CC------
T ss_pred c--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHH---Hhc-cc------
Confidence 1 2223445789999999999999999999999999999999999999986321 11222222 111 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eV 803 (854)
.+.... ...+.+++.+||+.||++||++.+.
T Consensus 257 ~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 QLKPNI----TNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCC----CHHHHHHHHHHcccCHHhCCCCCCC
Confidence 111122 2467889999999999999998543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.53 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=192.8
Q ss_pred HHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
...++|.+.++||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4457899999999999999999974 478999999996543 2234567899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-----cCCCceecccCc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-----EDMNPKISDFGM 683 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-----~~~~~kl~DFGl 683 (854)
||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 88888743 345899999999999999999999998 99999999999995 445599999999
Q ss_pred ceeccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
+...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.........
T Consensus 184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--IDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCT
T ss_pred ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--HHHHHHHHHHhCCCch
Confidence 9876422 1223345789999999999874 589999999999999999999999864321 1122222111111100
Q ss_pred cc---c------c--CCCCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 ME---L------V--DPNIRDSS-----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~---~------~--d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. . . .+...... .......+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0 0 00000000 0012356789999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.31 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=200.1
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 610 (854)
..++|++.+.||+|+||.||++..+ +++.||+|++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4577999999999999999999764 688999999976432 245788889888 7999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-C---CceecccCccee
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-M---NPKISDFGMARI 686 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~---~~kl~DFGla~~ 686 (854)
||+++|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||+.++ + .+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998853 345899999999999999999999998 9999999999998543 3 499999999987
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+. ......+...
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~-~~~i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEI-LARIGSGKFS--- 241 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHH-HHHHHHCCCC---
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHH-HHHHccCCcc---
Confidence 64322 2234467899999999999888999999999999999999999998743221 11111 1122222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111122346788999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.79 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=198.5
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 608 (854)
..++|++.++||+|+||+||+|+.. +++.||+|++.... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999765 78999999997542 33456788999999999 89999999999999999999
Q ss_pred EEEcCCCCChhhhhcCccc-ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC--------------
Q 003045 609 IYEYMPNKSLDLFIFDPAK-QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-------------- 673 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------- 673 (854)
||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999864322 256899999999999999999999998 9999999999999844
Q ss_pred -----CCceecccCcceeccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCc
Q 003045 674 -----MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747 (854)
Q Consensus 674 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~ 747 (854)
..+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 47999999999876422 224589999999999866 5678999999999999999998765421
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 748 SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 748 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..... ...+.. +.+.... ...+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~----~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQWHE----IRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHH----HHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHH----HHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111 112111 1111122 346788999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=370.57 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=197.8
Q ss_pred ccccCCcccEEEeEcC---CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 542 KLGRGGFGPVHKGKLP---EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
+||+|+||.||+|... ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999653 46679999997643 3457889999999999999999999999976 66899999999999
Q ss_pred hhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc-cc
Q 003045 618 LDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA-NT 696 (854)
Q Consensus 618 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 696 (854)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++......... ..
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99998543 345899999999999999999999998 9999999999999999999999999998764322111 12
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCC
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 775 (854)
....+++.|+|||++.+..++.++|||||||++|||++ |+.|+.... ...+...+ ..+... ..+
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i----~~~~~~---------~~p 561 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFI----EQGKRM---------ECP 561 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHH----HTTCCC---------CCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HcCCCC---------CCC
Confidence 22345688999999999999999999999999999998 999986432 22222222 222111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 776 ~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22345788999999999999999999999999886
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.74 Aligned_cols=264 Identities=14% Similarity=0.143 Sum_probs=206.6
Q ss_pred hcCcccCcccccCCcccEEEeEcCC---------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceee---------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE---------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR--------- 595 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~--------- 595 (854)
.++|.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999998653 789999998653 46889999999999999988
Q ss_pred ------eeeeEEe-CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcE
Q 003045 596 ------LLGCCIQ-GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNI 668 (854)
Q Consensus 596 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 668 (854)
+++++.. ....++||||+ +++|.+++... ....+++.+++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6677776 67889999999 99999999643 2356999999999999999999999998 99999999999
Q ss_pred EEccCC--CceecccCcceeccCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 669 LLDEDM--NPKISDFGMARIFGFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 669 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876432211 112345799999999999999999999999999999999999999875
Q ss_pred CcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 742 RLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 742 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
.......+......... ....+.+..... ......+.+++.+||+.||++||++.||++.|+.+..
T Consensus 271 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHHHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 43222223332222111 111122211110 0112468889999999999999999999999988743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.95 Aligned_cols=266 Identities=22% Similarity=0.332 Sum_probs=196.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccccc-CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ-GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|.+.++||+|+||+||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56888999999999999999765 6899999998654322 222456799999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 153 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence 98 4787777432 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc---ccccC-
Q 003045 693 EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA---MELVD- 767 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---~~~~d- 767 (854)
........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+......... .....
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHhchhhhcc
Confidence 222334578999999999876 568999999999999999999999986432 12222333222221111 00000
Q ss_pred --------CCCCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 768 --------PNIRDS----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 768 --------~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
+..... ........+.+++.+||+.||++|||++|+++ .+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000000 00112346789999999999999999999998 55554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.27 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=204.9
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67888999999999999999765 5788999998653 2334577899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 99999999998843 345899999999999999999999998 99999999999999999999999999976532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.|+..... .+...... .. +..+
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~-~~------~~~~ 231 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----TETHRRIV-NV------DLKF 231 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH-TT------CCCC
T ss_pred ---cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----hHHHHHHh-cc------ccCC
Confidence 122346789999999999999999999999999999999999999864221 11111111 11 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
... ....+.+++.+||+.||++||++.|+++ .+...
T Consensus 232 ~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 PPF----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 112 2346788999999999999999999997 45443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=335.21 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=197.0
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-EEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lV~Ey 612 (854)
.++|++.+.||+|+||.||+|+. +++.||||++... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999987 5889999998653 3567899999999999999999999997655 478999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998532 2234789999999999999999999998 999999999999999999999999999864321
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+...+ ..+. .+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~----~~~~-----~~~~- 235 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV----EKGY-----KMDA- 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHH----TTTC-----CCCC-
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----hcCC-----CCCC-
Confidence 223457889999999999999999999999999999998 9988864321 1222211 1111 1111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+......+.+++.+|++.||++||++.|+++.|+.+
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 112235688899999999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.94 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=205.2
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.+.|...++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46688899999999999999975 468999999997543 3456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999842 45899999999999999999999998 9999999999999999999999999998764222
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.|+..... ......+ .... .+.+.
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~----~~~~-----~~~~~ 240 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLI----PKNN-----PPTLE 240 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH----HHSC-----CCCCC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHh----hcCC-----CCCCc
Confidence 223446789999999999999999999999999999999999999863211 1111111 1111 11122
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 GNY----SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccc----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 222 246788999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=350.49 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=192.0
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--------ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--------GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ 602 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 602 (854)
...++|.+.++||+|+||+||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45688999999999999999999754 58999999997542 122345889999999999999999999975
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC---Cceec
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM---NPKIS 679 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~ 679 (854)
.+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5568999999999999988843 346899999999999999999999998 99999999999997544 59999
Q ss_pred ccCcceeccCccCcccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
|||+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+...+
T Consensus 285 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i--- 357 (419)
T 3i6u_A 285 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQI--- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHH---
T ss_pred ecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHH---
Confidence 9999987642 22234568999999999985 367889999999999999999999998743222 1222222
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.... .+.... .....+.+++.+||+.||++|||++|+++
T Consensus 358 -~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 -TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HTTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -hcCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111100 000001 12346888999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=343.28 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=198.8
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 67888999999999999999765 589999999865432 234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 177 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP- 177 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC-
Confidence 9999999888643 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred CcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH-----------hhc
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL-----------WNE 759 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~-----------~~~ 759 (854)
........||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+... +..
T Consensus 178 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 -GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHH
T ss_pred -ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHhhh
Confidence 1223345789999999999875 7899999999999999999999998643221 111111110 111
Q ss_pred C-CcccccCCCCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 G-KAMELVDPNIRDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~-~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .......+.+..... ......+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 111111111111111 122457889999999999999999999886
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=354.88 Aligned_cols=258 Identities=23% Similarity=0.265 Sum_probs=193.6
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------C
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------E 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 604 (854)
.++|++.++||+|+||+||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999965 46899999999754 233456788999999999999999999999654 3
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999876 444442 23889999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC----
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG---- 760 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---- 760 (854)
+.... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+.......
T Consensus 212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred eecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHH
Confidence 87532 2233457899999999999999999999999999999999999999864321 11111111111100
Q ss_pred ----------------Ccc-----cccCCCCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 ----------------KAM-----ELVDPNIRDS---SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ----------------~~~-----~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ......+... ........+.+++.+||+.||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000000 01122457889999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=344.29 Aligned_cols=249 Identities=20% Similarity=0.223 Sum_probs=189.6
Q ss_pred cCcccC-cccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHh-cCCCceeeeeeeEEe----CCeeE
Q 003045 535 NYFSEG-NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAK-LQHRNLVRLLGCCIQ----GEEKM 607 (854)
Q Consensus 535 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~----~~~~~ 607 (854)
++|.+. ++||+|+||+||++... +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345544 68999999999999764 688999999853 2467789988755 489999999999876 56789
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccCcc
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFGMA 684 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla 684 (854)
+||||+++|+|.+++.... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999986532 245899999999999999999999998 999999999999997 788999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC--chHHHHHHHHhhcCCc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN--SSLIEHVWNLWNEGKA 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~ 762 (854)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+. .+..
T Consensus 212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 212 KETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred cccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 86532 222345688999999999999999999999999999999999999986433211 11222211 1111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+..+. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 285 -~~~~~~-~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -EFPNPE-WS----EVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCCTTT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCcc-cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001110 01 12346788999999999999999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.42 Aligned_cols=260 Identities=23% Similarity=0.271 Sum_probs=201.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|.+.++||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467889999999999999999765 6899999998764 23345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999999843 34589999999999999999999985 7 99999999999999999999999999975421
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc-----------
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE----------- 759 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~----------- 759 (854)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+..........
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK--ELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH--HHHHHHC----------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccCCCCCCCccc
Confidence 1233467899999999999999999999999999999999999998643211 110000000000
Q ss_pred ---------------CCccc----ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 ---------------GKAME----LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ---------------~~~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+ +................+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000 00000000001112346888999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.74 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=203.8
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367888999999999999999865 57889999986542 23456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999874 3346899999999999999999999998 99999999999999999999999999987642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.|+..... .+..... ..... .
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~------~ 233 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRI-KKNEY------S 233 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH-HTTCC------C
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-hhccC------C
Confidence 21 223346789999999999999999999999999999999999999864221 1111111 11111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.... ...+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 IPKHI----NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred Ccccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11112 246778999999999999999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=336.49 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=205.8
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999765 57899999987542 23456789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++. ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999874 3346899999999999999999999998 99999999999999999999999999987642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.|+..... .+...... .... .
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~-~~~~------~ 259 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIK-KNEY------S 259 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHH-HTCC------C
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHh-cCCC------C
Confidence 21 223346789999999999999999999999999999999999999864221 11111111 1111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhc
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLES 809 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~ 809 (854)
+.... ...+.+++.+||+.||++|||+.|+++ .+..
T Consensus 260 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 260 IPKHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCccC----CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 11122 246778999999999999999999997 4444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=337.05 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=205.5
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--------cCHHHHHHHHHHHHhc-CCCceeee
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--------QGLEEFKNEIILIAKL-QHRNLVRL 596 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~h~niv~l 596 (854)
........++|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556688999999999999999999875 699999999865432 1245678999999999 79999999
Q ss_pred eeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 597 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999853 346899999999999999999999998 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeecc------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLI 750 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~ 750 (854)
||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 240 kl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~ 314 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILML 314 (365)
T ss_dssp EECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH
T ss_pred EEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--HHHHH
Confidence 99999999876422 22344689999999999863 358899999999999999999999986321 11111
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+ ..+.... ..+.. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 315 ~~i----~~~~~~~-~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMI----MEGQYQF-SSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH----HHTCCCC-CHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH----HhCCCCC-CCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1111100 00000 01 1246788999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.69 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=198.9
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3477899999999999999999875 588999999987766778899999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++++|..++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999988532 345899999999999999999999998 999999999999999999999999997643211
Q ss_pred Ccccccccccccccccceee-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 692 NEANTNRVVGTYGYMAPEYA-----MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
........||+.|+|||++ ....++.++||||||+++|+|++|+.|+..... ........... .....
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~~ 243 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSD-PPTLL 243 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSC-CCCCS
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHhccC-CcccC
Confidence 1122335789999999998 367789999999999999999999999864221 11111111111 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122346888999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=370.94 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=196.6
Q ss_pred cccccCCcccEEEeEc---CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKL---PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||.||+|.+ ..++.||||+++... ....+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 5799999999999954 246789999997643 334678999999999999999999999996 4568899999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc-c
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE-A 694 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 694 (854)
|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999994 3346899999999999999999999998 999999999999999999999999999876432221 1
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+... ...+... .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~----i~~~~~~---------~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAM----LEKGERM---------G 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCCC---------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCCC---------C
Confidence 2233456788999999999999999999999999999998 9999864221 122222 2222111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122335788999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.10 Aligned_cols=260 Identities=28% Similarity=0.373 Sum_probs=196.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC--CCc--EEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP--EGQ--DIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|++.++||+|+||+||+|+.. +++ .||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467889999999999999999742 333 6899998754 2344678899999999999999999999997655 8
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998542 345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+.. ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~---~~~~~~~~-- 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILH---KIDKEGER-- 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH---HHHTSCCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HHHHH---HHHccCCC--
Confidence 6432221 12234567888999999998889999999999999999999 9999864311 11111 11111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCC
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPT 813 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~ 813 (854)
.. ........+.+++.+|++.||++|||+.|+++.|+.+.+.
T Consensus 244 ---~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 ---LP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---CC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01 1112235788899999999999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.26 Aligned_cols=257 Identities=17% Similarity=0.247 Sum_probs=200.2
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEe--CCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQ--GEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~lV 609 (854)
.++|++.++||+|+||.||+|+. .+++.||||++.. ...+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36789999999999999999975 5789999999864 34578899999999997 9999999999988 5678999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~ 688 (854)
|||+++++|..++. .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3889999999999999999999998 99999999999999776 89999999998764
Q ss_pred CccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH--------Hhhc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN--------LWNE 759 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~--------~~~~ 759 (854)
.. .......|+..|+|||++.+ ..++.++|||||||++|||++|+.|+.........+...... ....
T Consensus 183 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CC---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 22 22334578999999999887 679999999999999999999999985433222222111110 0000
Q ss_pred CCc--------------ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 GKA--------------MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ~~~--------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ...................+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000111111223457889999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=338.10 Aligned_cols=263 Identities=20% Similarity=0.308 Sum_probs=198.9
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--------C
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--------G 603 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~ 603 (854)
++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6788999999999999999976 578999999986543 2335578899999999999999999999987 3
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
+..++||||+++ +|...+... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 565555432 235899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccC--cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 684 ARIFGFNQN--EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 684 a~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.... .......+.......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCC
Confidence 987643221 222344678999999999876 568999999999999999999999986432 122222222221111
Q ss_pred Cc---ccc-----cCC---CCCCCCC-HHH------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 KA---MEL-----VDP---NIRDSSS-QNQ------VLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ~~---~~~-----~d~---~l~~~~~-~~~------~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ... .+. ....... ... ...+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 000 000 0000000 111 234788999999999999999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=340.18 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=197.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-----cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-----QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
..++|.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999875 589999999865321 1234688999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 78777743 2345888999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
+... ........||+.|+|||++.+. .++.++|||||||++|||++|..|+.... .......+...........+
T Consensus 162 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTS
T ss_pred ccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHcCCCChhhh
Confidence 6422 2223346789999999998754 58999999999999999999998876432 12222222222111111111
Q ss_pred c------CC---CCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 003045 766 V------DP---NIRDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVLM 806 (854)
Q Consensus 766 ~------d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~ 806 (854)
. +. ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00 0000111 1223578899999999999999999999983
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.19 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=197.2
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~ 607 (854)
..|.+.++||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4577788999999999999975 46788999998754 23345678999999999999999999999875 35689
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCceecccCccee
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARI 686 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~ 686 (854)
+||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999984 3356899999999999999999999975 3599999999999998 789999999999975
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.. ........||+.|+|||++. +.++.++||||||+++|+|++|+.|+..... ..... .....+......
T Consensus 182 ~~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~-~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KR----ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIY-RRVTSGVKPASF 251 (290)
T ss_dssp CC----TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHH-HHHTTTCCCGGG
T ss_pred cc----ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----HHHHH-HHHhccCCcccc
Confidence 42 12233467899999999876 4589999999999999999999999864221 11111 111111111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+ ......+.+++.+||+.||++|||+.|+++
T Consensus 252 ~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 D--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 111246888999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.86 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=200.2
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc----ccCHHHHHHHHHHHHhcCCCceeeeeeeEE--eCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS----GQGLEEFKNEIILIAKLQHRNLVRLLGCCI--QGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~ 606 (854)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999864 68899999997542 344678999999999999999999999984 44578
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 55555432 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCcccccccccccccccceeeccCC--CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGL--FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.... ...+... ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~----i~~~~~-- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFEN----IGKGSY-- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH----HHHCCC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHH----HhcCCC--
Confidence 64333333344567899999999987644 4789999999999999999999986421 1111111 111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.+.... ...+.+++.+||+.||++|||+.|+++ .+...
T Consensus 231 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 111122 246778999999999999999999997 45554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.00 Aligned_cols=259 Identities=25% Similarity=0.329 Sum_probs=203.1
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l 608 (854)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367888999999999999999764 68999999997542 3345678999999999999999999998864 567899
Q ss_pred EEEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCC--CCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 609 IYEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDS--RLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... ........|++.|+|||++.+..++.++||||||+++|+|++|+.|+.... ...+...+ ..+...
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i----~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKI----REGKFR-- 234 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHTCCC--
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HHHHHHHH----hhcccc--
Confidence 65321 112234578999999999999999999999999999999999999986432 11222221 222211
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~ 809 (854)
.+.. .....+.+++.+||+.||++||++.||++.+..
T Consensus 235 ---~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 ---RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---cCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 223468889999999999999999999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=350.95 Aligned_cols=256 Identities=26% Similarity=0.331 Sum_probs=203.7
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
..++|.+.++||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999764 6899999998653 234567899999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc---cCCCceecccCccee
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMARI 686 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~ 686 (854)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999888743 346899999999999999999999998 99999999999995 456799999999986
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
+... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+...+ ..+.....
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i----~~~~~~~~- 242 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRV----ETGKYAFD- 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHTCCCSC-
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhCCCCCC-
Confidence 5322 22334679999999999875 59999999999999999999999986421 11222221 11111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.+ ........+.+++.+||+.||++|||+.|+++ .++..
T Consensus 243 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 243 LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp SG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred Cc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 00 00112346789999999999999999999998 35544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.00 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=186.3
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999764 68899999986542 33456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCc-----ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 610 YEYMPNKSLDLFIFDP-----AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12345899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccC---cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 685 RIFGFNQN---EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 685 ~~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... .... ......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLM---LTLQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHH---HHHTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHH---HHhccC
Confidence 76542211 112234578999999999876 56899999999999999999999998643221 1111 111111
Q ss_pred C--c-ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 K--A-MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ~--~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. . ....++......+ ..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0 1111222222222 46788999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.83 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=198.8
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcC--CCceeeeeeeEEe
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQ--HRNLVRLLGCCIQ 602 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~ 602 (854)
++.+....++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 334445567899999999999999999998889999999996542 334578899999999997 5999999999999
Q ss_pred CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 603 GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 603 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
.+..++||| +.+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 678899999853 346899999999999999999999998 999999999999964 889999999
Q ss_pred cceeccCccCcccccccccccccccceeecc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHH
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAME-----------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~ 751 (854)
++................||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~ 247 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----IS 247 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----HH
Confidence 9987643333233345678999999999875 46888999999999999999999998643221 11
Q ss_pred HHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 752 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....... +......+......+.+++.+||+.||++||++.|+++
T Consensus 248 ~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 KLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111 11111111111346788999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=342.22 Aligned_cols=269 Identities=20% Similarity=0.257 Sum_probs=199.3
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccccc-----------CHHHHHHHHHHHHhcCCCcee
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ-----------GLEEFKNEIILIAKLQHRNLV 594 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv 594 (854)
...++....++|.+.++||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456788889999999999999999999999888999999998653221 136789999999999999999
Q ss_pred eeeeeEEeC-----CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEE
Q 003045 595 RLLGCCIQG-----EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNIL 669 (854)
Q Consensus 595 ~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 669 (854)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999998 577777653 3346899999999999999999999998 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCch
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~ 748 (854)
++.++.+||+|||++..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--YN 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH
T ss_pred EcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--HH
Confidence 99999999999999985432 222334678999999999877 6799999999999999999999999864321 11
Q ss_pred HHHHHHHHhhcCCcc-----------cccCCCCCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 749 LIEHVWNLWNEGKAM-----------ELVDPNIRD-------SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 749 l~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+.......... ..+...+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 222221111111100 000000000 001112346788999999999999999999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.75 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=199.6
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
...++|++.+.||+|+||.||+|... +|+.||+|++... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999765 5899999999754 34577899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999852 2346899999999999999999999998 999999999999999999999999999876422
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
........|++.|+|||++.+..++.++||||||+++|+|++|+.|+..... .......... ....+.
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-~~~~~~---- 246 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MRAIFMIPTN-PPPTFR---- 246 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS-CCCCCS----
T ss_pred --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcC-CCcccC----
Confidence 1223345789999999999999999999999999999999999999863221 1111111111 111110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
........+.+++.+||+.||++|||+.|+++
T Consensus 247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11112356888999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.44 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=194.7
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67888999999999999999865 6899999999654 2345678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999999865322
Q ss_pred cCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|+.|+.... ...+...+ ..+.. .
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~----~~~~~------~ 229 (276)
T 2h6d_A 165 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKI----RGGVF------Y 229 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHCCC------C
T ss_pred ---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHh----hcCcc------c
Confidence 22234578999999999988765 689999999999999999999986421 11122211 11111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+... ....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IPEY----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cchh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111 1246788999999999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.73 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=195.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 604 (854)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999976 468999999986532 233567889999999999999999999997663
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++||||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899988843 45899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc-
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA- 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~- 762 (854)
+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.........
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHH
T ss_pred ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHH
Confidence 87532 2334678999999999887 6799999999999999999999999864321 1111111111110000
Q ss_pred -----------------ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 763 -----------------MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 763 -----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.......+ ..........+.+++.+||+.||++|||+.|+++ .++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 00000000 0011122346788999999999999999999998 45554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=349.74 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=197.9
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
..++|.+.++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999765 68899999997543 33467889999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC---CCceecccCccee
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED---MNPKISDFGMARI 686 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~ 686 (854)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999988874 3346899999999999999999999998 9999999999999764 4599999999987
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
+... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.... ...+...+ ..+... +.
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i----~~~~~~-~~ 257 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQEILRKV----EKGKYT-FD 257 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHTCCC-CC
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH----HhCCCC-CC
Confidence 6422 2233467999999999876 569999999999999999999999986422 11222222 111110 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~-~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPE-WKN----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGG-GTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chh-ccc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111 011 2246788999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=352.68 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=206.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
..++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578999999999999999999765 78999999996542 3457789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCcce
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMAR 685 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~ 685 (854)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999988853 345899999999999999999999998 9999999999999 567899999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
.+... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+...+ ..+....
T Consensus 178 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i----~~~~~~~- 246 (484)
T 3nyv_A 178 HFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKV----EKGKYTF- 246 (484)
T ss_dssp HBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHCCCCC-
T ss_pred Ecccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH----HcCCCCC-
Confidence 76322 22344679999999999876 69999999999999999999999986421 11222222 1111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
..+ ........+.+++.+||+.||++|||+.|+++ .++..
T Consensus 247 ~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 247 ELP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CSG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 000 00122346788999999999999999999997 44443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.15 Aligned_cols=253 Identities=11% Similarity=0.049 Sum_probs=181.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhc--CCCceeeee-------eeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKL--QHRNLVRLL-------GCCI 601 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~~~ 601 (854)
..|...++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888899999999999999854 789999999987532 3355678886555555 599988755 4443
Q ss_pred eC-----------------CeeEEEEEcCCCCChhhhhcCcccccCCCHHHH------HHHHHHHHHHHHHhhcCCCCce
Q 003045 602 QG-----------------EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKR------FAIIEGIARGLLYLHRDSRLRI 658 (854)
Q Consensus 602 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 658 (854)
.. ...++||||++ ++|.+++... ...+.+..+ +.++.||+.||+|||+.+ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 33799999999 8999998643 223455566 788899999999999998 9
Q ss_pred EEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCC
Q 003045 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGR 736 (854)
Q Consensus 659 vH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~ 736 (854)
+||||||+|||++.++.+||+|||+++..+. ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987531 1214567799999999987 77999999999999999999999
Q ss_pred CCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 737 RNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 737 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.||.......... +........................+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9987543211100 0000000011111111111123457888999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.19 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=186.2
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++|++.++||+|+||+||+|+. .+++.||+|++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47789999999999999999976 4789999999975422 22333455556688889999999999999999999999
Q ss_pred EcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 611 EYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||+++ +|.+++... .....+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99984 777766432 2345699999999999999999999997 7 9999999999999999999999999998753
Q ss_pred CccCcccccccccccccccceee----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYA----MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
.. .......||+.|+|||++ .+..++.++||||||+++|||++|+.|+.........+ .........
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~-- 232 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL----KQVVEEPSP-- 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH----HHHHHSCCC--
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH----HHHhccCCC--
Confidence 22 222335789999999996 56678999999999999999999999986432221111 111111111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 ----QLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----Ccc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 110 1112346788999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=351.39 Aligned_cols=242 Identities=14% Similarity=0.150 Sum_probs=189.1
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHH---HHHHhcCCCceeeee-------ee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEI---ILIAKLQHRNLVRLL-------GC 599 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~h~niv~l~-------~~ 599 (854)
.++|.+.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 46899999999743 334467889999 555666899999998 66
Q ss_pred EEeCC-----------------eeEEEEEcCCCCChhhhhcCccc----ccCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 003045 600 CIQGE-----------------EKMLIYEYMPNKSLDLFIFDPAK----QALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658 (854)
Q Consensus 600 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 658 (854)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55543 278999999 6899999854211 122446888899999999999999998 9
Q ss_pred EEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccC-----------CCCcccchhhHHH
Q 003045 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-----------LFSVKSDVYSFGV 727 (854)
Q Consensus 659 vH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~~~DVwSlGv 727 (854)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998642 12334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 728 LLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 728 il~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
++|||++|+.||....... ....+... .... ...+.+++.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~--------------~~~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG--------------GSEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------C--------------CSGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccccc--------------chhhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999986322110 01111110 0122 246788999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.63 Aligned_cols=199 Identities=24% Similarity=0.394 Sum_probs=166.2
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Ce
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 605 (854)
.++|.+.++||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999754 5889999999753 223456789999999999999999999999776 57
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 589888843 345899999999999999999999998 9999999999999999999999999999
Q ss_pred eccCccCc--------------------ccccccccccccccceee-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 686 IFGFNQNE--------------------ANTNRVVGTYGYMAPEYA-MEGLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 686 ~~~~~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76432211 123457899999999986 5667999999999999999999865554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=351.41 Aligned_cols=195 Identities=25% Similarity=0.420 Sum_probs=153.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Ce
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 605 (854)
.++|++.++||+|+||+||+|... +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999754 6899999999653 223456789999999999999999999998543 56
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 678888743 345899999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccCc-------------------------ccccccccccccccceee-ccCCCCcccchhhHHHHHHHHHhC
Q 003045 686 IFGFNQNE-------------------------ANTNRVVGTYGYMAPEYA-MEGLFSVKSDVYSFGVLLLEIVSG 735 (854)
Q Consensus 686 ~~~~~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~~DVwSlGvil~elltG 735 (854)
........ ......+||+.|+|||++ ....|+.++||||||||+|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422111 123346789999999986 566799999999999999999994
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.76 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=200.3
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
...++|.+.+.||+|+||.||+|+..+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345788999999999999999998743 59999986542 33456688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999998542 335889999999999999999999998 99999999999998 67999999999876532
Q ss_pred cc---Ccccccccccccccccceeecc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 690 NQ---NEANTNRVVGTYGYMAPEYAME---------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 690 ~~---~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
.. .........|++.|+|||++.+ ..++.++||||||+++|||++|+.|+..... .... .. .
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~---~~-~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAII---WQ-M 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--HHHH---HH-H
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HH-h
Confidence 11 1122334568999999999874 4578899999999999999999999864221 1111 11 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCCC
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPV 816 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~~ 816 (854)
..+........ .. ...+.+++.+|++.||++|||+.|++++|+.+......
T Consensus 256 ~~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 256 GTGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HTTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred ccCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 12111111111 11 23578899999999999999999999999998654433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=363.65 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=204.4
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (854)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567999999999999999999765 5888999999753 234566788999999988 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999853 346899999999999999999999998 999999999999999999999999999864
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.. .........||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+...+ ... ..
T Consensus 493 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i---~~~-~~----- 559 (674)
T 3pfq_A 493 IW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSI---MEH-NV----- 559 (674)
T ss_dssp CC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH---HSS-CC-----
T ss_pred cc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--CHHHHHHHH---HhC-CC-----
Confidence 32 222344578999999999999999999999999999999999999998642 212222222 111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM-----ASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~eVl~ 805 (854)
. .+......+.+++.+||+.||++||++ +||++
T Consensus 560 -~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -C----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -C----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 111223568889999999999999997 77764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=349.37 Aligned_cols=256 Identities=27% Similarity=0.342 Sum_probs=202.2
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc-------------cCHHHHHHHHHHHHhcCCCceeeeee
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG-------------QGLEEFKNEIILIAKLQHRNLVRLLG 598 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~~ 598 (854)
..++|.+.++||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999765 578999999875421 34577899999999999999999999
Q ss_pred eEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC---C
Q 003045 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM---N 675 (854)
Q Consensus 599 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~ 675 (854)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999888843 346899999999999999999999998 99999999999999776 6
Q ss_pred ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 676 PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 676 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
+||+|||++..+... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||.... ...+...+
T Consensus 188 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i-- 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQDIIKKV-- 259 (504)
T ss_dssp EEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH--
T ss_pred EEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH--
Confidence 999999999876422 2234467999999999886 469999999999999999999999986422 11222222
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
..+.... +...... ....+.+++.+||+.||.+|||++|+++ .+...
T Consensus 260 --~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 260 --EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp --HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred --HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1111100 0000011 1246888999999999999999999987 34443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.53 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=196.1
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--------ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--------GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG 603 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 603 (854)
..++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999764 58899999986532 12234688999999999999999999998765
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISD 680 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~D 680 (854)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999998843 346899999999999999999999998 999999999999987664 99999
Q ss_pred cCcceeccCccCcccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||...... ..+...+.
T Consensus 161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~--- 233 (322)
T 2ycf_A 161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQIT--- 233 (322)
T ss_dssp CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHH---
T ss_pred Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHH---
Confidence 9999876321 1223467899999999974 567899999999999999999999998643322 12222221
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+.... .+.... .....+.+++.+||+.||++||++.|+++
T Consensus 234 -~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 -SGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 000001 12346888999999999999999999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=345.15 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=198.0
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe------eE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE------KM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------~~ 607 (854)
..+|.+.++||+|+||+||+|+...+..+|+|++..... ...+|++++++++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357889999999999999999987777899998865422 22479999999999999999999965443 78
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCceecccCccee
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARI 686 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~ 686 (854)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998765554432333456899999999999999999999998 99999999999999 799999999999987
Q ss_pred ccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC-----
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG----- 760 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 760 (854)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 192 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred ccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 6322 222346789999999998765 599999999999999999999999874321 11111111111110
Q ss_pred -----CcccccCCCCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 761 -----KAMELVDPNIRD-----SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 761 -----~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
...+..-+.... .........+.+++.+||+.||++|||+.|+++ .++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 000000011110 011112347889999999999999999999997 34443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.18 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=204.1
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccC-----------------HHHHHHHHHHHHhcCCCceeee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQG-----------------LEEFKNEIILIAKLQHRNLVRL 596 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~h~niv~l 596 (854)
.++|.+.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36789999999999999999998 89999999997542211 1789999999999999999999
Q ss_pred eeeEEeCCeeEEEEEcCCCCChhhh------hcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEE
Q 003045 597 LGCCIQGEEKMLIYEYMPNKSLDLF------IFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNIL 669 (854)
Q Consensus 597 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIL 669 (854)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+|+||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 124569999999999999999999999 87 999999999999
Q ss_pred EccCCCceecccCcceeccCccCcccccccccccccccceeeccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCcccCc
Q 003045 670 LDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSV-KSDVYSFGVLLLEIVSGRRNTSFRLEENS 747 (854)
Q Consensus 670 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-~~DVwSlGvil~elltG~~p~~~~~~~~~ 747 (854)
++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|||++|+.|+...... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~ 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-V 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-H
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-H
Confidence 999999999999999875322 33446789999999999877 6766 999999999999999999998743221 1
Q ss_pred hHHHHHHHHhhcCCccccc------CCCCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 748 SLIEHVWNLWNEGKAMELV------DPNIR---DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 748 ~l~~~~~~~~~~~~~~~~~------d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+... ...+...... .+... ..........+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22222 1222111000 00000 0001223357889999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=344.65 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=205.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH-RNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||.||+|+. .+++.||||++.... ..+++.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999975 568999999876543 23468899999999987 566666777778888999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---ccCCCceecccCcceecc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFG 688 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 688 (854)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 345899999999999999999999998 9999999999999 688999999999999875
Q ss_pred CccCcc-----cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC-chHHHHHHHHhhcCCc
Q 003045 689 FNQNEA-----NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN-SSLIEHVWNLWNEGKA 762 (854)
Q Consensus 689 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~ 762 (854)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ......+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 332211 1235679999999999999999999999999999999999999997533221 1222222111111111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+ ...+ ...+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 238 ~~l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EAL-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 0111 24788999999999999999999999998775
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.40 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=198.6
Q ss_pred HHHHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe--
Q 003045 527 FNTIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ-- 602 (854)
Q Consensus 527 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-- 602 (854)
..++....++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445678899999999999999999976 468999999986543 3457889999999999 79999999999987
Q ss_pred ----CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 603 ----GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 603 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 46789999999999999998643 2346899999999999999999999998 999999999999999999999
Q ss_pred cccCcceeccCccCcccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHH
Q 003045 679 SDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753 (854)
Q Consensus 679 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~ 753 (854)
+|||++...... ........||+.|+|||++. +..++.++||||||+++|+|++|+.|+..... ....
T Consensus 171 ~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~ 243 (326)
T 2x7f_A 171 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRAL 243 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHH
T ss_pred eeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHH
Confidence 999999865321 12233457899999999987 56789999999999999999999999853211 1111
Q ss_pred HHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 754 WNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 754 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...... ...... .... ...+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~-~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPRN-PAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHS-CCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhcC-ccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 111111 1112 246788999999999999999999988
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=323.98 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=202.4
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---------ccCHHHHHHHHHHHHhcC-CCceeeeeeeEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---------GQGLEEFKNEIILIAKLQ-HRNLVRLLGCCI 601 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 601 (854)
..++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478899999999999999999765 68999999996542 122456789999999996 999999999999
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
..+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999843 346899999999999999999999998 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeec------cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAM------EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
|++...... .......|++.|+|||++. ...++.++||||||+++|||++|+.|+..... ......+
T Consensus 169 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~-- 241 (298)
T 1phk_A 169 GFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMI-- 241 (298)
T ss_dssp TTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH--
T ss_pred cchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHH--
Confidence 999876422 2233467899999999985 45688999999999999999999999864211 1111111
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+... ...+ ........+.+++.+||+.||++|||+.|+++
T Consensus 242 --~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 --MSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --hcCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111110 0001 11123356889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.22 Aligned_cols=261 Identities=22% Similarity=0.243 Sum_probs=199.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC--------CCceeeeeeeEE---
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ--------HRNLVRLLGCCI--- 601 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~--- 601 (854)
.++|.+.++||+|+||+||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999975 46889999999643 334567889999999996 788999999987
Q ss_pred -eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCC-----
Q 003045 602 -QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDM----- 674 (854)
Q Consensus 602 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~----- 674 (854)
.....++||||+.+ +|..++... ....+++..+..++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 45678999999955 454444322 224589999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CceecccCcceeccCccCccccccccccccccccee
Q 003045 675 --------------------------------------------NPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710 (854)
Q Consensus 675 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~ 710 (854)
.+||+|||++..... ......||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChh
Confidence 899999999987632 2234578999999999
Q ss_pred eccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCc----hHHHHHHHHhhcC--------C-cccccCCC--C-----
Q 003045 711 AMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS----SLIEHVWNLWNEG--------K-AMELVDPN--I----- 770 (854)
Q Consensus 711 ~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~----~l~~~~~~~~~~~--------~-~~~~~d~~--l----- 770 (854)
+.+..++.++|||||||++|||++|+.||........ .....+....... . ........ +
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999975432211 1111111111110 0 00000000 0
Q ss_pred ------------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 ------------RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+......+.+++.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234566778999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.20 Aligned_cols=258 Identities=23% Similarity=0.293 Sum_probs=192.0
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------eeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------EKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~ 607 (854)
.+|...++||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999875 58999999986532 22347999999999999999999986432 367
Q ss_pred EEEEcCCCCChhhhhcC-cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccCcce
Q 003045 608 LIYEYMPNKSLDLFIFD-PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMAR 685 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~ 685 (854)
+||||++++ |..++.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 999999874 4444422 223456899999999999999999999998 9999999999999965 568999999998
Q ss_pred eccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc-----
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE----- 759 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~----- 759 (854)
.+... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.+.+ .....
T Consensus 206 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~-~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEII-KVLGTPTREQ 280 (420)
T ss_dssp ECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH-HHHCSCCHHH
T ss_pred hcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-HHhCCCCHHH
Confidence 76422 122346789999999998764 799999999999999999999999874321 11222221 11111
Q ss_pred -----CCcccccCCCCCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 -----GKAMELVDPNIRDS-----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 -----~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....++.-+.+... ........+.+++.+||+.||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11111111111110 11122357889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.03 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=194.7
Q ss_pred HHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 003045 531 AVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------ 603 (854)
Q Consensus 531 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 603 (854)
+...++|.+.++||+|+||+||+|+. .+++.||||++..... ...+|++++++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999975 5789999999865422 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEcCCCCChhhhhcCc-ccccCCCHHHHHHHHHHHHHHHHHh
Q 003045 604 --------------------------------EEKMLIYEYMPNKSLDLFIFDP-AKQALLDWTKRFAIIEGIARGLLYL 650 (854)
Q Consensus 604 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL 650 (854)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 4777666432 2345699999999999999999999
Q ss_pred hcCCCCceEEcccCCCcEEEc-cCCCceecccCcceeccCccCcccccccccccccccceeeccC-CCCcccchhhHHHH
Q 003045 651 HRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVL 728 (854)
Q Consensus 651 H~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvi 728 (854)
|+.+ |+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999998 6889999999999876322 223345789999999998765 49999999999999
Q ss_pred HHHHHhCCCCCCCCcccCchHHHHHHHHhhcC----------CcccccCCCCCC-----CCCHHHHHHHHHHHhhccCCC
Q 003045 729 LLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG----------KAMELVDPNIRD-----SSSQNQVLRCIHVGMLCVQDS 793 (854)
Q Consensus 729 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~d 793 (854)
+|||++|+.||..... ......+....... ...+..-+.+.. ..+......+.+++.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999874321 11122221111111 011111111110 011123346889999999999
Q ss_pred CCCCCCHHHHHH
Q 003045 794 AMYRPTMASVVL 805 (854)
Q Consensus 794 p~~RPs~~eVl~ 805 (854)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=335.08 Aligned_cols=274 Identities=19% Similarity=0.218 Sum_probs=193.5
Q ss_pred HHHHHHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe-
Q 003045 528 NTIAVATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE- 605 (854)
Q Consensus 528 ~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~- 605 (854)
.......++|.+.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999864 68999999986543 334566788999999999999999999976443
Q ss_pred ------eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhh--cCCCCceEEcccCCCcEEEcc-CCCc
Q 003045 606 ------KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH--RDSRLRIIHRDLKASNILLDE-DMNP 676 (854)
Q Consensus 606 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~~ 676 (854)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999997544333322234456889999999999999999999 777 999999999999997 8999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..
T Consensus 172 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--AGQLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred EEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh--HHHHHHHHH
Confidence 99999999876422 222345789999999998665 489999999999999999999999864321 112222211
Q ss_pred HhhcC------------CcccccCCC------CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 756 LWNEG------------KAMELVDPN------IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 756 ~~~~~------------~~~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
..... ......+.. ............+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 11110 000000000 001111223567889999999999999999999997 34544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.61 Aligned_cols=266 Identities=25% Similarity=0.365 Sum_probs=182.9
Q ss_pred hcCccc-CcccccCCcccEEEeEcC---CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCeeE
Q 003045 534 TNYFSE-GNKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEKM 607 (854)
Q Consensus 534 ~~~f~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~ 607 (854)
.+.|++ +++||+|+||+||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345655 568999999999999854 5789999999653 234578899999999999999999999965 66889
Q ss_pred EEEEcCCCCChhhhhcCc------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE----ccCCCce
Q 003045 608 LIYEYMPNKSLDLFIFDP------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL----DEDMNPK 677 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~k 677 (854)
+||||+++ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 666665321 12224899999999999999999999998 9999999999999 6788999
Q ss_pred ecccCcceeccCccC-cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCccc-------Cch
Q 003045 678 ISDFGMARIFGFNQN-EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE-------NSS 748 (854)
Q Consensus 678 l~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~-------~~~ 748 (854)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643211 122345689999999999987 45999999999999999999999999643221 011
Q ss_pred HHHHHHHHhhcCCcccccCC---------------CCCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003045 749 LIEHVWNLWNEGKAMELVDP---------------NIRDSSSQ---------NQVLRCIHVGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 749 l~~~~~~~~~~~~~~~~~d~---------------~l~~~~~~---------~~~~~l~~l~~~Cl~~dp~~RPs~~eVl 804 (854)
....+...........+.+. ........ .....+.+++.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 12222222111100000000 00000000 0024677899999999999999999999
Q ss_pred H
Q 003045 805 L 805 (854)
Q Consensus 805 ~ 805 (854)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 8
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.82 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=199.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~ 606 (854)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999754 68899999997543 23346789999999999999999999999765 368
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||++ ++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 48888873 235899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCc-ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 687 FGFNQNE-ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 687 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG--GGHHHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHHHhCCCCHHH
Confidence 6432221 12344689999999998754 4589999999999999999999999864321 222222222111110000
Q ss_pred -----------c-cCCCCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 -----------L-VDPNIRDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 -----------~-~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. .......... ......+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000000 112246789999999999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.00 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=192.4
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe---------
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--------- 602 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 602 (854)
..++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356789999999999999999985 47899999999643 3445778999999999999999999998865
Q ss_pred ----CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCcee
Q 003045 603 ----GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKI 678 (854)
Q Consensus 603 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 678 (854)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 35678999999999999998642 234788999999999999999999998 999999999999999999999
Q ss_pred cccCcceeccCccC------------cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCccc
Q 003045 679 SDFGMARIFGFNQN------------EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE 745 (854)
Q Consensus 679 ~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~ 745 (854)
+|||++........ ........||+.|+|||++.+. .++.++||||||+++|||++ |+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 99999987542210 1122345789999999999864 78999999999999999998 332111
Q ss_pred CchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 746 NSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 746 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...... ...... ...............+.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 --ERVNIL-KKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHH-HHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hHHHHH-Hhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111 111111 111112222333456788999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=342.28 Aligned_cols=198 Identities=23% Similarity=0.286 Sum_probs=170.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhc------CCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKL------QHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~~~ 606 (854)
..+|++.++||+|+||+||+|... +++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999654 5899999999653 23346778899998888 467999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC--ceecccCcc
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN--PKISDFGMA 684 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla 684 (854)
++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 58888775432 234899999999999999999999998 999999999999999887 999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~ 742 (854)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7643 1223467899999999999999999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.06 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=200.6
Q ss_pred HhcCcccCcccccCCcccEEEeEc--CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhc---CCCceeeeeeeEE----
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL--PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKL---QHRNLVRLLGCCI---- 601 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~---- 601 (854)
+.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999986 468899999986542 22334677888888777 8999999999987
Q ss_pred -eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecc
Q 003045 602 -QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISD 680 (854)
Q Consensus 602 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 680 (854)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 68988885432 234899999999999999999999998 99999999999999999999999
Q ss_pred cCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 681 FGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 681 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
||++...... .......||..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......
T Consensus 164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCC
Confidence 9999865321 223346789999999999999999999999999999999999999864321 12222222211111
Q ss_pred Ccccc----------cC---CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 KAMEL----------VD---PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ~~~~~----------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+ .. ..............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00 00000111123356788999999999999999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=333.06 Aligned_cols=258 Identities=23% Similarity=0.255 Sum_probs=190.1
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 604 (854)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36789999999999999999975 468899999997532 234567889999999999999999999997665
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999985 6766663 24889999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH--------
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL-------- 756 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~-------- 756 (854)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 175 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHC-CCCCCHHH
T ss_pred ccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 86532 1223346789999999999999999999999999999999999999864321 1111111000
Q ss_pred -----------hhcC-Cc-----ccccCCCCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 -----------WNEG-KA-----MELVDPNIRDS---SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 -----------~~~~-~~-----~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... .. ........... ........+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 00 00000000000 11223567889999999999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.80 Aligned_cols=266 Identities=21% Similarity=0.283 Sum_probs=194.6
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEE-----------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCI----------- 601 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~----------- 601 (854)
.++|.+.++||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367889999999999999999865 48999999998766666788999999999999999999999873
Q ss_pred ---eCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCce
Q 003045 602 ---QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPK 677 (854)
Q Consensus 602 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 677 (854)
+....++||||++ ++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 68988883 245889999999999999999999998 99999999999997 567899
Q ss_pred ecccCcceeccCccC-cccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 678 ISDFGMARIFGFNQN-EANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 678 l~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
|+|||++........ ........+|..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--LEQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 999999987642211 122334567899999998865 6799999999999999999999999864321 111111111
Q ss_pred Hhhc----------CCcccccCCCCC-CC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhc
Q 003045 756 LWNE----------GKAMELVDPNIR-DS-----SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLES 809 (854)
Q Consensus 756 ~~~~----------~~~~~~~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~ 809 (854)
.... ......+..... .. ........+.+++.+||+.||++|||++|+++ .+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 0000 000000000000 00 00112356889999999999999999999987 4544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.31 Aligned_cols=257 Identities=25% Similarity=0.302 Sum_probs=182.6
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------C
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------E 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 604 (854)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999974 56899999998653 223456788999999999999999999998754 5
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
..++|+||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6888888742 45899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc-
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA- 762 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~- 762 (854)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.........
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHH
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHH
Confidence 86532 2334678999999999887 6799999999999999999999999864321 1222222221111100
Q ss_pred ----------ccccCCCC-CCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 ----------MELVDPNI-RDSSSQ-----NQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ----------~~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+.... ...... .....+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 000000 11246788999999999999999999997
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.33 Aligned_cols=252 Identities=26% Similarity=0.324 Sum_probs=201.7
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
...++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 45578999999999999999999765 68999999986542 3456789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC---CCceecccCcce
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED---MNPKISDFGMAR 685 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~ 685 (854)
||||+++++|.+++.. ...+++.++..++.||+.||.|||+.+ ++|+||||+|||++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888743 345899999999999999999999998 9999999999999764 469999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... .......|++.|+|||++.+ .++.++||||||+++|+|++|+.|+.... ...+... ...+....
T Consensus 173 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~----~~~~~~~~- 241 (287)
T 2wei_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKR----VETGKYAF- 241 (287)
T ss_dssp TBCCC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHH----HHHCCCCC-
T ss_pred eecCC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHH----HHcCCCCC-
Confidence 65322 12233568999999998865 48999999999999999999999986421 1112221 11211110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+...... ....+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 -DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000011 2246788999999999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.83 Aligned_cols=259 Identities=21% Similarity=0.237 Sum_probs=201.8
Q ss_pred hcCcccCcccccCCcccEEEeEc--CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc------eeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL--PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN------LVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~ 605 (854)
.++|++.++||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46889999999999999999975 36889999998643 234567889999999997654 9999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-------------
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE------------- 672 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~------------- 672 (854)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889988885432 235889999999999999999999998 999999999999987
Q ss_pred ------CCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC
Q 003045 673 ------DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN 746 (854)
Q Consensus 673 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~ 746 (854)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 239 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-- 239 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH--
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--
Confidence 67899999999986432 22346789999999999999999999999999999999999999874321
Q ss_pred chHHHHHHHHhhcC--------Cccccc---------------------CCC-CCCCCCHHHHHHHHHHHhhccCCCCCC
Q 003045 747 SSLIEHVWNLWNEG--------KAMELV---------------------DPN-IRDSSSQNQVLRCIHVGMLCVQDSAMY 796 (854)
Q Consensus 747 ~~l~~~~~~~~~~~--------~~~~~~---------------------d~~-l~~~~~~~~~~~l~~l~~~Cl~~dp~~ 796 (854)
......+....... ...... .+. ............+.+++.+||+.||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11111111111100 000000 000 001122345678899999999999999
Q ss_pred CCCHHHHHH
Q 003045 797 RPTMASVVL 805 (854)
Q Consensus 797 RPs~~eVl~ 805 (854)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=332.24 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=199.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~ 606 (854)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999764 68999999996432 23355788999999999999999999988764 678
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588888742 45899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCcc--------cccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 687 FGFNQNEA--------NTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 687 ~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RHQLLLIFGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHh
Confidence 64321111 1223578999999998764 6799999999999999999999999864321 11111111111
Q ss_pred hcCCccc------------ccCCC-CCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 758 NEGKAME------------LVDPN-IRDSS-----SQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 758 ~~~~~~~------------~~d~~-l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
....... .+... ..... .......+.+++.+||+.||++|||+.|+++ .++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 1110000 00000 00000 0112346788999999999999999999998 45544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=340.37 Aligned_cols=253 Identities=24% Similarity=0.292 Sum_probs=187.7
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 455667889999999998776668999999998653 345678999999987 8999999999999999999999999
Q ss_pred CCCChhhhhcCccccc----CCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-------------CCc
Q 003045 614 PNKSLDLFIFDPAKQA----LLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-------------MNP 676 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~ 676 (854)
. |+|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986532211 1133356789999999999999998 9999999999999754 479
Q ss_pred eecccCcceeccCccCcc--cccccccccccccceeecc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCcccC
Q 003045 677 KISDFGMARIFGFNQNEA--NTNRVVGTYGYMAPEYAME-------GLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEEN 746 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-------~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~ 746 (854)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|+.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875332211 2234679999999999975 678999999999999999999 898886322111
Q ss_pred chHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 747 SSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 747 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+ .... . . .+.............+.+++.+||+.||++|||+.||++
T Consensus 248 ----~~i---~~~~-~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNI---IRGI-F-S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHH---HHTC-C-C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHH---hcCC-C-C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 1110 0 0 011111223456678899999999999999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.82 Aligned_cols=217 Identities=14% Similarity=0.193 Sum_probs=168.8
Q ss_pred cccccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEE
Q 003045 30 RAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVL 109 (854)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~ 109 (854)
++.|+|.+|++|.+|++| ++|.|+|||+.+++. ++|.. +++||+|||+.| ..++|+|+.||||||+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl------~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL------VLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE------EEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE------EEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 567999999999999999 599999999866651 23442 799999999988 5689999999999999
Q ss_pred cCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCc-CCCCeEeEEe-cCCC-----ceeE
Q 003045 110 NGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTH-LPGMRVGVNS-ALGE-----NRVF 182 (854)
Q Consensus 110 ~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtl-lpg~kl~~~~-~~g~-----~~~L 182 (854)
|++|.+||+|++........|+|+|+|||||++. ++||||||||||+ |||| |.+. ..|+ ++.|
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~--------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L 141 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTL 141 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEE
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC--------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceE
Confidence 9999999999986544557899999999999842 6999999999887 6665 5554 4444 5678
Q ss_pred EeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCCCcceeeecccccccccccceeeeeccCCCCCceEEEEEec
Q 003045 183 TSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSVIFTGVPTMATLTSFLFGFKLSPRESDGSMYFTYVPA 262 (854)
Q Consensus 183 ~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (854)
++ .+||++|.|+|+++++| +++++++...||++++|++. +.+.+.+....+. + .+.. ++++++.+|...
T Consensus 142 ~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~--ly~~--~~~~vw~s~~~~ 210 (236)
T 1dlp_A 142 HA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-D--VLTN--QNIAVWTSGNSR 210 (236)
T ss_dssp CS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-E--EEET--TTEEEEECCCCC
T ss_pred Ec---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-E--EEeC--CCcEEEEeCCCC
Confidence 74 78999999999999999 78889888899999999754 5555665433211 1 1111 334555555444
Q ss_pred CCceEEEEEEeecCcEEEEE
Q 003045 263 NASYLLRFRIGWDGNEEQLR 282 (854)
Q Consensus 263 ~~~~~~r~~L~~~G~l~~~~ 282 (854)
.. ...|++|++||++++|.
T Consensus 211 ~~-~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 211 SA-GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SS-SCCEEEECSSSCEEEEC
T ss_pred CC-CCEEEEEcCCCcEEEeC
Confidence 33 46899999999999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=356.32 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=202.0
Q ss_pred HHhcCcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
...++|.+.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345778899999999999999997532 4579999986542 334577899999999999999999999984 5678
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999998532 335899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||.... .......+. .+...
T Consensus 541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i~----~~~~~-- 611 (656)
T 2j0j_A 541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIE----NGERL-- 611 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHH----HTCCC--
T ss_pred cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHH----cCCCC--
Confidence 64221 112233456789999999999999999999999999999997 888876321 112222221 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.. +......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 612 ---~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ---PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ---CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 112235788899999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=328.28 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=177.8
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEII-LIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++|...+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888999999999999999764 68999999997542 233445566666 777889999999999999999999999
Q ss_pred EcCCCCChhhhhcCc--ccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 611 EYMPNKSLDLFIFDP--AKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 776666421 1245689999999999999999999998 7 999999999999999999999999999865
Q ss_pred cCccCcccccccccccccccceee----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYA----MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 763 (854)
... .......||+.|+|||++ .+..++.++||||||+++|||++|+.|+...... .+... ...
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~------~~~ 243 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV----FDQLT------QVV 243 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------C------CCC
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH----HHHHH------HHh
Confidence 322 122334789999999998 4667899999999999999999999998642111 01100 000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 764 ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 764 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
....+.+...........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111111111123357888999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.68 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=194.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee----
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK---- 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~---- 606 (854)
.++|...++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468889999999999999999754 68999999997542 23356788999999999999999999999877655
Q ss_pred --EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 607 --MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 607 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
++||||++ ++|..++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57777662 23899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 763 (854)
+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+........ .
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~-~ 263 (371)
T 4exu_A 192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPG-T 263 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC-H
T ss_pred ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCc-H
Confidence 86532 2334678999999999887 7899999999999999999999999864221 111111111111000 0
Q ss_pred cc---------------cCCCCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 764 EL---------------VDPNIRDS---SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 764 ~~---------------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+. +....... ........+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 00000000 00112357889999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=327.62 Aligned_cols=201 Identities=24% Similarity=0.323 Sum_probs=169.7
Q ss_pred HHhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CC-----ceeeeeeeEEeCC
Q 003045 532 VATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HR-----NLVRLLGCCIQGE 604 (854)
Q Consensus 532 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~~~ 604 (854)
...++|.+.++||+|+||+||+|... +++.||||++... ....+++..|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999754 6889999999643 233567788999999885 55 4999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc--cCCCceecccC
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD--EDMNPKISDFG 682 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFG 682 (854)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+|||++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 48888885432 234899999999999999999999531 2399999999999995 57889999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSF 741 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~ 741 (854)
+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 207 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 207 SSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9987632 22346789999999999999999999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.89 Aligned_cols=258 Identities=19% Similarity=0.186 Sum_probs=174.4
Q ss_pred HhcCcccC-cccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCee
Q 003045 533 ATNYFSEG-NKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEK 606 (854)
Q Consensus 533 ~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 606 (854)
..++|.+. +.||+|+||+||+|... +++.||||++... .....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 34678774 46999999999999765 6899999998642 1222233344667799999999999976 4458
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccCc
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFGM 683 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGl 683 (854)
++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986532 246899999999999999999999998 999999999999986 45599999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 763 (854)
+..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .............
T Consensus 178 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~-- 249 (336)
T 3fhr_A 178 AKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA--ISPGMKRRIRLGQ-- 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh--hhhhHHHhhhccc--
Confidence 986532 22334678999999999998899999999999999999999999986432211 1000000000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 764 ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 764 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
..............+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00000011122346788999999999999999999998 55543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.89 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=201.8
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-----------CCceeeeeeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-----------HRNLVRLLGCCI 601 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~ 601 (854)
.++|.+.++||+|+||+||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36788999999999999999975 56899999998643 234567889999999887 889999999998
Q ss_pred eCC----eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEcc----
Q 003045 602 QGE----EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDE---- 672 (854)
Q Consensus 602 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~---- 672 (854)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. + |+||||||+|||++.
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 889999885432 23489999999999999999999998 8 999999999999953
Q ss_pred --CCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCccc----C
Q 003045 673 --DMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEE----N 746 (854)
Q Consensus 673 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~----~ 746 (854)
.+.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 34799999999987632 223457899999999999999999999999999999999999998743211 1
Q ss_pred chHHHHHHHHhhcC--------C-----------cccccCCC---------CCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 003045 747 SSLIEHVWNLWNEG--------K-----------AMELVDPN---------IRDSSSQNQVLRCIHVGMLCVQDSAMYRP 798 (854)
Q Consensus 747 ~~l~~~~~~~~~~~--------~-----------~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 798 (854)
......+....... . ...+.... -....+......+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111111111100 0 00000000 01124456778899999999999999999
Q ss_pred CHHHHHH--HHhcc
Q 003045 799 TMASVVL--MLESE 810 (854)
Q Consensus 799 s~~eVl~--~L~~~ 810 (854)
|++|+++ .+.+.
T Consensus 327 t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 DAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHhhChhhhcc
Confidence 9999998 44443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=324.86 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=190.2
Q ss_pred HHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc------cCHHHHHHHHHHHHhc----CCCceeeeee
Q 003045 530 IAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG------QGLEEFKNEIILIAKL----QHRNLVRLLG 598 (854)
Q Consensus 530 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l----~h~niv~l~~ 598 (854)
.+...++|.+.++||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345668899999999999999999975 4688999999975432 1234566899999999 8999999999
Q ss_pred eEEeCCeeEEEEEc-CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCc
Q 003045 599 CCIQGEEKMLIYEY-MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNP 676 (854)
Q Consensus 599 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 676 (854)
++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 899999999853 345899999999999999999999998 99999999999999 88999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCC-cccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFS-VKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~ 755 (854)
||+|||++...... ......|+..|+|||++.+..+. .++||||||+++|||++|+.|+.... + +
T Consensus 180 kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~-~-- 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E-I-- 245 (312)
T ss_dssp EECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H-H--
T ss_pred EEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H-H--
Confidence 99999999876422 23345789999999999877664 58999999999999999999986310 1 1
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... . ..+... ....+.+++.+||+.||++|||+.|+++
T Consensus 246 -~~~-~------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -LEA-E------LHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHT-C------CCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hhh-c------cCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 011111 2346788999999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.44 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=194.3
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe-----
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE----- 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 605 (854)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888999999999999999764 68999999996542 2235678899999999999999999999987654
Q ss_pred -eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 606 -KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 606 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
.++||||++ ++|..++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 57877762 23899999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC--
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK-- 761 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 761 (854)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+........
T Consensus 174 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGTE 246 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBCCHH
T ss_pred cCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHH
Confidence 86432 1234578999999999877 6789999999999999999999999864321 111111111110000
Q ss_pred ----------------cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 ----------------AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
......+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 0111123457889999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=325.41 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=198.9
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccccc------CHHHHHHHHHHHHhcC--CCceeeeeee
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQ------GLEEFKNEIILIAKLQ--HRNLVRLLGC 599 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~~~ 599 (854)
+.+...++|.+.++||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3444567899999999999999999974 56899999999764321 2356778999999996 5999999999
Q ss_pred EEeCCeeEEEEEcCCC-CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCce
Q 003045 600 CIQGEEKMLIYEYMPN-KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPK 677 (854)
Q Consensus 600 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 677 (854)
+.+.+..++|||++.+ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999986 899998843 456899999999999999999999998 99999999999999 788999
Q ss_pred ecccCcceeccCccCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH
Q 003045 678 ISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756 (854)
Q Consensus 678 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~ 756 (854)
|+|||++..... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.... . .
T Consensus 191 L~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~-~--- 255 (320)
T 3a99_A 191 LIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E-I--- 255 (320)
T ss_dssp ECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H-H---
T ss_pred EeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------h-h---
Confidence 999999987642 22234578999999999987765 678999999999999999999986321 0 0
Q ss_pred hhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 757 WNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 757 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... .. ...... ...+.+++.+||+.||++|||+.||++
T Consensus 256 ~~~-~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRG-QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHC-CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcc-cc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 00 011122 246788999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=320.60 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=178.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc--cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG--QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999865 689999999975432 12233445556788889999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+ ++.+..+... ....+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455444421 234689999999999999999999985 7 99999999999999999999999999976532
Q ss_pred ccCcccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
. .......||+.|+|||++. ...++.++||||||+++|||++|+.|+...... .+......... ...
T Consensus 178 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~-~~~ 249 (318)
T 2dyl_A 178 D---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----FEVLTKVLQEE-PPL 249 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHHHHHSC-CCC
T ss_pred C---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----HHHHHHHhccC-CCC
Confidence 2 2233457899999999984 566889999999999999999999998642221 11111221111 111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+.. ... ....+.+++.+||+.||++||++.|+++
T Consensus 250 ~~~---~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPG---HMG----FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCS---SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCc---cCC----CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 100 011 2246788999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.75 Aligned_cols=259 Identities=19% Similarity=0.230 Sum_probs=197.9
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CC-cEEEEEEeccccccCHHHHHHHHHHHHhcCCCc------eeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EG-QDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN------LVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~ 605 (854)
.++|.+.++||+|+||+||+|... ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999754 34 68999998643 234567889999999998766 8999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE---------------
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL--------------- 670 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--------------- 670 (854)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55555555332 2235899999999999999999999998 9999999999999
Q ss_pred ----ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC
Q 003045 671 ----DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN 746 (854)
Q Consensus 671 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~ 746 (854)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN-- 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--
Confidence 6788999999999986432 22346789999999999999999999999999999999999999874321
Q ss_pred chHHHHHHHHhhcC--------Cccc-ccCCC---------------------CCCCCCHHHHHHHHHHHhhccCCCCCC
Q 003045 747 SSLIEHVWNLWNEG--------KAME-LVDPN---------------------IRDSSSQNQVLRCIHVGMLCVQDSAMY 796 (854)
Q Consensus 747 ~~l~~~~~~~~~~~--------~~~~-~~d~~---------------------l~~~~~~~~~~~l~~l~~~Cl~~dp~~ 796 (854)
......+....... .... ..... ............+.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 11111211111100 0000 00000 000112334567889999999999999
Q ss_pred CCCHHHHHH
Q 003045 797 RPTMASVVL 805 (854)
Q Consensus 797 RPs~~eVl~ 805 (854)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=331.73 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=186.0
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 611 (854)
...+|...++||+|+||+|+.....+++.||||++.... .+.+.+|+++++++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345688889999999999665555689999999986532 23467899999999 79999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-----CCCceecccCccee
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-----DMNPKISDFGMARI 686 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~ 686 (854)
|++ |+|.+++..... .+.+..+..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 997 589888864332 2444566789999999999999998 999999999999953 33578999999987
Q ss_pred ccCccC-cccccccccccccccceeec---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 687 FGFNQN-EANTNRVVGTYGYMAPEYAM---EGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 687 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |..|+..... ...........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~ 246 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQANILLGACS 246 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HHHHHHTTCCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HHHHHHhccCC
Confidence 643221 12234467999999999997 4567889999999999999999 8888753211 11111111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... .........+.+++.+||+.||++|||+.||++
T Consensus 247 -~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 -LDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -CTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 111234456788999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=346.12 Aligned_cols=258 Identities=24% Similarity=0.281 Sum_probs=198.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe------CCee
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ------GEEK 606 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~~ 606 (854)
++|++.++||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999764 6899999998654 33446678999999999999999999998765 6678
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCC---ceecccCc
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMN---PKISDFGM 683 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGl 683 (854)
++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555556899999999999999999999998 999999999999997765 89999999
Q ss_pred ceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHH-------
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL------- 756 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~------- 756 (854)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+....
T Consensus 171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------
T ss_pred ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchh
Confidence 9876422 223446799999999999999999999999999999999999999864211 11100000
Q ss_pred -hhcCCcccc--cCC--CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 003045 757 -WNEGKAMEL--VDP--NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMAS 802 (854)
Q Consensus 757 -~~~~~~~~~--~d~--~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~e 802 (854)
......... ... .............+.+++.+||+.||++|||+.|
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000 000 0112234456678999999999999999999977
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=346.06 Aligned_cols=239 Identities=21% Similarity=0.263 Sum_probs=191.8
Q ss_pred hcCcccCcccccCCcccEEEeEcC--CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCe-----
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP--EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEE----- 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 605 (854)
.++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999764 58999999986532 3345678899999999999999999999987765
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999998 9999999999999986 89999999998
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+....... +
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------L 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------C
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------c
Confidence 76321 3467999999999987654 889999999999999999988765311100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhcc
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-MASVVLMLESE 810 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~eVl~~L~~~ 810 (854)
. ...........+.+++.+||+.||++||+ ++++...|...
T Consensus 285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00011122356888999999999999995 66666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.13 Aligned_cols=230 Identities=11% Similarity=0.067 Sum_probs=181.7
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367899999999999999999865 489999999976532 2346789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. . ....++.+++.||+.||+|||+.+ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 1 345678899999999999999998 9999999999999999999998543
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
|++| ++.++||||||+++|||++|+.||........ +. .....+...
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~----------~~~~~~~~~ 221 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LA----------PAERDTAGQ 221 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SE----------ECCBCTTSC
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hH----------HHHHHhccC
Confidence 3333 68899999999999999999999874322110 00 000000000
Q ss_pred CCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 770 IRD--SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 770 l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
... .........+.+++.+||+.||++| |+.|+++.|+....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000 0011123468899999999999999 99999999988644
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=313.83 Aligned_cols=242 Identities=16% Similarity=0.114 Sum_probs=184.4
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEecccc--------ccCHHHHHHHHHHHHhcC---------CCceeee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKS--------GQGLEEFKNEIILIAKLQ---------HRNLVRL 596 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------h~niv~l 596 (854)
.++|++.++||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999987 78999999997642 234578999999999996 7777666
Q ss_pred eeeEE-----------------e-------------CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHH
Q 003045 597 LGCCI-----------------Q-------------GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARG 646 (854)
Q Consensus 597 ~~~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 646 (854)
.+.+. + .+..++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 66542 2 6789999999999976665522 458999999999999999
Q ss_pred HHHhh-cCCCCceEEcccCCCcEEEccCC--------------------CceecccCcceeccCccCccccccccccccc
Q 003045 647 LLYLH-RDSRLRIIHRDLKASNILLDEDM--------------------NPKISDFGMARIFGFNQNEANTNRVVGTYGY 705 (854)
Q Consensus 647 L~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y 705 (854)
|+||| +.+ |+||||||+|||++.++ .+||+|||+++.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 888 99999999999999887 899999999987632 235899999
Q ss_pred ccceeeccCCCCcccchhhHHHH-HHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHH
Q 003045 706 MAPEYAMEGLFSVKSDVYSFGVL-LLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIH 784 (854)
Q Consensus 706 ~aPE~~~~~~~s~~~DVwSlGvi-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 784 (854)
+|||++.+.. +.++||||++++ .+++++|..|+... ..+............. ...............+.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHH
Confidence 9999998766 889999998777 78899999887410 0000011111111000 111111123356678999
Q ss_pred HHhhccCCCCCCCCCHHHHH
Q 003045 785 VGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 785 l~~~Cl~~dp~~RPs~~eVl 804 (854)
++.+||+.| |++|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999966 899988
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=321.20 Aligned_cols=241 Identities=15% Similarity=0.155 Sum_probs=178.2
Q ss_pred hcCcccCcccccCCcccEEEeE-cCCCcEEEEEEecccc---ccCHHHHHHHHHHHHhcCC-Ccee--------------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQH-RNLV-------------- 594 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h-~niv-------------- 594 (854)
+..|...++||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|+.+++.++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3557778899999999999998 4579999999987432 2346789999999999987 3211
Q ss_pred -ee------eeeEEe-----CCeeEEEEEcCCCCChhhhhcC----cccccCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 003045 595 -RL------LGCCIQ-----GEEKMLIYEYMPNKSLDLFIFD----PAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658 (854)
Q Consensus 595 -~l------~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 658 (854)
.+ +.++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11 111111 12356677764 6888888731 122345788899999999999999999998 9
Q ss_pred EEcccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceee----------ccCCCCcccchhhHHHH
Q 003045 659 IHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA----------MEGLFSVKSDVYSFGVL 728 (854)
Q Consensus 659 vH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~~~DVwSlGvi 728 (854)
+||||||+||||+.++.+||+|||+++..+.. .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865322 334577 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 003045 729 LLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804 (854)
Q Consensus 729 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl 804 (854)
+|||++|+.||....... ....++.. ....+ ..+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~--------------~~~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG--------------GSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS--------------CSGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh--------------hHHHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999986432111 01111111 01222 5688899999999999999976664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=298.05 Aligned_cols=231 Identities=18% Similarity=0.207 Sum_probs=178.4
Q ss_pred cCcccC-cccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHH-HhcCCCceeeeeeeEEe----CCeeE
Q 003045 535 NYFSEG-NKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILI-AKLQHRNLVRLLGCCIQ----GEEKM 607 (854)
Q Consensus 535 ~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~~~ 607 (854)
++|.+. +.||+|+||.||++.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 445555 7899999999999976 4689999999854 34678899988 55689999999999987 67789
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccCcc
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFGMA 684 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla 684 (854)
+||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999986432 235899999999999999999999998 999999999999998 788999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
.... +..++.++||||||+++|||++|+.||....... . .......
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~------~----~~~~~~~ 213 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------I----SPGMKTR 213 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCS
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh------h----hHHHHHH
Confidence 7542 2346789999999999999999999986322110 0 0000000
Q ss_pred ccCCCCCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 765 LVDPNIRDSSS----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 765 ~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
+..... ..+ ......+.+++.+||+.||++|||+.|+++ .+...
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 100000 011 112356888999999999999999999998 44443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-28 Score=283.07 Aligned_cols=185 Identities=17% Similarity=0.162 Sum_probs=131.9
Q ss_pred ccccCCcccEEEeE-cCCCcEEEEEEecccc----------ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 542 KLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS----------GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 542 ~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
.++.|+.|.+..++ .--|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777766653 2358899999996541 23356799999999999 699999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||++|++|.+++.. ...++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3446654 48899999999999999 99999999999999999999999999987642
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRN 738 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p 738 (854)
. .......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 223445789999999999875 467789999999999988777554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-25 Score=259.35 Aligned_cols=185 Identities=19% Similarity=0.231 Sum_probs=146.7
Q ss_pred ccCcccccCCcccEEEeEcCCCcEEEEEEecccccc--------CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 538 SEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQ--------GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
...++||+|+||.||+|+. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467999999999999955 5788999987543211 134589999999999999999777777788889999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++++|.+++.. +..++.||++||.|||+.+ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999998 999999999999999 999999999998743
Q ss_pred ccCcc-----cccccccccccccceeecc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 690 NQNEA-----NTNRVVGTYGYMAPEYAME--GLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 690 ~~~~~-----~~~~~~gt~~Y~aPE~~~~--~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
..... ......||+.|||||++.. ..|+..+|+|+..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22211 1235789999999999987 66888999999999988888776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-22 Score=213.67 Aligned_cols=155 Identities=17% Similarity=0.120 Sum_probs=124.1
Q ss_pred eHHHHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccc------------------cCHHHHHHHHHHHHh
Q 003045 526 NFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG------------------QGLEEFKNEIILIAK 587 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~ 587 (854)
....+......|.+.+.||+|+||.||+|...+|+.||+|+++.... .....+.+|+.++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34445555667778899999999999999887799999999964321 124568999999999
Q ss_pred cCCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCc
Q 003045 588 LQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASN 667 (854)
Q Consensus 588 l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 667 (854)
++ | +++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|
T Consensus 161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 99 5 66666554 356799999999999988 411 123469999999999999998 9999999999
Q ss_pred EEEccCCCceecccCcceeccCccCcccccccccccccccceeecc
Q 003045 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 713 (854)
||++ ++.+||+|||+++.. ..++|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence 9999 999999999999743 35788988753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.3e-21 Score=171.08 Aligned_cols=105 Identities=23% Similarity=0.424 Sum_probs=90.8
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.+||.|.+|++|.| |.|.|.|..+++ +.++. ..++||+||++.|. ...+.|+|+.||||||+|+
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCC-CccEEEEEeCCccEEEECC
Confidence 478999999999999988 889999987665 44443 36899999999997 4467999999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
++.+||+|++......+.|+|+|||||||++. .||||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 99999999987666678899999999999964 39998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-20 Score=167.62 Aligned_cols=110 Identities=23% Similarity=0.425 Sum_probs=95.6
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.+||+|.+|++|+ ++|.|.|+|+.+++ -++|+ ..++||.+|++.| +..+.+.|+.||||||+|.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~---~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD---SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE---CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECC
Confidence 37999999999999999 99999999987776 36776 3799999999877 3467999999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCC
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPT 161 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PT 161 (854)
++.++|+|++....+...++|+|+|||||++. .+||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 99999999987655667899999999999863 4999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-20 Score=169.47 Aligned_cols=108 Identities=19% Similarity=0.339 Sum_probs=94.7
Q ss_pred cccccccCCCccCCCCeEE--eCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeE
Q 003045 30 RAVNTITKGQSIKDGESLI--SNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLM 107 (854)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~ 107 (854)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+++ -+||+. +++||+||++.| +.++.|.|+.|||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 4678999999999999999 999999999998776 367875 799999999877 456899999999999
Q ss_pred EEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 108 VLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 108 l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
|+|.++.++|+|++....+...++|+|+|||||++. ++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 999999999999976545567899999999999872 59998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-19 Score=164.32 Aligned_cols=110 Identities=24% Similarity=0.396 Sum_probs=93.6
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++ -++|. ..++||.+|++.| +.++.|.|+.||||||+|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn------lvly~---~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN------LVKYQ---NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC------EEEEE---TTEEEEECSCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc------EEEEe---CCEEEEeCCCCCC--CCceEEEECCCCcEEEECC
Confidence 48999999999999998 8999999987665 23454 4789999999988 3568999999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCC
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTD 162 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTD 162 (854)
++.+||+|++........++|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 99999999976544567899999999999853 59999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=163.39 Aligned_cols=110 Identities=24% Similarity=0.449 Sum_probs=93.9
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.+||+|.+|++| .+|.|+|+|+.+++ -++|.. .++||.+|++.+ +.++.|.|..||||||+|
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999999999 58999999988776 346664 689999999764 456799999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCC
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHP 160 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 160 (854)
++.++|+|.+....+...++|+++|||||++.. +.++||||+|.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 889999998765555678999999999999854 57899999984
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=156.83 Aligned_cols=104 Identities=25% Similarity=0.455 Sum_probs=88.3
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.+||.|||+|.+|++|+ +|.|.|+|+.+++ -+.|.. .++||.+|++.+ +..+.|.|+.||||||+|.
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn------Lvly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN------LVLYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc------EEEEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 37899999999999996 7999999987765 223543 589999999876 4568999999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
++.++|+|++.+......|+|+||||||||++ ++|||
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 99999999987655557899999999999974 39998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.5e-18 Score=180.12 Aligned_cols=138 Identities=16% Similarity=0.176 Sum_probs=106.4
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcE--EEEEEecccccc------------------------CHHHHHHHHHHHHh
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQD--IAVKRLSRKSGQ------------------------GLEEFKNEIILIAK 587 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~ 587 (854)
..|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3466788999999999999987 68888 999987543111 01367899999999
Q ss_pred cCCCce--eeeeeeEEeCCeeEEEEEcCCC-C----ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhh-cCCCCceE
Q 003045 588 LQHRNL--VRLLGCCIQGEEKMLIYEYMPN-K----SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH-RDSRLRII 659 (854)
Q Consensus 588 l~h~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iv 659 (854)
++|+++ ..++.+ ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988764 333332 467899999942 4 55554321 124456789999999999999 887 99
Q ss_pred EcccCCCcEEEccCCCceecccCcceec
Q 003045 660 HRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 660 H~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=150.13 Aligned_cols=106 Identities=21% Similarity=0.328 Sum_probs=87.0
Q ss_pred ccccccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEE
Q 003045 29 GRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMV 108 (854)
Q Consensus 29 ~~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l 108 (854)
+++.|+|.+||+|.+|+.|+| |.|.|.|..+++ +.+ |.. .++|.+|++.. +..+.|.|+.||||||
T Consensus 3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl 68 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELII 68 (110)
T ss_dssp CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEE
T ss_pred ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEE
Confidence 578999999999999999998 458887755554 333 443 48999999763 4557999999999999
Q ss_pred EcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 109 LNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 109 ~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
+|.++.++|+|++......+.|+|+||||||||+. .+|+|
T Consensus 69 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 69 KDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred EeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 99999999999986544557899999999999973 49997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-17 Score=147.75 Aligned_cols=109 Identities=17% Similarity=0.296 Sum_probs=90.2
Q ss_pred ccccccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEE
Q 003045 29 GRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMV 108 (854)
Q Consensus 29 ~~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l 108 (854)
+++.|+|.+||.|.+|+.|. +|.|.|.|..+++ |.++ .. ...++||.+|+..+ +..+.|.|+.||||||
T Consensus 3 ~~~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----LvL~-~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl 71 (113)
T 3mez_B 3 PRVRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCN-----LVLT-KG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDI 71 (113)
T ss_dssp CCCSSEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEE-ET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred cccCCEeCCCCEECCCCEeE--cCCEEEEEcCCCE-----EEEE-EC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEE
Confidence 46789999999999999996 4889999976665 3443 22 24789999999876 4467999999999999
Q ss_pred EcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 109 LNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 109 ~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
+|.++.++|+|++......+.|+|+||||||||+. .||+|
T Consensus 72 ~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~~--------~~W~s 111 (113)
T 3mez_B 72 TDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP--------AVWST 111 (113)
T ss_dssp ECTTSCEEEECSCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred ECCCCCEEEECCCcCCCCCEEEEEcCCceEEEecC--------CEecC
Confidence 99999999999987554557899999999999973 49997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.2e-17 Score=145.79 Aligned_cols=109 Identities=27% Similarity=0.449 Sum_probs=89.6
Q ss_pred cccccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEE
Q 003045 30 RAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVL 109 (854)
Q Consensus 30 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~ 109 (854)
+|.|||.|||.|.+|+.| .+|.|.|.|..+++ -+.|.. +|.+|+..+ +..+.|.|+.||||||+
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN------Lvl~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN------LVLYNG------NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC------EEEETT------TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe------EEEEeC------eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 478999999999999999 57999999976665 223331 699998765 45689999999999999
Q ss_pred cCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCC
Q 003045 110 NGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPG 167 (854)
Q Consensus 110 ~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg 167 (854)
|.++.++|+|++.+......|+|+||||||||+. .+|+| .|.+||
T Consensus 65 d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~--------~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP--------SVFKI-----DPWVRG 109 (109)
T ss_dssp CTTSCEEEECCCCCSSSCCEEEEETTTEEEEECS--------EEEEE-----CTTSCC
T ss_pred eCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec--------CEECC-----CCccCC
Confidence 9999999999987544567899999999999973 49998 777765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=143.70 Aligned_cols=93 Identities=23% Similarity=0.437 Sum_probs=79.0
Q ss_pred CCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeE
Q 003045 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGV 172 (854)
Q Consensus 93 ~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~ 172 (854)
+...+|.|+.||+|+|++. +.+||++++.+......++|+++|||||++ + +.++||||+
T Consensus 18 ~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~-------------- 76 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT-------------- 76 (112)
T ss_dssp ETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC--------------
T ss_pred CCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc--------------
Confidence 4567999999999999987 799999998754445789999999999998 5 579999993
Q ss_pred EecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEe-cceeEEecCCCcc
Q 003045 173 NSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWE-QLKRRWRSGQWNS 225 (854)
Q Consensus 173 ~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~-~~~~yw~sg~w~~ 225 (854)
+|++|.|++.++++|. ++++. ....||++++|+|
T Consensus 77 -----------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred -----------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999997 67776 4679999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-16 Score=140.62 Aligned_cols=90 Identities=19% Similarity=0.454 Sum_probs=76.1
Q ss_pred CCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeE
Q 003045 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGV 172 (854)
Q Consensus 93 ~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~ 172 (854)
+...+|.|+.||||||++ .+.+||++++.+.+....++|+++|||||++.+ +.+|||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~--------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK--------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC---------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC---------------
Confidence 345789999999999999 589999999876555678999999999999876 68999998
Q ss_pred EecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCCC
Q 003045 173 NSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQW 223 (854)
Q Consensus 173 ~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~w 223 (854)
+++++|.|++.++++|. +++++. .||+++++
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35567999999999997 677765 79999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.3e-16 Score=171.82 Aligned_cols=145 Identities=15% Similarity=0.170 Sum_probs=104.4
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccc--------------cCHHH--------HHHHHHHHH
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG--------------QGLEE--------FKNEIILIA 586 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~~--------~~~Ei~~l~ 586 (854)
.+..-..-|++.++||+|+||.||+|...+|+.||||+++.... ..... ...|+..|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333444889999999999999999998999999998753210 01111 234667777
Q ss_pred hcCCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCC
Q 003045 587 KLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKAS 666 (854)
Q Consensus 587 ~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 666 (854)
++.+.++....-+. ....+|||||++++.|..+... .....++.||+.+|.|||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~--~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIA--QSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEE--EETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeee--ccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 77554432211111 1234799999999888665421 123567899999999999998 999999999
Q ss_pred cEEEccCCC----------ceecccCcceec
Q 003045 667 NILLDEDMN----------PKISDFGMARIF 687 (854)
Q Consensus 667 NILl~~~~~----------~kl~DFGla~~~ 687 (854)
|||+++++. +.|+||+.+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998874 889999988754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=5.3e-15 Score=135.27 Aligned_cols=87 Identities=23% Similarity=0.501 Sum_probs=74.3
Q ss_pred CceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 95 RGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 95 ~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
..+|.|+.||||+|++. +.+||++++...+....++|+++|||||++.+ +++|||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 35799999999999987 89999999876555678999999999999876 68999998
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCC
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQ 222 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~ 222 (854)
+||++|.|++.++++|. +++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999997 67776 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6e-15 Score=134.44 Aligned_cols=91 Identities=26% Similarity=0.433 Sum_probs=76.8
Q ss_pred CceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 95 RGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 95 ~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
...|.|+.||||+|++ .+.+||++++........++|+++|||||++.+ +.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC---------------
Confidence 3589999999999998 588999999875544578999999999999865 6799999997
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCCCcce
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWNSV 226 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~w~~~ 226 (854)
|++|.|++.++++|. +++++. .||+|++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356889999999997 777765 89999999764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=130.86 Aligned_cols=103 Identities=25% Similarity=0.349 Sum_probs=82.5
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.+||.|.+|+.| .+|.|.|.|..+++ + +.|.. .. +|.+|+..+ +..+.|.|+.||||||+|.
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----L-vl~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----L-VLYNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----E-EEECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----E-EEECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 5899999999999999 47999999976665 2 22432 23 999999876 4468999999999999999
Q ss_pred CCc-EEEEeccc--cccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 112 NSI-AVWSSNAS--VVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 112 ~~~-~vW~t~~~--~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
++. ++|+|++. .......++|++|||||||+ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 875 69999964 22346789999999999997 249997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=3.3e-12 Score=115.68 Aligned_cols=94 Identities=20% Similarity=0.371 Sum_probs=72.5
Q ss_pred CCCCCCCceEEEeccCCeEEEcC-CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCC
Q 003045 89 RPISDERGTLTIGNDGNLMVLNG-NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPG 167 (854)
Q Consensus 89 ~p~~~~~~~l~~~~~g~l~l~~~-~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg 167 (854)
.|+.+...+|.|+.||||||++. .+.++|++++........++|+++|||||++.+ +.++||| +|-
T Consensus 19 ~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S-----~t~--- 85 (113)
T 3mez_B 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVS-----NTV--- 85 (113)
T ss_dssp CEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEEC-----SCC---
T ss_pred CEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEEC-----CCc---
Confidence 34445567999999999999998 589999999875545678999999999999876 5789998 111
Q ss_pred CeEeEEecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCC
Q 003045 168 MRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQ 222 (854)
Q Consensus 168 ~kl~~~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~ 222 (854)
...|.|.+.++.+|. +++|+ ...|.+|+
T Consensus 86 -----------------------~~~~~~~~~L~~dGn--lvly~--~~~W~s~~ 113 (113)
T 3mez_B 86 -----------------------GQEGDYVLILQINGQ--AVVYG--PAVWSTAA 113 (113)
T ss_dssp -----------------------CSSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred -----------------------CCCCCEEEEEcCCce--EEEec--CCEecCCC
Confidence 013568999999996 44554 57898875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.1e-11 Score=128.16 Aligned_cols=145 Identities=15% Similarity=0.029 Sum_probs=114.3
Q ss_pred HhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 611 (854)
.-..|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3356777778888999999999864 6899999986532233456899999999995 6778889999988889999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS------------------------------------- 654 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 654 (854)
|++|.+|...+.. ......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999998775311 1223468889999999999821
Q ss_pred -------------------CCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 655 -------------------RLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 655 -------------------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14499999999999998766677999998764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.9e-11 Score=108.95 Aligned_cols=91 Identities=18% Similarity=0.341 Sum_probs=69.6
Q ss_pred CCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeE
Q 003045 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGV 172 (854)
Q Consensus 93 ~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~ 172 (854)
.....|.|+.||||||++.++ +|++++.+.+....++|+++|||||++.+. ..++|+|.-+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS-------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc-------------
Confidence 345689999999999999877 999998765555789999999999998762 2359998511
Q ss_pred EecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCC
Q 003045 173 NSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQ 222 (854)
Q Consensus 173 ~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~ 222 (854)
.....|.|.+.++.+|. +++|. ..+|.++.
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGN--lvly~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQH--VTIYG--PAIWSTPA 109 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSC--EEEEC--SEEEECCC
T ss_pred ----------------cCCCCcCEEEEECCCCe--EEEec--cCEEccCC
Confidence 01134789999999996 44554 67898874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2.8e-11 Score=127.37 Aligned_cols=116 Identities=20% Similarity=0.361 Sum_probs=87.4
Q ss_pred cccccccCCCc----cCCCCeEEeC----CCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEe
Q 003045 30 RAVNTITKGQS----IKDGESLISN----GEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIG 101 (854)
Q Consensus 30 ~~~~~l~~g~~----l~~~~~l~s~----~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~ 101 (854)
...|||.||+. |..|+.|.|+ .|.|.|.|-..+ ..+ +| .+ ..+++|.+++..+ +. +.|.|+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG---nlv--Ly-~~--~~~~yW~Sgt~~~--~~-~~l~l~ 202 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG---NLV--AY-GP--NGAATWNAGTQGK--GA-VRAVFQ 202 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS---CEE--EE-CT--TSSEEEECCCTTT--TC-CEEEEC
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCc---eEE--EE-eC--CCeEEEECCCCCC--cc-EEEEEc
Confidence 46799999999 8888888653 245555553222 222 33 22 3689999999876 33 789999
Q ss_pred ccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccC-CCCCc
Q 003045 102 NDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNH-PTDTH 164 (854)
Q Consensus 102 ~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~-PTDtl 164 (854)
.||+|+++|.++.++|++++.+. ....++|++||||||++. +++|||||| |+.-+
T Consensus 203 ~dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~~P~~~~ 258 (276)
T 3m7h_A 203 GDGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGFQPTYRH 258 (276)
T ss_dssp TTSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSCCTTSCE
T ss_pred CCCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCccCCccc
Confidence 99999999999999999997653 357899999999999974 369999998 44433
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-10 Score=104.44 Aligned_cols=85 Identities=22% Similarity=0.384 Sum_probs=66.0
Q ss_pred CceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 95 RGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 95 ~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
...|.|+.||||||++. .++|++++...+....++|+++|||||++.+ +.++|||-.+
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~--------------- 82 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSS--------------- 82 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCc---------------
Confidence 36899999999999987 5999999876544568899999999999876 5789998210
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecC
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSG 221 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg 221 (854)
...|.|.+.++.+|. +++|. ...|.+|
T Consensus 83 ----------------~~~~~~~~~L~~dGN--lvly~--~~~W~t~ 109 (110)
T 3r0e_B 83 ----------------SKQGEYVLILQDDGF--GVIYG--PAIFETS 109 (110)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEEC--SEEEESC
T ss_pred ----------------CCCCCEEEEEcCCcc--EEEec--CCEecCC
Confidence 013568899999996 44554 3788876
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-10 Score=104.16 Aligned_cols=87 Identities=22% Similarity=0.495 Sum_probs=67.1
Q ss_pred CceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 95 RGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 95 ~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
...|.|+.||||||++. +.+||++++........+.|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCCC--------------
Confidence 45899999999999988 79999999876544578899999999999876 57899983210
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCC
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQ 222 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~ 222 (854)
..+.|.+.++.+|. +++++. ..|.+|.
T Consensus 80 -----------------~~~~~~~~L~ddGN--lvly~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRN--VVIYGT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSC--EEEEES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCE--EEEECC--CEEeCCC
Confidence 13568899999996 445543 6677763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=122.37 Aligned_cols=131 Identities=17% Similarity=0.148 Sum_probs=100.3
Q ss_pred ccc-cCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 542 KLG-RGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 542 ~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
.++ .|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 444 55669999998877889999997543 3356789999999997555 45588888877888999999999988
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS-------------------------------------------- 654 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 654 (854)
. ... .. ...++.++++.|..||+..
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 211 11 2356778888888888753
Q ss_pred -----------CCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 655 -----------RLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 655 -----------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
...++|+|++|.|||+++++.++|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.2e-10 Score=102.78 Aligned_cols=89 Identities=27% Similarity=0.597 Sum_probs=68.6
Q ss_pred CCCCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeE
Q 003045 91 ISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRV 170 (854)
Q Consensus 91 ~~~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl 170 (854)
++.....|.|+.||||||+++ +|+|++...+....++|+++|||||++.+ +.++|+| +|
T Consensus 18 L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss-----~t------- 76 (109)
T 3r0e_A 18 LKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKS-----GA------- 76 (109)
T ss_dssp EEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEEC-----CC-------
T ss_pred eECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcC-----CC-------
Confidence 334556899999999999985 79999876555678899999999999876 5789976 11
Q ss_pred eEEecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCCC
Q 003045 171 GVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQW 223 (854)
Q Consensus 171 ~~~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~w 223 (854)
....+.|.+.++++|. ++++. ...|++++|
T Consensus 77 -------------------~~~~~~~~~~L~~dGN--lvly~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 -------------------QSVKGNYAAVVHPDGR--LVVFG--PSVFKIDPW 106 (109)
T ss_dssp -------------------CCSSSCCEEEEETTTE--EEEEC--SEEEEECTT
T ss_pred -------------------cCCCcCEEEEEcCCCe--EEEEe--cCEECCCCc
Confidence 0023668899999995 45554 678999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.9e-09 Score=115.51 Aligned_cols=141 Identities=16% Similarity=0.243 Sum_probs=106.9
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEec--ccc-ccCHHHHHHHHHHHHhcC--CCceeeeeeeEEeC---CeeEEEEE
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLS--RKS-GQGLEEFKNEIILIAKLQ--HRNLVRLLGCCIQG---EEKMLIYE 611 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~lV~E 611 (854)
.+.|+.|.++.||+.+.. +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 467999999999999875 4688888875 321 123457889999999997 45578888888766 45899999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS------------------------------------- 654 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 654 (854)
|+++..+.+.. ...++..++..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874422 123677888899999999999999731
Q ss_pred ------------------CCceEEcccCCCcEEEccCCC--ceecccCccee
Q 003045 655 ------------------RLRIIHRDLKASNILLDEDMN--PKISDFGMARI 686 (854)
Q Consensus 655 ------------------~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~ 686 (854)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.90 E-value=6.5e-09 Score=92.48 Aligned_cols=84 Identities=25% Similarity=0.600 Sum_probs=63.1
Q ss_pred ceEEEeccCCeEEEcCCCcEEEEecccccc-ccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 96 GTLTIGNDGNLMVLNGNSIAVWSSNASVVS-NNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 96 ~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
-+|.|+.||||||++. +.+||++++.... ....+.|+++|||||+|.+ +++||+| +|
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss-----~t----------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWAS-----HS----------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEEC-----CC-----------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEe-----cC-----------
Confidence 4799999999999985 5899999986543 3467899999999999987 6889987 11
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEec
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRS 220 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~s 220 (854)
....+.|.+.++++|.. ++++. ..|.|
T Consensus 79 ---------------~~~~~~~~l~L~ddGNl--Vly~~--~~W~S 105 (105)
T 4h3o_A 79 ---------------TRGSGNYILILQDDGNV--IIYGS--DIWST 105 (105)
T ss_dssp ---------------CCCSSCEEEEECTTSCE--EEEES--EEEEC
T ss_pred ---------------CCCCCCEEEEEeCCCeE--EEECC--cEecC
Confidence 11346789999999964 44432 35653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=3e-09 Score=114.35 Aligned_cols=187 Identities=18% Similarity=0.196 Sum_probs=121.2
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCc--eeeeeeeEEeCC---eeEEEEEcC
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRN--LVRLLGCCIQGE---EKMLIYEYM 613 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~Ey~ 613 (854)
.+.++.|....||+.. +.+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999864 56899986432 34567899999999884 333 334444433332 347899999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS--------------------------------------- 654 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 654 (854)
++..|..... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865331 23667777888888888888888621
Q ss_pred ----------------CCceEEcccCCCcEEEcc--CCCceecccCcceeccCccCcccccc------------cccccc
Q 003045 655 ----------------RLRIIHRDLKASNILLDE--DMNPKISDFGMARIFGFNQNEANTNR------------VVGTYG 704 (854)
Q Consensus 655 ----------------~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~------------~~gt~~ 704 (854)
...++|+|++|.||++++ +..+.|+||+.+........-..... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 235899999999999998 45688999999875321100000000 000001
Q ss_pred ccc-ceeeccCCCCcccchhhHHHHHHHHHhCCCCC
Q 003045 705 YMA-PEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNT 739 (854)
Q Consensus 705 Y~a-PE~~~~~~~s~~~DVwSlGvil~elltG~~p~ 739 (854)
... |+.... .....+.|+++.++|++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 221111 112358999999999999998654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.74 E-value=2.5e-08 Score=102.90 Aligned_cols=87 Identities=28% Similarity=0.526 Sum_probs=67.5
Q ss_pred ceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEec
Q 003045 96 GTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSA 175 (854)
Q Consensus 96 ~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~~ 175 (854)
-.|.|+.||+|+++++ +.+||.+++... ....+.|+++|||||++.+ +++||+|+++
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~-----~~~vW~s~~~---------------- 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ-----NTIRWSSGTK---------------- 84 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT-----TCCSCCCCCC----------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC-----CcEEEeCCcc----------------
Confidence 4788888999999986 789999997654 5567889999999999976 6889999864
Q ss_pred CCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCCCc
Q 003045 176 LGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQWN 224 (854)
Q Consensus 176 ~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~w~ 224 (854)
...|.|.+.++.+|.. +++.. .+|.|..+.
T Consensus 85 ---------------~~~~~~~~~l~d~Gnl--vl~~~--~~W~S~~~p 114 (236)
T 1dlp_A 85 ---------------GSIGNYVLVLQPDRTV--TIYGP--GLWDSGTSN 114 (236)
T ss_dssp ---------------CCSSCCEEEECSSSCE--EEECS--EEEECSCCC
T ss_pred ---------------ccCCcEEEEEeCCCCE--EEecC--CEEECCCCC
Confidence 0235678888888863 44432 789888664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.3e-06 Score=89.69 Aligned_cols=135 Identities=22% Similarity=0.167 Sum_probs=94.1
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC---ceeeeeeeEE-eCCeeEEEEEcCCCC
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR---NLVRLLGCCI-QGEEKMLIYEYMPNK 616 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lV~Ey~~~g 616 (854)
+.++.|....||+. ++.+++|+-.. ......+.+|.++|+.+.+. .+.+++.+.. ..+..++||||+++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46788888899987 57789998532 23356789999999999753 2455666654 345678999999998
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD------------------------------------------- 653 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 653 (854)
.+..... ..++..++..++.++++.|..||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8866321 1134445555555555555555543
Q ss_pred --------------CCCceEEcccCCCcEEEcc---CCC-ceecccCccee
Q 003045 654 --------------SRLRIIHRDLKASNILLDE---DMN-PKISDFGMARI 686 (854)
Q Consensus 654 --------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~DFGla~~ 686 (854)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 455 48999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=2.8e-06 Score=93.15 Aligned_cols=80 Identities=8% Similarity=-0.023 Sum_probs=56.7
Q ss_pred ccc-ccCCcccEEEeEcC-------CCcEEEEEEecccc---ccCHHHHHHHHHHHHhcC-C--CceeeeeeeEEeC---
Q 003045 541 NKL-GRGGFGPVHKGKLP-------EGQDIAVKRLSRKS---GQGLEEFKNEIILIAKLQ-H--RNLVRLLGCCIQG--- 603 (854)
Q Consensus 541 ~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~--- 603 (854)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88888999998764 26788999765432 112356788999999885 3 3466777776654
Q ss_pred CeeEEEEEcCCCCChhh
Q 003045 604 EEKMLIYEYMPNKSLDL 620 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~ 620 (854)
+..++||||+++..+..
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999887654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=5.6e-06 Score=86.82 Aligned_cols=135 Identities=16% Similarity=0.141 Sum_probs=95.9
Q ss_pred ccccCCcc-cEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 542 KLGRGGFG-PVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 542 ~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+-+++.++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 58988654 467899998643 23457889999999885 33466788888889999999999999887
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD--------------------------------------------- 653 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 653 (854)
....... ......+..+++..|..||..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6654211 112234555666666666632
Q ss_pred ----------CCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 654 ----------SRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 654 ----------~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112489999999999999887778999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=3.5e-05 Score=85.73 Aligned_cols=75 Identities=13% Similarity=0.162 Sum_probs=50.8
Q ss_pred CcccccCCcccEEEeEcC-CCcEEEEEEecccc-------ccCHHHHHHHHHHHHhcCC--Ccee-eeeeeEEeCCeeEE
Q 003045 540 GNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-------GQGLEEFKNEIILIAKLQH--RNLV-RLLGCCIQGEEKML 608 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~h--~niv-~l~~~~~~~~~~~l 608 (854)
.+.||.|..+.||+++.. +++.++||...... ....+.+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999754 46889999864321 1234567889999988853 3333 44433 4556789
Q ss_pred EEEcCCCC
Q 003045 609 IYEYMPNK 616 (854)
Q Consensus 609 V~Ey~~~g 616 (854)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=5.9e-05 Score=81.68 Aligned_cols=141 Identities=18% Similarity=0.262 Sum_probs=82.2
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCC--Cceeeeee------eEEeCCeeEEEEEc
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH--RNLVRLLG------CCIQGEEKMLIYEY 612 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~------~~~~~~~~~lV~Ey 612 (854)
+.|+.|..+.||+....+| .+++|+.... .+.+..|+.+++.+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987554 5899988652 3445566666666641 12333332 22346678999999
Q ss_pred CCCCChhh-----------h---hcCccc-----------ccCCCHHHHH------------------------------
Q 003045 613 MPNKSLDL-----------F---IFDPAK-----------QALLDWTKRF------------------------------ 637 (854)
Q Consensus 613 ~~~gsL~~-----------~---l~~~~~-----------~~~l~~~~~~------------------------------ 637 (854)
+++..+.. . ++.... ...-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876530 0 111000 0011232211
Q ss_pred -HHHHHHHHHHHHhhc----------CCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 638 -AIIEGIARGLLYLHR----------DSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 638 -~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223445666763 1234699999999999998888999999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=8.3e-05 Score=78.71 Aligned_cols=80 Identities=15% Similarity=0.186 Sum_probs=59.3
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC---ceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR---NLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~~~~lV~E 611 (854)
......+.+|.|..+.||+.+..+|+.+++|+-..........|..|...|+.|... -+.+++.+ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 344556789999999999999999999999987655444456788999999988532 23344443 23578999
Q ss_pred cCCCCCh
Q 003045 612 YMPNKSL 618 (854)
Q Consensus 612 y~~~gsL 618 (854)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00018 Score=76.95 Aligned_cols=138 Identities=20% Similarity=0.142 Sum_probs=92.6
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCeeEEEEEcCCCC
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ---HRNLVRLLGCCIQGEEKMLIYEYMPNK 616 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~Ey~~~g 616 (854)
.+.|+.|....+|+... +++.+++|+.... ....+..|...|+.|. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35799999999999986 5678899987542 3567889999999884 256778888888788899999999998
Q ss_pred Chhh--------h---hcCccc-c------------------cCCCHHHHH---HHH----------------HHHHHH-
Q 003045 617 SLDL--------F---IFDPAK-Q------------------ALLDWTKRF---AII----------------EGIARG- 646 (854)
Q Consensus 617 sL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia~g- 646 (854)
.+.. . ++.... . -.-+|.+.+ ++. ..++.-
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1 111111 0 012454322 111 111111
Q ss_pred HHHhhc-CCCCceEEcccCCCcEEEccCCCceecccC
Q 003045 647 LLYLHR-DSRLRIIHRDLKASNILLDEDMNPKISDFG 682 (854)
Q Consensus 647 L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 682 (854)
...|.. ...+.++|+|+.+.||+++.++ +.|+|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00037 Score=78.05 Aligned_cols=77 Identities=13% Similarity=0.130 Sum_probs=47.9
Q ss_pred CceEEcccCCCcEEEccCCCceecccCcceeccCccCccccccccc--ccccccceeeccCC---CCcccchhhHHHHHH
Q 003045 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVG--TYGYMAPEYAMEGL---FSVKSDVYSFGVLLL 730 (854)
Q Consensus 656 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~---~s~~~DVwSlGvil~ 730 (854)
..++|+|++|.|||++.++ ++|+||+.+..-.....- ..... ...|++|+...... -....++......+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999999876 999999998753211000 00111 23466666543111 112345667888888
Q ss_pred HHHhCC
Q 003045 731 EIVSGR 736 (854)
Q Consensus 731 elltG~ 736 (854)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00049 Score=73.81 Aligned_cols=158 Identities=12% Similarity=0.076 Sum_probs=88.0
Q ss_pred eHHHHHHHhcCccc-----CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeee
Q 003045 526 NFNTIAVATNYFSE-----GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLG 598 (854)
Q Consensus 526 ~~~~~~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~ 598 (854)
+.+++...-..|.. .+.|+.|....+|+....+| .+++|+.... ...+.+..|+.+++.+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34455444445544 24567788889999987555 6889988652 12345677888888875222 223332
Q ss_pred e------EEeCCeeEEEEEcCCCCChhhh--------------hcCcc----cc--cC---CCHHHHHH-----------
Q 003045 599 C------CIQGEEKMLIYEYMPNKSLDLF--------------IFDPA----KQ--AL---LDWTKRFA----------- 638 (854)
Q Consensus 599 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~----~~--~~---l~~~~~~~----------- 638 (854)
. ....+..++++||+++..+... ++... .. .. ..|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1234567899999998764210 11000 00 00 11222111
Q ss_pred -HHHHHHHHHHHhhcC----CCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 639 -IIEGIARGLLYLHRD----SRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 639 -i~~~ia~gL~yLH~~----~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
+...+.+.+..++.. .+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133445555422 234599999999999999876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0006 Score=72.54 Aligned_cols=138 Identities=12% Similarity=0.099 Sum_probs=77.1
Q ss_pred CcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEcC-CCCC
Q 003045 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEYM-PNKS 617 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~-~~gs 617 (854)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++. +++++ +.+..++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 568989999999998 57889987643221 12235788888888533333 44443 344567899999 6655
Q ss_pred hhhhh------------------cCccc--ccCCCH-HHHHHHHHH--------------HHHHH----HHhhc-CCCCc
Q 003045 618 LDLFI------------------FDPAK--QALLDW-TKRFAIIEG--------------IARGL----LYLHR-DSRLR 657 (854)
Q Consensus 618 L~~~l------------------~~~~~--~~~l~~-~~~~~i~~~--------------ia~gL----~yLH~-~~~~~ 657 (854)
+.... +.... ...... .....+... +.+.+ ..|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 53210 00000 000111 111111000 11111 11111 12345
Q ss_pred eEEcccCCCcEEEccCCCceecccCccee
Q 003045 658 IIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 658 ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6667889999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00063 Score=76.30 Aligned_cols=72 Identities=18% Similarity=0.291 Sum_probs=50.1
Q ss_pred cccccCCcccEEEeEcCC--------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCeeEEEEE
Q 003045 541 NKLGRGGFGPVHKGKLPE--------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL-VRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 611 (854)
+.|+.|-...+|+....+ ++.+++|+.... ...+.+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 468888889999997653 578999987432 222566789999998864444 456655432 38999
Q ss_pred cCCCCCh
Q 003045 612 YMPNKSL 618 (854)
Q Consensus 612 y~~~gsL 618 (854)
|+++..+
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0022 Score=70.41 Aligned_cols=141 Identities=19% Similarity=0.259 Sum_probs=83.5
Q ss_pred cccccCCcccEEEeEcC--------CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCeeEEEEE
Q 003045 541 NKLGRGGFGPVHKGKLP--------EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL-VRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 611 (854)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+...++ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888889998764 3578999986332 2345667799999998853333 455655533 29999
Q ss_pred cCCCCChhhh-h----------------cCc--ccccCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 003045 612 YMPNKSLDLF-I----------------FDP--AKQALLD--WTKRFAIIEGIAR-------------------GLLY-- 649 (854)
Q Consensus 612 y~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------gL~y-- 649 (854)
|+++..|..- + +.. .-..... |.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 0 110 0011122 3444445443322 1222
Q ss_pred --hhcC-CCCceEEcccCCCcEEEccC----CCceecccCccee
Q 003045 650 --LHRD-SRLRIIHRDLKASNILLDED----MNPKISDFGMARI 686 (854)
Q Consensus 650 --LH~~-~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~ 686 (854)
|... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 23468999999999999876 7899999998874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0014 Score=70.79 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=73.4
Q ss_pred cccccCCccc-EEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC--ceeeeeeeEEeCCeeEEEEEcCCCCC
Q 003045 541 NKLGRGGFGP-VHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR--NLVRLLGCCIQGEEKMLIYEYMPNKS 617 (854)
Q Consensus 541 ~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lV~Ey~~~gs 617 (854)
+.|+.|.... +|+....+++.+++|...... .+.+..|+.+++.+... .+.+++.+.. +..+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3565554444 677766446778887653321 13456678888777532 2445555532 33378999998766
Q ss_pred hhhhhcCcc---------------------c--ccCCCHHHHH-------H-H------------HHHHHHHHHHhh---
Q 003045 618 LDLFIFDPA---------------------K--QALLDWTKRF-------A-I------------IEGIARGLLYLH--- 651 (854)
Q Consensus 618 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-i------------~~~ia~gL~yLH--- 651 (854)
+...+.... . ...++..... . + ...+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543321100 0 0111111100 0 0 001111222221
Q ss_pred cCCCCceEEcccCCCcEEEccC----CCceecccCcceec
Q 003045 652 RDSRLRIIHRDLKASNILLDED----MNPKISDFGMARIF 687 (854)
Q Consensus 652 ~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~~ 687 (854)
......++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999874 67899999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0058 Score=65.50 Aligned_cols=142 Identities=13% Similarity=0.143 Sum_probs=83.7
Q ss_pred cccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCc--eeeeeee-----EEeCCeeEEEEEcC
Q 003045 541 NKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN--LVRLLGC-----CIQGEEKMLIYEYM 613 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~Ey~ 613 (854)
+.|+ |....||+....+|+.+++|+..... ...+.+..|..+++.+.... +.+++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 77889999887778889999986321 24567778998888885322 3444432 22345667899999
Q ss_pred CCCChhh-----h---------hcC----c--ccccCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 003045 614 PNKSLDL-----F---------IFD----P--AKQALLDWTKR----------------------FAIIEGIARGLLYLH 651 (854)
Q Consensus 614 ~~gsL~~-----~---------l~~----~--~~~~~l~~~~~----------------------~~i~~~ia~gL~yLH 651 (854)
++..+.. . ++. . .....+++... ...+..++..+.-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 0 010 0 00111222111 011112222222221
Q ss_pred c-CCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 652 R-DSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 652 ~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234589999999999999 4 899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.003 Score=71.26 Aligned_cols=73 Identities=15% Similarity=0.101 Sum_probs=48.2
Q ss_pred cccccCCcccEEEeEcCC-CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL-VRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
+.|+.|-...+|+....+ ++.+++|+......... ...+|..+++.|...++ .++++.+. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 578888889999998765 57888998754322211 22689999999975555 35666652 2 359999998655
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0025 Score=69.78 Aligned_cols=73 Identities=14% Similarity=0.155 Sum_probs=44.6
Q ss_pred cccccCCcccEEEeEcCC---------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCeeEEEE
Q 003045 541 NKLGRGGFGPVHKGKLPE---------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL-VRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 610 (854)
+.|+.|..-.+|+....+ ++.+++|+....... ......|..+++.+...++ .++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 467778888899987643 268888886543221 1234678888888864343 3555443 237899
Q ss_pred EcCCCCCh
Q 003045 611 EYMPNKSL 618 (854)
Q Consensus 611 Ey~~~gsL 618 (854)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0092 Score=64.50 Aligned_cols=68 Identities=9% Similarity=0.058 Sum_probs=44.5
Q ss_pred ccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCC---Cceeeeeee------EEeCCeeEEEEEcCC
Q 003045 544 GRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH---RNLVRLLGC------CIQGEEKMLIYEYMP 614 (854)
Q Consensus 544 G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~------~~~~~~~~lV~Ey~~ 614 (854)
|.|....||+....+| .+++|+...... ..|+.+++.|.. +++.+++.. ....+..+++|||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344678999987777 899998754321 456777766642 224444432 234567889999999
Q ss_pred CCCh
Q 003045 615 NKSL 618 (854)
Q Consensus 615 ~gsL 618 (854)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.22 E-value=0.051 Score=53.90 Aligned_cols=101 Identities=14% Similarity=0.080 Sum_probs=64.0
Q ss_pred ChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcccc
Q 003045 617 SLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT 696 (854)
Q Consensus 617 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 696 (854)
+|.++|. ....++++.++|.++.|.+++|.-+-... .+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 6777774 23457999999999999999988762111 01 1223457999999999988764 1110
Q ss_pred cccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCC
Q 003045 697 NRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737 (854)
Q Consensus 697 ~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~ 737 (854)
.....+.|||... ...+.+.-|||||++||.-+-=..
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888653 345678899999999999886333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.96 E-value=0.091 Score=58.32 Aligned_cols=140 Identities=15% Similarity=0.185 Sum_probs=83.5
Q ss_pred cccccCCcccEEEeEcCC--------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCeeEEEEE
Q 003045 541 NKLGRGGFGPVHKGKLPE--------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL-VRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 611 (854)
+.|..|-...+|+....+ ++.+++|+....... .-...+|..+++.+...++ .++++.+ .-++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 467777788899987653 578999986543222 2234679999988863333 3444432 2378999
Q ss_pred cCCCCChhhh-h----------------cCc-c---------cccCCCHHHHHHHHHHH-------------------HH
Q 003045 612 YMPNKSLDLF-I----------------FDP-A---------KQALLDWTKRFAIIEGI-------------------AR 645 (854)
Q Consensus 612 y~~~gsL~~~-l----------------~~~-~---------~~~~l~~~~~~~i~~~i-------------------a~ 645 (854)
|+++..|..- + +.. . ...+.-|.+..++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765211 0 100 0 11111243333333222 12
Q ss_pred HHHHhh---------------------cCCCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 646 GLLYLH---------------------RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 646 gL~yLH---------------------~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
.+..|. ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223322 112346899999999999 8888999999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.33 E-value=0.41 Score=52.72 Aligned_cols=30 Identities=30% Similarity=0.420 Sum_probs=25.7
Q ss_pred ceEEcccCCCcEEE------ccCCCceecccCccee
Q 003045 657 RIIHRDLKASNILL------DEDMNPKISDFGMARI 686 (854)
Q Consensus 657 ~ivH~Dlkp~NILl------~~~~~~kl~DFGla~~ 686 (854)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999998875
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.33 E-value=11 Score=38.57 Aligned_cols=67 Identities=16% Similarity=0.310 Sum_probs=40.4
Q ss_pred CCCceEEeecCCCC--CC----CCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcC
Q 003045 77 DEKAVVWVANRNRP--IS----DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNS 143 (854)
Q Consensus 77 ~~~~~vW~an~~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~ 143 (854)
...+++|......+ +. ..++.+-++.++.+..+|.+|..+|............+..+.+||+++-+.
T Consensus 23 ~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 23 DTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 46778888876542 10 123444455555666677889999998764222223345567788777653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.03 E-value=1.1 Score=31.87 Aligned_cols=13 Identities=31% Similarity=0.396 Sum_probs=6.2
Q ss_pred hhhhHHHHHHHHH
Q 003045 449 AVIAIIVVIGALL 461 (854)
Q Consensus 449 ~~i~~~vv~~~lv 461 (854)
..|++.|+.++++
T Consensus 10 ~aIA~gVVgGv~~ 22 (44)
T 2l2t_A 10 PLIAAGVIGGLFI 22 (44)
T ss_dssp HHHHHHHHHHHHH
T ss_pred ceEEEeehHHHHH
Confidence 3455555544443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.82 E-value=2 Score=30.67 Aligned_cols=11 Identities=36% Similarity=0.126 Sum_probs=5.1
Q ss_pred hhhHHHHHHHH
Q 003045 450 VIAIIVVIGAL 460 (854)
Q Consensus 450 ~i~~~vv~~~l 460 (854)
.|++.|+.+++
T Consensus 12 ~IA~gVVgGv~ 22 (44)
T 2ks1_B 12 SIATGMVGALL 22 (44)
T ss_dssp SSTHHHHHHHH
T ss_pred eEEeehhHHHH
Confidence 35555544443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.84 E-value=1.9 Score=30.78 Aligned_cols=31 Identities=19% Similarity=0.072 Sum_probs=17.4
Q ss_pred ccccchhhhHHHHHHHHHHHHHHHHHHHHhh
Q 003045 444 SKISNAVIAIIVVIGALLLGASVWLLWRFRA 474 (854)
Q Consensus 444 ~~~~~~~i~~~vv~~~lvl~~~~~~~~~~~~ 474 (854)
+...++..+++.+++++++++++++++++|+
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3345666666655555555555555555444
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=80.81 E-value=1.3 Score=36.42 Aligned_cols=34 Identities=21% Similarity=0.449 Sum_probs=28.5
Q ss_pred ccChhhHHHHHhccCCeeeeeccC-CceeeEeeec
Q 003045 384 SVGQETCKDKCLQNCSCNAYADIP-GIGCMLWRGE 417 (854)
Q Consensus 384 ~~s~~~C~~~Cl~nCsC~Aya~~~-g~gC~~w~~~ 417 (854)
.+++++|+..|+.+=.|+||.|+. ...|.+..+.
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~~ 63 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRGK 63 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEESS
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccCC
Confidence 678999999999999999999964 3458887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.15 E-value=4.1 Score=40.31 Aligned_cols=115 Identities=9% Similarity=0.037 Sum_probs=76.9
Q ss_pred CCCceeeeeeeEEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHH-HhhcCCCCceEEcccCCCc
Q 003045 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL-YLHRDSRLRIIHRDLKASN 667 (854)
Q Consensus 589 ~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~Dlkp~N 667 (854)
.||++ -...-.+.+...+.|+.-+++.-...+ ..++..++++++.+|+.... +++. -+|-=|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 334446667777777765443222222 24778899999999998887 6665 5788899999
Q ss_pred EEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 003045 668 ILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTS 740 (854)
Q Consensus 668 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~ 740 (854)
|+++.++.++|.=.|+-.. ++|..+. ..-=.-++=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e~~-----ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDEWD-----DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCSCC-----HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCCCC-----HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987665432 2333211 11113366778888888887664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 854 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 8e-20 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-05 | |
| d1emoa2 | 39 | g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sa | 4e-04 | |
| d2vj3a1 | 42 | g.3.11.1 (A:411-452) Neurogenic locus notch homolo | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 3e-73
Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 19/282 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+ G ++G G FG V+KGK + + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
+G + ++ ++ SL + + + K I A+G+ YLH S
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM---E 713
IIHRDLK++NI L ED+ KI DFG+A + ++ G+ +MAPE +
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 714 GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773
+S +SDVY+FG++L E+++G+ N + + + + G + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815
+ C++ RP ++ +E +LP
Sbjct: 239 PKA-----MKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-66
Identities = 82/274 (29%), Positives = 125/274 (45%), Gaps = 21/274 (7%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+LG G FG V G +AVK L ++ + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
RL Q E +I EYM N SL F+ P+ L K + IA G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
IHRDL+A+NIL+ + ++ KI+DFG+AR+ N+ A + APE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 715 LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774
F++KSDV+SFG+LL EIV+ R + + ++ ++ R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR--------------IPYPGMTNPEVIQNLERGYRMVR 231
Query: 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
N + LC ++ RPT + +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 9e-66
Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 21/272 (7%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+ ++G G FG VH G +A+K + R+ E+F E ++ KL H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
G C++ L++E+M + L ++ ++ L + + G+ YL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EA 120
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
+IHRDL A N L+ E+ K+SDFGM R + ++ + +PE +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 717 SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776
S KSDV+SFGVL+ E+ S + + + + +E + R +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGK--------------IPYENRSNSEVVEDISTGFRLYKPR 225
Query: 777 NQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
+ C ++ RP + ++ L
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 9e-65
Identities = 77/286 (26%), Positives = 122/286 (42%), Gaps = 21/286 (7%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
KLG+G FG V G +A+K L + E F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+L + E ++ EYM SL F+ L + + IA G+ Y+ R
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+ +HRDL+A+NIL+ E++ K++DFG+AR+ N+ A + APE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 715 LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774
F++KSDV+SFG+LL E+ + R + + ++ V+ R
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPC 235
Query: 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQP 820
+ C + RPT + LE + QP
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-64
Identities = 63/293 (21%), Positives = 117/293 (39%), Gaps = 29/293 (9%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGC 599
+G+G FG V +GK G+++AVK S + + + EI L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 600 CIQGEEK----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-- 653
+ L+ +Y + SL ++ + + + A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 654 ---SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN--EANTNRVVGTYGYMAP 708
+ I HRDLK+ NIL+ ++ I+D G+A + + N VGT YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 709 EYAMEGL------FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN---- 758
E + + ++D+Y+ G++ EI + + V + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 759 -EGKAMELVDPNIRDSSSQNQVLRCIH-VGMLCVQDSAMYRPTMASVVLMLES 809
+ + + PNI + + LR + + C + R T + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 5e-64
Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 21/272 (7%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+ +LG G FG V GK D+A+K + ++ +EF E ++ L H LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 597 LGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRL 656
G C + +I EYM N L ++ + + + + + + + YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 657 RIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
+ +HRDL A N L+++ K+SDFG++R + ++ + PE M F
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 717 SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQ 776
S KSD+++FGVL+ EI S + + + + E + +R
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRPH 224
Query: 777 NQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
+ + C + A RPT ++ +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (544), Expect = 9e-64
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 21/274 (7%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
+ +KLG G +G V++G + +AVK L + + +EEF E ++ +++H NLV+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 77
Query: 596 LLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
LLG C + +I E+M +L ++ + +Q + + I+ + YL +
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE---K 133
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
IHRDL A N L+ E+ K++DFG++R+ + A+ + APE
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNK 192
Query: 716 FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775
FS+KSDV++FGVLL EI + + + + + EL++ + R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMS--------------PYPGIDLSQVYELLEKDYRMERP 238
Query: 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+ + + C Q + RP+ A + E+
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (544), Expect = 1e-63
Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 36/301 (11%)
Query: 525 FNFNTIAVATNYFSE---------GNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRK- 570
F F A F++ +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 571 SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL 630
+ + +F +E ++ + H N++ L G + M+I E+M N SLD F+ Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 631 LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690
+ ++ GIA G+ YL + +HRDL A NIL++ ++ K+SDFG++R +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 691 QNEANTNRVVG---TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS 747
++ +G + APE F+ SDV+S+G+++ E++S
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 748 SLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLML 807
+ + ++ + R + + + C Q +RP +V L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 808 E 808
+
Sbjct: 288 D 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-62
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 36/305 (11%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKL---PEGQDIAVKRLSRKSGQG-LEEFKNEIILIAKLQH 590
N +LG G FG V +G + D+A+K L + + + EE E ++ +L +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
+VRL+G C Q E ML+ E L F+ ++ + + ++ ++ G+ YL
Sbjct: 69 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL 125
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEAN-TNRVVGTYGYMAPE 709
+HRDL A N+LL KISDFG+++ G + + + + APE
Sbjct: 126 EE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 710 YAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769
FS +SDV+S+GV + E +S + + + M ++
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQG 228
Query: 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTFTSMRSSV 829
R + C RP +V + + + S+ S V
Sbjct: 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC-----------YYSLASKV 277
Query: 830 DGDHF 834
+G H
Sbjct: 278 EGHHH 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-62
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 530 IAVATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGL-EEFKNEIILIAK 587
+ + + F + ++LG G G V K P G +A K + + + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 588 LQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+V G E + E+M SLD + K + + + +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
YL + +I+HRD+K SNIL++ K+ DFG++ ++ N VGT YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
PE +SV+SD++S G+ L+E+ GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 3e-61
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 45/305 (14%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRKSGQGLE-EFKNEIIL 584
N +G G FG V + + P +AVK L ++ ++ +F+ E L
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69
Query: 585 IAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-------------- 630
+A+ + N+V+LLG C G+ L++EYM L+ F+ + +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 631 -------LDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683
L ++ I +A G+ YL + +HRDL N L+ E+M KI+DFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL 743
+R +M PE ++ +SDV+++GV+L EI S
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL------ 240
Query: 744 EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803
+ + + V + +N L ++ LC RP+ S+
Sbjct: 241 --------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 804 VLMLE 808
+L+
Sbjct: 293 HRILQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-61
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 26/288 (9%)
Query: 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQD-----IAVKRLSRKSGQG-LEEFKNEI 582
T + + + +G G FG V+KG L +A+K L + +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 583 ILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEG 642
++ + H N++RL G + + M+I EYM N +LD F+ + K + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT-NRVVG 701
IA G+ YL + +HRDL A NIL++ ++ K+SDFG++R+ + T +
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 702 TYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761
+ APE F+ SDV+SFG+++ E+++ + + +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHE 221
Query: 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
M+ ++ R + + + M C Q RP A +V +L+
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 9e-61
Identities = 69/273 (25%), Positives = 111/273 (40%), Gaps = 27/273 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRL 596
+G+G FG V G G +AVK + + + F E ++ +L+H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65
Query: 597 LGCCIQGEEKM-LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSR 655
LG ++ + + ++ EYM SL ++ + +L + + YL +
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 656 LRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGL 715
+HRDL A N+L+ ED K+SDFG+ + + + + APE E
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKK 176
Query: 716 FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSS 775
FS KSDV+SFG+LL EI S R + + V+ + +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVPRVEKGYKMDAP 222
Query: 776 QNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
V C A RP+ + LE
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-60
Identities = 73/306 (23%), Positives = 128/306 (41%), Gaps = 27/306 (8%)
Query: 512 VDGSQVNGTDLAMFNFNTIAVATNYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRL 567
+D S +N + I ++ +GRG FG V+ G L + AVK L
Sbjct: 4 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 568 SRKSGQG-LEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK-MLIYEYMPNKSLDLFIFDP 625
+R + G + +F E I++ H N++ LLG C++ E +++ YM + L FI +
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 626 AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685
+ F + + + + +HRDL A N +LDE K++DFG+AR
Sbjct: 124 THNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 686 IFGFNQNEANTNR--VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRL 743
+ ++ N+ +MA E F+ KSDV+SFGVLL E+++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-PPYPD 237
Query: 744 EENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803
+ ++ + L+ P V + C A RP+ + +
Sbjct: 238 VNTFDITVYLL------QGRRLLQPEYCPDP-------LYEVMLKCWHPKAEMRPSFSEL 284
Query: 804 VLMLES 809
V + +
Sbjct: 285 VSRISA 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-60
Identities = 73/299 (24%), Positives = 116/299 (38%), Gaps = 39/299 (13%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKSGQG-LEEFKNEIILIAK 587
N S G LG G FG V + +AVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 588 L-QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFD---------------PAKQALL 631
L H N+V LLG C G ++I EY L F+ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 632 DWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691
D + +A+G+ +L IHRDL A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIE 751
N +MAPE +++ +SDV+S+G+ L E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 752 HVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810
+ + K +++ R S ++ + C + RPT +V ++E +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 73/324 (22%), Positives = 137/324 (42%), Gaps = 41/324 (12%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQD----IAVKRLSR-KSGQGLEEFKNEIILIAKLQH 590
F + LG G FG V+KG +PEG+ +A+K L S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
++ RLLG C+ LI + MP L ++ + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 651 HRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEY 710
R++HRDL A N+L+ + KI+DFG+A++ G + E + +MA E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 711 AMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770
+ +++ +SDV+S+GV + E+++ ++ + +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230
Query: 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE--------------SETPTLPV 816
R + + + C A RP +++ E LP
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 817 PRQPTFT-SMRSSVDGDHFMEAHD 839
P F ++ D D ++A +
Sbjct: 291 PTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (521), Expect = 3e-60
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 33/278 (11%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG---LEEFKNEIILIAKLQ 589
FS+ ++G G FG V+ + + + +A+K++S Q ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
H N ++ GC ++ L+ EY + DL + L + A+ G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
LH +IHRD+KA NILL E K+ DFG A I A N VGT +MAPE
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 710 YAM---EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766
+ EG + K DV+S G+ +E+ + S + H+ + ++ L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP--PLFNMNAMSALYHIA----QNESPALQ 235
Query: 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+ + + C+Q RPT ++
Sbjct: 236 SGHWSEY--------FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-60
Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 27/277 (9%)
Query: 539 EGNKLGRGGFGPVHKGKLPE---GQDIAVKRLSRKSGQG--LEEFKNEIILIAKLQHRNL 593
E +LG G FG V KG + +AVK L ++ +E E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
VR++G C + E ML+ E L+ ++ + ++ ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTN-RVVGTYGYMAPEYAM 712
+HRDL A N+LL KISDFG+++ ++N + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772
FS KSDV+SFGVL+ E S + + + +++ R
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERM 229
Query: 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+ LC RP A+V L L +
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-58
Identities = 75/270 (27%), Positives = 113/270 (41%), Gaps = 22/270 (8%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLV 594
+ LG G +G V + +AVK + K E K EI + L H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+ G +G + L EY L I + + G++YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
+ I HRD+K N+LLDE N KISDFG+A +F +N E N++ GT Y+APE
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 715 LF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773
F + DV+S G++L +++G + S ++ W E K I
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPW-----DQPSDSCQEYSDWKEKKTYLNPWKKI--D 233
Query: 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803
S+ +L +L SA R T+ +
Sbjct: 234 SAPLALLH----KILVENPSA--RITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-58
Identities = 65/276 (23%), Positives = 122/276 (44%), Gaps = 26/276 (9%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
+++ +LG G FG V+K + E A K + KS + LE++ EI ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V+LL ++ E+ ++D + + + L ++ + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH- 127
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
+IIHRDLKA NIL D + K++DFG++ + + +GT +MAPE M
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 713 -----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767
+ + K+DV+S G+ L+E+ ++ + + L
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP--PHHELNPMRVLLKIAK----SEPPTLAQ 237
Query: 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803
P+ S+ ++ + +C+ + R T + +
Sbjct: 238 PSRWSSNFKDFLKKCLEK-------NVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-58
Identities = 72/290 (24%), Positives = 117/290 (40%), Gaps = 38/290 (13%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEG---QDIAVKRLSR-KSGQGLEEFKNEIILIAKL-QHR 591
+ +G G FG V K ++ + D A+KR+ S +F E+ ++ KL H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFI-------------FDPAKQALLDWTKRFA 638
N++ LLG C L EY P+ +L F+ + + L +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 639 IIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR 698
+ARG+ YL + + IHRDL A NIL+ E+ KI+DFG++R +
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 185
Query: 699 VVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWN 758
+MA E +++ SDV+S+GVLL EIVS +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------TPYCGMT 231
Query: 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
+ E + R N + C ++ RP+ A +++ L
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-58
Identities = 70/302 (23%), Positives = 115/302 (38%), Gaps = 44/302 (14%)
Query: 537 FSEGNKLGRGGFGPVHKG------KLPEGQDIAVKRLSRKSGQG-LEEFKNEIILIAKL- 588
G LG G FG V K +AVK L K+ E +E+ ++ +L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 589 QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQ-------------------- 628
H N+V LLG C LI+EY L ++ ++
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 629 ALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688
+L + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSS 748
+ N +MAPE EG++++KSDV+S+G+LL EI S N + +++
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 749 LIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
+L+ + + C + RP+ ++ L
Sbjct: 276 F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 809 SE 810
+
Sbjct: 323 CQ 324
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-57
Identities = 62/277 (22%), Positives = 118/277 (42%), Gaps = 30/277 (10%)
Query: 536 YFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRN 592
+ ++GRG F V+KG E ++A L + + + FK E ++ LQH N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 593 LVRLLGCCIQGEEK----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
+VR + +L+ E M + +L ++ + ++ + I +GL
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQ 126
Query: 649 YLHRDSRLRIIHRDLKASNILL-DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
+LH + IIHRDLK NI + + KI D G+A + + V+GT +MA
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMA 181
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767
PE E + DVY+FG+ +LE+ + S + + + V + ++
Sbjct: 182 PEM-YEEKYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
P +++ + C++ + R ++ ++
Sbjct: 240 PEVKE------------IIEGCIRQNKDERYSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 73/280 (26%), Positives = 112/280 (40%), Gaps = 27/280 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGKLP----EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQ 589
KLG G FG V +G+ + +AVK L + +++F E+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
HRNL+RL G + KM + E P SL + LL R+A+ +A G+ Y
Sbjct: 70 HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 126
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE-ANTNRVVGTYGYMAP 708
L R IHRDL A N+LL KI DFG+ R N + + + AP
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768
E FS SD + FGV L E+ + + + + + + EG+ + +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQILHKIDKEGERLPRPE- 238
Query: 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
+ +V + C RPT ++ L
Sbjct: 239 --------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-56
Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 33/300 (11%)
Query: 537 FSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSR-KSGQGLEEFKNEIILIAKLQ 589
+ +LG+G FG V++G +A+K ++ S + EF NE ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIF-------DPAKQALLDWTKRFAIIEG 642
++VRLLG QG+ ++I E M L ++ + A +K +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
IA G+ YL+ + + +HRDL A N ++ ED KI DFGM R + +
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762
+M+PE +G+F+ SDV+SFGV+L EI + L E V EG
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFVMEGGL 253
Query: 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQPTF 822
++ D N + +C Q + RP+ ++ ++ E P R+ +F
Sbjct: 254 LDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFREVSF 302
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 25/276 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNL 593
+ +G G +G K + G+ + K L S + +E+ L+ +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 594 VRLLGCCIQGEEKML--IYEYMPNKSLDLFIFDPAKQ-ALLDWTKRFAIIEGIARGLLYL 650
VR I L + EY L I K+ LD ++ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 651 HR--DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
HR D ++HRDLK +N+ LD N K+ DFG+ARI N + + VGT YM+P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSP 183
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768
E ++ KSD++S G LL E+ + F L + EGK + P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKI----REGKFRRI--P 235
Query: 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+ R +++ +RP++ ++
Sbjct: 236 YRYSDELNEIITRMLNL-------KDYHRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 67/297 (22%), Positives = 134/297 (45%), Gaps = 31/297 (10%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN 592
++ K+G+G G V+ + GQ++A+++++ + E NEI+++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+V L + G+E ++ EY+ SL + + D + A+ + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLH- 133
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
++IHRD+K+ NILL D + K++DFG Q++ +T +VGT +MAPE
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772
+ K D++S G++ +E++ G + E + + EL +P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIAT----NGTPELQNPEKLS 243
Query: 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASV--------VLMLESETPTLPVPRQPT 821
+ ++ + RC+ + R + + L S TP + ++ T
Sbjct: 244 AIFRDFLNRCLDM-------DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 1e-54
Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRN 592
F G LG+G FG V+ + + +A+K L + + + E+ + + L+H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
++RL G LI EY P ++ + +K D + I +A L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS 124
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
R+IHRD+K N+LL KI+DFG + + + + GT Y+ PE
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIE 177
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772
+ K D++S GVL E + G+ F + + + E P+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISRV-------EFTFPDFVT 228
Query: 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVV 804
+++ + R + + RP + V+
Sbjct: 229 EGARDLISRLLKH-------NPSQRPMLREVL 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 4e-53
Identities = 78/295 (26%), Positives = 115/295 (38%), Gaps = 38/295 (12%)
Query: 537 FSEGNKLGRGGFGPVHKG------KLPEGQDIAVKRLSRKSGQG-LEEFKNEI-ILIAKL 588
G LGRG FG V + K + +AVK L + +E+ ILI
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 589 QHRNLVRLLGCCIQ-GEEKMLIYEYMPNKSLDLFIF-------------DPAKQALLDWT 634
H N+V LLG C + G M+I E+ +L ++ + + L
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 635 KRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694
+A+G+ +L + IHRDL A NILL E KI DFG+AR + +
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVW 754
+MAPE + +++++SDV+SFGVLL EI S + E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEEFC 247
Query: 755 NLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
EG M D + + C RPT + +V L +
Sbjct: 248 RRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 76/295 (25%), Positives = 117/295 (39%), Gaps = 40/295 (13%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE--------GQDIAVKRLSRK-SGQGLEEFKNEIILIAK 587
G LG G FG V + +AVK L + + L + +E+ ++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 588 L-QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQAL-------------LDW 633
+ +H+N++ LLG C Q +I EY +L ++ L L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 634 TKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693
+ +ARG+ YL + IHRDL A N+L+ ED KI+DFG+AR
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHV 753
T +MAPE + +++ +SDV+SFGVLL EI + +E +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-----GSPYPGVPVEEL 246
Query: 754 WNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808
+ L EG M+ N + C RPT +V L+
Sbjct: 247 FKLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-51
Identities = 57/275 (20%), Positives = 101/275 (36%), Gaps = 26/275 (9%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQD----IAVKRLSRKSGQGL-EEFKNEIILIAKLQHRNLV 594
G +G G FG VH+G ++ +A+K + + E+F E + + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+L+G + +I E L F+ LD ++ L YL
Sbjct: 72 KLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES-- 126
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEG 714
R +HRD+ A N+L+ + K+ DFG++R + ++ +MAPE
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 184
Query: 715 LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774
F+ SDV+ FGV + EI+ + + ++ R
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGV--------------KPFQGVKNNDVIGRIENGERLPM 230
Query: 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
N + C RP + L +
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRN 592
F G LG G F V + L ++ A+K L ++ + E ++++L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
V+L E+ Y N L +I D T I L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG 126
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
IIHRDLK NILL+EDM+ +I+DFG A++ +A N VGT Y++PE
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRR 737
E SD+++ G ++ ++V+G
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 2e-49
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 13/224 (5%)
Query: 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+++ +LG G FG VH+ G + A K + E + EI ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V L E ++IYE+M L + D + + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 654 SRLRIIHRDLKASNILLDEDMNP--KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
+H DLK NI+ + K+ DFG+ + + GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
+D++S GVL ++SG F E + + +V +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS--PFGGENDDETLRNVKS 239
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 2e-47
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 11/206 (5%)
Query: 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+Y+ +LG G FG VH+ G+ K ++ KNEI ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ L E +LI E++ L I A+ + + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 654 SRLRIIHRDLKASNILLDEDMNP--KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
I+H D+K NI+ + KI DFG+A ++ T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGRR 737
+D+++ GVL ++SG
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-46
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 9/227 (3%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG-LEEFKNEIILIAKLQHR 591
++ + +G G +G V +A+K++S Q + EI ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
N++ + + + Y+ + ++ K L + I RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANT-NRVVGTYGYMAPEY 710
++HRDLK SN+LL+ + KI DFG+AR+ + + V T Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 711 AMEGLFSVKS-DVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL 756
+ KS D++S G +L E++S R F + + H+ +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGI 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (422), Expect = 6e-46
Identities = 76/316 (24%), Positives = 134/316 (42%), Gaps = 28/316 (8%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQ- 589
N FS +GRGGFG V+ + + G+ A+K L +K QG NE I+++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 590 --HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+V + ++ I + M L + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
++H +++RDLK +NILLDE + +ISD G+A F + + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 708 PEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766
PE +G+ + +D +S G +L +++ G ++ I+ + L + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSF 232
Query: 767 DPNIRD------SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLPVPRQP 820
P +R N+ L C+ G V++S +R +V + + P +P +
Sbjct: 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEV 292
Query: 821 TFTSMRSSVDGDHFME 836
+ D F E
Sbjct: 293 NAA---DAFDIGSFDE 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (410), Expect = 7e-45
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRN 592
F LG G FG VH + G+ A+K L ++ + +E +E ++++ + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
++R+ G ++ +I +Y+ L + + A + L L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEY 119
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
II+RDLK NILLD++ + KI+DFG A+ T + GT Y+APE
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVS 174
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRR 737
++ D +SFG+L+ E+++G
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-45
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 14/219 (6%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
LGRG FG VH+ + K + + G K EI ++ +HRN++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 599 CCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRI 658
EE ++I+E++ + I A + L+ + + + + L +LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 659 IHRDLKASNILLDEDMNP--KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF 716
H D++ NI+ + KI +FG AR N + Y APE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVV 180
Query: 717 SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
S +D++S G L+ ++SG F E N +IE++ N
Sbjct: 181 STATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMN 217
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 2e-44
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG---LEEFKNEIILIAKLQ 589
++ + G LG GG VH + L +D+AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 590 HRNLVRLLGCCI----QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
H +V + G ++ EY+ +L + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE-ANTNRVVGTYG 704
L + H+ IIHRD+K +NI++ K+ DFG+AR + N T V+GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 705 YMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
Y++PE A +SDVYS G +L E+++G
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 6e-44
Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 16/227 (7%)
Query: 534 TNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE-FKNEIILIAKLQHR 591
+ + + LG G F V + + +A+K +++K+ +G E +NEI ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
N+V L G LI + + L I ++ +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 652 RDSRLRIIHRDLKASNILL---DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
I+HRDLK N+L DED ISDFG++++ + GT GY+AP
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAP 178
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
E + +S D +S GV+ ++ G F E ++ L E +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYP--PFYDENDAKLFEQILK 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 15/224 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSG---QGLEEFKNEI-ILIAKLQHR 591
F LG+G FG V + + Q A+K L + +E E +L +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 592 NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH 651
L + E + EY+ L I K D ++ I GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120
Query: 652 RDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
I++RDLK NILLD+D + KI+DFGM + + NT GT Y+APE
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEIL 175
Query: 712 MEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
+ ++ D +SFGVLL E++ G+ + F ++ L +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRM 217
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 6e-43
Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 38/284 (13%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGL---------EEFKNEIILIA 586
+ LGRG V + P ++ AVK + G E E+ ++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 587 KLQ-HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
K+ H N+++L L+++ M L ++ ++ L + I+ +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
+ LH+ L I+HRDLK NILLD+DMN K++DFG + + V GT Y
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSY 175
Query: 706 MAPEYAMEGL------FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE 759
+APE + + + D++S GV++ +++G F + ++ + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMS---- 229
Query: 760 GKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASV 803
+ P D S + + R T
Sbjct: 230 -GNYQFGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-42
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVR 595
+++ +G G FG V++ KL + G+ +A+K++ + E+ ++ KL H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 596 LLGCCIQGEEKM------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
L EK L+ +Y+P + + L + + R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 650 LHRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAP 708
+H I HRD+K N+LLD D K+ DFG A+ + E N + + Y
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPE 192
Query: 709 EYAMEGLFSVKSDVYSFGVLLLEIVSGRR 737
++ DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-41
Identities = 45/284 (15%), Positives = 98/284 (34%), Gaps = 24/284 (8%)
Query: 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL 593
N + G K+G G FG ++ G + G+++A+K K+ + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
+ + C + ++ + SL+ +++ + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS- 121
Query: 654 SRLRIIHRDLKASNIL---LDEDMNPKISDFGMARIFGFNQNEAN-----TNRVVGTYGY 705
IHRD+K N L + I DFG+A+ + + + + GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765
+ + S + D+ S G +L+ G + +E K
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---KRQKYERISEKKMSTP 236
Query: 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
++ + S+ C +P + + + +
Sbjct: 237 IEVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEE-----FKNEIILIAKLQHRNLV 594
+ LG G F V+K + Q +A+K++ ++ EI L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
LL L++++M + +L + A + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME- 713
I+HRDLK +N+LLDE+ K++DFG+A+ FG V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGA 175
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
++ V D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 62/294 (21%), Positives = 118/294 (40%), Gaps = 31/294 (10%)
Query: 533 ATNYFSEGNKLGRGGFGPVHKGK--LPEGQDIAVKRLSRKSGQG--LEEFKNEIILIAKL 588
A + ++G G +G V K + G+ +A+KR+ ++G+ E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 589 ---QHRNLVRLLGCCIQGEEKMLIYEYMPNKSLD---LFIFDPAKQALLDWTKRFAIIEG 642
+H N+VRL C + + +D D + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 643 IARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
+ RGL +LH R++HRDLK NIL+ K++DFG+ARI+ F VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNL------ 756
Y APE ++ ++ D++S G + E+ + FR + + + ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP--LFRGSSDVDQLGKILDVIGLPGE 236
Query: 757 --WNEGKAMELVDPNIRDSSSQNQVLRCIHVGML-----CVQDSAMYRPTMASV 803
W A+ + + + + + I C+ + R + S
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 2e-40
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNLV 594
+ K+G G +G V+K + G+ A+K RL ++ EI ++ +L+H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 595 RLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS 654
+L + +L++E++ L + L+ + + + G+ Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-- 118
Query: 655 RLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM-E 713
R++HRDLK N+L++ + KI+DFG+AR FG + + T Y AP+ M
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGS 175
Query: 714 GLFSVKSDVYSFGVLLLEIVSGR 736
+S D++S G + E+V+G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNL 593
F + K+G G +G V+K + G+ +A+K RL ++ EI L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
V+LL + L++E++ + + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSH 121
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE-YAM 712
R++HRDLK N+L++ + K++DFG+AR FG V T Y APE
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLG 176
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRR 737
+S D++S G + E+V+ R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 3e-39
Identities = 38/282 (13%), Positives = 89/282 (31%), Gaps = 28/282 (9%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRN-LVRLL 597
G ++G G FG + +G L Q +A+K R+S + ++E L + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVY 67
Query: 598 GCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLR 657
+G +L+ + + DL + + + +H
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 658 IIHRDLKASNILLDEDMNP-----KISDFGMARIFGFNQNEAN-----TNRVVGTYGYMA 707
+++RD+K N L+ + + DFGM + + + + + GT YM+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767
+ S + D+ + G + + + G ++ + ++ + + E
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLP--WQGLKAATNKQKYE------RIGEKKQ 233
Query: 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLES 809
+ P + +
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKS------GQGLEEFKNEIILIAK 587
+Y+ G +LG G F V K + G A K + ++ G E+ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 588 LQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+QH N++ L + +LI E + L F+ ++ L + ++ I G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNP----KISDFGMARIFGFNQNEANTNRVVGTY 703
YLH L+I H DLK NI+L + P KI DFG+A F + GT
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180
Query: 704 GYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
++APE +++D++S GV+ ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 6e-39
Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQG--LEEFKNEIILIAKLQHRNL 593
+ + K+G+G FG V K + GQ +A+K++ ++ + EI ++ L+H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 594 VRLLGCCIQGEEKM--------LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
V L+ C L++++ + L K ++ +++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 128
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR--VVGTY 703
GL Y+HR+ +I+HRD+KA+N+L+ D K++DFG+AR F +N V T
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 704 GYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGRR 737
Y PE + E + D++ G ++ E+ +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 20/209 (9%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEE------FKNEIILIAKLQ--H 590
G LG GGFG V+ G + + +A+K + + E E++L+ K+
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 591 RNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYL 650
++RLL + + +LI E ++ L + + + +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHC 126
Query: 651 HRDSRLRIIHRDLKASNILLDED-MNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPE 709
H ++HRD+K NIL+D + K+ DFG + + GT Y PE
Sbjct: 127 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 710 YAM-EGLFSVKSDVYSFGVLLLEIVSGRR 737
+ + V+S G+LL ++V G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 61/320 (19%), Positives = 117/320 (36%), Gaps = 34/320 (10%)
Query: 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRN 592
+Y LG G G V + + A+K L + + E+ L + Q +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 66
Query: 593 LVRLLGCCIQGEEK----MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLL 648
+VR++ +++ E + L I D QA + I++ I +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQ 125
Query: 649 YLHRDSRLRIIHRDLKASNILLDEDMNP---KISDFGMARIFGFNQNEANTNRVVGTYGY 705
YLH + I HRD+K N+L K++DFG A+ + + T Y
Sbjct: 126 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYY 179
Query: 706 MAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765
+APE + D++S GV++ ++ G F ++ + G+ E
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGLAISPGMKTRIRMGQ-YEF 236
Query: 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE--TPTLPVPRQPTFT 823
+P + S + + ++ R T+ + + VP+ P T
Sbjct: 237 PNPEWSEVSEE-----VKMLIRNLLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLHT 288
Query: 824 SMRSSVDGDHFMEAHDTVSS 843
S D + + + + ++S
Sbjct: 289 SRVLKEDKERWEDVKEEMTS 308
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-37
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 14/228 (6%)
Query: 532 VATNYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAK 587
V N F LG+G FG V + G+ A+K L ++ + + E ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 588 LQHRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+H L L + + EY L + +++ + + I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSAL 118
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
YLH +++RD+K N++LD+D + KI+DFG+ + + A GT Y+A
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLA 173
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN 755
PE + + D + GV++ E++ GR F +++ L E +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILM 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 11/224 (4%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVK--RLSRKSGQGLEEFKNEIILIAKLQHRNL 593
+ + K+G G +G V K K + +A+K RL EI L+ +L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 594 VRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD 653
VRL ++ L++E+ F D + + + +GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHS- 119
Query: 654 SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAME 713
++HRDLK N+L++ + K+++FG+AR FG + VV +
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGA 176
Query: 714 GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757
L+S D++S G + E+ + R F + ++ ++ L
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGR-PLFPGNDVDDQLKRIFRLL 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 535 NYFSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHR 591
+ + +G G +G V G +A+K+L R S + E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 592 NLVRLLGCCIQGE------EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIAR 645
N++ LL E + L+ +M L K L + ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 646 GLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGY 705
GL Y+H IIHRDLK N+ ++ED KI DFG+AR Q ++ V T Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 706 MAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGR 736
APE + + ++ D++S G ++ E+++G+
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 4e-35
Identities = 54/253 (21%), Positives = 102/253 (40%), Gaps = 24/253 (9%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRN 592
F LG G FG V K G A+K L ++ + +E NE ++ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 593 LVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
LV+L ++ EY+ + + + I YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
L +I+RDLK N+L+D+ +++DFG A+ + + T + GT +APE +
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIIL 211
Query: 713 EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772
++ D ++ GVL+ E+ +G F ++ + E + + ++ P+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP--PFFADQPIQIYEKIVS-------GKVRFPSHFS 262
Query: 773 SSSQNQVLRCIHV 785
S ++ + + V
Sbjct: 263 SDLKDLLRNLLQV 275
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-32
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 537 FSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS----GQGLEEFKNEIILIAKL 588
F LG G +G V + G+ A+K L + + + E + E ++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 589 QHR-NLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+ LV L + LI +Y+ L + + + I +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI------V 139
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
L L +L II+RD+K NILLD + + ++DFG+++ F ++ E GT YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMA 198
Query: 708 PEYAMEGL--FSVKSDVYSFGVLLLEIVSGRR 737
P+ G D +S GVL+ E+++G
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNL 593
+ +G G G V +++A+K+LSR + + E++L+ + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 594 VRLLGCCI------QGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGL 647
+ LL + ++ L+ E M + + D + ++ + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGI 132
Query: 648 LYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMA 707
+LH IIHRDLK SNI++ D KI DFG+AR G + V T Y A
Sbjct: 133 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRA 186
Query: 708 PEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
PE + + D++S G ++ E+V +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (307), Expect = 4e-31
Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLV 594
+ KLGRG + V + + + + VK L ++ K EI ++ L+ N++
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNII 93
Query: 595 RLLGCCIQGEEKM--LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
L + L++E++ N Q L D+ RF + I + L Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYCH- 146
Query: 653 DSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYA 711
+ I+HRD+K N+++D E ++ D+G+A + Q N V + + PE
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 201
Query: 712 ME-GLFSVKSDVYSFGVLLLEIVSGRR 737
++ ++ D++S G +L ++ +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 537 FSEGNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNL 593
+ + +G G +G V G +AVK+LSR S + E+ L+ ++H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 594 VRLLGCCIQGEEKMLI-YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR 652
+ LL Y+ + + + K L +I I RGL Y+H
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 653 DSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAM 712
IIHRDLK SN+ ++ED KI DFG+AR T Y APE +
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 191
Query: 713 EGL-FSVKSDVYSFGVLLLEIVSGR 736
+ ++ D++S G ++ E+++GR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 8e-29
Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 22/214 (10%)
Query: 540 GNKLGRGGFGPVHKGK-LPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLG 598
KLG G F V K + +A+K + R E ++EI L+ ++ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 599 CCIQGEEKMLIY---------------EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGI 643
K+L + E + L L + L + K+ I + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQL 134
Query: 644 ARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFGFNQNEANTNRVVGT 702
GL Y+HR R IIH D+K N+L++ D + +A + + + + T
Sbjct: 135 LLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 703 YGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGR 736
Y +PE + + +D++S L+ E+++G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 100 bits (250), Expect = 7e-25
Identities = 37/203 (18%), Positives = 65/203 (32%), Gaps = 27/203 (13%)
Query: 540 GNKLGRGGFGPVHKGKLPEGQDIAVK--RLSRKSGQ--------GLEEFKNEIILIAKLQ 589
G +G G V + + VK ++ S + G F I A+ +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 590 HRNLVRLLGCCIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLY 649
R L +L G + +Y + N L I + +++ I +
Sbjct: 65 FRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAK 118
Query: 650 LHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNR-VVGTYGYMAP 708
+ I+H DL N+L+ + I DF + G R V Y +
Sbjct: 119 FYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 709 EYAMEGLFSVKSDVYSFGVLLLE 731
Y + D+ S +L+
Sbjct: 175 TY------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 83.1 bits (205), Expect = 8e-20
Identities = 25/127 (19%), Positives = 50/127 (39%), Gaps = 20/127 (15%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
N +T G+ + G+SL + N L D VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLVLY---------DHSTSVWASNTGILG- 49
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
+ + +DGN +V + ++W+S++ + N +L++DGN+++ G
Sbjct: 50 KKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI--------YGSD 101
Query: 153 YWQSFNH 159
W + +
Sbjct: 102 IWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 70.7 bits (173), Expect = 3e-15
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 8/97 (8%)
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAA 130
I Y + + + L++ D NL VL VWS+N + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNL-VLFDRDDRVWSTNTAGKGTGCRA 70
Query: 131 LLEDDGNLILTNSEDIGNLGKAYWQSFN--HPTDTHL 165
+L+ +G + + ++ A W S N
Sbjct: 71 VLQPNGRMDVLTNQ-----NIAVWTSGNSRSAGRYVF 102
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 67.7 bits (165), Expect = 3e-14
Identities = 28/127 (22%), Positives = 46/127 (36%), Gaps = 21/127 (16%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
N + G+++ GE L F N L V W N
Sbjct: 2 NILYSGETLSTGEFLNYGS--FVFIMQEDCNLVLYDVDKPI---------WATNTGGLSR 50
Query: 93 DERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKA 152
L++ DGNL+V N ++ +W+SN + N +L+ D N+++ G
Sbjct: 51 S--CFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI--------YGTD 100
Query: 153 YWQSFNH 159
W + H
Sbjct: 101 RWATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.5 bits (136), Expect = 2e-10
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 7/89 (7%)
Query: 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAA 130
I + E + + + + T+ +D NL VL + + VW+SN + + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNL-VLFDSDVRVWASNTAGATGCRAV 61
Query: 131 LLEDDGNLILTNSEDIGNLGKAYWQSFNH 159
L DG L++ ++ W S
Sbjct: 62 LQ-SDGLLVILTAQ-----NTIRWSSGTK 84
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.6 bits (131), Expect = 1e-09
Identities = 24/136 (17%), Positives = 46/136 (33%), Gaps = 23/136 (16%)
Query: 21 IVCSLAHFGRAVNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKA 80
I+ S + +S+ E L + + N L D
Sbjct: 3 IIFSKQPDDNHPQILHATESL---EILFGTHV-YRFIMQTDCNLVLY---------DNNN 49
Query: 81 VVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLIL 140
+W N + R + DG L+V+ ++ VW S + + + +L+ D N+++
Sbjct: 50 PIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 141 TNSEDIGNLGKAYWQS 156
G A W +
Sbjct: 108 Y--------GDALWAT 115
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 42.9 bits (100), Expect = 1e-05
Identities = 17/117 (14%), Positives = 34/117 (29%), Gaps = 40/117 (34%)
Query: 33 NTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPIS 92
+ + G + G SL G + + N L VW + N S
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLVLYDNNR---------AVWASGTNGKAS 50
Query: 93 DERGTLT-IGN----------------------------DGNLMVLNGNSIAVWSSN 120
+ GN D N+++ + ++ A+W+++
Sbjct: 51 GCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATH 107
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 41.3 bits (96), Expect = 5e-05
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 27/98 (27%)
Query: 91 ISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSE------ 144
+++ I ND N +VL N+ AVW+S + ++ +++DGNL++ +
Sbjct: 16 LAEGGYLFIIQNDCN-LVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 145 --------------DIGNL------GKAYWQSFNHPTD 162
N+ A W + + +
Sbjct: 75 NTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 39 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (84), Expect = 4e-04
Identities = 15/31 (48%), Positives = 19/31 (61%)
Query: 299 DDCELYNFCGNFGICNALGSTKCTCMEGFVP 329
D+C + N CGN N +G +CTC EGF P
Sbjct: 2 DECSVGNPCGNGTCKNVIGGFECTCEEGFEP 32
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.1 bits (81), Expect = 0.001
Identities = 15/38 (39%), Positives = 21/38 (55%), Gaps = 2/38 (5%)
Query: 299 DDCELY-NFCGNFGIC-NALGSTKCTCMEGFVPKHFEQ 334
D+C L N C + G C N LGS +C C++G+ E
Sbjct: 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEI 41
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 854 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.83 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.82 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.65 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.55 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.42 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.22 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.1 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.09 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.95 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.73 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.82 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.68 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 83.83 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=411.89 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=204.2
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|++.++||+|+||+||+|+.+ +|+.||||++.... .+..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57889999999999999999764 68999999997543 33456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 3346999999999999999999999998 99999999999999999999999999998754444
Q ss_pred cccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........+... .......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~~~-------- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKTYL-------- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCTTS--------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCC--------
Confidence 444556789999999999988776 578999999999999999999997543322222111 1111100
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.........+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112246778899999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=414.58 Aligned_cols=263 Identities=30% Similarity=0.460 Sum_probs=204.0
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||+||+|+.+ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357888999999999999999874 36999998654 34456789999999999999999999998754 56899999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+++|+|.+++... ...+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998643 245999999999999999999999988 9999999999999999999999999998765433
Q ss_pred Ccccccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+...+ ..+.. .|
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~----~~~~~----~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMV----GRGYL----SP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHH----HHTSC----CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHH----hcCCC----CC
Confidence 3344456789999999999864 3589999999999999999999999863211 11122221 12111 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCC
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTL 814 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~ 814 (854)
.+ ..........+.+++.+||+.||++|||++||++.|+.+...+
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11 0111222357888999999999999999999999999875443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=410.14 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=200.5
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|+..++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||++++++|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467788999999999999999988899999999753 4456789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|+|.+++... ...+++..++.++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 99999988543 345899999999999999999999998 99999999999999999999999999987643221 2
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
......||+.|+|||++.+..|+.++|||||||++|||+|++.|+... .....+...+. .+. ....|.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~~~~~~~i~----~~~--~~~~p~----- 225 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDIS----TGF--RLYKPR----- 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCHHHHHHHHH----HTC--CCCCCT-----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCHHHHHHHHH----hcC--CCCCcc-----
Confidence 233467899999999999999999999999999999999965554321 12222222221 111 111121
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
....++.+++.+||+.||++||||+||++.|+++
T Consensus 226 --~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1234688999999999999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=406.05 Aligned_cols=249 Identities=23% Similarity=0.389 Sum_probs=208.3
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999975 469999999998766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+... .
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~ 170 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 170 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--c
Confidence 9999998873 235899999999999999999999998 999999999999999999999999999976422 2
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+........+.. .+ .
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~-~~-------~ 237 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTP-EL-------Q 237 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSC-CC-------S
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCC-CC-------C
Confidence 234456899999999999999999999999999999999999999863211 1112222222111 11 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222356888999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=406.73 Aligned_cols=256 Identities=32% Similarity=0.452 Sum_probs=207.6
Q ss_pred hcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.++|++.++||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999988899999999754 3456789999999999999999999998754 5679999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+++... ....+++.+++.|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+...... .
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 999999987543 2345899999999999999999999988 9999999999999999999999999999764322 1
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+..... ...+...+ ..+. .+..
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i----~~~~-----~~~~--- 231 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNL----ERGY-----RMVR--- 231 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH----HTTC-----CCCC---
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHH----HhcC-----CCCC---
Confidence 223346789999999999999999999999999999999997766543211 11222221 1111 1111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
+......+.+++.+||+.||++||||.||++.|+..
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 112234688899999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-48 Score=412.96 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=212.0
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|++.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467888899999999999999865 5889999998654 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+++|+|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~- 169 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 169 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence 9999999998543 2346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 693 EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
........|++.|+|||++.+..|+.++|||||||++|||++|+.|+..... ...+.+ ....+. +.
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~----~i~~~~---------~~ 235 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYE----LLEKDY---------RM 235 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHH----HHHTTC---------CC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHH----HHhcCC---------CC
Confidence 2223345688999999999999999999999999999999998877643221 112222 222221 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
..+......+.+++.+||+.||++|||++||++.|+.+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233578899999999999999999999999988744
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=401.96 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=205.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999764 6889999998643 3345678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999999984 3456999999999999999999999998 99999999999999999999999999986532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+...+ ..... .+
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i----~~~~~------~~ 223 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRI----SRVEF------TF 223 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHH----HTTCC------CC
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--CHHHHHHHH----HcCCC------CC
Confidence 2334568999999999999999999999999999999999999998632 111222221 11111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ....+.+++.+||+.||++|||++|+++
T Consensus 224 p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDF----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 2346788999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-48 Score=415.24 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=197.3
Q ss_pred cCcccCcccccCCcccEEEeEcCC-C---cEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-G---QDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.++||+|+||+||+|+.+. + ..||||++... .....++|.+|+++|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456667899999999999997643 3 25889988654 334567899999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++|+|.+++... ...+++.+++.++.|||+||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988542 345899999999999999999999988 99999999999999999999999999987643
Q ss_pred ccCccc---ccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 690 NQNEAN---TNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 690 ~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
...... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.... ...+...+ ..+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i----~~~~~--- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAI----EQDYR--- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH----HTTCC---
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCC---
Confidence 322211 222457899999999999999999999999999999998 888886321 11222222 12111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
...+......+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122234578889999999999999999999999988643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=398.24 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=211.2
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|+..++||+|+||+||+|+.++++.||||+++.. ....++|.+|+.++++++||||++++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578889999999999999999988889999999764 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|+|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-ce
Confidence 99999997543 345889999999999999999999988 9999999999999999999999999998764322 22
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++...+ ..+. ....|.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~~~i----~~~~--~~~~p~---- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHI----AQGL--RLYRPH---- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHH----HTTC--CCCCCT----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HHHHHHHH----HhCC--CCCCcc----
Confidence 3334678999999999999999999999999999999998 788876332 22222222 2221 111221
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.....+.+++.+||+.||++|||++||++.|..+
T Consensus 225 ---~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 ---LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2224788999999999999999999999998653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=403.36 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=206.3
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
+.|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56888999999999999999764 68999999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|..++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 99999998743 2345999999999999999999999998 999999999999999999999999999865321 1
Q ss_pred ccccccccccccccceeec-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 694 ANTNRVVGTYGYMAPEYAM-----EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||.... .......+ ... ....+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~~~~~~i---~~~-~~~~~--- 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKI---AKS-EPPTL--- 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHHH---HHS-CCCCC---
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHH---HcC-CCCCC---
Confidence 2233468999999999984 5568999999999999999999999986432 12222222 111 11111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+......+.+++.+||+.||++|||++|+++
T Consensus 236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223356888999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=401.60 Aligned_cols=260 Identities=29% Similarity=0.405 Sum_probs=206.1
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMP 614 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~ 614 (854)
++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 578899999999999999999988889999999654 445678999999999999999999999985 466899999999
Q ss_pred CCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCcc
Q 003045 615 NKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNEA 694 (854)
Q Consensus 615 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 694 (854)
+|+|..++... ....++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence 99999888543 2345999999999999999999999998 9999999999999999999999999998764222 22
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSS 774 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 774 (854)
......||+.|+|||++..+.++.++|||||||++|||++|..|+..... ...+...+ ..+. .+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i----~~~~-----~~~~~~-- 237 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQV----ERGY-----RMPCPP-- 237 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH----HTTC-----CCCCCT--
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHH----HhcC-----CCCCCc--
Confidence 23346789999999999999999999999999999999998777653222 11222222 1111 111112
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCCCCC
Q 003045 775 SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETPTLP 815 (854)
Q Consensus 775 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~~~~ 815 (854)
.....+.+++.+||+.||++||||.+|+++|+.......
T Consensus 238 --~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 238 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 223478899999999999999999999999998755443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=411.49 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=206.3
Q ss_pred hcCcccCcccccCCcccEEEeEcCC------CcEEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE------GQDIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 605 (854)
.++|++.++||+|+||+||+|+... ...||+|++... .....+.+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678889999999999999997543 236999998654 334556789999999998 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCccc--------------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCC
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAK--------------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKA 665 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 665 (854)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965432 235899999999999999999999998 99999999
Q ss_pred CcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcc
Q 003045 666 SNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLE 744 (854)
Q Consensus 666 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~ 744 (854)
+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333445678999999999999999999999999999999998 8888863221
Q ss_pred cCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 003045 745 ENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLE 808 (854)
Q Consensus 745 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~ 808 (854)
...+... ...+.. ...+......+.+++.+||+.||++|||++||++.|.
T Consensus 273 -~~~~~~~----~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 -DANFYKL----IQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -SHHHHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHH----HhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1222222 222111 1111222357889999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=400.44 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=194.0
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--GEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV 609 (854)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688899999999999999975 468999999997543 3345678999999999999999999999865 4567999
Q ss_pred EEcCCCCChhhhhcCcc-cccCCCHHHHHHHHHHHHHHHHHhhcCC--CCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 610 YEYMPNKSLDLFIFDPA-KQALLDWTKRFAIIEGIARGLLYLHRDS--RLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 3456999999999999999999999865 23599999999999999999999999999987
Q ss_pred ccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 687 FGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 687 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
+... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+...+ ..+....
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i----~~~~~~~-- 233 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKI----REGKFRR-- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHH----HHTCCCC--
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHH----HcCCCCC--
Confidence 6422 22334578999999999999999999999999999999999999998632 222222222 2222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
+...+ ...+.+++.+||+.||++|||++|+++
T Consensus 234 ---~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---IPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122 246888999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=401.05 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=203.3
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688999999999999999976 46899999999753 3445678999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999874 3456999999999999999999999998 999999999999999999999999999987544
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
..........||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+...+ ..... .+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i----~~~~~------~~ 229 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKI----IKLEY------DF 229 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH----HTTCC------CC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHH----HcCCC------CC
Confidence 4444445578999999999999999999999999999999999999998632 111222221 11111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
... ....+.+++.+||+.||++|||++|++.
T Consensus 230 p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112 2346788999999999999999998743
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=409.36 Aligned_cols=200 Identities=28% Similarity=0.365 Sum_probs=176.9
Q ss_pred HhcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
..++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999985 468999999997643 334567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
||+++|+|.+++. +...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999985 334689999999999999999999974 7 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFR 742 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~ 742 (854)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2234578999999999999999999999999999999999999999643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=392.25 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=196.1
Q ss_pred cccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCeeEEE
Q 003045 537 FSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ----GEEKMLI 609 (854)
Q Consensus 537 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV 609 (854)
|+..++||+|+||+||+|+.. +++.||+|++.... ....+.|.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 455678999999999999764 68899999987542 3345678999999999999999999999875 3457899
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc-cCCCceecccCcceecc
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD-EDMNPKISDFGMARIFG 688 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~ 688 (854)
|||+++|+|.+++. +...+++..+..++.||++||+|||+.+ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999984 3456899999999999999999999976 4599999999999996 57899999999998542
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP 768 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 768 (854)
........||+.|||||++.+ .++.++|||||||++|||++|+.||..... ... +......+......+
T Consensus 167 ----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-~~~----~~~~i~~~~~~~~~~- 235 (270)
T d1t4ha_ 167 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQ----IYRRVTSGVKPASFD- 235 (270)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHH----HHHHHTTTCCCGGGG-
T ss_pred ----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-HHH----HHHHHHcCCCCcccC-
Confidence 223345789999999998865 599999999999999999999999863211 111 122222221111111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 769 NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 769 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 236 ---~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ---KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 1235788999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=400.13 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=201.1
Q ss_pred cCcccCcccccCCcccEEEeEcCCC-----cEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEG-----QDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
+.|+..++||+|+||+||+|.++.. ..||||++.... ....++|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788999999999999976532 369999996543 3345678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+.++++..++... ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998887532 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+..... ...+... ...+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~----i~~~~------ 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKA----INDGF------ 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHH----HHTTC------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHH----HhccC------
Confidence 32221 223345689999999999999999999999999999999998777653222 1122222 22221
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
+...+......+.+++.+||+.||++||||.||++.|+.+..
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111222234578899999999999999999999999988643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=400.19 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=205.0
Q ss_pred cCcccCc-ccccCCcccEEEeEcC---CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGN-KLGRGGFGPVHKGKLP---EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|.+.+ +||+|+||+||+|..+ ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455555 5999999999999653 35579999997543 3446789999999999999999999999864 568999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++|+|.+++... +..+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987532 346899999999999999999999988 99999999999999999999999999998753
Q ss_pred ccCc-ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 690 NQNE-ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 690 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.... ..++...+ ..+....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i----~~~~~~~--- 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFI----EQGKRME--- 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHH----HTTCCCC---
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCCCC---
Confidence 3222 22334578999999999999999999999999999999998 899986422 22222222 2222111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 233 ------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122335788999999999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=399.63 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=197.5
Q ss_pred cccccCCcccEEEeEcC---CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcCCC
Q 003045 541 NKLGRGGFGPVHKGKLP---EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYMPN 615 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~ 615 (854)
++||+|+||+||+|.++ .++.||||+++... ....++|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999753 35689999996542 3345689999999999999999999999864 567899999999
Q ss_pred CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc-c
Q 003045 616 KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE-A 694 (854)
Q Consensus 616 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 694 (854)
|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999984 3346999999999999999999999988 999999999999999999999999999976433222 2
Q ss_pred cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCCC
Q 003045 695 NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDS 773 (854)
Q Consensus 695 ~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 773 (854)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..++... ...+... .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~----i~~~~~~---------~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAM----LEKGERM---------G 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH----HHTTCCC---------C
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHH----HHcCCCC---------C
Confidence 2334678999999999999999999999999999999998 899986321 1122222 2222111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 774 SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 774 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+......+.+++.+||+.||++|||++||+++|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122235788899999999999999999999988753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-46 Score=402.82 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=212.5
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccccc-cCHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKSG-QGLEEFKNEIILIAKLQHRNLVRLLGCCI 601 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 601 (854)
+++...++|++.++||+|+||+||+|+.+ +++.||||+++.... ...++|.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999753 457899999975433 34567999999999999999999999999
Q ss_pred eCCeeEEEEEcCCCCChhhhhcCcc---------------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEE
Q 003045 602 QGEEKMLIYEYMPNKSLDLFIFDPA---------------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIH 660 (854)
Q Consensus 602 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 660 (854)
+.+..+++|||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999985321 1234899999999999999999999988 999
Q ss_pred cccCCCcEEEccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCC-CC
Q 003045 661 RDLKASNILLDEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR-NT 739 (854)
Q Consensus 661 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~-p~ 739 (854)
|||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987644433344455778999999999999999999999999999999999975 44
Q ss_pred CCCcccCchHHHHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 740 SFRLEENSSLIEHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 740 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
... ...++... ...+.... . +.....++.+|+.+||+.+|++||||.||+++|++++
T Consensus 244 ~~~--~~~e~~~~----v~~~~~~~-----~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGM--AHEEVIYY----VRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTS--CHHHHHHH----HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC--CHHHHHHH----HHcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 321 11222222 22222211 1 1122346889999999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-46 Score=400.32 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=190.1
Q ss_pred HhcCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 533 ATNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 533 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
..+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999764 68999999997543 233456889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc---cCCCceecccCcceec
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMARIF 687 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~ 687 (854)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999853 346999999999999999999999998 99999999999995 5789999999999865
Q ss_pred cCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
.. .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+...+ ... ... ..
T Consensus 161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i---~~~-~~~--~~ 229 (307)
T d1a06a_ 161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQI---LKA-EYE--FD 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH---HTT-CCC--CC
T ss_pred cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHH---hcc-CCC--CC
Confidence 32 222345689999999999999999999999999999999999999986321 11222222 111 110 11
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..... .....+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWD----DISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Ccccc----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 22346788999999999999999999988
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-45 Score=401.25 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=207.2
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999975 468999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc--cCCCceecccCcceeccCcc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD--EDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 691 (854)
++|+|.+++... ...+++.++..++.||+.||.|||+.+ ||||||||+|||++ .++.+||+|||+++.+..
T Consensus 106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 999999988542 345999999999999999999999998 99999999999996 467899999999987642
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+ .... . ...
T Consensus 179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i---~~~~-~------~~~ 245 (350)
T d1koaa2 179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNV---KSCD-W------NMD 245 (350)
T ss_dssp -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH---HHTC-C------CSC
T ss_pred -ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHH---HhCC-C------CCC
Confidence 22334578999999999999999999999999999999999999998632 222222222 1111 1 000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122346788999999999999999999988
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=397.17 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=200.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV 609 (854)
.+.|+..++||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 35688899999999999999975 4688999999976432 3345789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++|+|..++. ....+++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999987663 3356999999999999999999999998 99999999999999999999999999986531
Q ss_pred ccCcccccccccccccccceeecc---CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAME---GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... ..+.+....... ...+.
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~i~~~~-~~~~~ 235 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNE-SPALQ 235 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC-CCCCS
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhCC-CCCCC
Confidence 234679999999999864 468999999999999999999999986321 112222222211 11111
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ... ...+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 112 246788999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-45 Score=398.98 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=206.8
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999975 469999999998765555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc--cCCCceecccCcceeccCcc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD--EDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 691 (854)
++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|..+..
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC--
Confidence 99999887643 2345899999999999999999999998 99999999999998 678999999999998642
Q ss_pred CcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
........||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+...+. . .... ......
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~---~-~~~~--~~~~~~ 252 (352)
T d1koba_ 182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVK---R-CDWE--FDEDAF 252 (352)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHH---H-CCCC--CCSSTT
T ss_pred -CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHH---h-CCCC--CCcccc
Confidence 22344568999999999999999999999999999999999999998632 1112222221 1 1110 111111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SS----VSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12 2346788999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=390.54 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=204.5
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc------ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS------GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999986 468999999996532 22467899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC----CceecccC
Q 003045 607 MLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM----NPKISDFG 682 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFG 682 (854)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999843 346999999999999999999999998 99999999999998776 49999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA 762 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 762 (854)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ . ....
T Consensus 163 ~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i---~-~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANV---S-AVNY 233 (293)
T ss_dssp TCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---H-TTCC
T ss_pred hhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--HHHHHHHH---H-hcCC
Confidence 99876422 22334678999999999999999999999999999999999999986321 11222211 1 1111
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 763 MELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 763 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
. ............+.+++.+||+.||++|||++|+++
T Consensus 234 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000112246788999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=393.79 Aligned_cols=260 Identities=28% Similarity=0.411 Sum_probs=199.1
Q ss_pred hcCcccCcccccCCcccEEEeEcC------CCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC-
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE- 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~- 604 (854)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|+.++.++ +|+||+++++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467899999999999999999742 34689999987543 33456788888888887 6899999999987654
Q ss_pred eeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999864322 235899999999999999999999998 99999999999999
Q ss_pred cCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCC-CCCCCcccCchHH
Q 003045 672 EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR-NTSFRLEENSSLI 750 (854)
Q Consensus 672 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~-p~~~~~~~~~~l~ 750 (854)
+++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. |+.. ......+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~-~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-VKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCCSHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 999999999999987654444444556789999999999999999999999999999999999865 5542 22222222
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+ ..+... .... .....+.+++.+||+.||++|||++||++.|+.+
T Consensus 248 ~~~----~~~~~~-----~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 248 RRL----KEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHH----HHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----hcCCCC-----CCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222 222211 1111 1234688999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=396.50 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=200.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCc----EEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQ----DIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
+.|++.++||+|+||+||+|+.. +|+ +||+|+++.. .....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999754 444 6899988653 445678899999999999999999999999864 5678
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
++||+.+++|.+++.. ....+++..++.++.|||+||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3456899999999999999999999998 9999999999999999999999999999875
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
............||+.|+|||++.++.|+.++|||||||++|||+| |..|+... ....+...+. .+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~~~~~~~i~----~~~~----- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILE----KGER----- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CGGGHHHHHH----HTCC-----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHH----cCCC-----
Confidence 4444444445678999999999999999999999999999999999 67776532 2222333221 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111122335688899999999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=385.50 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=196.9
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CeeEEEEEcC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-EEKMLIYEYM 613 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lV~Ey~ 613 (854)
++|++.++||+|+||.||+|+. .|++||||+++.. ...++|.+|++++++++||||+++++++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4577788999999999999998 5789999999653 4557899999999999999999999998654 5689999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----
Confidence 999999998543 2235899999999999999999999988 99999999999999999999999999986432
Q ss_pred ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCCC
Q 003045 694 ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIRD 772 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 772 (854)
......+|..|+|||++.++.++.++|||||||++|||+| |+.|+... ...++...+ ..+.. +.
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i----~~~~~-----~~--- 220 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRV----EKGYK-----MD--- 220 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHH----TTTCC-----CC---
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHH----HcCCC-----CC---
Confidence 2233567899999999999999999999999999999998 56665432 222333332 12111 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 773 SSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 773 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+.....++.+++.+||+.||++|||+.||+++|+.+
T Consensus 221 -~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 221 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1222235788999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=389.96 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=205.9
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788999999999999999975 47999999999754 3345678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~- 157 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc-
Confidence 9999999999884 3456899999999999999999999998 99999999999999999999999999986532
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
........+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ...+...+ ..+.. .+
T Consensus 158 -~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i----~~~~~------~~ 224 (337)
T d1o6la_ 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELI----LMEEI------RF 224 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH----HHCCC------CC
T ss_pred -CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHH----hcCCC------CC
Confidence 2233445789999999999999999999999999999999999999986432 12222222 11111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.... ...+.+++.+||+.||++||+ ++|+++
T Consensus 225 p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 PRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122 246788999999999999995 788876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=386.35 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=195.3
Q ss_pred hcCcccCcccccCCcccEEEeEcCC----CcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLPE----GQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKML 608 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 608 (854)
.++|++.+.||+|+||+||+|+... +..||||+++... ....+.|.+|++++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999997543 3468999886543 334567999999999999999999999985 567899
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceecc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFG 688 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 688 (854)
||||+++|+|..++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988753 3346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccccC
Q 003045 689 FNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMELVD 767 (854)
Q Consensus 689 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 767 (854)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..|+... ....+...+. .+...
T Consensus 160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i~----~~~~~---- 228 (273)
T d1mp8a_ 160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIE----NGERL---- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHH----TTCCC----
T ss_pred CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHHH----cCCCC----
Confidence 222 223344678999999999999999999999999999999998 78777643 2223333321 22111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 768 PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 768 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.... .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 229 -~~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 -PMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112 2235788999999999999999999999999765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=390.36 Aligned_cols=261 Identities=29% Similarity=0.428 Sum_probs=211.8
Q ss_pred hcCcccCcccccCCcccEEEeEc------CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCe
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL------PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 605 (854)
.++|++.++||+|+||.||+|+. ..++.||||+++... .....+|.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46788899999999999999964 346789999997643 33456789999999999 69999999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcc---------------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEE
Q 003045 606 KMLIYEYMPNKSLDLFIFDPA---------------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILL 670 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 670 (854)
.++||||+++|+|.++++... ....+++..+..++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986432 2235899999999999999999999998 9999999999999
Q ss_pred ccCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHH
Q 003045 671 DEDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLI 750 (854)
Q Consensus 671 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~ 750 (854)
+.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999987544444444557899999999999999999999999999999999996655543332222222
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
..+ ..+. +...+......+.+++.+||+.||++|||++||+++|++.
T Consensus 259 ~~i----~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 KMI----KEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHH----HHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----hcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222 2211 1111112235788999999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-44 Score=386.19 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=203.5
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688899999999999999986 46899999999753 3445678999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 9999999998884 3445788999999999999999999998 99999999999999999999999999987632
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+... .... .. ..
T Consensus 157 ----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~---i~~~-~~------~~ 220 (316)
T d1fota_ 157 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEK---ILNA-EL------RF 220 (316)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHH---HHHC-CC------CC
T ss_pred ----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--CHHHHHHH---HHcC-CC------CC
Confidence 233478999999999999999999999999999999999999998632 11122222 1111 11 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.... ...+.+++.+||+.||++|| |++|+++
T Consensus 221 p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112 24678899999999999996 8999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=390.70 Aligned_cols=259 Identities=29% Similarity=0.418 Sum_probs=206.6
Q ss_pred cCcccCcccccCCcccEEEeEcCC--------CcEEEEEEeccccc-cCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE--------GQDIAVKRLSRKSG-QGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGE 604 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 604 (854)
++|++.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578888999999999999996422 34799999976533 3457889999999998 7999999999999999
Q ss_pred eeEEEEEcCCCCChhhhhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAK-------------QALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD 671 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 671 (854)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999965431 245899999999999999999999998 99999999999999
Q ss_pred cCCCceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHH
Q 003045 672 EDMNPKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLI 750 (854)
Q Consensus 672 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~ 750 (854)
.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..|+.... ...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~~-- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEE-- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH--
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HHH--
Confidence 999999999999998765444444556788999999999999999999999999999999998 566665221 112
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 751 EHVWNLWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 751 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
+...+..+.... .+......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 246 --~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 --LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp --HHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 222222222111 11122346889999999999999999999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=387.90 Aligned_cols=244 Identities=22% Similarity=0.249 Sum_probs=204.2
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~ 610 (854)
++|++.++||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5789999999999999999976 46999999998643 2345678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCc
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFN 690 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 690 (854)
||+.+|+|..++. ....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 9999999999884 3346999999999999999999999998 99999999999999999999999999997642
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
......||+.|||||++.+..|+.++|||||||++|||++|+.||... ....+...+ . .+.. ..
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i---~-~~~~------~~ 257 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKI---V-SGKV------RF 257 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH---H-HCCC------CC
T ss_pred ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHH---h-cCCC------CC
Confidence 233468999999999999999999999999999999999999998632 112222222 1 1111 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRP-----TMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~eVl~ 805 (854)
.... ...+.+++.+||+.||.+|+ |++|+++
T Consensus 258 p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 PSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1122 34678899999999999994 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.1e-44 Score=379.04 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=201.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc---cCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----e
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG---QGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE----E 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~ 605 (854)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999975 5799999999976432 33457899999999999999999999987654 3
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+++++|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998874 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred eccCccC-cccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 686 IFGFNQN-EANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 686 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+........+....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQHVREDPIPP 234 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCCCCCG
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----HHHHHHHHHhcCCCCC
Confidence 6543222 223445689999999999999999999999999999999999999986321 1122222222221111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhcc
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRP-TMASVVLMLESE 810 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~eVl~~L~~~ 810 (854)
....... ...+.+++.+||+.||++|| |+++++..|..+
T Consensus 235 ---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 235 ---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0111122 24688899999999999999 899999988754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=391.54 Aligned_cols=256 Identities=29% Similarity=0.420 Sum_probs=202.9
Q ss_pred cCcccCcccccCCcccEEEeEcCC-Cc--EEEEEEeccc-cccCHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPE-GQ--DIAVKRLSRK-SGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.++||+|+||+||+|++++ +. .||||++... .....+.|.+|+++|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999998654 43 5788887643 344567899999999999 799999999999999999999
Q ss_pred EEcCCCCChhhhhcCc-------------ccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCc
Q 003045 610 YEYMPNKSLDLFIFDP-------------AKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNP 676 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 676 (854)
|||+++|+|.++++.. .....+++..+++++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23356999999999999999999999998 9999999999999999999
Q ss_pred eecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCC-CCCCcccCchHHHHHHH
Q 003045 677 KISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRN-TSFRLEENSSLIEHVWN 755 (854)
Q Consensus 677 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p-~~~~~~~~~~l~~~~~~ 755 (854)
||+|||+++.... ........||..|+|||.+.+..++.++|||||||++|||++|..| +.. .....+...
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--~~~~~~~~~--- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEK--- 238 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHH---
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--CCHHHHHHH---
Confidence 9999999986532 1222345789999999999999999999999999999999998764 432 111122221
Q ss_pred HhhcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccC
Q 003045 756 LWNEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESET 811 (854)
Q Consensus 756 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~ 811 (854)
...+.. +. .+......+.+++.+||+.||++||||.||++.|+.+.
T Consensus 239 -i~~~~~-----~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 -LPQGYR-----LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -GGGTCC-----CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHhcCC-----CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222111 11 11223357889999999999999999999999998874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=382.76 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=195.7
Q ss_pred cCcccCcccccCCcccEEEeEcC--CC--cEEEEEEeccc---cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP--EG--QDIAVKRLSRK---SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
++|++.+.||+|+||.||+|+.. ++ ..||||++... ..+..++|.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999753 23 36899998654 23445789999999999999999999999965 5678
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++|++.+++.. ....+++..++.++.|||+||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988754 2345999999999999999999999988 999999999999999999999999999987
Q ss_pred cCccCcc-cccccccccccccceeeccCCCCcccchhhHHHHHHHHHh-CCCCCCCCcccCchHHHHHHHHhhcCCcccc
Q 003045 688 GFNQNEA-NTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVS-GRRNTSFRLEENSSLIEHVWNLWNEGKAMEL 765 (854)
Q Consensus 688 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 765 (854)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||... ...... ......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~---~~i~~~~~~~-- 234 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQIL---HKIDKEGERL-- 234 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHH---HHHHTSCCCC--
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHH---HHHHhCCCCC--
Confidence 5433322 2334567889999999999999999999999999999998 88887532 111222 2222222111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 766 VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 766 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
. .+......+.+++.+||+.||++|||++||++.|++.
T Consensus 235 ---~----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ---P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1112234688899999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-43 Score=374.41 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=202.6
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccccc---------CHHHHHHHHHHHHhcC-CCceeeeeeeEEeC
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQ---------GLEEFKNEIILIAKLQ-HRNLVRLLGCCIQG 603 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~ 603 (854)
++|++.++||+|+||+||+|+. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999975 47899999999764321 2345889999999997 99999999999999
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
+..++||||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999995 3456999999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCcccccccccccccccceeecc------CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh
Q 003045 684 ARIFGFNQNEANTNRVVGTYGYMAPEYAME------GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW 757 (854)
Q Consensus 684 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~ 757 (854)
++.+... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+ .
T Consensus 157 a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i---~ 228 (277)
T d1phka_ 157 SCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMI---M 228 (277)
T ss_dssp CEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---H
T ss_pred eeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHH---H
Confidence 9976432 22344689999999999863 457889999999999999999999987421 11112111 1
Q ss_pred hcCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 758 NEGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 758 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.+... . ...........+.+++.+||+.||++|||++||++
T Consensus 229 -~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 -SGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -hCCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 0 11111122347888999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=382.65 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=202.3
Q ss_pred CcccccCCcccEEEeEcCCC----cEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CeeEEEEEcC
Q 003045 540 GNKLGRGGFGPVHKGKLPEG----QDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-EEKMLIYEYM 613 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lV~Ey~ 613 (854)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999986442 25899999753 444567899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
++|+|.+++... ...+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999988643 345788999999999999999999998 999999999999999999999999999976433222
Q ss_pred --ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCCC
Q 003045 694 --ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNIR 771 (854)
Q Consensus 694 --~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 771 (854)
.......||..|+|||++....++.++||||||+++|||++|+.|+...... .++...+ ..+.. ...|
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i----~~g~~--~~~p--- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYL----LQGRR--LLQP--- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH----HTTCC--CCCC---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHH----HcCCC--CCCc---
Confidence 1223457899999999999999999999999999999999998887643221 1222222 12211 1111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhccCC
Q 003045 772 DSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESETP 812 (854)
Q Consensus 772 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~~~ 812 (854)
......+.+++.+||+.||++||+|.||++.|+.+..
T Consensus 257 ----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 ----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1123468899999999999999999999999998843
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=385.47 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=209.8
Q ss_pred hcCcccCcccccCCcccEEEeEcC------CCcEEEEEEeccc-cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCee
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP------EGQDIAVKRLSRK-SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEK 606 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 606 (854)
.++|...++||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999753 3578999999754 333445789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhcCcc-------cccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceec
Q 003045 607 MLIYEYMPNKSLDLFIFDPA-------KQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKIS 679 (854)
Q Consensus 607 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 679 (854)
++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999885421 2234789999999999999999999988 9999999999999999999999
Q ss_pred ccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCC-CCCCCcccCchHHHHHHHHhh
Q 003045 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRR-NTSFRLEENSSLIEHVWNLWN 758 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~-p~~~~~~~~~~l~~~~~~~~~ 758 (854)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||.. |+.. ......... ..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--~~~~~~~~~---i~- 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--LSNEQVLRF---VM- 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--SCHHHHHHH---HH-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--CCHHHHHHH---HH-
Confidence 9999987754444444455678999999999999999999999999999999999964 4432 111122222 11
Q ss_pred cCCcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 759 EGKAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 759 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+.... .+......+.+++.+||+.+|++||||.||+++|++.
T Consensus 250 ~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222111 1112234788999999999999999999999999887
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=381.52 Aligned_cols=261 Identities=22% Similarity=0.253 Sum_probs=198.1
Q ss_pred CcccccCCcccEEEeEcC-CCcEEEEEEecccccc-----CHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEcC
Q 003045 540 GNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQ-----GLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEYM 613 (854)
Q Consensus 540 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~ 613 (854)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999864 6899999998654221 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccCc
Q 003045 614 PNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQNE 693 (854)
Q Consensus 614 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 693 (854)
+++++..+.. ....+++.++..+++||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--N 154 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--C
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--c
Confidence 9988776652 3456888999999999999999999998 999999999999999999999999999876432 2
Q ss_pred ccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCC----
Q 003045 694 ANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDP---- 768 (854)
Q Consensus 694 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~---- 768 (854)
.......||+.|+|||++.. ..|+.++|||||||++|||++|..||.... ..+....+.+.........+.+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchhccc
Confidence 23334679999999999865 468999999999999999999998886432 22223333322211111110000
Q ss_pred -----CCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 769 -----NIRDSSSQ-----NQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 769 -----~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
......+. .....+.+++.+||+.||++|||++|+++ .+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 00001111 12346889999999999999999999987 45543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=384.14 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=199.8
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHH--HHHHHHHHhcCCCceeeeeeeEEeCC----eeEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEF--KNEIILIAKLQHRNLVRLLGCCIQGE----EKML 608 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~l 608 (854)
+.|...++||+|+||.||+|++ +|+.||||+++... .+++ ..|+..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566778999999999999987 68999999986532 2333 34555666789999999999998654 5789
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceEEcccCCCcEEEccCCCceecccCc
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS-----RLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
||||+++|+|..++.. ..++|..++.++.|+|.||+|||... .++|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999953 35899999999999999999999741 24599999999999999999999999999
Q ss_pred ceeccCccCc--ccccccccccccccceeeccCC------CCcccchhhHHHHHHHHHhCCCCCCCCcccCc--------
Q 003045 684 ARIFGFNQNE--ANTNRVVGTYGYMAPEYAMEGL------FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS-------- 747 (854)
Q Consensus 684 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~------~s~~~DVwSlGvil~elltG~~p~~~~~~~~~-------- 747 (854)
++........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9987433221 2234578999999999987643 67789999999999999999887643221110
Q ss_pred -hHHHHHHHHhhcCCcccccCCCCCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 748 -SLIEHVWNLWNEGKAMELVDPNIRDSS-SQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 748 -~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
............+ ...|.+.... +.+....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1112222222111 1122222211 234567789999999999999999999999999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-43 Score=386.57 Aligned_cols=248 Identities=26% Similarity=0.284 Sum_probs=197.6
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc---ccCHHHHHHH---HHHHHhcCCCceeeeeeeEEeCCeeE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS---GQGLEEFKNE---IILIAKLQHRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E---i~~l~~l~h~niv~l~~~~~~~~~~~ 607 (854)
++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999764 68999999986431 2233344444 66677778999999999999999999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
+||||+++|+|..++. ....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 3456889999999999999999999998 999999999999999999999999999976
Q ss_pred cCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccccc
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELV 766 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 766 (854)
... ......||+.|+|||++.. ..|+.++|||||||++|||++|+.||...... ...... ......
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~-~~~~~~------ 224 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEID-RMTLTM------ 224 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHH-HHSSSC------
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-HhcccC------
Confidence 422 2344689999999999875 56899999999999999999999998743222 121111 111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 767 DPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 767 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
.+...... ...+.+++.+||+.||++||| ++|+++
T Consensus 225 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111122 246788999999999999999 688875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=379.47 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=203.5
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
.++|++.++||+|+||+||+|... +++.||||+++... .....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367899999999999999999764 68899999997643 3345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC--CCceecccCcceeccCc
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED--MNPKISDFGMARIFGFN 690 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~ 690 (854)
+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 9999999998532 235899999999999999999999998 9999999999999854 4799999999987632
Q ss_pred cCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCCC
Q 003045 691 QNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPNI 770 (854)
Q Consensus 691 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 770 (854)
........+|+.|+|||.+.+..|+.++||||+||++|||++|+.||.... ...+...+ .... .. .+...
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--~~~~~~~i---~~~~-~~--~~~~~ 226 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENI---MNAE-YT--FDEEA 226 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHH---HHTC-CC--CCHHH
T ss_pred --CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--HHHHHHHH---HhCC-CC--CChhh
Confidence 222344678999999999999999999999999999999999999986432 12222222 1111 10 00000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 771 RDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 771 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 245788999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=378.41 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=202.4
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccc---cccCHHHHHHHHHHHH-hcCCCceeeeeeeEEeCCeeEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRK---SGQGLEEFKNEIILIA-KLQHRNLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lV 609 (854)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|+.++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999764 6899999999753 2345566777877765 68999999999999999999999
Q ss_pred EEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccC
Q 003045 610 YEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGF 689 (854)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 689 (854)
|||+++|+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3446899999999999999999999998 99999999999999999999999999986532
Q ss_pred ccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccccCCC
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMELVDPN 769 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 769 (854)
.........||+.|+|||++.+..|+.++|||||||++|||++|+.||... ....+...+ ..+. +.
T Consensus 156 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i----~~~~------~~ 221 (320)
T d1xjda_ 156 --GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSI----RMDN------PF 221 (320)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHH----HHCC------CC
T ss_pred --ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHH----HcCC------CC
Confidence 223344568999999999999999999999999999999999999999632 222222222 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 003045 770 IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMA-SVVL 805 (854)
Q Consensus 770 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-eVl~ 805 (854)
..... ...+.+++.+||+.||++|||+. |+++
T Consensus 222 ~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11122 34678899999999999999995 7754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-43 Score=374.20 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=202.5
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999975 568999999996542 2346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
|+.++.+...... ....+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-- 154 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV-- 154 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC--
Confidence 9987655544322 3345999999999999999999999998 99999999999999999999999999987642
Q ss_pred CcccccccccccccccceeeccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC---ccccc-
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK---AMELV- 766 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~~~- 766 (854)
.........||+.|+|||++.... ++.++||||+||++|+|++|+.||..... ......+........ .....
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHHHHHhcCCCchhhcccccc
Confidence 223344568999999999887665 57899999999999999999999864321 111111111111110 00000
Q ss_pred CCCCCC------CCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 767 DPNIRD------SSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 767 d~~l~~------~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
.+.... ... ......+.+++.+||+.||++|||+.|+++ .++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000 000 112246788999999999999999999998 47665
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=379.22 Aligned_cols=251 Identities=19% Similarity=0.196 Sum_probs=195.9
Q ss_pred cCcccCc-ccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhc-CCCceeeeeeeEEe----CCeeE
Q 003045 535 NYFSEGN-KLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKL-QHRNLVRLLGCCIQ----GEEKM 607 (854)
Q Consensus 535 ~~f~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~~~ 607 (854)
++|.+.+ .||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5677654 699999999999975 5689999999864 35678899987665 89999999999875 35689
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc---CCCceecccCcc
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE---DMNPKISDFGMA 684 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla 684 (854)
+||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999996432 245899999999999999999999998 999999999999985 457999999999
Q ss_pred eeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCccc
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAME 764 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 764 (854)
+..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+......+.
T Consensus 162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~--~~~~~~~~~~i~~~~--- 233 (335)
T d2ozaa1 162 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQ--- 233 (335)
T ss_dssp EECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC--C--------CCCSCS---
T ss_pred eeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH--HHHHHHHHHHHhcCC---
Confidence 876432 233456899999999999999999999999999999999999999863221 111111111110000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..............+.+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111111233457889999999999999999999988
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-42 Score=370.77 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=201.2
Q ss_pred cCcccCcccccCCcccEEEeEcCCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey 612 (854)
++|++.++||+|+||+||+|+.++|+.||||++... .....+.+.+|+.+|++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578899999999999999999889999999999654 233467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQN 692 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 692 (854)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-- 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-- 153 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence 99887777763 3456999999999999999999999988 999999999999999999999999999876422
Q ss_pred cccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcccc------
Q 003045 693 EANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAMEL------ 765 (854)
Q Consensus 693 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~------ 765 (854)
........|++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+....+............
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhccchhhh
Confidence 2223345789999999998754 57999999999999999999999986422 11222222221111110000
Q ss_pred ---------cCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 766 ---------VDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 766 ---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+.............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000111122346789999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=367.11 Aligned_cols=240 Identities=24% Similarity=0.353 Sum_probs=194.9
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccc------cCHHHHHHHHHHHHhcC--CCceeeeeeeEEeCC
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSG------QGLEEFKNEIILIAKLQ--HRNLVRLLGCCIQGE 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~ 604 (854)
.++|++.++||+|+||+||+|+. .+|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999975 4689999999975421 12244678999999997 899999999999999
Q ss_pred eeEEEEEcCCC-CChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccC-CCceecccC
Q 003045 605 EKMLIYEYMPN-KSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDED-MNPKISDFG 682 (854)
Q Consensus 605 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFG 682 (854)
..++||||+.+ +++.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999986 56666663 3456999999999999999999999998 9999999999999854 789999999
Q ss_pred cceeccCccCcccccccccccccccceeeccCCC-CcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 683 MARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLF-SVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 683 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
+++.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||... ..+ ... .
T Consensus 157 ~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~i---~~~-~ 220 (273)
T d1xwsa_ 157 SGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------EEI---IRG-Q 220 (273)
T ss_dssp TCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHH---HHC-C
T ss_pred cceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--------hHH---hhc-c
Confidence 9986532 23345689999999999987765 57799999999999999999998631 011 111 1
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.......+ ..+.+++.+||+.||++|||++|+++
T Consensus 221 ------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01112222 46788999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=369.07 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=198.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CC-CcEEEEEEecccc--ccCHHHHHHHHHHHHhc---CCCceeeeeeeEEe----
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PE-GQDIAVKRLSRKS--GQGLEEFKNEIILIAKL---QHRNLVRLLGCCIQ---- 602 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~---- 602 (854)
.++|++.++||+|+||+||+|+. ++ ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999975 34 5679999986542 22344567888887776 79999999999864
Q ss_pred -CCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceeccc
Q 003045 603 -GEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDF 681 (854)
Q Consensus 603 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 681 (854)
....+++|||++++.+...... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999999877655432 3345889999999999999999999998 999999999999999999999999
Q ss_pred CcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC
Q 003045 682 GMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK 761 (854)
Q Consensus 682 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 761 (854)
|+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .......+........
T Consensus 161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCC
T ss_pred hhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCc
Confidence 99986532 223445789999999999999999999999999999999999999986432 1222222222211110
Q ss_pred cccc----------cC---CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 762 AMEL----------VD---PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 762 ~~~~----------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
...+ .. ..............+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00 00000111122346778999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-41 Score=367.52 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=195.3
Q ss_pred CcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC------CeeEE
Q 003045 536 YFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG------EEKML 608 (854)
Q Consensus 536 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~~l 608 (854)
.|...++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999864 689999999975432 234799999999999999999998653 24689
Q ss_pred EEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceec
Q 003045 609 IYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIF 687 (854)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 687 (854)
||||++++.+..+.........+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999998765555433334456999999999999999999999998 99999999999999775 8999999999876
Q ss_pred cCccCcccccccccccccccceeecc-CCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhc-------
Q 003045 688 GFNQNEANTNRVVGTYGYMAPEYAME-GLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNE------- 759 (854)
Q Consensus 688 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~------- 759 (854)
... .......||..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+......
T Consensus 174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCHHHHH
T ss_pred cCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHHHhCCChHHhhh
Confidence 422 22334689999999998875 5689999999999999999999999864321 1111111111100
Q ss_pred ----C----CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 760 ----G----KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 760 ----~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
. .....................+.+++.+||+.||++|||+.|+++ .++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 000000000000111122346788999999999999999999996 35544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=357.68 Aligned_cols=263 Identities=20% Similarity=0.302 Sum_probs=196.5
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccc--cccCHHHHHHHHHHHHhcCCCceeeeeeeEEe--------C
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRK--SGQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ--------G 603 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~ 603 (854)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7889999999999999999985 57999999998654 33445678999999999999999999998865 3
Q ss_pred CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCc
Q 003045 604 EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGM 683 (854)
Q Consensus 604 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 683 (854)
...++||||++++.+..+. .....+++..+..+++||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999988776655 23345889999999999999999999998 99999999999999999999999999
Q ss_pred ceeccCccCc--ccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcC
Q 003045 684 ARIFGFNQNE--ANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEG 760 (854)
Q Consensus 684 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 760 (854)
++.+...... .......||+.|+|||++.+. .|+.++||||+||++|||++|+.||.... .......+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence 9876532221 222335799999999998765 68999999999999999999999986322 122222222222111
Q ss_pred Cc---ccc--------cCCCCCCCCCH-H------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 761 KA---MEL--------VDPNIRDSSSQ-N------QVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 761 ~~---~~~--------~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.. ... +.......... . ....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 000 00000001111 1 1235678999999999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=352.78 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=204.1
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCCeeEEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E 611 (854)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+++.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999975 578899999996543 3346788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceeccCcc
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIFGFNQ 691 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 691 (854)
++.+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888774 3346889999999999999999999998 9999999999999999999999999999764322
Q ss_pred CcccccccccccccccceeeccCC-CCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc------c
Q 003045 692 NEANTNRVVGTYGYMAPEYAMEGL-FSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM------E 764 (854)
Q Consensus 692 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~------~ 764 (854)
.......++..|+|||++.... ++.++||||+||++|||++|+.|+.... ........+.......... .
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-CHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 2233356788899999987665 6899999999999999999999975322 2222223332222211000 0
Q ss_pred ccC---------CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 765 LVD---------PNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 765 ~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..+ ..............+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00001111222346778899999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=361.47 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=193.8
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE------ 604 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 604 (854)
.++|++.++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999975 469999999997542 233567889999999999999999999997665
Q ss_pred eeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcc
Q 003045 605 EKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMA 684 (854)
Q Consensus 605 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 684 (854)
+.++||||+ +.+|..+. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 55666665 2345999999999999999999999998 999999999999999999999999999
Q ss_pred eeccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCC--
Q 003045 685 RIFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGK-- 761 (854)
Q Consensus 685 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 761 (854)
+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.|+..... ...............
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHH
T ss_pred eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh--HHHHHHHHhccCCCcHH
Confidence 87532 23346799999999998764 578999999999999999999999864321 111111111100000
Q ss_pred ----------------cccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhccCCCCCCC
Q 003045 762 ----------------AMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESETPTLPVP 817 (854)
Q Consensus 762 ----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~~~~~~~p 817 (854)
........+ ..........+.+++.+||+.||++|||+.|+++ .++++......|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred HHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 000000000 0001112235678999999999999999999998 466654333333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-40 Score=352.31 Aligned_cols=259 Identities=17% Similarity=0.216 Sum_probs=195.7
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEEc
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYEY 612 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey 612 (854)
++|++.++||+|+||+||+|+. .+|+.||||++.... ..+++..|++++++++|+|++ .+..+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999975 468999999986543 234688999999999877655 555666778889999999
Q ss_pred CCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEc---cCCCceecccCcceeccC
Q 003045 613 MPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLD---EDMNPKISDFGMARIFGF 689 (854)
Q Consensus 613 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~ 689 (854)
+.+ +|...+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 954 55454432 2345899999999999999999999998 99999999999985 456799999999998753
Q ss_pred ccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCc-hHHHHHHHHhhcCCcc
Q 003045 690 NQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS-SLIEHVWNLWNEGKAM 763 (854)
Q Consensus 690 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~ 763 (854)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence 3221 123456899999999999999999999999999999999999999975332211 11111111000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 764 ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 764 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
.+.+...++ ..+.+++.+|++.+|++||+++++.+.|+.+
T Consensus 237 ---~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 ---IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011112222 4678899999999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=355.24 Aligned_cols=255 Identities=17% Similarity=0.270 Sum_probs=196.3
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeC--CeeEEEE
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQG--EEKMLIY 610 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 610 (854)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999976 46899999998643 3567899999999995 99999999999754 4689999
Q ss_pred EcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCC-CceecccCcceeccC
Q 003045 611 EYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDM-NPKISDFGMARIFGF 689 (854)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~ 689 (854)
||+++++|..+. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997764 24899999999999999999999998 99999999999998655 599999999987642
Q ss_pred ccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHh---------hc
Q 003045 690 NQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLW---------NE 759 (854)
Q Consensus 690 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~---------~~ 759 (854)
. .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.|+............ +.... ..
T Consensus 183 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~-i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 G---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR-IAKVLGTEDLYDYIDK 258 (328)
T ss_dssp T---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH-HHHHHCHHHHHHHHHH
T ss_pred C---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH-HHHHHCCchhhhhhhh
Confidence 2 223446789999999998765 4799999999999999999999998754322111111 11100 00
Q ss_pred ---CCcc---cccCC--------CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 760 ---GKAM---ELVDP--------NIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 760 ---~~~~---~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
.... ..... .............+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000 0011111122346788999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-40 Score=358.10 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=198.0
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc-ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----eeE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS-GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQGE----EKM 607 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~ 607 (854)
+.+|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999975 579999999997543 334567899999999999999999999987653 345
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcceec
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMARIF 687 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 687 (854)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677789999999842 35899999999999999999999998 999999999999999999999999999876
Q ss_pred cCccC-cccccccccccccccceeec-cCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc--
Q 003045 688 GFNQN-EANTNRVVGTYGYMAPEYAM-EGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM-- 763 (854)
Q Consensus 688 ~~~~~-~~~~~~~~gt~~Y~aPE~~~-~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-- 763 (854)
..... ........||+.|+|||++. ...++.++||||+||++|||++|+.||..... .................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHHHhhhccCCChhhh
Confidence 43322 22334567999999999985 45678999999999999999999999864321 11111111111110000
Q ss_pred ---------c--ccCCCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hhcc
Q 003045 764 ---------E--LVDPNIRDSSSQ-----NQVLRCIHVGMLCVQDSAMYRPTMASVVLM--LESE 810 (854)
Q Consensus 764 ---------~--~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~--L~~~ 810 (854)
. ...+.. ...+. ....++.+++.+||+.||++|||+.|+++- |+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 000000 00000 112367889999999999999999999973 5443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-40 Score=354.34 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=200.3
Q ss_pred cCcccCcccccCCcccEEEeEc----CCCcEEEEEEeccc----cccCHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCe
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL----PEGQDIAVKRLSRK----SGQGLEEFKNEIILIAKLQH-RNLVRLLGCCIQGEE 605 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~ 605 (854)
++|++.++||+|+||+||+|+. .+|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5689999999999999999964 24789999998653 23346678899999999976 899999999999999
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.+++|||+.+|+|..++. ....+.+.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999984 3345778899999999999999999998 9999999999999999999999999998
Q ss_pred eccCccCcccccccccccccccceeeccC--CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCcc
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEG--LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKAM 763 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 763 (854)
.+..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...... .....+........
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-- 252 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCC--
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcccCC--
Confidence 7643222 223446899999999999754 4788999999999999999999998644322 22222222111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 003045 764 ELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPT-----MASVVL 805 (854)
Q Consensus 764 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~eVl~ 805 (854)
+.+ +......+.+++.+||++||++||| ++|+++
T Consensus 253 ----~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 1123357888999999999999994 788886
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-39 Score=345.85 Aligned_cols=260 Identities=15% Similarity=0.170 Sum_probs=204.4
Q ss_pred hcCcccCcccccCCcccEEEeEcC-CCcEEEEEEeccccccCHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCeeEEEEE
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQH-RNLVRLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 611 (854)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999854 68999999886542 33467889999999975 899999999999999999999
Q ss_pred cCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEcc-----CCCceecccCccee
Q 003045 612 YMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDE-----DMNPKISDFGMARI 686 (854)
Q Consensus 612 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~ 686 (854)
|+ +++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68888887432 345899999999999999999999998 999999999999974 57899999999998
Q ss_pred ccCccCc-----ccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCc-hHHHHHHHHhhcC
Q 003045 687 FGFNQNE-----ANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENS-SLIEHVWNLWNEG 760 (854)
Q Consensus 687 ~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~ 760 (854)
+...... .......||+.|||||++.+..++.++|||||||++|||++|+.||........ .....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7432221 123346899999999999999999999999999999999999999974332211 1112221111111
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcc
Q 003045 761 KAMELVDPNIRDSSSQNQVLRCIHVGMLCVQDSAMYRPTMASVVLMLESE 810 (854)
Q Consensus 761 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~~L~~~ 810 (854)
... .+....+ ..+.+++..|++.+|++||+++.+.+.|+++
T Consensus 236 ~~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 1112222 4678888899999999999999988888765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=352.37 Aligned_cols=257 Identities=23% Similarity=0.257 Sum_probs=189.1
Q ss_pred cCcccCcccccCCcccEEEeEcC-CCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEe------CCe
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKLP-EGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQ------GEE 605 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 605 (854)
++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999764 69999999997542 2334568899999999999999999999964 367
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++||||+.++.+..+. ..+++..+..+++||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999877665442 24789999999999999999999998 9999999999999999999999999988
Q ss_pred eccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHH----------
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWN---------- 755 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~---------- 755 (854)
.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..
T Consensus 168 ~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred cccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccCCCHHHH
Confidence 7542 2233456789999999999999999999999999999999999999864321 111111110
Q ss_pred ---------HhhcC-Cc-----ccccCCCCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 003045 756 ---------LWNEG-KA-----MELVDPNIRDS---SSQNQVLRCIHVGMLCVQDSAMYRPTMASVVL 805 (854)
Q Consensus 756 ---------~~~~~-~~-----~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~ 805 (854)
..... .. ........... ........+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00 00010011111 11234567889999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=347.85 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=196.5
Q ss_pred hcCcccCcccccCCcccEEEeEc-CCCcEEEEEEecccc--ccCHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Ce
Q 003045 534 TNYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKS--GQGLEEFKNEIILIAKLQHRNLVRLLGCCIQG-----EE 605 (854)
Q Consensus 534 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 605 (854)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999975 579999999997543 23345788999999999999999999998643 34
Q ss_pred eEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceecccCcce
Q 003045 606 KMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKISDFGMAR 685 (854)
Q Consensus 606 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 685 (854)
.++++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677888899999999842 35999999999999999999999998 9999999999999999999999999997
Q ss_pred eccCccCcccccccccccccccceeeccC-CCCcccchhhHHHHHHHHHhCCCCCCCCcccCchHHHHHHHHhhcCCc--
Q 003045 686 IFGFNQNEANTNRVVGTYGYMAPEYAMEG-LFSVKSDVYSFGVLLLEIVSGRRNTSFRLEENSSLIEHVWNLWNEGKA-- 762 (854)
Q Consensus 686 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~~DVwSlGvil~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 762 (854)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......+.........
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHH
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChHH
Confidence 643 223346789999999987765 46889999999999999999999986432 11222222111111000
Q ss_pred ---------ccccCCCC-CCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcc
Q 003045 763 ---------MELVDPNI-RDSSS-----QNQVLRCIHVGMLCVQDSAMYRPTMASVVL--MLESE 810 (854)
Q Consensus 763 ---------~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~eVl~--~L~~~ 810 (854)
........ ..... ......+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000 00000 012245788999999999999999999998 55554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-34 Score=318.74 Aligned_cols=280 Identities=19% Similarity=0.230 Sum_probs=200.4
Q ss_pred cCcccCcccccCCcccEEEeEc-CCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-----------CCceeeeeeeEEe
Q 003045 535 NYFSEGNKLGRGGFGPVHKGKL-PEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-----------HRNLVRLLGCCIQ 602 (854)
Q Consensus 535 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~ 602 (854)
.+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3588999999999999999976 579999999997543 23467788999998886 4789999988865
Q ss_pred C--CeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhc-CCCCceEEcccCCCcEEEccCCC----
Q 003045 603 G--EEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHR-DSRLRIIHRDLKASNILLDEDMN---- 675 (854)
Q Consensus 603 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~---- 675 (854)
. ...+++++++..+..............+.+..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4566777776665544443333445568899999999999999999997 66 999999999999987654
Q ss_pred --ceecccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHHHHHhCCCCCCCCcccC-----ch
Q 003045 676 --PKISDFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLLEIVSGRRNTSFRLEEN-----SS 748 (854)
Q Consensus 676 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~elltG~~p~~~~~~~~-----~~ 748 (854)
+|++|||.+.... .......||+.|+|||++....++.++||||+||+++||++|+.||....... ..
T Consensus 169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 8999999998653 22234679999999999999999999999999999999999999986432110 11
Q ss_pred HHHHHHHHhhc--------C-C---------cccccCCC----------CCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 003045 749 LIEHVWNLWNE--------G-K---------AMELVDPN----------IRDSSSQNQVLRCIHVGMLCVQDSAMYRPTM 800 (854)
Q Consensus 749 l~~~~~~~~~~--------~-~---------~~~~~d~~----------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~ 800 (854)
+...+. .... . . ....+... ............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 244 IAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 111111 1100 0 0 00000000 0122345667789999999999999999999
Q ss_pred HHHHH--HHhccCC--CCCCCCCCcccc
Q 003045 801 ASVVL--MLESETP--TLPVPRQPTFTS 824 (854)
Q Consensus 801 ~eVl~--~L~~~~~--~~~~p~~~~~~~ 824 (854)
+|+++ .+++... ....|..+...+
T Consensus 323 ~e~L~Hp~f~~~~~~~~~~~p~~~~~~~ 350 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGMEEIRVPDRELYGS 350 (362)
T ss_dssp HHHHTCGGGTTCTTCTTCCCTTSCTTCB
T ss_pred HHHhcCcccCCCCCcccCCCCCcccCCC
Confidence 99998 3554322 233444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.2e-22 Score=201.83 Aligned_cols=170 Identities=18% Similarity=0.149 Sum_probs=121.0
Q ss_pred ccCcccccCCcccEEEeEcCCCcEEEEEEeccccc------------------cCHHHHHHHHHHHHhcCCCceeeeeee
Q 003045 538 SEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSG------------------QGLEEFKNEIILIAKLQHRNLVRLLGC 599 (854)
Q Consensus 538 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv~l~~~ 599 (854)
.++++||+|+||+||+|+..+|+.||||+++.... .....+..|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999988999999998753210 011234568899999999999988765
Q ss_pred EEeCCeeEEEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCCCCceEEcccCCCcEEEccCCCceec
Q 003045 600 CIQGEEKMLIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEDMNPKIS 679 (854)
Q Consensus 600 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 679 (854)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 3479999999875533 233345678999999999999998 99999999999999654 8999
Q ss_pred ccCcceeccCccCcccccccccccccccceeeccCCCCcccchhhHHHHHH
Q 003045 680 DFGMARIFGFNQNEANTNRVVGTYGYMAPEYAMEGLFSVKSDVYSFGVLLL 730 (854)
Q Consensus 680 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~~DVwSlGvil~ 730 (854)
|||+|.....+.......+.+. . -.| +..+.|+.++|+||..--+.
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR---N-IIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHHh
Confidence 9999986532211100000000 0 001 12456888999999865443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.83 E-value=1.1e-20 Score=169.32 Aligned_cols=112 Identities=23% Similarity=0.449 Sum_probs=95.1
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.|||.|.+|++|+ +|.|.|+|+.+++ +.++. ..++||.||++.|. ..+.|.|+.||+|+|+++
T Consensus 1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEE--ECCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCC--CCcEEEEeccccEEEEec
Confidence 48999999999999997 4999999987776 44543 46899999999884 457899999999999996
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCC
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTD 162 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTD 162 (854)
+.++|++++........++|+|||||||++.+ +.++|||+.+|+|
T Consensus 68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred -CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 56788888766566778999999999999876 6889999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.83 E-value=7.2e-21 Score=169.02 Aligned_cols=107 Identities=23% Similarity=0.413 Sum_probs=93.3
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
+|+|.+||.|.+|++|. +|.|.|.|+.+++ +.||. ..++||.||++.| +..+.|.|+.||+|+|+++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCC--CCccEEEEeccceEEEECC
Confidence 47999999999999994 6999999998876 55654 3588999999988 5567899999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccC
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNH 159 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 159 (854)
+|.+||+|++.......+|+|+|||||||++.. +||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~~--------~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------RWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEECC--------CCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCCC--------cccCCCC
Confidence 999999999876666778999999999999643 8999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.82 E-value=4e-20 Score=164.18 Aligned_cols=108 Identities=22% Similarity=0.393 Sum_probs=91.4
Q ss_pred cccccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcC
Q 003045 32 VNTITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNG 111 (854)
Q Consensus 32 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 111 (854)
.|+|.+||.|.+|++|. +|.|.|+|..+++ +.++. ..++||+||++.|. ...+.|.|+.||+|||+|+
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECS
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeC
Confidence 47899999999999996 5889999987665 33432 45899999999997 4567899999999999999
Q ss_pred CCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccC
Q 003045 112 NSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNH 159 (854)
Q Consensus 112 ~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 159 (854)
+|.+||+|++......+.|+|+|||||||++. .+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 99999999987655667899999999999964 39999754
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=7.5e-17 Score=145.15 Aligned_cols=101 Identities=20% Similarity=0.330 Sum_probs=86.6
Q ss_pred EEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCc
Q 003045 70 GIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNL 149 (854)
Q Consensus 70 ~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~ 149 (854)
.|||..++.++.+|++|++.|+....-+|.|+.||||+|++. +.++|++++.+.+....+.|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----
Confidence 689999999999999999999987777999999999999986 67899999887666778999999999999987
Q ss_pred cceeeeeccCCCCCcCCCCeEeEEecCCCceeEEeccCCCCCCCCceEeeecCCCCCe
Q 003045 150 GKAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQ 207 (854)
Q Consensus 150 ~~~~WqsFd~PTDtllpg~kl~~~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~ 207 (854)
+++|||||. +.++|.|.|.|+++|...
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlv 111 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLA 111 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEE
Confidence 689999963 335788999999999643
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=1.8e-15 Score=135.59 Aligned_cols=101 Identities=20% Similarity=0.409 Sum_probs=80.9
Q ss_pred CccCCCCeE--EeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCcEE
Q 003045 39 QSIKDGESL--ISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAV 116 (854)
Q Consensus 39 ~~l~~~~~l--~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~v 116 (854)
|.|.++|+| .+..|.|.|.|..+|+ |.+ |. ..+++|.+|+..+ +..+.|.|+.||+|+|+|++|.+|
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~v 83 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTV 83 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEE
Confidence 444445544 5679999999988777 333 33 3689999999877 345799999999999999999999
Q ss_pred EEeccccccccceeEeccCCceEEEcCCCcCCccceeeeecc
Q 003045 117 WSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFN 158 (854)
Q Consensus 117 W~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd 158 (854)
|++++.+......++|+|||||||+++ .+|||-.
T Consensus 84 WsS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 84 WQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp EECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred EECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 999987766677899999999999953 4999853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.55 E-value=1.5e-15 Score=135.02 Aligned_cols=110 Identities=23% Similarity=0.425 Sum_probs=91.8
Q ss_pred EEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCcc
Q 003045 71 IWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLG 150 (854)
Q Consensus 71 iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~ 150 (854)
|||.-.+..+..|+.+.+.++.....+|.|+.||||||++ ++.++|++++.+ .....+.|+++|||||++.+ +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEccC-----C
Confidence 6777777788889999999998777899999999999998 468999999875 34677899999999999887 6
Q ss_pred ceeeeeccCCCCCcCCCCeEeEEecCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCC
Q 003045 151 KAYWQSFNHPTDTHLPGMRVGVNSALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQ 222 (854)
Q Consensus 151 ~~~WqsFd~PTDtllpg~kl~~~~~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~ 222 (854)
++||||+- +.++|.|.|.|+++|. +++| +..+|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGN--lvlY--~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRT--VTIY--GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSC--EEEE--CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCc--EEEe--CCCeecCCC
Confidence 88999852 3467999999999997 4555 347899884
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.42 E-value=1.2e-13 Score=122.48 Aligned_cols=101 Identities=21% Similarity=0.326 Sum_probs=81.5
Q ss_pred ccCCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCc
Q 003045 35 ITKGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSI 114 (854)
Q Consensus 35 l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~ 114 (854)
.+..|+|.+++.| .+|.|.|.|..+|+ |.++. ...+||.+|...+ ..+.+.|+.||||||+|.++.
T Consensus 11 ~~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~ 76 (115)
T d1dlpa1 11 GSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNT 76 (115)
T ss_dssp SCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTC
T ss_pred CCCcceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCC
Confidence 3445777777877 67889999987776 45543 3578999987543 457899999999999999999
Q ss_pred EEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeec
Q 003045 115 AVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSF 157 (854)
Q Consensus 115 ~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsF 157 (854)
+||++++....+.+.++|++|||||||+. .+|+|-
T Consensus 77 ~vWsS~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssg 111 (115)
T d1dlpa1 77 IRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSG 111 (115)
T ss_dssp CSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECS
T ss_pred EEEEcCCCCCCCCEEEEECCCCcEEEeCC--------CeecCC
Confidence 99999987767778899999999999953 499983
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.22 E-value=9.8e-12 Score=111.19 Aligned_cols=99 Identities=23% Similarity=0.384 Sum_probs=73.4
Q ss_pred CCCccCCCCeEEeCCCeEEEEEecCCCCCceEEEEEEeeCCCCceEEeecCCCCCCCCCceEEEeccCCeEEEcCCCcEE
Q 003045 37 KGQSIKDGESLISNGEIFELGFFSPENSSLRYVGIWYHQIDEKAVVWVANRNRPISDERGTLTIGNDGNLMVLNGNSIAV 116 (854)
Q Consensus 37 ~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~v 116 (854)
+.+.|.+++.| ..|.|.|.|..+++ |.|+. ...++|.++... .+..+.+.|+.+|||||+|.++.+|
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~l 88 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAV 88 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec----CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEE
Confidence 33445555555 35667777765554 33432 346789887543 3556789999999999999999999
Q ss_pred EEeccccccccceeEeccCCceEEEcCCCcCCccceeeee
Q 003045 117 WSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQS 156 (854)
Q Consensus 117 W~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 156 (854)
|+|++......+.++|++|||||||+. .+|.|
T Consensus 89 W~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 89 WTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp EECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred EEeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 999987766678899999999999954 38976
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.10 E-value=1.4e-10 Score=101.72 Aligned_cols=85 Identities=25% Similarity=0.526 Sum_probs=66.4
Q ss_pred ceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEec
Q 003045 96 GTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSA 175 (854)
Q Consensus 96 ~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~~ 175 (854)
-+|.|+.||||||++ .+.+||++++.+.+....+.|+++|||||++.+ +++||+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc-------------------
Confidence 389999999999998 458999999887666678999999999999987 6889986
Q ss_pred CCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecC
Q 003045 176 LGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSG 221 (854)
Q Consensus 176 ~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg 221 (854)
......+.|.+.|+.+|. ++++.. ..|.|+
T Consensus 76 ------------~t~~~~~~~~l~L~ddGN--lVly~~--~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRN--VVIYGT--DRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSC--EEEEEC--CCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCC--EEEeCC--CcccCC
Confidence 111245778999999996 444533 367665
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.09 E-value=7.6e-10 Score=98.36 Aligned_cols=85 Identities=24% Similarity=0.521 Sum_probs=67.6
Q ss_pred eEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEecC
Q 003045 97 TLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSAL 176 (854)
Q Consensus 97 ~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~~~ 176 (854)
+|.|+.||||||+++ +.++|++++.+......+.|+++|||||++.+ +.+||+|. |
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~-----t------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP-----V------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----C-------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECC-----C-------------
Confidence 788999999999976 56899999877666778999999999999987 68899861 1
Q ss_pred CCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCC
Q 003045 177 GENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQ 222 (854)
Q Consensus 177 g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~ 222 (854)
.-+.|.|.+.|+++|.. +++. ...|.|+.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNl--vlYg--~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNV--VIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCE--EEEC--CCEeccCC
Confidence 11457899999999964 4453 46888874
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.95 E-value=2.6e-09 Score=93.49 Aligned_cols=87 Identities=28% Similarity=0.654 Sum_probs=66.3
Q ss_pred ceEEEeccCCeEEEcCCCcEEEEecccccc-ccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEe
Q 003045 96 GTLTIGNDGNLMVLNGNSIAVWSSNASVVS-NNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNS 174 (854)
Q Consensus 96 ~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~ 174 (854)
-.|.|+.||||||+. .+.+||++++.... ....+.|+++|||||++.+ ++++|+| +|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s-----~t----------- 78 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS-----HS----------- 78 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC-----CC-----------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEE-----ee-----------
Confidence 478999999999987 56899999986543 3566889999999999987 6889987 11
Q ss_pred cCCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEecceeEEecCCC
Q 003045 175 ALGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQLKRRWRSGQW 223 (854)
Q Consensus 175 ~~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~yw~sg~w 223 (854)
....|.|.+.|+++|.. ++++ ...|.|+.+
T Consensus 79 ---------------~~~~~~~~l~L~ddGNl--vly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 79 ---------------VRGNGNYVLVLQEDGNV--VIYG--SDIWSTGTY 108 (109)
T ss_dssp ---------------CCCSSCCEEEECTTSCE--EEEC--CEEEECCCC
T ss_pred ---------------ECCCCCEEEEEeCCCcE--EEEC--CCEecCCCc
Confidence 11357789999999964 4554 357887753
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.73 E-value=2.6e-08 Score=87.69 Aligned_cols=87 Identities=25% Similarity=0.518 Sum_probs=66.3
Q ss_pred ceEEEeccCCeEEEcCCCcEEEEeccccccccceeEeccCCceEEEcCCCcCCccceeeeeccCCCCCcCCCCeEeEEec
Q 003045 96 GTLTIGNDGNLMVLNGNSIAVWSSNASVVSNNTAALLEDDGNLILTNSEDIGNLGKAYWQSFNHPTDTHLPGMRVGVNSA 175 (854)
Q Consensus 96 ~~l~~~~~g~l~l~~~~~~~vW~t~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~PTDtllpg~kl~~~~~ 175 (854)
-.|.|+.||||||++ .+.+||++++........+.|+.+|||||++.. +.+|.|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC-------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE-------------------
Confidence 489999999999997 568999999876666678999999999999854 456654
Q ss_pred CCCceeEEeccCCCCCCCCceEeeecCCCCCeEEEEec-ceeEEecCC
Q 003045 176 LGENRVFTSWKSASDPSPGNFTMGVDPQGSPQIVIWEQ-LKRRWRSGQ 222 (854)
Q Consensus 176 ~g~~~~L~sw~s~~dps~G~~~l~~~~~g~~~~~~~~~-~~~yw~sg~ 222 (854)
...-..|.|.+.|+.+|. +++++. ....|.|+.
T Consensus 75 ------------~t~~~~~~~~l~L~ddGN--lvly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRN--VVIYDNSNNAIWATHT 108 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSC--EEEECTTSCEEEECCC
T ss_pred ------------eeccCCCceEEEEcCCCC--EEEECCCCcEEecCCC
Confidence 112234778999999996 455554 457898874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=3.3e-07 Score=93.29 Aligned_cols=149 Identities=15% Similarity=0.048 Sum_probs=102.2
Q ss_pred HHHHHhcCcccCcccccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCeeE
Q 003045 529 TIAVATNYFSEGNKLGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQ-HRNLVRLLGCCIQGEEKM 607 (854)
Q Consensus 529 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 607 (854)
++...-..|+..+..+-++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444445666555544444568999875 56678889887665555567788999988875 433567778888888999
Q ss_pred EEEEcCCCCChhhhhcCcccccCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------
Q 003045 608 LIYEYMPNKSLDLFIFDPAKQALLDWTKRFAIIEGIARGLLYLHRDS--------------------------------- 654 (854)
Q Consensus 608 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 654 (854)
+||+++++..+....... .....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998875543211 112234445555555555321
Q ss_pred -----------------------CCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 655 -----------------------RLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 655 -----------------------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999877678999998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=1.5e-05 Score=80.02 Aligned_cols=131 Identities=17% Similarity=0.146 Sum_probs=87.0
Q ss_pred ccccCCc-ccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCC--ceeeeeeeEEeCCeeEEEEEcCCCCCh
Q 003045 542 KLGRGGF-GPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHR--NLVRLLGCCIQGEEKMLIYEYMPNKSL 618 (854)
Q Consensus 542 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lV~Ey~~~gsL 618 (854)
.+..|.. +.||+....++..+++|..... ....+..|...++.+... .+.+++.+..+++..++|||++++..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455543 6789999888888999976543 234577888888887533 355677887888889999999998766
Q ss_pred hhhhcCcccccCCCHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 003045 619 DLFIFDPAKQALLDWTKRFAIIEGIARGLLYLH----------------------------------------------- 651 (854)
Q Consensus 619 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH----------------------------------------------- 651 (854)
..... .. ..++.++++.|.-||
T Consensus 94 ~~~~~--------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL--------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC--------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc--------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 43210 00 011122222222222
Q ss_pred ----cC----CCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 652 ----RD----SRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 652 ----~~----~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
.. ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 123489999999999999877778999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00028 Score=75.51 Aligned_cols=75 Identities=13% Similarity=0.139 Sum_probs=49.3
Q ss_pred cccccCCcccEEEeEcCC-CcEEEEEEeccc-------cccCHHHHHHHHHHHHhcC-C-C-ceeeeeeeEEeCCeeEEE
Q 003045 541 NKLGRGGFGPVHKGKLPE-GQDIAVKRLSRK-------SGQGLEEFKNEIILIAKLQ-H-R-NLVRLLGCCIQGEEKMLI 609 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-h-~-niv~l~~~~~~~~~~~lV 609 (854)
+.||.|....||+....+ ++.++||.-... -....+....|.+.|+.+. + | .+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 478999999999998754 678999975321 1123445667888888773 2 2 34445443 45677899
Q ss_pred EEcCCCCC
Q 003045 610 YEYMPNKS 617 (854)
Q Consensus 610 ~Ey~~~gs 617 (854)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.00095 Score=69.30 Aligned_cols=135 Identities=12% Similarity=0.106 Sum_probs=79.9
Q ss_pred ccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce--eeee-----eeEEeCCeeEEEEEcCCCCChhhh
Q 003045 549 GPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL--VRLL-----GCCIQGEEKMLIYEYMPNKSLDLF 621 (854)
Q Consensus 549 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~~ 621 (854)
-.||+.+.++|+.+++|+.+.. ....+++..|+..+..|....+ +..+ ..+...+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987543 2356778899999988853322 1111 123445677899999987543211
Q ss_pred -----------h---c----C--cccccCCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCCce
Q 003045 622 -----------I---F----D--PAKQALLDWT----------------------KRFAIIEGIARGLLYL-HRDSRLRI 658 (854)
Q Consensus 622 -----------l---~----~--~~~~~~l~~~----------------------~~~~i~~~ia~gL~yL-H~~~~~~i 658 (854)
+ + . ...+..+++. .....+..+...+.-+ ....+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0 0 0011112211 1112222333332222 22223458
Q ss_pred EEcccCCCcEEEccCCCceecccCccee
Q 003045 659 IHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 659 vH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.46 E-value=0.0035 Score=66.71 Aligned_cols=72 Identities=18% Similarity=0.289 Sum_probs=48.6
Q ss_pred cccccCCcccEEEeEcCC--------CcEEEEEEeccccccCHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCeeEEEEE
Q 003045 541 NKLGRGGFGPVHKGKLPE--------GQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNLV-RLLGCCIQGEEKMLIYE 611 (854)
Q Consensus 541 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~E 611 (854)
+.|+.|--=.+|+...++ .+.|++++... . .......+|..+++.+.-.++. ++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 567777778899987543 34577776642 2 2334567899999988644554 6666653 268999
Q ss_pred cCCCCCh
Q 003045 612 YMPNKSL 618 (854)
Q Consensus 612 y~~~gsL 618 (854)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.82 E-value=0.016 Score=59.03 Aligned_cols=158 Identities=11% Similarity=0.017 Sum_probs=85.6
Q ss_pred eHHHHHHHhcCcccCcc-----cccCCcccEEEeEcCCCcEEEEEEeccccccCHHHHHHHHHHHHhcCCCce-----ee
Q 003045 526 NFNTIAVATNYFSEGNK-----LGRGGFGPVHKGKLPEGQDIAVKRLSRKSGQGLEEFKNEIILIAKLQHRNL-----VR 595 (854)
Q Consensus 526 ~~~~~~~~~~~f~~~~~-----LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~ 595 (854)
+.++++..-..|.+++. |..|---+.|+.+..+| .+++|+.... ...+++..|++++..|...++ +.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence 45667777777876544 34555577899987655 5899998643 233456677888888753322 11
Q ss_pred ee---eeEEeCCeeEEEEEcCCCCChhhhh--------------c------CcccccCCC------------------HH
Q 003045 596 LL---GCCIQGEEKMLIYEYMPNKSLDLFI--------------F------DPAKQALLD------------------WT 634 (854)
Q Consensus 596 l~---~~~~~~~~~~lV~Ey~~~gsL~~~l--------------~------~~~~~~~l~------------------~~ 634 (854)
.. .+.........++.+..+....... + ......... ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 0122345566777777664432110 0 000000000 00
Q ss_pred HHHHHHHHHHHHHHHhhcC-CCCceEEcccCCCcEEEccCCCceecccCccee
Q 003045 635 KRFAIIEGIARGLLYLHRD-SRLRIIHRDLKASNILLDEDMNPKISDFGMARI 686 (854)
Q Consensus 635 ~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 686 (854)
.....+..+...+...+.. -+..+||+|+.++||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1112222223333333322 234599999999999999887778999998874
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.68 E-value=0.014 Score=37.12 Aligned_cols=33 Identities=45% Similarity=1.034 Sum_probs=26.6
Q ss_pred CCCCcccCCCCCCccccCC-CCcccCCCCCCccCc
Q 003045 298 ADDCELYNFCGNFGICNAL-GSTKCTCMEGFVPKH 331 (854)
Q Consensus 298 ~~~Cd~~~~CG~~giC~~~-~~~~C~C~~Gf~p~~ 331 (854)
.|.|.+-..|| +|.|+.- +.-.|.|-+||+|..
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 37899999998 5889743 566799999999865
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.83 E-value=0.2 Score=33.95 Aligned_cols=31 Identities=39% Similarity=0.958 Sum_probs=24.5
Q ss_pred CCCCcc-cCCCCCCccccCC-CCcccCCCCCCc
Q 003045 298 ADDCEL-YNFCGNFGICNAL-GSTKCTCMEGFV 328 (854)
Q Consensus 298 ~~~Cd~-~~~CG~~giC~~~-~~~~C~C~~Gf~ 328 (854)
.|+|.. ...|...|.|... +.-.|.|++||+
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 467875 5689999999643 466899999996
|